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Foreword
In the context of an aging population, use of services by the elderly throughout
the health care system continues to grow, particularly among those aged 85 years
and older. According to 2004 national survey data, 38% of hospital discharges
are people aged 65 years and older (Russo & Elixhauser, 2003). Simultaneously,
dramatic advances in prevention, treatment, and control of numerous chronic
diseases and related illnesses have led to greatly increased complexity of care
for older adults in today’s modern health care systems. Consequently, substan-
tial challenges for nursing care have emerged as treatment side effects from
medications, surgical procedures, and the hazards of hospitalization conspire
to threaten quality of life among older adults during the acute phase of care. A
growingbase of evidence confirms thepivotal role that bedsidenurses play in in-
fluencing health trajectories among older adults, particularly in the acute-care
setting (Fitzpatrick, Salinas, O’Connor, Callahan & White, 2004; Mezey, Boltz,
Esterson, & Mitty, 2005).
Concurrent with the growth in number of frail older adults in health care
settings, the scientific basis for care of the elderly has strengthened considerably.
New strategies for the synthesis and dissemination of this knowledge base for
care havemade scientific findingsmore broadly available to clinicians, adminis-
trators, patients, and family members and their advocates, raising expectations
for care.
To effectively care for today’s older adults, therefore, nurses must integrate
knowledge of care for acutely ill patients with the emerging science base of
how patterns of chronic, co-morbid conditions affect presentation of illness and
how to anticipate and treat geriatric syndromes. Nurses are charged with doing
this while eliciting and honoring patient preferences for various care options
and being mindful of how family and informal caregivers are involved in care.
Meeting this care standard would be a tall order under any circumstances, but it
becomes particularly challenging during a time of nursing shortage. Increased
utilization of paraprofessional nursing staff, for example, underscores the need
for standardized approaches to care that nurses can use with caregivers from
diverse educational and cultural backgrounds.
Evidence-Based Geriatric Nursing Protocols for Best Practice, now in its third
edition, is a timely addition to the resources nurses and health care organiza-
tions need to address the specialized-care needs of older adults throughout the
continuum of care. Editors Elizabeth Capezuti, DeAnne Zwicker, Mathy Mezey,
and Terry Fulmer have engaged some of the top clinician–scientists in the coun-
try to frame, acquire, appraise, and synthesize the best evidence for care of the
most prevalent clinical problems and syndromes faced by older adults when
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they are ill. Expanding on prior success with earlier editions of this book and
with the innovative geriatric nursing care portal, www.ConsultGeriRN.org, this
edition offers updated and refined sections on previously featured topics such as
advance directives. A key refinement to the protocols is making an explicit link
between the guideline recommendations and the supporting evidence. Several
new protocols critically needed for effective nursing care of the elderly, such
as protocols for dehydration prevention, recognition, and treatment, have been
added. Each section includes a model case study to demonstrate application of
the evidence and protocol.
The update and expansion of these protocols have important implications
for nurses at every level of practice. Bedside-care nurses now can have ready
access to preappraised scientific evidence, accompanied by practical implemen-
tation strategies on which to base practice as they confront growing numbers
of frail older adults in their care. Members of nursing practice councils, nurse
managers, and nurse executives now have an explicit, graded scientific basis
for standardizing care practices at the unit level, which should, in turn, assist in
forecasting needed staffing and services and development or refinement of sys-
tems of care that are “older adult-friendly.”Nursing facultywill find theprotocols
and evidence summary a useful guide for prioritizing curriculum improvements,
and the protocols also serve as a source for identifying gaps in our knowledge
base that require new empirical studies. The greatest beneficiaries of these new
practice protocols, however, will be the older adults and their family members
who stand to benefit from the greater consistency in care and improved out-
comes from care based on the best evidence that is tempered with the expertise
of advanced clinician–scholars.
Eleanor S. McConnell, RN, PhD, APRN, BC
Associate Professor & Director, Gerontological Nursing Specialty;
Clinical Nurse Specialist, DurhamVeterans AdministrationMedical Center,
Geriatric Research, Education, and Clinical Center
Durham, North Carolina
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Preface
As an experienced nursing leader in the hospital arena and with a specialty fo-
cus on older persons in our society, I can attest that this third edition holds the
promise of bringing yet another level of depth and sophistication to understand-
ing the best practices for assessment, interventions, and anticipated outcomes
in our care of older adults.
Health care in our nation, in particular, is becoming increasingly complex.
This complexity is also occurring at a time when the number of those older than
65 years of age will soon be the vast majority of our population. Providers of
care, both professional and our highly invested public, search daily for the best
way to address and manage the multiple levels of care challenges that our older
population faces. Third-party payers make decisions about the appropriateness
of care seemingly without regard to the efficacy of the treatment modality or
interventions but rather based on the short-term cost-effectiveness. Hospital
stays are shorter—and rightfully so in light of the higher risk for infection and
other complications in our nation’s facilities. The push toward subacute care,
intermediate-care units, long-term care, and assisted-living settings makes de-
cisionmaking about careproblemsevenmoredifficult and imperative. Providers
of care increasingly try to sort out the alternatives available for these issues, of-
tenwithout the time required to recall or find the best evidence-based approach.
Recognition that quality care is generally also the most cost-effective requires
use of the evidence that produces the best outcomes.
The nation’s “baby-boomers” are driving ever higher levels of expectation
for the best possible care for their parents, loved ones, and themselves. The
Internet is the vehicle for providing access to more information than most of
us have the time and capacity to absorb. That this text draws upon the valuable
resources of GeroNurseOnline.org is testament to the usefulness of this mode
of information. Therefore, it is critical that those of us who are perceived as
experts help our fellow professionals and the educated public to findwhat really
is evidenced based.
The dynamic of evidenced-based practice is an ever-changing area of
knowledge synthesis and contextual analysis. It is to the editors’ credit that
Stetler et al. and the Melnyk & Fineout-Overholt models of evidence ranking
were not only selected as the framework for this edition but also that the chap-
ter authors are required to reference the formal Level of Evidence (see chapter
1 on the AGREE rationale) within the text to provide that distinction and rein-
forcement of the models. Such referencing establishes the current state of the
evidence, lends reliability to the recommendations, sets forth potential areas
of inquiry for research, and demonstrates contemporary sound practice. Using
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evidence-based practice compels the provider to set aside biases, dispel and
destroy sacred cows, and exercise critical thinking at every step.
Evidence-Based Geriatric Nursing Protocols for Best Practice is intended to
bring the most current evidence-based protocols known to experts in geriatric
nursing to the audience of students, both graduate and undergraduate; practi-
tioners at the staff level, from novice to expert; clinicians in specialty roles (i.e.,
educators, care managers, and advanced practice nurses); and nursing leaders
of all levels. The content recognizes that nursing is a cognitive discipline and
gives professionals the tools to use. As with any text, the value is in the use
and implementation of the protocols to improve the care of older persons. That
challenge is clear to those of us in practice, service, and education. We owe a
debt of gratitude to the many authors and the editors for bringing this work
to us.
Susan Bowar-Ferres, PhD, RN, CNAA-BC
Senior Vice President & Chief Nursing Officer
New York University Hospitals Center
New York City, New York
Introduction
Older adults are overwhelmingly the majority of hospitalized patients and are
by far the most complicated patients to care for in the acute-care setting. They
suffer from multiple complex medical problems, take multiple medications, are
the most vulnerable to iatrogenic events, experience prolonged hospital stays,
and are more likely to die in the hospital (versus the community or other set-
ting). Acute-care nurses have an enormous responsibility when providing care
to older adults in this rapidly changing health care environment with increasing
regulatory requirements and short staffing. Even though older persons are our
fastest growing segment in theUnited States, most nursing programs, likemedi-
cal programs, are just now incorporating geriatrics into the curriculum. Many of
those unfamiliar with geriatricsmight ask:What’s so different about old people?
Don’t they have the same diagnoses as younger adults, like diabetes, hyperten-
sion, and heart disease? The answer to those questions is yes, they do have the
same diseases; however, physiological changes that occur with aging, multiple
coexistingmedical problems, andmultiplemedications place older adults at sig-
nificantly higher risk for complications, including death, while hospitalized. The
nurse armed with information on the unique ways in which older adults present
with subtle signs and symptoms may actually avert complications. Additionally,
the nurse equipped with knowledge about and skill in proactive assessment and
interventions may actually prevent these complications in the first place.
As in the previous second edition (titled Geriatric Nursing Protocols for Best
Practice and honored as American Journal of Nursing Geriatric Book of the Year
in 2003), we present assessment and interventions for common geriatric syn-
dromes. Geriatric syndromes are increasingly recognized as being related to
preventable iatrogenic complications, or those that occur as a direct result of
medical and nursing care, causing serious adverse outcomes in older patients
(see chapter 11, Iatrogenesis). We are also very happy to present 13 new topics
and several new expert contributors in this edition. Many of these topics have
been updated from the protocols that appear on theWeb site of TheHartford In-
stitute for Geriatric Nursing at NYU (www.ConsultGeriRN.org). The new topics
in this edition are as follows:
■ Dementia
■ Nutrition in Aging
■ Managing Oral Hydration in Older Adults
■ Oral Health Care
■ Age-Related Changes in Health
■ Sensory Changes
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■ Iatrogenesis: The Nurse’s Role in Preventing Patient Harm
■ Family Caregiving for Older Adults
■ Comprehensive Assessment and Management of the Critically Ill Older
Adult
■ Fluid Overload: Identifying and Managing Heart Failure Patients at Risk
for Hospital Readmission
■ Cancer and the Older Patient: Assessment and Intervention Strategies for
the Acute-Care Nurse
■ Issues Regarding Sexuality in Older Adults
■ Substance Abuse
In this third edition of Evidence-Based Geriatric Nursing Protocols for Best
Practice, we provide guidelines that are developed by experts on the topics of
each chapter and are based on best available evidence. A systematic method,
the AGREE Appraisal Process (see AGREE Collaboration, 2001; Levin, in press;
Singleton & Levin, in press), was used to evaluate the protocols in the second
edition and identify a process to help us improve validity of the book’s content.
This systematic process, described in chapter 1, was developed to retrieve and
evaluate the level of evidence of key references related to specific assessment
and management strategies in each chapter. The purpose of determining the
best available evidence was to answer the clinical questions posed. The chapter
authors rated the levels of evidence based on the work of Stetler et al. (1998)
and Melnyk and Fineout-Overholt (2005). Chapter 1, Developing and Evaluating
Clinical Practice Guidelines: A Systematic Approach, details the process of how
the clinical practice guidelines were developed and how they complied with
the AGREE items for rigor of development (AGREE Collaboration, 2001). This
chapter, written by leaders in the field of evidence-based practice in the United
States, will likely be the most important chapter reference for understanding
the rating of the levels of evidence. Most of the protocols reflect assessment
and intervention strategies for acute care recommended by expert authors who
have reviewed the evidence using this process; the evidence providedmay come
from all levels of care and may not have been specifically tested in the hospital
setting.
How to Best Use This Book
The standard nursing approach was used as a guideline for the outline of each
topic as deemed appropriate by the chapter author(s) providing overview and
background information on the topic, evidence-based assessment and interven-
tion strategies, and a topic-specific case study with discussion. The text of the
chapter provides the context and detailed evidence for the protocol; the tabular
protocol is not intended to be used in isolation from the text. We recommend
that readers consider the following when reading the chapters:
■ Review the objectives to ascertain what is to be achieved by reviewing the
chapter.
■ Review the text noting level of evidence that supports the content, with
Level I being the highest (i.e., Systematic Review/Meta-analysis) and
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Level VI the lowest (i.e., Expert opinion) and refer to chapter 1, Figure
1.2, for definitions of Level of Evidence to understand the quantitative
evidence that supports each recommendation. Keep in mind that it is
virtually impossible to have evidence for all assessments and interven-
tions, which does not mean it is not to be used as an intervention. Many
interventions that have been successfully used for years have not been
quantitatively researched but are well known to be effective to experts in
the field of geriatrics.
■ Review the protocols and keep in mind that they reflect assessment and
intervention strategies for acute care recommended by experts who have
reviewed the evidence. This evidence is from all levels of care (e.g., com-
munity, primary care, long-termcare), not necessarily thehospital setting,
and should be applied to the unique needs of individual patients.
■ The focus should always be patient-centered, which considers many
other factors specific to the individual.
■ Review the case study and discussion in each topic, which provides a
more real-life, practical manner in which the protocol may be applied in
clinical practice.
■ Resources in each chapter provide easy access to tools discussed in the
chapter and to link readers with organizations that provide ongoing, up-
to-date information and resources on the topic.
■ An appendix provides additional geriatric-specific resources for readers
that can be applied to all topics.
Although this book refers to Evidence-Based Geriatric Nursing Protocols for
Best Practice, the textmay be used by educators for geriatric nursing courses and
advance practice nurses and by many others, including interdisciplinary team
members, nursing-home and other staff educators, social workers, dieticians,
physician assistants, and physicians. Many interventions that are proactively
identified by nurses can make a significant difference in improving outcomes,
but nurses cannot provide for the complex needs of older adults in isolation.
Research has shown that interdisciplinary teams have dramatically improved
geriatric patient care and outcomes, as indicated in the Institute of Medicine
(IOM) report: communication and collaboration are vital to ensure appropriate
exchange of information and care coordination whereas lack of communication
is considered a major contributor to iatrogenic complications (IOM, 2001). Car-
ing for older adults as the baby-boomer population continues to “age in” will
be an ultimate challenge in health care. Each of us must work together and be
committed to provide a culture of safety that vulnerable older adults need in
order to receive the safest evidence-based clinical care with optimal outcomes.
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Developing
and Evaluating
Clinical Practice
Guidelines: A
Systematic
Approach
Rona F. Levin
Joanne K. Singleton
Susan Kaplan Jacobs
Clinical decision making that is grounded in the best available evidence is es-
sential to promote patient safety and quality health care outcomes. With the
knowledge base for geriatric nursing rapidly expanding, assessing geriatric clin-
ical practice guidelines for their validity and incorporation of the best available
evidence is critical to the safety and outcomes of care. In the second edition of
this book, Lucas and Fulmer (2003) challenged geriatric nurses to take the lead
in the assessment of geriatric clinical practice guidelines (CPGs), recognizing
that in the absence of best evidence, guidelines and protocols have little value
for clinical decision making.
The purpose of this chapter is to describe the process that was used to create
the third edition of Evidence-Based Geriatric Nursing Protocols for Best Practice.
In previous editions of this book, each chapter author individually gathered
and synthesized evidence on a particular topic and then developed a “Nursing
1
2 Chapter 1
Standard of Practice Protocol” based on that evidence. There was no standard
process or specific criteria for protocol development nor was there any indica-
tion of the “level of evidence” of each source cited in the chapter (i.e., the evi-
dence base for the protocol). In this third edition, the process previously used
to develop the geriatric nursing protocols has been enhanced. This chapter is a
guide to understanding how the geriatric nursing protocols in this third edition
were developed and describes how to use the process to guide the assessment
and/or development and updating of practice protocols in any area of nursing
practice.
Definition of Terms
Evidence-based practice (EBP) is a framework for clinical practice that inte-
grates the best available scientific evidence with the expertise of the clinician
and with patients’ preferences and values to make decisions about health care
(Levin & Feldman, 2006; Sackett, Straus, Richardson, Rosenberg, & Haynes,
2000). Health care professionals often use the terms recommendations, guide-
lines, and protocols interchangeably but they are not synonymous.
A recommendation is a suggestion for practice, not necessarily sanctioned
by a formal, expert group. A clinical practice guideline is an “official recommen-
dation” or suggested approach to diagnose andmanage a broad health condition
(e.g., heart failure, smoking cessation, or painmanagement). Aprotocol is amore
detailed guide for approaching a clinical problem or health condition and is tai-
lored to a specific practice situation. For example, guidelines for falls prevention
recommend developing a protocol for toileting elderly, sedated, or confused pa-
tients. The specific practices or protocol each agency implements, however, is
agency-specific. The validity of any of these practice guides can vary depending
on the type and the level of evidence on which they are based. Using stan-
dard criteria to develop or refine CPGs or protocols assures reliability of their
content. Standardization gives both nurses, who use the guideline/protocol,
and patients, who receive care based on the guideline/protocol, assurance that
the geriatric content and practice recommendations are based on the best
evidence.
In contrast to these practice guides, “standards of practice” are not specific
or necessarily evidence-based; rather, they are a generally accepted, formal,
published framework for practice. As an example, the American Nurses’ Asso-
ciation document, Nursing: Scope and Standards of Practice (2003), contains a
standard regarding nurses’ accountability formaking of a patient’s health status.
The standard is a general statement. A protocol, on the other hand, may specify
the assessment tool(s) to use in that assessment—for example, an instrument to
predict pressure-ulcer risk.
The AGREE Instrument
The AGREE instrument (Instrument for Appraisal of Guidelines for Research &
Evaluation, http://www.agreecollaboration.org/), created and evaluated by inter-
national guideline developers and researchers for use by the National Health
Developing and Evaluating Clinical Practice Guidelines 3
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Rigor of development.
Item  8. Systematic methods were used to search for evidence.
Item  9. The criteria for selecting the evidence are clearly described.
Item 10. The methods used for formulating the recommendations are clearly described.
Item 11. The health benefits, side effects and risks have been considered in formulating the
recommendations.
Item 12. There is an explicit link between the recommendations and the supporting evidence.
Item 13. The guideline has been externally reviewed by experts prior to its publication.
Item 14. A procedure for updating the guideline is provided.
AGREE Collaboration. (2001). Appraisal of Guidelines Research and Evaluation, AGREE
Instrument. Retrieved November 21, 2006 from the World Wide Web:
http://www.agreecollaboration.org/instrument/.
Services (AGREE Collaboration, 2001), was initially supported by the United
Kingdom National Health Services Management Executive and later by the Eu-
ropean Union (Cluzeau, Littlejohns, Grimshaw, Feder, & Moran, 1999).
Released in its final and current form in 2001, the purpose of the AGREE
instrument is to provide standard criteria with which to appraise CPGs. This ap-
praisal includes evaluation of themethods used to develop the CPG, assessment
of the validity of the recommendations made in the guideline, and considera-
tion of factors related to the use of the CPG in practice. Although the AGREE
instrument was created to critically appraise CPGs, the process and criteria can
also be applied to the development and evaluation of clinical practice protocols.
Thus, the AGREE instrument has been expanded for that purpose to standard-
ize the creation and revision of the geriatric nursing practice protocols in this
book.
The AGREE instrument has six quality domains: scope and purpose, stake-
holder involvement, rigor of development, clarity and presentation, application,
and editorial independence. A total of 23 items divided among the domains are
rated on a four-point Likert scale from “strongly disagree” to “strongly agree.”
Appraisers evaluate howwell the guideline they are assessingmeets the criteria
(i.e., items) of the six quality domains. For example, when evaluating the rigor
of development, appraisers rate seven items (Figure 1.1). The reliability of the
AGREE instrument is increased when each guideline is appraised by more than
one appraiser. Each of the six domains receives an individual domain score and,
based on these scores, the appraiser subjectively assesses the overall quality of
a guideline.
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The rigor of development section of the AGREE instrument provides
standards for literature-searching and documenting the databases and terms
searched. Adhering to these criteria to find and use the best available evidence
on a clinical question is critical to the validity of geriatric nursing protocols and
ultimately to patient safety and outcomes of care.
Published guidelines can be appraised using the AGREE instrument as dis-
cussed previously. In the process of guideline development, however, the clini-
cian is faced with the added responsibility of appraising all available evidence
for its quality and relevance. In other words, how well does the available evi-
dence support recommended clinical practices? The clinician needs to be able to
support or defend the inclusion of each recommendation in the protocol based
on its level of evidence. To do so, the guideline must reflect a systematic, struc-
tured approach to find and assess the available evidence.
Levels of Evidence
Levels of evidence are a schema for understanding the value of the informa-
tion presented to the clinical topic or question under review. Among the many
schema available, there are commonalities in their hierarchical structure, of-
ten represented by a pyramid or “publishing wedge” (Haynes, 2005; McKibbon,
Eady, & Marks, 1999, p. 8). The highest level of evidence is at the top of a pyra-
mid and is characterized by the increased relevance of the evidence to the clin-
ical setting (Duke University Medical Library, 2005). Authors in this book rated
levels of evidence based on the work of Stetler et al. (1998) and Melnyk and
Fineout-Overholt (2005) (Figure 1.2). A Level I evidence rating is given to evi-
dence obtained from synthesized sources: systematic reviews, which can either
bemeta-analyses or structured integrative reviews of evidence, and CPGs based
on Level I evidence. Evidence rated Level II derives from a single experimental
study or randomized controlled trial (RCT). A quasi-experimental study such as
a nonrandomized controlled single group pre-post test time series or matched
case-controlled study is considered Level III evidence. Level IV evidence is
a nonexperimental study, such as correlational descriptive research or case-
controlled studies. A case report systematically obtained and of verifiable qual-
ity or program evaluation data are rated as Level V. Level VI evidence consists
of the opinions of respected authorities based on their clinical experience or the
opinions of an expert committee, including their interpretation of nonresearch-
based information. This level also includes regulatory or legal opinions. Level I
evidence is considered the strongest level of evidence.
The Search for Evidence Process
Locating the best evidence in the published research is dependent on fram-
ing a focused, searchable clinical question. The PICO format—an acronym for
population, intervention (or occurrence or risk factor), comparison (or control),
and outcome—can frame an effective literature search (Glasziou, Del Mar, &
Salisbury, 2003). One example of an answerable clinical question asked in this
book is: “What is the effectiveness of restraints in reducing the occurrence of
falls in patients 65 years of age and older?” In this question, the population
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1.2
Levels of quantitative evidence.
is patients 65 years of age and older, the intervention is use of restraints, the
implied control or comparison is no restraints, and the outcome is falls.
Not every nurse, whether he or she is a clinical practitioner, educator, or
administrator, has proficient database-search skills to find the best evidence
on a clinical topic. Many nurses report that limited access to resources, gaps
in information, literacy skills, and—most of all—a lack of time are barriers to
“readiness” for EBP (Pravikoff, Tanner, & Pierce, 2005). For the third edition of
this book, the editors enlisted the assistance of the New York University Health
Sciences librarian to ensure a standardized and efficient approach to collecting
evidence on clinical topics. A literature search was conducted to find the best
available evidence for each clinical question addressed in the book. With the
framework of the evidence pyramid as a model (see Figure 1.2), the results were
rated for level of evidence and sent to the respective chapter author(s) to provide
possible substantiation for the nursing practice protocol being developed.
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1.3
Searchstepsused in finding theevidencebase forgeriatric nursingprotocols for thequestion:
“What is the effectiveness of restraints in reducing the occurrence of falls in patients 65 years
of age and older?”
1. Select a database (Cochrane Database of Systematic Reviews, CINAHL, MEDLINE…)
2. Translate the terms of the question into the controlled vocabulary of the database. For
example: Falls maps to “Accidental Falls”
3. Apply categorical limits for publication type, year, and age groups
For example:
Limit to age group “Aged, 65 and over”
Limit to publication years 2001–2006
Limit to publication type: “systematic review or meta analysis”
4. Consider other databases, e.g. PsycINFO
5. Evaluate search results; expand or narrow search terms; repeat from Step 2 as needed.
In addition to rating each literature citation as to its level of evidence, each
citation was given a general classification, coded as “Risks,” “Assessment,” “Pre-
vention,” “Management,” “Evaluation/Follow-up,” or “Comprehensive.” The ci-
tations were organized in a searchable database for later retrieval and output to
chapter authors. All authors had to review the evidence and decide on its quality
and relevance for inclusion in their chapter or protocol. They had the option, of
course, to reject or not use the evidence provided as a result of the search or to
dispute the applied level of evidence.
Developing a Search Strategy
Development of a search strategy to capture best evidence begins with database
selection and translation of search terms into the controlled vocabulary of the
database, if possible. Figure 1.3 details the search strategy used to find the
best evidence. In descending order of importance, the three major databases
for finding the best primary evidence for most clinical nursing questions are
the Cochrane Database of Systematic Reviews, Cumulative Index to Nursing
and Allied Health Literature (CINAHL), and Medline or PubMed. In addition,
the PsycINFO database was used to ensure capture of relevant evidence in the
psychology and behavioral sciences literature for many of the topics. Synthesis
sources such as UpToDate® and BMJ Clinical Evidence and abstract journals
such as Evidence Based Nursing supplemented the initial searches. Searching of
other specialty databases may have to be warranted depending on the clinical
question.
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An example of a coded literature citation supplied to protocol author.
REF ID: 1661
Level I: Systematic Reviews
Topic 2: Prevention
Gillespie, L. D., Gillespie, W. J., Robertson, M. C., Lamb, S. E., Cumming, R. G., & Rowe, B.
H. (2006). Interventions for preventing falls in elderly people. The Cochrane Library, (1).
It bears noting that the database architecture can be exploited to limit the
search to articles tagged with the publication type “meta-analysis” in Med-
line or “systematic review” in CINAHL. Filtering by standard age groups such
as “65 and over” is another standard categorical limit for narrowing for rele-
vance. A literature search retrieves the initial citations that begin to provide
evidence. Appraisal of the initial literature retrieved may lead the searcher to
other cited articles, triggering new ideas for expanding or narrowing the lit-
erature search with related descriptors or terms in the article abstract. Using
the previous example, a search of the CINAHL database on “falls” and phys-
ical restraints in the elderly may ultimately lead the searcher to explore the
broader area of patient safety or the related area of side rails. The process
of discovery is iterative, not linear. There is no single path to locating best
evidence.
An additional feature of this third edition is inclusion of the level and type of
evidence for each citation, which can then be applicable to a recommendation
for practice (Figure 1.4). This type of standardized approach ensures that this
book contains protocols and recommendations for use with geriatric patients
and their families that are based on the best available evidence.
Conclusion
The systematic process used for finding, retrieving, and disseminating the best
evidence for the third edition of Evidence-Based Geriatric Nursing Protocols for
Best Practice is a model both for nursing education and clinical practice. Trans-
lating nursing research into practice requires competency in information liter-
acy: the ability to gather evidence, critically appraise, and discern the context
of a research article. Best evidence was defined as published research, which
met the highest level of evidence according to availability. The authors of each
chapter, however, had the responsibility of evaluating thequality of the evidence.
The AGREE instrument was the standard for the process of evidence-searching
and evidence-utilization in chapter and protocol development. The protocols
contained in this edition have been refined, revised, and/or developed by the
authors using the best available research evidence as a foundation, with the
ultimate goal of improving patient safety and outcomes.
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Measuring
Performance,
Improving
Quality
Lenard L. Parisi
Educational
Objectives
After completion of this chapter, the reader will be
able to:
1. discuss key components of the definition of quality
as outlined by the Institute of Medicine (IOM)
2. describe three challenges of measuring quality of
care
3. delineate three strategies for addressing the
challenges of measuring quality
4. list three characteristics of a good performance
measure
Nadzam and Abraham (2003) state that “The main objective of implementing
best practice protocols for geriatric nursing is to stimulate nurses to practice
with greater knowledge and skill, and thus improve the quality of care to older
adults.” Although improved patient care and safety is certainly a goal, providers
also need to focus on the implementation of evidence-based practice (EBP) and
improving outcomes of care. The implementation of evidenced-based nursing
practice as ameans to providing safe, quality patient care, and positive outcomes
is well supported in the literature. However, to ensure that protocols are imple-
mented correctly, as is true with the delivery of all nursing care, it is essential
to evaluate the care provided. Outcomes of care are gaining increased atten-
tion and will be of particular interest to providers as the health care industry
continues to move toward a “pay-for-performance” reimbursement model.
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The improvement of care and clinical outcomes—or, as it is commonly
known, Performance Improvement—requires a defined, organized approach.
Improvement efforts are typically guided by the IOM’s Quality Assess-
ment (measurement) and Performance Improvement (process improvement)
model. Some well-known models or approaches for improving care and pro-
cesses include Plan-Do-Study-Act (PDSA) (Institute for Health Care Improve-
ment, see http://www.ihi.org/ihi) and Six Sigma (see http://www.motorola.com/
motorolauniversity.jsp). Thesemethodologies are simply an organized approach
to defining improvement priorities, collecting data, analyzing the data, mak-
ing sound recommendations for process improvement, implementing identified
changes, and then reevaluating the measures. Through Performance Improve-
ment, standards of care (e.g., Nurses Improving Care for Healthsystem Elders
[NICHE, www.nicheprogram.org] protocols, in this case) are identified, eval-
uated, analyzed for variances, and improved. The goal is to standardize and
improve patient care and outcomes. “Improvements in quality of patient care
occur through restructuring, redesigning and innovating processes. For these
changes to occur, nursing professionals need to be supported by a structure that
provides a vision for continuous improvement (CI), empowers them to make
changes, and delivers ongoing and reliable outcomes information” (Johnson,
Hallsey, Meredith, & Warden, 2006).
From the beginning of theNICHEproject in the early 1990s (for an overview,
see Fulmer et al., 2002), the NICHE team has struggled with the following ques-
tions: How can we measure whether the combination of models of care, staff
education and development, and organizational change leads to improvements
in patient care? How can we provide hospitals and health systems committed to
improving their nursing care to older adults with guidance and frameworks, let
alone tools for measuring the quality of geriatric care? In turn, these questions
generatedmany other questions: Is it possible tomeasure quality? Canwe iden-
tify direct indicators of quality? Or do we have to rely on indirect indicators (e.g.,
if 30-day readmissions of patients older than the age of 65 drop, can we reason-
ably state that this reflects an improvement in the quality of care)?What factors
may influence our desired quality outcomes,whether these are unrelated factors
(e.g., the pressure to reduce length of stay) or related factors (e.g., the severity
of illness)? How can we design evaluation programs that enable us to measure
quality without addingmore burden (of data collection, of taking time away from
direct nursing care)? No doubt, the results from evaluation programs should be
useful at the “local” level. Would it be helpful, though, to have results that are
comparable across clinical settings (i.e., within the same hospital or health sys-
tem) and across institutions (i.e., as quality benchmarking tools)? Many of these
questions remain unanswered today, although the focus on defining practice
through an evidence-based approach is becoming the standard. Defining out-
comes for internal and external reporting is expected as is the improvement of
processes required to deliver safe, affordable, quality patient care.
This chapter provides guidance in the selection, development, and use of
performance measures to monitor quality of care as a springboard to Perfor-
mance Improvement initiatives. Following a definition of quality of care, the
chapter identifies several challenges in the measurement of quality. The con-
cept of performance measures as the evaluation link between care delivery and
quality improvement is introduced. Next, the chapter offers practical advice on
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what and how to measure (Fulmer et al., 2002). It also describes external com-
parative databases sponsored by the Center for Medicare Services (CMS) and
other quality-improvement organizations. It concludes with a description of the
challenge to selecting performance measures.
It is important to reaffirm two key principles for the purposes of evaluating
nursing care in this context. First, at the management level, it is indispensable
to measure the quality of geriatric nursing care; however, doing so must help
those who actually provide care (i.e., nurses) andmust impact those who receive
care (i.e., elderly patients). Second,measuring quality of care is not the end goal;
rather, it is done to enable the continuous use of quality-of-care information to
improve patient care.
Quality Health Care Defined
It is not uncommon to begin a discussion of quality-related topics without re-
flecting on one’s own values and beliefs surrounding quality health care. Many
have tried to define the concept; however, like the old cliche´, “beauty is in the
eye of the beholder,” so is our own perception of quality. Health care consumers
and providers alike are often asked, what does quality mean to you? The re-
sponse typically varies and includes answers such as a safe health care experi-
ence, receiving correct medications, receiving medications in a timely manner,
a pain-free procedure or postoperative experience, compliance with regulation,
accessibility to services, effectiveness of treatments and medications, efficiency
of services, good communication among providers, and a caring environment.
These are important attributes to remember when discussing the provision of
care with clients and patients.
The IOM defines quality of care as “the degree to which health services for
individuals and populations increase[s] the likelihood of desired health out-
comes and are consistent with current professional knowledge” (Kohn, Corri-
gan, & Donaldson, 2000). This definition does not tell us what quality is but
rather what quality should achieve. This definition also does not say that quality
exists if certain conditions are met (e.g., a ratio of x falls to y elderly orthopedic
surgery patients; a 30-day readmission rate of z). Instead, it emphasizes that the
likelihood of achieving desired levels of care is what matters. In other words,
quality is not a matter of reaching something but rather the challenge, over and
over, of improving the odds of reaching the desired level of outcomes. Thus,
the definition implies the cyclical and longitudinal nature of quality: What we
achieve today must guide us as to what to do tomorrow—better and better, over
and over, the focus being on improving processeswhile demonstrating sustained
improvement.
The IOM definition stresses the framework within which to conceptual-
ize quality: knowledge. The best knowledge to have is research evidence—
preferably from randomized clinical trials (i.e., experimental studies)—yet with-
out ignoring the relevance of less rigorous studies (i.e., nonrandomized studies,
epidemiological investigations, descriptive studies, even case studies). Realis-
tically, in nursing we have limited evidence to guide the care of older adults.
Therefore, professional consensus among clinical and research experts is a
critical factor in determining quality. Furthermore, knowledge is needed at
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three levels: to achieve quality, we need to know what to do (knowledge about
best practice), we need to know how to do it (knowledge about behavioral
skills), and we need to know what outcomes to achieve (knowledge about best
outcomes).
The IOM definition of quality of care contains several other important ele-
ments. “Health services” focuses the definition on the care itself. Granted, the
quality of care provided is determined by such factors as knowledgeable profes-
sionals, good technology, and efficient organizations, yet these are not the focus
of qualitymeasurement. Rather, the definition implies a challenge to health care
organizations: The system should be organized in such a way that knowledge-
based care is provided and that its effects can bemeasured. This brings us to the
“desired health outcomes” element of the definition. Quality is not an attribute
(as in “My hospital is in the top 100 hospitals in the United States as ranked by
U.S. News & World Report”) but rather an ability (as in “Only x% of our elderly
surgical patients go into acute confusion; of those who do, y% return to normal
cognitive function within z hours after onset”).
In the IOM definition, degree implies that quality occurs on a continuum
from unacceptable to excellent. The clinical consequences are on a continuum
as well. If the care is of unacceptable quality, the likelihood that we will achieve
the desired outcomes is nil. In fact, we probably will achieve outcomes that
are the opposite of what are desired. As the care moves up the scale toward
excellent, the more likely the desired outcomes will be achieved. Degree also
implies quantification. Although it helps to be able to talk to colleagues about,
say, unacceptable, poor, average, good, or excellent care, these terms should
be anchored by a measurement system. Such systems enable us to interpret
what, for instance, poor care is by providing us with a range of numbers that
correspond to poor. In turn, these numbers can provide us with a reference
point for improving care to the level of average: Wemeasure care again, looking
at whether the numbers have improved, then checking whether these numbers
fall in the range defined as average. Likewise, if we see a worsening of scores, we
will be able to conclude whether we have gone from, say, good to average. The
term individuals and populations underscores that quality of care is reflected in
the outcomes of one patient and in the outcomes of a set of patients. It focuses
our attention on providing quality care to individuals while aiming to raise the
level of care provided to populations of patients.
In summary, the IOM definition of quality of care forces us to think about
quality in relative and dynamic rather than absolute and static terms. Quality of
care is not a state of being but rather a process of becoming. Quality is and should
be measurable, using performance measures: “a quantitative tool that provides
an indication of an organization’s performance in relation to a specified process
or outcome” (Schyve & Nadzam, 1998).
Quality improvement is a process of attaining ever better levels of care in
parallel with advances in knowledge and technology. It strives toward increasing
the likelihood that certain outcomes will be achieved. This is the professional
responsibility of thosewho are chargedwith providing care (i.e., clinicians,man-
agers, and their organizations). On the other hand, consumers of health care (i.e.,
patients, but also purchasers, payors, regulators, and accreditors) are much less
concerned with the processes in place, as with the results of those processes.
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Clinical Outcomes and Publicly Reported Quality Measures
Although it is important to evaluate clinical practices and processes, it is
equally important to evaluate and improve outcomes of care. Clinical-outcome
indicators are receiving unprecedented attention within the health care
industry from providers, payors, and consumers alike. Regulatory and ac-
crediting bodies review outcome indicators to evaluate the care provided by
the organization prior to and during surveys and to evaluate clinical and
related processes. Organizations are expected to use outcome data to identify
and prioritize the processes that support clinical care and demonstrate an
attempt to improve performance. Providers may use outcomes data to support
best practices by benchmarking their results with similar organizations. The
benchmarking process is supported through publicly reported outcomes data
at the national and state levels. National reporting occurs on the CMS Web site,
where consumers and providers alike may access information and compare
hospitals, home-care agencies, and nursing homes. For example, the Web sites
http://www.hospitalcompare.hhs.gov, http://www.medicare.gov/NHCompare,
and http://www.medicare.gov/HHCompare list outcome indicators relative to
the specific service or delivery model. Consumers may use those Web sites to
select organizations and compare outcomes, one against another, to aid in their
selection of a facility or service. These Web sites also serve as a resource for
providers to benchmark their outcomes against those of another organization.
Outcomes data also become increasingly important to providers as the industry
shifts toward a “pay-for-performance” model.
In a pay-for-performance model, practitioners are reimbursed for achieved
quality-of-care outcomes. Currently, the CMS has several pay-for-performance
initiatives (see http://www.cms.hhs.gov/apps/media/press/release.asp?Counter
=1,343 for details). The Hospital Quality Initiative is part of the U.S. Department
of Health and Human Services’ broader national quality initiative that focuses
on an initial set of 10 quality measures by linking reporting of those measures
to the payments the hospitals receive for each discharge. The purpose of the
Premier Hospital Quality Incentive Demonstration is to improve the quality of
inpatient care for Medicare beneficiaries by giving financial incentives to al-
most 300 hospitals for high quality. The Physician Group Practice Demonstra-
tion, mandated by the Medicare, Medicaid, and SCHIP Benefits Improvement
and Protection Act of 2000 (BIPA), is the first pay-for-performance initiative
for physicians under the Medicare program (BIPA, 2000). The Medicare Care
Management PerformanceDemonstration (MedicareModernizationAct [MMA]
section 649), modeled on the “bridges to excellence” program, is a 3-year pay-
for-performance demonstration with physicians to promote the adoption and
use of health information technology to improve the quality of patient care for
chronically ill Medicare patients. The Medicare Health Care Quality Demon-
stration (MMA section 646), mandated by section 646 of the MMA, will be a
5-year demonstration program under which projects enhance quality by im-
proving patient safety, reducing variations in utilization by appropriate use of
evidence-based care and best practice guidelines, encouraging shared decision
making, and using culturally and ethnically appropriate care.
14 Chapter 2
Measuring Quality of Care
Schyve and Nadzam (1998) identified several challenges to measuring quality.
First, the suggestion that quality of care is in the eye of the beholder points to
the different interests of multiple users. This issue encompasses both measure-
ment and communication challenges. Measurement and analysis methods must
generate information about the quality of care that meets the needs of different
stakeholders. In addition, the results must be communicated in ways that meet
these different needs. Second, we must have good and generally accepted tools
for measuring quality. Thus, user groups must come together in their conceptu-
alization of quality care so that relevant health care measures can be identified
and standardized. A common language of measurement must be developed,
grounded in a shared perspective on quality that is cohesive across yet meets
the needs of various user groups. Third, once the measurement systems are in
place, data must be collected. This translates into resource demands and logis-
tical issues as to who is to report, record, collect, and manage data. Fourth, data
must be analyzed in statistically appropriate ways. This is not just a matter of
using the right statistical methods; it is more important that user groups must
agree on a framework for analyzing quality data to interpret the results. Fifth,
health care environments are complex and dynamic in nature. There are differ-
ences across health care environments, between types of provider organizations,
and within organizations. Furthermore, changes in health care occur frequently,
such as the movement of care from one setting to another and the introduction
of new technology. Finding common denominators is a major challenge.
Addressing the Challenges
These challenges are not insurmountable. However, making a commitment to
quality care entails a commitment to putting the processes and systems in place
tomeasure quality through performancemeasures and to report quality-of-care
results. This commitment applies as much to a quality-improvement initiative
on a nursing unit as it does to a corporate commitment by a large health care
system. In other words, once an organization decides to pursue excellence (i.e.,
quality), it must accept measurement and reporting and overcome the various
challenges. Let us examine how this could be done in a clinical setting.
McGlynn and Asch (1998) offer several strategies for addressing the chal-
lenges to measuring quality. First, the various user groups must identify and
balance competing perspectives. This is a process of giving and taking: propos-
ing highly clinical measures (e.g., number of pressure ulcers) but also provid-
ing more general data (e.g., use of restraints). It is a process of asking and re-
sponding: asking management for monthly statistics on medication errors but
also agreeing to provide management with the necessary documentation of why
physical restraints have been used for some patients. Second, there must be an
accountability framework. Committing to quality care implies that nurses as-
sume several responsibilities and are willing to be held accountable for each of
them: (1) providing the best possible care to older patients, (2) examining their
own geriatric nursing knowledge and practice, (3) seeking ways to improve it,
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(4) agreeing to evaluation of their practice, and (5) responding to needs for im-
provement. Third, there must be objectivity in the evaluation of quality. This
requires setting and adopting explicit criteria for judging performance, then
building the evaluation process on these criteria. Nurses, their colleagues, and
their managers need to reach consensus on how performance will be measured
and what will be considered excellent (and good, average, etc.) performance.
Fourth, once these indicators have been identified, nurses need to select a sub-
set of indicators for routine reporting. Indicators should give a reliable snapshot
of the team’s care to older patients. Fifth, it is critical to separate asmuch as pos-
sible the use of indicators for evaluating patient care and the use of these indica-
tors for financial or nonfinancial incentives. Should the team be cost-conscious?
Yes, but cost should not influence any clinical judgment as to what is best for
patients. Finally, nurses in the clinical setting must plan how to collect the data.
At the institutional level, this may be facilitated by information systems that al-
low performance measurement and reporting. Ideally, point-of-care documen-
tation will also provide the data necessary for a systematic and goal-directed
quality-improvement program, thus eliminating separate data abstraction and
collection activities.
The success of a quality-improvement program in geriatric nursing care
(and the ability to overcome many of the challenges) hinges on the decision
as to what to measure. We know that good performance measures must be ob-
jective, that data collection must be easy and as burdenless as possible, that
statistical analysis must be guided by principles and placed within a frame-
work, and that communication of results must be targeted toward different user
groups. Conceivably, we could try to measure every possible aspect of care; re-
alistically, however, the planning for this will never reach the implementation
stage. Instead, nurses need to establish priorities by asking these questions:
Based on our clinical expertise, what is critical for us to know? What aspects of
our care to older patients are high risk or high volume? What parts of our el-
der care are problem-prone either because we have experienced difficulties in
the past or because we can anticipate problems due to the lack of knowledge or
resources?What clinical indicatorswould be of interest to other user groups: pa-
tients, the general public, management, payors, accreditors, and practitioners?
Throughout this prioritization process, nurses should keep asking themselves:
What questions are we trying to answer and for whom?
Measuring Performance-Selecting Quality Indicators
The correct selection of performance measures or quality indicators is a cru-
cial step in evaluating nursing care and is based on two important factors: fre-
quency and volume. Clearly, high-volume practices or frequent processes re-
quire focused attention—to ensure that the care is being delivered according to
protocol or processes are functioning as designed. Problem-prone or high risk
processes would also warrant a review because these are processes with inher-
ent risk to patients or variances in implementing the process. The selection of
indicators must also be consistent with organizational goals for improvement.
This provides buy-in from practitioners as well as administration when report-
ing and identifying opportunities for improvement. Performance measures (i.e.,
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indicators) must be based on either a standard of care, policy, procedure, or pro-
tocol. These documents, or standards of care, define practice and expectations
in the clinical setting and, therefore, determine the criteria for the monitoring
tool. The measurement of these standards simply reflects adherence to or im-
plementation of these standards. Once it is decided what to measure, nurses in
the clinical geriatric practice setting face the task of deciding how to measure
performance. There are two possibilities: Either the appropriate measure (indi-
cator) already exists or a new performance measure must be developed. Either
way, there are a number of requirements of a good performance measure that
will need to be applied.
Although indicators used to monitor patient care and performance do not
need to be subject to the rigors of research, it is imperative that they reflect
some of the attributes necessary to make relevant statements about the care.
The measure and its output need to focus on improvement, not merely the de-
scription of something. It is not helpful to have a very accurate measure that
just tells the status of a given dimension of practice. Instead, the measure needs
to inform about current quality levels and relate them to previous and future
quality levels. It needs to be able to compute improvements or declines in qual-
ity over time so that we can plan for the future. For example, to have a measure
that only tells the number of medication errors in the past month would not
be helpful. Instead, a measure that tells what types of medication errors were
made, perhaps even with a severity rating indicated, compares this to medica-
tion errors made during the previous months and shows in numbers and graphs
the changes over time that will enable us to do the necessary root-cause analysis
to prevent more medication errors in the future.
Performancemeasures need to be clearly defined, including the terms used,
the data elements collected, and the calculation steps employed. Establishing
the definition prior to implementing the monitoring activity allows for precise
data collection. It also facilitates benchmarking with other organizations, when
the data elements are similarly defined and the data-collection methodologies
are consistent. Imagine that we want to monitor falls on the unit. The initial
questions would be: What is considered a fall? Does the patient have to be on
the floor? Does a patient slumping against the wall or onto a table while trying to
prevent himself or herself from falling to the floor constitute a fall? Is a fall due
to physical weakness or orthostatic hypotension treated the same as a fall due to
tripping over an obstacle? The next question would be: Over what time period
are falls measured: a week, a fortnight, a month, a quarter, a year? The time
frame is not a matter of convenience but rather of accuracy. To be able to mon-
itor falls accurately, we need to identify a time frame that will capture enough
events to be meaningful and interpretable from a quality improvement point of
view. External indicator definitions, such as those defined for use in theNational
Database of Nursing Quality Indicators, provide guidance for both the indicator
definition and the data-collection methodology for nursing-sensitive indicators.
The nursing-sensitive indicators reflect the structure, process, and outcomes of
nursing care. The structure of nursing care is indicated by the supply of nursing
staff, the skill level of the nursing staff, and the education and certification of
nursing staff.Process indicatorsmeasure aspects of nursing care such as assess-
ment, intervention, and RN job satisfaction. Patient outcomes are determined
to be either nursing-sensitive indicators, which improve if there is a greater
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quantity or quality of nursing care (e.g., pressure ulcers, falls, IV infiltrations)
or those that are not considered nursing-sensitive (e.g., frequency of pri-
mary C-sections, cardiac failure) (for details, see http://www.nursingquality.org/
FAQPage.aspx#1). Several nursing organizations across the country participate
in data collection and submission, which allows for a robust data base and ex-
cellent benchmarking opportunities.
Additional indicator attributes include validity, sensitivity, and specificity.
Validity refers to whether the measure “actually measures what it purports to
measure” (Wilson, 1989). Sensitivity and specificity refer to the ability of the
measure to capture all true cases of the event being measured, and only true
cases. We want to ensure that a performance measure identifies true cases as
true, and false cases as false, and does not identify a true case as false or a
false case as true. Sensitivity of a performance measure is the likelihood of a
positive testwhena condition is present. Lack of sensitivity is expressed as false-
positives—that is, the indicator calculates a condition as present when in fact it
is not. Specificity refers to the likelihood of a negative test when a condition is
not present. False-negatives reflect lack of specificity: The indicators calculate
that a condition is not present when in fact it is. Consider the case of depression
and the recommendation in chapter 5 to use the Geriatric Depression Scale, in
which a score of 11 or greater is indicative of depression. How robust is this
cutoff score of 11? What is the likelihood that someone with a score of 9 or 10
(i.e., negative for depression) might actually be depressed (i.e., false-negative)?
Similarly, what is the likelihood that a patient with a score of 13 would not be
depressed (i.e., false-positive)?
Reliability means that results are reproducible; that is, the indicator mea-
sures the same attribute consistently across the same patients and across time.
Reliability begins with a precise definition and specification, as described pre-
viously. A measure is reliable if different people calculate the same rate for the
same patient sample. The core issue of reliability is measurement error, or the
difference between the actual phenomenon and its measurement: The greater
the difference, the less reliable the performance measure. For example, sup-
pose that we want to focus on pain management in elderly patients with end-
stage cancer. One way of measuring pain would be to ask patients to rate their
pain as none, a little, some, quite a bit, or a lot. An alternative approach would
be to administer a visual analog scale, a 10-point line on which patients indi-
cate their pain levels. Yet another approach would be to ask the pharmacy to
produce monthly reports of analgesic use by type and dose. Generally speak-
ing, the more subjective the scoring or measurement, the less reliable it will
be. If all these measures were of equal reliability, they would yield the same
result. The concept of reliability, particularly inter-rate reliability, becomes in-
creasingly important to consider in those situations in which data collection is
assigned to several staff members. It is important to review the data-collection
methodology and the instrument in detail to avoid different approaches by the
various people collecting the data.
Several of the examples givenpreviously imply the criterion of interpretabil-
ity. A performancemeasuremust be interpretable; that is, it must convey a result
that can be linked to the quality of clinical care. First, the quantitative output
of a performance measure must be scaled in such a way that users can inter-
pret it. For example, a scale that starts with 0 as the lowest possible level and
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ends with 100 is much easier to interpret than a scale that starts with 13.325
and has no upper boundary except infinity. Second, we should be able to place
the number within a context. Suppose we are working in a hemodialysis center
that serves a large proportion of end-stage renal disease (ESRD) patients older
than the age of 60—the group least likely to be fit for a kidney transplant yet
with several years of life expectancy remaining.We know that virtually all ESRD
patients develop anemia (i.e., Hb less than 11 g/dL), which in turn impacts their
activities of daily living (ADL) and independent activities of daily living (IADL)
performance. In collaboration with the nephrologists, we initiate a systematic
program of anemia monitoring and management, relying in part on published
best practice guidelines. We want to achieve the best practice guideline of 85%
of all patients having hemoglobin levels equal to or greater than 11 g/dL. We
should be able to succeed because the central laboratory provides us with Hb
levels, which allows us to calculate the percentage of patients at Hb of 11 g/dL
or greater.
The concept of risk-adjusted performance measures or outcome indicators
is an important one. Some patients are sicker than others, some have more co-
morbidities, some are older and frailer. No doubt, we could come up with many
more risk variables that influence how patients respond to nursing care. Good
performance measures consider this differential risk. They create a “level play-
ing field” by adjusting quality indicators on the basis of the (risk for) severity of
illness of the patients. It would not be fair to the health care team if the patients
on the unit are a lot sicker than those on the unit a floor above. The team is at
greater risk for having lower quality outcomes, not because they provide inferior
care but because the patients are a lot sicker and are at greater risk for a compro-
mised response to the care provided. The sicker patients are more demanding
in terms of care and ultimately less likely to achieve the same outcomes as less
ill patients. Performance measures must be easy to collect. The many examples
cited previously also refer to the importance of using performancemeasures for
which data are readily available, can be retrieved from existing sources, or can
be collected with little burden. The goal is to gather good data quickly without
running the risk of having “quick and dirty” data.
Webegin the process of deciding how tomeasure by reviewing existingmea-
sures. There is no need to “reinvent the wheel” especially if good measures are
out there.Nurses should review the literature, checkwithnational organizations,
and consult with colleagues. Yet, we should not blindly adopt existingmeasures;
instead, we need to subject them to a thorough review using the characteristics
identified previously. Also, health care organizations that have adopted these
measures can offer their experience.
It may be that after an exhaustive search, we cannot find measures that
meet the various requirements outlined herein. We decide instead to develop
our own in-house measure. Following are some important guidelines:
1. Zero in on the population to be measured. If we are measuring an undesirable
event, we must determine the group at risk for experiencing that event, then
limit the denominator population to that group. If we are measuring a de-
sirable event or process, we must identify the group that should experience
the event or receive the process. Where do problems tend to occur? What
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variables of this problem are within our control? If some are not within our
control, how can we zero in even more on the target population? In other
words, we exclude patients from the population when good reason exists to
do so (e.g., those allergic to the medication being measured).
2. Define terms. This is a painstaking but essential effort. It is better to measure
80% of an issue with 100% accuracy than 100% of an issue with 80% accuracy.
3. Identify and define the data elements and allowable values required to calculate
the measure. This is another painstaking but essential effort. The 80%/100%
rule applies here as well.
4. Test the data-collection process.Once we have a prototype of ameasure ready,
we must examine how easy or difficult it is to get all the required data.
Implementing the Quality Assessment and
Performance-Improvement Program
Successful Performance Improvement programs require an organizational com-
mitment to implementation of the Performance Improvement processes and
principles outlined in this chapter. Consequently, this commitment requires a
defined, organized approach that most organizations embrace and define in the
form of a written plan. The plan outlines the approach that the organization
uses to improve care and safety for its patients. There are several important
elements that must be addressed to implement the Performance Improvement
program effectively. The scope of service, which addresses the types of patients
and care that is rendered, provides direction on the selection of performance
measures. An authority and responsibility statement in the document defines
who is able to implement the quality program and make decisions that will
affect its implementation. Finally, it is important to define the committee struc-
ture used to effectively analyze and communicate improvement efforts to the
organization.
The success of the Performance Improvement program is highly dependent
on awell-defined structure and appropriate selection of performancemeasures.
The following is a list of issues that, if not addressed, may negatively impact the
success of the quality program:
■ Lack of focus: a measure that tries to track too many criteria at the same
time or is too complicated to administer, interpret, or use for quality mon-
itoring and improvement
■ Wrong type of measure: a measure that calculates indicators the wrong
way (e.g., uses rates when ratios are more appropriate; uses a continuous
scale rather than a discrete scale; measures a process, when the outcome
is measurable and of greater interest)
■ Unclear definitions: a measure that is too broad or too vague in its scope
and definitions (e.g., population is too heterogeneous, no risk adjustment,
unclear data elements, poorly defined values)
■ Too much work: a measure that requires too much clinician time to gen-
erate the data or too much manual chart abstraction
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■ Reinventing the wheel: a measure that is a reinvention rather than an im-
provement of a performance measure
■ Events not under control: measure focuses on a process or outcome that is
out of the organization’s (or the unit’s) control to improve
■ Trying to do research rather than quality improvement: data collection and
analysis are done for the sake of research rather than for improvement
of nursing care and the health and well-being of the patients
■ Poor communication of results: the format of communication does not tar-
get and enable change
■ Uninterpretable and underused: uninterpretable results are of little rele-
vance to improving geriatric nursing care
In summary, the success of the Quality Assessment Performance Improve-
ment Program’s ability to measure, evaluate, and improve the quality of nursing
care to health-system elders is in the planning. First, define the scope of ser-
vices provided and those to be monitored and improved. Second, identify per-
formance measures that are reflective of the care provided. Indicators may be
developed internally or obtained from external sources of outcomes and data-
collectionmethodologies. Third, analyze the data, pulling together the right peo-
ple to evaluate processes, make recommendations, and improve care. Finally, it
is important to communicate findings across the organization and celebrate suc-
cess.
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3Assessment ofFunction
Denise M. Kresevic
Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. identify physical functioning as an important
clinical indicator of health/illness, response to
treatment, and need for services for older adults
2. describe common components of standardized
functional assessment instruments
3. identify unique challenges to gathering information
from older adults regarding functional
assessments
4. describe common nursing care strategies to
restore, maintain, and promote functional health in
older adults
Overview
Physical functioning is a dynamic process of interaction between individuals
and their environments. The process is influenced by motivation, physical ca-
pacity, illness, cognitive ability, and the external environment including social
supports. Functional assessments serve as the common language of health for
patients, family members, and health care providers of older adults. The ability
to manage day-to-day activities such as eating, bathing, ambulating, manag-
ing money, and keeping track of medications serves as the foundation of safe,
independent functioning for all adults.
For a description of Evidence Levels cited in this chapter, see chapter 1,
Evaluating Clinical Practice Guidelines, page 4.
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The consequences of not assessing for change in status are significant. Acute
changes in functional ability often signal an acute illness and increased need
for assistance tomaintain safety. These changes have important implications for
nursing care across settings but especially during hospitalization. The ability to
assess functional status is a critical nursing competency to accurately assess
normal aging changes, illness, and disability and to develop an individualized
care plan for continuity of care across settings. The failure to assess function
can lead to increased decline including severe malnutrition and falls, resulting
in the need for institutional care as well as a decrease in quality of life.
Background
The ability to manage day-to-day rather than the absence of disease or age is
the cornerstone of health for older adults. Function includes the ability to carry
out activities of daily living (ADLs) such as bathing, dressing, and toileting, as
well as managing medications and walking. As individuals age or become ill,
they may require assistance to accomplish these activities independently. It is
estimated that between 20% and 40% of all older adults experience functional
decline during hospitalization (Landefeld, Palmer, Kresevic, Fortinsky, & Kowa,
1995 [Level II]). Whereas the exact cause of the decline is often a combination
of factors including acute illness, it can be due in part to environmental factors
of hospitalization that may be prevented or ameliorated by skilled nursing care
(McCusker, Kakuma, & Abrahamowicz, 2002 [Level I]). In fact, hospitalization
provides a unique opportunity to assess function, plan for services, and promote
“successful aging.”
Common risk factors for functional decline include injuries, acute illness,
medication side effects, depression, malnutrition, and decreased mobility from
the use of physical restraints due to associated iatrogenic complications such
as incontinence, falls, and pressure sores (Creditor, 1993 [Level VI]). In one
randomized clinical trial of hospitalized elders, the daily nursing assessment of
ability to perform bathing, dressing, grooming, toileting, transferring, and am-
bulation during routine nursing care yielded information necessary for mainte-
nance of function in self-care activities (Landefeld et al., 1995 [Level II]).
This chapter addresses the goals and the need for functional assessment of
older adults in acute care, and it provides a clinical practice protocol to guide
nurses in the functional assessment of older adults (Box 3.1).
Assessment of Function
Assessment of function includes an ongoing systematic process of identifying
the older person’s physical abilities and need for help. Functional assessment
also provides the opportunity to identify individual strengths and measures of
“successful aging.” This information is especially important for nurses in plan-
ning and evaluating care. Functional capacity may be assessed by self- or proxy
report and direct observation of actual performance. Nurses are in a pivotal po-
sition in all care settings to assess elders’ functional status by direct observation
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3.1 Functional Assessment of Older Adults
Dimension
Assessment
Parameter
Standardized
Instrument Nursing Strategy
ADLs
Bathing
Dressing
Eating
Toileting
Hygiene
Transferring
Self-report of patient,
surrogate report
Observation during
hospitalization
Katz ADL (Katz et al.,
1963)
Situation Test (Skurla,
Rogers, &
Sunderland, 1988)
(Lowenstein et al.,
1989; Kurianski &
Gurland, 1976)
Orient to environment
Encourage active
participation while in
hospital
Range of motion
exercises
Encourage to be out of
bed
Consult PT/OT for
strengthening
Mobility
Balance: sitting;
standing
Gait steadiness
Turns
Self-, surrogate report
Observation
Get up and Go test
(Mathias, Nayak, &
Isaacs, 1986)
Ambulate daily
PT/OT consult
Mobility aids
Community referrals
IADL’s
Housework
Finances
Driving
Shopping
Meal preparation
Reading
Medication
adherence
Aware of current
events
Hobbies
Employment
Volunteer work
Self-, surrogate report
(able to balance
check book), no
traffic violations
DAFS (Karagiozis
et al., 1989)
Lawton IADL
(Lawton & Brody,
1969; Gurland et al.,
1994)
Able to find hospital
room
Community referrals for
transportation
Meals on Wheels
Orders hospital meals
from menu
OT consult for
simulating kitchen
evaluation
Reads newspaper
Can read pill bottles
Family home care
Nurse to fill pill bottles
ADLs = activities of daily living; IADLs = instrumental activities of daily living; PT/OT = physical therapist/occupational
therapist
during routine care and through information gathered from the individual pa-
tient, the patient’s family, and any other long-term caregivers.
Including critical components of functional assessments into routine assess-
ments in the acute care setting can provide (1) baseline functional capacity and
recent changes in level of independence indicating possible illness, especially
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infections; (2) baseline information to benchmark patients’ response to treat-
ment as they move along the continuum from acute care to rehabilitation or
from acute to subacute care (e.g., following a new stroke or hip-replacement
surgery); (3) information regarding care needs and eligibility for services,
including safety needs, physical therapy needs, and posthospitalization needs;
and (4) information on quality of care. The ongoing use of a standardized func-
tional assessment instrument promotes systematic communication of patients’
health status between care settings and allows units to compare their level of
care with other units in the facility and to measure outcomes of care (see Table
3.1) (Campbell, Seymour, Primrose, & ACME-plus Project, 2004 [Level I]).
Although gathering information about functional status is a critical indi-
cator of quality care in geriatrics, it is not always a task easily accomplished
and requires significant time, skill, and knowledge. Older persons often present
to the care setting with multiple medical conditions resulting in fatigue and
pain. In addition, sensory aging changes, particularly vision and hearing, can
threaten the accuracy of responses. Ideally, information regarding functional
status should be elicited as part of the routine history of older adults and in-
corporated in daily-care routines of all caregivers. In addition, comprehensive
assessment of function provides an opportunity to teach patients and families
about normal aging and indicators of pathology.
Assessment Instruments
Systematic gathering of information on ADLs including bathing, dressing, and
ambulating, as well as using a telephone, taking medications, and managing fi-
nances, can be accomplished by the use of standardized instruments. The use
of standardized instruments serves to ensure inclusive assessments, the ability
to communicate in a common language, and the ability to benchmark infor-
mation over time. Several instruments have been developed over the years to
measure function. Although all measure components of function, the decision
of which instrument should be used depends on the primary purpose of the
assessment and the institutional preferences and resources. No single instru-
ment will meet the needs of all care settings. Each should be carefully eval-
uated for primary purpose of assessment and care setting priorities (Kane &
Kane, 2000 [Level VI]). Beginning in the 1950s, Dr. Sidney Katz began study-
ing the pattern of return to function in patients following hip fracture. He and
his colleagues identified a constellation of ADLs including bathing, dressing,
transferring, toileting, continence, and feeding that described outcomes of
rehabilitation and prognosis of older adults (Katz, Ford, Moscokowitz, Jack-
son, & Jaffe, 1963 [Level I]). Since that time, the Katz Index of Independence
in Activities of Living has been used widely to assess function of elders in all
settings, including during hospitalization (Mezey, Rauckhorst, & Stokes, 1993
[Level VI]).
Originally, the scale was proposed as an observation tool with scoring rang-
ing from 1 to 3, indicating independent ability, limited assistance, and extensive
assistance for each activity. Over time, the instrument has evolved into a di-
chotomized tool, independent versus dependent ability in each task (Kane &
Kane, 2000 [Level VI]). It has established reliability (i.e., 0.94–0.97) and is easy
to use either as an observational or self-reported measure (Kane & Kane, 2000
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[Level VI]). The Katz ADL index is easily incorporated into history and phys-
ical assessment flowsheets and takes little time to complete. Older adults are
evaluated according to levels of independence.
Similarly, the Barthel Index of Instrumental Activities of Daily Living
(IADLs) was originally developed in the 1950s in an effort to measure improve-
ments in independent functioning related to persons with neuromuscular dis-
orders and their ability to function within a specific environment. This measure
of physical function often relies on patient or proxy report. Scores range from
0, indicating total dependence on caregivers, to 100, indicating self-care for all
activities. High reliability coefficients have been reported (i.e., 0.95–0.96) (Kane
& Kane, 2000 [Level VI]).
The Barthel index for physical functioning includes bathing, grooming,
continence, stair-climbing, and the ability to propel a wheelchair (Mahoney &
Barthel, 1965 [Level III]; Mezey et al., 1993 [Level VI]). This instrument has
been useful in rehabilitation settings to monitor improvements over time. The
Barthel instrument allows differentiation among task performance, including
amount of help and amount of time needed to accomplish each task.
In addition to self-care in ADLs measured by Katz or Barthel tools, addi-
tional instruments to measure more complex physical function, called IADLs,
have also been proposed to include in a comprehensive assessment of function
in older adults. The majority of these instruments assess the individual’s func-
tion relative to the environment. Common IADL skills have been identified and
include using a telephone, shopping, meal preparation, housekeeping, laundry,
medication administration, transportation, and money management (Kane &
Kane, 2000 [Level VI]). Whereas assessment of ADL provides useful informa-
tion for nursing care needs during and after hospitalization, IADL information
helps target information critical for planning posthospital care needs. Common
instruments used to measure IADLs include the Lawton IADL scale, the Older
Americans Resource and Services (OARS–IADL) scale, and the Direct Assess-
ment of Functional Abilities (DAFA) scale. Perhaps the most widely used IADL
instrument for hospitalized older adults is the Lawton scale, which assesses
eight items and is scored from a total possible score of 8, indicating indepen-
dent self-care, to 0, indicating dependence in all areas. Reliability coefficients
have been reported to be 0.96 for men and 0.93 for women (Kane & Kane, 2000
[Level VI]).
The OARS instrument for physical function is similar in scope of measure-
ment to the Katz scale, including bathing, dressing, grooming, and continence
(Burton, Damon, Dillinger, Erickson, & Peterson, 1978 [Level III]; Kane & Kane,
2000 [Level VI]). However, unlike the Katz instrument, which uses caregiver
observation, the OARS instrument relies on self-report. Self-reports of capac-
ity may be less valid than observations of performance, with some older adults
overestimating or underestimating actual capacity (Kidd et al., 1995 [Level III]).
TheFunctional IndependenceMeasure (FIMTM)was designed to assess “the
burden of care” in six areas: self-care, transfers, sphincter control, locomotion,
communication, and social cognition. This instrument has been used to assess
outcomes of patients with orthopedic and neurologic conditions. Information
may be gathered by telephone, mail, self-report, or proxy report using the ap-
propriate version. Each item is scored from 1 to 7, with 1 indicating a need
for total assistance and 7 completely independent in a timely and safe manner
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(Kane & Kane, 2000 [Level VI]). (See www.ConsultGeriRN.org for assessment
instruments and the Resources section of this chapter.)
Assessment of function in individuals with dementia provides a unique
challenge. A recently developed instrument, the DAFA, is a 10-item obser-
vational measure of IADLs useful in assessing function in the presence of
dementia (Karagiozis, Gray, Sacco, Shapiro, & Dawas, 1998 [Level III]). The as-
sessment of IADLs, including the ability to prepare meals and administer med-
ications safely, may not be observed during an acute hospitalization, although
assessment of capacity in these domains has important implications for plan-
ning posthospitalization services. Regardless of the instrument used, basic ADL
and IADL function should be assessed for each patient, including capacity for
dressing, eating, transferring, toileting, hygiene, ambulation, and medication
adherence (see chapter 12, Reducing Adverse Drug Events). Appropriate assess-
ment instruments should be readily available on the acute care unit for easy
accessibility and reference and/or incorporated into routine documentation in-
struments for history, daily assessment, and discharge planning. To adequately
assess function, sensory capacity and cognitive capacity must be established.
Environmental adaptations such as magnifying glasses or amplifiers may be
necessary to ensure accurate assessment and should be accessible to nursing
staff.
Direct Assessment of Patient
Although nurses often rely on reports of patients and family members about
physical functioning and capacity for ADLs and IADLs, direct observation pro-
vides strong support for current capacity versus past ability.
Functional assessments are constantly conducted by nurses every time they
notice that a patient can no longer pick up a fork or has difficulty walking.
A comprehensive functional assessment leads to more than simply noticing a
change in activity or ability, however. In a systematic manner, nurses need to
assess the ability of a patient to perform ADLs in the context of the patient’s
baseline functional status and hospitalization status.
While assessing functional status, thepatient shouldbemadeas comfortable
as possible, with frequent rest periods allowed. Adaptive aids, such as glasses
and hearing aids, should be applied. Often, familymembers accompany an older
person and can assist in answering questions regarding function. It is important
for patients and family members to understand that baseline functional levels
as well as recent changes in function need to be reported. Many older adults
may be reluctant to report decline in function, fearing that such reports will
threaten their autonomy and independent living.
Occasionally, the history given in a physical exam may reveal clues to fur-
ther assess function. Muscle weakness and atrophy of legs may indicate lack of
ability to safely ambulate independently. Temporal muscle wastingmay indicate
moderate to severe malnutrition resulting from inability to shop, prepare, and
adequately consume sufficient calories. Hand contractures indicative of arthritis
or cerebral vascular accidents alert the nurse to assess performance versus self-
report of ability to open pill bottles, dial a telephone, or write checks. General
appearance, including hair, teeth, fingernails, condition of clothing, and clean
and dry versus urine-soaked undergarments, may give rise to information on
bathing, dressing, continence, and ability to do laundry.
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Specific Functional Assessments
Ambulation
Inherent in ADL and IADL ability is the capacity to walk, a critical parameter for
functional assessment. Early assessment of this function is important for nurses
in the hospital to ensure safety and prevent falls and injuries (see chapter 9,
Preventing Falls in Acute Care). The ability to safely ambulate is contingent on
the ability to transfer, propel forward, and pivot with sufficient strength and
balance. Ambulation is a critical skill necessary for self-care in the hospital and
posthospital discharge. It is also a sensitive indicator of acute health changes.
Therefore, the ability to ambulate should not be assessed only by self- or proxy
report but also by direct observation.
Some instruments used to assess ambulation, balance, and gait are sensitive
measures of mobility (Applegate, Blass, & Franklin, 1990 [Level IV]); however,
they are also complex and time-consuming to use. Direct observation of an in-
dividual’s ability to get out of bed, sit in a chair, assume a standing position, and
steadily walk a short distance–with or without assistive devices–is important to
ensure safety in ADL capacity (Applegate et al., 1990 [Level IV]; Cress et al.,
1995).
An efficient performance-based measure of ambulation, balance, and gait
that can be observed during routine care during hospitalization is the “Get Up
and Go” test (Applegate et al., 1990 [Level IV]). To do a Get Up and Go test,
patients can be observed sitting in a chair, standing, walking, and pivoting.
Performance is scored from 1, indicating normal balance and steady gait, to
5, severely abnormal, indicating clear evidence of a falls risk (Kane & Kane,
2000 [Level VI]). Although this bedside physical performance measure of am-
bulation is easy to do, it does yield significant subjectivity in scoring that may
be enhanced by timing the tasks (Kane & Kane, 2000 [Level VI]).
Direct observation of transfer and ambulation should include an assessment
of speed of performance, hesitancy, stumbling, swaying, grabbing for support,
or unsafe maneuvers such as sitting too close to the edge of a chair or dizzi-
ness while pivoting (Tinetti & Ginter, 1988 [Level I]). The Get Up and Go test
can be used by nurses for ambulation assessments during routine daily activi-
ties of older individuals (Applegate et al., 1990 [Level IV]). Assessment of unsafe
transfers or ambulation indicates the need to begin immediate restorative thera-
pies to prevent injuries and falls. Care should reflect attention to environmental
designs, including walking paths free of clutter, rails and rest areas, and care
routines that encourage daily ambulation as opposed to bedrest and immobility
(Creditor, 1993 [Level VI]).
Sensory Capacity
Evaluation of the potential impact of sensory changes on the performance of
ADLs is often underestimated. A simple test for functional vision is to have
older adults read a headline from the newspaper. A moderate impairment can
be noted if only the headline can be read (Tinetti & Ginter, 1988 [Level I]). An-
other way to assess vision is to have older persons read prescription bottles.
Functional assessment of safe medication administration use includes the abil-
ity to read pill bottles and repeat directions for use and side effects for when to
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contact a health care provider. Glasses should be available with clean lenses.
Inability to read raises questions of literacy, undiagnosed vision difficulties,
and safety for medication administration. Often overlooked is the number of
older people who may not be able to read but are too embarrassed to reveal
that information. In fact, as part of routine care, older adults should be encour-
aged to actively participate each day in learning about medications. In addition,
at the time of discharge, nurses need to verify patient and family knowledge
and skills regarding medications. This may include discussing medications as
well as directly observing older adults open pill bottles and identify correct
pills.
Hearing ability is essential to function and cognition. Individuals with de-
creased hearing may be inaccurately labeled as cognitively impaired. Hearing
aidsmay not have been sent to the hospital with the elder. The family should ob-
tain these aids.Hearing acuitymay be validated by asking patients to identify the
sound of a ticking watch. The “whisper test” may also be used. This is performed
by whispering 10 words while standing 6 inches away from the individual. In-
ability to repeat 5 of the 10 words indicates a need for further assessment of
hearing acuity. Occlusion of the external ear canal by cerumen may be found on
visualization, an easily treatable problem in decreased hearing acuity (Mathias,
Nayak, & Isaacs, 1986 [Level VI]). Individuals with hearing deficits, detected as
part of a bedside assessment, should be referred for additional assessment and
treatment. Amplifier devicesmay be useful and are an inexpensive item to stock
on nursing units in hospitals.
Cognitive Capacity
Cognitive function is a major factor in a person’s functional capacity. Baseline
cognitive function is important to assess. However, such assessments most of-
ten initially rely on information provided by family members because acute
illness may be clinically manifested as acute confusional states and does not re-
flect baseline cognitive function (Kurianski & Gurland, 1976 [Level VI]). Nurses
can assess components of cognitive function (including attention, language, and
memory) during interviews and routine care, although anxiety and illness may
be complicating factors. Observations to assess cognitive function during hos-
pitalization may include the ability to call the nurse for help; ordering food
from a menu; using the telephone; and following directions for activity, turning,
and bathing (Kresevic et al., 1998 [Level VI]). Fluctuating attention may indi-
cate an acute, reversible impairment (i.e., delirium) or temporary reactions to
hospitalization. An acute change in cognition should be evaluated immediately
for a potentially life-threatening, reversible medical condition (see chapter 7,
Delirium: Prevention, Early Recognition, and Treatment).
Cause of Functional Decline
All instances of functional decline should also be assessed for an underlying
reversible cause such as acute illness. In the presence of acute illness (e.g.,
urinary tract infection, pneumonia, or recovery after surgery), impaired ADLs
are expected to return to baseline with appropriate care and rehabilitation as
the illness resolves. Comprehensivemusculoskeletal or neurologic examination,
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laboratory tests, or referral for a therapeutic trial of physical or occupational
therapy may be needed.
Nursing Strategies to Prevent Functional Decline
Functional ability is a sensitive indicator of health in older adults. The need for
assistance with ADLs is an important nursing assessment that assists with care
planning in the hospital as well as for posthospitals care needs. Sudden loss
of function, including the ability to ambulate, is the hallmark of acute illness in
older adults. Whereas recovery from illness may be associated with improve-
ments in function, early nursing interventions to address care needs, refer to
therapy, andmodify environments of care are all interventions that ensure safety
and decrease further loss of function. Therefore, all nurses must be skilled at
incorporating a comprehensive functional assessment into all patient-care as-
sessments. Nurses need to be knowledgeable and skilled in assessment of func-
tion, adapting supportive environments, and providing geriatric sensitive care
to prevent functional decline. Geriatric sensitive care incorporates strategies to
prevent bedrest and encourage exercise and ambulation, to ensure adequate
nutrition, and to encourage ongoing communication among all team members.
Such care is essential to maximizing safe independent functioning of hospital-
ized older adults.
Use of Assessment Information
Knowledge of ADLs and IADLs, including shopping, housework, finances, food
preparation, medication administration, and transportation, is an important
part of providing individual nursing care for comprehensive discharge plan-
ning (Woolf, 1990 [Level VI]). In summary, for older people, the evaluation of
function represents the cornerstone of good nursing care and affords a sound
baseline by which to provide information essential to planning for continued
care across settings.
Case Study and Discussion
Mrs. Hope, a 74-year-old retired night nurse and recent widow, is admit-
ted to the hospital from her physician’s office. Her admitting diagnosis is
pneumonia, dehydration, and weakness. She is accompanied by her daugh-
ter. Her past medical history is significant for hypertension and COPD. She
is extremely hard of hearing but has refused to wear her hearing aide. She
smokes approximately 10 cigarettes a day, which she has done formore than
50 years. Her daughter admits that lately Mrs. Hope has been forgetting her
pills. She has also been losing weight despite a good appetite and intake.
Laboratory values indicate anemia with a very low hematocrit. A chest CT
scan reveals inoperable lung cancer and a bone scan indicates metastatic
bone disease.
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While on the unit, Mrs. Hope prefers to sleep in the recliner, saying
she is most comfortable there and prefers to nap during the day. Despite
intravenous fluids, oxygen therapy, occupational therapy for energy con-
servation, and round-the-clock acetaminophen for “aches and pains,” Mrs.
Hope continues to be weak and need assistance with daily bathing and am-
bulation. She is able to communicate well using an amplifier, after her ears
are cleaned for wax. She is assessed by the multidisciplinary care team
during the next several days. At the family conference, the staff shares
Mrs. Hope’s poor medical prognosis, declining ADLs, concerns for safety
and comfort, and available community services including hospice care. Mrs.
Hope, her daughter, and the care team all collaborate to plan for Mrs. Hope
to be discharged to her daughter’s home with hospice care.
This case study indicates the need to assess baseline function, changes
in function, and trajectory of function following acute care. Assessment in
this case used components from several standardized functional assess-
ment instruments and incorporated them into existing care routines. The
case relies on individual preferences and resources as well as the functional
level. Despite the level of function this case strives to maintain and en-
hancephysical functioningwithin the current care settingwithin a context of
safety.
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Box 3.1
Nursing Standard of Practice Protocol: Assessment of
Function in Acute Care
GOAL: The following nursing care protocol was designed to help bedside
nurses to monitor function in elders, to prevent decline, and to maintain
the function of elders during acute hospitalization.
OBJECTIVE: The goal of nursing care is to maximize physical functioning,
prevent or minimize decline in ADL function, and plan for future care
needs.
I. BACKGROUND
A. Functional status of individuals describes the capacity and perfor-
mance of safe ADLs and IADLs (Applegate et al., 1990 [Level IV];
Kane & Kane, 2000 [Level VI]; Katz et al., 1963 [Level I]; Lawton
& Brody, 1969 [Level IV]) and is a sensitive indicator of health or
illness in elders and therefore a critical nursing assessment (Byles,
2000 [Level I]; Campbell, et al., 2004 [Level I]; Kresevic & Holder,
1998 [Level VI]; Mezey, et al., 1993 [Level VI]).
B. Some functional decline may be prevented or ameliorated with
prompt and aggressive nursing intervention (e.g., ambulation, toilet-
ing schedules, enhanced communication, adaptive equipment, and
attention to medications and dosages) (Bates-Jensen et al., 2004
[Level V]; Counsell et al., 2000 [Level II]; Landefeld et al., 1995 [Level
II]; Palmer, Counsell, & Landefeld, 1998 [Level I]).
C. Some functional decline may occur progressively and is not re-
versible. This decline often accompanies chronic and terminal dis-
ease states such as degenerative joint disease, Parkinson’s disease,
dementia, heart failure, and cancer (Hirsch, 1990 [Level IV]).
D. Functional status is influenced by physiological aging changes, acute
and chronic illness, and adaptation to the physical environment.
Functional decline is often the initial symptom of acute illness such
as infections (e.g., pneumonia and urinary tract infection). These de-
clines are usually reversible and require medical evaluation (Ap-
plegate et al., 1990 [Level IV]; Sager & Rudberg, 1998 [Level II]).
Functional status is contingent on motivation, cognition, and sensory
capacity, including vision and hearing (Pearson, 2000 [Level VI]).
E. Risk factors for functional decline include injuries, acute illness,med-
ication side effects, pain, depression, malnutrition, decreased mobil-
ity, prolonged bedrest (including the use of physical restraints), pro-
longeduse of Foley catheters, and changes in environment or routines
(Counsell et al., 2000 [Level II]; Creditor, 1993 [Level VI]; Landefeld
et al., 1995 [Level II]).
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F. Additional complications of functional decline include loss of inde-
pendence, falls, incontinence, malnutrition, decreased socialization,
and increased risk for long-term institutionalization and depression
(Covinsky et al., 1998 [Level II]; Creditor, 1993 [Level VI]; Landefeld
et al., 1995 [Level II]). (See related chapters.)
G. Recovery of function can also be a measure of return to health,
such as for those individuals recovering from exacerbations of car-
diovascular or respiratory diseases and acute infections, recovering
from joint replacement surgery, or new strokes (Katz et al., 1963
[Level I]).
H. Functional status evaluation assists in planning future care needs
posthospitalization, such as short-term skilled care and home care
(Graf, 2006 [Level V]; Landefeld et al., 1995 [Level II]).
I. Physical environments of care with attention to the special needs
of older adults serve to maintain and enhance function (i.e., chairs
with arms, elevated toilet seat, levers versus doorknobs, enhanced
lighting) (Kresevic & Holder, 1998 [Level VI]; Landefeld et al., 1995
[Level II]).
II. ASSESSMENT PARAMETERS
A. Comprehensive functional assessment of elders includes indepen-
dent performance of basic ADLs, social activities, or IADLs; the as-
sistance needed to accomplish these tasks; and sensory ability, cogni-
tion, and capacity to ambulate. (Campbell et al., 2004 [Level I]; Doran
et al., 2006 [Level VI]; Freedman, Martin, & Schoeni, 2002 [Level I];
Kane & Kane, 2000 [Level VI]; Katz et al., 1963 [Level I]; Lawton
& Brody, 1969 [Level IV]; Lightbody & Baldwin, 2002 [Level VI];
McCusker, Kakuma, & Abramowicz, 2002 [Level I]; Tinetti & Gin-
ter, 1988 [Level I]).
1. Basic ADLs
a. Bathing
b. Dressing
c. Grooming
d. Eating
e. Continence
f. Transferring
2. IADLs
a. Meal preparation
b. Shopping
c. Medication administration
d. Housework
e. Transportation
f. Accounting
3. Mobility
a. Ambulation
b. Pivoting
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B. Elderly patients may view their health in terms of how well they can
function rather than in terms of disease alone. Strengths should be
emphasized aswell as needs for assistance (Dopp& Jeste, 2006 [Level
I]; Pearson, 2000 [Level VI]).
C. The clinician should document baseline functional status and recent
or progressive decline in function (Graf, 2006 [Level V]).
D. Function should be assessed over time to validate capacity, decline,
or progress (Applegate, 1990 [Level VI]; Callahan et al., 2002 [Level
VI]; Kane & Kane, 2000 [Level VI]).
E. Standard instruments selected to assess function should be effi-
cient to administer and easy to interpret. They should provide useful
practical information for clinicians and be incorporated into rou-
tine history taking and daily assessments (Kane & Kane, 2000 [Level
VI]; Kresevic & Holder, 1998 [Level VI]). (See Function topic at
www.ConsultGeriRN.org for tools.)
F. Interdisciplinary communication regarding functional status, chan-
ges, and expected trajectory should be part of all care settings (Coun-
sell et al., 2000 [Level II]; Kresevic & Holder, 1998 [Level VI]; Lan-
defeld et al., 1995 [Level II]).
G. Multidisciplinary team conferences including patient and family
whenever possible (Covinsky et al., 1998 [Level II]; Kresevic &
Holder, 1998 [Level VI]).
III. CARE STRATEGIES
A. Strategies to maximize functional status and to prevent decline:
1. Maintain individual’s daily routine. Help to maintain physical,
cognitive, and social function through physical activity and so-
cialization. Encourage ambulation, allow flexible visitation in-
cluding pets, and encourage reading of the newspaper (Kresevic
& Holder, 1998 [Level VI]; Landefeld et al., 1995 [Level II]).
2. Educate elders, family, and formal caregivers on the value of inde-
pendent functioning and the consequences of functional decline
(Graf, 2006 [Level V]; Kresevic & Holder, 1998 [Level VI]; Vass,
Avlund, Lauridsen, & Hendriksen, 2005 [Level II]).
a. Physiological and psychological value of independent func-
tioning.
b. Reversible functional decline associated with acute illness
(Hirsch, 1990 [Level VI]; Sager & Rudberg, 1998 [Level II]).
c. Strategies to prevent functional decline: exercise, nutrition,
pain management, and socialization (Kresevic & Holder, 1998
[Level VI]; Landefeld et al., 1995 [Level II]; Siegler, Glick, &
Lee, 2002; Tucker et al., 2004 [Level VI]).
d. Sources of assistance to manage decline.
3. Encourage activity, including routine exercise, range of motion,
and ambulation to maintain activity, flexibility, and function
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(Counsell et al., 2000 [Level II]; Landefeld et al., 1995 [Level II];
Pedersen & Saltin, 2006 [Level I]).
4. Minimize bedrest (Bates-Jensen et al., 2004 [Level VI]; Covinsky
et al., 1998 [Level II]; Landefeld et al., 1995 [Level II]; Kresevic &
Holder, 1998 [Level VI]).
5. Explore alternatives to physical-restraints use (Covinsky et al.,
1998 [Level II]; Kresevic & Holder, 1998 [Level VI]). (See chapter
22, Physical Restraints and Side Rails in Acute and Critical Care
Settings: Legal, Ethical, and Practice Issues.)
6. Judiciously use medications, especially psychoactive medica-
tions, in geriatric dosages (Inouye, 1998 [Level III]). (See chapter
12, Reducing Adverse Drug Events.)
7. Assess and treat for pain (Covinsky et al., 1998 [Level II]).
8. Design environments with handrails, wide doorways, raised toi-
let seats, shower seats, enhanced lighting, low beds, and chairs of
various types and height (Kresevic et al., 1998 [Level VI], Cun-
ningham & Michael, 2004 [Level I]).
9. Help individuals regain baseline function after acute illnesses
by using exercise, physical therapy consultation, nutrition, and
coaching (Conn, Minor, Burks, Rantz, & Pomeroy, 2003 [Level I]);
Engberg, Serika, McDowell, Weber, & Brodak, 2002 [Level II];
Forbes, 2005 [Level VI]; Hodgkinson, Evans, &Wood, 2003 [Level
I]; Kresevic et al., 1998 [Level V]).
10. Obtain assessment for physical and occupational therapies
needed to help regain function (Covinsky et al., 1998 [Level II]).
B. Strategies to help older individuals cope with functional decline
1. Help older adults and family members determine realistic func-
tional capacity with interdisciplinary consultation (Kresevic &
Holder, 1998 [Level VI]).
2. Provide caregiver education and support for families of individ-
uals when decline cannot be ameliorated despite nursing and
rehabilitative efforts (Graf, 2006 [Level V]).
3. Carefully document all intervention strategies and patient re-
sponse (Graf, 2006 [Level V]).
4. Provide information to caregivers on causes of functional decline
related to acute and chronic conditions (Covinsky et al., 1998
[Level II]).
5. Provide education to address safety care needs for falls, injuries,
and common complications. Short-term skilled care for physical
therapy may be needed; long-term care settings may be required
to ensure safety (Covinsky et al., 1998 [Level II]).
6. Provide sufficient protein and caloric intake to ensure adequate
intake and prevent further decline. Liberalize diet to include per-
sonal preferences (Edington et al., 2004 [Level II]; Landefeld et
al., 1995 [Level II]).
7. Provide caregiver support community services, such as home
care, nursing, and physical and occupational therapy services to
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manage functional decline (Covinsky et al., 1998 [Level II]; Graf,
2006 [Level V]).
IV. EXPECTED OUTCOMES
A. Patients can:
1. Maintain safe level of ADLs and ambulation.
2. Make necessary adaptations to maintain safety and indepen-
dence, including assistive devices and environmental adapta-
tions.
3. Strive to attain highest quality of life despite functional level.
B. Providers can demonstrate:
1. Increased assessment, identification, and management of pa-
tients susceptible to or experiencing functional decline. Routine
assessment of functional capacity despite level of care.
2. Ongoing documentation and communication of capacity, inter-
ventions, goals, and outcomes.
3. Competence in preventive and restorative strategies for function.
4. Competence in assessing safe environments of care that foster
safe independent function.
C. Institution will experience:
1. System-wide incorporation of functional assessment.
2. A reduction in incidence and prevalence of functional decline.
3. A decrease inmorbidity andmortality rates associated with func-
tional decline.
4. Reduction in the use of physical restraints, prolonged bedrest,
Foley catheters.
5. Decreased incidence of delirium.
6. An increase in prevalence of patients who leave hospital with
baseline or improved functional status.
7. Decreased readmission rate.
8. Increased early utilization of rehabilitative services (i.e., occupa-
tional and physical therapy).
9. Support of institutional policies and programs that promote func-
tion.
10. Evidence of geriatric-sensitive physical-care environments that
facilitate safe independent function, such as caregiver educa-
tional efforts and walking programs.
11. Evidence of continued interdisciplinary assessments, care plan-
ning, and evaluation of care related to function.
VII. RELEVENT PRACTICE GUIDELINES
Several resources are now available to guide adoption of evidenced-
based nursing interventions to enhance function in older adults.
A. AHRQ Clinical Practice Guidelines, 1996. Accessed October 2006.
http://www.ahrq.gov/clinic/cpgonline.htm
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B. Joanna Briggs Best Practice, McGill University Web site. Accessed
October 2006. http://www.muhc-ebn.mcgill.ca/
C. Joanna Briggs Best Practice, McGill University Web site. Accessed
October 2006. http://www.muhc-ebn.mcgill.ca/EBN tools.htm
D. National Quality Forum Web site. Accessed October 2006. http://
www.qualityforum.org/nursing/defult.htm
E. Registered Nurses Association of Ontario (RNAO)/NGC, 2005,
McGill University Web site. Accessed October 2006. http://www.
muhc-ebn.mcgill.ca/EBN tools.htm
F. Geriatric Protocols - University of Iowa www.nursing.uiowa.edu/
centers/gnirc/protocols.htm
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Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. discuss the importance of assessing cognitive
function
2. describe the goals of assessing cognitive function
3. compare and contrast the clinical features of
delirium, dementia, and depression
4. incorporate the assessment of cognitive function
into daily practice
Overview
Cognitive functioning comprises perception, memory, and thinking—the pro-
cesses by which a person perceives, recognizes, registers, stores, and uses in-
formation (Foreman & Vermeersch, 2004 [Level I]). Cognitive functioning can
be affected, positively and negatively, by illness and its treatment. Consequently,
assessing an individual’s cognitive functioning is paramount for identifying
the presence of specific pathological conditions, such as dementia and delir-
ium; for monitoring the effectiveness of various health interventions; and for
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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determining an individual’s readiness to learn and ability to make decisions
(Foreman &Vermeersch, 2004 [Level I]). Despite the importance of assessment,
physicians and nurses routinely fail to assess an individual’s cognitive function-
ing (Foreman & Milisen, 2004 [Level I]). This has profoundly serious conse-
quences that include the failure to detect a potentially correctable condition of
cognitive impairment and death (Inouye, Foreman, Mion, Katz, & Cooney, 2001
[Level IV])—outcomes that could be prevented or minimized by early recogni-
tion of their existence afforded by the routine assessment of cognitive function-
ing (Foreman &Milisen, 2004 [Level I]). More important, given that nurses tend
to have themost frequent and longest duration of contact with individuals seek-
ing health care, they are instrumental for the early recognition of impairment
and monitoring of cognitive functioning (Milisen, Braes, Fick, & Foreman, 2006
[Level VI]).
Background and Statement of Problem
Declines in cognitive functioning are a hallmark of aging (McEvoy, 2001 [Level
VI]); however, most declines in cognition with aging are not pathological. Exam-
ples of nonpathological changes include a diminished ability to learn complex
information, a delayed response time, andminor loss of recentmemory; declines
are especially evident with complex tasks or with those requiring multiple steps
for completion (McEvoy, 2001 [Level VI]).
Pathological conditions of cognitive impairment that are prevalent with ag-
ing include delirium, dementia, and depression (Table 4.1 compares the clin-
ical features among delirium, dementia, and depression. See also chapter 6,
Dementia, and chapter 7, Delirium). There are protocols to prevent and treat
delirium and protocols to slow the progression of decline with dementia; how-
ever, these opportunities exist only when and if these conditions are detected
early, and the possibility of early detection exists only when cognitive func-
tion is assessed systematically (Chow & MacLean, 2001 [Level I]; Registered
Nurse Association of Ontario [RNAO], 2003 [Level I]). Without systematic as-
sessment, these pathological conditions go unchecked, and the individuals with
these conditions face much greater accelerated and long-term cognitive and
functional decline and death (Fick, Agostini, & Inouye, 2002 [Level I]; Fick &
Foreman, 2000 [Level IV]; Hopkins & Jackson, 2006 [Level IV]; Lang et al.,
2006 [Level IV]). Health care providers report greater frustration and job stress
in caring for these individuals (Milisen et al., 2004 [Level IV]), and the cost
of providing care to these individuals is much greater (Milbrandt et al., 2004
[Level IV]).
Despite these profoundly negative consequences for the afflicted individu-
als and their families, as well as for their care providers, nurses and physicians
fail to assess cognitive function (Ely et al., 2004 [Level IV]; Foreman & Milisen,
2004 [Level I]; Inouye et al., 2001 [Level IV]). Yet, it is clear that the assessment
of cognitive function is the first and most crucial step in a cascade of strategies
to prevent, reverse, halt, or minimize cognitive decline (Chow & MacLean, 2001
[Level I]; RNAO, 2003 [Level I]). Thus, the purpose of this chapter is to provide
a best practice protocol for the assessment of cognitive function, see Box 4.1.
4.1 A Comparison of the Clinical Features of Delirium,Dementia, and Depression
Clinical
Feature Delirium Dementia Depression
Onset Sudden/abrupt; depends
on cause; often at
twilight
Insidious/slow and often
unrecognized;
depends
on cause
Coincides with major life
changes; often abrupt but
can be gradual
Course Short; diurnal fluctuations
in symptoms; worse at
night, in darkness, and
on awakening
Long, no diurnal effects,
symptoms
progressive
yet relatively stable
over time, may see
deficits with
increased stress
Diurnal effects, typically
worse in the morning;
situational fluctuations in
symptoms but less than
with delirium
Progression Abrupt Slow but uneven Variable; rapid or slow but
generally even
Duration Hours to less than
1 month; longer if
unrecognized and
untreated
Months to years At least 6 weeks, can be
several months to years
Consciousness Disturbed Clear Clear
Alertness Fluctuates from stuporous
to hypervigilant
Generally normal Normal
Attention Inattentive, easily
distractible and may
have difficulty shifting
attention from one focus
to another
Generally normal Minimal impairment but is
distractible
Orientation Generally impaired;
disoriented to time and
place, should not be
disoriented to person
Generally normal Selective disorientation
Memory Recent and immediate
impaired; unable to
recall events of
hospitalization
and current illness;
forgetful, unable to
recall instructions
Recent and remote
impaired
Selective or “patchy”
impairment, “islands” of
intact memory, evaluation
often difficult due to low
motivation
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4.1 A Comparison of the Clinical Features of Delirium,Dementia, and Depression
Clinical
Feature Delirium Dementia Depression
Thinking Disorganized; rambling,
irrelevant and
incoherent
conversation; unclear or
illogical flow of ideas
Difficulty with
abstraction, thoughts
impoverished;
judgment impaired;
words difficult to find
Intact but with themes of
hopelessness,
helplessness, or
self-deprecation
Perception Perceptual disturbances
such as illusions and
visual and auditory
hallucinations;
misperceptions of
common people and
objects
Misperceptions usually
absent
Intact; delusions and
hallucinations absent
except in severe cases
Psychomotor
behavior
Variable; hypoactive,
hyperactive, and mixed
Normal, may have
apraxia
Variable; psychomotor
retardation or agitation
Associated
features
Variable affective changes;
symptoms of autonomic
hypo-hyper-arousal
Affect tends to be
superficial,
inappropriate, and
labile; attempts to
conceal deficits in
intellect; personality
changes, aphasia,
agnosia may be
present; lacks insight
Affect depressed; dysphoric
mood, exaggerated and
detailed complaints;
preoccupied with personal
thoughts; insight present;
verbal elaboration;
somatic complaints; poor
hygiene; and neglect of self
Assessment Distracted from task; fails
to remember
instructions, frequent
errors without notice
Failings highlighted by
family, frequent “near
miss” answers,
struggles with test,
great effort to
find an appropriate
reply, frequent
requests for feedback
on performance
Failings highlighted by
individual; frequent “don’t
know” answers, little
effort; frequently gives up;
indifferent toward test:
does not care or attempt to
find answer
Source: Adapted from Foreman et al. (2003). Assessing cognitive functioning. In M. Mezey et al., Geriatric nursing
protocols for best practice (2nd ed., pp. 102–103). New York: Springer Publishing Company.
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Assessment of Cognitive Functioning
Reasons for Assessing Cognitive Functioning
As mentioned previously, there are several reasons or purposes for assessing
an individual’s cognitive functioning, described as follows.
Screening is conducted to determine the presence or absence of impairment.
Information obtained in screening can be useful for determining whether the
individual is cognitively impaired; however, bedside screening methods such
as those described herein (e.g., Mini-Mental State Examination [MMSE] and
Mini-Cog) are not useful in and of themselves for diagnosing specific patholog-
ical conditions of impairment such as delirium or dementia. Screening is also
an important element in determining an individual’s readiness to learn and ca-
pacity to consent (Assessing Care of Vulnerable Elders [ACOVE] Investigators,
2001 [Level I]). As a result, screening activities enable the early detection of
impairment that affords the opportunity to determine the nature of the impair-
ment. That is, is the impairment delirium, dementia, or depression, or possibly
one superimposed on another? Only through early detection can treatment be
initiated promptly and accurately to either reverse, halt, or slow the progression
of impairment (Chow & MacLean, 2001 [Level I]; RNAO, 2003 [Level I]).
Monitoring is conducted to track cognitive function over time as a means for
following the progression or regression of impairment, especially in response
to treatment (ACOVE Investigators, 2001 [Level I]; RNAO, 2003 [Level I]).
How to Assess Cognitive Functioning
For assessing cognitive functioning, Folstein’s MMSE (Folstein, Folstein, &
McHugh, 1975 [Level IV]) is the most frequently recommended instrument
(British Geriatrics Society, 2005 [Level I]; Brodaty, Low, Gibson, & Burns, 2006
[Level I]; Fletcher, 2007 [Level VI]; Michaud et al., 2007 [Level I]; Milisen et al.,
2006 [Level VI]; O’Keefe, Mulkerrin, Nayeem, Varughese, & Pillay., 2005 [Level
IV]; RNAO, 2003 [Level I]; Scottish Intercollegiate Guidelines Network, 2005
[Level I]; Tullman, Mion, Fletcher, & Foreman, 2007 [Level VI]). The MMSE has
been the most commonly used screening instrument for cognitive functioning
for more than 25 years because it is brief, it consists of 11 items and takes about
7 to 10 minutes to complete, and it is easy to use. It is composed of items assess-
ing orientation, attention, memory, concentration, language, and constructional
ability (Tombaugh &McIntyre, 1992 [Level I]). Each question is scored as either
correct or incorrect; the total score ranges from 0 to 30 and reflects the number
of correct responses. A score of less than 24 is considered evidence of impaired
cognition (Tombaugh & McIntyre, 1992 [Level I]).
Although considered the best available method for screening for impair-
ment, the performance on the MMSE is significantly influenced by education
(individuals with less than an eighth-grade education commit more errors), lan-
guage (individuals for whomEnglish is not their primary language commitmore
errors), verbal ability (the MMSE can only be used with individuals who can re-
spond verbally to questioning), and age (older people do less well) (Tombaugh
& McIntyre, 1992 [Level I]). Others contend that the MMSE takes too long to
administer (Borson, Scanlan, Watanabe, Tu, & Lessig, 2005 [Level IV]). Despite
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these limitations, it remains the most frequently recommended and most com-
monly used tool to assess cognitive functioning.
Tominimize the limitations of theMMSEwhilemaximizing practical aspects
of assessing cognitive function, the Mini-Cog was developed (Borson, Scan-
lan, Brush, Vitaliano, & Dokmak, 2000 [Level IV]). The aim was to have a brief
screening test that required no equipment and little training to use while not
being negatively influenced by age, education, or language (Borson et al., 2000
[Level IV]; Borson et al., 2005 [Level IV]). TheMini-Cog is a four-item screening
test consisting of a three-item recall similar to the MMSE and a clock-drawing
item. For the three-item recall, the individual is asked to listen to three unrelated
words, repeat them, and, finally, remember them for later. The individual is then
asked to draw the face of a clock, number the clock face, and place the hands on
the clock face to indicate a specific time, such as 10:20. The individual is then
asked to recall the three items he or she was previously instructed to remember.
Each item correctly recalled receives 1 point for a total of 3 points; a correctly
drawn clock face receives 2 points, for a total score of 5 (Borson et al., 2000
[Level IV]). If any error is made in drawing the clock, no points are assigned.
Since its initial development in 2000, the Mini-Cog has been used with var-
ious samples of people from different cultural, educational, age, and language
backgrounds. In a recent systematic review, it was reported that the Mini-Cog
was suitable for the routine screening for cognitive impairment (Brodaty et al.,
2006 [Level I]); even more recently, it was found to predict the development of
in-hospital delirium (Alagiakrishnan et al., 2007 [Level IV]).
The fact that most practice guidelines and systematic reviews recommend
the use of the MMSE for systematic screening of cognitive functioning does not
necessarily mean it is the best instrument for this purpose. Using it is benefi-
cial, but studies in which the performance of the MMSE and the Mini-Cog are
compared in the same subjects have demonstrated the Mini-Cog to be more
accurate while less influenced by age, education, and language (Brodaty et al.,
2006 [Level I]). Moreover, the Mini-Cog takes about half the time to administer
and score than the MMSE, making the practical value of the Mini-Cog greater
than the MMSE. However, more research is needed on this topic (Brodaty et al.,
2006 [Level I]).
Both the MMSE and the Mini-Cog are classified as simple bedside cognitive
screens. This means that they are both qualified for determining the presence
or absence of cognitive impairment; however, neither is capable of indicating
whether the impairment is delirium, dementia, or depression. If the results
of this cognitive assessment or screening indicate that the individuals are im-
paired, further evaluation is necessary to confirm a diagnosis of dementia, de-
pression, delirium, or some other health problem (Brodaty et al., 2006 [Level I]).
One example of a diagnostic instrument is the Confusion Assessment Method
(Inouye et al., 1990 [Level IV]) for diagnosing delirium; other instruments use-
ful for diagnosing dementia and delirium and these diagnostic instruments are
discussed in greater detail in chapters 6, Dementia and 7, Delirium: Prevention,
Early Recognition, and Treatment.
When to Assess Cognitive Functioning
When and how frequently to assess cognitive functioning, using either the
MMSE or Mini-Cog, is in part a function of the purpose for the assessment,
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the condition of the patient, and the results of prior or current testing.
Recommendations for the systematic assessment of cognition using standard-
ized and validated tools include the following:
■ On admission to and discharge from an institutional care setting (ACOVE
Investigators, 2001 [Level I]; British Geriatric Society, 2005 [Level I])
■ On transfer from one care setting to another (ACOVE Investigators, 2001
[Level I])
■ During hospitalization, every 8 to 12 hours throughout hospitalization
(http://www.icudelirium.org/delirium)
■ As follow-up to hospital care, within 6 weeks of discharge (ACOVE In-
vestigators, 2001 [Level I])
■ Before making important health care decisions as an adjunct to deter-
mining an individual’s capacity to consent (ACOVE Investigators, 2001
[Level I])
■ On the first visit to a new care provider (ACOVE Investigators, 2001
[Level I])
■ Following major changes in pharmacotherapy (ACOVE Investigators,
2001 [Level I])
■ With behavior that is unusual for the individual and/or inappropriate to
the situation (Foreman & Vermeersch, 2004 [Level I])
It also is recommended that formal cognitive testing, with either the MMSE
or Mini-Cog, be supplemented with information from intimate others (Cole et
al., 2002 [Level II]; RNAO, 2003 [Level I]) and from naturally occurring ob-
servations and conversations (Foreman et al., 2003 [Level VI]). One method
for obtaining information from intimate others (Cole et al., 2002 [Level II]) is
through the use of the Informant Questionnaire on Cognitive Decline in the
Elderly (IQCDE) (Jorm, 1994 [Level IV]). Obtaining information from intimate
others about an individual’s cognitive functioning assists in determining the
duration of impairment necessary for determining whether the impairment is
delirium or dementia (see chapters 6, Dementia and 7, Delirium: Prevention,
Early Recognition, and Treatment). However, naturally occurring observations
and conversations during everyday nursing care activities in which it becomes
apparent that an individual is inattentive and responding unusually or inappro-
priately to conversation or questioning may be the first indication of the need
to assess the individual’s cognitive functioning.
Cautions for Assessing Cognitive Functioning
When assessing cognitive functioning, various characteristics of the physical
assessment environment should be considered to ensure that the results of the
assessment accurately reflect the individual’s abilities and not extraneous fac-
tors. Overall, the ideal assessment environment should maximize the comfort
and privacy of both the assessor and the individual. With respect to the indi-
vidual, the environment should enhance performance by maximizing the indi-
vidual’s ability to participate in the assessment process (Dellasega, 1998 [Level
VI). To accomplish this, the room should be well lit and of comfortable ambient
temperature so that neither participant is distracted from the cognitive task.
Lighting must be balanced to be sufficient for the individual to adequately see
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the examination materials while not being so bright as to create glare. Also, the
assessment environment should be free from distractions that can result from
extraneous noise, scattered assessment materials, or brightly colored and/or
patterned clothing and flashy jewelry on the assessor (Lezak, Howieson, & Lor-
ing, 2004 [Level VI]).
Regarding the interpersonal environment, it will be vital to prepare the in-
dividual for the assessment; explaining what will take place and how long it will
take reduces anxiety and creates an emotionally nonthreatening environment
and a safe individual–assessor relationship (Engberg & McDowell, 1999 [Level
VI]). Performing the assessment in the presence of others should be avoided
when possible because the other individual may be distracting. If the other is a
significant intimate relative, additional problems arise. For example, when the
individual fails to respond or responds in error, significant others have been
known to provide the answer or to make comments such as, “Now, you know the
answer to that” or “Now, you know that’s wrong.” Inmost instances, the presence
of another only heightens anxiety. Rarely does the presence of another facilitate
theperformanceof an individual on cognitive assessment.Older adults are espe-
cially sensitive to any insinuation that they may have some “memory problem”;
therefore, the dilemma for the assessor is to stress the importance of the assess-
ment while taking care not to increase the individual’s anxiety. It is important
to create an environment in which the individual is motivated to perform and
to perform well while not being overly anxious and, therefore, perform poorly.
Similarly, it can be counterproductive to describe the assessment as consisting
of “simple,” “silly,” or “stupid” questions. Such explanations tend to diminish
motivation to perform and only heighten anxiety when errors are committed.
Anxiety also is heightened following a series of failures on assessment.
Various characteristics of the assessor and individual should also be consid-
ered. The assessment of cognitive functioning can be perceived by the individual
as intrusive, intimidating, fatiguing, and offensive—characteristics that can seri-
ously and negatively affect performance. Consequently, Lezak et al. (2004 [Level
VI]) recommend an initial period to establish rapport with the individual. This
period also allows a determination of the individual’s capacity for assessment.
For example, this period can be used to establish whether the individual has any
special problems that could influence testing or its interpretation (e.g., sensory
decrements). With elderly individuals who may have some decrements in sen-
sory abilities, the assessor can improve the examinee’s ability to perform through
simple methods. For example, if the individual has any degree of hearing im-
pairment, taking a position across from the assessor or a little to the side may
enhance hearing. In this position, the individual can readily use the assessor’s
nonverbal communication as well as read the assessor’s lips. Both strategies im-
prove communication and therefore assessment. Sitting or standing a little to the
side of the ear with the better auditory function of the individual also improves
better hearing. Positioning also is important relative to lighting and glare.
When selecting the most suitable moment for assessing an individual’s cog-
nitive status, one should generally avoid periods immediately on awakening
from sleep (wait at least 30 minutes), immediately before and after meals, im-
mediately before and after medical diagnostic or therapeutic procedures, and
when the individual is in pain or is uncomfortable. By avoiding these periods,
performance ismore likely to reflect the individual’s cognitive abilities (Foreman
et al., 2003 [Level VI]).
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Case Study and Discussion
Mrs. O. is a 79-year-old retired nurse who lives at home with her husband,
who is physically frail. Mrs. O. was diagnosed with probable Alzheimer’s
disease approximately 3 years ago. In addition, she has Type II diabetes that
is generally well controlled on Actoplus (i.e., pioglitazone hydrochloride and
metformin hydrochloride). She and her husband are able to remain living
in their own home because of help from their children, neighbors, friends,
and a monthly visit from a home health nurse. Mrs. O. is quite mobile but
recently has begun to wander at times. Her husband reports that she seems
more confused in the past few days and has fallen twice since yesterday.
There is evidence ofminor physical injury, whichMrs. O. insists is “nothing.”
Her husband also is concerned that she has not been taking her Actoplus as
prescribed; although she has been eating okay, he is concerned that she has
not been drinking enough. Because of these concerns, he calls the home
health nurse to come and evaluate the situation because he is concerned
that his wife may need urgent attention. [Mr. O.’s concerns are real and the
call to the home health nurse is appropriate.]
When the nurse arrives, she assesses Mrs. O., including her cognitive
functioning. The results of her assessmentwith theMMSE indicate thatMrs.
O.’s cognitive functioning has deteriorated significantly since the nurse’s
visit 2 weeks ago. Mrs. O. is more disoriented to time and place, is more eas-
ily distracted, her conversation is disorganized, and shehas greater difficulty
following commands and remembering simple objects. She scored 18 out of
30 on theMMSE 2weeks ago, which is usual for her, but now scores 12 out of
30. In talkingwith thehusband, thenurse learns that these changes occurred
in the past 2 days. The nurse suspects delirium, as evidenced by the sudden
and dramatic decline in Mrs. O.’s cognitive abilities. The nurse thinks that
Mrs. O. may be severely dehydrated because her diabetes is no longer con-
trolled and is concerned about impending hyperosmolar, nonketotic coma.
The nurse seeks an emergency admission to the local hospital for further
diagnostic work to determine the cause for her suspected delirium; is she
hyperglycemic and dehydrated? [The nurse’s suspected diagnosis is cer-
tainly a health emergency warranting further diagnostic workup to confirm
a diagnosis of delirium and the identification of the underlying causes.]
Mrs. O. is admitted with a diagnosis of mental-status changes. On ad-
mission to the hospital, the nurse describes Mrs. O. as “cooperative, lying
quietly in bed, but being slow to respond.” Being short staffed that day and
given Mrs. O.’s history of dementia, the hospital nurse decides that the hus-
band is being overprotective and that these changes are merely a worsening
of her dementia and nothing new. The nurse moves on to other patients and
more “important” patient-care concerns. A couple of hours later, the nurse
goes back to check on Mrs. O., only to find her obtunded, unresponsive to
physical stimuli, hypotensive, and tachycardic. The nurse calls a code, but
Mrs. O. fails to respond and dies. [What went wrong here? It is likely that the
assessment performed by the home health nurse was not transmitted to the
nurse in the hospital. Thus, vital information was missing, and the nurse in
the hospital was working at a disadvantage.] In addition, it is not uncommon
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for health care providers to assume that an older person’s confusion is a
result of either age or an exacerbation of an underlying dementia or both
(Fick&Foreman, 2000 [Level IV]). However, this is an erroneous assumption
and, in this case, dangerous because the undetected worsening of Mrs. O.’s
cognitive impairment resulted in lack of treatment of the underlying hyper-
glycemia and severe dehydration, leading to her eventual death. The cascade
of mortal events could have been prevented with detection of the impair-
ment, diagnosis of delirium, and prompt treatment of the underlying cause.
Summary and Conclusions
The determination of an individual’s cognitive status is critical in the process
and outcomes of illness and its treatment. Being competent in the assessment
of cognitive functioning requires (1) knowledge and skill as they relate to the
performance of the assessment of cognitive functioning, (2) sensitivity to the
issues that can negatively bias the results and interpretation of this assessment,
(3) accurate and comprehensive documentation of the assessment, and (4) the
incorporation of the results of the assessment in the development of the indi-
vidual’s plan of care.
Resources
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Mini-Mental State (Tombaugh & McIntyre, 1992 [Level I]). Retrieved March 9,
2007, from http://www.minimental.com
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from http://fm.iowa.uiowa.edu/fmi/xsl/iigat/index.xsl
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older adults sponsored by The Hartford Institute for Geriatric Nursing at
New York University College of Nursing. Retrieved March 9, 2007, from
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March 9, 2007, from http://rnao.org/Page.asp?PageID=924&ContentID=818
The U.S. Preventive Services Task Force recommendations for Screening for
Dementia. Retrieved March 9, 2007, from http:www.ahrq.gov/clinic/cps3dix.
htm
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Recommendations for the early detection of dementia from The American
Academy of Neurology. Retrieved March 9, 2007, from http://aan.com/
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Geriatric Toolkits. Retrieved March 9, 2007, from http://www.gericareonline.
net/tools/index.html
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trieved March 9, 2007, from http://www.contexio.com/englishversion.htm
The Health Service/Technology Assess Text Service of the National Library of
Medicine provides full text documents of information for making health de-
cisions. Retrieved March 9, 2007, from http://hstat.nlm.nih.gov/hg/Hquest
The National Guideline Clearinghouse. http://www.guideline.gov
Treating delirium: A quick reference guide, by the American Psychiatric Asso-
ciation. Retrieved March 9, 2007, from http://www.psych.org/psych pract/
treatg/pg/prac guide.cfm
British Geriatrics Society Guidelines for the prevention, diagnosis, and manage-
ment of delirium in older people in hospital. Retrieved March 9, 2007, from
http://www.bgs.org.uk/publications/Publications%20Downloads/Delirium-
2006.DOC
Delirium & Cognitive Impairment Study Group (2006). Brain dysfunction in crit-
ically ill patients.RetrievedMarch 9, 2007, from http://www.icudelirium.org/
delirium/
European Delirium Association Web site. Retrieved March 9, 2007, from http://
www.europeandeliriumassociation.com
Assessing care of vulnerable elders (ACOVE). Retrieved March 9, 2007, from
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Box 4.1
Nursing Standard of Practice Protocol: Assessing
Cognitive Functioning
I. GOAL: The goals of cognitive assessment include:
A. To determine an individual’s cognitive abilities.
B. To recognize early the presence of an impairment in cognitive func-
tioning.
C. To monitor an individual’s cognitive response to various treatments.
II. OVERVIEW
A. Undetected impairment in cognition is associated with greater mor-
bidity and mortality (Inouye et al., 2001 [Level IV]).
B. Assessing cognitive function is the foundation for early detection
and prompt treatment of impairment (ACOVE Investigators, 2001
[Level I]).
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III. BACKGROUND AND STATEMENT OF PROBLEM
A. Definition of cognitive functioning includes the processes by which
an individual perceives, registers, stores, retrieves, and uses infor-
mation.
B. Conditions in which cognitive functioning is impaired:
1. The Dementias (e.g., Alzheimer’s or vascular) are a syndrome of
cognitive deterioration that involves memory impairment and a
disturbance in at least one other cognitive function (e.g., apha-
sia, apraxia, or agnosia) that results in changes in function and
behavior (APA, 2000).
2. Delirium is a disturbance of consciousness with impaired atten-
tion and disorganized thinking that develops rapidly. Evidence
of an underlying physiologic or medical condition is generally
present (APA, 2000).
3. Depression is a syndrome of either depressed mood or loss of
interest or pleasure in most activities of the day. These symptoms
represent a change from usual functioning for the individual and
have been present for at least 2 weeks (APA, 2000).
IV. ASSESSMENT OF COGNITIVE FUNCTION
A. Reasons/Purposes of Assessment
1. Screening: to determine the absence or presence of impairment
(Foreman et al., 2003 [Level VI]).
2. Monitoring: to track cognitive status over time, especially re-
sponse to treatment (Foreman et al., 2003 [Level VI]).
B. How to Assess Cognitive Function
1. Mini-Mental State Examination (Folstein et al., 1975 [Level IV])
can be used to screen for or monitor cognitive function in-
strument; however, performance on the MMSE is adversely in-
fluenced by education, age, language, and verbal ability. The
MMSE also is criticized for taking too long to administer and
score.
2. Mini-Cog (Borson et al., 2000 [Level IV]) also can be used to
screen and monitor cognitive function; is not adversely influ-
enced by age, language, and education; and it takes about half
as much time to administer and score as the MMSE.
3. IQCDE is useful to supplement testing with the MMSE or Mini-
Cog because it is useful to determine onset, duration, and
functional impact of the cognitive impairment. Information from
intimate others can be obtained by using the InformantQuestion-
naire on Cognitive Decline in the Elderly (IQCDE) (Jorm, 1994
[Level IV]).
4. Naturally occurring interactions: Observations and conversations
during naturally occurring care interactions can be the impetus
for additional screening/monitoring of cognitive functionwith the
MMSE or Mini-Cog (Foreman et al., 2003 [Level VI]).
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C. When to Assess Cognitive Function
1. On admission to and discharge from an institutional care setting
(ACOVE Investigators, 2001 [Level I]; British Geriatric Society,
2005 [Level I]).
2. On transfer from one care setting to another (ACOVE Investiga-
tors, 2001 [Level I]).
3. During hospitalization, every 8 to 12 hours throughout hospital-
ization (http://www.icudelirium.org/delirium).
4. As follow-up to hospital care, within 6 weeks of discharge
(ACOVE Investigators, 2001 [Level I]).
5. Before making important health care decisions as an adjunct to
determining an individual’s capacity to consent (ACOVE Investi-
gators, 2001 [Level I]).
6. On the first visit to a new care provider (ACOVE Investigators,
2001 [Level I]).
7. Following major changes in pharmacotherapy (ACOVE Investi-
gators, 2001 [Level I]).
8. With behavior that is unusual for the individual and/or inappro-
priate to the situation (Foreman & Vermeersch, 2004 [Level I]).
D. Cautions for Assessing Cognitive Function
1. Physical environment (Dellasega, 1998 [Level VI]).
a. Comfortable ambient temperature.
b. Adequate lighting (i.e., not glaring).
c. Free of distractions (e.g., should be conducted in the absence
of others and other activities).
d. Position self to maximize individual’s sensory abilities.
2. Interpersonal environment (Engberg & McDowell, 1999 [Level
VI]).
a. Prepare individual for assessment.
b. Initiate assessment within nonthreatening conversation.
c. Let individual set pace of assessment.
d. Be emotionally nonthreatening.
3. Timing of assessment (Foreman et al., 2003 [Level VI]).
a. Select time of assessment to reflect actual cognitive abilities of
the individual.
b. Avoid the following times:
i. Immediately on awakening from sleep; wait at least 30min-
utes.
ii. Immediately before and after meals.
iii. Immediately before and after medical diagnostic or thera-
peutic procedures.
iv. In the presence of pain or discomfort.
V. EVALUATION/EXPECTED OUTCOMES
A. Patient
1. Is assessed at recommended time points.
54 Chapter 4
2. Any impairment detected early.
3. Care tailored to appropriately address cognitive status/impair-
ment.
4. Satisfaction with care improved.
B. Health Care Provider
1. Competent to assess cognitive function.
2. Able to differentiate among delirium, dementia, and depression.
3. Uses standardized cognitive assessment protocol.
4. Satisfaction with care improved.
C. Institution
1. Improved documentation of cognitive assessments.
2. Impairments in cognitive function identified promptly and accu-
rately.
3. Improved referral to appropriate advanced providers (e.g., geri-
atricians, geriatric nurse practitioners) for additional assessment
and treatment recommendations.
4. Decreased overall costs of care.
VI. FOLLOW-UP MONITORING
A. Provider competence in the assessment of cognitive function.
B. Consistent and appropriate documentation of cognitive assessment.
C. Consistent and appropriate care and follow-up in instances of im-
pairment.
D. Timely and appropriate referral for diagnostic and treatment rec-
ommendations.
VII. RELEVANT PRACTICE GUIDELINES
A. The Registered Nurse Association of Ontario Best Practice Guide-
line for Screening for Delirium, Dementia and Depression in Older
Adults. Retrieved March 9, 2007, from http://rnao.org/Page.asp?
PageID=924&ContentID=818
B. The U.S. Preventive Services Task Force recommendations for
Screening for Dementia. Retrieved March 9, 2007, from http:www.
ahrq.gov/clinic/cps3dix.htm
C. Recommendations for the early detection of dementia from The
American Academy of Neurology. Retrieved March 9, 2007, from
http://aan.com/professionals/practice/guideline/index.cfm?a=0&
fc=1.
D. The National Guideline Clearinghouse. http://www.guideline.gov.
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5Depression
Lenore H. Kurlowicz
Theresa A. Harvath
Educational
Objectives
On completion of this chapter, the reader will be
able to:
1. discuss the consequences of late-life depression
2. discuss the major risk factors for late-life
depression
3. identify the core competencies of a systematic
nursing assessment for depression with older
adults
4. identify nursing strategies for older adults with
depression
Depression in Older Adults
Contrary to popular belief, depression is not a normal part of aging. Rather,
depression is a medical disorder that causes suffering for patients and their
families, interferes with a person’s ability to function, exacerbates coexisting
medical illnesses, and increases utilization of health services (Lebowitz, 1996).
Despite the efficacious treatments available for late-life depression, many older
adults lack access to adequate resources; barriers in the health care reim-
bursement system are particular challenges for low-income and ethnicminority
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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elders (Charney et al., 2003). In a comprehensive review of research on the
prevalence of depression in later life, Hybels & Blazer (2003) found that al-
though major depressive disorders are not prevalent in late life (1% to 5%),
the prevalence of clinically significant depressive symptoms is high. What is
more, these depressive symptoms are associated with higher morbidity and
mortality rates in older adults (Bagulho, 2002 [Level V]; Lyness et al., 2007
[Level IV]).
The rates of depressive symptomsvary, dependingon thepopulationof older
adults: community-dwelling older adults (3% to 26%), primary care (10%), hospi-
talized elders (23%), and nursing home residents (16% to 30%) (Hybels & Blazer,
2003). Certain subgroups have higher levels of depressive symptoms, partic-
ularly those with more severe or chronic disabling conditions, such as those
older adults in acute- and long term care settings. Depression also frequently
coexists with dementia, specifically Alzheimer’s disease, with prevalence rates
ranging from 22% to 54% (Zubenko et al., 2003). Cognitive impairment may be a
secondary symptom of depression or depression may be the result of dementia
(Blazer, 2002; Blazer, 2003 [both Level VI]). The prevalence of major depression
has been increasing in those born more recently; therefore, it can be expected
that the prevalence of depression in older adults will increase in the years to
come.
Late-life depression occurs within a context of medical illnesses, disability,
cognitive dysfunction, and psychosocial adversity frequently impeding timely
recognition and treatment of depression, with subsequent unnecessary mor-
bidity and death (Bagulho, 2002 [Level V]; Lyness et al., 2007 [Level IV]). A
substantial number of older patients encountered by nurses will have clinically
relevant depressive symptoms. Nurses remain at the front line in the early
recognition of depression and the facilitation of older patients’ access tomental-
health care. This chapter presents an overview of depression in older patients,
with emphasis on age-related assessment considerations, clinical decisionmak-
ing, and nursing-intervention strategies for older adults with depression. A
standard of practice protocol for use by nurses in practice settings also is
presented.
What Is Depression?
In the broadest sense, depression is defined as a syndrome consisting of a
constellation of affective, cognitive, and somatic or physiological manifesta-
tions (National Institute of Health [NIH] Consensus Development Panel, 1992
[Level I]). Depressionmay range in severity frommild symptoms tomore severe
forms, both ofwhich can persist over longer periodswith negative consequences
for the older patient. Suicidal ideation, psychotic features (especially delusional
thinking), and excessive somatic concerns frequently accompany more severe
depression (NIH Consensus Development Panel, 1992 [Level I]). Symptoms of
anxiety may also coexist with depression in many older adults (Cassidy, Laud-
erdale, & Sheikh, 2005 [Level III]; DeLuca et al., 2005 [Level IV]). In fact, co-
morbid anxiety and depression have been associated with more severe symp-
toms, decreases in memory, poorer treatment outcomes (Deluca et al., 2005
[Level IV]; Lenze et al., 2001), and increased rates of suicidal ideation (Sareen
et al. [Level IV], 2005).
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Major Depression
The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (Amer-
ican Psychiatric Association, 2000 [Level VI]) lists criteria for the diagnosis of
major depressive disorder, the most severe form of depression. These criteria
are frequently used as the standard by which older patients’ depressive symp-
toms are assessed in clinical settings (American Psychiatric Association, 2000
[Level VI]). Five criteria from a list of nine must be present nearly every day
during the same 2-week period and must represent a change from previous
functioning: (1) depressed, sad, or irritable mood; (2) anhedonia or diminished
pleasure in usually pleasurable people or activities; (3) feelings of worthless-
ness, self-reproach, or excessive guilt; (4) difficulty with thinking or diminished
concentration; (5) suicidal thinking or attempts; (6) fatigue and loss of energy;
(7) changes in appetite and weight; (8) disturbed sleep; and (9) psychomotor
agitation or retardation. For this diagnosis, at least one of the five symptoms
must include either depressed mood, by the patient’s subjective account or ob-
servation of others, or markedly diminished pleasure in almost all people or
activities. Concurrent medical conditions are frequently present in older pa-
tients and should not preclude a diagnosis of depression; indeed, there is a high
incidence of medical co-morbidity.
Major depression, as defined by the DSM-IV-TR, seems to be as common
among older as younger cohorts. However, older adults may more readily re-
port somatic or physical symptoms than depressedmood (Pfaff & Almeida, 2005
[Level IV]). The somatic or physical symptoms of depression, however, are often
difficult to distinguish from somatic or physical symptoms associated with acute
or chronic physical illness, especially in hospitalized older patients, or the so-
matic symptoms that are part of common aging processes (Kurlowicz, 1994). For
instance, disturbed sleepmay be associatedwith chronic lung disease or conges-
tive heart failure. Diminished energy or increased lethargy may be caused by an
acutemetabolic disturbance or drug response. Therefore, a challenge for nurses
in acute care hospitals and other clinical settings is to not overlook or disregard
somatic or physical complaints while also “looking beyond” such complaints
to assess the full spectrum of depressive symptoms in older patients. In older
adults with acute medical illnesses, somatic symptoms that persist may indicate
amore seriousdepression, despite treatment of theunderlyingmedical illness or
discontinuance of a depressogenic medication (Kurlowicz, 1994). Older patients
may link their somatic or physical complaints as the cause of their depressed
mood or anhedonia. Depression may also be expressed through repetitive ver-
balizations (e.g., calling out for help) or agitated vocalizations (e.g., screaming,
yelling, or shouting), repetitive questions, expressions of unrealistic fears (e.g.,
fear of abandonment, being left alone), repetitive statements that something
bad will happen, repetitive health-related concerns, and verbal and/or physical
aggression (Cohen-Mansfield, Werner, & Marx, 1990).
Minor Depression
Depressive symptoms that do not meet standard criteria for a specific depres-
sive disorder are highly prevalent (15% to 25%) in older adults. These symptoms
are clinically significant andwarrant treatment (Bagulho, 2002 [Level V]; Lyness
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et al., 2007) [Level IV]. Such depressive symptoms have been variously referred
to in the literature as minor depression, subsyndromal depression, dysthymic de-
pression, subclinical depression, elevated depressive symptoms, and mild depres-
sion. The DSM-IV-TR also lists criteria for the diagnosis of minor depressive
disorder and includes episodes of at least 2 weeks of depressive symptoms but
with fewer than the five criteria required for major depressive disorder. Minor
depression is two to four times as common asmajor depression in older adults, is
associated with increased risk of subsequent major depression and greater use
of health services, and has a negative impact on physical and social functioning
and quality of life (Bagulho, 2002 [Level V]; Gaynes, Burns, Tweed, & Erickson,
2002 [Level III]; Lyness et al., 2007 [Level IV]).
Course of Depression
Depression can occur for the first time in late life or it can be part of a long-
standing affective or mood disorder with onset in earlier years. Hospitalized
oldermedical patients with depression are alsomore likely to have had previous
depression and experience higher rates of mortality than older patients without
depression (von Ammon Cavanaugh, Furlanetto, Creech, & Powell, 2001 [Level
III]). As in younger people, the course of depression in older adults is character-
ized by exacerbations, remissions, and chronicity (NIHConsensusDevelopment
Panel, 1992 [Level I]). Therefore, a wait-and-see approach with regard to treat-
ment is not recommended.
Depression in Late Life Is Serious
Depression is associated with serious negative consequences for older adults,
especially for frail older patients, such as those recovering from a severe med-
ical illness or those in nursing homes. Consequences of depression include
heightened pain and disability, delayed recovery frommedical illness or surgery,
worsening of medical symptoms, risk of physical illness, increased health care
utilization, alcoholism, cognitive impairment, worsening social impairment,
protein-calorie subnutrition, and increased rates of suicide and nonsuicide-
related death (Bagulho, 2002 [Level V]; von Ammon Cavanaugh et al., 2001
[Level III]). The “amplification” hypothesis proposed by Katz, Streim, and
Parmelee (1994) stated that depression can “turn up the volume” on several
aspects of physical, psychosocial, and behavioral functioning in older patients,
ultimately accelerating the course of medical illness. Indeed, a recent study by
Gaynes et al. (2002 [Level III]) found thatmajor depression and co-morbidmedi-
cal conditions interacted to adversely affect health-related quality of life in older
adults. For older nursing home residents, depression is also associatedwith poor
adjustment to the nursing home, resistance to daily care, treatment refusal, in-
ability to participate in activities, and further social isolation (Achterberg et al.,
2003 [Level IV]).
Mortality by suicide is higher among older persons with depression than
among their counterparts without depression (Juurlink, Herrmann, Szalai,
Kopp, & Redelmeier, 2004 [Level IV]). Rates of suicide among older adults
(i.e., 15 to 20 per 100,000) are the highest of any age group and even exceed
rates among adolescents (McKeown, Cuffe, & Schulz, 2006 [Level V]). This is
in large part due to the fact that White men older than age 85 are at greatest
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risk for suicide, where rates of suicide are estimated to be 80 to 113 per 100,000
(Erlangsen, Vach, & Jeune, [Level IV] 2005 [Level III]). In the oldest old (i.e., 80
years or older), men and women have higher suicide rates than nonhospitalized
older adults in the same age range; this age group has significantly higher rates
of hospitalization than younger cohorts; and three or more medical diagnoses
are associated with increased suicide risk (Erlangsen et al., 2005 [Level III]).
Depressive symptoms, perceived health status, sleep quality, and absence of
confidant predict late-life suicide (Turvey et al., 2002 [Level IV]).Whereas phys-
ical illness and functional impairment increase risk for suicide in older adults,
it appears that this relationship is strengthened by co-morbid depression (Con-
well, Duberstein, & Caine, 2002 [Level VI]). Disruption of social support (Con-
well et al., 2002 [Level VI]), family conflict, and loneliness (Waern, Rubenowitz,
& Wilhelmson, 2003 [Level V]) are also significantly associated with suicide in
late life. Treatment of depression rapidly decreases suicidal ideation in older
adults (Bruce et al., 2004 [Level II]; Szanto, Mulsant, Houck, Dew, & Reynolds,
2003 [Level V]). However, elders in higher risk groups (i.e., male, older) need a
significantly longer response time to demonstrate a decrease in suicidal ideation
(Szanto et al., 2003 [Level V]).
Studies have also shown that contact between suicidal older adults and
their primary-care provider is common (Luoma, Martin, & Pearson, 2002 [Level
V]). Almost half of older suicide victims have seen their primary-care provider
within 1 month of committing suicide (Luoma et al., 2002 [Level V]), and 20%
have seen a mental-health provider. Most of the suicidal patients experienced
their first episode of major depression, which was only moderately severe, yet
the depressive symptoms went unrecognized and untreated. Older adults with
clinically significant depressive symptomatology present with physical rather
than psychological symptoms, including patients who, when asked, admitted
having suicidal ideation (Pfaff & Almeida, 2005 [Level IV]).
Although the risk for suicide increases with advancing age (Hybels & Blazer,
2003), a growing body of evidence suggests that depression is also associated
with higher rates of nonsuicidemortality in older adults (Schulz, Drayer, & Roll-
man, 2002). Depression can also influence decision-making capacity and may
be the cause of indirect life-threatening behavior such as refusal of food, med-
ications, or other treatments in older persons (McDade-Montez, Christensen,
Cvengros, & Lawton, 2006; Stapleton, Nielsen, Engelberg, Patrick, & Curtis,
2005). These observations suggest that accurate diagnosis and treatment of de-
pression in older patients may reduce the mortality rate in this population. It
is in the clinical setting, therefore, that screening procedures and assessment
protocols have the most direct impact.
Depression in Late Life Is Misunderstood
Despite its prevalence, associated negative outcomes, and good treatment re-
sponse, depression in older adults is highly under-recognized, misdiagnosed,
and subsequently under-treated. According to a report by the Administra-
tion on Aging (2001), less than 3% of older adults receive treatment from
mental-health professionals. Use of mental-health services is lower for older
adults than any other age group (Administration on Aging, 2001). Barriers to
care for older adults with depression exist at many levels. In particular, some
older adults refuse to seek help because of perceived stigma of mental illness.
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Others may simply accept their feelings of profound sadness without realizing
they are clinically depressed. Recognition of depression also is frequently ob-
scured by anxiety and/or the various somatic or dementia-like symptoms man-
ifest in older patients with depression, or because patient or providers believe
that it is a “normal” response to medical illness, hospitalization, relocation to
a nursing home, or other stressful life events. However, depression—major or
minor—is not a necessary or normative consequence of life adversity (Snow-
don, 2001). When depression occurs after an adverse life event, it represents
pathology that should be treated.
Treatment for Late-Life Depression Works
The goals of treating depression in older patients are to decrease depressive
symptoms, reduce relapse and recurrence, improve functioning and quality of
life, improvemedical health, and reducemortality andhealth care costs. Depres-
sion in older patients can be effectively treated using either pharmacotherapy
or psychosocial therapies, or both (Blazer, 2002; Blazer, 2003; Mackin & Arean,
2005 [all LevelVI]). If recognized, the treatment response for depression is good:
60% to 80% of older adults remain relapse-free withmedicationmaintenance for
6 to 18 months (NIH Consensus Development Panel, 1992 [Level I]). In addi-
tion, treatment of depression improves pain and functional outcomes in older
adults (Lin et al., 2003 [Level II]). Recurrence of depression is a serious problem
and has been associated with reduced responsiveness to treatment and higher
rates of cognitive and functional decline (Driscoll et al., 2005 [Level IV]). When
compared to younger patients, older adults demonstrate comparable treatment
response rates; however, they tend to have higher rates of relapse following
treatment (Mitchell & Subramaniam, 2005 [Level I]). Therefore, continuation of
treatment to prevent early relapse and longer-term maintenance treatment to
prevent later occurrences is important. Even in those patients with depression
who have a co-morbid medical illness or dementia, treatment response can be
good (Iosifescu, 2007 [Level V]). Depressed older patients who have mild cogni-
tive impairment are at greater risk for developing dementia if their depression
goes untreated (Modrego & Ferrandez, 2004 [Level IV]).
Cause and Risk Factors
Several biologic and psychosocial causes for late-life depression have been
proposed. Genetic factors or heredity seem to play more of a role when older
adults have had depression throughout their life (Blazer & Hybels, 2005 [Level
VI]). Additional biologic causes proposed for late-life depression include neu-
rotransmitter or “chemical messenger” imbalance or dysregulation of endocrine
function (Blazer, 2002; Blazer, 2003 [both Level VI]). Neuroanatomic correlates,
cerebrovascular disease, brain metabolism alterations, gross brain disease, and
the presence of apolipoprotein E have also been etiologically linked to late-
life depression (Butters et al., 2003 [Level IV]). Possible psychosocial causes for
depression in older adults include cognitive distortions, stressful life events (es-
pecially loss), chronic stress, low self-efficacy expectations (Blazer, 2002; Blazer,
2003; Blazer &Hybels, 2005 [all Level VI]), and a history of alcohol abuse (Hasin
& Grant, 2002 [Level III]) (see chapter 29, Substance Abuse).
Depression 63
The social and demographic risk factors for depression in older adults in-
clude female sex, unmarried status (particularly widowed), stressful life events,
and the absence of a supportive social network (NIH Consensus Development
Panel, 1992 [Level I]). It is interesting that in a meta-analysis of the impact of
negative life events on depression in older adults, Kraaij, Arensman, and Spin-
hoven (2002 [Level I]) found that although specific negative life events (e.g.,
death of significant others, illness in self or spouse, or negative relationship
events) weremoderately associatedwith increases in depression, the total num-
ber of negative life events and daily hassles had the strongest relationships to
depression in older adults. The stress associated with family caregiving has
been repeatedly associated with higher rates of depression in older caregivers
(Pinquart & Sorensen, 2004 [Level I]). In particular, caring for an older adult
with dementia has been associated with higher rates of depression than other
caregiving situations (Pinquart & Sorensen, 2004 [Level I]). This suggests that
clinicians should pay close attention to the accumulation of negative life events
and daily hassles when developing programs and targeting interventions tomit-
igate depression in an older adult who is at risk for developing depression.
In older adults, there is additional emphasis on the co-occurrence of spe-
cific physical conditions such as stroke, cancer, dementia, arthritis, hip-fracture
surgery, myocardial infarction, chronic obstructive pulmonary disease, and
Parkinson’s disease. Medical co-morbidity is the hallmark of depression in
older patients, and this factor represents a major difference from depression
in younger populations (Alexopoulos, Schultz, & Lebowitz, 2005 [Level VI]). In
an evidence-based review, Cole (2005 [Level I]) found that disability, older age,
new medical diagnosis, and poor health status were among the most robust and
consistent of all correlates of depression among older medical patients. Those
with functional disabilities, especially those with new functional loss, are also at
risk. For example, co-morbid depression is common in older patients with hip
fractures (Holmes & House, 2000 [Level I]; see table 5.1).
Major depressive disorder has been found to be twice as common in
community-dwelling older adults compared to primary-care settings (Bruce
et al., 2002 [Level VI]). In a systematic review and meta-analysis, Cole and
Dendukuuri (2003 [Level I]) found that depression in community-dwelling older
adults was associated with bereavement, sleep disturbance, disability, prior de-
pression, and female gender. Other significant factors included poor health sta-
tus, poor self-perceived health, and new medical illness with disability (Cole,
2005; Cole & Dendukuuri, 2003 [both Level I]).
Depression Among Minority Older Adults
Rates of depression among minority older adults are not well understood.
Beals and colleagues (2005 [Level IV]) found that the rates of major depres-
sive episodes among older American Indians were 30% of the national average.
In a review, Kales and Mellow (2006 [Level VI]) found lower rates of depres-
sion and higher rates of psychotic diagnoses among African American older
adults. Williams and colleagues (2007 [Level IV]) found that when African
American and Caribbean Blacks experience a major depressive disorder, it
is usually untreated, more severe, and more disabling than for non-Hispanic
Whites. Furthermore, significant disparities exist in the quality ofmental-health
services received by minority older adults (Virnig et al., 2004 [Level IV]). A
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5.1
Physical Illnesses Associated with
Depression in Older Patients Alexopoulos
et al., 2005 [Level VI]; Cole, 2005 [Level I];
Holmes & House, 2000 [Level I]
Metabolic disturbances
■ Dehydration
■ Azotemia, uremia
■ Acid-base disturbances
■ Hypoxia
■ Hyponatremia and hypernatremia
■ Hypoglycemia and hyperglycemia
■ Hypocalcemia and hypercalcemia
Endocrine disorders
■ Hypothyroidism and hyperthyroidism
■ Hyperparathyroidism
■ Diabetes mellitus
■ Cushing’s Disease
■ Addison’s Disease
Infections
■ Viral
■ Pneumonia
■ Encephalitis
■ Bacterial
■ Pneumonia
■ Urinary tract
■ Meningitis
■ Endocarditis
■ Other
■ Tuberculosis
■ Brucellosis
■ Fungal meningitis
■ Neurosyphilis
Cardiovascular disorders
■ Congestive heart failure
■ Myocardial infarction, angina
Pulmonary disorders
■ Chronic obstructive lung disease
■ Malignancy
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5.1 (continued)
Gastrointestinal disorders
■ Malignancy (especially pancreatic)
■ Irritable bowel
■ Other organic causes of chronic abdominal pain, ulcer, diverticulosis
■ Hepatitis
Genitourinary disorders
■ Urinary incontinence
Musculoskeletal disorders
■ Degenerative arthritis
Osteoporosis with vertebral compression or hip fractures
■ Polymyalgia rheumatica
■ Paget’s disease
Neurologic disorders
■ Cerebrovascular disease
■ Transient ischemic attacks
■ Stroke
■ Dementia (all types)
■ Intracranial mass
■ Primary or metastatic tumors
■ Parkinson’s disease
Other Illness
■ Anemia (of any cause)
■ Vitamin deficiencies
■ Hematologic or other systemic malignancy
Immune Disorders
study of Medicare-plus enrollees revealed that minority older adults received
substantially less follow-up for mental-health problems following hospitaliza-
tion (Virnig et al., 2004 [Level IV]).
Althoughmisdiagnosis and subsequent inappropriate treatment can lead to
poorhealth outcomes forminority older adults (Kales&Mellow, 2006 [LevelVI]),
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it is not clear that “simple” bias alone can explain the disparities in depres-
sion management that exist. For example, Beals and colleagues (2005 [Level
IV]) point out that differences in the social construction of depressive expe-
riences may confound the measurement of depression in ethnic older adults.
Older American Indians may be reluctant to endorse symptoms of depression
because cultural norms associate these complaints with weakness (Beals et al.,
2005 [Level IV]). In a thoughtful analysis of health disparities, Cooper and col-
leagues (2006 [Level VI]) explored the complex interactions and relationships
between patients and providers that frame the context in which disparities can
occur. They point out thatmany historical, cultural, and class-related factors can
influence the development of therapeutic relationships between providers and
patients. Until more research clarifies the symptom pattern of late-life depres-
sion in minority populations, it is important that clinicians be open to atypical
presentations of depression that warrant closer scrutiny.
Assessment of Depression in Older Adults
Box 5.1 presents a standard of practice protocol for depression in older adults
that emphasizes a systematic assessment guide for early recognition of depres-
sion by nurses in hospitals and other clinical settings. Early recognition of de-
pression is enhanced by targeting high risk groups of older adults for assess-
ment methods that are routine, standardized, and systematic, by use of both a
depression-screening tool and individualized depression assessment or inter-
view (Piven, 2001 [Level VI]).
Depression-Screening Tool
Nursing assessment of depression in older patients can be facilitated by the
use of a screening tool designed to detect symptoms of depression. Several
depression-screening tools have been developed for use with older adults. In
a systematic review, Watson and Pignone (2003 [Level I]) evaluated the accu-
racy of different depression-screening tools. They found that the Geriatric De-
pression Scale-Short Form (GDS-SF) (Sheikh & Yesavage, 1986), the Center
for Epidemiological Studies Depression Scale (CES-D) (Radloff, 1977), and the
SELFCARE(D) (Banerjee, Shamash, MacDonald, & Mann, 1998) were the most
accurate screening tools to detect major depression as well as subsyndromal
depressive symptoms (Watson & Pignone, 2003 [Level I]).
The GDS-SF is a 15-item self-report depression screening tool that is fre-
quently used in a variety of clinical settings. This scale has been validated and
used extensively with older adults, including those who are mentally ill, mild
to moderately cognitively impaired, or institutionalized. It has a brief yes/no
response format and takes approximately 5 minutes to complete. The GDS-SF
contains few somatic items that may be potentially confounded with symptoms
caused by a medical illness. A GDS-SF score of 11 or greater is almost always
indicative of depression, and a score of 6 to 9 indicates possible depression
warranting further evaluation (Sheikh & Yesavage, 1986). The GDS-SF is not
a substitute for an individualized assessment or a diagnostic interview by a
mental-health professional but is a useful screening tool to identify an elderly
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patient’s depression. Because many older adults do not present with obvious
depressive symptoms (Pfaff & Almeida, 2005 [Level IV]), it is important that
screening for depression among older adults is incorporated into routine health
assessments.
Individualized Assessment and Interview
Central to the individualized depression assessment and interview is a focused
assessment of the full spectrum of symptoms (nine) for major depression as
delineated by the DSM-IV-TR (American Psychiatric Association, 2000 [Level
VI]). Furthermore, patients should be asked directly and specifically if they have
been having suicidal ideation—that is, thoughts that life is not worth living—or if
they have been contemplating or have attempted suicide. The number of symp-
toms, type, duration, frequency, and patterns of depressive symptoms, as well
as a change from the patient’s normal mood of functioning, should be noted.
Additional components of the individualized depression assessment include
evidence of psychotic thinking (especially delusional thoughts), anniversary
dates of previous losses or nodal/stressful events, previous coping style (specif-
ically alcohol or other substance abuse), relationship changes, physical health
changes, a history of depression or other psychiatric illness that required some
form of treatment, a general loss and crises inventory, and any concurrent life
stressors. Subsequent questioning of the family or caregiver is recommended to
obtain further information about the elder’s verbal and nonverbal expressions
of depression.
Differentiation of Medical or Iatrogenic Causes of Depression
Once depressive symptoms are recognized, medical and drug-related causes
should be explored. As part of the initial assessment of depression in the older
patient, it is important to obtain and review the medical history and physical
and/or neurological examinations. Key laboratory tests also should be obtained
and/or reviewed and include thyroid-stimulating hormone levels, chemistry
screen, complete blood count, and medication levels, if needed. An electrocar-
diogram, serum B12, urinalysis, and serum folate also should be considered
to assess for coexisting medical conditions. These conditions may contribute
to depression or might complicate treatment of the depression (Alexopoulos,
Katz, Reynolds, Carpenter, & Docherty, 2001 [Level VI]; see Table 5.2). In med-
ically ill older patients, who frequently have multiple medical diagnoses and
are prescribed multiple medications, these “organic” factors in the cause of de-
pression are a major issue in nursing assessment. In collaboration with the
patient’s physician, efforts should be directed toward treatment, correction, or
stabilization of associated metabolic or systemic conditions. When medically
feasible, depressogenic medications should be eliminated, minimized, or sub-
stituted with those that are less depressogenic (Dhondt et al., 1999 [Level IV]).
Even when an underlying medical condition or medication is contributing to
the depression, treatment of that condition or discontinuation or substitution of
the offending agent alone is often not sufficient to resolve the depression, and
antidepressant medication is often needed.
5.2
Drugs Used to Treat Physical Illness That
Can Cause Symptoms of Depression in
Patients Dhondt et al., 1999 [Level IV]
Antihypertensives
■ Reserpine
■ Methyldopa
■ Propranolol
■ Clonidine
■ Hydralazine
■ Guanethidine
■ Diuretics*
Narcotic analgesics
■ Narcotic
■ Morphine
■ Codeine
■ Meperidine
■ Pentazocine
■ Propoxphene
Nonnarcotic analgesic
■ Indomethacin
Antiparkinsonian agents
■ L-Dopa
Antimicrobials
■ Sulfonamides
■ Isoniazid
Cardiovascular agents
■ Digitalis
■ Lidocaine+
Hypoglycemic agents+
■ Steroids
■ Corticosteroids
■ Estrogens
Others
■ Cimetidine
■ Cancer chemotherapeutic agents
*By causing dehydration or electrolyte imbalance.
+Toxicity.
++By causing hypoglycemia.
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Clinical Decision Making and Treatment
Regardless of the setting, older patientswho exhibit thenumber of symptoms in-
dicative of a major depression, specifically suicidal thoughts or psychosis, and
who score above the established cutoff score for depression on a depression-
screening tool (e.g., 5 on the GDS-SF) should be referred for comprehen-
sive psychosocial services (i.e., psychiatric liaison nurses, geropsychiatric
advanced practice nurses, social workers, psychiatrists, psychologists, clergy)
psychiatric evaluation. Older patients with less severe depressive symptoms
without suicidal thoughts or psychosis but who also score above the cutoff score
on the depression screening tool (e.g., 5 on the GDS-SF) should be referred to
available psychosocial services (i.e., psychiatric liaison nurses, geropsychiatric
advancedpracticenurses, socialworkers, psychiatrists, psychologists, clergy) for
psychotherapy or other psychosocial therapies, as well as to determine whether
medication for depression is warranted. Older adults at risk for depression may
benefit from brief interventions that prevent the development of depression
(Cole & Dendukuuri, 2004 [Level I]).
The two major categories of treatment for depression in older adults are
biologic therapies (e.g., pharmacotherapy and electroconvulsive therapy) and
psychosocial therapies (e.g., psychotherapies such as cognitive-behavioral, in-
terpersonal, and brief psychodynamic) in both individual and group formats. A
compelling body of evidence supports the efficacy of both treatment modalities
for older adults with depression (Arean & Cook, 2002 [Level VI]; Hollon et al.,
2005 [Level VI]). Marital and family therapy may also be beneficial in treating
older adults with depression, especially older spouses engaged in caregiving
(Buckwalter et al., 1999; Gitlin et al., 2003 [both Level IV]).
Several studies support the use of an interdisciplinary geriatric assessment
team for late-life depression. These teams improve physical functioning in older
adults with major depressive disorder (Callahan et al., 2005 [Level II]) and ef-
fectively reduce the depressive symptoms in community-dwelling older adults
(age 70+ years) who were at risk for hospitalization (Boult et al., 2001 [Level
II]). Ethnic minority elders experience improved treatment of depression when
treated by an interdisciplinary treatment team (Arean et al., 2005 [Level VI]).
Similarly, patients with multiple co-morbid medical conditions responde pos-
itively to an interdisciplinary approach to depression management (Harpole
et al., 2005; Unutzer et al., 2002 [both Level II]). Although older adults with
co-morbid anxiety disorders took longer to respond to treatment, they expe-
rience greater reductions in depression when treated by an interdisciplinary
team than similar patients receiving usual primary care (Hegel et al., 2005
[Level II]).
In the past, tricyclic antidepressants (TCAs) were often contraindicated in
older adults because of the anticholinergic side-effect profile (Mottram,Wilson,
& Strobl, 2006 [Level I]). More recently, however, there has been a dramatic in-
crease in the development and testing of different pharmacological agents used
to treat depression in older adults. The most common classes of these newer
medications include the Selective Serotonin Reuptake Inhibitors (SSRIs),
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and TCA-related
medications. These agents work selectively on neurotransmitters in the brain
to alleviate depression. When the SSRIs are compared to other classes of
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antidepressants to treat late-life depression (e.g., SNRIs, TCAs, TCA-related
medications), they have similar treatment efficacy (Salzman, Wong, & Wright,
2002 [Level V]; Shanmugham, Karp, Drayer, Reynolds, & Alexopoulos, 2005
[Level VI]). However, SSRIs and SNRIs generally pose a lower treatment risk
for older adults with depression (Shanmugham et al., 2005 [Level VI]). Still, in
a systematic review of the literature, Wilson andMottram (2004 [Level I]) found
that although SSRIs are generally well tolerated in the elderly, a significant
minority of older adults experiences serious side effects, including nausea,
vomiting, dizziness, and drowsiness. TCA-related drugs may be an effective
alternative for older adults who cannot tolerate SSRIs (Wilson & Mottram, 2004
[Level I]).
The type and severity of depressive symptoms influence the type of treat-
ment approach. In general, more severe depression, especially with suicidal
thoughts or psychosis, requires intensive psychiatric treatment, including hos-
pitalization, medication with an antidepressant or antipsychotic drug, electro-
convulsive therapy, and intensive psychosocial support (Blazer, 2002; Blazer,
2003 [both Level VI]). Less severe depression without suicidal thoughts or psy-
chosis may require treatment with psychotherapy or medication, often on an
outpatient basis. Collectively, these data also suggest that patients who have de-
pression complicated by multiple medical and psychiatric co-morbidities may
benefit from a referral to an interdisciplinary treatment team with specific ex-
pertise in geropsychiatry.
Individualized Nursing Interventions
Psychosocial and behavioral nursing interventions can be incorporated into the
plan of care, based on the patient’s individualized need. Provision of safety pre-
cautions for patientswith suicidal thinking is a priority. In acutemedical settings,
patientsmay require transfer to the psychiatric servicewhen suicidal risk is high
and staffing is not adequate to provide continuous observation of the patient. In
outpatient settings, continuous surveillance of the patient should be provided
while an emergency psychiatric evaluation and disposition is obtained.
Promotion of nutrition, elimination, sleep/rest patterns, physical comfort,
and pain control have been recommended specifically for depressed medically
ill older patients (Voyer &Martin, 2003 [Level VI]). Relaxation strategies should
be offered to relieve anxiety as an adjunct to pain management. Nursing in-
terventions should also focus on enhancement of the elder’s physical function
through structured and regular activity and exercise; referral to physical, oc-
cupational, and recreational therapies; and the development of a daily activity
schedule (Barbour & Blumenthal, 2005 [Level VI]). Enhancement of social sup-
port is also an important function of the nurse. This may be done by identifying,
mobilizing, or designating a support person such as family, a confidant, friends,
volunteers or other hospital resources, a church member, support groups, pa-
tient or peer visitors, and particularly by accessing appropriate clergy for spiri-
tual support.
Nurses should maximize an older adult’s autonomy, personal control, self-
efficacy, and decision making about clinical care, daily schedules, and personal
routines (Lawton, Moss, Winter, & Hoffman, 2002 [Level IV]). The use of a
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graded task assignment where a larger goal or task is subdivided into several
smaller steps can be helpful in enhancing function, assuring successful experi-
ences, and building elderly patients’ confidence in their performance of various
activities (Arean & Cook, 2002 [Level VI]). Participation in regular, predictable,
pleasant activities can result in more positive mood changes for elderly patients
with depression (Koenig, 1991 [Level VI]). A pleasant-events inventory, elicited
from the patient, can be used to incorporate pleasurable activities into an older
patient’s daily schedule (Koenig, 1991 [Level VI]). Music therapy customized to
the patient’s preference also is recommended to reduce depressive symptoms
(Siedliecki & Good, 2006 [Level IV]).
Pleasant reminiscences can enhance self-esteem and sometimes alleviate a
depressedmood (Hsieh &Wang, 2003 [Level I]). In systematic reviews of the lit-
erature, reminiscence therapy was also found to significantly reduce depression
in older adults (Bohlmeijer, Smit, & Cuijpers, 2003 [Level I]; Hsieh &Wang, 2003
[Level I]; Mackin & Arean, 2005 [Level VI]). Nursing interventions to encour-
age reminiscence include asking patients directly about their past or by linking
events in history with a patient’s life experience. The use of photographs, old
magazines, scrapbooks, and other objects can also stimulate discussion. Nurses
should provide emotional support to depressed older patients by providing em-
pathetic, supportive listening; encouraging patients to express their feelings in
a focusedmanner on issues such as grief or role transition; providing supportive
adaptive coping strategies; identifying and reinforcing strengths and capabili-
ties; maintaining privacy and respect; and instilling hope.
Older patients should be closely monitored for therapeutic response to and
potential side effects of antidepressant medication in order to assess whether
dose adjustment may be warranted. Although, in general, it is necessary to start
antidepressant medication at low doses in older patients, it is also necessary
to ensure that older adults with persistent depressive symptoms receive ade-
quate treatment (American Association of Geriatric Psychiatry, 1992; Buffum &
Buffum, 2005 [both Level VI]). In particular, it is important to increase the pa-
tient’s and family’s awareness of the symptoms as part of a depression that is
treatable and not the person’s fault as a result of personal inadequacies.
Case Study and Discussion
Ray Stimson is an 87-year-old man with multiple medical problems. He has
a history of coronary artery disease (CAD) and had triple bypass surgery
4 years ago. He also has hypertension and Type II diabetes and is hard of
hearing. He was admitted to the hospital for surgical repair of a hip frac-
ture following a fall in his home. Mr. Stimson is widowed (11 months) and
has two adult children who do not live locally. Prior to his fall, he was liv-
ing independently in the community; however, his children were growing
increasingly concerned about his safety. Following surgery, Mr. Stimson was
irritable and resisted efforts by the nursing staff to participate in self-care
activities (e.g., walking, bathing). They often found him laying stoically in
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bed, staring into space. The nurses also observed that he was occasionally
confused and would ask about his deceased wife.
A subsequent referral to the geropsychiatric consultation liaison nurse
revealed that Mr. Stimson was experiencing a great deal of postoperative
pain thatwas notwell treated onhis currentmedicine regimen.Nursing staff
had charted concerns that his opiod analgesic was contributing to his men-
tal confusion. The geropsychiatric evaluation also revealed that Mr. Stim-
son had been growing increasingly depressed over the past few months and
was still actively grieving the loss of his wife of 62 years. As his health had
failed and his independent living was threatened, he admitted he had con-
templated suicide, stating, “Life is just not worth living anymore.” Further
assessment revealed that he did not have a specific plan in mind and admit-
ted that he didn’t really think that was a solution to his problems, but that
he couldn’t see that he had many options.
The liaison nurse worked with the medical team to develop a more ag-
gressive plan for pain management. She also arranged for a family confer-
ence to discuss discharge-planning issues. During the family conference, the
liaison nurse spoke toMr. Stimson’s children about long-term planning. She
explained how important it was for Mr. Stimson to participate in any place-
ment decisions they may be contemplating and to have a sense of control.
Although his children were able to express their reservations and concerns
about safety, they agreed to explore kinds of community support services
that could be activated to help support their father in his own home for as
long as possible.
Mr. Stimson was able to participate in rehabilitation and gained enough
strength to return to his home. Arrangements were made for follow-up with
mental-health services.Hewas started on an antidepressantmedication and
agreed to participate in the senior lunch program twice a week to increase
the opportunity for socialization. Several months after his discharge, Mr.
Stimson reported that he still missed his wife terribly and that he still was
lonely at times. However, he had developed some friendships at the senior
center and was getting out one or two times each week. His children called
more often and had, for the time being, stopped sending him brochures for
assisted-living facilities. He acknowledged that he may need to move to a
more supervised setting in the future, but for now, he was content to stay in
the home where he had many pleasant memories to keep him company.
Conclusion
Depression significantly threatens the personal integrity and “experience of
life” of older adults. Depression is often reversible with prompt and appropri-
ate treatment. Early recognition can be enhanced by the use of a standardized
protocol that outlines a systematic method for depression assessment. Early
identification of depressed intervention and successful treatment demonstrates
to society that depression is the most treatable mental problem in late life. As
Blazer (1989) stated, “When there is depression, hope remains.”
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165–173.
Center for Epidemiological Studies Depression Scale (CES-D):
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for re-
search in the general population. Applied Psychological Measurement, 1,
385–401.
SELFCARE(D):
Banerjee, S., Shamash, K., MacDonald, A. J. D., & Mann, A. H. (1998). The use
of SELFCARE(D) as a screening tool for depression in the clients of local
authority home care services—A preliminary study. International Journal of
Geriatric Psychiatry, 13, 695–699.
Box 5.1
Nursing Standard of Practice Protocol: Depression in
Older Adults
I. BACKGROUND
A. Depression—both major depressive disorders and minor
depression—is highly prevalent in community-dwelling, medi-
cally ill, and institutionalized older adults.
B. Depression is not a natural part of aging or a normal reaction to acute
illness hospitalization.
C. Consequences of depression include amplification of pain and dis-
ability, delayed recovery from illness and surgery, worsening of drug
side effects, excess use of health services, cognitive impairment, sub-
nutrition, and increased suicide- and nonsuicide-related death.
D. Depression tends to be long lasting and recurrent. Therefore, a wait-
and-see approach is undesirable, and immediate clinical attention is
necessary. If recognized, treatment response is good.
E. Somatic symptoms may be more prominent than depressed mood in
late-life depression.
F. Mixed depression and anxiety features may be evident among many
older adults.
G. Recognition of depression is hindered by the coexistence of physical
illness and social and economic problems common in late life. Early
recognition, intervention, and referral by nurses can reduce the neg-
ative effects of depression.
*Somatic symptoms, also seen in many physical illnesses, are frequently
associated with A and B; therefore, the full range of depressive symptoms
should be assessed.
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II. ASSESSMENT PARAMETERS
Several studies support the use of an interdisciplinary geriatric assess-
ment team for late-life depression (Boult et al., 2005; Callahan et al.,
2005; Harpole et al., 2005; Unutzer et al., 2002 [all Level II]) with the
following being specific parameters of assessment:
A. Identify risk factors/high risk groups:
1. Current alcohol /substance-use disorder (Hasin & Grant, 2002
[Level III]).
2. Medical co-morbidity (Alexopoulos, Schulz, & Lebowitz, 2005
[Level VI]). Specific co-morbid conditions: dementia, stroke, can-
cer, arthritis, hip fracture, myocardial infarction, chronic obstruc-
tive pulmonary disease, and Parkinson’s disease (Alexopoulos
et al., 2005; Butters et al., 2003 [both Level VI]).
3. Functional disability (especially new functional loss). Disability,
older age, new medical diagnosis, and poor health status (Cole,
2005; Cole & Dendukuuri, 2003 [both Level I]).
4. Widow/widowers (NIH, 1992 [Level I]).
5. Older family caregivers, especially those caring for persons with
dementia (Pinquart & Sorensen, 2004 [Level I]).
6. Social isolation/absence of social support (Kraaij, Arensman, &
Spinhoven, 2002; NIH, 1992 [both Level I]).
7. Psychosocial causes for depression in older adults include cog-
nitive distortions, stressful life events (especially loss), chronic
stress, low self-efficacy expectations (Blazer, 2002 [Level VI];
Blazer, 2003 [Level VI]; Blazer & Hybels, 2005 [Level VI]; Spin-
hoven (2002) [Level I]).
B. Assess all at-risk groups using a standardized depression screen-
ing tool and documentation score. The GDS-SF (Sheikh & Yesav-
age, 1986) is recommended because it takes approximately 5minutes
to administer, has been validated and extensively used with medi-
cally ill older adults, and includes few somatic items that may be
confounded with physical illness (Pfaff & Almeida, 2005 [Level IV];
Watson & Pignone, 2003 [Level I]).
C. Perform a focused depression assessment on all at-risk groups and
document results. Note the number of symptoms; onset; frequency/
patterns; duration (especially 2 weeks); change from normal mood,
behavior, and functioning (American Psychiatric Association, 2000
[Level VI]):
1. Depressive symptoms
2. Depressed or irritable mood, frequent crying
3. Loss of interest, pleasure (in family, friends, hobbies, sex)
4. Weight loss or gain (especially loss)
5. Sleep disturbance (especially insomnia)
6. Fatigue/loss of energy
7. Psychomotor slowing/agitation
8. Diminished concentration
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9. Feelings of worthlessness/guilt
10. Suicidal thoughts or attempts, hopelessness
11. Psychosis (i.e., delusional/paranoid thoughts, hallucinations)
12. History of depression, current substance abuse (especially alco-
hol), previous coping style
13. Recent losses or crises (e.g., death of spouse, friend, pet, re-
tirement; anniversary dates; move to another residence, nursing
home); change in physical health status, relationships, roles
D. Obtain/review medical history and physical/neurological examina-
tion (Alexopoulos et al., 2001 [Level VI]).
E. Assess for depressogenic medications (e.g., steroids, narcotics,
sedative/hypnotics, benzodiazepines, antihypertensives, H2 antago-
nists, beta-blockers, antipsychotics, immunosuppressives, cytotoxic
agents)
F. Assess for related systematic and metabolic processes that may con-
tribute to depression or might complicate treatment of the depres-
sion (e.g., infection, anemia, hypothyroidism or hyperthyroidism, hy-
ponatremia, hypercalcemia, hypoglycemia, congestive heart failure,
kidney failure (Alexopoulos et al., 2001 [Level VI])
G. Assess for cognitive dysfunction
H. Assess level of functional ability
III. CARE PARAMETERS
A. For severe depression (i.e., GDS score 11 or greater, five to nine
depressive symptoms [must include depressed mood or loss of
pleasure] plus other positive responses on individualized assess-
ment [especially suicidal thoughts or psychosis and co-morbid
substance abuse], refer for psychiatric evaluation. Treatment op-
tions may include medication or cognitive-behavioral, interper-
sonal, or brief psychodynamic psychotherapy/counseling (individ-
ual, group, family); hospitalization; or electroconvulsive therapy
(Arean & Cook, 2002; Hollon et al., 2005 [both Level VI]).
B. For less severe depression (i.e., GDS score 6 or greater, fewer
than five depressive symptoms plus other positive responses on
individualized assessment), refer to mental-health services for
psychotherapy/counseling (see previous types), especially for spe-
cific issues identified in individualized assessment and to determine
whether medication therapy may be warranted. Consider resources
such as psychiatric liaison nurses, geropsychiatric advanced prac-
tice nurses, socialworkers, psychologists, and other community- and
institution-specificmental-health services. If suicidal thoughts, psy-
chosis, or co-morbid substance abuse is present, a referral for a com-
prehensive psychiatric evaluation should always be made (Arean &
Cook, 2002; Hollon et al., 2005 [both Level VI]).
C. For all levels of depression, develop an individualized plan integrat-
ing the following nursing interventions:
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1. Provide an approach to depression management (Arean et al.,
2005 [LevelVI];Harpole et al., 2005 [Level II];Hegel, 2005 [Level
II]; Unutzer et al., 2002 [Level II]).
2. Institute safety precautions for suicide risk as per institutional
policy (in outpatient settings, ensure continuous surveillance of
the patient while obtaining an emergency psychiatric evaluation
and disposition).
3. Remove or control etiologic agents:
a. Avoid/remove/change depressogenic medications.
b. Correct/treat metabolic/systemic disturbances.
4. Monitor and promote nutrition, elimination, sleep/rest patterns,
physical comfort (especially pain control).
5. Enhance physical function (i.e., structure regular exercise/
activity; refer to physical, occupational, recreational therapies);
develop a daily activity schedule.
6. Enhance social support (i.e., identify/mobilize a support per-
son(s) [e.g., family, confidant, friends, hospital resources, sup-
port groups, patient visitors]); ascertain need for spiritual sup-
port and contact appropriate clergy.
7. Maximize autonomy/personal control/self-efficacy (e.g., include
patient in active participation in making daily schedules, short-
term goals).
8. Identify and reinforce strengths and capabilities.
9. Structure and encourage daily participation in relaxation thera-
pies, pleasant activities (conduct a pleasant-activity inventory),
music therapy.
10. Monitor and document response to medication and other ther-
apies; readminister depression-screening tool.
11. Provide practical assistance; assist with problem-solving.
12. Provide emotional support (i.e., empathic, supportive listen-
ing, encourage expression of feelings, hope instillation), support
adaptive coping, encourage pleasant reminiscences.
13. Provide information about the physical illness and treatment(s)
and about depression (i.e., that depression is common, treatable,
and not the person’s fault).
14. Educate about the importance of adherence to prescribed treat-
ment regimen for depression (especially medication) to prevent
recurrence; educate about specific antidepressant side effects
due to personal inadequacies.
15. Ensuremental-health community link-up; consider psychiatric,
nursing-home-care intervention.
IV. EVALUATION OF EXPECTED OUTCOMES
A. Patient:
1. Patient safety will be maintained.
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2. Patients with severe depression will be evaluated by psychiatric
services.
3. Patients will report a reduction of symptoms that are indicative
of depression. A reduction in the GDS score will be evident and
suicidal thoughts or psychosis will resolve.
4. Patient’s daily functioning will improve.
B. Health care provider:
1. Early recognition of patient at risk, referral, and interventions for
depression, and documentation of outcomes will be improved.
C. Institution:
1. The number of patients identified with depression will increase.
2. The number of in-hospital suicide attempts will not increase.
3. The number of referrals to mental-health services will increase.
4. The number of referrals to psychiatric nursing-home-care ser-
vices will increase.
5. Staff will receive ongoing education on depression recognition,
assessment, and interventions.
V. OTHER CLINICAL PRACTICE GUIDELINES
Practice guideline for the treatment of patients with major depressive
disorder. American Psychiatric Association—Medical Specialty Society,
1993 (revised 2000; reviewed 2005). 45 pages. NGC: 001831. Retrieved
on June 6, 2007, from http://www.guideline.org/summary/summary.
aspx?doc id=2605&nbr=001831&string=depression.
Detection of depression in the cognitively intact older adult. Univer-
sity of Iowa Gerontological Nursing Interventions Research Center,
Research Translation and Dissemination Core—Academic Institu-
tion, 1998 (revised 2005 May). 33 pages. NGC: 004519. Retrieved on
June 6, 2007, from http://www.guideline.org/summary/summary.aspx?
doc id=8112&nbr=004519&
string=depression
Depression. AmericanMedical Directors Association—Professional As-
sociation, 2003. 36 pages.NGC: 003520AMDA.Retrieved on June 6, 2007,
from http://www.guideline.org/summary/summary.aspx?doc id=4952&
nbr=003520&string=depression
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6Dementia
Kathleen Fletcher
Educational
Objectives
At the completion of this chapter, the reader should be
able to:
1. describe the spectrum of dementia syndromes
2. recognize the clinical features of dementia
3. discuss pharmacological and nonpharmacological
approaches in the management of dementia
4. develop a nursing plan of care for an older adult
with dementia
Overview
Dementia is most commonly defined as a clinical syndrome of cognitive deficits
that involves both memory impairments and a disturbance in at least one other
area of cognition (DSM-IV-TR) (American Psychiatric Association, 2000 [Level
VI]). In addition to disruptions in cognition, dementia is associated with a grad-
ual decline in function and changes in mood and behavior.
There are many causes of dementia and dementia-like presentations. Dif-
ferentiating these changes early in the course of illness is important because
condition-specific assessment, monitoring, and management strategies can be
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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employed. Differential diagnoses among conditions that cause cognitive impair-
ment are confounded by the fact that these conditionsmay coexist and disparate
dementing disorders may be similarly clinically expressed.
Major goals in the clinical approach to a person presenting with cognitive
impairments are identification and resolution of potentially reversible condi-
tions (e.g., delirium), recognition and control of co-morbid conditions, and early
diagnosis and management of a dementing illness. The focus of this chapter is
on assessment and management of the progressive dementia syndromes.
Background and Statement of The Problem
The rapid growth of the older adult population in the United States is associated
with a significant increase in theprevalence of dementia.Dementia affects about
5% of individuals 65 and older (Richie & Lovestone, 2002 [Level VI]). More than
4.5 million Americans have the most common form of dementia, Alzheimer’s
disease (AD), a number that is expected to triple by themiddle of the 21st century
(Hebert, Scheer, Bienias, Bennett, & Evans, 2003 [Level IV]).
Age is the strongest risk factor for dementiawith the risk increasing tonearly
50% of individuals 85 and older (Evans et al., 1989 [Level IV]). The most com-
mon forms of progressive dementia, and discussed in this chapter, include AD,
vascular dementia (VaD), and Dementia with Lewy bodies (DLB). Less common
although not less significant is progressive dementia associated with Parkin-
son’s disease, frontotemporal dementia, and the dementias associated with HIV,
and Creutzfeld-Jacob disease.
AD, the most common form of dementia, accounts for more than 60% of all
cases. Currently, 4 million to 5 million Americans have AD and the number is
expected to increase to 13.2 million by 2050 (Hebert, Scheer, Bienias, Bennett, &
Evans, 2003 [Level IV]). A chronic neurodegenerative disease, first described by
Alos Alzheimer in 1907, it is characterized by neurofibrillary plaques and “tan-
gles” in the brain. The production and accumulation of beta-amyloid peptide is
increasingly recognized as key to the pathogenesis of AD (Hardy & Selkoe, 2002
[Level I]). Classic features of AD include progressive loss of memory, deteriora-
tion of language and other cognitive functions, decline in the ability to perform
activities of daily living (ADLs), and changes in personality and behavior (Desai
& Grossberg, 2005 [Level VI]). Mild cognitive impairment (MCI), a syndrome
defined as cognitive decline greater than expected for an individual’s age that
minimally interferes with ADLs (Gauthier et al., 2006 [Level VI]), may be a pre-
cursor of dementia. Individuals with MCI are nearly twice as likely to die and
more than three times as likely to develop AD in a 5-year period than a cohort
of individuals without MCI (Bennett et al., 2002 [Level IV]).
VaD, previously known as multi-infarct dementia (MID), refers to dementia
resulting from cerebrovascular disease. It is the second most common cause of
dementia among older adults and represents approximately 20% of all cases of
dementia in the United States (Roman, 2003a [Level VI]). Broad classifications
of VaD include those attributed to multiple discrete infarctions, strategic single
infarctions, diffuse subcortical white matter disease (Geldmacher, 2004 [Level
VI]), and hemorrhagic lesions (Roman, 2003b [Level VI]). The diagnosis of VaD
is based on the association between a cerebrovascular event and the onset of
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clinical features of dementia, including evidence of focal deficits, gait distur-
bances, and impairments in executive function. Compared to AD, memory may
not be impaired or is more mildly affected. It is not uncommon that AD and VaD
pathology coexist and this, often referred to as a mixed dementia, is likely to
increase as the population ages (Langa, Foster, & Larson, 2004 [Level V]).
DLB is a neurodegenerative dementia that resultswhenLewybodies form in
the brain. Lewy bodies are pathological aggregations of alpha-synuclein found
in the cytoplasma of neurons (McKeith et al., 2003 [Level V]). Clinical fea-
tures include cognitive and behavioral changes in combination with features
of Parkinsonism. Disorders of executive function occur early. Hallucinations
and visuospatial disturbances are prominent. Although rigidity and unsteady
gait are common, tremors are not (Geldmacher, 2004 [Level VI]). Many but not
all patients with Parkinson’s disease develop a dementia years after the motor
symptoms appear. Distinctions have been made clinically between the DLB and
the dementia associated with Parkinson’s disease based on the sequence of the
appearance of symptoms (McKeith et al., 2005 [Level VI]).
Assessment of The Problem
Goals of Assessment
Early identification of cognitive impairment is themost important goal in assess-
ment. Cognitive impairment resulting from conditions like dementia, delirium,
and depression represents critically serious pathology and requires urgent as-
sessment and tailored interventions. Yet, diminished or altered cognitive func-
tioning is often perceived by health care professionals as a normal consequence
of aging, and opportunities for timely intervention are too oftenmissed (Milisen,
Braes, Flick, &Foreman, 2006 [LevelVI]). Althoughdistinctions have beenmade
comparing the clinical features of the common cognitive impairments associ-
ated with delirium, dementia, and depression, this is difficult to do clinically
because these conditions often coexist and older adults can demonstrate atypi-
cal features in any of these conditions.
The second most important assessment goal is to identify a potentially re-
versible primary or contributing cause of a cognitive impairment. Table 6.1 lists
some of the most common causes of reversible cognitive impairment (i.e., delir-
ium) in older adults; these causes are also covered in chapter 7, Delirium: Pre-
vention, Early Recognition, and Treatment.
History Taking
Complaints from the patient or observations made by others of memory loss,
problems with decision making and/or judgment, or a decline in an ADL func-
tion should alert the health care professional that a progressive form of demen-
tia might exist. A detailed dementia assessment and screening is important;
however, the extant tools to help guide this process lack specificity and sensitiv-
ity (Freund & Gravenstein, 2004 [Level VI]). There is no single comprehensive
evidence-based tool that can elicit a definitive diagnosis of dementia. Suggested
approaches, techniques, and tools are identified later in this chapter.
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6.1 Common Causes of Reversible CognitiveImpairment (Delirium)
Metabolic disturbances
Vitamin deficiencies (B12, folate)
Thyroid dysfunction
Infections
Depression
Drug-related effect
Fluid and electrolyte disorder
Hypovolemia
Hypoxia
Cerebrovascular inflammation
Brain lesions
Hydrocephalus
Pain
Collecting an accurate history is the cornerstone to the assessment process,
yet this obviously is a challenge in the individual presenting with cognitive im-
pairment. The assessment domains covered in history taking include functional,
cognitive, and behavioral queries and observations. The history-taking process
involves first interviewing the patient, followed perhaps by clarifying, elabo-
rating, and validating information with the family or others familiar with the
capabilities and expressions of the patient.
Functional Assessment
Because cognitive assessment can be embarrassing and/or threatening, it may
be more respectful to initiate the conversation around the patient’s functional
domain. Asking the patient to elaborate on his or her functional abilities in
ADLs as well as instrumental activities of daily living (IADLs) and eliciting
any identified decline with specified chronology can provide some insight (see
chapter 3, Assessment of Function, for the approach and tools for functional
assessment).
The functional activities questionnaire (FAQ) is an informant-based mea-
sure of functional ability and has been recognized for its ability to discriminate
early dementia (Pfeffer, Kurosaki, Harrah, Chance, & Filos, 1982 [Level IV]).
An informant, typically the primary caregiver, is asked to rate the performance
of the patient in 10 different activities. The modified Alzheimer’s disease co-
operative study–activities of daily living inventory (ADCS–ADL) is a specific
functional tool used primarily in clinical trials to assess and monitor patients
with moderate to severe AD (Galasko et al., 1997 [Level IV]). The patient’s daily
caregiver is asked to rate the older adult’s usual performance on the more basic
measures of function compared to the previous month to identify progression
of functional decline.
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6.2 Components of Mental-Status Evaluation
Orientation: person, place, time
Attention and concentration: ability to attend and concentrate
Memory: ability to register, recall, retain
Judgment: ability to make appropriate decisions
Executive-control functions: ability to abstract, plan, sequence, and use feedback to
guide performance
Speech and language: ability to communicate ideas and receive and express a
message
Presence of delusions, hallucinations
Mood and affect
Cognitive Assessment
The cognitive domain is assessed as part of a broader mental-status evaluation,
the components of which are listed in Table 6.2. Whereas some of the parame-
ters of amental-status evaluation (e.g.,memory or cognition)might bemeasured
with a standardized tool such as the Mini-Mental State Exam (MMSE), others
require specific inquiry or direct or indirect observation by the health care pro-
fessional and/or caregiver. The measure of mood is totally subjective and is
based on self-report status. The evaluation always provides the opportunity to
identify sensory impairments (i.e., vision and hearing loss), which can further
impact cognition, function, and behavior.
The “gold standard” of tools that measure cognition is the MMSE developed
more than 30 years ago (Folstein, Folstein, & McHugh, 1975 [Level IV]). Used
extensively in clinical trials as well as in a variety of clinical settings, it is rela-
tively easy to administer and score and can be used to assess cognitive changes
over time. The annual rate of decline on the MMSE in AD is 3.3 points annually
(Han, Cole, Bellavance, McCusker, & Primeau, 2000 [Level I]). The MMSE has
established validity and reliability, although concerns continue to be expressed
by clinicians that it is time-consuming and in some circumstances the relevancy
of selected questions has been raised. The MMSE score is strongly related to
education, with high false-positive rates for those with little education, and pre-
dictive power is also significantly influenced by language (Parker & Philp, 2004
[Level VI]). It is insensitive to executive dysfunction and has been criticized for
a lack of sensitivity in detecting early or mild dementia (Leifer, 2003 [Level VI]).
As has been suggested with other measures of cognitive testing, the MMSEmay
have a cultural bias (Manley & Espino, 2004 [Level I]). Clinicians must remain
aware that a high score on the MMSE does not rule out cognitive decline or the
possibility of dementia, particularly in high-functioning individuals with cog-
nitive complaints (Manning, 2004 [Level VI]). The tool is available on-line at
http://www.minimental.com.
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A simple and reliable measure of visual-spatial ability in dementia is the
Clock Drawing Test (CDT) (Sunderland et al., 1989 [Level IV]). Scoring is based
on the ability to free-hand draw the face of a clock, insert the hour numbers in
the appropriate locations, and then set the hands of the clock to the time des-
ignated by the examiner. The CDT is strongly correlated with executive func-
tion (i.e., the ability to execute complex behaviors and to solve problems) and
is useful in the detection of mild dementia (Royall, Mulroy, Chiodo, & Polk,
1999 [Level IV]). It also correlates moderately with driving performance be-
cause the CDT score drops as the number of driving errors increases (Freund,
Gravenstein, & Ferris, 2002 [Level IV]; Freund, Gravenstein, Ferris, Burke, &
Shaheen, 2005 [Level IV]). The test and instructions are available on-line at
www.neurosurvival.ca/ClinicalAssistant/scales/clock drawing test.htm.
A clinically useful tool that combines the CDT with measures of cognition
(i.e., three-word recall) is the Mini-Cognitive (Mini-Cog) test (Borson, Scan-
lan, Brush, Vitaliano, & Dokmak, 2000 [Level IV]). This test demonstrates a
high level of sensitivity and specificity for dementia, takes less time to ad-
minister, and has less language and educational-level bias than the MMSE
(Borson, Scanlan, Chen, & Ganguli, 2003 [Level IV]; Borson, Scanlan, Watan-
abe, Tu, & Lessig, 2005 [Level IV]). The Mini-Cog detected cognitive im-
pairment in a community sample of a predominantly ethnic minority bet-
ter than primary-care physician assessment (84% versus 41%), particularly
in milder stages of the disease (Borson, Scanlan, Watanabe, Tu, & Lessig,
2006 [Level IV]). The Mini-Cog test and instructions are available on-line at
http://www.hospitalmedicine.org/geriresource/toolbox/minicog.htm.
Behavioral Assessment
Behavioral changes become increasingly common as individuals progress
through the stages of dementia (Volicer & Hurley, 2003 [Level V]). Regular as-
sessment and monitoring can help identify the triggers of disruptive behavior
and early manifestations of the behavior. Timely interventions that result in
de-escalation of the behavior can help decrease the level of distress experi-
enced by both the patient and the caregiver. Behavioral management can help
maintain functionality and safety. Commonly demonstrated behaviors are those
associated with agitation and psychosis. Asking the patient about levels of rest-
lessness, anxiety, and irritability is important because, at times, these emotional
and behavioral states occur even earlier than cognitive changes. Aggression,
wandering, delusions and hallucinations, and resistance to care are manage-
able with pharmacological and nonpharmacological treatment options.
The Neuropsychiatric Inventory (NPI) measures frequency and severity of
psychiatric symptoms andbehavioralmanifestations in individualswith demen-
tias and additionally helps to distinguish the potential cause of the dementia
(Cummings et al., 1994 [Level IV]). The NPI takes about 10 minutes to adminis-
ter, during which the caregiver is asked screening and probing questions related
to the presence and degree of behaviors such as agitation, anxiety, irritability,
apathy, and disinhibition. TheNPI also includes ameasure of caregiver stress. A
briefer questionnaire version, the NPI-Q, also has established validity (Kaufer
et al., 2000 [Level IV]).
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Because as many as 50% of individuals with dementia have coexisting de-
pressive symptoms (Zubenko et al., 2003 [Level IV]), it is important to conduct
an adjunctive assessment of depression. Recognizing depressive symptoms in
older adults is challenging, and using an interviewer-rated instrument is rec-
ommended in addition to using clinical judgment (Onega, 2006 [Level VI]). The
Geriatric Depression Scale (GDS) is a screening instrument that takes only a
few minutes to administer and is discussed along with appropriate depression-
management strategies in detail in chapter 5, Depression.
Referral of the patient to a neuropsychologist for more extensive neuro-
psychological testing might be indicated to provide more specific diagnostic in-
formation associated with neurodegenerative disease states and areas of brain
dysfunction (Manning, 2004 [Level VI]). This kind of assessment can identify
subtle cognitive impairments in higher functioning individuals, distinguishmild
cognitive impairment fromdementia, and provide direction and support for care
providers and the family (Adelman & Daly, 2005 [Level VI]).
Physical Exam and Diagnostics
Once the functional, cognitive, and behavioral domains in progressive demen-
tia have been established through history taking of the patient and caregiver,
a thorough review of systems is undertaken followed by the physical examina-
tion. The history-taking process narrows the differential diagnosis of reversible
and irreversible causes for dementia. A thorough neurological and cardiovas-
cular examination will help to specify the etiology of a single type or combined
dementia that will direct the need for laboratory and imaging tests. Cardiovascu-
lar findings such as hypertension, arrhythmias, extra heart sounds or murmurs
along with focal neurological findings such as weakness and sensory deficit
may favor a diagnosis of VaD; pathological reflexes, gait disorders, and abnor-
mal cerebellar findings may be indicative of AD; and parkinsonian signs might
indicate dementia associated with either Lewy bodies or Parkinson’s disease
(Kane, Ouslander, & Abrass, 2004 [Level VI]).
There are no specific laboratory tests for the diagnosis of progressive de-
mentia other than those that can primarily indicate a potentially reversible or
contributing cause (see Table 6.1). The American Academy of Neurology (AAN)
recommends two specific laboratory tests (i.e., thyroid function and B12) in the
initial evaluation of suspected dementia (Knopman et al., 2001 [Level VI]). The
AAN similarly recommends that all patients with suspected dementia have a
magnetic resonance imaging (MRI) study or noncontrast computed tomography
(CT) as part of the initial workup. Once dementia has become clinically relevant
and a cause becomes apparent, there is no further diagnostic yield afforded by
imaging.
Caregiver Assessment
It is important to remember that the caregiver is a patient, too, in that they suf-
fer as does the patient with dementia. Caregiver need and burden refer to the
psychological, physical, and financial burden associated with caregiving. Care-
givers are at risk for depression, physical illness, and death (Schulz & Beach,
1999 [Level IV]). The Zarit Burden Interview (ZBI) can be used to identify the
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degree of burden experienced by the caregiver. The ZBI is a 4-item screening
followed by an additional 12 items with good reliability and validity (Bedard
et al., 2001 [Level IV]). Administration of this tool to a community-dwelling
caregiver can indicate the extent of impact caregiving has on the caregiver’s
health, social and emotional well-being, and finances. The Caregiver Strain
Index (CSI) is another tool that has been used to identify families with care-
giving concerns (Robinson, 1983 [Level IV]). The CSI is available on-line at
http://www.ConsultGeriRN.org/publications/trythis/issue14.pdf.
Interventions and Care Strategies
There is no cure for progressive dementia. Themanagement of individuals with
dementia requires pharmacological and nonpharmacological interventions.
Pharmacological Interventions
The goals of pharmacological therapy in dementia include preserving what the
disease destroys in cognitive and functional ability, minimizing what the dis-
ease imposes in the way of behavior disturbances, and slowing the progression
of the disease effects brought on by the destruction of neurons (Geldmacher,
2003 [Level VI]). Nurses, regardless of whether they are the prescribers of drug
therapy, need to be informed about the variety of drugs used in managing de-
mentia and the evidence supporting the pharmacological approaches. Although
there is substantial evidence that adults withmild to moderate AD (and perhaps
VaD and LBD) should have drug therapy, there are no solid data in support for
drug therapy into the advanced stage of the disease (Olsen, Poulsen, & Lublin,
2005 [Level I]).
Acetyl cholinesterase inhibitors are themainstay of treatment. Four are cur-
rently available in the United States: donepezel hydrochloride (Aricept), riv-
istigmine tartrate (Exelon), galantamine hydrobromide (Reminyl), and tacrine
hydrochloride (Tacrine)—the oldest and less favored drug due to its adverse ef-
fect and multiple daily dosing. Cognitive improvements in patients with mild to
moderateADhave been shown for each of these four drugs in large double-blind
randomized controlled clinical trials (Masterman, 2004 [Level VI]). These drugs
also provide cognitive and behavioral improvement in other forms of progres-
sive dementia including VaD (Del Ser et al., 2000 [Level I]) and DLB (Erkinjuntti
et al., 2002 [Level VI]). With the exception of Tacrine, the acetyl cholinesterase
inhibitors are safe and well tolerated; however, they may have gastrointestinal
side effects (i.e., nausea, anorexia, and diarrhea). Dementia pharmacological
therapy can improve the quality of life for the patient and the caregiver and
delays nursing home placement (Geldmacher, 2003 [Level II]; Lopez et al., 2002
[Level III]).
Memantine (Namenda), a newer drug approved by the Federal Drug Ad-
ministration (FDA) for moderate to severe dementia, has a different mech-
anism of action than the acetyl cholinesterase inhibitors. This N-methyl-D-
aspartate receptor antagonist hasneuroprotective effects that prevent excitatory
neurotoxicity. Individuals with AD and VaD have improved cognition and be-
havior (McShane, Areosa Sastre, & Minakaran, 2006 [Level I]). Side effects of
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memantine, although uncommon, include diarrhea, insomnia, and agitation.
Combined administration of donepezel with memantine demonstrated in-
creased efficacy in advanced AD when compared to donepezel alone (Tariot
et al., 2004 [Level II]).
Pharmacologic Therapy for Problematic Behaviors
Behavior changes are common in themid to later stages of progressive dementia
and, although nonpharmacological interventions are preferred, supplementa-
tion with a tailored drug regimen is sometimes necessary. Psychotropic med-
ications, primarily antipsychotics, can be administered to help the individual
regain control and be less disruptive—positive outcomes for the caregiver as
well as the patient. Drugs must be prescribed in the lowest effective dose for
the shortest amount of time (Gray, 2004 [Level VI]). The patient needs to be
closely monitored for effectiveness and adverse side effects. Psychotropic med-
ications have a high risk of adverse drug events, which are discussed in chapter
12, Reducing Adverse Drug Events.
Psychotropic therapy for different behaviors is always short term (i.e., 3 to 6
months). Once the target symptoms are relieved or abbreviated, then terminat-
ing therapy must be considered. Long-term psychotropic drug therapy should
be considered only if the symptoms reoccur after two attempts at withdrawal
(Geldmacher, 2003 [Level VI]).
Psychotic symptoms (e.g., delusions and hallucinations) frequently occur
in the later stages of progressive dementia (Ropacki & Jeste, 2005 [Level I])
and are often associated with agitation and aggression (Holroyd, 2004 [Level
VI]). The conventional antipsychotic haloperidol (i.e., Haldol) has been used
for decades and remains the most commonly used drug for control of psychotic
symptoms in individuals with dementia. A recent Cochrane Review by Loner-
gan, Luxenberg, and Colford (2002 [Level I]) validated the useful role of Haldol
in managing aggression but did not find evidence for its role in managing agita-
tion for patients with dementia. The side effects of conventional antipsychotics
are considerable and include extrapyramidal symptoms, tardive dyskinesia, se-
dation, orthostatic hypotension, and falls. There is evidence from recent studies
to support the use of the newer atypical antipsychotics over the conventional
ones (Tariot, Profenno, & Ismail, 2004 [Level I]). Agents available on the mar-
ket include risperidone, olanzapine, quetiapine, and the newest, aripiprazole.
Increasingly prescribed, these drugs appear to be as equally effective as the
conventionals with fewer negative effects such as Parkinsonism and tardive
dysknesia (Gray, 2004 [Level VI]). Recent concerns have been raised that use of
risperidone is associated with increased risk of stroke; yet, the data are not con-
clusive, therefore making it difficult to determine if the benefits of risperidone
outweigh the risks (Carson, McDonaugh, & Peterson, 2006 [Level I]). Olanzap-
ine, now available orally, can be most advantageous in managing an individual
with dementia with a catastrophic reaction, who is resistive, combative, and
at serious risk to harming self or others. Quetiapine (i.e., seroquel) is help-
ful in treating the hallucinations commonly occurring with agitation in DLB
(Takahashi, Yoshida, Sugita, Higuchi, & Shimiqu, 2003 [Level IV]). Evidence
suggests that both risperidone and olanzapine are useful in reducing aggres-
sion, but both are associated with serious adverse cardiovascular events and
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extrapyramidal symptoms; therefore, it should not be used routinely to treat
patients with dementia unless there is considerable risk or severe distress (Bal-
lard & Waite, 2006 [Level I]). Antipsychotic medications have been used exten-
sively in individuals with AD and some patients can benefit from the therapy;
however, the adverse effects are considerable and are no more effective than
placebowhen these are considered (Schneider et al., 2006 [Level II]). Additional
research is needed to determine when and how to use psychotropic medications
to address behaviors in individuals with dementia.
Benzodiazepines (e.g., lorazepan, oxazepan) are sometimes used to manage
agitation and aggression; however, the risk-benefit ratio is often unsatisfactory.
Patients with dementia are particularly sensitive to the anticholinergic effects
of these drugs that can exacerbate behavioral symptoms; therefore, they should
be used cautiously (Allain et al., 2000 [Level VI]). Sleep disorders can be ame-
liorated, for some patients, with low-dose Trazadone, which can also be helpful
with depressive, psychotic, and behavioral symptoms.
Findings are equivocal in using antidepressants to treat agitated depression
in dementia (Cummings, 2004 [Level VI]). Tricyclic antidepressants should be
avoided because of the high anticholinergic and cardiovascular risk potential.
Data from studies of selective serotonin inhibitors and mood-stabilizing anti-
convulsants do not consistently support their effectiveness in agitated dementia
(Lyketsos et al., 2006 [Level VI]). The narrow therapeutic window and the need
for ongoing blood-level monitoring of the anticonvulsants limit the usefulness
of these drugs.
Supplemental Drugs
Anti-inflammatory drugs and estrogen; herbals such as gingko; and vitamins
such as B12, folate, and Vitamin E—although sometimes touted and commonly
used—have no proven efficacy for dementia. Dementia associated with VaD re-
quires appropriate control of hypertension, hyperlipidemia, and aspirin therapy.
Parkinsonism (rigidity), seen with DLB, may benefit from levodopa therapy.
Nonpharmacologic Strategies
Nonpharmacological strategies including those from the cognitive, behavioral,
and environmental domains, in combination with staff support and education,
are effective (Burgener & Twigg, 2002 [Level I]). Physical/functional, environ-
mental, psychosocial, behavioral, and end-of-life (EOL) care interventions are
discussed in this section.
Physical/Functional Interventions
Maintaining physical and functional well-being of the individual with progres-
sive dementia facilitates independence, maintains health status, and can ease
the caregiving burden. Interventions include adequate nutrition and hydration,
regular exercise,maintenance ofADLs, proper rest and sleep, appropriate bowel
and bladder routines, proper dental hygiene and care, and current vaccina-
tions. Because co-morbidities are common (Lyketsos et al., 2005 [Level IV]),
regular assessment, vigilant monitoring, and aggressive management of acute
and chronic conditions are necessary. Vehicular driving safety might need to be
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examined because recent evidence indicates that individuals with mild demen-
tia pose a risk in driving safety (Dubinsky, Stein, & Lyons, 2000 [Level VI]).
Environmental Interventions
A specialized ecological model of care, which facilitates interaction between the
person and environment in a more home-like environment, has proven to be
beneficial for individuals with dementia. This model affords greater privacy,
encourages meaningful activities, and permits more choice than the traditional
model of care. It also demonstrates that individuals with dementia experience
less decline in ADLs; are more engaged with the environment; and no measur-
able differences are found in cognitive measures, depression, or social with-
drawal (Reimer, Slaughter, Donaldson, Currie, & Eliasziw, 2004 [Level IV]).
A systematic review reported inclusive results and suggested that more re-
search is needed with regard to the use of bright light in sleep in fostering bet-
ter sleep and reducing behavior problems in dementia (Kim, Song, & Yoo, 2003
[Level I]). The use of aromatherapy to reduce disturbed behavior, promote sleep,
and stimulate motivation also shows promise but needs more study (Thorgrim-
sen, Spector, Wiles, & Orrell, 2006 [Level I]). Manipulation of the environment
(e.g., alarms, circular hallways, visual or structural barriers) to minimize wan-
dering has not conclusively demonstrated to be effective (Peatfield, Futrell, &
Cox, 2002 [Level I]).
Psychosocial Interventions
Mental and social engagement is important to the well-being of all older adults.
Meaningful activity and involvement is no less important in individuals with de-
mentia. Although the effectiveness of counseling or procedural memory stimu-
lation is not supported in mild-stage dementia, reality orientation does appear
to be effective (Bates, Boote, & Beverley, 2004 [Level I]). The evidence suggests
that cognitive therapy is more beneficial than no therapy at all, but it may be
patient-specific (Forbes, 2004 [Level II]). Validation therapy, based on caregiver
acceptance of the reality of the person with dementia’s experience, may be of
value but the evidence is lacking (Neal & Briggs, 2003 [Level I]).
Recreational therapies including music and art have been explored, al-
though the evidence to substantiate effectiveness is scanty (Gerdner, 2000 [Level
VI]). Music, in particular, may have some value in reducing behavioral problems
in dementia (Lou, 2001 [Level I]), but additional research is needed to demon-
strate immediate and sustained benefit.
Support groups, counseling sessions, availability of a counselor, and ed-
ucation delay nursing home placement of those with mild to moderate AD
(Mittelman, Ferris, Shulman, Steinberg, & Levin, 1996 [Level II]). Caregivers
experience physical, financial, social, and emotional losses that become more
pronounced over time (Bullock, 2004 [Level VI]). Teaching caregivers how to
change their interactions with the person with dementia and to use problem-
solving skills is effective (Burgener, Bakas, Murray, Dunahee, & Tossey, 1998
[Level II]) and can reduce caregiver burden and depression and increase their
knowledge (Acton & Winter, 2002 [Level I]). Areas for caregiver education are
detailed in Table 6.3.
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6.3 Educating Caregivers
Information about the disease and its progression
Strategies to maintain function and independence
Preservation of cognitive and physical vitality in dementia
Maintaining a safe and comfortable environment
Giving physical and emotional care
Communicating with the individual with dementia
Managing behavioral problems
Advance planning: health care and finances
Caregiver survival tips
Building a caregiver support network
Behavioral Interventions
Behavioral and psychosocial symptoms of dementia are common with every
form of progressive dementia, particularly in the moderate stage. The three
most troublesome symptoms are agitation, aggression, and wandering. Prob-
lematic behaviors that occur during meals or bathing can be particularly chal-
lenging. It is important to recognize and realize that any new behavior could be
a sign of an acute illness or an environmental influence. Unrecognized pain can
cause disruptive behavior. Short-term use of physical restraints may be nec-
essary, but those selected should always be the least restrictive type and used
for the shortest duration of time. The Progressively Lowered Stress Thresh-
old (PLST) is a framework to optimize function, minimize disruption, and help
the caregiver (Smith, Hall, Gerdner, & Buckwalter, 2006 [Level V]). By adapt-
ing the environment and routines, interventions are designed to help the pa-
tient with dementia use his or her functional skills and minimize potentially
triggering reactions. There are six essential principles of care in the PLST, as
follows:
1. Maximize safe function: Use familiar routines, limit choices, provide rest pe-
riods, reduce stimuli when stress occurs, routinely identify and anticipate
physical stressors (i.e., pain, urinary symptoms, hunger, or thirst).
2. Provide unconditional positive regard: Use respectful conversation, simple and
understandable language, nonverbal expressions of touch.
3. Use behaviors to gauge activity and stimulation: Monitor for early signs of anx-
iety (e.g., pacing, facial grimacing) and intervene before behavior escalates.
4. Teach caregivers to “listen” to the behaviors:Monitor the language pattern (e.g.,
repetition, jargon) and behaviors (e.g., rummaging) that might be showing
how the person reduces stress when needs are not being met.
5. Modify the environment: Assess the environment to ensure safe mobility and
promote way-finding and orientation through cues.
6. Provide ongoing assistance to the caregiver: Assess and address the need for
education and support.
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Advance Planning and EOL Care Interventions
Advanced planning and providing directives for care are important in guiding
the types of interventions used at the end of life and can decrease the caregiver
stress in proxy decision making. Nursing homes are common sites for EOL care
for people with progressive dementia; however, nationally only 51% of all nurs-
ing home residents have an advance directive (Mezey, Mitty, Bottrell, Ramsey,
& Fisher, 2000 [Level VI]). As many as 90% of the 4 million Americans with de-
mentia will be institutionalized before death (Smith, Kokmen, & O’Brien, 2000
[Level IV]), making this environment in particular an important focus for EOL
care. Older adults with dementia have increased mortality rates compared to
older adults without dementia (Ostbye, Hill, & Steenhuis, 1999 [Level IV]) and
often die from the complication of immobility, infection, and heart disease. The
end stage of AD may last as long as 2 to 3 years (Brookmeyer, Corrada, Curriero,
& Kawas, 2002 [Level IV]) and frequently distressing signs and symptoms occur
at this time.
Dementia itself or often-associated conditions can cause physical symptoms
such as poor nutrition, urinary incontinence, skin breakdown, pain, infection,
shortness of breath, fatigue, difficulty in swallowing, choking, and gurgling, in
addition to the behavioral symptoms mentioned previously. There is no accept-
able standard treatment for the consequences of advanced dementia and, where
guidelines do exist, there is minimal to no palliative-care content. Aggressive
treatments such as antibiotics, tube feedings, psychotropic drugs, and physical
restraints to address problematic behaviors appear to be prevalent, although
there is no substantial evidence that this approach is effective in end-stage de-
mentia and that prognosis and life expectancy are improved by these strategies
(Evers, Purohit, Perl, Khan, & Martin, 2002 [Level IV]; Finucane, Christmas, &
Travis, 1999 [Level VI]). Measuring quality of care at the end of life for those
with dementia poses significant challenges due to the limitations in subjective
reporting and, therefore, relies on the caregiver’s analysis of cues to monitor the
patient’s condition and experience (Volicer,Hurley, &Blasi, 2001 [Level IV]). De-
spite the clear recognition that significant improvements in EOL care for those
with dementia is needed (Horgas & Tsai, 1998 [Level IV]; Scherder et al., 2005
[Level I]), there is a lack of systematic evidence on how to approach pallia-
tive care for this population (Sampson, Ritchie, Lai, Raven, & Blanchard, 2005
[Level I]).
Case Study and Discussion
Mrs. P. is an 85-year-old White woman brought into the primary-care clinic
by her daughter for a geriatric consultation. She has a 4-year history of
cognitive impairment that began with memory loss and impaired judgment
and that appears to be worsening; she is now experiencing some behavioral
problems. Mrs. P. is high school educated, has been widowed for 10 years,
and is a retired short-order cook. She currently lives with her daughter,
son-in-law (both work full time), and grandson.
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Her primary-care physician completed a dementia workup at the time
the symptoms appeared 4 years ago and started her on Donepezil, which
was discontinued within a few days because of gastrointestinal side effects.
She recently had paranoid ideation in which she accused her 15-year-old
grandson of listening in on her telephone conversations and taking some
money from her purse. Her daughter reports that Mrs. P. has “a short fuse”
and gets agitated easily. “She called me a moron and even took a swing at
me the other day when I told her she smelled bad and needed to take a
shower.”
Mrs. P. performs her own personal hygiene although she needs re-
minders and cueing at times; she is continent. She does not do any IADLs
(e.g., cooking, shopping) and it was unclear if she truly was no longer capa-
ble of performing these functions or no longer had the opportunity or desire
to do them. Mrs. P. reports no desire to eat and had a weight loss resulting
in a change of at least three clothing sizes that has occurred slowly during
the past few years. When asked about her mood, she becomes tearful and
says, “I get disgusted; no one cares about me anymore.” Mrs. P. says she
hates to be alone and that the family “just come and goes—they never talk
with me.” Her MMSE score is 18/30 with deficits in memory, calculation, and
ability to copy the intersecting pentagons. She scores 10/15 on the Geriatric
Depression Scale (see www.ConsultGeriRN.org for the GDS scale).
Past medical history includes thyroidectomy, left cataract extraction,
cholecystectomy, and hysterectomy for benign disease. Her daughter thinks
that Mrs. P. may have been on antihypertensives in the past. The only med-
ication Mrs. P. takes at present is for her thyroid, but neither she nor her
daughter knew the name of the drug.
On physical exam, she is afebrile; blood pressure is 132/70, and is she
is about 10 pounds below her ideal body weight. Mrs. P. is alert and co-
operative and smiles at intervals during the examination. She has slight
hearing loss with clear canals; no thyromegaly. The cardiovascular exam
reveals no murmur, edema, or discolorations of the extremities. Pulses are
strong throughout. There are no focal neurological symptoms. Gait is slow
but steady. Breasts are free of masses and abdomen is soft, nontender with
no organ enlargement.
A diagnosis of depression and progressive dementia of the Alzheimer’s
type is made and she is started on the combination of Donepezil and
Mementine, both to be titrated slowly. Additional information from Mrs. P.’s
primary-care physician will be consulted about her thyroid function. An-
tidepressant therapy may be considered at a later date. Take the initiative to
do some health teaching and provide additional resource information to the
family.
Depression is not uncommon in those with a progressive dementia. Se-
vere anxiety, agitation, and aggression can occur; tearfulness and decreased
appetitewithweight lossmay also be present (Holroyd, 2004 [Level VI]). Us-
ing thePLSTmodel, focus on teaching thedaughter to recognize triggers and
prodromal signs of increasing anxiety, and intervene appropriately when
anxiety and agitation occur. Emphasize strategies in each of the six PLST
principles of care:maximize safe function, provideunconditional regard, use
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behaviors to gauge activity and stimulation, “listen” to the behaviors, modify
the environment, and provide ongoing assistance to the caregiver. Empha-
size using less confrontational language and behaviors in approaches and
interactionswithMrs. P. Provide herwith specific contact information for the
geriatrician’s office and for the caretaker, as well as the local and national
resources available through the Alzheimer’s Association (1-800-272-3900;
www.alz.org) and the Alzheimer’s Disease Education and Referral Center
(ADEAR) (1-800-438-4380; www.alzheimers.org). Give dietary instructions
and strategies to increase nutritional density, noting that additional resource
information is available at the ADEAR site listed herein. Give specific med-
ication instructions with particular emphasis on how to use the titration
packet provided; further suggest the co-administration with food to reduce
the likelihood of gastrointestinal side effects. Plan a follow-up telephone
call for the next day and schedule a follow-up medical and health teaching
appointment in 1 month to evaluate the effectiveness of the plan of care.
Instruct the patient and family to call or return if new or changed behaviors
or physical symptoms develop.
Summary and Conclusions
It is important that health care professionals identify cognitive impairments
in older adults early and differentiate a progressive from a reversible etiology,
such as delirium. Comprehensive assessment, monitoring, and pharmacologi-
cal and nonpharmacological management of physical, functional, cognitive, and
behavioral problems are important, both in initial identification and in the on-
going care of the individual with progressive dementia. Education and support
of the family and professional caregiver are essential. It is difficult to iden-
tify clearly what constitutes quality of life for the individual with progressive
dementia, which interventions enhance this quality, and how this is accom-
plished. Abraham, MacDonald, and Nadzam (2006 [Level VI]) note that in geri-
atric nursing, there is limited evidence to guide our care. It is imperative that
geriatric nurses evaluate practice and generate new knowledge to ensure best
practice in the care of individuals with progressive dementia as well as their
caregivers.
Resources
Alzheimer’s Association www.alz.org
Alzheimer’sDiseaseEducation andReferralCenterwww.alzheimers.nia.nih.gov
The National Family Caregiver’s Association (NFCA) www.nfcacares.org
American Association of Retired Persons (AARP) www.aarp.org/caregiving
ElderWeb www.elderweb.com
Nurse Competence in Aging http://www.ConsultGeriRN.org/
The Hartford Institute for Geriatric Nursing http://www.ConsultGeriRN.org/
National Conference of Gerontological Nurse Practitioners: Mental Health
Toolkit http://www.ncgnp.org/
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Box 6.1
Nursing Standard of Practice Protocol: Recognition
and Management of Dementia
I. GOALS
A. Early recognition of dementing illness.
B. Appropriate management strategies in care of individuals with de-
mentia.
II. OVERVIEW
The rapid growth of the aging population is associated with an increase
in the prevalence of progressive dementias. It is imperative that a differ-
ential diagnosis be ascertained early in the course of cognitive impair-
ment and that the patient is closelymonitored for coexistingmorbidities.
Nurses have a central role in assessment andmanagement of individuals
with progressive dementia.
III. BACKGROUND
A. Definitions/Distinctions
1. Dementia is a clinical syndrome of cognitive deficits that involves
bothmemory impairments and a disturbance in at least one other
area of cognition (e.g., aphasia, apraxia, agnosia) and disturbance
in executive functioning (American Psychiatric Association, 2000
[Level VI]).
2. In addition to disruptions in cognition, dementias are commonly
associated with changes in function and behavior.
3. Themost common forms of progressive dementia areAlzheimer’s
disease, vascular dementia, and dementia with Lewy bodies; the
pathophysiology for each is poorly understood.
4. Differential diagnosis of dementing conditions is complicated by
the fact that concurrent disease states (i.e., co-morbidities) often
coexist.
B. Prevalence
1. Dementia affects about 5% of individuals 65 and older (Richie &
Lovestone, 2002 [Level VI]).
2. Four to five million Americans have Alzheimer’s disease (AD)
(Hebert et al., 2003 [Level IV]).
3. 13.2 million are projected to have AD by 2050 (Hebert et al., 2003
[Level IV]).
4. Global prevalence of dementia is about 24.3million,with 6million
new cases every year (Ferri et al., 2005 [Level IV]).
C. Risk Factors
1. Advanced age
2. Mild cognitive impairment
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3. Cardiovascular disease
4. Genetics: family history of dementia, Parkinson’s disease, car-
diovascular disease, stroke, presence of ApoE4 allele on chromo-
some 19
5. Environment: head injury, alcohol abuse
IV. PARAMETERS OF ASSESSMENT
No formal recommendations for cognitive screening are indicated
in asymptomatic individuals. Clinicians are advised to be alert for
cognitive and functional decline in older adults to detect dementia
and dementia-like presentation in early stages. Assessment domains
include cognitive, functional, behavioral, physical, caregiver, and
environment.
A. Cognitive Parameters
1. Orientation: person, place, time
2. Memory: ability to register, retain, recall information
3. Attention: ability to attend and concentrate on stimuli
4. Thinking: ability to organize and communicate ideas
5. Language: ability to receive and express a message
6. Praxis: ability to direct and coordinate movements
7. Executive function: ability to abstract, plan, sequence, and use
feedback to guide performance
B. Mental Status Screening Tools
1. Folstein Mini-Mental State Examination (Folstein et al., 1975
[Level IV]): the most commonly used test to assess serial cog-
nitive change. On average, the MMSE declines 3 points per year
in those with AD (Han et al., 2000 [Level I]). It is composed of
items assessing orientation, attention, concentration, memory,
language, and construction ability. Age, education, cultural
background, and perceptual and physical abilities can affect
performance. The MMSE might not detect mild cognitive loss
and, as well, it is not diagnostic of decision-making capacity
(Parker & Philp, 2004 [Level VI]).
2. Clock Drawing Test (CDT) (Royall et al., 1999 [Level IV]):
a useful measure of cognitive function that correlates with
executive-control functions (i.e., the cognitive process necessary
to plan and carry out goal-directed behaviors). The patient is
asked to draw a clock free-hand, put in all the numbers, and set
a time asked for by the examiner. Physical ability and dexterity
can influence performance.
3. Mini-Cognitive (Mini-Cog) (Borson et al., 2000 [Level IV])
combines the Clock Drawing Test with the three-word recall.
The patient is asked to remember three unrelated words and
later is asked to recall the three words. This clinically useful
tool, rapidly administered, has a high level of sensitivity and
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specificity and less bias than some other instruments (e.g., the
MMSE) (Borson et al., 2003 [Level IV]).
When the diagnosis remains unclear, the patient may be referred
formore extensive screening and neuropsychological testing, which
might provide more direction and support for the patient and the
caregivers.
C. Functional Assessment
1. Tests that assess functional limitations such as the Functional
Activities Questionnaire (FAQ) (Pfeffer et al., 1982 [Level IV])
can detect dementia with sensitivity and specificity comparable
to mental-status testing. They are also useful in monitoring the
progression of functional decline.
2. The severity of disease progression in dementia can be demon-
strated by performance decline in ADL and IADL tasks and
is closely correlated with mental-status scores (Galasko et al.,
1997 [Level IV]). See also chapter 3, Assessment of Function, for
additional tools.
D. Behavioral Assessment
1. Assess and monitor for behavioral changes; in particular,
the presence of agitation, aggression, anxiety, disinhibitions,
delusions, and hallucinations.
2. Evaluate for depression because it commonly coexists in individ-
uals with dementia (Zubenko et al., 2003 [Level IV]). Symptoms
and signs may include the presence of neurovegetative signs
(e.g., hypersomnia, insomnia, increased or decreased appetite,
decreased energy, weight loss or gain, psychomotor agitation
or slowing) or mood changes (e.g., depressed mood, feelings
of worthlessness or helplessness, suicidal ideation). See also
chapter 5, Depression. Determine if there is a diminished level of
interest in life. Is there a lack of motivation, decreased initiation,
or a poor ability to sustain effort?
E. Physical Assessment
1. A comprehensive physical examination with a focus on the
neurological and cardiovascular system is indicated in individ-
uals with dementia to identify the potential cause and/or the
existence of a reversible form of cognitive impairment.
2. A thorough evaluation of all prescribed, over-the-counter,
homeopathic, herbal, and nutritional products taken is done to
determine the potential impact on cognitive status.
3. Laboratory tests are valuable in differentiating irreversible from
reversible forms of dementia. Structural neuroimaging with
noncontrast computed tomography (CT) or magnetic resonance
imaging (MRI) scans are appropriate in the routine initial
evaluation of patients with dementia.
F. Caregiver/Environment
The caregiver of the patient with dementia often has as many
needs as the patient with dementia; therefore, a detailed
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assessment of the caregiver and the caregiving environment is
essential.
1. Elicit the caregiver perspective of patient function and the level
of support provided.
2. Evaluate the impact that the patient’s cognitive impairment and
problem behaviors have on the caregiver (mastery, satisfac-
tion, and burden). Two useful tools include the Zarit Burden
Interview (ZBI) (Bedard et al., 2001 [Level IV]) and the Care-
giver Strain Index (CSI) Tool CSI–Caregiver strain Index (see
www.ConsultGeriRN.org Topic: Caregiving).
3. Evaluate the caregiver experience and patient–caregiver rela-
tionship. The caregiving experience is a stressful one and the
potential for elder mistreatment and caregiver illness exists.
V. NURSING CARE STRATEGIES
Based on evidence provided under the Interventions and Care Strate-
gies in this chapter; specifically, use of the PLST that provides a frame-
work for the nursing care of individuals with dementia (Smith et al.,
2006 [Level V]).
A. Monitor the effectiveness and potential side effects of medications
given to improve cognitive function or delay cognitive decline.
B. Provide appropriate cognitive-enhancement techniques and social
engagement.
C. Ensure adequate rest, sleep, fluid, nutrition, elimination, pain con-
trol, and comfort measures.
D. Avoid the use of physical and pharmacologic restraints.
E. Maximize functional capacity: Maintain mobility and encourage in-
dependence as long aspossible, provide gradedassistance asneeded
with ADLs and IADLs, provide scheduled toileting and prompted
voiding to reduce urinary incontinence, encourage an exercise rou-
tine that expends energy and promotes fatigue at bedtime, establish
bedtime routine and rituals.
F. Address behavioral issues: Identify environmental triggers, medical
conditions, caregiver–patient conflict thatmaybe causing thebehav-
ior, define the target symptom (i.e., agitation, aggression, wander-
ing) and pharmacological (psychotropics) and nonpharmacological
(manage affect, limit stimuli, respect space, distract, redirect) ap-
proaches, provide reassurance, refer to appropriate mental health
care professionals as indicated.
G. Ensure a therapeutic and safe environment: Provide an environ-
ment that is modestly stimulating, avoiding overstimulation that can
cause agitation and increase confusion, and understimulation that
can cause sensory deprivation and withdrawal. Utilize patient iden-
tifiers (name tags), medic alert systems and bracelets, locks, wander
guard; eliminate any environmental hazards and modify the envi-
ronment to enhance safety; provide environmental cues or sensory
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aides that facilitate cognition; maintain consistency in caregivers
and approaches.
H. Encourage and support advance-care planning: Explain trajectory
of progressive dementia, treatment options, and advance directives.
I. Provide appropriate end-of-life care in terminal phase: Provide
comfort measures including adequate pain management; weigh the
benefits/risks of the use of aggressive treatment (tube feeding, an-
tibiotic therapy).
J. Provide caregiver education and support: Respect family sys-
tems/dynamics and avoid making judgments, encourage open di-
alogue, emphasize the patient’s residual strengths, provide access
to experienced professionals, teach caregivers the skills of care-
giving.
K. Integrate community resources into the plan of care to meet the
needs for patient and caregiver information; identify and facilitate
both formal (i.e., Alzheimer’s Association, Respite Care, Specialized
Long Term Care) and informal (i.e., churches, neighbors, extended
family/friends) support systems.
VI. EVALUATION/EXPECTED OUTCOMES
A. Patient Outcomes: The patient remains as independent and func-
tional in the environment of choice for as long as possible, the
co-morbid conditions the patient may experience are well managed,
and the distressing symptoms that may occur at end of life are min-
imized or controlled adequately.
B. Caregiver Outcomes (lay and professional): Caregivers demonstrate
effective caregiving skills; verbalize satisfaction with caregiving; re-
portminimal caregiver burden; are familiar with, have access to, and
utilize available resources.
C. Institutional Outcomes: The institution reflects a safe and enabling
environment for delivering care to individuals with progressive de-
mentia; the quality improvement plan addresses high risk problem-
prone areas for individuals with dementia, such as falls and the use
of restraints.
VII. FOLLOW-UP TO MONITOR CONDITION
A. Follow-up appointments are regularly scheduled; frequency de-
pends on the patient’s physical, mental, and emotional status and
caregiver needs.
B. Determine the continued efficacy of pharmacological/nonpharma-
cological approaches to the care plan and modify as appropriate.
C. Identify and treat any underlying or contributing conditions.
D. Community resources for education and support are accessed and
utilized by the patient and/or caregivers.
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VIII. RELEVANT PRACTICE GUIDELINES
A. American Academy of Neurology: Detection of Dementia, Diagno-
sis of Dementia, Management of Dementia, and Encounter Kit for
Dementia: http://www.aan.com/professionals/practice/guideline/
index
B. American Geriatrics Society: Clinical Recommendations for Feed-
ing Tube Placement in Elderly Patients with Advanced Dementia:
http://www.americangeriatrics.org/education/cp index.shtml
C. American Association of Geriatric Psychiatry: Position Statement:
Principles of Care for Patients with Dementia Resulting from
Alzheimer’s Disease: http://www.aagponline.org/prof/position
caredmnalz.asp
D. Alzheimer’s Foundation of America (AFA): Excellence in Care:
www.alzfdn.org
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Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. describe hospitalized older adults at risk for
delirium
2. discuss the importance of early recognition of
delirium
3. identify four clinical characteristics of delirium
4. develop a plan to prevent or treat delirium
5. list five outcomes associated with delirium
Overview
Delirium is a common syndrome in hospitalized older adults. Sometimes re-
versible, delirium is one of the major contributors to poor outcomes of health
care and institutionalization for older patients. A significant proportion of delir-
ium cases has been shown to be preventable by identifying modifiable risk
factors and utilizing a standardized nursing practice protocol. If delirium does
develop, early recognition is of paramount importance to treat the underlying
pathology and minimize delirium’s sequelae. Nurses play a key role in both the
prevention and early recognition of this potentially devastating condition.
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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Background and Statement of Problem
Delirium is a disturbance of consciousness with impaired attention and disorga-
nized thinking that develops rapidly and with evidence of an underlying physi-
ologic or medical condition (American Psychiatric Association, 2000). Delirium
is characterized by a reduced ability to focus, sustain, or shift attention; mem-
ory impairment, disorientation, and/or illusions; visual or other hallucinations;
andmisperceptions of stimuli. Delusional thinking may also occur. Unlike other
chronic cognitive impairments, delirium develops over a short period and tends
to fluctuate during the course of the day. A patient may present with either hy-
peractive, hypoactive, ormixed subtypes of delirium (de Rooij, Schuurmans, van
derMast, & Levi, 2005 [Level I]). Nurses typically associate deliriumwith hyper-
activity and distressing, time-consuming, harmful patient behaviors. However,
the hypoactive subtype with its lack of overt psychomotor activity is also com-
mon (O’Keeffe & Lavan, 1999 [Level IV]).
Delirium is present on admission (prevalence) to the hospital in 10% to 15%
of older patients; the in-hospital incidence (new onset) is 10% to 40% in older
medical and surgical patients (Fann, 2000 [Level I]). Amonghip-surgerypatients
alone, the incidence of delirium is 43% to 61% (Holmes & House, 2000 [Level I]).
Older adults admitted to intensive care units (ICUs) have both a prevalent and
an incident delirium of 31% (McNicoll et al., 2003 [Level IV]) and up to 83%
of mechanically ventilated patients (all ages) experience delirium (Ely et al.,
2001a [Level IV]). The incidence of delirium superimposed on dementia ranges
from 22% to 89% (Fick, Agostini, & Inouye, 2002 [Level I]). The onset of delirium
generally occurs shortly after admission, has a varied and unpredictable course,
and may persist for several weeks after hospital discharge (Kiely et al., 2003
[Level IV];Marcantonio et al., 2003 [Level IV]; Rudberg, Pompei, Foreman, Ross,
& Cassel, 1997 [Level IV]).
The pathophysiology of delirium is not well understood (Trzepacz & van der
Mast, 2002 [Level VI]) and a number of risk factors have been identified suggest-
ing that the etiology of delirium is multifactorial (Inouye & Charpentier, 1996
[Level VI]). The most common risk factors for delirium include dementia, male
gender, advanced age, and medical illness (Elie, Cole, Primeau, & Bellavance,
1998 [Level I]). Other predisposing risk factors identified are poor functional
status, alcohol abuse, and depression (Fann, 2000 [Level I]), as well as dehydra-
tion and sensory impairment (Inouye, Viscoli, Horwitz, Hurst, & Tinetti, 1993
[Level IV]).
Precipitating risk factors occurring during hospitalization include polyphar-
macy, malnutrition, physical restraints, a bladder catheter, or any iatrogenic
event (Inouye & Charpentier, 1996 [Level IV]). Multiple medications have been
implicated as precipitating factors for delirium. These include but are not lim-
ited to anticholinergics, narcotics (meperidine), sedative hypnotics (benzodi-
azepines), histamine (H2) receptor antagonists, corticosteroids, centrally act-
ing antihypertensives, and antiparkinsonian drugs (Fann, 2000 [Level I]). Other
precipitating factors include under-treated pain (Morrison et al., 2003 [Level
IV]) and care-setting relocation (especially to ICU) (McCusker et al., 2001
[Level IV]).
Delirium results in significant distress for the patient, their family mem-
bers, and nurses (Breitbart, Gibson, & Tremblay, 2002 [Level IV]). In addition,
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delirium is associated with increased mortality, increased postoperative
complications, longer hospital stay, functional decline, and new nursing home
placement (Fann, 2000 [Level I]). Long-term cognitive decline (Ely et al., 2004a
[Level IV]; McCusker, Cole, Dendukuri, Belzile, & Primeau, 2001 [Level IV]) and
increased health care costs (Inouye, 2006 [Level VI];Milbrandt et al., 2004 [Level
IV]) have also been associated with delirium. Clearly, delirium is a high-priority
nursing challenge for all who care for older adults.
Parameters of Assessment
Identifying the risk factors for delirium (stated previously) is critically impor-
tant. Eliminating or reducing these risk factors can prevent delirium in many
cases (Milisen, Lemiengre, Braes, & Foreman, 2005 [Level I]).
Recognizing the first signs of delirium is also important to further identify,
eliminate, or reduce the precipitating factor(s) such as pain, infection, or other
acute illnesses. The criteria used to distinguish delirium or acute confusion from
other changes in mental status include the following:
■ Disturbance of consciousness (i.e., reduced clarity and awareness of the
environment) with reduced ability to focus, sustain, and shift attention.
Patients have trouble following instructions or making sense of their en-
vironment, even with cues. They may also get “stuck” on a particular con-
cern or thought.
■ A change in cognition: memory deficit, disorientation, language distur-
bance, and/or perceptual disturbance. Symptoms are often associated
with disturbances in the sleep/wake cycle and rapidly shifting emotional
disturbances, with escalation of the disturbed behavior at night (i.e., sun-
downing). Hallucinations and delusions are common. Patients can be hy-
peractive and agitated or lethargic and less active. The latter presentation
is particularly of concern because it is often not recognized by health care
providers as delirium. The presentation may also be mixed, with the pa-
tient fluctuating from one to the other.
■ The cardinal sign of delirium is that these changes occur rapidly over
several hours or days.
It is important to remember that delirium may occur concurrently with de-
mentia or depression. In fact, those patients are at increased risk to develop
delirium. Family and caregivers can be invaluable in helping to distinguish cog-
nitive changes in those circumstances when the patient is not well known to the
nurse or physician.
Despite its importance, delirium is under-recognized by nurses and physi-
cians (Ely et al., 2004b [Level IV]; Fick & Foreman, 2000 [Level IV]; Inouye,
Foreman, Mion, Katz, & Cooney, Jr., 2001 [Level IV]). Personal philosophies
about aging are a factor in nurses’ inability to distinguish delirium from demen-
tia (McCarthy, 2003 [Level IV]). In addition, the hypoactive subtype of delirium,
with no agitated behavior to alert physicians and nurses to its presence, is an-
other reason why delirium is not identified. Failure to recognize deliriummeans
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that the underlying cause cannot be identified and treated in a timely manner,
contributing to the sequelae associated with delirium.
Nurses are in the best position to recognize delirium. Screening tools have
been developed to assist nurses in their assessment (Schuurmans, Deschamps,
Markham, Shortridge-Baggett, & Duursma, 2003 [Level V]). Experienced clin-
icians can train nurses to use these instruments in their routine assessment
of older adults (Pun et al., 2005 [Level IV]). In the absence of such training,
however, nurses can identify the clinical features of delirium and alert the
physician or nurse practitioner to continue the diagnostic process (see Sec-
tion IV, Parameters of Assessment, in Box 7.1, Nursing Standard of Practice
Protocol).
Intervention and Care Strategies
Multicomponent nursing interventions, guided by the multiple risk factors for
delirium, are modestly successful in preventing delirium (Cole, Primeau, &
McCusker, 1996 [Level I]; Milisen, Lemiengre, Braes, & Foreman, 2005 [Level
I]). However, such multicomponent interventions are not effective for treating
delirium once it has developed (Milisen et al., 2005 [Level I]; Pitkala, Laurila,
Strandberg, & Tilvis, 2006 [Level II]) and are possibly less effective for older
medical than surgical patients (Cole, Primeau, & Elie, 1998 [Level I]). None
of the multicomponent intervention studies focused on patients with chronic
cognitive impairment—patients at greatest risk for delirium (Britton & Russell,
2004 [Level I]). Medications are not effective in preventing delirium (Kalisvaart
et al., 2005 [Level II]).
Once it has been determined that the patient is either at risk for or has
already developed delirium, a standardized deliriumprotocol should be initiated
immediately. Protocols tested in two multicomponent interventions effectively
prevented delirium (Inouye et al., 1999 [Level II]; Marcantonio, Flacker, Wright,
& Resnick, 2001 [Level II]). The protocols varied somewhat but two principles
emerged from the research: (1) minimize the risk for delirium by preventing or
eliminating the etiologic agent(s); and (2) provide a therapeutic environment
and general supportive nursing care (see Section V, Nursing Care Strategies, in
Box 7.1 Protocol for details).
Although nonpharmacologic interventions are preferred, medications are
also used in the treatment of delirium (Meagher, 2001 [Level VI]). Antipsy-
chotics (e.g., haloperidol) are frequently used although their efficacy and safety
have not been established by double-blind, randomized, placebo-controlled tri-
als (Seitz, Gill, & van Zyl, 2007 [Level I]). Medications such as diazepam to
enhance post-laparotomy sleep in older patients (Aizawa et al., 2002 [Level II]),
risperidone (Parellada, Baeza, de Pablo, & Martinez, 2004 [Level II]), and olan-
zapine (Skrobik, Bergeron, Dumont, & Gottfried, 2004 [Level II]) may prevent
delirium but more robust studies are needed. Diazepam should not be used in
older adults (Fick et al., 2003 [Level IV]) and, given the adverse affects in older
adults with many medications (see chapter 12, Reducing Adverse Drug Events),
any newmedication approved for delirium should be used with extreme caution
in these patients.
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Case Study and Discussion
Mr. Z. is an 82-year-old patient admitted to your unit for prostate surgery.
He is a retired accountant, lives with his wife, and is very active. He drives
a car, plays golf, and regularly participates in activities at the senior center.
His Type II diabetes is well controlled on Actoplus-met (i.e., pioglitazone
hydrochloride and metformin hydrochloride). Mr. Z. reports that he has de-
creased his fluid intake so he can avoid waking several times during the
night to urinate. He also has a history of hypertension, moderate hearing
loss (hearing aids bilaterally), and previous surgery for inguinal hernia re-
pair. He wears bifocal glasses for distance and reading. He is alert, oriented,
and expresses a good understanding of his upcoming surgery. His preoper-
ative laboratory values are within normal limits except for a hematocrit of
28% and a blood urea nitrogen/creatinine (BUN/Cr) ratio slightly elevated at
21:1. His medications include Actoplus-met for his diabetes and verapamil
for hypertension.
Which factors present on admission to the hospital put Mr. Z
at risk for developing delirium?
■ Age. Older adults are at greater risk for delirium, particularly if they have
underlying dementia or depression. Physiologic changes that occur with
aging can affect the ability of older adults to respond to physical and
physiologic stress and to maintain homeostasis.
■ Dehydration. An elevated BUN/Cr ratio indicates dehydration (from de-
creased fluid intake), a frequent contributing factor (along with elec-
trolyte imbalance) to delirium of hospitalized older adults.
■ Anemia. Because of a low hematocrit, the body has diminished abil-
ity to deliver adequate oxygen to the brain, making delirium more
likely.
■ Sensory deficits. Those with vision and hearing loss are more likely to
misinterpret sensory input, which places them at increased risk for delir-
ium.
■ It is important to understand that it might not be one particular factor
but the interplay of patient vulnerability (i.e., predisposing factors) and
precipitating factors—common during hospitalization—that place older
adults at risk for delirium.
What can you do to help prevent delirium in Mr. Z.?
■ If possible, consult with a geriatric specialist (physician or nurse) for a
thorough geriatric assessment of Mr. Z.
■ Make sure his glasses and hearing aids are on and functioning.
■ Explore reasons for the low hematocrit.
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Care is again provided for Mr. Z. 2 days after surgery. He is confused and
picking at the air and oriented to self only. An indwelling urinary catheter
and peripheral intravenous line are in place. In his report, the day-shift nurse
mentioned considering a physical restraint becauseMr. Z. was increasingly rest-
less and might be delirious.
What are the clinical features of delirium?
■ Disturbance of consciousness characterized by reduced clarity and aware-
ness of the environment; reduced ability to focus, sustain, and shift atten-
tion. Patients have trouble following instructions or making sense of their
environment, even with cues. They may also get “stuck” on a particular
concern or thought.
■ Cognitive changes: memory deficit, disorientation, language disturbance,
and/or perceptual disturbance.
■ Perceptual disturbances: Hallucinations and delusions are common. Pa-
tients can be hyperactive and agitated or lethargic (i.e., hypoactive) and
less active. The latter presentation is of particular concern because it is
often not recognized as delirium by health care providers. The presenta-
tion may also be mixed, with the patient fluctuating from one to the other
behavioral state.
■ Deliriumcanbe characterized bydisturbances in the sleep/wake cycle and
rapidly shifting emotional disturbances, with escalation of the disturbed
behavior at night (i.e., sundowning).
■ The cardinal sign of delirium is that these changes occur rapidly over
several hours or days.
It is also important to consider that delirium may occur concurrently with
dementia or depression. In fact, these patients are at increased risk to develop
delirium. Family and caregivers can be invaluable in helping to identify or dis-
tinguish cognitive changes in circumstances when the patient is not well known
to the nurse or physician.
Which additional factors may now be contributing
to Mr. Z.’s delirium?
■ Anesthesia and other medications. It takes several hours for the body to
clear the effects of anesthesia. Inasmuch as older adults have a larger
percentage of body fat than younger persons and many drugs are fat-
soluble, drug effects will last longer. Also, older adults tend to have less
cellular water; therefore, water-soluble drugs will be more concentrated
and have a more pronounced effect. Nurses need to ask the patient or
family if any new drugs other than pain medication have been added.
What is the dose and frequency of the pain medications? Is the dose
appropriate?
■ Pain. What is Mr. Z.’s pain-control regimen and status? Poor pain control
contributes to restlessness and is associated with delirium. Is the current
drug the best for good pain relief in this patient?
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■ Hypoxemia. Mr. Z. is at risk because of limited mobility and possible at-
electasis after surgery. What is his oxygen saturation (SpO2)? Does he
have crackles or diminished breath sounds?
■ Infection, inflammation, or other medical illness. Postoperative infections,
intra-operative myocardial infarctions (MIs), or strokes are possible
causes of delirium in this case. Could Mr. Z. have a urinary tract infection
(UTI) because he is post-prostate surgery and particularly because he has
a Foley catheter? An inflammatory response to a new medical problem
may be the cause of the delirium.
■ Unfamiliar surroundings. Particularly for those with sensory deficits, an
unfamiliar environment can lead to misinterpretations of information,
which may contribute to delirium.
What steps should be taken now?
■ Avoid the use of restraints, which could worsen Mr. Z.’s agitation.
■ Call the physician or nurse practitioner (NP) immediately and report your
findings; request that he or she evaluate the patient to determine the
underlying cause of the delirium. If Mr. Z.’s delirium worsens, he may
also need medication (e.g., haloperidol) to control his symptoms.
■ Frequent reality orientation. Frequent orientation, reassurance, and help-
ingMr. Z. interpret his environment andwhat is happening to him should
be helpful. (Monitor the patient’s reaction. If the patient becomes upset or
angry, modify your approach to that of more reassurance and validating
the patient’s experience rather than reorienting.)
■ Are Mr. Z.’s hearing aids and glasses in place and clean? Functioning?
Impaired sensory input contributes significantly to delirium. Also, hemay
seem more confused than he really is if he is not able to hear what you
are saying.
■ Invite family/significant others to stay as long as they are able to assist
with his orientation, reassurance, and sense of well-being. Monitor the
effect of family visitation. If the patient has increased agitation or anxiety,
then limit the visitation of the individual who seems to be triggering Mr.
Z.’s upset.
■ Mobilize the patient. Mobility assists with orientation and helps prevent
problems associated with immobility, such as atelectasis and deep venous
thrombosis.
■ Judicious use of medications for pain, sleep, or anxiety. Drugs used to ad-
dress these issues can exacerbate the delirium. Try nonpharmacologic
approaches for sleep and anxiety first. If Mr. Z. is having pain, are the
drug and dose appropriate for him? A regular schedule of a smaller
dose or nonnarcotic pain medication almost always is better than prn
dosing.
■ Try to provide for adequate sleep: noise reduction at night; soft, relaxing
music; warm milk or herbal tea; massage; and rescheduling care in order
not to interrupt sleep.
■ Make sure the patient is well hydrated.
■ Talk to the doctor or NP about removing the indwelling urinary catheter.
Because of his surgery, Mr. Z. may need it immediately post-op, but it
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should be removed as soon as possible. Additionally, recommend a uri-
nalysis to rule out UTI.
■ Address safety concerns (e.g., increase surveillance). Mr. Z. is now also at
risk for falls and/or pressure ulcers.
Summary
Delirium is a common occurrence in hospitalized older adults and contributes to
poor outcomes. Thus, it is important to promptly identify those patients at risk
for delirium and implement preventive measures, as well as to promptly recog-
nize delirium when it appears. Nursing assessments using validated delirium
screening instruments must become routine. A standard of practice protocol
provides concise information to guide nursing care of individuals at risk of or
experiencing delirium (see Box 7.1.).
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Resources
Recommended Delirium-Screening Instruments
Confusion Assessment Method (CAM) (Inouye, 2003; Inouye et al., 1990 [Level
IV]). Recommended for verbal patients by Laurila, Pitkala, Strandberg, &
Tilvis (2002 [Level IV]).
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) (Ely
et al., 2001a [Level IV]; Ely et al., 2001b [Level IV]). Recommended for non-
verbal patients by Schuurmans et al. (2003 [Level V]).
Other Delirium-Screening Instruments
Delirium-O-Meter (deJonge, Kalisvarrt, Timmers, Kat, & Jackson, 2005 [Level
VI])maybeused formonitoring thedifferent characteristics and the severity
of delirium in geriatric patients.
Delirium Rating Scale (DRS)-98 (Trzepacz et al., 2001 [Level IV]) may be used
to assess delirium severity.
Mini-Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975
[Level IV]) may be used to monitor course of delirium in hospitalized pa-
tients according to O’Keeffe, Mulkerrin, Nayeem, Varughese, and Pillay
(2005 [Level IV]).
Additional On-line Information About Delirium
http://www.icudelirium.org/delirium/
http://elderlife.med.yale.edu/public/pubs.php?pageid=01.03.07
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Box 7.1
Nursing Standard of Practice Protocol: Delirium:
Prevention, Early Recognition, and Treatment
I. GOAL: To reduce the incidence of delirium in hospitalized older adults.
II. OVERVIEW
A. Delirium is a common syndrome in hospitalized older adults.
B. Although sometimes reversible, delirium is associatedwith increased
mortality, increased hospital costs, and long-term cognitive and func-
tional impairment.
C. Delirium can be prevented with recognition of high risk patients and
the implementation of a standardized protocol.
D. Delirium, when it develops, may be under-recognized by physicians
and nurses.
E. Routine screening for delirium should be part of comprehensive
nursing care of older adults.
III. BACKGROUND
A. Definition: Delirium is a disturbance of consciousness with impaired
attention and disorganized thinking or perceptual disturbance that
develops acutely, has a fluctuating course, and with evidence that
there is an underlying physiologic or medical condition causing the
disorder.
B. Epidemiology
1. Prevalence (present on admission): 10% to 15% in acute care
(Fann, 2000 [Level I]); 31% in ICU (McNicoll et al., 2003 [Level
IV]).
2. Incidence (newonset): 10% to 40% in acute care (Fann, 2000 [Level
I]); 43% to 61%post– hip surgery (Holmes&House, 2000 [Level I]);
31% in ICU (McNicoll et al., 2003 [Level IV]); 83% of mechanically
ventilated patients (Ely et al., 2001a [Level IV]).
3. Duration: May resolve in a few hours to days or persist for weeks
to months (Fann, 2000 [Level I]).
C. Etiology
1. Pathophysiologic mechanisms unclear (Trzepacz & Van derMast,
2002 [Level VI]).
2. Risk factors for delirium are multifactorial:
a. Advanced age (Fann, 2000 [Level I])
b. Dementia (Elie et al., 1998 [Level I])
c. Medical illness (Elie et al., 1998 [Level I])
d. Multiple medications (Elie et al., 1998 [Level I]; see chapter 12,
Reducing Adverse Drug Events)
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e. Alcohol abuse (Elie et al., 1998 [Level I])
f. Male gender (Elie et al., 1998 [Level I])
g. Poor functional status (Fann, 2000 [Level I])
h. Depression (Fann, 2000 [Level I])
i. Pain (Fann, 2000 [Level I])
j. Increased blood urea nitrogen/creatinine (BUN/Cr) ratio (In-
ouye & Charpentier, 1996 [Level IV])
k. Sensory impairment (Inouye & Charpentier, 1996 [Level IV])
3. Potential outcomes of delirium:
a. Increased mortality (Fann, 2000 [Level I])
b. Increased morbidity (Fann, 2000 [Level I])
i. Long-term cognitive impairment (Ely et al., 2004a; Mc-
Cusker et al., 2001 [Level IV])
ii. Postoperative complications (Fann, 2000 [Level I])
iii. Decreased functional ability (Fann, 2000 [Level I])
iv. Increased hospital length of stay (Ely et al., 2004a; Pompei
et al., 1994 [Level IV])
v. Institutionalization (Fann, 2000 [Level I])
vi. Increased health care costs (Inouye, 2006 [Level VI])
IV. PARAMETERS OF ASSESSMENT
A. Assess for risk factors
1. Baseline or pre-morbid cognitive impairment (see chapter 4, As-
sessing Cognitive Function)
2. Medications review (see chapter 12, Reducing Adverse Drug
Events)
3. Pain
4. Metabolic disturbances (i.e., hypoglycemia, hypercalcemia, hy-
ponatremia, hypokalemia)
5. Dehydration (physical signs/symptoms, intake/output, Na+,
BUN/Cr)
6. Infection (fever, WBCs with differential, cultures)
7. Environment (sensory overload or deprivation)
8. Impaired mobility
B. Features of delirium—assess every shift (see Resources for validated
instruments)
1. Acute onset; evidence of underlying medical condition
2. Alertness: Fluctuates from stuporous to hypervigilant
3. Attention: Inattentive, easily distractible, and may have difficulty
shifting attention fromone focus to another; has difficulty keeping
track of what is being said
4. Orientation: Disoriented to time and place; should not be disori-
ented to person
5. Memory: Inability to recall events of hospitalization and cur-
rent illness; unable to remember instructions; forgetful of names,
events, activities, current news, and so on
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6. Thinking: Disorganized thinking; rambling, irrelevant, incoher-
ent conversation; unclear or illogical flow of ideas; or unpre-
dictable switching from topic to topic; difficulty in expressing
needs and concerns; speech may be garbled
7. Perception: Perceptual disturbances such as illusions and visual
or auditory hallucinations; and misperceptions such as calling a
stranger by a relative’s name
8. Psychomotor activity: May fluctuate between hypoactive, hyper-
active, and mixed subtypes
V. NURSING CARE STRATEGIES
Based on protocols in multicomponent delirium prevention studies (In-
ouye, et al., 1999; Marcantonio, et al., 2001 [Level II])
A. Collaboratewith physician/nurse practitioner to treat the underlying
pathology and contributing factors. If available, consult with geriatri-
cian and/or Geriatric Nurse Practitioner or Clinical Nurse Specialist.
B. Eliminate or minimize risk factors
1. Administer medications judiciously; avoid high risk medications
(see chapter 12, Reducing Adverse Drug Events).
2. Prevent/promptly and appropriately treat infections.
3. Prevent/promptly treat dehydration and electrolyte disturbances.
4. Provide adequate pain control (see chapter 10,PainManagement).
5. Maximize oxygen delivery (supplemental oxygen, blood, and BP
support as needed).
6. Use sensory aids as appropriate.
7. Regulate bowel/bladder function.
8. Provide adequate nutrition.
C. Provide a therapeutic environment.
1. Foster orientation: frequently reassure and reorient patient (un-
less patient becomes agitated); utilize easily visible calendars,
clocks, caregiver identification; carefully explain all activities;
communicate clearly.
2. Provide appropriate sensory stimulation: quiet room; adequate
light; one task at a time; noise-reduction strategies.
3. Facilitate sleep: backmassage,warmmilk or herbal tea at bedtime;
relaxationmusic/tapes; noise-reductionmeasures; avoid awaken-
ing patient.
4. Foster familiarity: encourage family/friends to stay at bedside;
bring familiar objects from home; maintain consistency of care-
givers; minimize relocations.
5. Maximize mobility: avoid restraints (see chapter 22, Physical Re-
straints and Side Rails in Acute and Critical Care Settings) and uri-
nary catheters; ambulate or active range of motion three times
daily.
6. Communicate clearly, provide explanations.
7. Reassure and educate family.
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8. Minimize invasive interventions.
9. Consider psychotropic medication as a last resort.
VI. EVALUATION/EXPECTED OUTCOMES
A. Patient
1. Absence of delirium or
2. Cognitive status returned to baseline (prior to delirium)
3. Functional status returned to baseline (prior to delirium)
4. Discharged to same destination as prehospitalization
B. Health Care Provider
1. Increased detection of delirium
2. Implementation of appropriate interventions to prevent/treat
delirium
3. Use of standardized delirium-prevention protocol
4. Decreased use of physical restraints
5. Decreased use of antipsychotic medications
6. Increased satisfaction in care of hospitalized elderly
C. Institution
1. Decreased overall cost
2. Decreased length of stays
3. Decreased morbidity and mortality
4. Increased referrals and consultation to the specified specialists
5. Improved satisfaction of patients, families, nursing staff
VII. FOLLOW-UP MONITORING OF CONDITION
A. Decreased delirium to become a measure of quality care
B. Incidence of delirium to decrease
C. Patient days with delirium to decrease
D. Staff competence in recognition and treatment of acute confu-
sion/delirium
E. Documentation of a variety of interventions for acute confu-
sion/delirium
Na+ = sodium; BUN/Cr = blood urea nitrogen/creatinine ratio; BP = blood
pressure; Hgb/Hct = hemoglobin and hematocrit; SpO2 = pulse oxygen
saturation; WBCs = white blood cells; URI = upper respiratory infection;
UTI = urinary tract infection
References
Agostini, J. V., Leo-Summers, L. S., & Inouye, S. K. (2001). Cognitive and other adverse effects
of diphenhydramine use in hospitalized older patients. Archives of Internal Medicine, 161,
2091–2097. Evidence Level IV: Nonexperimental Study.
Aizawa, K., Kanai, T., Saikawa, Y., Takabayashi, T., Kawano, Y., Miyazawa, N., et al. (2002).
A novel approach to the prevention of postoperative delirium in the elderly after
Delirium: Prevention, Early Recognition, and Treatment 123
gastrointestinal surgery. Surgery Today, 32, 310–314. Evidence Level II: Single Experi-
mental Study.
American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders
(4th ed., text revision). Washington, DC: Author.
Breitbart, W., Gibson, C., & Tremblay, A. (2002). The delirium experience: Delirium recall and
delirium-related distress in hospitalized patients with cancer, their spouses/caregivers,
and their nurses. Psychosomatics, 43, 183–194. Evidence Level IV: Nonexperimental Study.
Britton, A., & Russell, R. (2004). Multidisciplinary team interventions for delirium in patients
with chronic cognitive impairment. Cochrane Data Base Systematic Reviews, 2, CD000395.
Evidence Level I: Systematic Review.
Cole, M. G., McCusker, J., Bellavance, F., Primeau, F. J., Bailey, R. F., Bonycastle, J. J., et al. (2002).
Systematic detection and multidisciplinary care of delirium in older medical inpatients: A
randomized trial. Canadian Medical Association Journal, 167(7), 753–759. Evidence Level
II: Single Experimental Study.
Cole, M. G., Primeau, F. J., & Elie, L. M. (1998). Delirium: Prevention, treatment, and outcome
studies. Journal of Geriatric Psychiatry and Neurology, 11, 126–137. Evidence Level I: Sys-
tematic Review.
Cole,M.G., Primeau, F.,&McCusker, J. (1996). Effectiveness of interventions toprevent delirium
in hospitalized patients: A systematic review. Canadian Medical Association Journal, 155,
1263–1268. Evidence Level I: Systematic Review.
de Jonge, J. F.M., Kalisvarrt, K. J., Timmers, J. F.M., Kat,M.G., & Jackson, J. C. (2005). Delirium-O-
Meter: A nurses’ rating scale formonitoring delirium severity in geriatric patients. Interna-
tional Journal of Geriatric Psychiatry 20, 1158–1166. Evidence Level IV: Nonexperimental
Study.
de Rooij, S. E., Schuurmans, M. J., van der Mast, R. C., & Levi, M. (2005). Clinical subtypes of
delirium and their relevance for daily clinical practice: A systematic review. International
Journal of Geriatric Psychiatry 20, 609–615. Evidence Level I: Systematic Review.
Elie, M., Cole, M. G., Primeau, F. J., & Bellavance, F. (1998). Delirium risk factors in elderly
hospitalized patients. Journal of General Internal Medicine, 13, 204–212. Evidence Level I:
Systematic Review.
Ely, E. W., Inouye, S. K., Bernard, G. R., Gordon, S., Francis, J., May, L., et al. (2001a). Delirium
in mechanically ventilated patients: Validity and reliability of the confusion assessment
method for the intensive care unit (CAM-ICU). Journal of theAmericanMedical Association,
286, 2703–2710. Evidence Level IV: Nonexperimental Study.
Ely, E. W., Margolin, R., Francis, J., May, L., Truman, B., Dittus, R., et al. (2001b). Evaluation of
delirium in critically ill patients: Validation of the Confusion Assessment Method for the
Intensive Care Unit (CAM-ICU). Critical Care Medicine, 29, 2091–2097. Evidence Level IV:
Nonexperimental Study.
Ely, E. W., Shintani, A., Truman, B., Speroff, T., Gordon, S. M., Harrell, F. E., Jr., et al. (2004a).
Delirium as a predictor of mortality in mechanically ventilated patients in the intensive
care unit. Journal of the American Medical Association, 291, 1753–1762. Evidence Level IV:
Nonexperimental Study.
Ely, E. W., Stephens, R. K., Jackson, J. C., Thomason, J. W., Truman, B., Gordon, S., et al. (2004b).
Current opinions regarding the importance, diagnosis, andmanagement of delirium in the
intensive care unit: A survey of 912 health care professionals. Critical Care Medicine, 32,
106–112. Evidence Level IV: Nonexperimental Study.
Fann, J. R. (2000). The epidemiology of delirium: A review of studies andmethodological issues.
Seminars in Clinical Neuropsychiatry, 5, 64–74. Evidence Level I: Systematic Review.
Fick, D. M., Agostini, J. V., & Inouye, S. K. (2002). Delirium superimposed on dementia: A
systematic review. Journal of the American Geriatric Society, 50, 1723–1732. Evidence Level
I: Systematic Review.
Fick, D.M., Cooper, J.W.,Wade,W. E.,Waller, J. L.,Maclean, J. R., &Beers,M.H. (2003). Updating
the Beers criteria for potentially inappropriate medication use in older adults: Results of
a U.S. consensus panel of experts. Archives of Internal Medicine 163, 2716–2724. Evidence
Level IV: Nonexperimental Study.
Fick, D., & Foreman, M. (2000). Consequences of not recognizing delirium superimposed on
dementia in hospitalized elderly individuals. Journal of Gerontological Nursing, 26, 30–40.
Evidence Level IV: Nonexperimental Study.
124 Chapter 7
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-Mental State”: A practical method
for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research,
12, 189–198. Evidence IV: Nonexperimental Study.
Holmes, J. D., &House,A.O. (2000). Psychiatric illness in hip fracture.Age&Ageing, 29, 537–546.
Evidence Level I: Systematic Review.
Inouye, S. K. (2003). The Confusion Assessment Method (CAM): Training manual and cod-
ing guide. Yale University School of Medicine. Retrieved September 15, 2006, from
http://elderlife.med.yale.edu/pdf/The%20Confusion%20Assessment%20Method.pdf
Inouye, S. K. (2006). Delirium in older persons. New England Journal of Medicine, 354, 1157–
1165. Evidence Level VI: Expert Opinion.
Inouye, S. K., Bogardus, S. T., Charpentier, P. A., Leo-Summers, Acampora, D., Holford, T. R.,
et al. (1999). A multicomponent intervention to prevent delirium in hospitalized older
patients. The New England Journal of Medicine, 340, 669–676. Evidence Level II: Single
Experimental Study.
Inouye, S. K., & Charpentier, P. A. (1996). Precipitating factors for delirium in hospitalized
elderly persons: Predictive model and interrelationship with baseline vulnerability. Jour-
nal of American Medical Association, 275, 852–857. Evidence Level IV: Nonexperimental
Study.
Inouye, S. K., Foreman, M. D., Mion, L. C., Katz, K. H., & Cooney, Jr., L. M. (2001). Nurses’
recognition of delirium and its symptoms: Comparison of nurse and researcher rat-
ings. Archives of Internal Medicine, 161, 2467–2473. Evidence Level IV: Nonexperimental
Study.
Inouye, S. K., VanDyck, C. H., Alessi, C. A., Balkin, S., Siegel, A. P., et al. (1990). Clarify-
ing confusion: The Confusion Assessment Method. A new method for detecting delir-
ium. Annals of Internal Medicine, 113(12), 941–948. Evidence Level IV: Nonexperimental
Study.
Inouye, S. K., Viscoli, C.M.,Horwitz, R. I., Hurst, L. D., &Tinetti,M. E. (1993). A predictivemodel
for delirium in hospitalized elderly medical patients based on admission characteristics.
Annals of Internal Medicine, 119, 474–481. Evidence Level IV: Nonexperimental Study.
Kalisvaart, K. J., de Jonghe, J. F., Bogaards, M. J., Vreeswijk, R., Egberts, T. C., Burger, B. J.,
et al. (2005). Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium:
A randomized placebo-controlled study. Journal of the American Geriatrics Society, 53,
1658–1666. Evidence Level II: Single Experimental Study.
Kiely, D. K., Bergmann,M. A., Murphy, K.M, Jones, R. N., Orav, E. J., &Marcantonio, E. R. (2003).
Delirium among newly admitted post-acute facility patients: Prevalence, symptoms, and
severity. Journal of GerontologyMedical Sciences, 58A(5), 441–445. Evidence Level IV: Non-
experimental Study.
Laurila, J. V., Pitkala, K. H, Strandberg, T. E., & Tilvis, R. S. (2002). Confusion assessment
method in the diagnostics of delirium among aged hospital patients: Would it serve better
in screening than as a diagnostic instrument? International Journal of Geriatric Psychiatry,
18(12), 1112–1119. Evidence Level IV: Nonexperimental Study.
Marcantonio, E. R., Flacker, J. M., Wright, R. J., & Resnick, N. M. (2001). Reducing delirium after
hip fracture: A randomized trial. Journal of the American Geriatrics Society, 49(3) 516–679.
Evidence Level II: Nonexperimental Study.
Marcantonio, E. R., Simon, S. E., Bergmann, M. A., Jones, R. N., Murphy, K. M., & Morris, J.
N. (2003). Delirium symptoms in post-acute care: Prevalent, persistent, and associated
with poor functional recovery. Journal of the American Geriatrics Society, 51, 4–9. Evidence
Level IV: Nonexperimental Study.
McCarthy,M. C. (2003). Detecting acute confusion in older adults: Comparing clinical reasoning
of nursesworking in acute, long-term, and community health care environments.Research
in Nursing and Health, 26, 203–212. Evidence Level II: Single Experimental Study.
McCusker, J., Cole, M., Abrahamowicz, M., Han, L., Podoba, J. E., & Ramman-Haddad, L. (2001).
Environmental risk factors for delirium in hospitalized older people. Journal of the Amer-
ican Geriatrics Society, 49, 1327–1334. Evidence Level IV: Nonexperimental Study.
McCusker, J., Cole, M., Dendukuri, N., Belzile, E., & Primeau, F. (2001). Delirium in older
medical inpatients and subsequent cognitive and functional status: A prospective study.
Canadian Medical Association Journal, 165, 575–583. Evidence Level IV: Nonexperimental
Study.
Delirium: Prevention, Early Recognition, and Treatment 125
McNicoll, L., Pisani, M. A., Zhang, Y., Ely, E. W., Siegel, M. D., & Inouye, S. K. (2003). Delirium
in the intensive care unit: Occurrence and clinical course in older patients. Journal of the
American Geriatrics Society, 51, 591–598. Evidence Level IV: Nonexperimental Study.
Meagher, D. J. (2001). Delirium: Optimizing management. British Medical Journal, 322(7279),
144–149. Evidence Level VI: Expert Opinion.
Milbrandt, E. B., Deppen, S., Harrison, P. L., Shintani, A. K., Speroff, T., Stiles, R. A., et al. (2004).
Costs associated with delirium in mechanically ventilated patients. Critical Care Medicine,
32, 955–962. Evidence Level IV: Nonexperimental Study.
Milisen, K., Lemiengre, J., Braes, T., & Foreman, M. D. (2005). Multicomponent intervention
strategies for managing delirium in hospitalized older people: Systematic review. Journal
of Advanced Nursing, 52, 79–90. Evidence Level I: Systematic Review.
Morrison, R. S., Magaziner, J., Gilbert, M., Koval, K. J., McLaughlin, M. A., Orosz, G., et al.
(2003). Relationship between pain and opioid analgesics on the development of delirium
following hip fracture. Journals of Gerontology Series A—Biological Sciences & Medical
Sciences, 58(1), 76–81. Evidence Level IV: Nonexperimental Study.
O’Keeffe, S. T., & Lavan, J. N. (1999). Clinical significance of delirium subtypes in older people.
Age and Ageing, 28, 115–119. Evidence Level IV: Nonexperimental Study.
O’Keeffe, S. T., Mulkerrin, E. C., Nayeem, K., Varughese, M., & Pillay, I. (2005). Use of se-
rial Mini-Mental State Examinations to diagnose and monitor delirium in elderly hospital
patients. Journal of the American Geriatrics Society, 53, 867–870. Evidence Level IV: Non-
experimental Study.
Parellada, E., Baeza, I., de Pablo, J., & Martinez, G. (2004). Risperidone in the treatment of
patients with delirium. Journal of Clinical Psychiatry, 65(3), 348–353. Evidence Level II:
Single Experimental Study.
Pitkala, K. H., Laurila, J. V., Strandberg, T. E., & Tilvis, R. S. (2006). Multicomponent geriatric
intervention for elderly inpatients with delirium: A randomized controlled trial. Journals
of Gerontology A, Biologic Sciences & Medical Sciences 61(2), 176–181. Evidence Level II:
Single Experimental Study.
Pompei, P., Foreman, M., Rudberg, M. A., Inouye, S. K., Braund, V., & Cassel, C. K. (1994).
Delirium in hospitalized older persons: Outcomes and predictors. Journal of the America
Geriatrics Society, 42, 809–815. Evidence Level IV: Nonexperimental Study.
Pun, B. T., Gordon, S. M., Peterson, J. F., Shintani, A. K., Jackson, J. C., Foss, J., et al. (2005).
Large-scale implementation of sedation and delirium monitoring in the intensive care
unit: A report from two medical centers. Critical Care Medicine, 33, 1199–1205. Evidence
Level IV: Nonexperimental Study.
Rudberg, M. A., Pompei, P., Foreman, M. D., Ross, R. E., & Cassel, C. K. (1997). The natural
history of delirium in older hospitalized patients: A syndrome of heterogeneity. Age and
Ageing, 26, 169–174. Evidence Level IV: Nonexperimental Study.
Schuurmans, M. J., Deschamps, P. I., Markham, S. W., Shortridge-Baggett, L. M., & Duursma,
S. A. (2003). The measurement of delirium: Review of scales. Research Theory in Nursing
Practice, 17, 207–224. Evidence Level V: Literature Review.
Seitz, D. P., Gill, S. S., & van Zyl, L. T. (2007). Antipsychotics in the treatment of delirium: A
systematic review. Journal of Clinical Psychiatry, 68(1), 11–21. Evidence Level I: Systematic
Review.
Skrobik, Y. K., Bergeron, N., Dumont, M., & Gottfried, S. B. (2004). Olanzapine vs. haloperidol:
Treating delirium in a critical care setting. Intensive Care Medicine, 30, 444–449. Evidence
Level II: Single Experimental Study.
Trzepacz, P. T., Mittal, D., Torres, R., et al. (2001). Validation of the Delirium Rating Scale-
revised-98: Comparison with the delriium rating scale and the cognitive test for delirium.
Journal of Neuropsychiatry and Clinical Neuroscience 13(3), 229–242. Evidence Level IV:
Nonexperimental Study.
Trzepacz, P. T., & Van Der Mast, R. C. (2002). The neuropathophysiology of delirium. In J.
Lindesay, K. Rockwood, & A. Macdonald (Eds.), Delirium in old age (pp. 51–100). New
York: Oxford University Press. Evidence Level VI: Expert Opinion.
This page intentionally left blank 
8FamilyCaregiving
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Educational
Objectives
After completing this chapter, the reader will be
able to:
1. describe characteristics and factors that put family
caregivers at risk for strain and/or depression
2. identify key aspects of a family caregiving
assessment
3. list specific interventions to support family
caregivers of older adults
4. identify family caregiver outcomes expected from
the implementation of this protocol
Overview
Prevalence of Caregiving
Being a family caregiver is a widespread experience in the United States. De-
pending on how family caregiving is defined, national surveys estimate that
anywhere from 22.4 million to 52 million people provide care for a chroni-
cally ill, disabled family member or friend during any given year (National Al-
liance for Caregiving [NAC]&AmericanAssociation of RetiredPersons [AARP],
2004 [Level IV]; Opinion Research Corporation [OPC], 2005 [Level IV]; U.S.
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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Department of Health and Human Services [USDHHS], 1998 [Level IV]). The
lower estimate of 22.4 million, or 23%, of all U.S. households, applies when the
definition of family care is restricted to care provided in the past 12 months to
an older adult with substantial activities of daily living (ADL) and instrumental
activities of daily living (IADL) needs (NAC&AARP, 2004 [Level IV]). When the
definition of caregiving is expanded to include all ages older than 18 and past
and present care, close to 60% of adult Americans are providing or have provided
unpaid care to an adult family member or friend. Family caregiving is prevalent
across all socioeconomic levels and among all ethnic groups. For example, 59%
of non-Hispanic Whites, 53% of African Americans, and 51% of Hispanic adults
in the United States report that they are or have been caregivers (OPC, 2005
[Level IV]).
Profile of Caregivers
Reflecting an increasing trend, 44% of all family caregivers of adults older than
age 18 are men, 56% are women, and the majority is older than age 45 (OPC,
2005 [Level IV]). Among the primary family caregivers of older disabled or ill
adults older than age 65, the proportion of male caregivers is lower (about 32%),
but this number has increased from prior years (Wolf & Kasper, 2006 [Level
I]). The most common caregiver arrangement is that of an adult female child
providing care to an elderly female parent (USDHHS, 1998 [Level IV]). Pri-
mary family caregivers are children (41.3%), spouses (38.4%), and other family
or friends (20.4%) (Wolf &Kasper, 2006 [Level I]). Many caregivers are older and
are at risk for chronic illness themselves. Nearly 45% of all primary caregivers
are older than age 65, with 47.4% of spousal primary caregivers being age 75 or
older (Wolf & Kasper, 2006 [Level I]). Caregiving work can be hard and time-
consuming and is often a long-term commitment. It is estimated that 17% of fam-
ily caregivers are providing 40 hours of care a week or more (NAC&AARP, 2004
[Level IV]). The average duration of years spent caregiving is 4.3 (NAC &AARP,
2004 [Level IV]; USDHHS, 1998 [Level IV]).
Trends in Caregiving
National surveys indicate a trend in the United States of care recipients being
older and more disabled, and more caregivers acting as the primary source of
care (i.e., an increase from 34.9% in 1989 to 52.8% in 1999) without help from
secondary caregivers (Wolf & Kasper, 2006 [Level I]). In the future, the need
for family caregivers will increase. The number of people older than age 65 is
expected to increase at a rapid rate; however, the number of family members
available to care for them will not keep pace (NAC & AARP, 2004 [Level IV]).
Family and friends now provide more than 80% of all long term care services
in the country. The cost of the unpaid care they provide is enormous and is
estimated to be $306 billion a year, more than twice as much as was actually
spent on home care and nursing home services combined (Arno, 2006 [Level
IV]). A typical working family caregiver can expect to lose $109 per day in wages
and health benefits due to the need to provide full-time care at home (Altman,
Cooper, & Cunningham, 1999 [Level IV]). The loss in income is the direct result
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of needing to make adjustments in work life such as reporting late to work or
giving up work entirely (NAC & AARP, 2004 [Level IV]).
Impact of Caregiving on Caregiver
Caregiving has documented negative consequences for the caregiver’s physical
and emotional health. Caregiving-related stress in a chronically ill spouse re-
sults in a 63% higher mortality rate than in their noncaregiving peers (Schulz &
Beach, 1999 [Level II]). Stress from caring for an older adult with dementia has
been shown to impact the caregiver’s immune system for up to 3 years after their
caregiving ends (Kiecolt-Glaser & Glaser, 2003 [Level III]). Spouse caregivers
who provide heavy care (i.e., 36 or more hours per week) are six times more
likely than noncaregivers to experience symptoms of depression or anxiety; for
adult-child caregivers, the rate is twice as high (Cannuscio et al., 2002 [Level
IV]). In addition to mental health morbidity, family caregivers also experience
physical health deterioration. Family caregivers have chronic conditions atmore
than twice the rate of noncaregivers (NAC & AARP, 2004 [Level IV]; USDHHS,
1998 [Level IV]). Family caregivers experiencing extreme stress have also been
shown to age prematurely. It is estimated that this stress can take as many as 10
years off a family caregiver’s life (Arno, 2006 [Level IV]).
Background and Statement of The Problem
Definitions
Family Caregiving
Family caregiving is broadly defined and refers to a broad range of unpaid care
provided in response to illness or functional impairment to a chronically ill or
functionally impaired older family member, partner, friend, or neighbor that ex-
ceeds the support usually provided in family relationships (Schumacher, Beck,
& Marren, 2006 [Level VI]).
Informal Caregiving
Informal caregiving is a more inclusive term that refers to help provided by all
nonprofessional providers of care, including family members, friends, neigh-
bors, and/or members of a religious or other type of community. In addition
to family members or significant others, friends, neighbors, or members of
a faith community may provide informal caregiving (Schumacher et al., 2006
[Level VI]).
Family Caregiving Activities
Family caregiving activities includeassistancewithday-to-day activities, illness-
related care, care management, and invisible aspects of care. Day-to-day ac-
tivities include personal care activities (e.g., bathing, eating, dressing, mobil-
ity, transferring from bed to chair, and using the toilet) and IADLs (e.g., meal
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preparation, grocery shopping, making telephone calls, and money manage-
ment) (NAC & AARP, 2004 [Level IV]; Walker, Pratt, & Eddy, 1995 [Level I]).
Illness-related activities include managing symptoms, coping with illness be-
haviors, carrying out treatments, and performing medical or nursing proce-
dures that include an array of medical technologies (Smith, 1994 [Level IV]).
Care-management activities include accessing resources, communicating with
and navigating the health care and social services systems, and acting as an
advocate (Schumacher, Stewart, Archbold, Dodd, & Dibble, 2000 [Level IV]).
Invisible aspects of care are protective actions the caregiver takes to ensure
the older adult’s safety and well-being without their knowledge (Bowers, 1987
[Level IV]).
Caregiving Roles
Caregiving roles can be classified into a hierarchy according to who takes on the
majority of responsibilities versus only intermittent supportive assistance. Pri-
mary caregivers tend to provide most of the everyday aspects of care, whereas
secondary caregivers help out as needed to fill the gaps (Cantor & Little, 1985
[LevelV]; Penning, 1990 [Level IV]; Tennstedt,McKinlay,&Sullivan, 1989 [Level
IV]). Among caregivers who live with their care recipients, spouses account for
the majority of primary caregivers, whereas adult children are more likely to
be secondary caregivers. The range of the family caregiving role includes pro-
tective caregiving such as “keeping an eye on” an older adult who is currently
independent but at risk to full-time, around-the-clock care for a severely im-
paired family member. Health care providers may fail to assess the full scope
of the family caregiving role if they associate family caregiving only with the
performance of tasks.
Caregiver Assessment
This term refers to an ongoing iterative process of gathering information that de-
scribes a family caregiving situation and identifies the particular issues, needs,
resources, and strengths of the family caregiver.
Risk Factors for Negative Outcomes with Caregiving
Female caregivers are more likely to provide a higher level of care than men,
which is defined as helping with at least two ADLs and providing more than
40 care hours per week. Male caregivers are more likely to provide care at the
lowest level, which is defined as no ADLs and devoting very few hours of care
per week (NAC&AARP, 2004 [Level IV]; Pinquart & Sorensen, 2006 [Level I]). A
number of studies have found that female caregivers are more likely than male
caregivers to suffer from anxiety, depression, and other symptoms associated
with emotional stress due to caregiving (Mahoney, Regan, Katona, & Livingston,
2005 [Level IV]; Yee& Schulz, 2000 [Level I]); lower levels of physical health and
subjective well-being than caregiving men (Pinquart & Sorensen, 2006 [Level
I]); and are at higher risk for adverse outcomes (Schultz,Martire, &Klinger, 2005
[Level I]). In the pooled analysis from the Resources for Enhancing Alzheimer’s
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Caregiver Health (REACH) trials, females had higher initial levels of burden
and depression (Gitlin et al., 2003 [Level I]).
Ethnicity
Rates of caregiving vary somewhat by ethnicity. Among the U.S. adult popu-
lation older than age 18, 17% of White and 15% of African American families
are providing informal care, whereas slightly lower percentages of Asian Amer-
icans (14%) andHispanicAmericans (13%) are engaged in caregiving for persons
older than age 50 (NAC & AARP, 2004 [Level IV]). However, in another national
survey that looked only at people 70+ years old, 44% of Latinos were found to
receive informal home care compared to 34% of African Americans and 25% of
non-HispanicWhites (Weiss, Gonzalez, Kabeto, & Langa, 2005 [Level IV]). Eth-
nic differences are also found with regard to the care recipient. Among people
aged 70+ who require care, Whites are the most likely to receive help from their
spouses, Hispanics are the most likely to receive help from their adult children,
and African Americans are the most likely to receive help from a nonfamily
member (National Academy on an Aging Society, 2000 [Level V]).
Studies show that ethnic minority caregivers provide more care (McCann et
al., 2000 [Level IV]; Pinquart&Sorenson, 2005 [Level I]) and reportworse physi-
cal health thanWhite caregivers (Dilworth-Anderson,Williams, & Gibson, 2002
[Level I]; Pinquart & Sorenson, 2005 [Level I]). African American caregivers
experience less stress and depression and get more rewards related to care-
giving when compared to White caregivers (Cuellar, 2002 [Level IV]; Dilworth-
Anderson, et al., 2002 [Level I]; Gitlin et al., 2003 [Level I]; Haley et al., 2004
[Level II]; Pinquart & Sorenson, 2005 [Level I]). However, Hispanic and Asian
American caregivers exhibit more depression than White caregivers (Gitlin
et al., 2003; Pinquart, & Sorenson, 2005 [both Level I]). In addition, formal ser-
vices are rarely used by ethnic minorities, which puts them at further risk for
negative outcomes (Dilworth-Anderson et al., 2002; Pinquart & Sorenson, 2005
[both Level I]). A meta-analysis of three qualitative studies examined African
American, Chinese, and Latino caregiver impressions of their clinical encoun-
ters around their care receiver’s diagnosis of Alzheimer’s disease (Mahoney,
Cloutterbuck, Neary, & Zhan, 2005 [Level I]). The primary issues identified in
the analysis by Mahoney et al. were disrespect for concerns as noted by African
American caregivers, stigmatization of persons with dementia as noted by Chi-
nese caregivers, and fears that home care would not be supported as noted by
Latino caregivers. These findings indicate a need for greater culturally sensitive
communications from health care providers.
Income and Educational Level
Low income is also related to being an ethnic minority and being “non-White”;
these are risk factors for poorer health outcomes. Persons who become care-
givers may be more likely to have incomes below the poverty level and be in
poorer health, independent of caregiving (Vitaliano, Zhang, & Scanlan, 2003
[Level I]). Usually, educational level has been combined with income in most
caregiving studies, so there is a lack of data on this variable. One study (Buck-
walter et al., 1999 [Level II]) reported that caregivers who were less educated
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tended to report slightly more depression than those who were better educated.
This is consistent with the findings from the REACH trial meta-analysis (Gitlin
et al., 2003 [Level I]). In the meta-analysis completed by Schultz, Martire, &
Klinger (2005 [Level I]), caregivers with low incomes and low levels of educa-
tion were more at risk for adverse outcomes.
Relationship (Spouse, Non-Spouse)
Past research conducted primarily among non-Hispanic White samples has
shown that caregiving outcomes differ between non-spouse (who are mostly
adult children) and spouse caregivers (Pinquart & Sorensen, 2004 [Level I]). In
some literature reviews, authors noted that spousal caregivers have reported
higher levels of depression than non-spouses (Pruchno & Resch, 1989 [Level
I]). However, Gitlin and colleagues’ (Gitlin, Corcoran, Winter, Boyce, & Hauck,
2001 [Level II]) intervention study found spouses reported less “upset” with the
care receiver’s behavior than non-spouses, who showed no decrease in “upset.”
In a meta-analysis of caregiving studies, spousal caregivers benefited less from
existing interventions than adult children (Sorensen, Pinquart, & Duberstein,
2002 [Level I]).
Quality of Caregiver–Care Receiver Relationship
Disruption in the caregiver and care receiver relationship (Croog, Burleson,
Sudilovsky, & Baume, 2006 [Level IV]; Flannery, 2002 [Level VI]) and/or a poor
quality of relationship (Archbold, Stewart, Greenlick, & Harvath, 1990, 1992
[both Level II]) can make caregiving seem more difficult even if the objec-
tive caregiving situation (e.g., hours devoted to caregiving, number of tasks
performed) does not seem to be too demanding. Archbold et al. reported that
the deleterious effects of lack of preparedness on caregiver strain faded after
9months; however, a poor relationship with the care receiver remained strongly
related to caregiver strain. Reporting a poorer quality of relationship with the
care receiver was associated with a 23.5% prevalence of anxiety and 10% preva-
lence of depression in Mahoney and colleagues’ descriptive study (Mahoney,
Regan, Katona, & Livingston, 2005 [Level IV]).
Lack of Preparedness
Most caregivers are not prepared for the many responsibilities they face and
do not receive formal instruction in caregiving activities (NAC & AARP, 2004
[Level IV]). According to a national opinion survey, “Attitudes and Beliefs About
Caregiving in the U.S.,” 58% of respondents say they are only somewhat or not at
all prepared to handle health insurance matters for an adult family member or
friend, and 56% say they feel unprepared to assist with medications. Moreover,
64% worry about selling the home of a loved one and moving that person to an-
other location or setting up a will or trust for that person (OPC, 2005 [Level IV]).
Stewart and colleagues reported that although health care professionals were
a caregiver’s main source of information on providing physical care, the care-
giver received no preparation on how to care for the patient emotionally or deal
with the stresses of caregiving (Stewart, Archbold, Harvath, & Nkongho, 1993
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[Level IV]). Lack of preparedness can greatly increase the caregiver’s percep-
tions of strain, especially during times of transition fromhospital to home (Arch-
bold et al., 1990, 1992 [both Level II]).
Baseline Levels of Burden and Depressive Scores
In a meta-analysis of 84 caregiving studies, Pinquart and Sorensen (2003
[Level I]) found that caregivers have higher levels of stress and depression as
well as lower levels of subjective well-being, physical health, and self-efficacy
than noncaregivers. The strongest negative effects of caregiving were observed
for clinician-rated depression. Differences in perceived stress and depression
between caregivers and noncaregivers were larger in spouses than in adult chil-
dren (Pinquart & Sorensen, 2003 [Level I]). Caregivers of care receivers who
have dementia (Pinquart & Sorensen, 2006 [Level I]) have more problems with
symptom management (Butler et al., 2005; Grande, Farquhar, Barclay, & Todd,
2004 [bothLevel II]) andproblematic communication (Tolson, Swan,&Knussen,
2002 [Level II]) and have also reported increased burden, strain, and depression
across studies.
Physical Health Problems
Vitaliano and colleagues’ (2003 [Level I]) quantitative review of 23 studies from
NorthAmerica, Europe, andAustralia examined relationships of caregivingwith
several health outcomes. They found that caregivers are at greater risk for health
problems than noncaregivers. These studies included 1,594 caregivers of per-
sons with dementia and 1,478 noncaregivers who were similar in age (i.e., mean
65.6 years old) and sex ratio (i.e., 65% women, 35% men). In this review, six
physiological and five self-reported categories that are indicators of illness risk
and illness were examined. The physiological categories included level of stress
hormones, antibodies, immune counts and functioning, and cardiovascular and
metabolic variables. Caregivers had a 23% higher level of stress hormones (e.g.,
ACTH, catecholamines, cortisol) and a 15% lower level of antibodies (e.g., EBV,
herpes simplex, IgG) than noncaregivers. Co-morbid medical illnesses are im-
portant because many caregivers are middle-aged to older adults, and they may
be ill before they become caregivers. It is interesting that the relationship be-
tween caregiver status and physiological risk was stronger for men than women
(Vitaliano et al., 2003 [Level I]).
Assessment and Assessment Tools
Although systematic assessment of the patient is a routine element of clini-
cal practice, assessment of the family caregiver is rarely carried out to deter-
mine what help the caregiver may need. Effective intervention strategies for
caregivers should be based on an accurate assessment of caregiver risk and
strengths. According to a broad consensus of researchers and family caregiv-
ing organizations (Family Caregiver Alliance, 2006 [Level VI]), assessing the
caregiver should involve addressing the following topics, which are applicable
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across settings (e.g., home, hospital) but may not need to be measured in every
assessment. Specific topics may differ for:
■ initial assessments compared to reassessments (the latter focus on what
has changed over time)
■ new versus continuing-care situations
■ an acute episode prompting a change in caregiving versus an ongoing
need
■ type of setting and focus of services (Family Caregiver Alliance, 2006
[Level VI])
Caregiving Context
The caregiving context includes the background on the caregiver and the care-
giving situation. The caregiver’s relationship to the care recipient (i.e., spouse,
non-spouse) is important because spouse and non-spouse caregivers have dif-
ferent risks andneeds (Gitlin et al., 2003 [Level I]; Sorensen et al., 2002 [Level I]).
The caregiver’s various roles and responsibilities can either take away from or
enhance their ability to provide care. For example, working caregivers may have
to develop strategies to juggle family and work responsibilities, so it is neces-
sary to know their employment status (i.e., work/home/volunteer) (Pinquart
& Sorensen, 2006 [Level I]). The duration of caregiving (Sorensen et al., 2002
[Level I]) can give the clinician clues about how new caregiving is for the care-
giver or alert the clinician to the possibility of caregiver exhaustionwith the role.
Questions about household status, such as howmanypeople are in the home and
the existence and involvement of extended family and social support (Pinquart
& Sorensen, 2006 [Level I]), can give the clinician clues about how much sup-
port the caregiver has readily available. Depending on the type of impairment
of the care receiver, the physical environment of the home or facility where care
takes place can be significant (Vitaliano et al., 2003 [Level I]). It is important
to determine what the caregiver’s financial status is—for example, are they get-
ting by or are they short of funds to provide for everyday necessities (Vitaliano
et al., 2003 [Level I])? The clinician should ask about potential resources that the
caregiver could choose to use and list them (Pinquart & Sorensen, 2006 [Level
I]). In addition, the clinician should explore the family’s cultural background
(Dilworth-Andersen et al., 2002 [Level I]), looking for clues on how to use this
information as a resource.
Caregiver’s Perception of Recipient’s Health
and Functional Status
List activities the care receiver needs help with, including both ADLs and IADLs
(Pinquart & Sorensen, 2003, 2006 [both Level I]). Determine if there is any
cognitive impairment of the care recipient; if the answer is yes, ask if there are
any behavioral problems (Gitlin et al., 2003 [Level I]; Sorensen et al., 2002 [Level
I]). The presence ofmobility problems can alsomake caregivingmore difficult—
the clinician can assess this by simply asking if the care recipient has problems
getting around (Archbold et al., 1990 [Level II]) (see chapter 3, Assessment of
Function).
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Caregiver Preparedness for Caregiving
Does the caregiver have the skills, abilities, and knowledge to provide the care
recipient with needed care? To assess preparedness, the clinician can use the
Preparedness for Caregiving Scale (PCGS) (see www.ConsultGeriRN.org, Care-
giving topic). The PCGS was developed by Archbold et al. (1990, 1992 [both
Level II]). The concept of preparedness was derived from role theory, in which
socialization to a role is assumed to be important for role enactment and perfor-
mance. ThePCGS is a self-report questionnaire thatmeasures four perspectives
of domain-specific preparedness: physical needs, emotional needs, resources,
and stress. The PCGSwas evaluated in a longitudinal correlational study of fam-
ily caregivers (N=103) of older patients with chronic diseases (Archbold et al.,
1990, 1992 [both Level II]). The scale has five Likert-type items with possible
responses ranging from 1 = not at all prepared to 4 = very well prepared. Over-
all scores are computed by averaging responses to the five items. Scores range
from 1.00 to 4.00, the lowest score correlating with least preparedness. Archbold
and colleagues (1992) reported internal reliability (Cronbach’s alpha) of 0.72 at
6 weeks and 0.71 at the 9-month interview.
Quality of Family Relationships
The caregiver’s perception of the quality of the relationship with the care re-
ceiver is a key predictor of the presence or lack of strain from caregiving (Arch-
bold et al., 1990 [Level II]). The quality of the relationship can be assessed using
the Mutuality Scale (see Mutuality Scale at www.ConsultGeriRN.org, Caregiv-
ing topic), developed by Archbold et al. (1990, 1992 [both Level II]). Mutuality
is defined as the caregiver’s perceived quality of the relationship with the care
receiver. It is a self-report instrument that asks caregivers to rate how they feel
about the care recipient, with possible responses ranging from 0 = not at all to 4
= a great deal. The caregiver’smutuality score is computed by taking the average
of the scores on the 15 items. Internal reliability and consistency (Cronbach’s
alpha) of the scale was 0.91 at both 6 weeks and 9 months from discharge from
the hospital (Archbold et al., 1990 [Level II]).
Indicators of Problems with Quality of Care
Indicators of problems with the quality of care can include evidence of an un-
healthy environment, inappropriate management of finances, and demonstra-
tion of a lack of respect for the older adult (see Resources section). The nurse’s
observations can be guided by the Elder Assessment Instrument (EAI) (Ful-
mer, 2002 [Level VI]), which helps the nurse identify elder abuse and neglect
issues (see EAI at www.ConsultGeriRN.org). The EAI consists of seven sections
that reviews signs, symptoms, and subjective complaints of elder abuse, ne-
glect, exploitation, and abandonment (Fulmer, Paveza, Abraham, & Fairchild,
2000 [Level II]; Fulmer, Street, & Carr, 1984 [Level II]; Fulmer & Wetle, 1986
[Level II]). There is no “score,” but the elder should be referred to social ser-
vices if there is evidence of mistreatment; a complaint by the elder; or high
risk of or probable abuse, neglect, exploitation, or abandonment of the older
adult.
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Caregiver’s Physical and Mental Health Status
The caregiver’s perception of their own health (Pinquart & Sorensen, 2006
[Level I]) is one of the most reliable indicators of a physical health problem.
Depression or other emotional distress (e.g., anxiety) can be assessed using the
Center for Epidemiological Studies–Depression Scale (CES–D) (see Resources
section) (Pinquart & Sorensen, 2003, 2006; Sorensen et al., 2002 [all Level I]).
The CES–Dwas initially designed as a screen for the community dwelling at risk
of developing major depressive symptomatology. It has been used widely in in-
tervention studies with family caregivers, where it has been self-administered.
The BrownUniversity Center for Gerontology andHealthcare Research created
a set of End-of-Life Care Toolkit instruments, which are available for use on its
Web site at no charge. For each of the 20 items, participants rate its frequency of
occurrence during the past week on a 4-point scale from 0 (rarely) to 3 (most of
the time). Scores range from 0 to 60, with a higher score indicating the presence
of a greater number and frequency of depressive symptoms. A score of 16 or
higher has been identified as discriminatory between groups with clinically rel-
evant and nonrelevant depressive symptoms (Radloff, 1977 [Level II]; Radloff
& Teri, 1986 [Level II]).
Burden or strain can be assessed using the Caregiver Strain Index (CSI)
(see www.ConsultGeriRN.org, Family Caregiving topic) (Sullivan, 2002 [Level
II]). Preexisting burden or strain places caregivers at greater risk and may pre-
vent them from benefiting from interventions (Schultz & Beach, 1999 [Level II];
Vitaliano et al., 2003 [Level I]; Sullivan, 2002 [Level II]). The CSI is a tool that
can be used to quickly identify families with potential caregiving concerns. It
is a 13-question tool that measures strain related to care provision. There is at
least one item for each of the following major domains: employment, financial,
physical, social, and time. Positive responses to seven or more items on the CSI
indicate a greater level of strain. Internal consistency reliability is high (alpha
= 0.86) and construct validity is supported by correlations with the physical and
emotional health of the caregiver and with subjective views of the caregiving
situation. A positive screen (seven or more items positive) on the CSI indicates
a need for more in-depth assessment to facilitate appropriate intervention.
Rewards of Caregiving
Although early family caregiving research focused almost exclusively on nega-
tive outcomes of caregiving, clearly there aremany positive aspects of providing
care. Spouses can be drawn closer together by caregiving, which can act as an
expression of love. Adult child caregivers can feel a sense of accomplishment
from helping their parents. Caregivers should be asked to enumerate their per-
ceived benefits of caregiving (Archbold et al., 1995 [Level II]). These can include
the satisfaction of helping a family member, developing new skills and compe-
tencies, and or improved family relationships.
Self-Care Activities for Caregivers
Self-care activities can include setting aside time to exercise, getting time for
oneself, and obtaining respite. Even if caregivers do not use this strategy, the
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clinician should ask them to think about strategies that would work for them.
Caregivers need to be reminded that self-care is not a luxury, it is a necessity.
At a minimum, caregivers need to learn how to put themselves first, manage
stress, socialize, and get help.
Interventions
Definitions
Psychoeducational Interventions
Psychoeducational interventions involve a structured program geared toward
providing information about the care receiver’s disease process, resources and
services, and training caregivers to respond effectively to disease-related prob-
lems, such as memory and behavior problems in dementia patients or depres-
sion and anger in cancer patients. These interventions use lectures, group dis-
cussions, and written materials and are always led by a trained leader. Support
may be part of a psychoeducational group, but it is secondary to the educational
content.
Supportive Interventions
This category subsumes both professionally led and peer-led unstructured sup-
port groups focused on building rapport among participants and creating a
space in which to discuss problems, successes, and feelings regarding care-
giving.
Respite/Adult Day Care
Respite care is either in-home or site-specific supervision, assistance with
ADLs, or skilled nursing care designed to give the caregiver time off.
Psychotherapy
This type of intervention involves a therapeutic relationship between the care-
giver and a trained professional. Most psychotherapeutic interventions with
caregivers follow a cognitive–behavioral approach.
Interventions to Improve Care-Receiver Competence
These interventions include memory clinics for patients with dementia
and activity therapy programs designed to improve affect and everyday
competence.
Multicomponent Interventions
Interventions in this group included various combinations of educational inter-
ventions, support, psychotherapy, and respite in Sorensen et al.’s meta-analysis.
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Individual studies included after the 2002 meta-analysis include nursing man-
agement and interdisciplinary-care interventions.
Overview of Interventions
Past reviews of caregiver interventions, such as support groups, individual coun-
seling, and education confirm that there is no single, easily implemented, and
consistently effective method for eliminating the stresses and/or strain of be-
ing a caregiver (Knight, Lutzky, & Macofsky-Urban, 1993 [Level I]; Toseland &
Rossiter, 1989 [Level I]). Sorensen and colleagues (2002 [Level I]) performed a
more recent meta-analysis on the effects of a second generation of 78 caregiver
intervention studies. The most consistent significant improvements in all out-
comedomains (i.e., burden, depression,well-being, ability and knowledge, care-
receiver symptoms) assessed in the meta-analysis resulted from psychotherapy
and caregiver psychoeducational interventions aimed at improving caregiver
knowledge and abilities. Multicomponent interventions, which combined fea-
tures of psychotherapy and knowledge/skill-building, had the largest effect on
burden and, in addition, were effective for improving well-being and ability
and knowledge. The effects of different types of interventions on selected care-
giver outcomes from the meta-analysis and studies completed since 2002 are
presented in Table 8.1.
More current studies of psychotherapy and psychoeducational interven-
tions (Akkerman & Ostwald, 2004 [Level II]; Burns et al., 2005 [Level II]; Coon,
Thompson, Steffen, Sorocco, & Gallagher-Thompson, 2003 [Level II]; Hebert
et al., 2003 [Level II]; Hepburn et al., 2005 [Level II]) and multicomponent in-
terventions (Mittelman, Roth, Coon, & Haley, 2004 [Level II]; Mittelman, Roth,
Haley, & Zarit, 2004 [Level II]) fit the same pattern of results. All of these inter-
ventions address key negative aspects of caregiving: being overwhelmed with
the physical demands of care, feeling isolated, not having time for oneself, hav-
ing difficulties with the care recipient’s behavior, and dealing with one’s own
negative responses.
There are several characteristics across interventions that seem to have
a moderating effect on caregiving outcomes. Focusing the caregiver training
exclusively on care receivers to alter their symptoms has almost no effect on
caregivers (Sorensen et al., 2002 [Level I]). In the Sorensenmeta-analysis, group
interventions were less effective at improving caregiver burden than individual
and mixed interventions, which is consistent with Knight et al. (1993 [Level I])
but inconsistent with the meta-analysis performed by Yin, Zhou, and Bashford
(2002 [Level I]). Length of an intervention appears to be important in alleviating
caregiver depression and care-receiver symptoms. Caregivers do less well with
shorter interventionswith regard to depression because they lose the supportive
aspects of prolonged contact with a group or a professional before they can
benefit.
Characteristics of the caregiver are also associated with intervention effec-
tiveness. Some caregivers benefit less from interventions than others. For ex-
ample, Sorensen found that spouse caregivers benefited less from interventions
than adult children (2002 [Level I]). Table 8.2 presents caregiver characteristics
associated with various intervention outcomes.
8.1 Effects of Different Types of Interventions on Caregiver Outcomes
Type of
intervention
Burden or
strain
Depression or
distress
CG
(Caregiver)
well-being
CG ability,
knowledge
CR (Care Receiver)
symptoms
Health Service
Utilization
Institutionalization
Costs
Psychoeducation
Skill-building
Significant effect
(Sorensen
et al., 2002
[Level I])
Decreased burden
– 6 studies
(Acton & Winter,
2002 [Level I])
Significant effect (Sorensen
et al., 2002 [Level I])
Decreased depression – 6
studies (Acton & Winter,
2002 [Level I])
Significant reduction in
depressive symptoms
(Gallagher-Thompson
et al., 2003 [Level II])
Decreased bother, anxiety,
depression (Mahoney,
Tarlow, & Jones, 2003
[Level II])
Decreased depression
(Coon et al., 2003
[Level II])
Decreased distress
(Hepburn et al., 2005
[Level II])
Significant effect
(Sorensen
et al., 2002
[Level I])
Significant effect
(Sorensen
et al., 2002
[Level I])
Increased
knowledge – 9
studies (Acton
& Winter, 2002
[Level I])
14% improved
reaction to CR
symptoms
(Hebert et al.,
2003 [Level II])
Significant effect (Sorensen
et al., 2002 [Level I])
Supportive
Interventions
Significant effect
(Sorensen
et al., 2002
[Level I])
Significant effect
(Sorensen
et al., 2002
[Level I])
8.1 Effects of Different Types of Interventions on Caregiver Outcomes
Type of
intervention
Burden or
strain
Depression or
distress
CG
(Caregiver)
well-being
CG ability,
knowledge
CR (Care Receiver)
symptoms
Health Service
Utilization
Institutionalization
Costs
Psychotherapy Significant effect
(Sorensen et al.,
2002 [Level I])
Decreased
objective burden
Significant effect (Sorensen
et al., 2002 [Level I])
Decreased anxiety
(Akkerman & Ostwald, 2004
[Level II])
Significant effect
(Sorensen
et al., 2002
[Level I])
Significant effect
(Sorensen
et al., 2002
[Level I])
Some improved
reaction to CR
symptoms
(Burns et al.,
2005 [Level II])
Significant effect (Sorensen
et al., 2002 [Level I])
Respite Significant effect
(Sorensen et al.,
2002 [Level I])
Significant effect (Sorensen
et al., 2002 [Level I])
Decreased depression – 3
studies (Acton & Winter,
2002 [Level I])
Significant effect
(Sorensen
et al., 2002
[Level I])
Institutionalization
treatment less than
control – 1 study
(Acton & Winter, 2002
[Level I])
Focus on care
receiver (CR)
Significant effect
(Sorensen
et al., 2002
[Level I])
Significant effect (Sorensen
et al., 2002 [Level I])
Improved quality of life
(Clark et al., 2006 [Level II])
Reduction in care-
receiver anxiety
(Smith, Forster, &
Young, 2004 [Level II])
Multicomponent
added to this
category
Large significant
effect (Sorensen
et al., 2002
[Level I])
Improved distress and
depression (Callahan
et al., 2006 [Level II])
(Bass et al., 2003
[Level II])
Significant effect
(Sorensen
et al., 2002
[Level I])
Significant effect
(Sorensen
et al., 2002
[Level I])
Improved perceptions of
health, decreased
negative emotion
and dependence (Burton
& Gibbon, 2005 [Level II])
No differences (Callahan
et al., 2006 [Level II])
Nursing and
interdisci-
plinary care
management
– includes
hospital or
rehabilitation
at home and
primary care
Improved carer
strain (Burton &
Gibbon, 2005
[Level II])
Decreased
burden/strain –
2 studies (Acton
& Winter, 2002
[Level I])
REACH
intervention
overall
decreased
burden (Gitlin
et al., 2003
[Level I])
Decreased burden
(Kalra et al.,
2004 [Level II])
Burden and strain
were responsive
to intervention
(Schultz et al.,
2005 [Level I])
Less burden (Crotty,
Whitehead, Miller, & Gray,
2003 [Level II])
Less strain (Harris et al.,
2005 [Level II])
More strain after
intervention (Wade et al.,
2003 [Level II])
Significant decrease in
depressive symptoms
(Eisdorfer et al., 2003
[Level II])
Decreased depression,
distress, anxiety – 4
studies (Acton & Winter,
2002 [Level I])
Decreased anxiety and
depression (Kalra et al.,
2004 [Level II])
Decreased depression
(Mittleman, Roth, Coon
et al., 2003 [Level II])
Decreased reaction ratings
(Mittleman, Roth, Haley,
et al., 2004 [Level II])
Clinically significant
decreases in depression
and anxiety (Schulz et al.,
2005 [Level I])
Higher role
rewards (Li
et al., 2003
[Level I])
Caregiver affect
improved
(Gitlin et al.,
2005 [Level II])
Well-being
worse in
control group
(Burns et al.,
2003 [Level II])
Worse mental health (Wade
et al., 2003 [Level II])
Some but not all service
utilization outcomes
(Bass et al., 2003
[Level II])
Cost twice as much as
usual inpatient care
(Harris et al., 2005
[Level II])
Lower hospitalization,
reduced ER use
(Shelton et al., 2001
[Level II])
Lower costs due to lower
readmission (Teng
et al., 2003 [Level II])
Delayed
institutionalization
(Schultz et al., 2005
[Level I])
Focus on
physical or
emotional
health of CG
Decreased psychological
distress (King et al., 2002
[Level II])
Decreased depression &
anxiety (Waelde et al.,
2004 [Level III])
8.2 Effects of Different Types of Caregiver Characteristics on Caregiver Outcomes
Characteristics
of caregiving
situation Burden Depression
CG (Caregiver)
Well-being
CG ability
knowledge
CR (Care Receiver)
Symptoms
CR has dementia Less effective
(Sorensen et al.,
2002 [Level I])
Less effective (Sorensen et al.,
2002 [Level I])
Less effective
(Sorensen et al.,
2002 [Level I])
Less effective
(Sorensen et al., 2002
[Level I])
No effect (Sorensen
et al., 2002
[Level I])
Adult-child CGs Greater improvement
(Sorensen et al.,
2002 [Level I])
Greater improvement (Sorensen
et al., 2002 [Level I])
Non-spouses did better (Gitlin
et al., 2003 [Level I])
Greater improvement
(Sorensen et al.,
2002 [Level I])
Greater improvement
(Sorensen et al., 2002
[Level I])
Smaller improvement
(Sorensen et al.,
2002 [Level I])
Spouse CGs Smaller improvement
(Sorensen et al.,
2002 [Level I])
Smaller improvement (Sorensen
et al., 2002 [Level I])
Wives with low mastery and high
anxiety benefited the most
(Mahoney et al., 2003 [Level II])
Cuban husbands improved more
on depressive symptoms
(Eisdorfer
et al., 2003 [Level II])
Smaller improvement
(Sorensen et al.,
2002 [Level I])
Smaller improvement
(Sorensen et al., 2002
[Level I])
Greater improvement
(Sorensen et al.,
2002 [Level I])
Older CGs Greater improvement
(Sorensen et al.,
2002 [Level I])
Higher risk for
(Schulz et al., 2005
[Level I])
No effects (Sorensen et al., 2002
[Level I])
Higher risk for (Schulz et al., 2005
[Level I])
Greater improvement
(Sorensen et al.,
2002 [Level I])
Greater improvement
(Sorensen et al., 2002
[Level I])
Greater improvement
(Sorensen et al.,
2002 [Level I])
Female CGs Greater improvement
(Sorensen et al.,
2002 [Level I])
Better improvement
(Gitlin et al., 2003
[Level I])
Higher risk for
(Schulz et al., 2005
[Level I])
Females benefit more
(Gallagher-Thompson et al., 2003
[Level II])
Cuban daughters improved more
on depressive symptoms
(Eisdorfer
et al., 2003 [Level II])
Higher risk for (Schulz et al., 2005
[Level I])
Greater improvement
(Sorensen et al., 2002
[Level I])
Greater improvement
(Sorensen et al.,
2002 [Level I])
Ethnicity (Sorensen et al., 2002
[Level I])
Latinos benefit as much
(Gallagher-Thompson
et al., 2003 [Level II])
Cuban husbands and daughters
improved more on depressive
symptoms (Eisdorfer
et al., 2003 [Level II])
Hispanics did better (Gitlin et al.,
2003 [Level I])
(Sorensen et al., 2002
[Level I])
(Sorensen et al., 2002
[Level I])
Lower education Better improvement
(Gitlin, et al., 2003
[Level I])
Higher risk for
(Schulz et al., 2005
[Level I])
Better improvement (Gitlin et al.,
2003 [Level I])
Higher risk for (Schulz et al., 2005
[Level I])
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Intervention Approaches with Disappointing Results
Some intervention approaches have been consistently disappointing, either
showing no significant effects or limited responses. In Lee and Cameron’s 2004
([Level I]) update of the Cochrane database review, reanalysis of three trials
of respite care found no significant effects of respite on any outcome vari-
able. Interventions focused on medication management of the care receiver’s
dementing condition (Lingler, Martire, & Schulz, 2005 [Level I]) and/or targeted
to managing problematic behavior (Livingston et al., 2005 [Level I]) were sim-
ilarly disappointing. A meta-analysis of habit training for the management of
urinary-incontinence interventions showed that not only were there no signif-
icant differences in incontinence between the intervention and control groups
but that caregivers also found the intervention labor-intensive (Ostaszkiewicz,
Johnston, & Roe, 2004 [Level I]).
Interventions with Little Effect Due to Study Flaws
In Acton and Winter’s (2002 [Level I]) meta-analysis of dementia caregiving
studies, small, diverse samples; lack of intervention specificity; diversity in the
length, duration, and intensity of the intervention strategies; and problematic
outcome measures led to nonsignificant results for many tested interventions.
Cooke, McNally, Mulligan, Harrison, and Newman (2001 [Level I]) also reported
that two-thirds of the interventions they examined did not show any improve-
ment in any outcomemeasures. Their analysis was hampered by lack of detailed
description of the interventions in the studies they examined. Study limitations
have also been a factor leading to disappointing results for some innovative
caregiving interventions for caregivers of care receivers with other long-term,
debilitating illnesses. For example, interventions designed to teach arthritis
management as a couple (Martire et al., 2003 [Level II]), to decrease the gap
between caregivers’ expectations and patients’ actual functional abilities with
skill-building, and nurse-coached pain management all had disappointing re-
sults due to either small sample sizes or the complexity of the problems they
were designed to address (Martin-Cook,Davis,Hynan,&Weiner, 2005 [Level II];
Schumacher et al., 2002 [Level IV]). According to Price, Hermans, Grimley, and
Evans (2006 [Level I]), modification interventions for wandering have never
been adequately tested due to the many flaws identified in the existing pub-
lished research; outcome measurement has also been problematic. More dis-
tal outcomes, such as depression, perceived stress, caregiver strain, and self-
efficacy, that are less directly related to the actual intervention, are less likely
to change significantly (Bourgeois, Schulz, Burgio, & Beach, 2002 [Level II];
Burgio, Stevens, Guy, Roth, & Haley, 2003 [Level II]) than outcomes that are
more specific to the intervention (Hebert et al., 2003 [Level II]).
Interventions with Little Effect Due to Debilitating Nature of
Care Receiver Illness
Caregivers caring for care receivers who have conditions that worsen substan-
tially over time (e.g., dementia, Parkinson’s disease, stroke) have reported ei-
ther less improvement, no improvement, or increased strain after intervention
(Forster et al., 2006 [Level I]; Sorensen et al., 2002 [Level I]; Wright, Litaker,
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Laraia, &DeAndrade, 2001 [Level II]). Acrossmany studies, Sorensen et al (2002
[Level I]) reported that interventions with caregivers of dementia patients are
less successful than with other caregivers. They also noted that if levels of care-
giving are relativelyhighand cannot be reduced, as is the case for dementia care-
givers, thenburden anddepression are also less amenable to change.Amultidis-
ciplinary rehabilitationprogram forParkinson’s patients resulted inno improve-
ment in depression for caregivers after treatment (Trend, Kaye, Gage, Owen, &
Wade, 2002 [Level III]). A meta-analysis of hospital and home care for stroke
patients reported no evidence from clinical trials to support a radical shift in the
care of acute stroke patients from hospital-based (Langhorne et al., 2006 [Level
I]). Individual studies that examined other psychoeducational and/or support
and counseling interventions for stroke caregivers (albeit with relatively small
samples) found no significant changes between the intervention and control
groups (Clark, Rubenach, & Winsor, 2003 [Level II]; Grasel, Biehler, Schmidt, &
Schupp, 2005 [Level III]; Larson et al., 2005 [Level II]). Only an intensive, multi-
component, skills-training intervention significantly decreased burden anxiety
and depression for this category of caregivers (Kalra et al., 2004 [Level II]). A
number of family-based and symptom-management interventions for cancer
patients have also found no significant intervention effects (Hudson, Aranda,
& Hayman-White, 2005 [Level II]; Kozachik et al., 2001 [Level II]; Kurtz, Kurtz,
Given, & Given, 2005 [Level II]; Northouse, Kershaw, Mood, & Schafenacker,
2005 [Level II]; Wells, Hepworth, Murphy, Wujcik, & Johnson, 2003 [Level II]).
In several of these studies, therewas a large dropout rate among the intervention
participants due to the rapidly deteriorating condition of the care receivers.
Novel Caregiver-Focused Intervention Approaches
That Show Promise
A moderate-intensity exercise program was tested among older women fam-
ily caregivers. Exercise participants showed significant improvements in total
energy expenditure, stress-induced blood pressure reactivity, and sleep qual-
ity along with a decrease in psychological distress (King, Baumann, O’Sullivan,
Wilcox, & Castro, 2002 [Level II]). In another pilot study, 12 older female de-
mentia caregivers participated in a six-session manualized combined yoga and
meditation program (Waelde, Thompson, & Gallagher-Thompson, 2004 [Level
III]) in which participants experienced significant decreases in depression and
anxiety. Secker and Brown (2005 [Level II]) had very good success with a pilot
intervention that used cognitive behavioral therapy to treat caregiver psycho-
logical distress.
Resources for Enhancing Alzheimer’s Caregiver
Health (Reach)
The REACH project was designed to test promising interventions for enhanc-
ing family caregiving for persons with dementia and to overcome several of
the limitations of prior research (Schultz et al., 2003 [Level V]). More than
1,200 caregivers participated at six sites nationwide. The sample was more
diverse than most caregiving studies due to the multisite design: participants
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were 56%White, 24% African American, and 19% Latino (Wisniewski et al., 2003
[Level II]).
1. In the REACH study, Mahoney and colleagues (2003 [Level II]) examined the
main outcome effects of a 12-month, computer-mediated automated inter-
active voice response (IVR) intervention designed to assist family caregivers
managing care receivers with dementia. There was a significant intervention
effect for bother, anxiety, and depression. Wives who exhibited low mastery
and high anxiety benefited most from the automated telecare intervention.
2. Gallagher-Thompson et al. (2003 [Level II]) tested apsychoeducational (skill-
building) approach modeled after community-based support groups. The in-
tervention was tailored to be sensitive to ethnic groups. In this study, female
caregivers benefited more from the skill-building approach than from sup-
port group alone, and the Latino caregivers benefited as much as the other
caregivers.
3. Burgio et al. (2003 [Level II]) developed a manual-guided intervention tai-
lored on cultural preferences ofWhite and African American caregivers. The
intervention combined both care recipient-focused behavior management
skill training and caregiver-focused, problem-solving training. White care-
givers showedmore improvement in the control condition, andAfricanAmer-
ican caregivers had the greatest improvements in the skill-training condition.
Spouse and non-spouse caregivers responded differently to the intervention,
with non-spouse caregivers benefiting more than spouses.
4. Eisdorfer et al. (2003 [Level II]) used a family-systems approach to develop
a family-therapy intervention designed to enhance communication between
caregivers and other family members by identifying existing problems in
communication and facilitating changes in interaction patterns that encour-
age caregivers to gather and more effectively manage available family and
community resources. In the second experimental condition, they added a
computer-telephone integrated system of support. The combined family-
therapy and technology-intervention caregivers experienceda significant de-
crease in depressive symptoms, which was particularly beneficial for Cuban
American husband and daughter caregivers.
5. Burns and colleagues (2003 [Level II]) tested two primary-care interventions
delivered during a 24-month period: patient-behavior management only and
patient-behavior management plus caregiver stress and coping. Participants
who received patient-behavior management only had significantly worse
outcomes for well-being. When caregiving issues were not addressed, care
was inadequate for reducing caregiver distress.
6. Gitlin et al. (2005 [Level II]) tested an intervention that consisted of in-home
occupational therapy visits designed to help familiesmodify the environment
to reduce caregiver burden. At 12 months, caregiver affect improved signif-
icantly, but no other caregiver outcomes were significantly different from
baseline.
When the results from the REACH interventions were pooled, overall in-
terventions decreased burden significantly compared to the control conditions
(Gitlin et al., 2003 [Level I]). Only the family therapy with computer technol-
ogy intervention was effective for reducing depressive symptoms. Interventions
were superior to control conditions on burden for women and caregivers with
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lower education; on depression, Hispanics, non-spouses, and caregivers with
lower education had bigger responses.
Aspects of Interventions That Improve Effectiveness
A key conclusion of the REACH trial and several of the meta-analyses (Gitlin
et al., 2003 [Level I]; Schulz et al., 2005 [Level I]; Sorensen et al., 2002 [Level
I]) reviewed in this chapter was that family-caregiver interventions need to be
multicomponent and tailored. Multicomponent interventions have the poten-
tial to include a repertoire of various strategies that target different aspects of
the caregiving experience. In focus groups conducted during a caregiving clin-
ical trial, Farran, Loukissa, Perraud, and Paun (2003 [Level II]) identified and
catalogued the information and skills that caregivers reported they needed to
respond to their own needs or the caregiving process, including care-receiver
issues such as managing difficult behaviors, worrisome symptoms, personal-
care problems, and caregiver concerns such as managing competing respon-
sibilities and stressors, finding and using resources, and handling their emo-
tional and physical responses to care. Tailored interventions are interventions
that are crafted to match a specific target population (e.g., spouse caregivers of
Alzheimer’s patients) and their specific caregiving issues and concerns iden-
tified through thorough assessment (Archbold et al., 1995 [Level II]; Horton-
Deutsch, Farran, Choi, & Fogg, 2002 [Level III]). Interventions that are indi-
vidualized or tailored in combination with skill-building demonstrated the best
evidence of effectiveness (Pusey & Richards, 2001 [Level I]). Among the psy-
choeducational interventions, some of the most effective were predicated on a
skills-building approach (Gallagher-Thompson et al., 2003 [Level II]; Hepburn,
Tornatore, Center, & Ostwald, 2001 [Level II]). Collaboration or a partnership
model with the caregiver is also a key component ofmaking the tailoring process
more effective (Harvath et al., 1994 [Level V]). Programs that work collabora-
tively with care receivers and their families and aremore intensive andmodified
to the caregivers’ needs are also more successful (Brodaty, Green, & Koschera,
2003 [Level I]).
Nursing Care Strategies
1. Identify content and skills needed to increase preparedness for caregiv-
ing.
Psychoeducational skill-building interventions include information about
the care needed by the care receiver and how to provide it, as well as coaching
on how to manage the caregiving role. Tasks associated with taking on the
caregiving role include dealingwith change, juggling competing responsibili-
ties and stressors, providing andmanaging care, finding and using resources,
and managing the physical and emotional responses to care (Acton & Win-
ter, 2002 [Level I]; Farran et al., 2003 [Level IV]; Farran et al., 2004 [Level II];
Gitlin et al., 2003 [Level I]; Sorensen et al., 2002 [Level I]).
2. Form a partnership with the caregiver prior to generating strategies to
address issues and concerns.
The goal of this partnership is blending the nurse’s knowledge and expertise
in health care with the caregiver’s knowledge of the family member and the
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caregiving situation. Each party brings essential knowledge to the process of
mutual negotiation between the family and the nurse. Together they develop
ideas to address the issues and concerns that aremost salient for the caregiver
and care receiver. Every family situation will be different, and interventions
cannot be individualized without nurse–family collaboration (Brodaty et al.,
2003 [Level I]; Gitlin et al., 2005 [Level II]; Harvath et al., 1994 [Level V];
Nolan, 2001 [Level V]).
3. Identify the caregiving issues and concerns onwhich the caregiverwants
to work and generate strategies.
Multiple strategies should be generated for each caregiving issue and con-
cern.One of themost important findings from the reviewof literature on care-
giving is that multicomponent interventions are superior to narrow, single-
approach problem solving (Acton & Winter, 2002 [Level I]; Gitlin et al., 2003
[Level I]; Sorensen et al. 2002 [Level I]; several Level II individual studies
[see Table 8.1]).
4. Assist the caregiver in identifying strengths in the caregiving situa-
tion.
Not all outcomes from caregiving are negative, and caregiving can be reward-
ing for some caregivers who derive pride and satisfaction from the important
role they are filling. Incorporating pleasurable activities into the daily rou-
tine or incorporating into some caregiving task something that is either fun
or meaningful are ways of enhancing caregiving. Even in really difficult sit-
uations, there may be some positive benefit derived, such as satisfaction in
meeting an important commitment and/or recognition of personal growth
(Archbold et al., 1995 [Level II]).
5. Assist the caregiver in finding and using resources.
Navigating the health care system is one of themost difficult skills caregivers
have to master (Archbold et al., 1995 [Level II]; Farran et al., 2004 [Level II];
Schumacher et al., 2002 [Level IV]). Caregivers rarely know how to translate
a need that they have into a request for help from the health care system.
Learning how to speak to health care providers, negotiate billing, request
help with transportation—all of these tasks can be overwhelming. For some
caregivers, Internet and other on-line sources of support and information
can be helpful.
6. Help caregivers identify and manage their physical and emotional re-
sponses to caregiving.
We know that caregiving is sometimes associated with deterioration of the
caregiver’s health or significant depression (Schulz et al., 2003 [Level V]).
Generating strategies to take care of the caregiver is just as important as the
strategies for caring for the care recipient.
7. Use an interdisciplinary approach whenworking with family caregivers.
Multicomponent interventions have the strongest record in terms of alleviat-
ing some of the global negative consequences of caregiving. Involving a team
of other health professionals helps the nurse and family generate new ideas
for strategies and brings a fresh perspective to the idea-generating process
(Acton & Winter, 2002 [Level I]; Farran et al., 2003 [Level IV]; Farran et al.,
2004 [Level II]; Gitlin et al., 2003 [Level I]; Sorensen et al., 2002 [Level I];
several Level II studies [see Table 8.1]).
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Expected Outcomes
Outcomes Specific to the Caregiver
The goal of the guideline is to lower strain, depression, and poor physical health
for caregivers. Indicators of problems include reports of depression and/or
fatigue, increased use of over-the-counter and prescription medications, in-
creased use of health services, neglect of own health, and substance abuse.
Increased focus on the caregiver system as the unit of service should increase
a nurse’s confidence in working with family caregivers.
Outcomes Specific to the Patient
These include improvement (where possible) in patient functional status, nu-
trition, and hygiene. Improved symptom management for care recipients with
significant chronic disease is also a desired outcome. This could include better
pain management for care recipients with cancer, improved glycemic control
for care recipients with diabetes, and/or diminished problematic behaviors for
care recipients with dementia. The emotional well-being of the care recipient
should also be an outcome of interventions to aid the caregiver. Decreased use
of emergency services and increased use of formal care supports are system
outcomes we might expect.
Resources
Preparedness Scale at www.ConsultGeriRN.org, Caregiving topic.
Mutuality Scale at www.ConsultGeriRN.org, Caregiving topic.
Elder Assessment Instrument at www.ConsultGeriRN.org, Elder Mistreatment
and Abuse topic.
CES-D at http://www.chcr.brown.edu/pcoc/cesdscale.pdf.
Caregiver Strain Index at www.ConsultGeriRN.org, Caregiving topic.
Box 8.1
Nursing Standard of Practice Protocol: Family
Caregiving
I. GOAL
Identify viable strategies to monitor and support family caregivers.
II. OVERVIEW
Family caregivers provide more than 80% of the long-term care for older
adults in this country. Caregiving can be difficult, time-consuming work
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added on top of job and other family responsibilities. If caregivers suffer
negative consequences from their caregiving role and these are not mit-
igated, increased morbidity and mortality may result for caregivers. Not
all outcomes from caregiving are negative; there are many caregivers
that report rewards from caregiving.
III. BACKGROUND AND STATEMENT OF PROBLEM
A. Definitions
1. Family caregiving: This is broadly defined and refers to a wide
range of unpaid care provided in response to illness or functional
impairment to a chronically ill or functionally impaired older
familymember, partner, friend, or neighbor that exceeds the sup-
port usually provided in family relationships (Schumacher, Beck,
& Marren, 2006 [Level VI]).
2. Informal caregiving: This is a more inclusive term that refers to
help provided by all nonprofessional providers of care, including
family members, friends, neighbors, and/or members of a reli-
gious or other type of community. In addition to family members
or significant others, friends, neighbors, or members of a faith
community may provide informal caregiving (Schumacher et al.,
2006 [Level VI]).
3. Family caregiving activities: These include assistance with day-
to-day activities, illness-related care, care management, and
invisible aspects of care. Day-to-day activities include personal-
care activities (e.g., bathing, eating, dressing, mobility, transfer-
ring from bed to chair, and using the toilet) and IADLs (e.g.,
meal preparation, grocery shopping, making telephone calls, and
money management) (NAC & AARP, 2004 [Level IV]; Walker
et al., 1995 [Level I]). Illness-related activities include manag-
ing symptoms, coping with illness behaviors, carrying out treat-
ments, and performing medical or nursing procedures that in-
clude an array of medical technologies (Smith, 1994 [Level IV]).
Care-management activities include accessing resources, com-
municating with and navigating the health care and social ser-
vices systems, and acting as an advocate (Schumacher et al., 2000
[Level IV]). Invisible aspects of care are protective actions care-
givers take to ensure the older adults’ safety andwell-beingwith-
out their knowledge (Bowers, 1987 [Level IV]).
4. Caregiving roles: These can be classified into a hierarchy accord-
ing towho takes on themajority of responsibilities versus only in-
termittent supportive assistance. Primary caregivers tend to pro-
vide most of the everyday aspects of care, whereas secondary
caregivers help out as needed to fill the gaps (Cantor & Little,
1985 [Level V]; Penning, 1990 [Level IV]; Tennstedt et al., 1989
[Level IV]). Among caregivers who live with their care recipients,
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spouses account for the majority of primary caregivers, whereas
adult children are more likely to be secondary caregivers. The
range of the family caregiving role includes protective caregiv-
ing such as “keeping an eye on” an older adult who is cur-
rently independent but at risk, to full-time, around-the-clock care
for a severely impaired family member. Health care providers
may fail to assess the full scope of the family caregiving role if
they associate family caregiving only with the performance of
tasks.
5. Caregiver assessment: This refers to an ongoing iterative process
of gathering information that describes a family caregiving situ-
ation and identifies the particular issues, needs, resources, and
strengths of the family caregiver.
B. Risk factors associated with negative outcomes for caregiving
1. Just being a caregiver puts an individual at increased risk for
higher levels of stress and depression and lower levels of subjec-
tive well-being and physical health (Pinquart & Sorenson, 2003;
Vitaliano et al., 2003 [both Level I]).
2. Female caregivers, on average, provide more direct care and re-
port higher levels of burden and depression (Gitlin et al., 2003
[Level I]).
3. Ethnic minority caregivers provide more care, use less formal
services, and report worse physical health thanWhite caregivers
(Dilworth-Anderson, et al., 2002 [Level I]; McCann et al., 2000
[Level IV]; Pinquart & Sorenson, 2005 [Level I]).
4. African American caregivers experience less stress and depres-
sion and get more rewards from caregiving than White care-
givers (Cuellar, 2002 [Level IV]; Dilworth-Anderson et al., 2002
[Level I]; Gitlin et al., 2003 [Level I]; Haley, et al., 2004 [Level II];
Pinquart & Sorenson, 2005 [Level I]).
5. Hispanic and Asian American caregivers exhibit more de-
pression (Gitlin et al., 2003; Pinquart & Sorenson, 2005 [both
Level I]).
6. Less-educated caregivers report more depression (Buckwalter
et al., 1999 [Level II]; Gitlin et al., 2003 [Level I]).
7. Spouse caregivers report higher levels of depression than non-
spouse caregivers (Pinquart&Sorenson, 2005; Pruchno&Resch,
1989 [both Level I]).
8. Caregivers who have a poor-quality relationship with the care
recipient report more strain (Archbold, et al., 1990, 1992 [Level
II]; Croog, Burleson, Sudilovsky, & Baume, 2006 [Level IV]; Flan-
nery, 2002 [Level VI]).
9. Caregivers who lack preparedness for the caregiving role also
increases strain (Archbold, et al., 1990, 1992 [both Level II]).
10. Caregivers of care recipients who have dementia suffer from in-
creased strain (Pinquart & Sorenson, 2006 [Level I]).
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IV. PARAMETERS OF ASSESSMENT
A. Caregiving Context:
1. Caregiver relationship to care recipient (spouse, non-spouse)
(Gitlin et al., 2003; Sorensen et al., 2002 [both Level I])
2. Caregiver roles and responsibilities
a. Duration of caregiving (Sorensen et al., 2002 [Level I])
b. Employment status (i.e., work, home, volunteer) (Pinquart &
Sorensen, 2006 [Level I])
c. Household status (e.g., number in home) (Pinquart &
Sorensen, 2006 [Level I])
d. Existence and involvement of extended family and social sup-
port (Pinquart & Sorensen, 2006 [Level I])
3. Physical environment (i.e., home, facility) (Vitaliano et al., 2003
[Level I])
4. Financial status (Vitaliano et al., 2003 [Level I])
5. Potential resources that caregiver could choose to use—list (Pin-
quart & Sorensen, 2006 [Level I])
6. Family’s cultural background (Dilworth-Andersen et al., 2002
[Level I])
B. Caregiver’s perception of health and functional status of care recip-
ient:
1. List activities care receiver needs help with; include both ADLs
and IADLs (Pinquart & Sorensen, 2003, 2006 [both Level I]).
2. Presence of cognitive impairment—if yes, any behavioral prob-
lems? (Gitlin et al., 2003 [Level I]; Sorensen et al., 2002
[Level I]).
3. Presence of mobility problems—assess with single question
(Archbold et al., 1990 [Level II]).
C. Caregiver preparedness for caregiving:
1. Does caregiver have the skills, abilities, knowledge toprovide care
recipient with needed care? (see Preparedness for Caregiving
Scale at www.ConsultGeriRN.org, Family Caregiving topic).
D. Quality of family relationships:
1. The caregiver’s perception of the quality of the relationship with
the care receiver (Archbold et al., 1990 [Level II]) (see Mutuality
Scale at www.ConsultGeriRN.org, Family Caregiving topic).
E. Indicators of problems with quality of care:
1. Unhealthy environment
2. Inappropriate management of finances
3. Lack of respect for older adult (see Elder Assessment Instru-
ment [EAI]) at http://www.hartfordign.org/publications/trythis/
issue15.pdf).
F. Caregiver’s physical and mental health status:
1. Self-rated health: single item—asks what is caregivers’ percep-
tion of their health (Pinquart & Sorensen, 2006 [Level I]).
2. Health conditions and symptoms
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a. Depression or other emotional distress (e.g., anxiety) (Pin-
quart & Sorensen, 2006, 2003; Sorensen et al., 2002 [all Level
I]). (See CES-D in Resources section).
b. Reports of burden or strain (Schultz & Beach, 1999 [Level II];
Vitaliano et al., 2003 [Level I]). (See Caregiver Strain Index at
www.ConsultGeriRN.org, Family Caregiving topic).
3. Rewards of caregiving:
a. List of perceived benefits of caregiving (Archbold et al., 1995
[Level II])
b. Satisfaction of helping family member
c. Developing new skills and competencies
d. Improved family relationships
4. Self-care activities for caregiver
V. NURSING CARE STRATEGIES
A. Identify content and skills needed to increase preparedness for care-
giving (Acton & Winter, 2002 [Level I]; Gitlin et al., 2003 [Level I];
Sorensen et al., 2002 [Level I]; Farran et al., 2003 [Level IV]; Farran
et al., 2004 [Level II]).
B. Form a partnership with the caregiver prior to generating strategies
to address issues and concerns (Brodaty et al., 2003 [Level I]; Gitlin
et al., 2003 [Level I]; Harvath et al., 1994 [Level V]).
C. Identify the caregiving issues and concerns on which the caregiver
wants to work and generate strategies (Acton & Winter, 2002 [Level
I]; Gitlin et al., 2003 [Level I]; Sorensen et al., 2002 [Level I]; several
Level II studies [see Table 8.1]).
D. Assist the caregiver in identifying strengths in the caregiving situa-
tion (Archbold, et al., 1995 [Level II]).
E. Assist the caregiver in finding and using resources (Archbold et al.,
1995 [Level II]; Farran et al., 2004 [Level II]; Schumacher et al., 2002
[Level IV]).
F. Help caregivers identify and manage their physical and emotional
responses to caregiving (Schulz & Beach, 1999 [Level II]).
G. Use an interdisciplinary approach when working with family care-
givers (Acton & Winter, 2002 [Level I]; Gitlin et al., 2003 [Level I];
Farran et al., 2003 [Level IV]; Farran et al., 2004 [Level II]; Sorensen
et al., 2002 [Level I]; several Level II studies [see Table 8.1]).
VI. EVALUATION AND EXPECTED OUTCOMES
A. Outcomes specific to caregiving
1. Lower caregiver strain
2. Decreased depression
3. Improved physical health
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B. Outcomes specific to patient
1. Quality of family caregiving
2. Care-recipient functional status, nutrition, hygiene, and symptom
management
3. Care-recipient emotional well-being
4. Decreased occurrence of adverse events such as increased
frequency of emergent care
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9Preventing Fallsin Acute Care
Deanna Gray-Miceli
Educational Objectives
At the completion of this chapter, the reader should be
able to:
1. gain knowledge about the consequences of falls
among older adults
2. identify factors contributing to risk for falls and
serious injury and utilize this knowledge to further
direct nursing plans of care for the primary
prevention of falls
3. understand the etiological basis for falls among
older adults, particularly those who are
hospitalized
4. utilize findings from a comprehensive post-fall
assessment to develop an individualized plan of
nursing care for the secondary prevention of
recurrent falls
5. identify accepted “general safety measures” to
prevent falls from occurring and to provide a safe
environment for hospitalized older adult patients
Overview
Spurred by the rising incidence of patient falls in health care organizations
across the United States (e.g., fall-related sentinel events rose from 3% in 2002
to more than 5% in 2006), the Joint Commission on Accreditation of Healthcare
Organizations (JCAHO) has sanctioned National Patient Safety Goals (NPSG)
for all JCAHO-approved institutions across the health care continuum. Two spe-
cific aims of this new health policy in acute care institutions are (1) to reduce
risk of injury from falls including fatal falls, and (2) to provide a program to
prevent patient falls. Both aims seek to promote improvements in patient safety
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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by reducing preventable falls through systemwide solutions whenever possible
(JCAHO, 2006 [Level VI]).
Overall, across all patient settings, evidence exists that fall-prevention pro-
grams are effective. The RAND report cites, from ameta-analysis of 20 random-
ized clinical trials (among all patient settings), that fall-prevention programs
reduced either the number of older adults who fell or the monthly rate of falling
(U.S. Department of Health and Human Services, 2004 [Level I]). In hospital
settings, however, studies are lacking and sorely needed to provide solid scien-
tific evidence of the effect of fall-prevention programs on fall rates among older
adult patients.
Current literature of hospital-based fall-prevention programs and their ef-
fect on fall prevention is predominantly descriptive, often void of evidence re-
lating to intervention effectiveness. Conclusions drawn from two systematic re-
views during a 7-year period of published hospital fall-prevention programs,
showed no significant benefit from individual components of the interventions
(i.e., the pooled effect of 25% reduction in fall rate), potentially attributable to
methodological design issues (Oliver, Hopper, & Seed, 2000 [Level I]). In a few
hospital-based studies, some evidence exists that multi-faceted interventions
reduce the number of falls (Oliver, Daly, Martin, & McMurdo, 2004 [Level I]).
For example, a multipronged approach of education, intervention, and exer-
cise reduced falls by 30% and had less injury outcomes observed among pa-
tients (Haines, Bennell, Osborne, & Hill, 2004 [Level II]). Although relatively
few studies focus on interventions to prevent falls in hospitalized-based older
adult populations, the state of the science supports its use. Findings from a large
meta-analysis support multifactorial interventions for fall prevention in the
elderly (Chang et al., 2004 [Level I]).
The call for national improvements in patient safety and fall prevention
warrant further development and testing of approaches actually used inpractice.
Despite fall-prevention program variability (according to available resources),
organizational and staff commitment, and fall program/intervention type, two
factors are consistent: (1) nurses are central to any mission of patient safety, fall
prevention, and injury reduction; and (2) nurses who utilize evidenced-based
interventions and sound clinical judgment to prevent patient falls in hospital
settings are likely to be successful.
Nursing: A Quintessential Component to
Preventing Patient Falls
Although promoting a culture of safety is everyone’s shared responsibility in
health care organizations, nurses are essential core members and team leaders
for any salient commitment to reduce patient falls at the bedside, on the unit, or
anywhere in the health care encounter (e.g., in the operating room or outpatient
clinic).
Markers of quality fall-prevention and -management programs in hospi-
tal settings call for adherence to the same principles that guide the delivery of
quality health care for older adult patients in any other setting: coordinated,
communicated, and continuous patient-centered care (Resnick, 2003 [Level
VI]). Nurses provide individualized patient assessment and reassessment,
manage environmental-control issues on the unit, and develop and implement
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comprehensive plans of care for fall assessment and management that range
from early detection of those at risk to continually monitoring for fall-related
problems post-fall.
Although we typically think of fall prevention as exclusive to the patient,
fall-prevention activities assumed by nurses also extend to family caregivers of
older patients planning discharge to the home. When professional nurses are
at the helm of decision-making, policy and practice benefit. In daily practice,
the nurse’s primary commitment is to the recipient of nursing and health care
services whether the recipient is an individual, family, group, or community
(American Nurses Association, 2002 [Level VI]).
Effective Fall-Prevention Programs
Models of Effective Programs Used by Nurses
Best practice exemplars of effective, successful fall-prevention programs exist
within severalmodels of care of hospitalized elderly and incorporate an interdis-
ciplinary team with a strong geriatric nurse-centered approach. Models of care,
serving as exemplars of the geriatric nurse-centered approach, realize improve-
ments in hospital lengths of stay and health outcomes aswell as fewer iatrogenic
geriatric syndromes, such as inpatient falls. These models of care include Acute
Care of the Elderly (ACE) Units, Nursing Improving Care for Health System
Elders (NICHE) program, and the Geriatric Resource Nurse (GRN) model. ACE
units provide geriatric interdisciplinary models of care and physically support-
ive environments that focus on the unique needs of older adults during hospi-
talization and report higher patient, family, and staff satisfaction compared to
control units (Counsell et al., 2000 [Level II]). (See Resources for more informa-
tion on ACE units.)
NICHE is a national geriatric nursing program currently implemented in
more than 200 hospitals in more than 40 states as well as parts of Canada and
The Netherlands. Since 1996, The Hartford Institute has administered NICHE,
a national program aimed at improving systems to achieve positive outcomes for
hospitalized older adults. The focus of NICHE is on programs and protocols that
are predominantly under the control of nursing practice; in other words, areas
where nursing interventions have a substantive and positive impact on patient
care of older adults. Through NICHE, evidence-based geriatric best practices
are facilitated into hospital care.
Evidenced-based research of three different types of models of care that
incorporated a geriatric nurse practitioner found that when the geriatric nurse
practitioner and nurse manager addressed the issue of falls risk with an edu-
cational program for the staff, the fall rate decreased by 5.8% (Smyth, Dubin,
Restrepo, Nueva-Espana, & Capezuti, 2001 [Level IV]).
Essential Components of Effective Fall-Prevention Programs
Expert agreement concludes that an effective response by health care orga-
nizations and professionals to prevent and reduce falls and associated injuries
include a structuredprogramof three important components: (1) fall risk assess-
ment along with individually designed action-based interventions, (2) post-fall
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assessment and appropriate data collection, and (3) use of fall-reduction tools
(ECRI Institute, 2006 [Level VI]). All of these fundamental programmatic com-
ponents are carried out by nurses and are included in nursing policy and prac-
tice. Fall prevention (both primary and secondary) implemented by nurses fol-
lows the nursing assessment process, which allows for multiple and continual
types of assessment, reassessment, and evaluation following a fall or interven-
tion to prevent a fall. It is a dynamic process with a continuous feedback loop.
Throughout the nursing process, there are discrete points for nursing assess-
ment to be performed including (1) health assessment of the older adult patient
“at risk” (fall risk assessment); (2) nursing assessment of the patient following a
fall (post-fall assessment); (3) assessment of the environment, equipment, and
other situational fall circumstances upon admission and during hospitalization;
and (4) assessment of the older adult’s knowledge of falls and their prevention,
including willingness to change behavior, if necessary, to prevent falls.
There are many assessment tools available for use by nurses who perform
fall risk assessment. In the acute care setting, these tools have been summarized
in an analytic review by Perell and colleagues (2001 [Level V]). The nursing as-
sessment of the older adult patientwho falls does not stopwith administration of
these assessment tools or other types of assessment. Rather, the nursing assess-
ment is a process, which extends to formulate an analysis of the information and
situational context of the patient so that corrective plans of action can unfold.
Inherent in any fundamental fall-prevention program is current knowledge
of fall etiology, its assessment and prevention strategies. To prevent falls among
older adult patients in acute care, professional nurses must have an informed
awareness of (1) what constitutes a fall, (2) why falls are so important to pre-
vent in the acute care setting, (3) which older adult patient is at greatest risk to
fall and/or develop serious injury, (4) why older adult patients in an acute care
setting fall, (5) what can be done to prevent the older adult patient from falling,
and (6) what should be done once a patient has fallen. This chapter outlines an
overview of the approach to fall assessment and prevention when each of these
questions is asked and answered.
Background and Statement of the Problem
Defining Falls
There are several operational definitions of a fall, each utilized for either admin-
istrative, research, or clinical purposes. The first consensus opinion–definition
of falling is an “unintentional coming to the ground or some lower level and other
than as a consequence of sustaining a violent blow, loss of consciousness, sudden
onset of paralysis as in stroke, or epileptic seizure” (Kellogg InternationalWork-
ing Group on Fall Prevention in the Elderly, 1987 [Level VI]). This definition is
more consistent to the epidemiological definitions used in public health tabulat-
ing falls as intentional or unintentional events (Centers for Disease Control and
Prevention [CDC], National Center for Injury Prevention and Control [NCIPC],
2007 [Level VI]). The Kellogg definition stipulates outcome but does not ac-
knowledge potential antecedents or mechanisms of occurrence—for example,
not from the identified medical problems. This definition is contrasted to clini-
cal observations and diagnostic coding in practice—for instance, “syncopal-type
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falls or falls due to syncope” (International Classification of Disease Manual
ICD-10, 2006 [Level VI]).
The strongest level of research evidence shows that falls in older adults are
due to multifactorial clinical causes (Chang et al., 2004 [Level I]), as reflected
in the Prevention of Falls Network Europe (ProFaNE) consensus definition that
falls occurring from all causes is “an unexpected event in which the participant
comes to rest on the ground, floor or lower level” (ProFaNE, 2006 [Level VI]).
The regulatory definition for the hospital setting, proposed by the Centers
for Medicare and Medicaid Services (CMS), considers whether or not falls are
witnessed and whether the person was lowered to the ground with assistance.
In all practice settings, falls can occur while walking or during a transition from
bed, chair, stretcher, or toilet. Theymay bewitnessed or unwitnessed (i.e., where
the patient is found on the floor or self-reported by the patient, visitor, or family
member). Specific to the acute care facility and to nursing, falls are tabulated ac-
cording to the National Database of Nursing Quality Indicators (NDNQI), which
provides reference points of comparison to measure program effectiveness. Us-
ing the NDNQI fall definitions, any unplanned descent to the floor with or with-
out injury to the patient is a fall, and any staff assistance of the patient to the
floor is considered an assisted fall (NDNQI, 2005 [Level VI]). Referral to the
hospital policy and procedure manual for the facility-specific definition of a fall
is recommended for comparison.
Why Falls Are Important in Acute Care
Many of the known negative health care outcomes from falls, such as injury
and/or functional decline, typically strike those patients older than age 85 and
are typically preventable. Overall, state departments of health, which analyze
patient safety data, have reported to JCAHO that up to 30% of adverse medical
events are due to avoidable patient falls.
The most serious outcome of a fall concerning the older adult, the health
care provider, and the organizational system is a fatality due to a fall. Although
the exact fatal-fall incidence in the in-patient setting is not known, the most
approximate estimate is reported through the Patient Safety Reporting System,
adopted in several states in the United States. Because true point incidences on
in-patient fatal falls are not aggregated from individual states, we rely on global
fatal-fall incidences from all settings in the CDC’s NCIPC analysis. The CDC’s
most recent report of fatalities from falls among older adults in theUnited States
during a 10-year period (1993–2003) shows a 55% increase in fatal falls (CDC,
Morbidity and Mortality Weekly Report [MMWR], 2006 [Level VI]). Although
the most current national incidences of fatal falls are under-represented (due
to limitations in cause of death certificate-coding limitations) each year, falls
result in more than 14,000 fatalities among seniors, ranking as the seventh lead-
ing cause of unintentional injury–fatality (CDC, NCIPC, 2007 [Level VI]). The
fatal-fall incidence increases with age, those older than age 85 being the most
vulnerable. In 2002, there were 1,208 deaths per 100,000 due to falls for all sexes
and races among those 70 to 74 years, more than 2,000 deaths for those 75 to
79 years, and more than 5,999 deaths for those 85 and older. In 2001, more than
1.6 million older adults were treated in emergency departments for fall-related
injuries and nearly 388,000 were hospitalized (Runyan et al., 2005 [Level V]).
About 30% to 40% of emergency room visits resulted in hospitalization with an
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average length of stay of 8 to 15 days at an average cost of $10,000 to $12,000
per stay. Hospital in-patient falls are estimated to vary according to the unit,
with one study reporting 3.1 falls per 1,000 patient-days (Fischer et al., 2005
[Level IV]). In this study, bleeding or laceration occurred in 53.6%, fracture or
dislocation in 15.9%, and hematoma or contusion in 13%. Patients older than age
75 and those in geriatric psychiatric units were more likely to develop serious
fall-related injury. Other serious injuries documented from falls included hip
fracture and traumatic brain injury (TBI), among others.
The actual incidence of falls with serious injury, such as hip fracture, in the
acute care hospital are nationally tabulated through external injury codes and
then reported in the National Hospital Discharge Survey (NHDS) data bank and
the Patient Safety Indicator at the Agency for Healthcare Research and Qual-
ity (AHRQ) (see Resources for further information). The CDC’s analysis of the
NHDS shows a decrease in the overall age-adjusted hospitalization rate of hip
fracture from 917.6 per 100,000 to 775.7 per 100,000 (CDC, MMWR, 2006 [Level
VI]). As 1 of 20 patient safety indicators [PSI] monitored in hospitals, postop-
erative hip fracture occurred among 5,200 in-patients in 2000, with risk for this
PSI increasing with age (Romano et al., 2003 [Level V]). Hip fracture is a serious
problem for older adults in terms ofmortality and the excessmorbidity incurred,
especially for adults older than 70 years of age; thus, it is important for targeted
proactive nursing interventions. Strong evidence reveals the high mortality rate
at 6 months post–hip fracture (from 10% to 28%) (Kenne, Parker, & Pryor, 1993,
[Level II]; Magaziner, et al., 1997 [Level V]) with more than 50% never regaining
prefracture status (Marottolli, Berkman, & Cooney, 1992 [Level II]).
Evaluation of hospital-unit effectiveness in fall prevention depends on the
operational fall definition, fall measurement, and how falls aremonitored. Unit-
based analysis of fall rates are regularly conducted by nursing care managers
and risk analysts. When one considers the multifactorial causes of falls in older
adults, it becomes clear as to why fall rates fluctuate individually within and
between units. Typically, an averagemedical–surgical unit fall rate may bemuch
lower than a neurological intensive care unit or rehabilitation unit. The patient
demography of these two units is very different. Theremay be fewer patients on
a specialized unit; however, aggregately, the patient may have many more risk
factors and individualized reasons to fall.
Research has demonstrated that there are many predisposing risk factors
that contribute to falls in older adults in any setting. Fall risk means that a fac-
tor or condition is present, significantly more often, in a person who falls than
a person who does not fall. Risk factors are of two varieties: (1) those occur-
ring in the person’s environment (called extrinsic risks); which include envi-
ronmental and situational context that patients encounter; and (2) those occur-
ring within the person, or intra-individually (called intrinsic risks) (Table 9.1).
Intrinsic risks include the person’s underlying medical problem or presence of
chronic disease, physical status such as presence of weakness, and use of certain
medications.
Hospital settings possessmany environmental hazards, which for an acutely
ill older adult signal risk. Hazards exist on the floor surface itself in terms of its
glossiness (i.e., from bright lights glaring against shiny linoleum tile), wetness
from spills (e.g., overfilled water pitchers that may drip onto the floor), and slip-
pery surface areas. In health care settings, environmental falls are commonly
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9.1 Examples of Extrinsic and Intrinsic Risksfor Falls
Extrinsic Risks
Floor surfaces that are slippery, wet, extra-shiny, or uneven or cracked
Equipment that is faulty, nonsupportive, or collapsing when used, laden with debris
IV poles, stretchers, or beds that are not sturdy or move away from the patient when used
for support
Poor lighting or extra-glaring “blinding” bright lights
Bathrooms lacking grabrails, bars, or nonskid applique´s or mats
Physical restraints
Inappropriate footwear
Intrinsic Risks
Lower extremity weakness
History of falls
Gait deficit
Balance deficit
Use of an assistive device
Visual deficit
Arthritis
Impaired ADLs
Dependency in transferring/mobility
Depression
Cognitive impairment
Agitated confusion
Older than age 80
Urinary incontinence/frequency
Culprit medications: benzodiazepines, sedatives/hypnotics, alcohol, antidepressants,
neuroleptics, anti-arrhythmics, digoxin, and diuretics
Source: Adapted fromECRI Institute (2006). Falls prevention strategies in healthcare settings guide. Plymouth
Meeting, PA: ECRI [Level VI].
Oliver, D., Daly, F., Martin, F. C., & McMurdo, M. E. (2004). Risk factors and risk assessment tools for falls in
hospital in-patients: A systematic review. Age and Ageing, 33(2), 122–130 [Level I].
Papaioannou, A., Parkinson, W., Cook, R., Ferko, N., Corker, E., & Adachi, J. D. (2004). Prediction of falls using
a risk assessment tool in the acute care setting. BioMed Central, 1, 1 [Level III].
Rubenstein, L. Z., & Josephson, K. R., (2002). The epidemiology of falls and syncope. Clinics of Geriatric
Medicine, 18, 141–158 [Level II].
found where a slip may occur from a spill or wet surface (Connell, 1996 [Level
VI]). Slippery surface areas pose threats if adequate precaution is not taken.
For instance, if an older adult does not wear anti-skid slippers while walking, a
slip and fall can occur. Built-up debris on bed wheels, stretchers wheels, bed-
side tables, or intravenous poles can lead to poor contact between two surfaces
and a slippage or sliding of the equipment can occur when used for support.
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When brakes are not used on wheelchairs or a bed, slides can occur when a
patient attempts to stand up (the wheelchair can slide away from the person)
or sit down on a bed (the bed slides away from the person). Uneven floor sur-
faces are problematic in doorways when a ledge or raised tile is present. An
older patient with lack of steppage height (e.g., from Parkinson’s disease, loss of
lower extremity sensation, or Type II diabetes) can trip over the uneven edge.
Improper footwear constitutes a hazard; a few studies have found evidence for
risk of falls in older adults related to footwear. In one study, greater heel height
was associated with increased risk of a fall, whereas greater sole contact area
was associated with reduced fall risk (Tencer et al., 2004 [Level IV]). Shoes such
as those worn by athletes appear to be beneficial for older adults with lower
risks of falling (Koepsell et al., 2004 [Level IV]).
Assistive devices and other types of equipment need to be routinely assessed
for function and structural support. If they are defective, bedrails or assistive
devicesmay collapse whenweight is applied. Grabrails in the bathroom, around
the toilet, and in the shower stall are essential to help maintain upright postural
stability for older adult patients. Bedside commodes should be placed against a
wall or another source of support and used only with assistance of nursing staff.
A bedside commode (and the patient) can easily topple over when a patient
exiting from a bed or chair leans on one handrail of the bedside commode when
it is not securedagainst a supportive structure suchas awall or piece of furniture.
Physical Restraint Use
Capezuti and colleagues (2002 [Level III]) cite physical restraint use as a contrib-
utor to risk for falling, not a solution for fall prevention. Also noted by Capezuti
et al., neither physical restraints nor side rails have ever been shown to reduce
falls or associated injury. In fact, in the last 20 years, there have been numer-
ous reports of restraint-related injuries reported in the professional literature,
by the U.S. Food and Drug Administration (FDA), and the Joint Commission on
Accreditation of Healthcare Organizations (JCAHO). Many of these injuries are
due to a patient’s attempts to remove restraints or to ambulate while restrained
(Agostini, Baker, & Bogardus, 2001 [Level VI]). The injuries include neurolog-
ical injuries (DiMaio, Dana, & Bux, 1986 [Level V]), stress-induced complica-
tions (related to agitation secondary to restraint), and strangulation (Dube &
Mitchell, 1986 [Level VI]; Miles, 2002 [Level VI]). Themost commonmechanism
of restraint-related death is by asphyxiation—that is, the person is suspended
by a restraint from a bed or chair and the ability to inhale is inhibited by grav-
itational chest compression (DiNunno, Vacca, Costantinedes, & DiNunno, 2003
[Level V]). Clearly, the risk of serious injury or fatality due to physical restraint
is substantial and must be considered when deciding about using restraints.
Intrinsic Risks to Fall
A summary of 16 studies defined the most common intrinsic risk factors for
falling among older adults in any setting (Rubenstein & Josephson, 2002 [Level
II]) (see Table 9.1). When their relative risk was determined, lower extremity
weakness ranked as the most potent risk factor, with a four times greater risk
to fall than if the restraint were not present. History of falls ranked second,
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9.2 Examples of Co-morbidity Impact on Aging Changes
Changes Impact
Visual changes
Presbyopia (reduced
accommodation)
Difficulty may be encountered with descending steps, particularly the
last step may be missed, or surface edges
Senile miosis (smaller pupils) Dimly lit rooms or hallways difficult to visualize Surface edges without
bold, contrast colors may visually “blend” together
Cardiovascular changes
Orthostatic hypotension (OH) Positional changes (e.g., lying to sitting up in bed or standing from
sitting) may cause sudden drop in blood pressure precipitating a fall
Neuromuscular changes
Reduced steppage height Stumbles, trips with ascending steps or walking on uneven surfaces
Impaired reaction time Trips, stumbles, or pushes causing a sudden loss of balance can result
in impaired ability to maintain upright stance
Source: Adapted from Maki, B. E., & McIllroy, W. E. (2003). Effects of aging on control of stability. In L. Luxon et al. (Eds.), A
textbook of audiological medicine: Clinical aspects of hearing and balance (pp. 671–690). London: Marin Dunitz Publishers.
increasing the risk of falling threefold; gait or balance deficit ranked third and
fourth, respectively, increasing fall risk about threefold. Other factors increas-
ing risk of falling at least twofold were use of an assistive device, visual deficit,
arthritis, impaired activities of daily livings (ADLs), and depression. Cognitive
impairment and being older than age 80 increased fall risk 1.8 and 1.7 times,
respectively. Evidence-based research of fall risks seen among older adults in
hospital in-patient settings have confirmed similar findings (see Table 9.1) and
include gait instability, agitated confusion, urinary incontinence/frequency, his-
tory of falls, and use of “culprit” medications (Oliver, Daly, Martin, & McMurdo,
2004 [Level I]). Positive predictive validity of falls has also been evidenced by
intrinsic risk of a history of falls, visually impaired, toileting assistance, depen-
dency in transfer andmobility, andmental impairment (Papaioannou et al., 2004
[Level III]). Of all these associated risks for falling, Papaioannou et al. found that
cognitive impairmentwas themost significant predictor. Some intrinsic risks are
also implicated as underlying causative agents (Rubenstein & Josephson, 2006
[Level I]), such as diseases causing cognitive impairment or gait and balance
instability. The contribution of chronic disease to increased fall risk is notable
(Tinetti, Williams, & Mayewski, 1986 [Level II]) as well as the co-morbidity of
changes related to aging (Table 9.2).
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Age-Related Changes Contributing to Fall Risk
There may be subtle changes in older persons’ organ systems; coupled with the
effects of co-morbidities and acute or chronic illness, the risk for falls increases
significantly. Experts agree that it is the co-morbidity of the aging changes, and
not age per se, that increases the risk of falls (Public Health Agency of Canada,
2007 [Level VI). Some of the visual changes experienced by older adults include
presbyopia—a reduction in accommodation. The effects of presbyopia are most
obvious when descending steps. Because of this condition, older adults may
miss the last step (an important reason why handrails must end on the landing
surface and why the use of handrails is essential). A reduction in the diameter
of the pupil, a condition called senile miosis, results in smaller pupils. Dimly lit
rooms andhallways or surface edges that do not have bold contrasting colors can
lead to trips and falls. The presence of a cataract, more prevalent in older age
groups and with certain conditions, obstructs central vision and can contribute
to falls when steps or obstacles are not visualized. In a study of older adults with
cataracts, removal of the cataracts was associated with a reduced risk for recur-
rent falling (Brennan et al., 2003 [Level III]). Neuromuscular aging changes in-
clude reduced steppage height. If reduced steppage height is evident, stumbles,
trips, and falls can occurwhen ascending a step orwalking on anuneven surface.
Also, transitioning from a flat floor surface to a thicker carpeted surface can re-
produce similar fall occurrences. Other changes include impaired ability to react
to sudden loss of balance (from a push or trip) or impaired ability to maintain
upright stance (Maki & McIllroy, 2003 [Level VI]). In addition to disease and co-
morbidities of aging, other sources of intrinsic risk to falls includes medications.
Medications Contributing to Fall Risk
Medications implicated in increasing fall risk are those causing potentially dan-
gerous side effects, including drowsiness, mental confusion, problems with bal-
ance, loss of urinary control, and sudden drops in blood pressure with standing
(i.e., postural hypotension). All of these effects may lead to a slip and fall (En-
srud et al., 2002 [Level II]; Neutel, Perry, & Maxwell, 2002 [Level VI]; Smith,
2003 [Level VI]). Classifications of medications implicated in falls for older
adults include psychotropic agents (e.g., benzodiazepines, sedatives and hyp-
notics, antidepressants, and neuroleptics), anti-arrhythmics, digoxin, and di-
uretics (Leipzig, Cumming, & Tinetti, 1999 [Level I]).
Factors Increasing the Risk to Develop Serious Injury
Risk factors for the development of serious injury such as hip fracture have
been isolated to include advancing age, lack of physical activity, presence of
osteoporosis, low body mass index, and a previous hip fracture (Stevens, 2000
[Level V]). Almost all older individuals with hip fractures have osteoporosis, yet
from findings from a retrospective analysis of records of patients receiving hip-
fracture surgery, it appears that the frequency of treating these high risk older
patients for osteoporosis is less than optimal (Kamel, 2004 [Level IV]). Kamel
further points out that inadequate treatment for osteoporosis increases risk for
osteoporotic fractures, including recurrent hip fractures. Advancing age is a
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significant risk for those older thanage85whoexperiencenearly aneightfold in-
crease in hospitalization due to hip facture. TBI is another serious injury that can
occur from a fall and is caused by a “blow to the head or jolt to the head or pen-
etrating head injury that disrupts function of the brain; however, not all blows
result in TBI (CDC, NCIPC, 2007 [Level VI]). Of all causes, falls are the leading
cause of TBI (CDC, NCIPC, 2007 [Level VI]), with adults age 75 and older having
the highest rate of TBI-related hospitalization and death (Langlois, Rutland-
Brown, & Thomas, 2006 [Level V]). Groups at risk for the development of TBI
include men, who are twice as likely to sustain a TBI; adults age 75 or older; and
African Americans, who have the highest death rate from TBI (CDC, NCIPC,
2007 [Level VI]). There is strong clinical reason to suspect that anticoagulated
older adults are at higher risk for TBI, should they sustain a fall with head injury,
but empiric research in this age group is lacking. Still, best practice approaches
to care of older adults must include a risk-benefit evaluation of medications,
such as Coumadin, Plavix, and/or aspirin, among others, that place the older
adult at increased risk of bleeding following a fall (Resnick, 2003 [Level VI]).
The quality and quantity of life for older adults at risk for falling in the acute
care setting depends on the reduction of risk factors so as to prevent a fall, es-
pecially one resulting in serious injury. In licensed medical-care settings, the
onus of responsibility rests on the licensed practitioner to follow appropriate
standards of care to ensure that patients are safe and free from injury during
periods of illness and treatment recovery. Nurses share in this enormous re-
sponsibility to provide both safe care and safe environments. Just how this is
accomplished occurs when knowledge is integrated in the nursing assessment
so that fall-prevention interventions are individualized. Answers to the ques-
tion: “Why do older adult patients in an acute care setting fall?” begin with a
focused patient assessment.
Assessment of Older Adults Post-Fall
The assessment of an older adult who has fallen in any setting is complex be-
cause falls in this age group are due to multifactorial and interacting predis-
posing intrinsic and extrinsic risks (see Tables 9.1 and 9.2) and precipitating
causes (Rubenstein & Josephson, 2006 [Level I]), as illustrated in Table 9.3
(Gray-Miceli, Johnson, & Strumpf, 2005 [Level VI]). Through many interactive
mechanisms, we are learningmuchmore about why patients in hospital settings
fall. This knowledge has been mostly realized through improved reporting sys-
tems, such as the electronic medical record and greater attention to the types of
information gathered from assessment tools. When this information is coupled
with results from a root-causes analysis performed following a sentinel event
and funneled to patient safety databanks, a clearer understanding of patient
falls is evident.
The most up-to-date knowledge of root causes of all patient falls in the
inpatient setting in 2005 is derived from tabulated reported incidences to JCAHO
(2006 [Level V]) and includes inadequate:
■ patient assessment—accounting for 70% of patient falls
■ communication—accounting for more than 60% of patient falls
■ environmental safety and security—accounting for 50% of patient falls
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9.3 Medical Events and Diseases AssociatedWith Falls in Older Adults
Age-Related
Dizziness with standing from physiological age-related changes
Dizziness with head rotation from physiological age-related changes
Accidental/Environmental
Slipping or tripping on a wet/slippery surface
Trip/slip
Lack of support from equipment or assistive device
Acute (Treatable) Sudden Symptoms
Mental confusion/delirium
Heart racing or skipping beats (arrhythmia)
Dizziness with standing up (orthostatic hypotension)
Dizziness with room spinning (vertigo)
Generalized weakness (infection, sepsis)
Involuntary movement of limbs accompanied by confusion, unresponsiveness, or
absent facial features (seizure)
Lower extremity weakness (electrolyte imbalance)
Gait ataxia associated with acute alcohol ingestion
Feeling faint or dizzy or unable to sustain consciousness (hypoglycemia)
Blacking out or loss of recall of fall event (syncope)
Unilateral weakness, sudden speech change, and/or facial droop (TIA/CVA)
Chronic (Manageable) Gradual or Recurrent Symptoms
Lower extremity numbness (neuropathy, diabetes, PVD, B12 deficiency)
Lower extremity weakness (arthritis, CVA, thyroid disease)
Fatigue (anemia, CHF)
Dyspnea on exertion (emphysema, pneumonia)
Weakness (frailty, disuse, anemia)
Lightheadedness (carotid stenosis, cerebrovascular disease, emphysema)
Dizziness with standing (OH secondary to diabetes)
Dizziness with head rotation (carotid stenosis, hypersensitivity)
Dizziness with movement (labyrinthitis)
Forgetting the fall (dementia)
“I don’t know” responses (depression)
Lower extremity joint pain (arthritis)
Unsteadiness with walking (dementia, CVA/MID)
Poor balance (Parkinson’s disease)
Reprinted with permission from Gray-Miceli, D., Johnson, J. C., & Strumpf, N. E. (2005). A step-wise
approach to a comprehensive post-fall assessment. Annals of Long Term Care, 13(12), 16–24, Table II, p. 20.
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9.4 Some Examples of Fall Causes
Accident/environment (31%)
Gait and balance disorders or weakness (17%)
Dizziness and vertigo (13%)
Drop attack (9%)
Confusion (5%)
Postural hypotension (OH; 3%)
Visual disorder (2%)
Syncope (0.03%)
Source: Adapted from Rubenstein, L. Z., & Josephson, K. R. (2006). Falls and their prevention in elderly
people: What does the evidence show? Medical Clinics of North America, 90(5), 807–824 [Level I].
Multifactorial Causes of Falls
Falls among older adults are a multifactorial phenomenon, attributable to med-
ications (Ensrud et al., 2002 [Level II]; Leipzig et al., 1999 [Level I]; Neutel et al.,
2002 [Level VI]; Smith, 2003 [Level VI]), chronic diseases (Shaw, 2002; Stolze
et al., 2004 [both Level VI]), the co-morbidity of aging and age-related changes,
environmental causes, prodromal causes (Gray-Miceli, Waxman, Cavalieri, &
Lage, 1991 [Level IV]); Rubenstein et al., 2000 [Level II]), or other acute illness.
Falls related to acute cardiovascular events include heart blocks, arrhythmia
causing rate disturbances, and disorders causing orthostatic hypotension [OH]
(Heitterachi, Lord, Meyerkorf, McCloskey, & Fitzpatrick, 2002 [Level III]; Ooi,
Hossain, & Lipsitz, 2000 [Level IV]). OH can occur from acute illnesses such
as volume depletion or blood loss, chronic illness such as Type II diabetes with
autonomic neuropathy, or from adverse medication effects (e.g., from diuretics
or vasodilators). Hospitalized adults older than age 85 frequently possess many
of these acute and chronic conditions (see Table 9.3) and when coupled with
frailty, associated functional decline can lead to lower extremity weakness and
subsequent falling.
Evidence-based research by Rubenstein and Josephson (2006 [Level I]) on
fall etiology in older persons is summarized from 12 large studies (with a sample
size of 3,628 reported falls) in Table 9.4. The data are drawn from six studies
conducted in community-dwellingpopulations and six studies conducted among
institutionalized populations and is limited by factors such as patient recall,
reporting, and classification methods of falls.
Fall Assessment
There are several interrelated components of the fall assessment of an
older adult recommended by geriatric experts and national guidelines for fall
prevention in older adults (American Geriatrics Society [AGS], 2001 [Level VI];
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American Medical Directors Association [AMDA], 1998 [Level VI]). One com-
ponent outlined in the guidelines is primary prevention, or screening for “risk to
fall” among all older adults admitted to amedical facility. For those at high risk to
fall or who have recently experienced a fall, amore comprehensivemultidimen-
sional assessment (inclusive of a review of fall risk) is appropriate (AGS, 2001
[Level VI]) and is often provided by an interdisciplinary team in the medical-
care setting.
Assessment Tools Used for Fall-Risk Determination
The purpose of fall-risk assessment is to identify risk for falling in advance and
to correct problems so as to prevent patient falls. Fall-risk determination is also
performed following a patient fall to help direct interventions. Many published
tools are available to assist clinicians in fall-risk determination. Tools selected
for use in practice should ideally have been empirically tested for determina-
tions of reliability, validity, and predictability of future falls; sensitivity scores
are reported for some tools (Table 9.5). Because of wide availability of fall-risk
screening tools for use with older adults, home-grown tools developed by the
facility that are not empirically tested should be avoided because they lack va-
lidity, reliability, and often sensitivity testing. Fall-risk status is likely to fluctuate
over time, especially among hospitalized older adults experiencing acute illness.
For this reason, the standard of care calls for fall-risk assessment to be done on
admission, when transferred to a new unit or when level of care changes, if a
change in condition occurs, and after a fall. Fall-risk assessment tools used for
patient assessment tend to focus on intrinsic and, to a lesser degree, extrinsic
risks. They tend to be brief in length, some taking only a fewminutes to adminis-
ter. Used in isolation, they provide limited information and often lack sufficient
detail about the fall history and situational context, patient symptoms, or impor-
tant examination findings (as can be obtained through a comprehensive post-
fall assessment [PFA]). Intrinsic items assessed range from a yes or no response
to presence or absence of visual impairment, confusion, high risk medications,
OH, and gait or balance impairment. Summed scores help to identify risk pro-
files and specific areas of impairment and to monitor patient status over time.
Assessment tools are always used along with sound nursing judgment. In
the case of PFA, fall-risk tools do not replace it, rather, the complement it. It is
important to recognize nursing judgment in the process of fall-risk assessment.
Although the relative odds of falling are statistically much higher for older per-
sons with one, two, or multiple risk factors, falls can still occur if no risk factors
are present; therefore, the scores with certain patients are sometimes mislead-
ing. Some tools, particularly homegrown ones, may fail to detect known risk
factors because their presence is lacking on the tool itself. For this reason, sole
reliance on tools becomes problematic in practice.
This clinical concern is supportedby evidenced-based researchof theTimed
Get Up and Go Test (TUG), a tool used in practice to predict falls. Among a sam-
ple of elderly patients admitted to a hospital who were followed prospectively,
the TUG test, used in isolation, failed to identify those patients likely to fall. In
short, it did not possess predictive validity for acutely ill older adults when used
alone (Lindsay, James, & Kippen, 2004 [Level III]).
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9.5 Listing of Some Empirically Tested FallAssessment Tools
Name of Tool Author Setting Training
Time to
Administer Sensitivity
Assessment of High Risk to
Fall
Spellbring IP Y 17 minutes UK
Berg Balance Test Berg OP Y 15 minutes 77
Patient Fall Questionnaire Rainville IP Y UK UK
STRATIFY Oliver IP N UK 93
Fall Prediction Index Nyberg IP-CVA UK UK 100
Resident Assessment
Instrument
Morris NH Y 80 minutes UK
Post-Fall Index Gray-Miceli NH Y 22 minutes UK
Morse Fall Scale Morse IP Y <1 minute 78
Fall Risk Assessment Tool MacAvoy IP N UK 93
Hendrich Fall Risk Model Hendrich IP N <1 minute 77
Timed Get Up and Go Shumway-
Cook
OP Y <1 minute 87
Tinetti Performance
Oriented Mobility
Tinetti IP Y 20 minutes 80
Key: IP: in-patient; IP-CVA: cerebrovascular accident; OP: outpatient; NH: nursing home; Y: yes; N: no;
UK: unknown
Source: Adapted from ECRI: Fall Prevention Strategies in Healthcare Settings (2006): In ECRI and Perell, et al. (2001), Fall
risk assessment measures: An analytic review. Journal of Gerontology, 56A(12), 761–766.
Extrinsic risk assessment is another vital component, particularly in an in-
patient settingwhere environmental slips and falls are commonplace. Checklists
are available to guide health care providers in conducting environmental and
equipment assessment for risks. Fall-risk assessment results in identification of
individualized risks for falling, which are communicated to other members of
the team so that plans of care can be targeted to the older adult’s needs.
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Post-Fall Assessment
Another component of patient assessment after a fall is referred to as “post-fall
assessment” (PFA) and is designated for the secondary prevention of falls. PFAs
are recommended in clinical guidelines and are multifactorial in nature, focus-
ing on identifying intrinsic and extrinsic risks and other causative etiology. The
purpose of PFA is to identify the underlying causes of the fall and to respond
to it appropriately. Components of the PFA are typically routinely performed
by professional nurses in all patient settings, although this evaluation may be
skeletal or limited according to the completeness of questions and examination
included on the tool used. Few empirically published tools for PFA exist, and
previous research has shown that fall-risk determination, using short forms,
asking five to eight questions about risk, often replace (inappropriately) PFA
in institutionalized settings (Gray-Miceli, Strumpf, Reinhard, Zanna, & Fritz,
2004 [Level IV]). There is evidence that comprehensive PFA tools are useful
and available to assist professional registered nurses in performing a PFA, es-
pecially in institutionalized settings (Gray-Miceli, Strumpf, Johnson, Dragascu,
& Ratcliffe, 2006 [Level III]). In settings where teams are unavailable, compre-
hensive PFA may be carried out through consultation with a specially trained
geriatrician, neurologist, or advanced practice nurses.
The PFA is a comprehensive yet fall-focused history and physical examina-
tion of the present problem (i.e., falling), often coupled with a functional assess-
ment and review of past medical problems and medications. Clinical guidelines
are clear about all of the necessary components for inclusion for patients who
have fallen, including fall history, fall circumstance, medical problems, medi-
cation review, mobility assessment, vision assessment, and neurological exam-
ination including mental status and cardiovascular assessment. In addition to
this information, data are collected about the patient’s physical status through
administration of selected tools to assess gait and balance (see Table 9.5 for ad-
ditional information on tools; TUG test [see chap. 3, Assessment of Function];
Tinetti Performance Oriented Mobility; The Berg Balance Test). Performing a
comprehensive PFA allows the clinician to identify intrinsic risks such as bal-
ance impairment or OH determination, as well as historical or physical exami-
nation findings consistent with a range of underlying fall causes such as brady-
or tachy-arrhythmia associated with dizziness. Until recently, there have been
no comprehensive, empirically tested PFA tools that allow registered nurses to
determine potential underlying fall causes (Gray-Miceli, et al. 2006 [Level III]).
In the hospital setting, certain components of a PFA can be elicited immedi-
ately following a patient’s fall, whereas other questions will follow later during
an intermediate period. The decision to ask certain questions immediately de-
pends on the medical stability of the patient and nursing judgment. A PFA can
help determine the underlying cause of the fall, whenever possible, if the right
set of questions is asked. Furthermore, this information can be communicated
to senior-level providers, staff, and family.
The PFA begins with eliciting a clear history of the fall event by asking the
older adult patient to describe the details andwhat he or she recalls occurring. In
cases of aphasia or poor recall from delirium or dementia, a piece of the history
can be obtained by using alterative communication methods such as nods of
the head, eliciting details from observers such as other health care providers
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9.6 Sample of Key Symptoms Associated WithFalls
Symptoms to Elicit Possible Etiology
Cardiovascular
Lightheadedness
Dizziness with standing
Dizziness with head rotation
Shortness of breath
Syncope
Carotid stenosis, medications, CAD; arrhythmia
OH (Orthostatic hypotension)
Carotid stenosis/hypersensitivity
Arrhythmia
Vaso vagal, neurological, carotid hypersensitivity
Neurological/musculoskeletal
Gait unsteadiness
Lower extremity weakness (bilateral)
Lower extremity weakness (unilateral)
Lower extremity numbness
Dementia, PD, CVA, foot problems
Disuse, thyroid disease, and electrolyte disorders
CVA, arthritis
Neuropathy, DM, B12 deficiency, PD
General
Sudden weakness
Fatigue
Focal bone pain
Disuse, anemia
Infection, CHF
Bone fracture
Genito urinary
Urinary frequency/urgency
Urinary incontinence
UTI
UTI
Behavioral
Thirst, hunger
Continuous wandering/motor
restlessness
Unmet physical needs
Dementia
Reprinted with permission from Gray-Miceli, D., Johnson, J. C., & Strumpf, N. E. (2005). A step-wise
approach to a comprehensive post-fall assessment. Annals of long term care: clinical care and aging,
13(12), 16–24. Table I, p. 19.
who may have witnessed the fall, from visitors, or from roommates. Much of
the historical information seeks to determine the presence of symptoms, which
might further explain the fall, and to recreate a visual image of the fall event.
Lists of key symptoms, which often herald an acute or chronicmedical cause, are
listed in Table 9.6. In the hospital setting, key symptoms such as OH, syncope,
or dizziness can be further evaluated, monitored, and/or treated as directed by
the medical plan of care.
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9.7 Immediate Post-Fall Assessment
Actions Taken by Professional Nurses and Nursing Staff
If an older adult patient is found on the floor, remain with the patient, summon additional help, and
proceed to:
Ask the older adult to explain what happened, if possible
Ask the how he or she is feeling and if there is pain
Control any bleeding (follow unit protocol) from injured site
Assess level of consciousness and perform neurological assessment, including pupillary checks
(according to unit protocol)
Gather and document vital signs: note the apical pulse rate and the supine blood pressure
Examine for signs of external injury to the head, spine, neck, and extremities
Determine oxygenation status
Determine finger-stick glucose if hypoglycemia is suspected
If stable, sit the patient up with support and assess sitting blood pressure
Gather and review pertinent symptoms at the time of the fall
Immobilize an extremity if fracture is suspected
Reassure the older patient
If the patient is stable, assist with transfer to bed or appropriate area for further evaluation
Diagnosis and treatment
Reprinted with permission from ECRI. Gray-Miceli, D. (2006). Fall Prevention Strategies in Healthcare Settings, chap. 5,
Patient Post-Fall Assessment: ECRI. Level VI.
The Immediate Post-Fall Assessment
As soon as possible after a patient has fallen or a resident is discovered, an
assessment is made by the RN to determine the extent of any sustained in-
juries. Before any intervention is taken, any staff member should remain with
the patient and call for help. During this time, the older adult patient is ver-
bally reassured and kept warm (but not moved) until help arrives. There are
many key observations to be noted about the fallen individual’s medical and
psychological condition, as well as the condition of the environment. The med-
ical stability of the patient determines the sequence of information gathered
either immediately or in the interim period, according to current standards of
practice followed by licensed professionals. For instance, if the patient is uncon-
scious from a head injury sustained during the fall, neurological checks, vital
signs with apical pulse rate, and pulse oxygenation are assessed first. Other
assessments of gait or functional status are conducted after the patient has sta-
bilized. While this is being performed, other staff members can assess envi-
ronmental spills or if shoes or slippers are worn. The nursing staff can use the
intercom system to call for help, reassure the other residents in a calm manner,
and keep the fallen resident comfortable. Information about the lighting and
use of assistive devices can be gathered. Any verbalizations made by the patient
should be noted about his or her condition. There are certain key actions that
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9.8 Critical Observations Made During theImmediate Post-Fall Assessment
Expressions or verbalizations of pain (facial grimacing, crying, screaming, agitation)
Changes in behavior or function, which may indicate pain
Swelling of an extremity (wrist, arm, leg) or head (hematoma, skull pain)
Unstable vital signs
Discolored cyanotic skin
Skin temperature (cold, clammy, diaphoretic)
Skin lacerations, contusions
Loss of consciousness, no response to stimuli or significant change in level of
consciousness
Changed range of motion of extremities
Evidence of neck, head, or spinal-cord injury
Abnormal or erratic neurological responses, such as absent pupil response, fixed or
dilated pupils, seizures, or abnormal changes in posture
Reprinted with permission from ECRI (2006). Fall prevention strategies in healthcare settings, chapter 5,
Patient Post-Fall Assessment: ECRI Institute [Level VI].
should be taken by licensed professional nursing staff when evaluating a fallen
patient (Table 9.7); some of these areas can be expanded on later when obtain-
ing more detailed information about the fall. Critical observations made during
the immediate PFA that should be communicated to the primary-care provider
(Table 9.8) include observation or verbalizations of pain, extremity swelling, un-
stable vital signs, discolored skin, temperature, laceration or contusions of the
skin, loss of consciousness, decreased range of motion, evidence of head or neck
injury and abnormal or erratic neurological responses, uncontrollable bleeding,
and incontinence of bowel or bladder at the time of the fall.
Interim Post-Fall Assessment
During the interim period of PFA and monitoring (from several days to weeks),
professional nurses continue to review, determine, and communicate pertinent
findings from this assessment and its progression or resolution. Once the pa-
tient is medically stable, fall-risk assessment can be reassessed by the inter-
disciplinary team revaluating intrinsic and extrinsic risks so that a plan of care
can be determined. The interim PFA period often requires a different set of as-
sessments, and this may be an ideal time to administer a cognitive, functional,
and/or emotional assessment, such as use of the Geriatric Depression Scale, or
a problem-focused mobility assessment. Develop a plan of care and request a
change in physician orders for level of supervision required by nursing staff of
the older patient or specific activity restrictions, depending on the fall assess-
ment findings.
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Longitudinal Post-Fall Assessment
Following a patient fall, the presence of injury may not be apparent until days
or even weeks later. When cognitive impairment exists, the accuracy of the
historical accounts of pain obtained immediately after the fall may be ques-
tioned. Observations of functional status with attention to any subtle or blatant
changes in mobility can signal an underlying fracture or a looming unstable
joint that was not previously reported. Likewise, during a patient fall in which
the older adult is cognitively intact and then later develops an acute delirium
or post-fall confusional state should signal to the professional nurse the pos-
sibility of injury. In these two instances, the standard of care is warranted as
part of the ongoing PFA to monitor vital signs and neurological status for a pe-
riod of several days or more, as clinically indicated. Fall policy and procedures
should reflect this provision because any change in patient condition warrants
follow-through, documentation, and communication to senior-level providers,
other nursing staff, and family.
Interventions for Fall Prevention and Management
Influencing the nursing plan of care are decisionsmade at discrete points in time
aboutwhichnursing interventions shouldbe selected.Decisions about interven-
tion choice are formed by clinical judgment, which always factors in themedical
stability of the older adult patient (includingwhether his or her judgment or cog-
nition is impaired) and the range of possible measures to promote safety and
minimize risks of injury. Often, a panorama of interventions is chosen, which
may or may not be effective in fall prevention. The most important determining
factor hinges on findings obtained during an individualized assessment—for ex-
ample, standard of care calls for stuporous or delirious patients with impaired
level of consciousness, cognition, and judgment to receive more intense obser-
vation and clinical care. Likewise, although research evidence is lacking, the
standard of care calls for a patient at risk for serious injury (e.g., hip fracture,
subdural hematoma, or other type of TBI), secondary to bleeding disorders or
use of anticoagulants, to be carefully assessed and more intensely monitored in
an acute care setting.
Evidenced-based interventions and their clinical effectiveness are evolv-
ing. Action-based interventions range from imminent threats to patient safety
requiring “emergency treatment” to interventions requiring routine monitoring
and surveillance. Because available resources vary among facilities, a central
component of any fall prevention program is for health care organizations to
ensure that available toolkits exist to help staff manage patient falls (ECRI,
2006 [Level VI]).
Nursing judgment and team discussion about risks versus benefits of an in-
tervention is central to the nurse’s mission to protect older adults from harm.
Some best practice exemplars for fall prevention are presented, which can help
determine what is in the best nursing intervention for a particular patient at a
particular moment in time. As the status of the patient changes, so too do in-
terventions, which range from various types and degrees of surveillance and
supervision to actual physical assistance. Also keep in mind, many nursing
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practices and interventions once thought to prevent falls, now outdated, are
found to either cause harm or are ineffectual in preventing falls, as in the case
of physical-restraint use. See chapter 22, Physical Restraints.
The most current evidenced-based research from systematic review and
meta-analysis of randomized controlled trials (until 2002) concludes that in-
dividualized multifactorial risk assessment combined with risk-reducing inter-
ventions are the most effective fall-prevention strategies (Chang et al., 2004
[Level I]). Further research on effective interventions applicable to in-patient
hospital settings support use of tailored exercise to improve gait and balance or
muscular strength (Close et al., 1999 [Level II]), geriatric consultationwithmed-
ication review and management (Ray et al., 1997 [Level II]), visual correction,
and patient education.
Instituting General Safety Measures
Hospitals have a legal responsibility to ensure that the facility is free from en-
vironmental hazards and safe for patients as well as staff and visitors. Routine
environmental assessment includes the unit, corridors, entrances, and exits, as
well as patient holding areas, patient rooms, and areas to which patient are
transported (e.g., radiology, nuclear imaging, operating room). In each area, an
environmental assessment is performed focusing on floor surfaces, furniture,
hallways, steps, safety devices (e.g., stretchers, wheelchairs, and other types of
chairs), clutter, bathrooms with appropriate grabrails, and routine assessment
of equipment. Use of a checklist signed by the designated employee allows for
audit review of compliance.
As part of general safety, some facilities designate any adult older than age
65 admitted to be on “safety precautions,” which can include various other safety
measures (discussed herein). Clinically, it is important to recognize—in advance,
whenever possible—that if instructions are given to patients for general safety
precautions, they are actually able to hear, understand, and demonstrate that
they can follow instructions. Simply “telling the older adult” to be careful or to not
get up without assistance is insufficient and negligent in the face of an ongoing
or new onset of delirium or cognitive impairment. Rather, other safety mea-
sures need to be immediately instituted, discussed with the team and the family
caregiver, and incorporated as part of the plan of care. Immediate options al-
ways include (1) increasing surveillance by either continuously staying with the
patient; (2)moving the patient to a closer location (provided there is a staffmem-
ber constantly observing the patient); (3) providing a one-on-one type of sitter
service for continual surveillance; or (4) engaging the older patient in activities
or other forms of recreation and therapeutic or diversional activity. Sitter-type
services can be provided by hospital staff, volunteers, or through private-duty
services. Discussion with family caregivers and the interdisciplinary team are
essential in these cases.
Exercise for Older Adults Who Fall
More than a decade of research evidence supports use of exercise in improving
muscular weakness, balance, and gait and in reducing the risk and incidence of
falls compared to control groups among older adults (Carter, Kannus, & Khan,
182 Chapter 9
2001 [Level I]). Specific use of exercise in older adults who are impaired has also
been found to be beneficial (Rubenstein et al., 2000 [Level II]). In the community,
exercise also has beneficial outcomes for older adults at risk. In a study using
a community-based exercise intervention, consisting of weekly group exercises
and ancillary home exercises, the rate of falls in the intervention group was
reduced by 40% compared to the control group (Barnett, Smith, Lord, Williams,
& Baumand, 2003 [Level II]). A narrative review of the epidemiological evidence
of prospective and case-control studies showed that higher levels of leisure-time
physical activity is associated with a 20% to 40% reduced risk of hip fracture
(Gregg, Pereira, & Caspersen, 2000 [Level V]).
Many opportunities exist for older adult patients in a hospital setting to ben-
efit from focal lower extremity strengthening exercises, offered through physi-
cal therapy, and/or more global types of exercise, such as walking and mobility
programs or group exercises and the use of a pool in rehabilitation hospitals.
Once a prescription is written, medical clearance may often be needed or a pre-
screening performed by the physical therapist. In the case initiating focal lower
extremity exercise for an identified “intrinsic fall risk factor,” referrals should
be made by the primary care provider because symptoms of lower extremity
weakness may be due to other coexisting but treatable illnesses. Two classic ex-
amples of treatable illness manifesting as “lower extremity weakness” (which
is considered an intrinsic risk factor) in an older adult are thyroid disease and
giant cell arteritis (i.e., polymyalgia rheumatica).
Hospitalized older adults carry an increased risk for co-morbidities, such
as coronary artery disease, vertigo, and dizziness, which are likely to require
a medical clearance prior to engaging in strenuous, aerobic types of exercise.
Falls among this population can also occur during exercise due to peripheral
neuropathy, particularly in diabetics who may be unable to sense their feet on
the floor.
A thorough assessment of co-morbidities in frail older adults can help to
minimize potential safety concerns or risks thatmay exist on the part of the clini-
cian. This is an important aspect of the overall decision to institute strenuous ex-
ercise in frail older adults but is beyond the scope of this chapter. Research evi-
dence supports use of strengthening, functional motor activities, and balance
exercises during rehabilitation in an outpatient hospital setting in high risk geri-
atric patients with a history of injurious falls (Hauer et al., 2001 [Level II]).
Early Mobility for Older Patients Who Fall
Early mobility, whenever the older patient is medically stable, is a fundamen-
tal and basic aspect of care for all older adult patients to receive during their
hospitalization. It is a step toward the prevention of deconditioning, reduced
mobility, and immobility and other cascading problems that can result when
less sedentary (e.g., statis pneumonia or atelectasis). Early mobility as an inter-
vention begins with the simple and conscious decision by nursing to assist the
patient out of bed to walk to the bathroom whenever possible rather than to use
a bedpan or even a bedside commode that offers little opportunity for mobility.
Wearing proper footwear, corrective lenses, and clearing a path that is clutter-
and spill-free are essential. Use of a walking aid such as a standard cane or
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walker may also be required; appropriate assistive devices can be ascertained
through an occupational or physical therapist (OT, PT) consultation.
Another essential aspect for older adults with co-morbidities is for nurses to
preemptively ask the older patients “Who is assisting you, from sitting to stand-
ing?” and then, while walking, “How are you feeling”? Of concern is the detec-
tion of symptoms such as lightheadedness, vertigo with rotational movement,
or muscular stiffness. If significant enough to prohibit mobility, these symptoms
can be managed and monitored once they are detected. Another concern exists
for older adult patients with OH. In this instance, gradual upright incline with
assistance while monitoring for symptoms of lightheadedness are important. If
an older adult experiences symptoms or develops acute physiological evidence
of a problem (e.g., near syncope, syncope, or changes in heart rate or blood pres-
sure), slowly easing the older adult back to a recumbent position and notifying
the physician for further evaluation is warranted.
Mobility programs build on the positive feedback that the patient is feeling
and objectively gaining strength each day that mobility is instituted. A check-
list can monitor progress and serve to validate clinical progression to the pa-
tient. Care must be taken, however, to remind persons who are restricted from
independent mobility to always wait for assistance. Recommendations are set
to a similar time each day and to use consistent staff.
Fall-Prevention Program
Fall prevention begins with an integrated and coordinated approach including
fall-risk determination and PFA to identify risk factors. Accurate documenta-
tion should be provided in the plan of care, nursing and interdisciplinary notes,
and other aspects of the medical record such as the problem-list to help to en-
sure communication and ongoingmonitoring. Reviewof fall-related information
collected about a fall event, or a person deemed at risk to fall by the interdis-
ciplinary team adds an important dimension to fall care. The team offers input
from their unique perspective of the fall circumstance and how to best manage
a fall or a patient at high risk for falls. The interdisciplinary team consists of the
medical provider (physician or advance practice nurse), nurse, PT or OT, risk
manager, pharmacist, and other direct health care providers.
Hospital-based fall-prevention programs have been described in the liter-
ature but few clinical trails have been conducted demonstrating their effective-
ness. One study examined the effect of a programof fall prevention that includes
multifactorail components of fall-risk assessment, a choice of interventions, pa-
tient and staff education, as well as labels or “graphics alerting others to at risk
patients.” Use of this model and its outcomes were examined prospectively for 5
years by Dempsey (2004 [Level IV]), who reported a significant reduction in fall
rates. However, over time, compliance deteriorated, warranting further nursing
inquiry considering use of a process approach to increase nurse autonomy in
fall prevention.
Some Best Practice Exemplars Used by Acute Care Hospitals
The difference between environmental safety assessment and safety rounds is
that the latter are a regular, systematic observation by one or two key personnel
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of the hospital unit; when assumed by the same personnel, hazardsmay bemore
quickly appreciated. Further, they occur at regular points in time, such as every
2 or 4 hours around the clock and also detect patients in need of assistance.
This level of frequency is likely to detect problems early so that intervention
can ensure the prevention of environmental type of falls. Use of a checklist can
help ensure compliance andmonitor for patterns and types of hazards that need
correction.
Many hospital-based fall-prevention programs include toileting rounds.
Toileting rounds utilize nurses’ aides to regularly assess older adult patients
for the need to urinate and to provide the patient with assistance. The purpose
of toileting rounds is to prevent patients from incurring urinary accidents (and
potential falls) by encouraging regular voiding. In many circumstances, urinary
accidents can lead to falls. Scenarios include the older adult sensing a need to
urinate, getting up out of bed unassisted, and incurring a fall by an unrecog-
nized physiologic mechanism (e.g., OH). Another scenario is en route to the
bathroom: the older adult has a urinary accident on the floor and slips and falls
on the wet floor. By offering toileting rounds on a regular basis, the potential for
these occurrences are minimized, reducing fall rates as well as the iatrogenic
complications (e.g., hip fracture). Toileting is a fundamental element of basic
care that has an important place in the prevention of patient falls but its im-
portance is under-recognized. In a study by Brown, Vittinghoff, & Wyman (2000
[Level III]), urge incontinence (and not stress), especially if occurring weekly
or more often, increased the risk of falls and nonspinal, nontraumatic fractures
in older White women living in the community.
Specific Nursing Interventions
Personal alarms are routinely used to alert nursing staff to impending falls or
changes in patient mobility status. Care should be taken when deciding to use
these devices because they do no prevent a fall from occurring; rather, they
heighten staff’s awareness by sounding an alarm, indicating that a change in
position has occurred. There are many commercial products available, but gen-
erally they are of two types: personal alarms clipped to a patient’s gown or chair
and bed-chair pressure sensors. Despite their widespread use, there is little
evidence as to their effectiveness in reducing falls in an acute care hospital set-
ting. Use of a bed-sensor alarm was studied in a geriatric rehabilitation unit
with older adult patients who were deemed by nurses to be at increased risk for
falling (Kwok, Mok, Chien, & Tam, 2006 [Level II]). In this study, the availability
of bed-sensor devices neither reduced physical-restraint use nor improved the
clinical outcomes of older adults with perceived fall risk. In a nursing home–
based study, however, use of the “NOC WATCH,” a nonintrusive monitor used
with older adults at high risk for falling (Kelly, Phillips, Cain, Polissar, & Kelly,
2002 [Level IV]), reduced the fall rate by 91%, thereby supporting other clinical
trails using a randomized design.
The use of both floor mats and low-rise beds has an important place in the
armamentarium of clinical interventions to prevent the occurrence of serious
injury when a bed fall occurs. Floor mats are simply placed surrounding the bed
and serve to cushion the impact of the fall. They vary in thickness and, if portions
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of an area are uncovered, substantial injury could still occur if a patient attempts
to get out of bed and a bed fall ensues. Little if any empirical research evidence
exists as to their effectiveness in preventing bed falls causing fractures to the hip
or TBI. Other common interventions used in hospitals also potentially relevant
in reducing serious injury in the aftermath from a bed fall are low-rise beds. In
principle, they shorten the height of the fall and thus potentially minimize any
serious injury. Theoretically, however, use of either floor mats or low-rise beds
could still result in serious injury in an older adult with co-morbidities such as
osteoporosis. More research is needed to explore this relationship.
The minimization of physical-restraint use has been the subject of case
reports and descriptive research in residential- and acute care facilities, with
few randomized controlled trials evaluating its effectiveness, especially in acute
care. See chapter 22, Physical Restraints and Side Rails in Acute and Critical Care
Settings, for an evidence-based review of restraints and side-rail use.
The standard of care recommends that older adults at risk for falling or who
have fallen be offered a hip protector, which is especially important in the acute
care setting, where limited scientific evidence exists to the contrary. Older adults
compliance for use of a hip protector is limited by issues related to the feasi-
bility of applying them and then getting them off quickly enough for toileting.
Esthetically, they may appear too bulky and cumbersome and thus be a deter-
rent to the potential user. Facilities may not even stock hip protectors, which
are not covered by Medicare and average an out-of-pocket expense of up to
$100 each. A recent meta-analysis of their effectiveness from studies conducted
in institutionalized settings or the community indicates that hip protectors are
an ineffective intervention for those living at home and that their effective-
ness in the institutional setting is uncertain (Parker, Gillespie, & Gillespie, 2006
[Level I]).
Technological advances have offered staff and patients a greater variety of
solutions to the problem of falling. Improvements have occurred with walking
aides such as canes that “talk” and provide feedback to the user, balance re-
training that helps patients learn about where their body is in space and how
to compensate for muscular impairments, and other types of equipment used at
the bedside when transitioning patients. Although these devices are available,
research is evolving and limited in terms of their effectiveness in fall prevention
(Nelson et al., 2004 [Level VI]).
An integral component of any fall-prevention educational intervention for
hospitalized older adults or preparing for discharge home concerns their work-
ing knowledge of what caused their fall and what can be done about it. Explor-
ing the older adults’ beliefs and attitudes is important and can lead to dispelling
myths they may hold about falling (e.g., it is a normal part of aging or that noth-
ing can be done about it). An older person’s view and conceptualization about
falling is a starting point for a tailored educational intervention. A systematic
review of the literature of many studies examining older adults’ preferences,
views, and experiences relative to fall-prevention strategies reported several
important findings (McInnes & Askie, 2004 [Level I]): (1) in clinical practice,
it is important to consult with individuals to find out what they are willing to
modify; and (2) what changes they are prepared to make to reduce their risk of
falling. Otherwise, they may not attend fall-prevention educational programs.
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Case Study and Discussion
Mrs. S. is an 80-year-old White female admitted to the step-down rehabil-
itation unit at the hospital following a 3-week admission for treatment of
a community-acquired pneumonia. Mrs. S. received IV antibiotics and flu-
ids for management of the infiltrate and associated dehydration. Mrs. S.’s
hospitalization was complicated by development of acute confusion, which
escalated following use of IV theophylline and Atrovent and Proventil neb-
ulizers. Mrs. S. also developed a deep-vein thrombosis of the leg, which was
treated with IV heparin, and she now receives Coumadin. Mrs. S.’s fall-risk
score was significant for visual impairment due to a cataract, delirium, fo-
cal lower extremity weakness due to osteoarthritis, chronic obstructive lung
disease, osteoporosis, and forgetfulness with short-term memory loss.
Prior to this hospitalization, Mrs. S. was functioning independently in
her home until her son and daughter found her on the floor, mildly confused
and disoriented, complaining of dizziness. Mrs. S. was transported to the
emergency room for further evaluation. Shewas diagnosedwith a right-lung
infiltrate via chest x-ray andmoderate to severe dehydration. An IV line was
started, and she was treated with antibiotics and admitted for observation. A
12-lead EKG showed a sinus bradycardia at 54 beats per minute. A CT scan
of the head was not performed; instead, Mrs. S. was placed on observation
and admitted to a medical–surgical unit.
After the 3-week-long hospitalization, Mrs. S. is transferred via
wheelchair to the rehabilitation unit. During the admission assessment, you
note Mrs. S.’s total fall-risk score increased by 4 points due to increased
confusion and disorientation, periods of restlessness, and reduced mobil-
ity. Mrs. S.’s vital signs are stable. You learn from the nursing report that
Mrs. S. needs constant supervision or she wanders off the unit. During the
physical examination, you are paged overhead and respond by going to the
nursing station. When you return to examine Mrs. S., she is gone. A second
overhead page is called “stat” for assistance on your unit. Apparently, Mrs.
S. was found sitting on the floor outside of the elevator, complaining of pain
in her right hip and right ankle.
The immediate post-fall assessment shows possible loss of conscious-
ness because Mrs. S. was observed unresponsive for a few seconds. There
is evidence of a head injury with a laceration and hematoma to the scalp, as
well as right lower leg pain and swelling. Mrs. S.’s sitting BP is 80/50 and her
pulse is 60, regular but weak. Ice is applied to her scalp and her leg is im-
mobilized. The physician is notified immediately and a STAT CT scan of the
head is ordered, which later confirmed an acute intracranial bleed. Mrs. S. is
prepared for cranial surgery and then hip-fracture repair the following day.
1. What nursing actions should have been taken to prevent the fall and
serious injury?
Mrs. S. is at high risk for serious injury due to her fall-risk screen score and
use of an anticoagulation medication, Coumadin. The standard of practice
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for caring for an older adult hospitalized with increased risk for falls with se-
rious injury requires the nurse to recognize that this patient is likely to have
impaired judgment and inability to follow directions due to her disorienta-
tion, relocation to a new unit, and evidence of restlessness. Because she is
ambulatory but forgetful, this creates a situation in which the patient needs
constant supervision. Mrs. S. should be allowed to ambulate but only with 1:1
supervision and/or physical assistance whenever possible. The nurse failed
to recognize the importance of providing constant supervision to the patient.
Actions that should have been undertaken include constant supervision by
support staff, such as volunteers and/or a special assignment of a nurse’s aide
to stay with the patient. Family would need to be notified of this decision and
to enlist their support for considering a private-duty nursing assistant. Acute
confusion or delirium rendersMrs. S. unsafe tomake the necessary decisions
or judgments about her care.
In terms of preventing serious injury, Mrs. S. should be offered a hip
protector, which are indicated in the standard of practice, especially for older
adults who are deemed of high risk for fracture. Osteoporotic older adults
who fall are likely to fracture an extremity or incur serious injury. Thus, the
standard of practice also calls for the use of a low-rise bed and floor mats in
the event of a potential bed fall. Anticipating the patient’s needs by regular
rounds and toileting can help prevent urinary accidents and/or falls en route
to the bathroom.
It is imperative for Mrs. S.’s mobility that she be allowed to continue to
move freely and ambulate, provided she is supervised and/or assisted be-
cause of her disorientation. Daily walking on the unit, in the patient’s room,
and whenever possible to increase mobility is essential.
2. How should the nursing assessment be focused?
Further assessment for reversible causes of delirium is warranted. Because
the Theophylline and Atrovent may have exacerbated the confusion, thus
they may need to be discontinued. A pharmacy consultation as part of
the interdisciplinary assessment would be appropriate. Alternative respi-
ratory interventions for increased pulmonary secretions such as clapping,
postural drainage deep breathing, and use of an inspirometery could be
instituted.
Further assessment of Mrs. S.’s falls (i.e., a fall evaluation) is clinically
indicated. She has had two falls recently, one at home and one at the hospital.
The etiology of these falls is not clear. The history of “being dazed” occurring
in both falls warrants additional workup. In the emergency room, the patient
did not receive a CT scan of her head. The fall evaluation includes, among
other tests, a 24-hour Holter monitor. A consultation with a geriatrician and
/or neurologist is clinically warranted.
Summary
Fall prevention is a shared responsibility by all health care providers and pro-
fessionals caring for older adult patients. National recommendations exist to
guide practice and should be routinely incorporated into any fall-prevention
program and practice policy. Some of the evidence-based research presented
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in this chapter can help clinicians make choices about the most efficacious or
effective interventions, remembering that this choice changes with changes in
the patient’s condition. Therefore, selecting the most appropriate intervention
will always depend on what the nursing and medical assessment determine
the likely cause of the fall to be and the medical stability of the patient at that
time. Among older adults with advanced years of age with complex illness and
multiple co-morbidites and geriatric syndromes, this determination becomes in-
creasinglymore challenging but not impossible to determine. The safety of older
adults in the hospital and continuing on discharge to home depends on contin-
ual assessment and reevaluation of their condition coupled with education, use
of the most effective and safest technology, and the older adult’s knowledge and
willingness to participate in evidenced-based care.
Resources
ACE Units
www.NICHE.org
Patient Safety Goals for Fall Prevention
http://www.jointcommission.org/PatientSafety/NationalPateintsSafetyGoals
Evidenced-Based Clinical Practice Guidelines for Falls Prevention
http://www.ngc.gov/search/searchresults.aspx?Type=3&txtSearch=falls+
prevention&num=20
Clinical Practice Guidelines for Falls Prevention
http://www.amda.com/clinical/falls
http://www.americangeriatrics.org/products/postionpapers/Falls.pdf
Fall Prevention Strategies in Healthcare Settings
http://www.ecri.org
Best Practice Examples Related to Falls Prevention
Institute for Healthcare Improvement http://www.ihi.org National Center for
Injury Prevention and Control What You Can Do to Prevent Falls: Senior
Falls, A Toolkit to Prevent Falls http://www.cdc.gov/ncipc/pub-res/toolkit/
WhatYouCanDoToPreventFalls.htm Accessed May 9, 2007.
Medical Standards and Guidelines
Clinical Guidelines for the Assessment and Implementation of Bedrails in Hos-
pitals, Long Term Care Facilities http://www.medmalrx.com Accessed May
9, 2007
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Box 9.1
Nursing Standard of Practice Protocol: Fall Prevention
I. GOALS
A. Prevent falls and serious injury outcomes in hospitalized older adults.
B. Recognize multifactorial risks and causes of falls in older adults.
C. Institute recommendations for falls prevention and management
consistent with clinical practice guidelines and standards of care.
II. OVERVIEW
Falls among older adults are not a normal consequence of aging; rather,
they are considered a geriatric syndromemost often due to discretemul-
tifactorial and interacting, predisposing (intrinsic and extrinsic risks),
and precipitating (dizziness, syncope) causes (Rubenstein & Josephson,
2006 [Level I]; Gray-Miceli et al., 2005 [Level VI]). Fall epidemiology
varies according to clinical setting. In acute care, fall incidence ranges
from 2.3 to 7 falls per 1,000 patient days depending on the unit (Fletcher,
2005). Nearly one-third of older adults living in the community fall each
year in their home. The highest fall incidence occurs in the institutional
long term care setting (i.e., nursing home), where 50% to 75% of the
1.63 million nursing home residents experience a fall yearly. Falls rank
as the eighth leading cause of unintentional injury for older Americans
and were responsible for more than 16,000 deaths in 2006 (CDC, NCIPC,
2007 [Level VI]).
III. BACKGROUND AND STATEMENT OF THE PROBLEM
A. Definition
1. Fall: A fall is an unexpected event in which the participant comes
to rest on the ground, floor, or lower level (ProFaNE, 2006 [Level
VI]).
B. Fall Etiology
1. Fall risk factors include intrinsic risks of cognitive, vision, gait
or balance impairment, high risk/contraindicated medications,
and/or the extrinsic risks of assistive devices, inappropriate
footwear, restraint, use of nonsturdy furniture or equipment, poor
lighting, uneven or slippery surfaces (Chang et al., 2004 [Level I]).
2. Fall causes include, among others, orthostatic hypotension, ar-
rhythmia, infection, generalized or focal muscular weakness, syn-
cope, seizure, hypoglycemia, neuropathy, and medication.
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IV. PARAMETERS OF ASSESSMENT
A. Assess and document all older adult patients for intrinsic risk factors
to fall:
1. Advancing age, especially if older than 75
2. History of a recent fall
3. Specific co-morbidities: dementia, hip fracture, Type II diabetes,
Parkinson’s disease, arthritis, and depression
4. Functional disability: use of assistive device
5. Alteration in level of consciousness or cognitive impairment
6. Gait, balance, or visual impairment
7. Use of high risk medications (Chang et al., 2004 [Level I])
8. Urge urinary incontinence (Brown, Vittinghoff, & Wyman, 2000
[Level III])
9. Physical restraint use (Capezuti, Maislin, Strumpf, & Evans, 2002
[Level III])
10. Bare feet or inappropriate footwear
11. Identify risks for significant injury due to current use of antico-
agulants such as Coumadin, Plavix, or aspirin and/or those with
osteoporosis or risks for osteoporosis (Resnick, 2003 [Level VI])
B. Assess and document patient-care environment routinely for extrin-
sic risk factors to fall and institute corrective action:
1. Floor surfaces for spills, wet areas, unevenness
2. Proper level of illumination and functioning of lights (night light
works)
3. Table tops, furniture, beds are sturdy and are in good repair
4. Grabrails and grabbars are in place in the bathroom
5. Use of adaptive aides work properly and are in good repair
6. Bedrails do not collapse when used for transitioning or support
7. Patient gowns/clothing do not cause tripping
8. IV poles are sturdy if used during ambulation and tubing does not
cause tripping
C. Perform a PFA following a patient fall to identify possible fall causes
(if possible, begin the identification of possible causes within 24
hours of a fall) as determined during the immediate, interim, and
longitudinal post-fall intervals. Because of known incidences of de-
layed complication of falls, including fractures, observe all patients
for about 48 hours after an observed or suspected fall (AGS, 2001
[Level VI]; ECRI, 2006 [Level VI]; Gray-Miceli et al., 2006 [Level
III]):
1. Perform a physical assessment of the patient at the time of the fall,
including vital signs (whichmay include orthostatic bloodpressure
readings), neurological assessment, and evaluation for head, neck,
spine, and/or extremity injuries.
2. Once the assessment rules out any significant injury:
a. obtain a history of the fall by the patient or witness description
and document
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b. note the circumstances of the fall: location, activity, time of day,
and any significant symptoms
c. review of underlying illness and problems
d. review medications
e. assess functional, sensory, and psychological status
f. evaluate environmental conditions
g. review risk factors for falling (AGS, 2001; AMDA, 1998; ECRI,
2006; UIGN, 2004; Resnick, 2003 [all Level VI])
D. In the acute care setting, an integrated multidisciplinary team (con-
sisting of the physician, nurse, health care provider, risk manager,
physical therapist, and other designated staff) plans care for the older
adult, at risk for falls or who has fallen, hinged on findings from an in-
dividualized assessment (ECRI, 2006; JCAHO, 2006 [both Level VI]).
E. The process approach to an individualized PFA includes use of stan-
dardized measurement tools of patient risk in combination with a
fall-focused history and physical examination, functional assess-
ment, and review of medications (AGS, 2001; AMDA, 1998; Resnick,
2003; UIGN, 2004 [all Level VI]). When plans of care are targeted to
likely causes, individualized interventions are likely to be identified.
If falling continues despite attempts at individualized interventions,
the standard of care warrants a reexamination of the older adult and
their falls
V. NURSING CARE STRATEGIES
A. General safety precaution and fall prevention measures that apply to
all patients, especially older adults:
1. Assess the patient care environment routinely for extrinsic risk
factors and institute appropriate corrective action.
a. Use standardized environmental checklists to screen; document
findings.
b. Communicate findings to risk managers, housekeeping, main-
tenance department, all staff and hospital administration, if
needed.
c. Reevaluate environment for safety (ECRI, 2006 [Level VI]).
2. On admission, assess/screen older adult patient for multifactorial
risk factors to fall, following a change in condition, on transfer to
a new unit, and following a fall (ECRI, 2006 [Level VI]):
a. Use standardized or empirically tested fall-risk tools in con-
junction with other assessment tools to evaluate risk for falling
(e.g., Tinetti Performance Oriented Mobility, The Timed Get Up
and Go Test; AGS, 2001 [Level VI]).
b. Document findings in nursing notes, interdisciplinary progress
notes, and the problem list.
c. Communicate and discuss findings with interdisciplinary team
members.
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d. In the interdisciplinary discussion, include review and reduc-
tion or elimination of high risk medications associated with
falling.
e. As part of falls protocol in the facility, flag the chart or
use graphic or color display of the patient’s risk potential to
fall.
f. Communicate to the patient and the family caregiver identified
risk to fall and specific interventions chosen to minimize the
patient’s risk.
g. Include patient and family members in the interdisciplinary
plan of care and discussion about fall-prevention measures.
h. Promote early mobility and incorporate measures to increase
mobility, such as daily walking, if medically stable and not oth-
erwise contraindicated.
i. Upon transfer to another unit, communicate the risk assess-
ment and interventions chosen and their effectiveness in fall
prevention.
j. Upon discharge, review with the older patient and or family
caregiver the fall risk factors and measures to prevent falls in
the home. Provide patient literature/brochures if available. If
not readily available, refer to the Internet for appropriate Web
sites and resources.
k. Explore with the older patient and/or family caregiver avenues
to maintain mobility and functional status; consider referral to
home-based exercise or group exercises at community senior
centers. If discharge is planned to a subacute or rehabilitation
unit, label the older adult’s mobility status, functional status,
and other forms of activity in the home to increase gait or bal-
ance on the transfer form.
3. Institute general safety precautions according to facility protocol,
which may include:
a. Referral to a falls-prevention program
b. Use of a low-rise bed that measures 14 inches from floor
c. Use of floor mats if patient is at risk for serious injury, such as
osteoporosis
d. Easy access to call light
e. Minimization and/or avoidance of physical restraints
f. Use of personal or pressure sensors alarms
g. Increased observation and surveillance
h. Use of rubber-soled healed shoes or nonskid slippers
i. Regular toileting at set intervals and/or continence program;
provide easy access to urinals and bedpans
j. Observation during walking rounds or safety rounds
k. Use of corrective glasses for walking
l. Reduction of clutter in traffic areas
m.Early mobility program (ECRI, 2006 [Level VI])
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4. Provide staff with clear, written procedures describing what to do
when a patient fall occurs.
B. Identify specific patients requiring additional safety precautions
and/or evaluation by a specialist, or:
1. those with impaired judgment or thinking due to acute or chronic
illness (delirium, mental illness)
2. those with osteoporosis, at risk for fracture
3. those with current hip fracture
4. those with current head or brain injury (standard of care)
C. Review and discuss with interdisciplinary team findings from the in-
dividualized assessment and develop a multidisciplinary plan of care
to prevent falls (Chang et al., 2004 [Level I]).
1. Communicate to the physician or advance practice nurse impor-
tant PFA findings (ECRI, 2006 [Level VI]).
2. Monitor the effectiveness of the falls prevention interventions in-
stituted.
3. Following a patient’s fall, observe for serious injury due to a
fall and follow facility protocols for management (standard of
care).
4. Following a patient’s fall, monitor vital signs, level of conscious-
ness, neurological checks, and functional status per facility pro-
tocol. If significant changes in patient’s condition occurs, consider
further diagnostic tests such as plain film x-rays, CT scan of the
head/spine/extremity, neurological consultation, and /or transfer
to a specialty unit for further evaluation (standard of care).
VI. EVALUATION/EXPECTED OUTCOMES
A. Patient:
1. Safety will be maintained.
2. Falls will be avoided.
3. Will not develop serious injury outcomes from a fall if it occurs.
4. Will know their risks for falling.
5. Will be prepared on discharge to prevent falls in their homes.
6. Prehospitalization level of mobility will continue.
7. Who develops fall-related complications such as injury or change
in cognitive function will be promptly assessed and treated to pre-
vent adverse outcomes.
B. Nursing Staff:
1. Will be able to accurately detect, refer, and manage older adults at
risk for falling or who have experienced a fall.
2. Will integrate into their practice comprehensive assessment and
management approaches for falls prevention in the institution.
3. Will gain appreciation for older adults’ unique experience of
falling and how it influences their daily living, functional, phys-
ical, and emotional status.
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4. Will educate older adult patients anticipating discharge about falls
prevention strategies.
VII. FOLLOW-UP MONITORING OF CONDITION
A. Monitor fall incidence and incidences of patient injury due to a fall,
comparing rates on the same unit over time.
B. Compare falls per patient month against national benchmarks avail-
able in the National Database of Nursing Quality Indicators.
C. Incorporate continuous quality improvement criteria into falls pre-
vention program.
D. Identify falls teammembers and roles of clinical and nonclinical staff
(ECRI, 2006 [Level VI]).
E. Educate patient and family caregivers about falls prevention strate-
gies so they are prepared for discharge (JHF, 2003 [Level VI]; UIGN,
2004 [Level VI]).
VIII. RELEVANT PRACTICE GUIDELINES
A. American Geriatrics Society, British Geriatrics Society, American
Academy of Orthopedic Surgeons (AGS/BGS/AAOS) Guidelines for
the Prevention of Falls in Older Persons (2001). Journal of American
Geriatrics Society, 49, 664–672. Evidence Level VI: Expert Opinion.
B. American Medical Directors Association (AMDA). Falls and fall risk.
Columbia, MD: American Medical Directors Association. Evidence
Level VI: Expert Opinion.
C. University of Iowa Gerontological Nursing Interventions Research
Center (UIGN). (2004). Falls prevention for older adults. IowaCity, IA:
University of Iowa Gerontological Nursing Interventions Research
Center, Research Dissemination Core. Evidence Level VI: Expert
Opinion.
D. ECRI Institute: Falls Prevention Strategies in Healthcare Settings
(2006). Plymouth Meeting, PA. Evidence Level VI: Expert Opinion.
E. Resnick, B. (2003). Preventing falls in acute care. In: M. Mezey, T.
Fulmer, I. Abraham (Managing Ed.) & D. Zwicker (Eds.). Geriatric
nursing protocols for best practice (2nd ed., pp. 141–164). New York:
Springer Publishing Company, Inc. Evidence Level VI: Expert Opin-
ion.
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Educational
Objectives
At the completion of this chapter, the reader will be
able to:
1. discuss the importance of effective pain
management for older adults
2. describe best methods of assessing pain
3. discuss pharmacological and nonpharmacological
strategies for managing pain
4. state at least two key points to include in education
for patients and families
Background and Significance
Physical pain is a significant problem for many older adults. It has been esti-
mated that at least 50% of community-dwelling older adults suffer from pain
(Herr, 2002a; Sha et al., 2005), and among nursing home residents, as many as
85% reportedly experience pain (AmericanGeriatrics Society [AGS], 2002 [Level
VI]; Thomas, Flaherty, & Morley, 2001).
The high prevalence of pain is primarily related to the high rate of chronic
health disorders among older adults, particularly painful musculoskeletal
For a description of Evidence Levels cited in this chapter, see chapter 1,
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conditions such as arthritis, gout, and peripheral vascular disease (Helme &
Gibson, 1999). In addition, there is a high prevalence of more acute conditions,
such as cardiovascular disease or infection, and other painful medical diseases
and syndromes in this age group (Feldt, Warne, & Ryden, 1998). Cancer, in par-
ticular, is associated with significant pain for one-third of patients with active
disease and for two-thirds of those with advanced disease (Reiner & Lacasse,
2006 [Level I]). Thus, pain among older adults is quite common and also of-
ten complicated by the concomitant presence of different types, locations, and
causes of pain.
Why is knowledge about pain in older adults so important?There are several
key reasons. First, pain hasmajor implications for older adults’ health, function-
ing, and quality of life (AGS, 2002 [Level VI]) and is associated with depression,
withdrawal, sleep disturbances, impaired mobility, decreased activity engage-
ment, and increased health care use (Gordon et al., 2002 [Level I]; Herr, 2002a).
Other geriatric conditions that can be exacerbated by pain include falls, decon-
ditioning, malnutrition, gait disturbances, and slowed rehabilitation (AGS, 2002
[Level VI]; Gordon et al., 2002 [Level I]). Thus, pain has major implications for
physical, functional, and mental health among older adults.
Second, nurses have a key role in assessing and managing pain. The pro-
motion of comfort and relief of pain is fundamental to nursing practice and, as
integral members of interdisciplinary health care teams, nurses must work ef-
fectively to both assess and treat pain. Given that the prevalence of pain in older
adults is substantially higher than among younger adults, this nursing role be-
comes increasingly important in the older population. In addition, nurses have
the primary responsibility to teach the patient and family about pain and how to
manage it, both pharmacologically and nonpharmacologically. As such, nurses
must be knowledgeable about painmanagement in general and aboutmanaging
pain in older adults in particular.
Third, the Joint Commission on Accreditation of Healthcare Organizations
(JCAHO), the accrediting body for health care organizations that provide di-
rect care, mandates pain assessment and management as part of the survey and
accreditation process (JCAHO, 2001). The Joint Commission declared that “pa-
tients have the right to appropriate assessment and management of pain” and
considers pain as the fifth vital sign (JCAHO, 2001). Thus, provider compliance
with regulatory guidelines about pain management helps guarantee patients’
rights, but this does not address pain management needs of older adults expe-
riencing significant pain unless they are hospitalized.
Definitions of Pain
Pain is a multidimensional, subjective experience with sensory, cognitive, and
emotional dimensions (AGS, 2002 [Level VI]); Melzack & Casey, 1968). For clin-
ical practice, McCaffery’s classic definition of pain is perhaps the most relevant.
She states, “Pain is whatever the experiencing person says it is, existing when-
ever he says it does” (McCaffery, 1968;McCaffery&Pasero, 1999). This definition
serves as a reminder that pain is highly subjective and that patients’ self-report
and description of pain is paramount in the pain assessment process.
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Types of Pain
There are several different types and classifications of pain. The most ba-
sic distinction is whether the pain is acute or persistent (e.g., chronic pain).
Although persistent pain and chronic pain have been used interchangeably,
the term persistent pain has recently been adopted because it is believed to
have fewer negative connotations (AGS, 2002 [Level VI]; Weiner, Herr, & Rudy,
2002).
Acute pain results from an injury, surgery, or disease-related tissue damage
(Panda & Desbiens, 2001). Usually associated with autonomic activity, such as
tachycardia and diaphoresis, acute pain is usually relatively brief and subsides
with healing. In contrast, persistent pain is defined as a painful experience that
continues for a prolonged period of time (usually more than 3 to 6 months)
(AGS, 2002 [Level VI]; Harkins, 2002). Persistent pain may or may not be as-
sociated with a diagnosable disease process and autonomic activity is usually
absent (AGS, 2002 [Level VI]; Panda & Desbiens, 2001). Persistent pain can lead
to functional loss, reduced quality of life, and mood and behavior changes, es-
pecially when it is untreated (Gordon et al., 2002 [Level I]). Persistent and acute
pain often coexist among older adults due to high rates of co-morbidity.
Pain is further classified as either nociceptive or neuropathic, depending on
the cause. Nociceptive pain results from disease processes (e.g., osteoarthritis),
soft-tissue injuries (e.g., falls), and medical treatment (e.g., surgery, venipunc-
ture, and other procedures) and is associatedwith stimulation of specific periph-
eral or visceral receptors. Nociceptive pain is usually localized and responsive
to treatment. Neuropathic pain, caused by pathology in the peripheral or cen-
tral nervous system, is often associated with diabetic neuropathies, phantom-
limb pain, post-herpetic and trigeminal neuralgias, stroke, and chemotherapy
treatment for cancer. Neuropathic pain is more diffuse and less responsive to
analgesics. However, these pain types often overlap and are not always clearly
differentiated.
Pain Assessment Strategies
Despite the prevalence and consequences of pain, evidence suggests that pain
is under-detected and poorly managed among older adults (Horgas & Tsai,
1998 [Level IV]; Miller, Nelson, & Mezey, 2000; Smith, 2005 [Level I]). There
are several factors that contribute to this situation, including individual- and
caregiver-based factors. Individual factors that may impair pain assessment in-
clude (1) belief that pain is a normal part of aging, (2) concern of being labeled a
hypochondriac or complainer, (3) fear of the meaning of pain relative to disease
progression or prognosis, (4) fear of narcotic addiction and analgesics, (5) worry
about health care costs, and (6) a belief that pain is not important to health
care providers (AGS, 2002 [Level VI]; Gordon et al., 2002 [Level I]). Other fac-
tors, such as hearing and speech difficulties, may prevent older adults from
effectively communicating pain to health care providers (Feldt et al., 1998). In
addition, cognitive impairment is an important factor in reducing older adults’
ability to report pain (Smith, 2005 [Level I]).
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Pain detection and management are also influenced by provider-based fac-
tors. Health care providers have been found to share the mistaken belief that
pain is a part of the normal aging process and to avoid using opioids due to fear
about potential addiction and adverse side effects (Wells, Kaas, & Feldt, 1997).
Similarly, cognitive status influences providers’ assessment and treatment of
pain. For instance, it has been found that cognitively impaired nursing home
residents were prescribed and administered significantly less analgesic med-
ication than were cognitively intact older adults (Horgas & Tsai, 1998 [Level
IV]). This finding may reflect cognitively impaired adults’ inability to recall and
report the presence of pain to their health care providers. It may also reflect
caregivers’ inability to detect pain, especially among frail older adults. In one
nursing home study, it was found that patients’ and caregivers’ reports of pain
were congruent in only about one-third of cases (Horgas & Dunn, 2001 [Level
IV]). Furthermore, it was noted that depression was highest in residents for
whom pain was not perceived by their caregivers. Pain assessment and man-
agement can be a complicated clinical issue. Health care providers should face
the challenge of pain assessment by first systematically examining their own
biases and beliefs about pain and eliciting and understanding the challenges
and beliefs their patients bring to the situation as well.
Self-Reported Pain
There is no objective biological marker or laboratory test for the presence of
pain. Thus, the most accurate and reliable measure of pain is the patient’s
self-report. This is also consistent with the definition provided earlier in this
chapter—that pain is defined as “whatever the experiencing person says it is, ex-
isting whenever he [or she] says it does” (McCaffery, 1968; McCaffery & Pasero,
1999). Evidence suggests that patients with mild to moderate cognitive impair-
ment can report their pain when asked clear questions and given sufficient time
to respond (Ferrell, Ferell, & Rivera, 1995 [Level IV]).
The first principle of pain assessment is to ask about the presence of pain in
regular and frequent intervals (AGS, 2002 [Level VI]). It is mandatory to allow
patients sufficient time to consider questions and formulate answers, especially
when working with cognitively impaired older adults. It is also important to
explore different words that patients may use synonymously with pain, such as
discomfort or aching.
Pain intensity can be measured in various ways. Some commonly used tools
include the visual analog scale (VAS), the verbal descriptor scale, and the faces
scale (Herr, 2002a). In the VAS, widely used in hospital settings, patients are
asked to rate the intensity of their pain on a 0 to 10 scale. The VAS requires
the ability to discriminate subtle differences in pain intensity and may be dif-
ficult for some older adults to complete. The verbal descriptor scale, however,
has been specifically recommended for use with older adults (Herr, 2002a). This
tool measures pain intensity by asking participants to select a word that best
describes their present pain (e.g., no pain to worst pain imaginable). This mea-
sure has been found to be a reliable and valid measure of pain intensity and is
reported to be the easiest to complete and the most preferred by older adults
(Taylor, Harris, Epps, & Herr, 2005 [Level V]). Pictures of faces (i.e., the faces
scales) are also used to measure pain intensity, especially among cognitively
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impaired older adults. The Faces Pain Scale (FPS), initially developed to assess
pain intensity in children, consists of seven cartoon facial depictions, ranging
from the least pain to themost pain possible (Bieri, Reeve, Champion, Addicoat,
& Ziegler, 1990). Among adults, the FPS is considered more appropriate than
other pictorial scales because the cartoon faces are not age-, gender-, or race-
specific. However, the FPS has relatively low reliability and validity when used
among older adults with cognitive impairment and is not recommended for use
in this population (Taylor et al., 2005 [Level V]). See the Resources section for
information on accessing these measurement tools.
Observed Pain Indicators
Because some older adults cannot adequately report pain due to dementia and
deficits such as compromised cognitive and verbal skills (i.e., memory loss, loss
of judgment, confusion, and attention and language deficits), observational as-
sessment of pain behaviors is often necessary. Several researchers have devel-
oped methods to directly observe pain behaviors (Feldt, 2000; Hurley, Volicer,
Hanrahan, House, &Volicer, 1992; Keefe & Block, 1982; Snow et al., 2004). These
methods include recognizing behaviors such as guarded movement, bracing,
rubbing the affected area, grimacing, painful noises or words, and restlessness.
For instance, Hurley and colleagues (1992) developed theDiscomfort Scale-DAT
to assess discomfort in persons with advanced Alzheimer’s disease. They identi-
fiednine indicators of discomfort associatedwith fever: noisy breathing, absence
of a look of contentment, looking sad, looking frightened, frowning, absence of a
relaxed body posture, looking tense, negative vocalizations, and fidgeting. This
measure, however, has been reported to require significant training and to be too
complex for routine nursing care (Miller, Moore, Schofield, & Ng’andu, 1996).
Feldt and colleagues developed the Checklist for Nonverbal Pain Behaviors to
assess the presence of six pain behaviors during rest andmovement (Feldt et al.,
1998). This tool is based on naturalistic observations of hospitalized older adults,
has shown high inter rater reliability (93% agreement; Kappa = 0.63 − 0.82),
and is positively associated with self-reports of pain (Feldt, 2000). More re-
cently, Snow and colleagues developed the NOPPAIN scale for assessing pain
in noncommunicative nursing home residents (Snow et al., 2004). The NOP-
PAIN is used by certified nursing assistants to rate the presence and intensity of
pain among residents following usual care activities. The results of preliminary
studies testing the NOPPAIN indicate that it is reliable and valid but that fur-
ther testing is needed in different clinical settings (Taylor et al., 2005 [Level VI]).
Taken together, several tools are available to measure behavioral indicators of
pain, but all of them need further development and testing before they can be
adopted for widespread use in clinical practice (Herr, Bjoro, & Decker, 2006
[Level I]).
In summary, pain assessment is a clinical procedure that can be hampered
by many factors. Systematic and thorough assessment, however, is a critical
first step in appropriately managing pain in older adults. Assessment issues are
summarized in the recommended painmanagement protocol. The use of a stan-
dardized pain assessment tool is important in measuring pain: it enables health
care providers to document their assessment; measure change in pain; evaluate
treatment effectiveness; and communicate to other health care providers, the
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patient, and the family. Comprehensive pain assessment includes measures of
self-reported pain and pain behaviors and includes information from patients
and families as well.
Pain Management Strategies
Managing pain in older adults can be a challenging process. The main goal
is to maximize function and quality of life (Herr, 2002b) by minimizing pain
whenever possible (WisconsinMedical SocietyTaskForce onPainManagement,
2004 [Level VI]). Pain treatments that use a multidimensional approach and
are tailored to the patient, however, are often effective (Gibson, Farrell, Katz, &
Helme, 1996). Thus, a combination of pharmacological and nonpharmacological
strategies should be used to ease the pain.
Several excellent pain assessment protocols have been developed for use
with older adults. For instance, the American Geriatrics Society (AGS) pub-
lished clinical practice guidelines for managing persistent pain in older adults
(AGS, 2002 [Level VI]) and evidence-based exercise practice recommenda-
tions for older adults with osteoarthritis pain (AGS, 2001 [Level VI]). These
guidelines provide comprehensive information specific to the needs of geri-
atric patients. In addition, there are other published guidelines for the man-
agement of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic
arthritis (American Pain Society, 2002) and for the relief of cancer pain (Amer-
ican Pain Society, 2005; World Health Organization, 1996). These guidelines
are disease-specific, rather than age-group specific but provide comprehen-
sive information for managing these chronic pain conditions. See the Treat-
ment Guidelines section of Box 10.1 for information on how to access this infor-
mation.
Pharmacological Pain Treatment
Pain treatment with medications involves a complex decision-making process
based on multiple considerations. Ideally, it is a mutual process among health
care providers, patients, and caregivers. It includes a careful discussion of risks
versus benefits, frequent reviews of drug regimens used by older adults, and the
establishment of clear goals of therapy. Often it is a process of trial and error
that aims to balance medication effectiveness with management of side effects.
Other considerations included in the process are frequency of use, type of pain,
severity of pain, duration of treatment, and cost.
TheWorldHealthOrganization (WHO, 1996) provides a three-step analgesic
ladder that has been widely used as a guide for treating cancer pain. Choices are
made from three drug categories based on three levels of pain severity: nono-
pioids, opioids, and adjuvant agents. Combinations of drugs are used because
two ormore drugs can treat different underlying painmechanisms and different
types of pain and allow for smaller doses of each analgesic to be used, thus min-
imizing side effects. The WHO (1996) recommends choosing analgesics based
on the principles of by mouth, by the clock, by the ladder, for the individual, and
attention to detail. These principles can be applied to effectively manage per-
sistent noncancer pain. Adjuvant drugs are those with a primary purpose other
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than pain relief but that can be used for analgesic effects in certain painful
conditions (AGS, 2002 [Level VI]).
Special Considerations for Administering Analgesics
Older adults are at higher risk for side effects with drug therapies due to age-
related physiologic decline in drug metabolism and elimination. Specific age-
related changes influence the pharmacodynamics (i.e., mechanisms of drug
action in the body) and pharmacokinetics (i.e., processes of drug absorption,
distribution, metabolism, and elimination in the body) of medications (Buxton,
2006). Some pharmacokinetic changes with advanced age include altered body
composition (e.g., decreased lean body mass and total body water, increased
percentages of body fat) and changes in function of drug-eliminating organs
(e.g., declined renal function, reduced hepatic blood flow with reduction of
serum albumin and certain drug-metabolizing enzymes). Some pharmacody-
namic changes in older adults are due in part to physiological changes and
decreased homeostatic resilience. These changes can result in increased drug
side effects (Nies, 2001).
Recommendations for beginning medication treatment include starting at
low doses and gradually titrating upward, while monitoring and managing side
effects. The adage “start low and go slow” is often used. Titrate doses upward
to desired effect using short-acting medications first, and consider using longer
duration medications for long-lasting pain. Choose a drug with a short half-life
and the fewest side effects if possible (Pasero, Reed, & McCaffery, 1999).
Multiple drug routes are available for administration of pain medications.
As long as patients are able swallow safely, the oral route is the first choice be-
cause it is the least invasive and very effective. The onset of action is within
30 minutes to 2 hours. For more immediate pain relief, intravenous adminis-
tration is recommended, although topical and rectal routes may also be used.
However, relief from pain with intravenous medication has a shorter duration;
therefore, it may be particularly useful for relieving breakthrough pain. Intra-
muscular injections should be avoided in the elderly, however, because of tissue
injury and because they typically produce pain. Overall, adopting a preventive
approach to painmanagement, whenever possible, is recommended. By treating
pain before it occurs, less medication is required than to relieve it (American
Pain Society, 2002 [Level VI]). Examples of pain prevention are around-the-
clock dosing, dosing prior to a painful treatment or event, and giving the next
dose before the previous dose wears off.
Pain Management in Dementia
People with dementia are often under-treated and poorly assessed for pain,
although they have diagnoses (e.g., osteoarthritis) known to cause pain (Horgas
& Tsai, 1998 [Level IV]). In situations in which clinicians suspect a patient may
be experiencing pain (e.g., direct observation, patient has a condition known
to cause pain, or patient has agitation), a clinical trial of pain medication and
nonpharmacologic strategies should be initiated. The Assessment of Discomfort
in Dementia (ADD) protocol has been designed to assess and treat physical pain
and affective discomfort in persons with late-stage dementia. See Treatment
10.1 Common Pain Medications for Use with Older Adults
Indication
and
Effects Type Medication
Starting Dose
(Maximum
Daily Dose)
Half-
Life Special Considerations (Adverse Reactions)
Mild Pain Nonopioids Acetaminophen
(Tylenol)
325–650 mg po q4-6h
[4000 mg/day]
1–3h Decreased maximum dose in patients (50%–75%) with
hepatic disease, excessive alcohol use (if >3
alcoholic drinks/day), impaired renal dysfunction
(Renal insufficiency with chronic use)
NSAIDs: Ibuprofen
(Advil, Motrin)
200–400 mg po q6-8h
(3200 mg)
1.8–2.5h Caution with hepatic and renal disease, may cause
central nervous system symptoms
(gastrointestinal bleeding)
COX–2 Inhibitor:
Celecoxib
(Celebrex)
100–200 mg po q12-24h
[400 mg/day]
11h Higher doses may cause higher risk of GI side effects
Contraindicated in patients with sulfa sensitivity (GI
bleeding, nausea, diarrhea, headache)
Mild to
Moderate
Pain
Opioids Tramadol (Ultram)
for mild to
moderate pain
25–50 mg po q 4-6 hr (300
mg/day)
5–9h Caution in patients with renal or liver impairment,
avoid in patients with risk for seizures (Nausea,
constipation, sedation, fatigue)
Codeine 15–30 mg po q 4-6 h No
maximum
2–4h Usually not recommended for older adults due to
greater risk of having nausea and constipation
(Central nervous system depression, nausea,
constipation, respiratory depression, hypotension,
dizziness)
Hydrocodone:
(Vicodin, Lorcet,
Lortab)*
2.5–5 mg po q 4-6 h See
comments
3-4h *Dose limitation by fixed-dose combinations with
acetaminophen and/or NSAIDs (CNS depression,
nausea, constipation, respiratory depression)
Oxycodone:
(OxyContin)
(Percocet,
Tylox) *
10 mg po q 12 2.5–5 mg
po q 4 – 6 h
(oxycodone) (Variable)
2-3h 4.5h Decrease dose in patients with severe hepatic
impairment *Dose limitation by fixed-dose
combinations with acetaminophen and/or NSAIDs
(CNS depression, nausea, constipation, respiratory
depression)
Moderate to
Severe
Pain
Morphine
immediate
release
(Roxanol)
10–30 mg po q 4 h
(Variable)
2-4h Recommended for breakthrough pain (CNS
depression, nausea, constipation, respiratory
depression)
Morphine
sustained
release (MS
Contin)
15 mg po q 12h (Variable) Limited usefulness in patients with renal
insufficiency (CNS depression, nausea,
constipation, respiratory depression)
Transdermal
Fentanyl
(Duragesic)
25 µg/hr patch q 72h
(Variable)
13–24h The lowest patch (25 µg/hr) recommended for
patients requiring oral morphine 60 mg per day,
peak effects of first dose between 18–24 hours
(CNS depression, nausea, constipation, respiratory
depression)
Hydromorphone
(Dilaudid)
2–4 mg po q 3-4h
(Variable)
2–3h Can be used for breakthrough pain or for
around-the-clock dosing (CNS depression,
nausea, constipation, respiratory depression)
Source: Adapted from: American Geriatrics Society Panel on Persistent Pain in Older Adults (2002). The management of persistent pain in older persons. Journal of the American
Geriatrics Society, 50, S205–S224 [Level VI].
Glen, V. L., & St. Marie, B. (2002). Overview of pharmacology. In B. St. Marie (Ed.), American Society of Pain Management Nurses: Core curriculum for pain management nursing (pp.
181–237). Philadelphia: W. B. Saunders Company [Level VI].
McCaffery, M., & Portenoy, R. (1999). Nonopiods. In M. McCaffery & C. Pasero (Eds.), Pain clinical manual (2nd ed.). St. Louis, MO: Mosby [Level VI].
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Guidelines (access to ADD tool) in Box 10.1. Use of the protocol has shown
significant decrease in discomfort in dementia patients (Herr et al., 2006 [Level
VI]; Kovach,Weissman, Griffie, Matson, &Muchka, 1999) andmay be employed
to improve pain control in this population.
Analgesic Drug Tolerance, Dependency, and Addiction
The use of opioids in treating severe, long-lasting pain or in terminal conditions
may lead to drug tolerance or dependency. Fear of developing dependency, how-
ever, does not justify withholding these medications, especially in terminally ill
patients or for any condition known to cause pain. Understanding tolerance,
dependency, and addiction is important in effectively managing pain in older
adults.Drug tolerance is defined as a decline in drug effectiveness over time due
to continual use (Panda & Desbiens, 2001). Increasing the dose can overcome
this effect.Drug dependence is identified by uncomfortable symptoms that occur
with abrupt withdrawal of the drug (Panda & Desbiens, 2001). Opioid tapering
is recommended when discontinuing use to alleviate this effect. The American
Pain Society (2003) defines drug addiction as a psychological condition charac-
terized by compulsive drug use and an uncontrollable craving to obtain effects
other than relief of pain. It occurs rarely when opioids are used as medications
for pain control and occurs even more rarely in older adults (American Pain
Society, 2003 [Level VI]; Pasero, Portenoy, & McCaffery, 1999).
Types of Analgesic Medication
Medications commonly used to treat pain in older adults are summarized in Ta-
ble 10.1, which also includes recommended dosages and special considerations.
Specific information about these types of medications is discussed herein.
Nonopioids are the first line in pharmacologic pain treatment. This group
includes acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and
cyclooxygenase-2 (COX-2) inhibitors (AGS, 2002 [Level VI]). They are generally
used for a wide variety of painful conditions, both acute and chronic, from mild
to moderate severity. Acetaminophen (e.g., Tylenol) is considered the drug of
choice for relief of musculoskeletal pain (AGS, 2002 [Level VI]) because it has
few side effects and is probably the safest nonopioid for most people. However,
it should be used with caution in people with underlying hepatic or renal dis-
ease. The NSAIDs (e.g., ibuprofen and naproxen sodium) are also effective for
treating mild to moderate pain and, along with acetaminophen, are often used
in combination with opioids for moderate to severe pain.
The most common side effect of the NSAIDs is gastric damage. This occurs
locally (as gastric irritant) and systemically (through inhibition of prostaglandin
synthesis), resulting in increased gastrointestinal(GI) tract susceptibility to in-
jury. Older adults aremore likely to develop ulcer disease and renal insufficiency
and have a greater incidence of death from the GI effects of NSAIDs. Other side
effects include increased bleeding time, central nervous system effects, hepatic
disease, and worsening asthma. When NSAIDs are used as single doses, in low
doses, and for short periods, side effects are usually less common than with
long-term use.
The COX-2 inhibitor, celecoxib (e.g., Celebrex), has been shown to be as
effective as NSAIDs for pain relief and is indicated for mild to moderate pain
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but should not be used in persons with sulfa sensitivities (Wiholm, 2001 [Level
IV]). Although this COX-2 inhibitor is often prescribed instead of nonselective
NSAIDs to reduce risk of GI bleeding, one study showed no significant reduction
of GI risk (Stockl, Cyprien, & Change, 2005 [Level IV]) and a similar risk of other
side effects such as cardiovascular events (e.g., myocardiac infarction, stroke),
hypertension, acute renal failure, and nephritic syndrome (Mukherjee, Nissen,
&Topol, 2001 [Level I];Whelton, 2006 [LevelV]). Celecoxib loses itsGI benefit, if
there is any, over traditional NSAIDs when it is combined with low-dose aspirin
(Lanas, 2005 [Level V]). Because proton-pump inhibitor (PPI) therapy reduces
the incidence of gastroduodenal ulcers and reduces the risk and incidence of
GI complications in patients taking NSAIDs, it may be helpful to recommend or
to prescribe this form of gastro-protection for older patients who must combine
NSAIDs and aspirin (Kimmey & Lanas, 2004 [Level V]).
Tramadol (e.g., Ultram, Ultracet) has characteristics of both nonopioids and
opioids in analgesic properties. It is effective for moderate to severe pain, and
its mechanism of action is not completely understood. Nausea and vomiting are
common side effects associated with the use of tramadol, along with dizziness,
sedation, restlessness, diarrhea or constipation, dyspepsia, weakness, diaphore-
sis, seizures, and respiratory depression (Glen & St. Marie, 2002 [Level VI]). It
should not be used in people with a history of codeine allergy, and it should be
used cautiously in persons with hepatic or renal impairment.
Opioid drugs (e.g., codeine and morphine) are effective at treating mod-
erate to severe pain from multiple causes. They provide effective pain relief
for elderly people, although many older adults and health care providers are
reluctant to use them due to fears of overdose, side effects, and intolerance.
Potential side effects include nausea, constipation, drowsiness, cognitive ef-
fects, and respiratory depression. The Agency for Healthcare Research and
Quality (AHRQ) recommends achieving safe administration of opioids to older
adults by reducing the dose to 25% to 50% of the usual adult dose (U.S. De-
partment of Health and Human Services, 1992). Tolerance to the side effects
develops with use over time, but it is strongly recommended that stool softeners
or routine laxatives are co-administeredwith opioids from the outset (AGS, 2002
[Level VI]).
Adjuvant drugs, drugs administered in conjunction with analgesics, are of-
ten administered with nonopioids and opioids to achieve optimal pain control
through additive analgesic effects or to enhance response to analgesics, espe-
cially for neuropathic pain (AGS, 2002 [LevelVI]). Although tricyclic antidepres-
sants (e.g., nortriptyline, desipramine) have shown dual effects on both pain and
depression, they are inappropriate for pain management in older adults due to
high rates of serious side effects (AGS, 2002 [Level VI]; Fick et al., 2003 [Level
VI]). Anticonvulsants (e.g., gabapentin), often used for trigeminal neuralgia,
may be used as adjuvant drugs with fewer side effects than tricyclic antidepres-
sants (AGS [Level VI], 2002). Local anesthetics, such as lidocaine as a patch, gel,
or cream, can be used as an additional treatment for the pain of post-herpetic
neuralgia.
Equianalgesia refers to equivalent analgesia effects. Understanding of
equianalgesic dosing (e.g., dose conversion chart, conversion ratio) improves
prescribing practices for managing pain in older adults. Equianalgesic dosing
charts provide lists of drugs and doses of commonly prescribed pain medica-
tions that are approximately equal in providing pain relief. They can provide
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practical information for selecting appropriate starting doses or when chang-
ing from one drug to another (Pasero et al.). In addition, utilizing equianalgesic
dosing practices (Pasero et al.) and theWHO analgesic ladder (WHO, 1996) may
provide more optimal pain relief with fewer side effects in older adults as op-
posed to trying to alleviate pain with maximum daily doses of mild analgesics
alone.
Drugs to Avoid in Older Adults
Some medications should be generally avoided in older adults because they are
either ineffective for them or cause higher risk of having side effects. Inappro-
priate analgesic medications for older adults are meperidine (e.g., Demerol),
propoxyphene and its combination products (e.g., Darvon, Darvocet, Darvon-N,
and Davocet-N), ketorolac (e.g., Toradol), and pentazocine (e.g., Talwin). These
medications cause central nervous system side effects including confusion or
hallucinations,maynot be effective enoughwhenadministered at the commonly
prescribed dose, or may produce more side effects than positive analgesic ef-
fect (Fick et al., 2003 [Level VI]). Additionally, sedatives, antihistamines, and
antiemetics should be avoided, if possible, or used with caution due to long du-
ration of action, risk of falls, hypotension, anticholinergic effects, and sedating
effects (Fick et al., 2003; Pasero et al., 1999a [both Level VI]).
Nonpharmacological Pain Treatment
Older adults are at higher risk of having side effects from pharmacological
treatment due to age-related physiological changes (Buxton, 2006) and in-
creased use of multiple medications (i.e., polypharmacy) for managing multiple
chronic health conditions (Helme & Gibson, 1999). Therefore, nonpharmaco-
logical treatments should be implemented, whenever possible, to accomplish
maximum pain relief with the fewest side effects (Nikolaus & Zeyfang, 2004). It
is recommended that nonpharmacological pain treatments be used as comple-
mentary therapy rather than as a substitute for pharmacological pain treatments
(Herr, 2002b).
Many older adults are willing to use nonpharmacological modalities toman-
age pain (Herr, 2002b). In fact, one study indicated that more than 50% of older
adults reportedusing three ormore strategies for pain (Barry,Gill, Kerns,&Reid,
2005 [Level IV]). The most commonly reported nonpharmacological strategies
reported were activity restriction, heat/cold application, and exercise. Another
study reported that 96% of older adults reported using at least one comple-
mentary/alternative therapy modality and that prayer was the most commonly
reported strategy (Dunn & Horgas, 2000 [Level IV]).
Types of Nonpharmacological Treatment Strategies
Nonpharmacological pain treatment strategies generally fall into two categories:
physical pain relief approaches and cognitive-behavioral approaches (Herr,
2002b). Physical strategies include but are not limited to transcutaneous electri-
cal nerve stimulation (TENS), physical therapies, use of heat and cold, massage,
exercise, and various complementary/alternative therapies (e.g., acupuncture,
chiropractic services). Cognitive-behavioral strategies are designed to change
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the person’s perception of the pain and improve coping strategies (Rudy, Han-
lon, & Markham, 2002). These include strategies such as relaxation, distraction
guided imagery, hypnosis, and biofeedback. Other nonpharmacological pain
treatment includes self-management and low-level laser therapy (LLLT). To
date, few of these nonpharmaceutical strategies have been empirically evalu-
ated for their effectiveness in pain management.
Several physical strategies to relieve pain—exercise, electrical stimulation
(ES) including TENS, and LLLT—have been evaluated and revealed conflicting
results (Furlan et al., 2001 [Level I]). However, exercise prescriptions for older
adults recommended by the American Geriatrics Society Panel on Exercise and
Osteoarthritis (AGS, 2001 [Level VI]) should be considered for those with os-
teoarthritis pain. ES has shown significant benefits for passive humeral lateral
rotation of shoulder pain after stroke but no improvement in the quality of life
(Price, 2001 [Level I]). Although only limited data are available, ES seems to be a
low-risk intervention with no negative effects for managing post-stroke shoul-
der pain (Price, 2001 [Level I]). LLLT can be considered for short-term relief of
pain with few side effects for adults with rheumatoid arthritis. The therapeutic
effect of LLLT for persons with osteoarthritis, however, is supported by some
empirical findings and needs further investigation (Brosseau et al., 2000 [Level
I]). Laser therapy for chronic low-back pain, however, showed no effect (Furlan
et al., 2001 [Level I]).
Cognitive-behavioral strategies include, among others, self-management,
cognitive behavioral therapy, biofeedback, and attentional pain control strategy
(i.e., distraction). Biofeedback may be beneficial for selected older adults with
persistent pain (Middaugh & Pawlick, 2002 [Level V]). Attentional pain control
strategies, those that manipulate attention to alter perception of pain, for cancer
pain seem to be beneficial but need further study (Buck & Morley, 2006 [Level
III]). Selfmanagement programshavenot indicated clinical benefit in painman-
agement or improved function for older adults with osteoarthritis (Chodosh et
al., 2005 [Level I]), and self-management in a group format appears to have lim-
ited benefit (Ersek, Turner, McCurry, Gibbons, & Kraybill, 2003 [Level II]). For
example, older adults with chronic pain showed improvement in their physical
role function and pain intensity after group self-management interventions but
not in their pain-related activity, depression, or beliefs about pain relief (Ersek
et al., 2003 [Level II]). These psychoeducational therapies, however, appear to
be effective as adjuvant therapy for treating pain in older adults with cancer
(Devine, 2003 [Level I]).
Special Considerations of Using Nonpharmacological Treatment for Older Adults
It is essential for nurses to understand an individual’s barriers to and pref-
erences for using nonpharmacological treatments, his or her cognitive status,
and the availability and effectiveness of such treatments when they are recom-
mended to older adults with pain. Personal barriers may include limited access
to the treatment modality, individual preferences for the type of program (e.g.,
group versus individual) or treatment (e.g., physical versus cognitive), and per-
sonal beliefs and attributions (Austrian, Kerns, & Reid, 2005 [Level IV]). For ex-
ample, someolder adultsmay lackfinancial resources or transportation to attend
group interventions, whereas others may fear adverse effects of the treatment
(e.g., more pain/injury). Some may have low energy or simply lack interest in a
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specific program being offered to them (Austrian et al., 2005 [Level IV]). Other
personal barriers include reluctance to addmore painmanagement strategies to
existing medication regimens, belief that pain is a normal part of aging, knowl-
edge deficits about pain management methods, and poor communication with
health care providers (Davis, Hiemenz, & White, 2002 [Level IV]).
Thus, individuals differ widely in their preferences for and ability to use
nonpharmacologic interventions tomanage pain. Spiritual and/or religious cop-
ing strategies, for instance, must be consistent with individual values and be-
liefs. Other strategies, such as imagery, biofeedback, or relaxation techniques,
may not be feasible for cognitively impaired older adults. Psychoeducational
interventions may be burdensome for some patients (Devine, 2003 [Level I]);
therefore, it is important for health care providers to consider a broad array of
nonpharmacological pain management strategies and to tailor selections to the
individual. It is also important to gain individual and family input about the use
of home and folk remedies because use of herbals or home remedies is often
not disclosed to health care providers and may result in negative drug–herb in-
teractions (Yoon & Horne, 2001 [Level IV]; Yoon, Horne, & Adams, 2004 [Level
IV]; Yoon & Schaffer, 2006 [Level IV]).
Summary
Pain is a significant problem for older adults, which has the potential to neg-
atively impact independence, functioning, and quality of life. For pain to be
effectively managed, it must first be carefully and systematically assessed. Pain
assessment in older adults should start with self-reported pain. It should also
incorporate assessment of nonverbal pain behaviors and family input about
usual pain responses and patterns, particularly in patients unable to communi-
cate their pain. The use of established pain assessment/measurement tools is
recommended. Pain treatment in older adults should be tailored to the type and
severity of pain, withmedications that can be safely used in older adults (or com-
bined with nonpharmacological treatment for heightened effectiveness). Older
adults, their families, and their care providers should be knowledgeable about
pain and how to manage it. Thus, education is an important part of the process
and should not be overlooked. Empowering individuals and their caregivers to
effectively manage pain is a critical nursing role that can improve quality of life
for older adults.
Case Study and Discussion
Mr. J. is an 87-year-old man living in a skilled nursing facility. He has been
diagnosed with Alzheimer’s disease and has an MMSE score of 17. He has a
history of osteoarthritis, diabetes, and hypertension. He has been residing in
the residential facility for 1 year and his memory has been slowly declining
during that time. Recently, Mr. J. has exhibited a change in behavior. He
usually walks around the facility frequently throughout the day but now sits
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in his chair. The nursing assistants note that he has been frequently rubbing
his knees. He denies pain when asked.
The nursing assistants informed the nurse of their observations and
the change in Mr. J.’s usual behavior. The nurse initiated a more thorough
pain assessment, starting with self-report questions and also asking Mr. J.’s
wife for her observations about his behavior. The nurse also conducted a
thorough nursing assessment to rule out physical causes such as infection
or sensory changes (e.g., lost glasses, which would impair walking). Then
the nurse completed the NOPPAIN to assess behavioral indicators of pain.
AlthoughMr. J. verbally denied pain, he demonstrated facial grimacing, non-
verbal vocalization, and rigidity/guarding while transferring from the chair
to bed. The nurse consulted the medication orders and then initiated a trial
of Tylenol ES 1 tab q 6 hours. Mr. J. demonstrated a reduction in his pain
behaviors and began to resume his walking routine.
Among older adults, it is important to routinely ask about the presence
of pain and when there is a change in behavior. Older adults are often reluc-
tant to complain about pain, and persons with dementia are often unable to
recall the presence of pain due to memory changes. Thus, it is important to
use an observational tool to assess the presence of pain behaviors in older
adults. It is also important to investigate the causes of pain when behavioral
pain indicators are present. For instance, onset of abdominal pain would
be considered a more emergent condition than knee pain. Thus, thorough
patient assessment is necessary, particularly in older adults who are likely
to experience persistent and acute pain conditions simultaneously.
Box 10.1
Nursing Standard of Practice Protocol: Pain
Management in Older Adults
STANDARD: All older adults will either be pain free or their pain will be
controlled to a level that is acceptable to the patient and allows the person
to maintain the highest level of functioning possible.
OVERVIEW: Pain, a common, subjective experience for many older adults,
is associated with a number of chronic (e.g., osteoarthritis) and acute (e.g.,
cancer, surgery) conditions. Despite its prevalence, evidence suggests that
pain is often poorly assessed and poorly managed, especially in older
adults. Cognitive impairment due to dementia and/or delirium represents
a particular challenge to painmanagement because older adults with these
conditions may be unable to verbalize their pain. Nurses, an integral part
of the interdisciplinary care team, need to understand myths associated
with painmanagement, including addiction and belief that pain is a normal
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result of aging, to provide optimal care and to educate patients and families
about managing pain.
I. BACKGROUND
A. Definitions
1. Pain: Pain is defined as “an unpleasant sensory and emotional ex-
perience” (AGS, 2002; Melzack & Casey, 1968) and also as “what-
ever the experiencing person says it is, existing whenever he says
it does” (McCaffery, 1968;McCaffery &Pasero, 1999). These defini-
tions highlight the multidimensional and highly subjective nature
of pain. Pain is usually characterized according to the duration of
pain (e.g., acute versus persistent) and the cause of pain (e.g., no-
ciceptive versus neuropathic). These definitions have implications
for pain management strategies.
2. Acute Pain: Defines pain that results from injury, surgery, or tissue
damage. It is usually associated with autonomic activity, such as
tachycardia and diaphoresis. Acute pain is usually time-limited
and subsides with healing.
3. Persistent Pain: Defines pain that persists for a prolonged period
(usually more than 3 to 6 months) (AGS, 2002; Harkins, 2002). Per-
sistent pain may or may not be associated with a diagnosable dis-
ease process and autonomic activity is usually absent. Persistent
pain is often associated with functional loss, mood and behavior
changes, and reduced quality of life.
4. Nociceptive Pain: The term refers to pain caused by stimulation
of specific peripheral or visceral pain receptors. This type of pain
results from disease processes (e.g., osteoarthritis), soft-tissue in-
juries (e.g., falls), and medical treatment (e.g., surgery, venipunc-
ture, and other procedures). It is usually localized and responsive
to treatment.
5. Neuropathic Pain: Refers to pain caused by damage to the periph-
eral or central nervous system. This type of pain is associated
with diabetic neuropathies, post-herpetic and trigeminal neural-
gias, stroke, and chemotherapy treatment for cancer. It is usually
more diffuse and less responsive to analgesic medications.
B. Epidemiology
1. Approximately 50% of community-dwelling older adults have
pain.
2. Approximately 85% of nursing home residents experience pain.
C. Etiology
1. More than 80% of older adults have chronic medical conditions
that are typically associated with pain, such as osteoarthritis and
peripheral vascular disease.
2. Older adults often have multiple medical conditions, both chronic
and/or acute, and may suffer from multiple types and sources of
pain.
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D. Significance
1. Pain has major implications for older adults’ health, functioning,
and quality of life. If unrelieved, pain is associated with the fol-
lowing:
a. depression
b. sleep disturbances
c. withdrawal and decreased socialization
d. functional loss and increased dependency
e. exacerbation of cognitive impairment
f. increased health care utilization and costs
2. Nurses have a key role in pain management. The promotion of
comfort and relief of pain is fundamental to nursing practice.
Nurses need to be knowledgeable about pain in late life to pro-
vide optimal care, to educate patients and families, and to work
effectively in interdisciplinary health care teams.
3. The Joint Commission on Accreditation of Healthcare Organiza-
tions (JCAHO) now requires regular and systematic assessment of
pain in all hospitalized patients. Because older adults constitute
a significant portion of the patient population in many acute care
settings, nurses need to have the knowledge and skill to address
specific pain needs of older adults.
II. ASSESSMENT PARAMETERS
A. Assumptions
1. The majority of hospitalized older patients suffer from both acute
and persistent pain.
2. Older adults with cognitive impairment experience pain but are
often unable to verbalize it (Smith, 2005 [Level I]).
3. Both patients and health care providers have personal beliefs,
prior experiences, insufficient knowledge, and mistaken beliefs
about pain and painmanagement that (a) influence the painman-
agement process, and (b) must be acknowledged before optimal
pain relief can be achieved [AGS, 2002 [Level VI]).
4. Pain assessment must be regular, systematic, and documented
to accurately evaluate treatment effectiveness (AGS, 2002 [Level
VI]).
5. Self-report is the gold standard for pain assessment (AGS, 2002
[Level IV]).
B. Strategies for Pain Assessment
1. Review medical history, physical exam, and laboratory and diag-
nostic tests to understand sequence of events contributing to pain
(AGS, 2002 [Level VI]).
2. Assess present pain, including intensity, character, frequency, pat-
tern, location, duration, and precipitating and relieving factors
(AGS, 2002 [Level VI]).
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3. Review medications, including current and previously used pre-
scription drugs, over-the-counter drugs, and home remedies. De-
termine which pain control methods have previously been effec-
tive for the patient. Assess patient’s attitudes and beliefs about
use of analgesics, adjuvant drugs, and nonpharmacological treat-
ments (AGS, 2002 [Level VI]).
4. Use a standardized tool to assess self-reported pain. Choose from
published measurement tools and recall that older adults may
have difficulty using 10-point visual analog scales. Vertical verbal
descriptor scales or faces scales may be more useful with older
adults (Taylor et al., 2005 [Level V]).
5. Assess pain regularly and frequently but at least every 4 hours.
Monitor pain intensity after giving medications to evaluate effec-
tiveness.
6. Observe for nonverbal and behavioral signs of pain, such as fa-
cial grimacing, withdrawal, guarding, rubbing, limping, shifting of
position, aggression, agitation, depression, vocalizations, and cry-
ing. Also watch for changes in behavior from the patient’s usual
patterns (Taylor et al., 2005 [Level V]).
7. Gather information from family members about the patient’s
pain experiences. Ask about the patient’s verbal and nonver-
bal/behavioral expressions of pain, particularly in older adults
with dementia.
8. When pain is suspected but assessment instruments or observa-
tion is ambiguous, institute a clinical trial of pain treatment (i.e.,
in persons with dementia). If symptoms persist, assume pain is
unrelieved and treat accordingly (Herr, et al., 2006 [Level VI]).
III. NURSING CARE STRATEGIES
A. Prevention of Pain
1. Assess pain regularly and frequently to facilitate appropriate
treatment (AGS, 2002 [Level VI]).
2. Anticipate and aggressively treat for pain before, during, and af-
ter painful diagnostic and/or therapeutic treatments (AGS, 2002
[Level VI]).
3. Educate patients, families, and other clinicians to use analgesic
medications prophylactically prior to and after painful proce-
dures (AGS, 2002 [Level VI]).
4. Educate patients and families about pain medications and their
side effects; adverse effects; and issues of addiction, dependence,
and tolerance (AGS, 2002 [Level VI]).
5. Educate patients to take medications for pain on a regular basis
and to avoid allowing pain to escalate (AGS, 2002 [Level VI]).
6. Educate patients, families, and other clinicians to use nonphar-
macological strategies to manage pain, such as relaxation, mas-
sage, and heat/cold (AGS, 2002 [Level VI]).
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B. Treatment Guidelines
1. Pharmacologic (AGS, 2002 [Level VI])
a. Older adults are at increased risk for adverse drug reactions.
b. Monitor medications closely to avoid over- or under-
medication.
c. Administer pain drugs on a regular basis to maintain thera-
peutic levels; avoid PRN drugs.
d. Document treatment plan to maintain consistency across
shifts and with other care providers.
e. Use equianalgesic dosing and the WHO three-step ladder to
obtain optimal pain relief with fewer side effects.
2. Nonpharmacologic (AGS, 2002 [Level VI])
a. Investigate older patients’ attitudes and beliefs about, pref-
erence for, and experience with nonpharmacological pain-
treatment strategies.
b. Tailor nonpharmacologic techniques to the individual.
c. Cognitive-behavioral strategies focus on changing the per-
son’s perception of pain (e.g., relaxation therapy, education,
and distraction) and may not be appropriate for cognitively
impaired persons.
d. Physical pain relief strategies focus on promoting comfort and
altering physiologic responses to pain (e.g., heat, cold, TENS
units) and are generally safe and effective.
3. Combination approaches that include both pharmacological
and nonpharmacological pain treatments are often the most
effective.
C. Follow-up Assessment
1. Monitor treatment effects within 1 hour of administration and at
least every 4 hours.
2. Evaluate patient for pain relief and side effects of treatment.
3. Document patient’s response to treatment effects.
4. Document treatment regimen in patient care plan to facilitate
consistent implementation.
IV. EXPECTED OUTCOMES
A. Patient:
1. Will be either pain free or pain will be at a level that the patient
judges as acceptable.
2. Maintains highest level of self-care, functional ability, and activity
level possible.
3. Experiences no iatrogenic complications, such as falls, GI upset/
bleeding, or altered cognitive status.
B. Nurse:
1. Will demonstrate evidence of ongoing and comprehensive pain
assessment.
2. Will document evidence of prompt and effective pain manage-
ment interventions.
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3. Will document systematic evaluation of treatment effectiveness.
4. Will demonstrate knowledge of pain management in older pa-
tients, including assessment strategies, pain medications, non-
pharmacological interventions, and patient and family education.
C. Institution
1. Facilities and institutions will provide evidence of documentation
of pain assessment, intervention, and evaluation of treatment ef-
fectiveness.
2. Facilities and institutions will provide evidence of referral to
specialists for specific therapies (e.g., psychiatry, psychology,
biofeedback, physical therapy, or pain treatment centers).
3. Facilities and institutions will provide evidence of pain manage-
ment resources for staff (e.g., care-planning and pain manage-
ment references, pain management consultants).
V. TREATMENT GUIDELINES
A. Pain
1. The Hartford Institute for Geriatric Nursing: Try This Series:
Assessing Pain in Older Adults http://www.ConsultGeriRN.org/
resources/zeducation/tryThis.html
2. American Geriatric Society Guideline on the Management
of Persistent Pain http://www.americangeriatrics.org/education/
manage pers pain.shtml
3. Herr, K., Steffensmeier, J., Rakel, B. (2006). University of Iowa
Gerontological Nursing Interventions Research Center, Research
Translation and Dissemination Core, Iowa City, IA.
4. American Association of Pain Management Nurses (ASPMN):
Geriatric Pain Assessment: Self-Directed Learning https://www.
commercecorner.com/aspmn/productlist1.aspx
5. American Pain Society: Pain Guidelines and Online Resource
Centers http://www.ampainsoc.org/links/clinician1.htm
6. International Association for the Study of Pain: Curriculum on
Pain for Schools of Nursing; Pain in Older Persons Book http://
www.iasp-pain.org/
B. Pain in Persons with Dementia and Long Term Care
1. American Medical Directors Association (AMDA): Clinical Prac-
tice Guideline: Pain Management in the Long Term Care Setting
http://www.amda.com/tools/cpg/chronicpain.cfm
2. City of Hope: State-of-the-Art Review of Tools for Assessing
Pain in Nonverbal Older Adults http://www.cityofhope.org/prc/
elderly.asp
3. American Association of Pain Management Nurses (ASPMN):
Pain Assessment in the Nonverbal Patient: Position Statement
with Clinical Practice Recommendations. http://www.aacn.org/
AACN/practice.nsf/vwdoc/PainAssmt
C. Measurement Tools
1. See City of Hope Web site listed previously for comprehensive
review of tools for persons with dementia
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Iatrogenesis:
The Nurse’s
Role in
Preventing
Patient Harm
Deborah C. Francis
Educational
Objectives
At the completion of this chapter, the reader will be
able to:
1. define iatrogenesis and the most common types of
iatrogenic events affecting older adults
2. understand the scope of the problem of iatrogenic
events
3. describe the nurse’s role in preventing iatrogenic
harm in hospitalized patients
4. recognize the increasing incidence of hospital-
acquired infections and the nurse’s role in
prevention
5. identify the nursing and organizational priorities
needed to promote geriatric patient safety
Overview
Iatrogenesis is a common and serious hazard of hospitalization and health care
interventions that is associated with significant adverse patient outcomes. Ia-
trogenic illness and injury is known to prolong hospital stays and increase pa-
tient morbidity and mortality at significant cost to health care organizations,
third-party payers, and patients alike. From the Greek word iatros, meaning
healer, iatrogenesis means “brought forth by a healer.” It has also been referred
to as nursigenic when the harm is caused by nurses. A more appropriate term
might be comiogenic illness, which comes from the Greek komein, meaning to
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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care, and referring to any adverse event associated with the “care” of patients
(Sharpe & Faden, 1998 [Level VI]). Iatrogenic harm refers to an unintended
adverse patient outcome due to any therapeutic, diagnostic, and prophylactic
intervention that is not considered the natural course of the disease. Common
iatrogenic illnesses include adverse drug events (ADEs), complications of di-
agnostic and therapeutic procedures, and nosocomial complications that occur
in the course of medical and health care. The latter includes hospital-acquired
infections (HAIs), geriatric syndromes, and falls or other injuries related to the
environment or equipment defects. Less well recognized are the harmful effects
to patients’ values, beliefs, prejudices, fears, and attitudes of well-intentioned
health care providers.
Background and Significance of The Problem
Steele, Gertman, Crescenzi, & Anderson (1981, 2004 [both Level IV]) were some
of thefirst to recognize iatrogenesis as aproblem inolder adultswhen they found
that 38% of geriatric patients suffered an iatrogenic illness during a hospital stay.
Citing the lack of progress made since a similar report was published 15 years
earlier, they raised the alarm about the extent of adverse events in hospitalized
patients. Iatrogenesis came to the forefront whenmedical errors causing patient
harm made headlines with the release of the Institute of Medicine (IOM) land-
mark report entitled “To Err Is Human: Building a Safer Health System” (Kohn,
Corrigan, & Donaldson, 1999 [Level I]). It demonstrated that errors made by
medical practitioners cause between 44,000 and 98,000 deaths per year at a
cost of up to $29 billion in unnecessary health care costs, disability, and lost
income. The report strongly urged immediate, vast, and comprehensive sys-
temwide changes, including both voluntary and mandatory reporting programs
by health care organizations, and jump-started the patient safety movement of
today. Starfield (2000 [Level VI]) estimates that 1 million persons are injured
and up to 250,000 persons die every year as a direct result of iatrogenic com-
plications, making it the third most common cause of death after cancer and
heart disease. A national study of 37 million Medicare patients found that an
average of 195,000 people die every year due to potentially preventable patient
safety incidents (Health Grades, Inc., 2004 [Level IV]). Particularly concerning
is the fact that despite dramatic improvements made in recent years, especially
in the reduction of infections and anesthesia-associated mortality, an alarming
increase in adverse events among Medicare beneficiaries has been noted (Vil-
lanueva&Anderson, 2001 [Level IV]).Most recently, a 2005 survey conducted by
the Kaiser Family Foundation, AHRQ, and the Harvard School of Public Health
revealed that one-third of respondents reported that they or a family member
had been harmed by a medical error during their lifetime, while one in five
noted that it caused serious health consequences (Kaiser Family Foundation,
2004 [Level IV]). The literature available on medical-error–related iatrogene-
sis is vast and will not be covered in this chapter. Readers are referred to the
Resources section of this chapter for more information on medical errors.
The true extent of the problem of iatrogenesis is not well understood and
is complicated by various factors. The majority of the research has occurred in
acute care and, to a lesser degree, nursing home settings, with the incidence of
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iatrogenic events in the community not well understood yet. Lack of standard-
ization in the literature as to what constitutes an iatrogenic event and different
methods of data collection and analysis make it difficult to understand the true
extent of the problem. In addition, there is both a lack of recognition and stan-
dardized reporting procedures by hospitals and providers. As such, what we
know of the problem of iatrogenesis may be but the tip of the iceberg.
Retrospective chart reviews of patients in the United States, Canada, Eng-
land,NewZealand,Australia, andDenmarkhave demonstrated that between 3%
and 16.6% of patients experience one or more adverse events during the course
of hospitalization (Baker et al., 2004 [Level IV]; Brennan et al., 1991 [Level IV];
Brennan et al., 2004 [Level IV]; Davis et al., 2002 [Level IV]; Forster et al., 2004
[Level IV]; Schioler et al., 2001 [Level IV]; Thomas et al., 2000 [Level IV]; Vin-
cent, Neale, & Woloshynowych, 2001 [Level IV]; Wilson et al., 1995 [Level IV]).
Evidence suggests that admissions to U.S. emergency rooms for iatrogenic com-
plications are on the rise, accounting for 3.1 visits per 1,000 patients in 1992 and
5.2 visits per 1,000 in 1999, with substantially higher rates noted for older adults
(Burt, 2001). More than 50% of adverse events occur prior to hospitalization,
up to 70% of which are considered preventable (Sharpe & Faden, 1998 [Level
VI]), whereas close to 25% occur after hospital discharge (Forster et al., 2004
[Level IV]). Of those adverse events that occur during hospitalization, 20% to
51% were considered preventable and 2% to 26% life-threatening or fatal (Bren-
nan et al., 1991, 2004; Forster et al., 2004; Giraud et al., 1993; Lefevre et al., 1992;
Steele et al., 2004 [all Level IV]). Up to 75% of iatrogenic disease in the hospital
is thought to be due to medications or adverse events after medical or surgi-
cal procedures. It is difficult to estimate the human and financial cost of this
problem and it is thought to be underestimated.
The risk of an iatrogenic event is highest among patients 65 years and older,
with evidence suggesting it affects between 36% and 58% of hospitalized older
adults (Steele et al., 1981, 2004 [both Level IV]; Lefevre, 1992 [Level IV]; Roth-
schild, Bates,&Leape, 2000 [LevelV]).Otherhigh risk groups includepatients in
the emergency room and interventional radiology and those admitted to inten-
sive care units (ICUs) and thoracic, cardiac surgery, and vascular units. Studies
of patients admitted to an ICU have found that between 1.2% and 31% suffer
an adverse event, with 45% considered preventable and 13% life-threatening or
fatal (Darchy, LeMiere, Figueredo, Bavoux, & Domart, 1999 [Level IV]; Giraud
et al., 1993 [Level IV]; Lehmann, Puopolo, Shaykevich, & Brennan 2005 [Level
IV]; Rothschild et al., 2005 [Level IV]).
Iatrogenesis in Older Adults
The landmark Harvard Medical Practice Study (1991) found that patients 65
years and older suffered twice as many diagnostic complications, two and a half
times as many medication reactions, four times as many therapeutic mishaps,
and nine times as many falls as compared to younger patients. A more recent
review corroborated these data, finding that older adults experience 2.2% more
adverse events due to perioperative complications and 10%more falls than those
patients younger than 65 years (Rothschild et al., 2000 [Level V]). The rea-
sons include normal age-related physiological changes and concomitant chronic
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medical conditions that place older adults at much greater risk of harm. The in-
crease in medical or psychiatric conditions with age requires more medications
and diagnostic or therapeutic procedures, making older adults far more prone
to be harmed by medical care. Age-related diminished physiologic reserve (es-
pecially in hepatic, renal, and cognitive function) and impaired homeostatic
and compensatory mechanisms impede the ability of older adults to respond to
physiological and psychological stressors. Age-associated physiologic changes
tend to exaggerate the effects of medications, leading to more adverse side ef-
fects and iatrogenic harm. This risk is potentiated by the increased number
of co-morbid conditions that occur with age and drug–drug and drug–disease
interactions from subsequent polypharmacy.
In addition to the increased potential for adverse effects of medications,
aging is associated with an increased risk of infection. An age-related blunted
febrile response can mask the early signs of infection, which may be missed
by the clinician who relies on a spike in temperature or increased white blood
cell count to recognize an infection. A blunted thirst sensation dramatically in-
creases the risk of dehydration in older patients who may, for functional or cog-
nitive reasons, be unable to independently drink adequate amounts of fluids.
An older adult with age-associated decline in cardiac reserve who is receiving
continuous intravenous fluids is at increased risk of iatrogenic congestive heart
failure (CHF).
Another important consideration is the atypical presentation of disease in
the elderly. Early symptoms of acute medical conditions tend to be more vague,
insidious, and atypical and therefore are oftenmissed ormisinterpreted by clini-
cians, family/caregivers, and patients alike. This complicates accurate diagnosis
and timely treatment and, consequently, results in a high number of emergent,
high risk interventions. For example, an acute appendicitis in an older adult may
present as nonlocalized abdominal discomfort or may not manifest symptoms
until perforation occurs; or a person with a myocardial infarction may have no
pain at all. More common in older adults is a urinary tract infection (UTI) or
pneumonia presenting with confusion, falls, or functional impairment, rather
than the typical symptoms of infection in younger persons.
Older adults are at a particularly high risk for cascade iatrogenesis, which is
a phenomenon that occurs when an initial medical intervention triggers a series
of complicating events, initiating a cascade of decline, which is often irreversible.
For example, a patient who is medicated for agitated behaviors associated with
delirium becomes lethargic from over-sedation, aspirates, and develops aspira-
tion pneumonia. Subsequent functional decline due to prolonged bedrest results
in a fractured hip when a patient falls while trying to get to the bathroom. This
then increases the length of stay and further increases the potential for compli-
cations. Iatrogenic cascades have been found to occur most frequently among
the oldest, most functionally impaired patients and those with a higher severity
of illness on admission (Potts et al., 1993 [Level IV]).
To further complicatematters, most physicians and nurses are inadequately
trained in geriatric care and therefore are not prepared to manage the complex,
chronic care needed by frail older patients. Without a solid understanding of
the geriatric approach, providers can inadvertently cause more harm during
the course of treatment. The purpose of this chapter is to describe the role
of the nurse in preventing iatrogenic harm, as well as to briefly summarize
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the organizational priorities needed to minimize adverse events in hospitalized
older adults.
Assessment and Proactive Intervention for Iatrogenesis
Adverse Drug Events (ADEs)
Adverse effects of medications are the most common type of iatrogenesis in
older adults. It is estimated that 35% of older persons experience ADEs, almost
half of which are preventable (Safran et al., 2005 [Level IV]). The majority of
cases in which patients are admitted to the hospital with an iatrogenic illness
or injury can be attributed to ADEs (Darchy et al., 1999 [Level IV]). A study
of four ambulatory care clinics in Boston found that 25% of patients in pri-
mary care reported an ADE, with 13% considered serious and 11% preventable
(Gandhi et al., 2003 [Level IV]). McDonnell (2002 [Level IV]) found that not
only were 62% of ADEs resulting in hospital admission during an 11-month pe-
riod potentially preventable but also that 25% were deemed life-threatening.
Most resulted from inadequate drug-monitoring therapy or inappropriate dos-
ing. Despite widespread recognition of the adverse effects of medications, the
incidence of ADE-related hospital admissions has not decreased during the past
20 years. Perhaps most concerning is the fact that the absolute numbers may
have increased (Green, Mottram, Rowe, & Pirmohamed, 2000 [Level IV]).
Once admitted, ADEs tend to be themost common type of treatment-caused
injury in the hospitalized patient, with at least one-third related to errors and
thus considered preventable. Baune et al. (2003 [Level IV]) noted a 9.9% preva-
lence rate of ADEs in a Paris hospital, concluding that 73% were serious and
25% preventable. Lazarou, Pomeranz, & Corey (1998 [Level I]) demonstrated
that there were approximately 106,000 fatal ADEs in hospitalized patients in
the United States in 1994.
The potential for ADEs is highest among older adults, who are the greatest
consumers of medications. It is well known that the risk increases exponen-
tially with the increase in number of drugs (Gandhi et al., 2003 [Level IV]).
Polypharmacy, which is prevalent among older patients, increases the risk of
drug–drug interactions, whose effect on this population is more dramatic. It
has been shown to be a significant predictor of hospitalization, nursing home
placement, death, hypoglycemia, fractures, impaired mobility, pneumonia, and
malnutrition (Frazier, 2005 [Level I]). Any and all medications can cause ADEs,
although certain classes, such as antibiotics and cardiovascular drugs, have been
identified in studies of hospitalized patients to be particularly problematic. (See
chapter 12, Reducing Adverse Drug Events, for assessment and interventions to
prevent ADEs).
Nosocomial or Health Care-Acquired Complications
Nosocomial or health care–acquired injuries that are not directly related to the
illness or specific treatment of the acute problem occur in hospitalized older
patients with far greater frequency (Rothschild et al., 2000 [Level V]. The most
common preventable and potentially life-threatening iatrogenic complications
in hospitalized older adults include nosocomial infection and certain geriatric
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syndromes. The latter include but are not limited to delirium, functional de-
cline/deconditioning, falls, malnutrition, pressure ulcers, depression, and in-
continence that occur in the course of receiving medical and nursing care. The
reader is referred to the appropriate book chapters (chapters 3, 5, 7, 9, 13, 15,
and 18, respectively) in this text for protocols to identify, prevent, and manage
these common iatrogenic geriatric syndromes.
HAI, first defined in 1970 by the Centers for Disease Control (CDC) as one
that develops in a patient after hospital admission, is a serious risk for any
patient and, like other iatrogenic harm, the risk rises dramatically with age
(Beaujean et al., 1997 [Level IV]). HAI is one of the leading causes of death
and morbidity in hospitalized patients (WHO, 2002 [Level I]). It is estimated
that HAIs affect more than 2 million patients in the United States every year
and cause at least 90,000 deaths (Leape, 2005a [Level V]), at a cost exceeding
$4.5 billion (Hollenbeak et al., 2006 [Level IV]). Although the true incidence
is difficult to determine, evidence suggests that 5% to 10% of patients develop
an HAI, which increases morbidity, mortality, length of stay, and cost of care
(Hugonnet, Chevrolet, & Pittet, 2007 [Level IV]; Hussain et al., 1996 [Level IV]).
In addition, a disturbing increase in risk has been noted in recent decades
(Burke, 2003 [Level V]). The state of Pennsylvania, which recently mandated
hospitals to report catheter-associated bloodstream infections (CABSIs), UTIs
from catheters, andHAIs from specified surgeries, found that 19,154 patients ac-
quired an infection in 2005. Themortality ratewas 12.9% compared to 2.3% for all
patients, whereas the length of stay for those patients who acquired an infection
was 20.6 days compared to 4.5 days for all patients. Of note, the average cost was
six times higher for a patient who acquired an infection and, in some cases, the
charges exceeded the reimbursement (Hollenbeak et al., 2006 [Level IV]).
The rate of HAI is highest among older and critically ill patients, who tend to
be the sickest and most immune-compromised, undergo more invasive proce-
dures, and receive more intravascular devices, which significantly increases the
risk of secondary infection. Studies of older adults in geriatric and rehabilitation
units of acute care facilities suggest an even higher rate of HAI, noting a preva-
lence rate of 2.7% to 32.7% and an incidence rate of between 10.7% and 32.7%
(Beaujean et al., 1997; Eveillard et al., 1998; Hussain et al., 1996 [all Level IV]).
Once infected with an HAI, an older patient is much more likely to experience
subsequent adverse complications and a prolonged hospital stay (Rothschild
et al., 2000). It has been suggested that 25% of HAIs occur in patients in critical
care units (CCUs) and up to 70% are due to resistant microorganisms. A 4-year
prospective study of patients admitted to a medical–surgical ICU found that 34%
of patients developed an HAI after a median of 9 days. The infection not only
prolonged the length of hospital stay by 8 to 9 days but also doubled the risk of
death (Appelgren et al., 2001 [Level IV]). Analysis of the National Nosocomial
Surveillance Index found that themost common infections in an ICU are urinary
tract (31%), pneumonia (27%), and bloodstream infections (19%) and are related
to invasive devices in the vast majority of cases (Richards, Edwards, Culver, &
Gaynes, 1999 [Level IV]).
UTIs are the most common HAIs, accounting for 30% to 40% of all noso-
comial infections and increasing patient morbidity, length of stay, and costs
of care (Brosnahan & Kent, 2004 [Level I]). The risk is directly related to the
use and duration of indwelling bladder catheters, accounting for approximately
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80% of hospital-acquired UTIs. The risk for developing a catheter-associated
UTI (CAUTI) increases by approximately 5% for every hospital day (Nicolle,
2005 [Level V]). In one series, 9% of older patients who received an indwelling
catheter developed a nosocomial UTI during the acute hospital stay; 50% of
catheters used were determined to be inappropriate (Hazelett, Tsai, Gareri, &
Allen, 2006 [Level IV]). A systematic review of the effects of duration of in-
dwelling catheters on patient outcomes during a 37-year period revealed both
a significant increase in UTIs when the catheter was removed after 48 hours
and a reduction in hospital length of stay when removed within 24 to 48 hours
(Fernandez &Griffiths, 2006 [Level I]). Coates, Hu, Bax, & Page (2002 [Level V])
found that catheter duration over 6 days was the highest risk factor for CAUTI
and that by day 30, 100% of patients with catheters developed a UTI. Older
patients are at particular risk for a UTI due to functional abnormalities (e.g.,
obstruction, prostate enlargement), certain medications, and chronic diseases
(e.g., diabetes and cardiovascular and neurological diseases).
Hospital-acquired bloodstream infections are common, serious, and costly
infections that appear to be the eighth leading cause of death in theUnitedStates
(Wenzel & Edmond, 2001 [Level V]). These infections are most often related to
theuse of an invasive device andoccurmore than50%of the time in ICUpatients.
CABSIs are serious and costly infections in ICUpatients, occurring in 3% to 7% of
all patients with central venous catheters (Warren, Zack, Cox, Cohen, & Fraser,
2003 [Level III]). A recent 3-year study of patients in the ICU and CCUs found a
disturbingly high mortality and disability rate in 54 patients with CABSIs: 20 of
the 54 patients died and only 9 were discharged home. Of note is the significant
cost of care imposed by these infections, with the hospital losing money in 50 of
54 cases (Shannon et al., 2006 [Level IV]). The rising proportion of infections
due to antibiotic-resistant organisms, as demonstrated in the largest multisite
prospective surveillance study to date of nosocomial bloodstream infections in
the United States, is of great concern (Wisplinghoff et al., 2004 [Level IV]).
Hospital-acquired pneumonia (HAP) is the second most common type of
nosocomial infection after UTI, with an estimated mortality rate of 20% to 46%
(Arozullah, Khuri, Henderson, & Daley, 2001 [Level IV]) and is the third most
common postoperative complication after urinary tract and wound infections.
Patients receiving continuous mechanical ventilation have a 6- to 21-fold in-
creased risk of developing bacterial HAP (CDC, 2003 [Level I]). Pulmonary as-
piration of secretions from the orophargeal or gastrointestinal tract is the most
common cause of HAP and is considered preventable in the majority of cases
(Brooks-Brunn, 1995 [Level V]). Although there is good evidence that the rate
of aspiration pneumonia can be reduced by routine oral care (Hockenbury &
Litwiller, 2004 [Level V]; Schleder, Stott, & Lloyd, 2002 [Level III]; Simmons-
Trau, Cenek, Counterman, 2004 [Level V]), oral hygiene continues to be a nurs-
ing function of “low priority” in most health care settings (Weitzel, Robinson, &
Holmie, 2006 [Level III]).
Surgical-site infections (SSIs) are the most common type of nosocomial in-
fection in patients undergoing surgery, with incidence rates ranging from 5.6%
to 24.5% of patients (de Oliveira, Ciosak, Ferraz, & Grinbaum, 2006 [Level IV];
Segers, de Jong, Kloek, Spanjaard, & de Mol, 2006 [Level IV]). Patients who
develop an SSI have prolonged and more costly hospitalizations. They are
also twice as likely to die, 60% more likely to be admitted to an ICU, and five
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times more likely to be rehospitalized than patients who do not develop an SSI
(Kirkland, Briggs, Trivette, Wilkinson, & Sexton, 1999 [Level III]). Although the
risk of an SSI varies according to type of surgery and patient-specific factors,
Hollenbeak et al. (2006 [Level IV]) clearly demonstrated that factors related
to the hospital itself, such as practice patterns and the environment of care,
significantly increase the risk of patient harm.
Other infections that commonly affect hospitalized older patients in-
clude those affecting the skin (e.g., methicillin-resistant streptococcal aureus
[MRSA]), the gastrointestinal tract (e.g., clostridium difficile [c. difficile] col-
itis), and candida infections of the oropharyngeal cavity. Clostridium difficile
infections are affecting significant numbers of hospitalized older patients. It is
estimated that 20% to 40% of hospitalized patients are colonized with the c. diffi-
cile toxin as compared to 2% to 3% of healthy adults (Bartlett, 2006 [Level V]). Of
patients with antibiotic-associated diarrhea, 15% to 25% and more than 95% of
patients with pseudomembranous colitis carry the c. difficile toxin. Since 2003,
there has been an increase in frequency and severity of c. difficile infections,
which are also becoming more refractory to treatment and more apt to relapse
(Bartlett, 2006 [Level V]).
The alarming increase in antimicrobial-resistant organisms, such as MRSA
and vancomycin resistant enterococcus (VRE), is of great concern to all health
care providers and organizations. MRSA has increased in prevalence from 2%
of staph aureus infections in 1974 to 63% in 2004, whereas VRE has steadily
increased from <1% in 1990 to 28.5% of enterococcol isolates in 2003 (CDC, 2006
[Level I]). Vancomycin resistance has been shown to be an independent risk
factor for death and is associated with poor patient outcomes, including longer
length of stay, increased mortality, and higher costs of care (Salgado & Farr,
2003 [Level I]). More recently, the increase in multi drug resistant organisms
has been associated with significantly longer hospital stays, increased cost, and
mortality. The CDC has responded with the management of Multi-Drug Resis-
tant Organisms in Health Care Settings Guideline, which outlines administrative
priorities, education and training, judicious use of antibiotics, surveillance pro-
cedures, infection-control precautions, and environmental measures that must
be implemented to prevent transmission of these potentially deadly organisms
(CDC, 2006 [Level I]).
Nursing Strategies for HAI
Reducing the rate of HAI of is one of the Joint Commission’s National Patient
Safety Goals and comprises three of the six goals of the Institute for Healthcare
Improvement’s (IHI) 100,000 Lives Campaign. To that end, it is imperative that
evidence-based medical and nursing care be implemented and that a system
be in place to effectively and efficiently translate this into practice. The WHO
and the CDC have published numerous guidelines for the prevention of health
care infections with recommendations based on levels of evidence from the lit-
erature (see the Resources section). The CDC Guideline for Hand Hygiene in
Health Care Settings (2002) includes the ban on artificial and long nails, man-
dated surveillance programs, and use of waterless-based antiseptic hand rubs
before and after contact with a patient (CDC, 2002 [Level I]). Additional CDC
guidelines include prevention of intravascular site-related infections (2002),
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infection control (2003), health care–associated pneumonia (2003), and MRSA
(2006).
Hand washing and disinfection remains the most effective strategy to elimi-
nateHAI (Rotter, 1998 [LevelV]), and strict handhygiene as outlinedby theCDC
guideline needs to be maintained at all times (Boyce & Pittet, 2002 [Level I]).
Yet, despite widespread knowledge of the problem, health care providers con-
tinue to remain amajor source of nosocomial infection. Studies of hand-hygiene
practices have demonstrated low compliance rates, although coordinated efforts
to address this problem have demonstrated significant improvements in adher-
ence to hand hygiene (Eldridge et al., 2006 [Level V]), and subsequent reduction
in nosocomial infection rates (Aragon, Sole, & Brown, 2005 [Level V]); Halwani,
Solaymani-Dodaran, Grundmann, Coupland, & Slack (2006 [Level IV]) demon-
strated a clear link between cross transmission of nosocomial infection in the
ICU and understaffing, and factors that result in multiple staff–patient contacts,
emphasizing the importance of good hand hygiene. Basic nursing interventions
consisting of strict adherence to hand hygiene and gloves, elevating the head
of the bed (HOB) for patients at risk for aspiration, and routine oral care can
effectively reduce the rate of HAP in ICU patients (Weitzel, Robinson, &Holmie,
2006 [Level III]).
Encouragingdeepbreathing and coughing and incentive spirometry forhigh
risk patients, as well as early mobilization, are critical nursing interventions
to prevent pneumonia. Patients on mechanical ventilation are at substantially
greater risk of ventilator-associated pneumonia (VAP), one of the infections tar-
geted for reduction by the use of the IHI bundles. Elevating the HOB between
30 and 45 degrees has been shown to decrease the incidence of VAP from 34%
to 8% in mechanically ventilated patients (Drakulovic et al., 1999 [Level II]).
Nursing-specific strategies to reduce the risk of VAP are critical and include
hand hygiene; HOB elevation; oral care with an antiseptic rinse for cardiac-
surgery patients; noninvasive positive pressure ventilation; early extubation;
subglottic secretion drainage; and avoiding gastric over-distension, condensate
collection, and unplanned extubation (Hsieh & Tuite, 2006 [Level V]). A reduc-
tion in the rates of VAP and length of stay in the ICUwas demonstrated through
development of an evidence-based guideline that included five nursing inter-
ventions (i.e., HOB elevation, oral care, ventilator tubing condensate removal,
hand hygiene, and glove use) (Abbott, Dremsa, Stewart, Mark, & Swift, 2006
[Level V]). Tolentino-DelosReyes, Ruppert, & Shiao (2007 [Level III]) demon-
strated a significant improvement in critical care nurses’ knowledge and adher-
ence to evidence-based practice after an educational program on the ventilator
“bundle,” or set of interventions, to decrease VAP.
Nurses must be alert to and proactively collaborate with the physician to
ensure the necessity of all invasive devices. Nurse-generated daily reminders
to remove indwelling catheters within 5 days significantly reduced the duration
of catheter use, rate of CAUTI, and the associated costs of care (Huang et al.,
2004 [Level III]). Decision support tools, such as computerized physician order
entry (CPOE) prompts, or standardized orders, have demonstrated the poten-
tial to decrease variation in care and improve patient care (Morris, 2004 [Level
V]; Quinn & Mannion, 2005 [Level III]). A collaborative physician–nurse prac-
tice model utilizing computerized prompts and evidence-based guidelines for
catheter use effectively decreased the use of indwelling bladder catheters and
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the subsequent nosocomial infection rate (Conklin, 2006 [Level III]). A 3-year
prospective cohort study of all patients admitted to four general medical units
at Yale–New Haven Hospital demonstrated that a multidisciplinary approach
using technology (i.e., computerized prompts and bladder scans), staff educa-
tion, and nurse empowerment to encourage timely removal resulted in an 81%
reduction in catheter use and a 73% decrease in nosocomial UTIs (Topal et al.,
2005 [Level III]). When clinically indicated, the use of antimicrobial bladder
catheters (i.e., nitrofurazone-coated silicone or silver-coated latex) can prevent
bacteriuria in hospitalized patients in need of short-term catheterization (John-
son, Kuskowski & Wilt, 2006 [Level I]). Gentry & Cope (2005 [Level III]) found
that silver-alloy hydrogel-coated catheters reduced the risk of nosocomial UTIs
by at least 33.5%. The authors reported that had an assessment for the appropri-
ate indication for the catheter beenperformed in thefirst place, the increased the
risk of infection may have been avoided; therefore, every effort must be made to
address clinical necessity. In addition, the cost of these specialty catheters may
offset the benefits if the use of inappropriate catheterization is not addressed
(Gentry & Cope, 2005). A prospective study to determine risk factors for CAUTI
found not only fecal incontinence to be a major risk but also that the hospi-
tal that used the silver-alloy catheters had a higher rate of CAUTIs, suggesting
that overdependence on this technology may lead to laxity in care (Tsuchida
et al., 2006 [Level IV]). As such, nurses need to be aware of the evidence-based
criteria for an indwelling catheter (Griffiths & Fernandez, 2005 [Level I]) and
collaborate with the primary provider to ensure that the device is clinically jus-
tified and not used for convenience or prevention of iatrogenic skin breakdown
and pressure ulcers rather than good nursing care. When needed, select and
maintain a closed catheter system with a small-size catheter, and insert using
aseptic technique. Properly securing the catheter to avoid any movement that
can introduce bacteria, ensuring unobstructed flow of urine, and properly po-
sitioning the drainage bag are additional interventions that can decrease the
risk of UTI. Routine catheter irrigation should also be avoided (Smith, 2003
[Level IV]).
Risk-screening tools used to identify and stratify a patient’s risk for nosoco-
mial infections such as the National Nosocomial Infections Surveillance (NNIS)
should be used not only for ongoing surveillance and reporting but also consid-
ered to target evidence-based interventions. Golliot et al. (2001 [Level IV]) sug-
gest that all geriatric patients need to be considered as high risk for infection and
closely monitored, and a risk index for nosocomial infection in geriatric rehabil-
itation and long term care facilities should be implemented. Segers et al. (2006
[Level IV]) demonstrated a steady decline in incidence of SSIs during a 2-year
period with the implementation of risk assessment, novel treatment strategies,
and a good surveillance program. A postoperative risk index, which was devel-
oped to identify patients at highest risk of nosocomial pneumonia and better
guide perioperative respiratory care, successfully decreased the rate of pneu-
monia in patients undergoing major noncardiac surgery (Arozullah et al., 2001
[Level IV]). The risk factors includedolder than60years, functional impairment,
and weight loss, suggesting that optimizing nutritional status preoperatively
and promoting timely perioperative physical therapy and nursing mobilization
of a surgical patient can reduce the risk of infection. Central venous catheter
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infections can be reduced significantly using nontechnologic strategies such as
strict hand washing, maximal sterile barrier precautions, use of antiseptic solu-
tions, insertion and management by trained personnel, and continuing quality
improvement programs (Gnass et al., 2004 [Level IV]). Caparros, Lopez, & Grau
(2001 [Level II]) decreased the incidence of catheter-related sepsis by enrich-
ing high-protein formula in critically ill patients receiving enteral feeding with
arganine, fiber, and antioxidants. It is well known that SSIs are reduced with
antibiotic prophylaxis within 2 hours of incision, and the incidence of noso-
comial infection can be safely and effectively reduced by tightening glycemic
control in the critically ill patient population (Grey & Perdrizet, 2004 [Level
II]). To reduce the incidence of SSI, the timing of antibiotic administration
must be a nursing priority and attention given to processes of care (Vazquez-
Aragon, Lizan-Garcia, Cascales-Sanchez, Villar-Canovas, & Garcia-Olmo, 2003
[Level IV]).
Approximately one-third of nosocomial infections can be prevented by ef-
fective evidence-based infection control programs (Haley et al., 1985 [Level I]).
Active, continuous infection control surveillance (rather than passive, volunt-
ary-reporting programs) must be implemented to decrease hospital infection
rates. infection control staff must be actively involved in implementing the
guidelines, training staff, and performing ongoing surveillance and reporting
processes with strong support from hospital leadership. In addition, because
of increasing problems with bacterial resistance, antibiotic therapy needs to be
prescribed judiciously and the use of vancomycin restricted. infection control
efforts need to address strict adherence to appropriate cleansing of equipment
and the environment, isolation of colonized patients, and appropriate surveil-
lance programs.
Processes of care need to be reviewed and interdisciplinary quality improve-
ment efforts initiated tominimize infection. A 5-year nurse-led interdisciplinary
patient safety initiative that addressed systems problems, human factors, staff
education, and reporting systems effectively reduced VAP (from 47.8 to 10.9 per
1,000 ventilator days) and CABSI (from 90th to 50th percentile). In addition, the
rate of serious ADEs decreased by 45%, length of hospital stay was reduced from
8.1 to 4.5 days, RN vacancy rate decreased, and the use of contracted nurses was
reduced by more than half (50% ICU, 65% medical–surgical) (Luther et al., 2002
[Level III]. In a study by Coopersmith et al. (2002 [Level III]), monthly feedback
of infection rates was provided to staff along with an educational program; this
intervention resulted in a 66% reduction in the occurrence of CABSI in the ICU.
Performance feedback to individual surgeons has also been shown to decrease
surgical-wound infection rates (Garcia-Rodriguez et al., 2006 [Level IV]). Ed-
ucation and performance feedback to staff and physicians on compliance with
catheter care and hand hygiene led to a significant reduction in the CAUTI rate
(Rosenthal, Guzman, & Safdar, 2004 [Level III]). Providing nursing staff with
quarterly unit-specific data on CAUTI rates reduced the overall rate of CAUTI
from 32 to 17.4 per 1,000 catheter-patient days at a cost savings of $403,000 dur-
ing an 18-month period (Goetz, Kedzuf, Wagener, & Muder, 1999 [Level III]).
Gastmeier et al. (2002 [Level II]) demonstrated that nosocomial infection rates
can be reduced by introducing quality-improvement efforts such a quality cir-
cles and continuous surveillance.
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Geriatric Syndromes
Geriatric syndromes are increasingly being recognized as serious and pre-
ventable iatrogenic complications. Those that occur as a direct result of medical
and nursing care (iatrogenesis) cause serious adverse outcomes in older pa-
tients. The reader is referred to chapters 3, 7, 9, 12, 13, 15, and 18, which discuss
geriatric syndromes that may be iatrogenic in origin. Geriatric syndromes are
generally defined as highly prevalent, atypical, single-symptom states with var-
ious causes; they need to be recognized as a valuable theoretical framework
and used to train medical students (Olde-Rikkert, Rigaud, van Hoeyweghen, &
de Graaf, 2003 [Level V]) and nurses (Stierle et al., 2006 [Level V]). Geriatric
syndromes are also considered indicative of the quality of care of older adults
in the nursing home setting (Sloss et al., 2000 [Level III]).
Tsilimingras, Rosen, and Berlowitz (2003 [Level V]) contend that the pati-
ent-safety initiatives sparked by the “To Err Is Human” publications do not go
far enough to address the unique needs of older patients who are at greatest risk
of iatrogenic harm. They suggest that geriatric syndromes need to be recognized
as distinct iatrogenic events—going so far as to call them medical errors—and
urge major system reform to address these preventable and costly problems.
Strategies include the need to routinely identify and report all geriatric syn-
dromes and, when they occur, proactively identify and address system failures,
reduce ADEs, improve the continuity of care, improve geriatric training pro-
grams, and establish dedicated geriatric units (Tsilimingras et al., 2003 [Level
V]). Covinsky et al. (1998 [Level III]) demonstrated that functional outcomes
can be improved at no additional cost with the use of a dedicated acute care
for the elderly (ACE) unit, which utilized patient-centered care (i.e., routine
nursing assessment of patient functional status and use of nursing protocols,
rounds by a multidisciplinary team), a specially designed environment, regu-
lar review of medical care, and emphasis on discharge planning. Recognizing
that older patients are at greatest risk of costly adverse outcomes, many health
care organizations are utilizing geriatric specialists, dedicated acute care units
for older patients, interdisciplinary teams, and other innovative models of care
delivery that have dramatically improved geriatric patient care and outcomes.
Berntsen (2006 [Level V]) calls for the implementation of patient centeredness
as a way of minimizing patient harm. One of the original six aims to maintain
patient safety outlined in a major IOM report (2001 [Level I]), patient centered-
ness expects that the needs, wants, and preferences of the patient should drive
health care interventions. Nurses providing patient-centered care compassion-
ately and empathetically respond to the needs of the patient and offer ample
opportunities for patients and families to direct their care through involved and
informed decision making (Berntsen, 2006 [Level V]). Kane (2002 [Level V])
provides a compelling argument that major system reform for chronic disease
is needed if quality geriatric patient care is to be achieved. He suggests reevalu-
ating the roles of not only patients and their families but also hospital personnel
at all levels and utilizing information technology to more closely monitor and
quickly intervene with higher risk patients.
Hospital staff needs to understand the increased vulnerability of older and
critically ill patients, to readily identify those at higher risk, and to proactively
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intervene to prevent patient harm. Evidence-based medical care and nursing
standards of practice for falls, delirium, pressure ulcers, and other geriatric syn-
dromes as outlined in this book need to be adopted. Screening tools, such as the
High Risk Diagnoses for the Elderly Scale, designed to predict 1-year mortal-
ity in hospitalized elders (Desai, Bogardus, Williams, Vitagliano, & Inouye, 2002
[Level IV]), can be used to target patients for interventions to minimize pa-
tient harm and suffering and cost of care. Screening hospitalized older adults
for malnutrition and dehydration early is effective in decreasing protein-calorie
malnutrition (Rypkema et al., 2003 [Level III]). It is widely accepted that hospi-
talized patients with dementia are at greatest risk of developing delirium (Fick,
Agnostini, & Inouye, 2002 [Level I]). Seminal work by Inouye and others in the
area of delirium demonstrated that this serious and costly complication can be
prevented with early preventive strategies, as outlined in chapter 7, Delirium:
Prevention, Early Recognition, and Treatment (Inouye et al., 1999 [Level II]; In-
ouye, 2004 [Level VI]; Milisen, Lemiengre, Braes, & Foreman, 2005 [Level I]).
Adverse Effects of Diagnostic, Medical,
and Surgical Procedures
Patients in CCUs and the elderly are at increased risk of iatrogenic harm due to
the need for more medical procedures and therapies. Iatrogenic pneumothorax
due to either barotraumas or invasive procedures is a life-threatening compli-
cation in 3% of ICU patients (de Lassence et al., 2006 [Level IV]), whereas ICU-
acquired paresis (generalized weakness) appears to affect 25.3% of patients (de
Jonghe et al., 2002 [Level IV]). Patients requiring prolonged mechanical venti-
lation in the ICU are well known to be at significantly greater risk of develop-
ing VAP and suffering poorer outcomes. A 2-year retrospective study of 11,119
patients who underwent cardiac catheterization and/or percutaneous interven-
tions with femoral artery access found that patients older than 70 were at higher
risk of vascular complications (Dumont, Keeling, Bourguignon, Sarembock, &
Turner, 2006 [Level IV]).
Diagnostic tests and procedures involve some degree of risk based on
whether they are invasive or administer a pharmacologically inert agent such
as contrast dye or radiation therapy. Contrast dye, commonly used in CT scans
and myelography, can produce both allergic and nonallergic reactions ranging
from urticaria and angioedema to anaphylaxis. Radiocontrast infusion in pa-
tients with renal impairment can cause acute renal failure or an exacerbation
of CHF. Intrathecal use of contrast media in myelography is known to produce
various adverse effects including vasovagal syncope, nausea, postural headache,
hearing loss, aseptic meningitis, and encephalopathy.
Medical procedures, such as thoracentesis and cardiac catheterization, have
also been linked to significantly more preventable adverse effects, such as
cardiac arrhythmias, bleeding, infection, and pneumothorax, in older adults
(Thomas & Brennan, 2000 [Level IV]). The literature is full of case reports
of iatrogenic injuries and deaths due to procedures such as venous embolism
caused by the injection of CT contrast (Imai, Tamada, Gyoten, Yamashita,
& Kajihara, 2004 [Level V]), aspiration deaths due to barium (Blackmore,
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Cranshaw, & Soar, 2005 [Level V]), emollient laxatives and contrast medium
(Hunsaker & Hunsaker, 2002 [Level V]), and colonic perforations due to en-
doscopy or enema (Bobba & Arsura, 2004 [Level V]). As mentioned previously,
device-related infections, particularly central venous catheter bloodstream in-
fection, VAP, and CAUTIs, pose an enormous threat to geriatric and critically
ill patients and are of even greater concern in developing countries (Rosenthal
et al., 2006 [Level IV]).
Even relatively risk-freemedical andnursingprocedures suchas the admin-
istration of intravenous fluids can be dangerous in an older patient with age-
related reduced cardiac reserve, leading to preventable CHF or hypokalemia.
Sherman (2005 [Level V]) identifies three new forms of geriatric iatrogenesis,
referred to as the “hypos” of hospitalization, that can delay discharge, increase
costs, and lead to adverse patient outcomes. Iatrogenic-induced hypokalemia
occurs when intravenous fluids are given without potassium, whereas hypoten-
sion can be induced when an as-needed antihypertensive is administered for
a high blood pressure taken while the patient is in the supine position. Tran-
sient decreases in oral intake in patients receiving oral hypoglycemic agents or
standing insulin orders can cause preventable hypoglycemia, if the lower limit at
which the insulin is administered is not at least a blood glucose of 200 or 250g/dl.
Hospital-acquired acute renal failure is common, with iatrogenic causes impli-
cated in half of all patients (Finn, 2003 [Level V]). Unnecessary bedrest, in and
of itself, can have serious negative effects on older patients, including functional
decline, venous thrombotic embolism (VTE), pressure ulcers, falls, delirium, or-
thostatic hypotension, anorexia, and constipation and fecal impaction, among
others adverse outcomes.
Surgical and perioperative complications are also common, although great
strides have been made, especially in the areas of perioperative management,
anesthesia, surgical technique, and intensive care. A 5-year study examining
iatrogenic ureter injuries found that incidence of injuries declined from 31.7%
to 11.8%, attributing the decline to the use of prophylactic J stent or ureteric
catheter placement (Al-Awadi, Kehinde, Al-Hunayan, & Al-Khayat, 2005 [Level
IV]). Although age per se is not an independent risk factor for perioperative
complications, pathologic changes associated with age especially in the cardio-
vascular and pulmonary systems tend to place an older patient at greater risk.
Age-associated changes and atypical presentation of disease further complicate
the picture, making diagnosis more difficult. As such, geriatric patients account
for half of all surgical emergencies and three-fourths of all operative deaths;
therefore, timely diagnosis and optimal perioperative care is critical for survival.
Assessment and Interventions to Reduce Adverse Effects of
Diagnostic, Medical, and Surgical Procedures
Nurses have a responsibility to recognize the increased risk to older patients
of any diagnostic, prophylactic, and medical procedures. Collaboration with the
physician is important to ensure that the patient is giving informed consent and
that the patient is appropriately screened, assessed, and managed to prevent
unnecessary harm. Nursesmust also ensure the patient clearly understands the
inherent risks and benefits. Given the significantly greater risk of harm in older
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adults, a geriatric patient requires a careful and comprehensive assessment of
the appropriateness of all invasive procedures and devices. Although health
care professionals are trained to always weigh the risk and benefits, it is critical
to heighten one’s assessment of the situation and to err on the side of caution
with older patients. Potentially harmful diagnostic and therapeutic procedures
may well be contraindicated if the potential benefit does not clearly increase
the potential for improving patient outcomes. This is particularly important,
given the strong evidence that the older population tends to have lower rates
of informed consent (Sugarman, McCrory, & Hubal, 1998 [Level I]). Ensuring
that an older patient clearly understands the risks and benefits of any and all
invasive procedures and is truly making an “informed” decision is critical and
may warrant several discussions to evaluate the patient’s understanding of the
situation. Given the age-associated increase in sensory deficits (see chapter 21,
Sensory Changes), it is critical to identify visual or hearing loss that may impair
patient understanding and provide the patient with appropriate sensory aides
(e.g., glasses, hearing amplifier).
Nurses must take a more active role in identifying patients at higher risk of
surgical complications, given the evidence that only a small percentage of sur-
geons and anesthetists recognized the higher risk patients or ordered improved
postoperative monitoring (Pirret, 2003 [Level III]). A simple nursing preoper-
ative assessment tool identified the higher risk patients in need of improved
postoperative monitoring and reduced acute admissions to the ICU from 40% to
19%. Barbosa-Silva and Barros (2005 [Level IV]) determined that a newmethod
of nutritional screening is an important nutritional prognostic variable that can
be used to identify the risk of postoperative complications. Collaborating with
nutrition services to identify the higher risk patient, nursing can intervene to
increase postoperative monitoring and management.
Contrast dye needs to be avoided in patients with renal insufficiency, and
nursing staff needs to closely monitor the patient’s hydration status before
and after the use of contrast dye in diagnostic studies. Careful monitoring and
stabilization of all active medical problems and attention to age-adjusted ap-
proaches during the perioperative phase is equally important. Administering
age-adjusted appropriatemedications to premedicate prior to procedures is crit-
ical, as is the ability of the nurse to question what may be a high risk dose or
drug. A geriatric patient’s oral intake needs to be carefully monitored and re-
ported, and insulin needs to be adjusted to prevent hypoglycemia (Sherman,
2005 [Level V]). Nursing staff needs to routinely take orthostatic vital signs or
to at least measure the blood pressure of older patients in at least the sitting po-
sition to ensure that standing systolic and diastolic hypotension is not induced
by treating supine systolic hypertension (Sherman, 2005 [Level V]).
Evidence-based guidelines need to be adopted, with fastidious attention to
the implementation process. Nursing care focused on preventing infection, re-
ducing tension at the surgical site, and optimizing nutritional status has been
shown to effectively prevent surgical-wound dehiscence, a serious complica-
tion with up to 50% mortality (Hahler, 2006 [Level V]). Given the plethora of
evidence that communication and other systems problems cause iatrogenic pa-
tient harm, the Joint Commission recently mandated timeouts and other verifi-
cation procedures at high risk times to prevent wrong-site surgeries and other
errors (Edmonds, Liguori, & Stanton, 2005 [Level V]).
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Provider Beliefs and Attitudes
Although the majority of the literature focuses on iatrogenic illness and injuries
that result from either the commission or omission of a physical act, arguments
can bemade that equally detrimental effects to patients can occur as a direct re-
sult of a health care practitioner’s values, beliefs, fears, prejudices, and attitudes.
For example, the early belief that ulcers were due to psychological problems
and that leprosy was a contagious disease that warranted lifetime quarantine
resulted in undue suffering by large numbers of people. A nurse’s perception of
older adults as chronically ill and frail may foster increasing dependence and
functional declinewhen the patient is not provided the opportunity or assistance
to routinely ambulate or engage in self-care skills. A diagnosis of dementia may
lead a prejudiced or uneducated health care practitioner to expect less of a pa-
tient and to subsequently offer fewer treatment options.
Providers who fail to place the patient’s values ahead of their own can cause
undue suffering and harm when these values are in conflict. It is well known
that a significant number of nursing home patients suffer needlessly in pain,
sometimes due to a clinician’s fear of narcotic dependence that takes prece-
dence over comfort. Older adults, more than any other age group, tend to be
under-treated for pain (Robinson, 2007 [Level V]; Lovheim, Sandman, Kallin,
Karlsson, & Gustafson, 2006 [Level IV]) and other conditions, including osteo-
porosis (Davis, Ashe, Guy, & Khan, 2006 [Level IV]) and depression (Harman
et al., 2002 [Level IV]). In a study examining the attitudes of family physicians
toward late-life depression, the authors attributed its under-treatment to over-
confidence by providers with no recent training in the condition, 41% of whom
identifieddepression as themost commongeriatric problem (Harmanet al., 2002
[Level IV]). The assumption that the quality of life of the demented person is
“poor” may contribute to the assumption by the nurse or physician that pallia-
tion or institutionalization is the most appropriate goal of care, regardless of the
values of the older adult. Kenny (1990 [Level V]) asserts that the present sys-
tem of hospital care not only perpetuates dependency and iatrogenesis among
geriatric patients but also tends to “erode their self-esteem, identity and in-
dividuality.” In addition, prolonged hospital stays are known to increase social
isolation and foster dependence (Mayo,Wood-Dauphinee, Gayton, & Scott, 1997
[Level IV]). One is left to wonder howmuch thismay contribute to the high rates
of depression in hospitalized older patients. To make matters worse, older pa-
tients are known to under-report or deny symptoms, in part because they have
grown accustomed to living with chronic aches and pains andmay interpret new
symptoms as yet another symptomof a long-standing health problem. Theymay
believe the symptom is a normal part of aging or fear a loss of independence or,
worse, institutionalization if they admit to a physical or cognitive deficit. Older
adults today are also from a generation who respect and more readily accept
the word of the physician and are less inclined to be assertive with the provider
or aggressive in seeking a second opinion. These factors can have disastrous
results when it is considered that most physicians are poorly trained in geriatric
health care and may be unaware of core concepts of geriatric medicine, such as
the importance of a functional approach to care and the atypical presentation of
disease that makes diagnosis more difficult. As such, it is important that health
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care practitioners examine their belief systems and educate themselves and not
unwittingly contribute to the patient’s suffering and despair because of biases
toward older patients that can compromise clinical objectivity and patient care.
Medical and Nursing Error and Other
Care-Related Factors
The plethora of literature and research sparked by the patient-safetymovement
hasdocumented that theprovisionofmedical andnursing care itself places older
patients at increased risk of health care–related harm. It is now well recognized
that a significant proportion of iatrogenic complications are directly related to
the complex interplay of organizational and human factors that create opportu-
nities for patient harm. A prospective study of patients admitted for CHF found
that 7% of admissions were the result of improper treatment, including fluid
overload, and inappropriate medications and procedures. In addition, hospi-
tal mortality for this group was three times greater than older patients admitted
without iatrogenic CHF (Rich et al., 1996 [Level IV]). TheHarvardMedical Prac-
tice Study found that a disturbing 20.7% of adverse events was due to negligence,
with a significantly greater proportion occurring among older patients (Brennan
et al., 1991, 2004 [both Level IV]).
Lack of provider and organizational awareness of the risk and lack of atten-
tion to patient and environmental safety further increase the risk of iatrogenic
harm.As such,maintaining patient safety depends onunderstanding andproac-
tively addressing measures to ensure systems and processes of care that foster
safe, evidence-based patient care. An in-depth discussion of medical and nurs-
ing error and the organizational interventions needed tomaintain patient safety
is beyond the scope of this chapter. However, nurses need to be at the forefront
and engaged in interdisciplinary efforts to prevent unnecessary patient harm.
Nurses play a pivotal role in preventing patient harm. They are not only the
largest workforce of health care providers, they also provide the final “barrier
a patient has to being a victim of error” (Hughes & Clancy, 2005 [Level V]).
Significant strides in improving patient care have been made with nurses ac-
tively involved in identifying care-related problems. For example, the Institute
for Healthcare Improvement (IHI) and The Robert Wood Johnson Foundation–
sponsored national initiative, Transforming Care at the Bedside (TCAB), cre-
ates, tests, and implements nurse-generatedpractice changes (Viney, Batcheller,
Houston, & Belcik, 2006 [Level V]) to improve patient care and safety. A 6-
week nationwide study of the effect of nursing rounds at least every 2 hours
demonstrated a significant decrease in call-light use and a subsequent re-
duction in patient falls and increase in patient satisfaction (Meade, Bursell &
Ketelsen, 2006 [Level III]. Connor (2002 [Level IV]) reports on effective multi-
disciplinary approaches that include patient safety rounds and problem-specific
teams that created and implemented evidence-based opiate guidelines, im-
proved painmanagement through amultidisciplinary educational program, and
routinely reviewed and addressed medication events. Of import, a recent sur-
vey of 1,200 critical care nurses demonstrated that nurses in hospitals who had
adopted an oral care protocol were more apt to implement evidence-based care
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than those who did not use the protocol, and that there is inconsistent adop-
tion and adherence to the CDC guidelines for VAP in the United States (Cason,
Tyner, Saunders, Broome, & Centers for Disease Control and Prevention, 2007
[Level IV]). The critical need for optimal implementation of and adherence to
evidence-based guidelines, including adoption of nursing protocols, cannot be
underemphasized.
National and Organizational Priorities
Despite early recognition of the problem, better care, and prophylaxis for ia-
trogenic events, progress has been slow and the rate of preventable adverse
events remains alarmingly high; several appear to be increasing. The IOM To
Err Is Human report increased provider awareness to the dangers of diagnos-
tic and therapeutic interventions and led to a significant increase in patient-
safety research, literature, and initiatives (Stelfox, Palmisani, Scurlock, Orav,
& Bates, 2006 [Level V]). Continued funding for patient-safety research and
major patient-safety initiatives by organizations such as Agency for Healthcare
Research and Quality (AHRQ), the IHI, Leapfrog Group, IOM, and others must
be a priority (Leape, 2005a [Level V]). IHI’s “5 Million Lives Campaign” aims to
protect that many patients from incidents of medical error in the 2 years pre-
ceding. Affonso, Jeffs, Doran, & Ferguson-Pare (2003 [Level V]) and Johnstone
and Kanitsaki (2006 [Level V]) contend that health professional groups and or-
ganizations are morally obligated to make patient-safety research a priority and
that nursing organizations need to provide active leadership and commitment
to this endeavor.
Developing, implementing, and regularly updating evidence-based inter-
ventions at the national and local levels are critical. National evidence-based
guidelines and standards of practice, especially in the areas of infection con-
trol by the CDC and WHO, and geriatric best practice by geriatric nursing ex-
perts working with The John A. Hartford Foundation, have been and continue
to be developed and regularly updated. Health care organizations have not only
a responsibility to ensure that these standards are implemented and adhered
to but also an economic imperative, due to the unnecessary costs associated
with iatrogenesis (Hwang & Herndon, 2007 [Level V]). Inouye and colleagues
(2003 [Level III]) demonstrated that effective delirium prevention in acutely ill
patients was dependent on nurse’s adherence to nonpharmacologic protocols.
The Joint Commission has taken the lead in hospitals by mandating adherence
to annual patient safety goals, such as improving the accuracy of patient iden-
tification and communication between caregivers, improving medication safety,
reducing the risk of infection, and preventing falls and pressure ulcers.
Effortsmust continue to increase education and training to allmedical, nurs-
ing, and ancillary health care professionals (HCPs) in the areas of iatrogene-
sis, gerontological nursing, geriatric syndromes, patient safety, and teamwork.
Wakefield et al. (2005 [Level V]) argue that nursing and medical schools must
integrate patient-safety principles into their curricula in order to teach HCPs
to more effectively prevent and manage errors and to ease the burden on an
already overstretched health care system. More emphasis needs to be placed on
teaching the aviation model, which emphasizes teamwork and communication,
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and for nurses to understand human factors as a cause of and means to prevent
error and patient harm (Sherwood, Thomas, Bennett, & Lewis, 2002 [Level V]).
Of concern is the disturbing lack of geriatric education in health care professions
schools that is only beginning to be addressed. Research in the area of delirium,
restraints, and CHF has demonstrated that nurses with training in geriatrics
provide significantly better care to older patients (Foreman, Wakefield, Culp, &
Milisen, 2001 [Level V]; Lacko et al., 2000 [Level III], Naylor, 2004 [Level V];
Neufeld et al., 1999 [Level IV]). Initiatives to promote more geriatric education
in nursing schools and geriatric competence for all nurses need to continue and
to be supported (Stierle et al., 2006 [Level V]). Medical trainees need additional
training in malnutrition (Singh, Watt, Veitch, Cantor, & Duerksen, 2006 [Level
III]), geriatric syndromes (Olde-Rikkert et al., 2003 [Level V]), and functional
and diagnostic assessment of frail older patients in order to prevent iatrogenic
harm, including cascade iatrogenesis (Potts et al., 1993 [Level IV]). Every effort
must be taken to ensure that nursing and other health-professional students
receive similar training. Although improvements have been made in the past
decade integrating more gerontological nursing education into nursing-school
curricula, Bermanet al. (2005 [Level IV]) demonstrated a critical need to address
the shortage of nursing faculty qualified in gerontology.
Nurse staffing and competence is imperative, given strong evidence that
both staffing levels and educational preparation inversely affect patient care.
The groundbreaking AHRQ report entitled “Keeping Patients Safe: Transform-
ing the Work Environment of Nurses” demonstrated that staffing and workflow
design clearly impact errors and patient-safety outcomes (Page, 2004 [Level I]).
A study ofHAIs in the ICU confirmed previous data that nurse staffing is directly
related to infection rate. The authors noted an increase in infection several days
after heavy workload, and they advocate maintaining staffing at higher levels
to minimize the risk of infection (Hugonnet, Chevrolet, & Pittet, 2007 [Level
IV]). Yet, despite increased attention and major research done in this area, lack
of standardized data and other problems continue to hinder attempts to find a
clear solution to the optimal staffing needed to minimize error (Blegen, 2006
[Level I]). Research must continue in this area so that improvements in nurse
staffing, work areas, and transfer of knowledge bothwithin the organization and
between providers is optimized to maintain patient safety.
Health care organizations need to ensure that coordinated and effective
training in both patient safety and geriatric patient care is well integrated into
staff orientation and ongoing in-service and annual mandatory and compe-
tency training programs. Collaboration between education and risk manage-
ment, quality and infection control is important to effectively identify educa-
tional priorities and themost effective training strategies. Lee, Fletcher,Westley,
& Fankhauser (2004 [Level V]) successfully enhanced the competence of nurs-
ing staff in geriatric nursingusing a series of self-paced learningmodules in con-
junction with the implementation of the geriatric resource nurse (GRN) model
of care and staff development. Parke, Ross, & Moss (2003 [Level V]) created
and implemented the gerontological enrichment program in which knowledge,
skills, and abilities were successfully integrated into existing acute care nursing
competencies.
Hospital and nursing leadership need to embrace patient safety as an ex-
plicit organizational goal and actively promote a culture of safety in which
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everyone is aware of the significance of iatrogenesis and accepts that human
beingsmakemistakes even in perfect systems (Dennison, 2005 [LevelV]). Lead-
ership must foster a safety-oriented environment in which all staff and physi-
cians are encouraged to identify, report, and actively work in a positive manner
to eliminate potentially harmful situations (Leape, 2000 [Level VI]). A national
survey of nurses in 25 U.S. hospitals found a large percentage of iatrogenic harm
is not reported by nurses, a mere 36% of whom felt near misses should be re-
ported (Blegen et al. (2004 [Level IV]). Leape, a leading and respected authority
on patient safety, considers it an ethical imperative to “first, do no harm,” and
encourages physicians to do everything practical to keep patients safe, including
being open and honest with patients and ensuring the competence of colleagues
(Leape, 2005b [Level VI]).
Safe patient care cannot be ensured without the appropriate organizational
structure and processes that promote efficient communication of pertinent in-
formation. It is imperative that hospitals address systems problems, including
staffing and workflow design, processes of care such as communication and
teamwork, and human factors such as fatigue, all of which are known to jeop-
ardize patient safety. Communication and collaboration is vital “to ensure ap-
propriate exchange of information and coordination of care” (IOM, 2001 [Level
I]), whereas lack of communication is considered a major contributor to ia-
trogenic complications. The Joint Commission recognized that communication
breakdown is the cause of close to 70% of all sentinel events, although a study to
elicit stories of preventable physical or psychological harm due to medical error
found breakdown in communication was a far greater problem than technical
error (Kuzel et al., 2004 [Level IV]).
Hospitals need to examine information processes to ensure that pertinent
data are routinely and consistently shared with the health care team, includ-
ing the patient. It is critical to evaluate and optimize which patient information
is communicated during any handoff report, especially at high risk times, and
create evidence-based guidelines regarding what needs to be included during
this process (Alvarado et al., 2006 [Level IV]). Inaccurate or absent informa-
tion can dramatically increase the risk of harmful effects on older patients. The
“kardex” and care plan for an older patient that lacks critical baseline functional
and cognitive data can hamper recognition of subtle changes in condition and
may contribute to functional decline and other adverse outcomes, including cas-
cade iatrogenesis. Nursing staff needs to include daily functional priorities and
goals that have been developed with the patient and/or family into every shift
or handoff report.
Evidence suggests that patient transfer from either another unit or hospital
maybe independently associatedwith the development of nosocomial infections
(Eveillard, Quenon, Rufat,Mangeol, & Fauvelle, 2001 [Level IV]). Boockvar et al.
(2004 [Level IV]) demonstrated that patient transfer from hospital to a skilled
nursing facility was a significant risk factor for ADEs. Every effort must bemade
to also address the communication of appropriate data during these high risk
times. It is widely recognized that hospital discharge is a potentially high risk
opportunity for ADEs; therefore, posthospital medication-management strate-
gies using interdisciplinary teams, information technology, and transitional-
care models need to be considered (Foust, Naylor, Boling, & Cappuzzo, 2005
[Level V]). Telephone calls to recently discharged patients can be an effective
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measure to minimize adverse events and prevent unnecessary readmissions
(Forster et al., 2004 [Level IV]). Because so many hospital admissions are re-
lated to ADEs, hospitals should consider screening for them in the emergency
department to better understand and address the problem in the outpatient
setting (Hafner, Belknap, Squillante, & Bucheit, 2002 [Level IV]).
Information technology has the potential to significantly improve our ability
to provide safe patient care by enhancing communication and providing deci-
sion support. The electronic medical record (EMR) needs to be a considered a
priority by organizations as a means to ensure that evidence-based patient care
is implemented and monitored (IOM, 2001 [Level I]). A well-designed EMR
with CPOE has been shown to reduce the number of medication errors by 81%
(Koppel et al., 2005 [Level IV]). Not only are prescription errors due to illegible
handwriting prevented, but the EMR can also ensure best-practice prescribing
using standardized order sets and preprogrammed medication alerts to prevent
adverse drug–drug interactions. The EMR also has the capability to provide de-
cision support, promote continuity of care, and decrease adverse events with
more efficient communication between care providers, especially at high risk
times such as during cross-coverage (Petersen, Orav, Teich, O’Neil, & Brennan,
1998 [Level III]) and during handoff. However, after identifying 22 types of error
risks with the CPOE system, Koppel et al. (2005 [Level IV]) warn that attention
needs to be given to the role of the EMR in facilitating medication errors and
every measure taken to reduce this risk,. It is also important that health care
professionals with geriatric background be involved from the onset with the
building of the EMR to ensure that best-practice geriatric assessment and man-
agement protocols are included. Nurses need to be aware of the limitations of
CPOE and remain vigilant partners in care to ensure patient safety.
Health care organizations need to recognize both what constitutes high risk
situations and those populations most at risk for adverse outcomes and im-
plement effective patient-safety strategies designed to minimize harm. Other
evidence-based priorities needed by health care organizations to address all
the factors required to promote patient safety are critical; however, they are
beyond of scope of this chapter. The IHI has developed an eight-step process
for leaders to follow to improve patient safety (http://www.ihi.org/IHI/Results/
WhitePapers/LeadershipGuidetoPatientSafetyWhitePaper.htm), whereas Den-
nison (2005 [Level V]) suggests hospital leadership use the “PATIENT SAFE”
mneumonic to ensure that the numerous, necessary steps are taken to ensure
patient safety.
Nurses are in a unique role to prevent the cascade of iatrogenesis (Jacelon,
1999 [Level V]) and must use their knowledge of aging to proactively intervene
to promote and advocate safe, quality geriatric patient care to members of the
health care team, including physicians. For example, knowledge of the concept
of diminishing physiologic reserve capacity with aging should prompt the nurse
to understand the need to balance diagnostic and therapeutic interventions with
the need for rest and sleep (Hart, Birkas, Lachmann, & Saunders, 2002 [Level
V]). Closely monitoring sleep patterns in order to prevent sleep deprivation
and scheduling tests and therapy only after the patient has adequate rest are
critical to prevent delirium and promote healing. Computerized prompts to use a
nonpharmacological sleep protocol, which is as effective and less harmful than
sedative-hypnotic medications and promotes higher quality sleep (McDowell,
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Mion, Lydon, & Inouye, 1998 [Level III]), have decreased the use of higher risk
sleeping medications (Agostini et al., 2007 [Level III]).
Promoting a more collaborative relationship between the nurse and the pa-
tient to attain mutually agreed-upon goals is an important but often overlooked
process of care that can foster more patient control, self-care, and autonomy.
Faulkner (2001 [Level III]) developed a tool that measures the extent to which
a nursing unit empowers or disempowers patients, implying that the latter will
increase their risk of becoming dependent, and suggests that the tool can posi-
tively augment quality-improvement efforts. Nurses must effectively encourage
patients to be vigilant and proactive partners in care in order to prevent un-
necessary harm (Hibbard, Peters, Slovic, & Tusler, 2005 [Level IV]). Providing
patient education about medical errors and what they could do about them has
been shown to increase actual protective behaviors in patients (Hibbard et al.,
2005 [Level IV]). Given the evidence, the Joint Commission is following suit with
its 2007 patient-safety goal mandating more active involvement of patients in
their plan of care. Hospitals are encouraged to provide patients with fall pre-
vention and restraint-reduction patient-safety information upon admission in
order to encouragemore active involvement of the patient and significant others
in maintaining safety.
Conclusion
Significant progress has been made in better understanding and addressing the
problem of iatrogenesis with the work of agencies such as the AHRQ, IHI, Joint
Commission, National Patient Safety Foundation, IOM, Leapfrog Group, and
others. Major strides have been made in the Veterans Administration health
system, which implemented systemwide patient-safety and training initiatives
and created four patient-safety research centers, emerging as a leader in pa-
tient safety. Yet, there remains much work to be done, especially in the area of
preventing harm to vulnerable geriatric patients.
Nursesmust recognize their critical role in preventing these iatrogenic com-
plications, which far too often can and do trigger a cascade of inevitable decline
that could have been prevented if the initial iatrogenic event had not occurred.
Nurses have a responsibility to advocate for their patients, and this duty is crit-
ical for patients who cannot do so for themselves, such as cognitively impaired
elders and those without family support. They depend on the nurse’s knowledge
of their baseline functional and cognitive status and risk factors to appreciate
the goals of and barriers to care. They rely on the nursing staff’s ability to rec-
ognize subtle changes and to proactively intervene to keep older patients safe
while hospitalized. Involving family and caregivers as much as possible and
providing predischarge training and referral to community resources can help
discharge at-risk patients in a timelier manner and minimize recidivism. No
longer should iatrogenic harm be the unfortunate price that patient’s pay for
medical progress, nor should we accept the fact that random, unlucky events
happen in a chaotic environment. Rather, nurses need to take a stand to ed-
ucate themselves and others to the problem of iatrogenesis and to take every
precaution necessary to ensure a culture and practice of patient safety that will
one day result in a decline in this major public health problem.
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Resources
Patient Safety
Agency for Health Care Research and Quality (AHRQ): Patient Safety Network
http://www.psnet.ahrq.gov/
Institute for Healthcare Improvement http://www.ihi.org/IHI/
Institute of Medicine http://www.iom.edu/
IOM Crossing the Quality Chasm http://www.iom.edu/CMS/8089.aspx
Joint Commission www.jointcommission.org/PatientSafety
National Patient Safety Foundation http://www.npsf.org/
U.S. Department of Veterans Affairs National Center for Patient Safety http://
www.patientsafety.gov/
WorldHealthOrganizationWorldAllianceonPatient Safetyhttp://www.who.int/
patientsafety/en/
InfectionControl Centers forDiseaseControl andPrevention (CDC)http://www.
cdc.gov
Association for Professionals in InfectionControl andEpidemiology (APIC), So-
ciety of Healthcare Epidemiology of America (SHEA) http://www.apic.org/
Content/NavigationMenu/GovernmentAdvocacy/MandatoryReporting/
PositionPapers/mrpositionpapers.htm
National Nosocomial Infection Surveillance System http://www.cdc.gov/ncidod/
dhqp/nnis.html
Handwashing Guidelines http://www.mrw.interscience.wiley.com/cochrane/
clsysrev/articles/CD005186/frame.html
World Health Organization’s World Alliance for Patient Safety
Guidelines onHandHygiene inHealth Care (AdvancedDraft, 2005) http://www.
who.int/patientsafety/events/05/HH en.pdf
Clinical Practice
AHRQ (Agency for Healthcare Research and Quality) Clinical Practice Guide-
lines http://www.ahrq.gov/clinic/cpgsix.htm
EPIQ (Effective Practice, Informatics and Quality Improvement) Supports
effective, evidence-based practice, health informatics, and quality im-
provement initiatives http://www.health.auckland.ac.nz/population-health/
epidemiology-biostats/epiq/
National Guideline Clearinghouse
A public resource for evidence-based clinical practice guidelines http://
www.guideline.gov/
Joanna Briggs Institute (Promote and Support Best Practice) International, in-
terdisciplinary evidence-based resources http://www.joannabriggs.edu.au/
about/home.php
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Reducing
Adverse Drug
Events
DeAnne Zwicker
Terry Fulmer
Educational
Objectives
On completion of this chapter, the reader will be
able to:
1. conduct a comprehensive medication assessment
2. specify four medications or medication classes
with a high potential for toxicity in older adults
3. describe five reasons that older adults experience
adverse drug events
4. delineate strategies to prevent common
medication-related problems in older adults
5. develop an individualized plan to promote
medication safety of an older adult
Overview
Adults become increasingly susceptible to adverse drug events (ADEs) as they
age. Physiological changes characteristic of aging predispose older adults to
experience ADEs resulting in four times more hospitalizations in older versus
younger persons. People older than 65 experiencemedication-related problems
for seven major reasons: (1) age-related physiologic changes that result in al-
tered pharmacokinetics (i.e., reduced ability to metabolize and excrete med-
ications) and pharmacodynamics (i.e., changes in sensitivity to medications)
(Mangoni & Jackson, 2003 [Level VI]; Rochon, 2006 [Level V]); (2) multiple
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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medications (i.e., polypharmacy), which are often prescribed by multiple
providers (Hajjar & Kotchen, 2003 [Level IV]; Hanlon, Schmader, Ruby, &Wein-
berger, 2001 [Level V]); (3) incorrect doses of medications (over or under a ther-
apeutic dosage) (Astin, Pelletier, Marie, & Haskell, 2000 [Level IV]; Doucette,
McDonough, Klepser, & McCarthy, 2005 [Level V]; Hanlon, Schmader, Ruby, &
Weinberger, et al., 2001 [Level V]; Sloane, Zimmerman, Brown, Ives, & Walsh,
2002 [Level II]); (4) medication consumption for the treatment of symptoms that
are not disease-dependent or -specific (i.e., self-medication or prescribing cas-
cades) (Neafsey & Shellman, 2001 [Level IV]; Rochon & Gurwitz, 1997 [Level
V]); (5) iatrogenic causes such as adverse drug reactions (ADRs) including drug–
drug or drug–disease interactions (Gurwitz et al., 2005 [Level II]; Hohl et al.,
2005 [Level IV]; Lazarou, Pomeranz, & Corey, 1998 [Level I]; Petrone & Katz,
2005 [Level IV]; Pirmohamed et al., 2004 [Level IV]) and inappropriate prescrib-
ing for older adults (Fick et al., 2003 [Level VI]); (6) problems with medication
adherence; and (7) medication errors (Doucette et al., 2005 [Level V]; National
Council on Patient Information and Education (NCPIE), 1997 [Level VI]).
Background
It is estimated that the majority of adults older than 65 (79%) are taking medica-
tions, with 39% taking five or more drugs and up to 90% taking over-the-counter
(OTC) drugs (Hanlon, Fillenbaum, Ruby, Gray & Bohannon, 2001 [Level V]).
Other studies reported that older adults consume more than one-third of all
prescription drugs and purchase 40% of all over-the-counter (OTC)medications
(Besdine et al., 1998 [Level VI]; Hanlon, Fillenbaum, Ruby, Gray, & Bohannon,
2001 [Level V]; Kohn, Corrigan, & Donaldson, 2000 [Level VI]). Even if older
adults are adherent with their prescribed medications, the combination with
OTCs (often unreported to health care providers by older adults), herbal reme-
dies, and dietary supplements may lead to adverse drug–disease interactions
(Astin et al., 2000 [Level IV]) and drug–drug interactions (Rochon, 2006 [Level
V]). Information, communication, andmonitoring systems are needed to reduce
if not eliminate preventable ADEs in this population.
Adverse Drug Events
An ADE is an adverse outcome that occurs during normal use of medicine, in-
appropriate use, inappropriate or suboptimum prescribing, poor adherence or
self-medication, or harm due to a medication error. Older adults’ susceptibil-
ity to ADEs is noted in the literature on iatrogenic events and medication er-
rors (Childs, 2000; Gurwitz et al., 2003 [Level IV]; Hohl et al., 2005 [Level IV]).
ADEs are an important cause of morbidity in older adults, leading to emer-
gency room visits and hospital admissions (Budnitz et al., 2006 [Level V]). It
is estimated that 35% of older persons experience ADEs, almost half of which
are preventable (Safran et al., 2005 [Level IV]). Older adults are also at signif-
icant risk for further ADEs while in the hospital (Lazarou et al., 1998 [Level I])
and after discharge (Hanlon et al., 2006 [Level II]). Significant morbidity (Han-
lon, Fillenbaum, Ruby, Gray, & Bohannon, 2001 [Level V]; Budnitz et al., 2006
[Level V]) and mortality are associated with ADEs, which are estimated to cost
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the health system approximately $75 billion to $85 billion annually (Fick et al.,
2003 [Level VI]). ADEs are associated with preventable outcomes (i.e., depres-
sion, constipation, falls, immobility, confusion, hip fractures, rehospitalization,
anorexia, and death) (Bootman,Harrison, &Cox, 1997 [Level VI]) and are linked
to 106,000 deaths annually (Lazarou et al., 1998 [Level I]).
Iatrogenic Causes of ADEs
The term iatrogenic, as it relates to ADEs, means any undesirable condition
in a patient occurring as the result of treatment by a health care professional,
pertaining to an illness or injury resulting from amedication/drug or treatment.
An iatrogenic medication event is one that is preventable, such as the wrong
dose of amedication given resulting in an adverse outcome.ADRs, inappropriate
prescribing of high risk medication to older adults, and medication errors are
also considered preventable, or iatrogenic ADEs.
ADRs
Anadverse drug reaction (ADR) is any toxic or unintended response to amedica-
tion. According to the Committee of Experts on SafeMedication Practices (COE,
2005), ADRs are ADEs that are preventable. The prevalence of ADR-related
hospitalizations ranges from 5% to 35% (Gurwitz et al., 2003 [Level IV]; Kohn
et al., 2000 [Level VI]). Among a community-dwelling population of older adults,
38% of ADRs were considered serious, life-threatening, or fatal; 27% were con-
sidered preventable (Gurwitz et al., 2005 [Level II]). Generalized to the cur-
rent Medicare population, the ADR rate would be approximately 1.9 million per
year with 180,000 characterized as life-threatening reactions. Pirmohamed et al.
(2004 [Level IV]) reported that 70% of ADRs were either possibly avoidable or
definitely avoidable in a study of 18,820 older adults. Twenty-nine percent of
ADEs require evaluation by a physician, evaluation in the emergency room, or
hospitalization for clinicalmanagement of the adverse reaction (Hohl et al., 2005
[Level IV]; Petrone & Katz, 2005 [Level IV]). A meta-analysis by Lazarou et al.
(1998 [Level I]) reported that ADRs accounted for 6.7% of hospital admissions
and in-hospital ADRs;when extrapolated, theywould be the fourth to sixth lead-
ing cause of in-hospital mortality for all causes of death, which is a conservative
estimate because it does not include ADRs related to errors, nonadherence,
overdose, or therapeutic failures. Drug–drug and drug–disease interactions are
the most common ADRs and often are preventable (Hansten, Horn, & Hazlet,
2001 [Level IV]; Juurlink, Mamdani, Kopp, Laupacis, & Redelmeier, 2003 [Level
III]; Zhan et al., 2005 [Level IV]).
Inappropriate Medications
The Beers criteria comprise the standard by which inappropriate medications
in aging persons are determined (Beers et al., 1991; Beers, 1997; Fick et al., 2003
[all Level VI], Health Benchmarks, 2005). Despite the criteria’s acceptance by
themedical community, as demonstrated by theirwide use,many physicians and
pharmacists remain unaware of the criteria or their updates. Studies indicate
that clinicians in all settings (i.e., community, nursing home, emergency room,
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assisted living, and ambulatory care) continue to prescribe inappropriate medi-
cationswith a high severity rating (according to the Beers criteria) to older adults
(Hanlon, Fillenbaum, Schmader, Kuchibhatla, & Horner, 2000 [Level V]; Sloane,
Zimmerman, Brown, Ives, &Walsh, 2002 [Level II]; Zhan et al., 2001, 2005 [both
Level IV]). Approximately 23% of older adults take at least one medication on
the Beers list that should be avoided (Fick et al., 2003 [Level VI]).
Medication Errors
The Institute of Medicine (IOM) reported in 1999 that almost 7,000 hospital
deaths were associated with medication errors in 1993 (Kohn et al., 2000 [Level
VI]).Medication errors occur frequently, yetmany hospitals do not have systems
in place such as automated order entry systems that are reported to decrease
the number of medication errors (National Coordinating Council for Medication
Errors Reporting and Prevention, 2001).
A medication error is defined by the Committee of Experts on Management
of Safety and Quality in Health Care (COE, 2005) as any preventable event that
may cause or lead to inappropriate medication use or patient harm while the
medication is in the control of the health care professional, patient, or consumer.
Such eventsmay be related to professional practice, health care products, proce-
dures, and systems, including prescribing; order communication; product label-
ing, packaging, and nomenclature; compounding, dispensing, and distribution;
administration; education; and use. A large percentage of errors are due to ad-
ministration of the wrong medication or the correct medication with the wrong
dose or at the wrong time interval between dosing (NCPIE, 1997 [Level VI]).
There are many reasons medication errors occur, including hospitals not using
drug–drug interaction software; however, that discussion is beyond the scope of
this chapter. Information regarding the immense literature onmedication errors
is provided in the Resources section of this chapter.
Nonadherence
A national survey of 17,685 Medicare beneficiaries older than 65 found that 52%
do not take medications as prescribed (Safran et al., 2005 [Level IV]). Nonad-
herence (formerly called noncompliance) was primarily associated with a be-
lief that the drug made them feel worse or was not helping (25%), or the cost
of the medicine, resulting in a decision to skip or take a smaller dose (26%).
Prescription drug coverage significantly impacted adherence, with 37% non-
adherence among those without coverage compared to 22% nonadherence of
beneficiaries with coverage. Nursing assessment and intervention directed at
underlying nonadherence issues is important, but it is beyond the scope of this
chapter. Further information sources are listed in the Resources section.
Acute care nurses are ideally positioned to identify or prevent potential
ADEs in hospitalized older adults, as well as those about to be discharged,
by reinforcing drug monitoring and focusing on drug–drug interactions, ex-
cess dosages (Doucet et al., 2002 [Level V]), drug–disease interactions (avoid-
ing prescribing cascades) (Rochon, 2006 [Level V]), and avoiding inappropriate
medications in aging persons (Fick et al., 2003 [Level VI]). However, to fulfill
this role, nurses need a good system of communication with doctors, advance
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practice nurses, and pharmacists and must take a proactive role in assuring the
safety of prescribing.
Assessment
Assessment Tools
Assessment tools are used to evaluate an older adult’s ability to self-administer
medications (i.e., functional capacity assessment) and the clinician’s assessment
for potential inappropriate medications, drug–drug interactions, drug–disease
interactions, and assessment of renal function. Commonly used tools include
the following:
■ 2002 Criteria for Potentially Inappropriate Medication Use in Older Adults:
Independent of Diagnoses or Condition. Also known as the Beers Criteria.
(Fick et al., 2003 [Level VI]) (Table 12.1). Used to assess medication list
for medications that should generally be avoided in older adults.
■ 2002 Criteria for Potentially Inappropriate Medication Use in Older Adults:
Considering Diagnoses or Condition. Also known as the Beers Criteria.
(Fick et al., 2003 [Level VI]) (Table 12.2). Used to assess for the presence
of medications that may interact adversely with a disease or condition a
person has.
■ Drug–Drug Interactions (Table 12.3) List of some common medications
known to interact with other medications. This is most accurately deter-
mined by a computer/PDA program, such as the Facts and Comparisons
PDA program to identify drug–drug and drug–disease interactions (see
Resources in this chapter).
■ Cockroft-Gault Formula (Figure 12.1) Useful for estimating creatinine
clearance based on age, weight, and serum creatinine levels (Terrell,
Heard, & Miller, 2006 [Level V]). A creatinine clearance of less than
50 ml/min places an older adult at risk for ADEs (Fouts, Hanlon, Pier-
per, Perfetto, & Feinberg, 1997]) and virtually all people older than 70
have a creatinine clearance of less than 50.
■ Functional Capacity (ADL, IADL, Mini-Cog/MMSE). Used to assess phys-
ical and cognitive ability to self-administer medications. See chapter
3, Assessment of Function, and chapter 6, Dementia, respectively, or
www.ConsultGeriRN.org.
■ Brown Bag Method (Nathan, Goodyer, Lovejoy, & Rahid, 1999 [Level IV]).
Method used to assess all medications an older adult has at home includ-
ing prescriptions from all providers, OTC medications, and herbal reme-
dies. Should be used in conjunction with a complete medication history.
(See Interventions and Nursing Care Strategies in this chapter for details
on taking a complete medication history and Table 12.4, which outlines
medication history questions.)
■ Drugs Regimen Unassisted Grading Scale (DRUGS) Tool. Standardized
method for assessing potential medication-adherence problems. Used at
transfer to other levels of care (Edelberg, Shallenberger, & Wei, 1999;
Hutchinson, Jones,West, &Wei, 2006 [both Level IV]). (See the Resources
section in this chapter.)
262 Chapter 12
Assessment
Pharmacokinetic and Pharmacodynamic Changes with Aging
There are patterns related to aging that are important to consider prior to assess-
ing medications in older adults (Mangoni & Jackson, 2003 [Level VI]; Rochon,
2006 [Level V]). Pharmacokinetics is best defined as the time course of absorp-
tion, distribution across compartments, metabolism, and excretion of drugs in
the body. Themetabolism and excretion ofmany drugs decreases and the physi-
ologic changes of aging require dose adjustment for some drugs (MerckManual,
2005 [Level VI]). Pharmacodynamics is defined as the response of the body to
the drug, which is affected by receptor binding, post-receptor effects, and chem-
ical interactions (Merck Manual, 2005 [Level VI]). Pharmacodynamic problems
occur when two drugs act at the same or interrelated receptor sites, resulting in
additive, synergistic, or antagonistic effects. Many interactions of drugs aremul-
tifactorial, however, with a sequence of events that are both pharmacokinetic
and pharmacodynamic (Spina & Scordo, 2002 [Level VI]).The following are age-
related changes in pharmaco-kinetics and -dynamics in older persons:
■ Changes in drug absorption (i.e., increased gastric pH and decreased gas-
trointestinal motility in an absorptive surface) once thought to be due
mainly to aging changes are more recently thought to be due at least in
some part to underlying disease states rather than normal aging changes
(Mangoni & Jackson, 2003 [Level VI]). There may be, however, a change
of absorption rate in persons taking multiple medications—for example,
fluorquinolones takenwith ironmay impair absorption (Semla &Rochon,
2004 [Level VI]).
■ Drug distribution changes associated with aging include decreased car-
diac output, reduced total body water, decreased serum albumin (which
is more likely to be related to malnutrition or acute illness than aging),
and increased body fat. Reduced total body water creates a potential for
higher serum drug levels due to a low volume of distribution and occurs
with water-soluble drugs (i.e., hydrophilic) such as alcohol or lithium.
Decreased serum albumin results in higher unbound drug levels with
protein-bound drugs such as warfarin, phenytoin, salicylic acid, and di-
azepam. Lipophilic drugs (e.g., long-acting benzodiazepines) are stored in
the body fat of older persons and slowly leach out, resulting in increased
half-life and resulting in the drug staying around longer.
■ A significant change in drug metabolism is reduction in the cytochrome
p-450 enzyme system, which affects metabolism of many drugs cleared
by this enzyme system (Mangoni & Jackson, 2003 [Level VI]; Merck Man-
ual, 2005 [Level VI]; Tune, 2001 [Level V]). Many classes of drugs are
cleared by the p-450 system, including cardiovascular drugs, analgesics,
NSAIDs, antibiotics, diuretics, psychoactive drugs, and others (Merck
Manual, 2005 [Level VI]). (For a list drugs cleared by this enzyme system,
see the Merck Manual online at http://www.merck.com/mmpe/sec20/
ch306/ch306b.html.) Metabolism may be affected by disease states com-
mon in older individuals (e.g., thyroid disease, congestive heart failure,
and cancer) or can be a result of drug-induced metabolic changes as well
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Formula for Men:
CrCl in milliliters per minute* =
(140 – age in years) (weight in kilograms)
72 (serum creatinine in milligrams per deciliter)
Formula for Women: *Use above formula and multiply by 0.85.
12.1
Cockroft-Gault
Formula for
Estimation of
Creatinine
Clearance (CrCl)
(Mangoni & Jackson, 2003 [Level VI]). Several drugs are cleared bymulti-
stage hepatic metabolism (nonsynthetic and synthetic reactions), which
is more likely to be prolonged in older persons. However, age does not
greatly affect clearance of drugs that are metabolized by glucuronic acid
conjugation (Merck Manual, 2005 [Level VI]). Conjugation is an impor-
tant mechanism for the rapid inactivation and extensive removal of drugs
from the body; therefore, it has major significance in the toxic effects
of drugs. The capacity for conjugation of some drugs is large, but with
others, saturation may occur with over-dosage or even high therapeu-
tic doses (Prescott, 1994). Some drugs undergo hepatic metabolism, then
renal clearance. Drugs such as diazepam have enormously longer half-
lives in older adults because both systems are impaired.
■ Elimination or clearance of medications from the body may be slowed due
to decline in glomerular filtration rate, renal tubular secretion, and renal
bloodflow that naturally decreaseswith age (Semla&Rochon, 2004 [Level
VI]). A decrease in glomerular filtration is usually not accompanied by
an increase in serum creatinine due to decreasing lean muscle mass with
age and subsequent decline in creatinine production. Therefore, serum
creatinine is not an accurate measure of renal function in the elderly.
Instead, assessment of renal function using the Cockroft-Gault formula
(see Figure 12.1) should be calculated prior to initiation of renal-clearing
medications (Mangoni & Jackson, 2003; Semla & Rochon, 2004 [both
Level VI]).
Beers Criteria
In 1999, the Centers for Medicare & Medicaid Services (CMS) incorporated the
Beers criteria (Beers et al., 1991; Beers, 1997 (Fick et al., 2003) [all Level VI])
into regulatory guidelines in long-term care. Long term care facilities can be
cited if any of the drugs on the list are prescribed. The Joint Commission on
Accreditation of Health Care Organizations (JCAHO) also adopted the criteria
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as a potential sentinel event (2007 [Level VI]) in hospitals. Many insurance
providers have also incorporated the Beers criteria into quality indicators for
older adults (e.g., Health Benchmarks, 2005).
Although the Beers criteria for inappropriate medications are an excellent
guideline for assessingpotential inappropriatemedications, theyneed to beused
in conjunction with patient-centered care (Swagerty & Brickley, 2005 [Level
VI]). A joint position statement of the American Medical Directors Association
(AMDA) and American Society of Consulting Pharmacists (ASCP) points out
that the Beers criteria are based on consensus data (i.e., lower level of evidence)
rather than on higher levels of evidence such as systematic reviews or random-
ized controlled trials.
The Beers criteria address two key areas: (1) medications or medication
classes that should generally be avoided in people 65 and older; and (2) med-
ications that should be avoided in persons older than 65 with specific medical
conditions. A severity rating of high or low is given to each medication based on
its potential negative impact on older adults. The most recent criteria, updated
in 2003 by Fick et al., identifies 48 medications or classes that should generally
be avoided in people older than 65, as well as 20 specificmedications that should
not be used in the presence of specific conditions (Fick et al., 2003 [Level VI])
(see Tables 12.1 and 12.2).
Several studies link medications on the inappropriate list to poor health
outcomes. Fick and colleagues (2003 [Level VI]) reported that ambulatory older
adults who were prescribed medications from the Beers list were more likely
be hospitalized or evaluated in an emergency room than those not taking such
medications. Another study reports a positive association between potentially
inappropriate drug-prescribing (as defined by the Beers criteria) and ADRs in
first-visit elderly outpatients (Chang et al., 2005 [Level IV]; Fu, Liu, & Chris-
tensen, 2002 [Level V]). These findings not only support the use of the Beers
criteria in assessing the appropriateness of medications in the older outpatient
population but also support the criteria’s effectiveness in preventing hospital-
izations due to ADRs in these settings. Although these findings cannot be gen-
eralized to acute care, acute care nurses (and other members of the health care
team) need to be proactive at discharge of older adults by implementing strate-
gies to reduce ADEs and ADRs that lead to rehospitalization of older adults
transitioning to other care levels. A prospective observational study of 18,820
older patients found that 1,225 admissions were related to an ADR, a prevalence
of 6.5%, after the ADR directly lead to admission in 80% of cases (Pirmohamed
et al., 2004 [Level IV]).
Assessment for Adverse Drug Reactions (ADRs)
ADRs occur due to the number of medications taken by older persons and their
concomitant medical conditions. The severity of adverse reactions increases in
older adults due to age-related changes in pharmacokinetics and pharmaco-
dynamics. Assessment for potential drug–disease and drug–drug interactions
must be considered before initiating medications in the elderly. The most pre-
ventable ADRs in the outpatient setting are cardiovascular medications followed
by diuretics, nonopioid analgesics, hypoglycemics, and anticoagulants (Gurwitz
et al., 2003 [Level IV]). Gurwitz and colleagues (2005 [Level II]) reported that the
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12.1
2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Independent of
Diagnoses or Condition
Drug Concern
Severity Rating
(High or Low)
Propoxyphene (Darvon) and
combination products (Darvon with
ASA, Darvon-N, and Darvocet-N)
Offers few analgesic advantages over
acetaminophen, yet has the
adverse, effects of other narcotic
drugs.
Low
Indomethacin (Indocin and Indocin
SR)
Of all available nonsteroidal
antiinflammatory drugs, this drug
produces the most CNS adverse
effects.
High
Pentazocine (Talwin) Narcotic analgesic that causes more
CNS adverse effects, including
confusion and hallucinations,
more commonly than other
narcotic drugs. Additionally, it is a
mixed agonist and antagonist.
High
Trimethobenzamide (Tigan) One of the least effective antiemetic
drugs, yet it can cause
extrapyramidal adverse effects.
High
Muscle relaxants and
antispasmodics: methocarbamol
(Robaxin), carisoprodol (Soma),
chlorzoxazone (Paraflex),
metaxalone (Skelaxin),
cyclobenzaprine (Flexeril), and
oxybutynin (Ditropan). Do not
consider the extended-release
Ditropan XL.
Most muscle relaxants and
antispasmodic drugs are poorly
tolerated by elderly patients
because these cause
anticholinergic adverse effects,
sedation, and weakness.
Additionally, their effectiveness at
doses tolerated by elderly patients
is questionable.
High
Flurazepam (Dalmane) This benzodiazepine hypnotic has an
extremely long half-life in elderly
patients (often days), producing
prolonged sedation and increasing
the incidence of falls and fracture.
Medium- or short-acting
benzodiazepines are preferable.
High
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12.1
2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Independent of
Diagnoses or Condition
Drug Concern
Severity Rating
(High or Low)
Amitriptyline (Elavil),
chlordiazepoxide-amitriptyline
(Limbitrol), and
perphenazine-amitriptyline
(Triavil)
Because of its strong anticholinergic
and sedation properties,
amitriptyline is rarely the
antidepressant of choice for
elderly patients.
High
Doxepin (Sinequan) Because of its strong anticholinergic
and sedating properties, doxepin
is rarely the antidepressant of
choice for elderly patients.
High
Meprobamate (Miltown and Equanil) This is a highly addictive and
sedating anxiolytic. Those using
meprobamate for prolonged
periods may become addicted and
may need to be withdrawn slowly.
High
Doses of short-acting
benzodiazepines: doses greater
than lorazepam (Ativan) 3 mg;
oxazepam (Serax) 60 mg;
alprazolam (Xanax) 2 mg;
temazepam (Restoril) 15 mg; and
triazolam (Halcion) 0.25 mg
Because of increased sensitivity to
benzoadiazepines in elderly
patients, smaller doses may be
effective as well as safer. Total
daily doses should rarely exceed
the suggested maximums.
High
Long-acting benzodiazepines:
chlordiazepoxide (Librium),
chlordiazepoxide-amitriptyline
(Limbitrol), clidinium-
chlordiazepoxide (Librax),
diazepam (Valium), quazepam
(Doral), halazepam (Paxipam), and
chlorazepate (Tranxene)
These drugs have a long half-life in
elderly patients (often several
days), producing prolonged
sedation and increasing the risk of
falls and fractures. Short- and
intermediate-acting
benzodiazepines are preferred if a
benzodiazepine is required.
High
Disopyramide (Norpace and Norpace
CR)
Of all antiarrhythmic drugs, this is
the most potent negative inotrope
and therefore may induce heart
failure in elderly patients. It is also
strongly anticholinergic. Other
antiarrhythmic drugs should be
used.
High
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12.1 (continued)
Drug Concern
Severity Rating
(High or Low)
Digoxin (Lanoxin) (should not exceed
>0.125 mg/d except when treating
atrial arrhythmias)
Decreased renal clearance may lead
to increased risk of toxic effects.
Low
Short-acting dipyridamole
(Persantine). Do not consider the
long-acting dipyridamole (which
has better properties than the short-
acting in older adults) except for
patients with artificial heart valves.
May cause orthostatic hypotension. Low
Methyldopa (Aldomet) and
methyldopa-hydrochlorothiazide
(Aldoril)
May cause bradycardia and exacerbate
depression in elderly patients.
High
Reserpine at doses >0.25 mg May induce depression, impotence,
sedation, and orthostatic
hypotension.
Low
Chlorpropamide (Diabinese) It has a prolonged half-life in elderly
patients and could cause prolonged.
hypoglycemia. Additionally, it is the
only oral hypoglycemic agent that
causes SIADH.
High
Gastrointestinal antispasmodic drugs:
dicyclomine (Bentyl), hyoscyamine
(Levsin and Levsinex),
propantheline (Pro-Banthine),
belladonna alkaloids (Donnatal and
others), and
clidinium-chlordiazepoxide (Librax)
GI antispasmodic drugs are highly
anticholinergic and have uncertain
effectiveness. These drugs should
be avoided (especially for long-term
use).
High
Anticholinergics and antihistamines:
chlorpheniramine (Chlor-
Trimeton), diphenhydramine
(Benadryl), hydroxyzine (Vistaril and
Atarax), cyproheptadine (Periactin),
promethazine (Phenergan),
tripelennamine,
dexchlorpheniramine (Polaramine)
All nonprescription (OTCs) and many
prescription antihistamines may
have potent anticholinergic
properties. Nonanticholinergic
antihistamines are preferred in
elderly patients when treating
allergic reactions.
High
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12.1
2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Independent of
Diagnoses or Condition
Drug Concern
Severity Rating
(High or Low)
Diphenhydramine (Benadryl) May cause confusion and sedation.
Should not be used as a hypnotic,
and when used to treat emergency
allergic reactions, it should be
used in the smallest possible dose.
High
Ergot mesyloids (Hydergine) and
cyclandelate (Cyclospasmol)
Have not been shown to be effective
in the doses studied.
Low
Ferrous sulfate >325 mg/d Doses >325 mg/d do not
dramatically increase the amount
absorbed but greatly increase the
incidence of constipation.
Low
All barbiturates (except
phenobarbital) except when used
to control seizures
Are highly addictive and cause more
adverse effects than most sedative
or hypnotic drugs in elderly
patients.
High
Meperidine (Demerol) Not an effective oral analgesic in
doses commonly used. May cause
confusion and has many
disadvantages to other narcotic
drugs.
High
Ticlopidine (Ticlid) Has been shown to be no better than
aspirin in preventing clotting and
may be considerably more toxic.
Safer, more effective alternatives
exist.
High
Ketorolac (Toradol) Immediate and long-term use should
be avoided in older persons
because a significant number have
asymptomatic GI pathologic
conditions.
High
Amphetamines and anorexic agents These drugs have potential for
causing dependence,
hypertension, angina, and
myocardial infarction.
High
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12.1 (continued)
Drug Concern
Severity Rating
(High or Low)
Long-term use of full-dosage, longer
half-life, non–COX-selective
NSAIDs: naproxen (Naprosyn,
Avaprox, and Aleve), oxaprozin
(Daypro), and piroxicam (Feldene)
Have the potential to produce GI
bleeding, renal failure, high blood
pressure, and heart failure.
High
Daily fluoxetine (Prozac) Long half-life of drug and risk of
producing excessive CNS
stimulation, sleep disturbances,
and increasing agitation. Safer
alternatives exist.
High
Long-term use of stimulant laxatives:
bisacodyl (Dulcolax), cascara
sagrada, and Neoloid except in the
presence of opiate analgesic use
May exacerbate bowel dysfunction. High
Amiodarone (Cordarone) Associated with QT interval problems
and risk of provoking torsades de
pointes. Lack of efficacy in older
adults.
High
Orphenadrine (Norflex) Causes more sedation and
anticholinergic adverse effects
than safer alternatives.
High
Guanethidine (Ismelin) May cause orthostatic hypotension.
Safer alternatives exist.
High
Guanadrel (Hylorel) May cause orthostatic hypotension. High
Cyclandelate (Cyclospasmol) Lack of efficacy. Low
Isoxsurpine (Vasodilan) Lack of efficacy. Low
Nitrofurantoin (Macrodantin) Potential for renal impairment. Safer
alternatives available.
High
Doxazosin (Cardura) Potential for hypotension, dry mouth,
and urinary problems.
Low
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12.1
2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Independent of
Diagnoses or Condition
Drug Concern
Severity Rating
(High or Low)
Methyltestosterone (Android, Virilon,
and Testrad)
Potential for prostatic hypertrophy
and cardiac problems.
High
Thioridazine (Mellaril) Greater potential for CNS and
extrapyramidal adverse effects.
High
Mesoridazine (Serentil) CNS and extrapyramidal adverse
effects.
High
Short-acting nifedipine (Procardia
and Adalat)
Potential for hypotension and
constipation.
High
Clonidine (Catapres) Potential for orthostatic hypotension
and CNS adverse effects.
Low
Mineral oil Potential for aspiration and adverse
effects. Safer alternatives
available.
High
Cimetidine (Tagamet) CNS adverse effects including
confusion.
Low
Ethacrynic acid (Edecrin) Potential for hypertension and fluid
imbalances. Safer alternatives
available.
Low
Desiccated thyroid Concerns about cardiac effects. Safer
alternatives available.
High
Amphetamines (excluding
methylphenidate hydrochloride
and anorexics)
CNS stimulant adverse effects. High
Estrogens only (oral) Evidence of the carcinogenic (breast
and endometrial cancer) potential
of these agents and lack of
cardio-protective effect in older
women.
Low
Abbreviations: CNS: central nervous system; COX: cyclooxygenase; GI: gastrointestinal; NSAIDs: nonsteroidal anti-
inflammatory drugs; SIADH: syndrome of inappropriate antidiuretic hormone secretion.
Reprinted with permission: Fick, D. M., Cooper, F. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003).
Updating the Beers criteria for potentially inappropriate medication use in older adults. Archives of Internal Medicine,
163(22), 2716–2724. Evidence Level VI: Expert Opinion.
Copyright c© 2003, American Medical Association. All rights reserved.
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12.2
2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Considering
Diagnoses or Condition
Disease or
Condition Drug Concern
Severity Rating
(High or Low)
Heart failure Disopyramide (Norpace), and
high-sodium-content drugs
(sodium and sodium salts
[alginate bicarbonate,
biphosphate, citrate,
phosphate, salicylate, and
sulfate])
Negative inotropic effect.
Potential to promote
fluid retention and
exacerbation of heart
failure.
High
Hypertension Phenylpropanolamine
hydrochloride (removed
from the market in 2001),
OTC pseudoephedrine
(sudafed), diet pills, and
amphetamines
May produce elevation of
blood pressure
secondary to
sympathomimetic
activity.
High
Gastric or
duodenal ulcers
NSAIDs and aspirin (>325 mg)
(COX2 inhibitors excluded)
May exacerbate existing
ulcers or produce new
or additional ulcers.
High
Seizures or
epilepsy
Clozapine (Clozaril),
chlorpromazine (Thorazine),
thioridazine (Mellaril), and
thiothixene (Navane)
May lower seizure
thresholds.
High
Blood clotting
disorders or
receiving
anticoagulant
therapy
Aspirin, NSAIDs, dipyridamole
(Persantin), ticlopidine
(Ticlid), and clopidogrel
(Plavix)
May prolong clotting time
and elevate INR values
or inhibit platelet
aggregation, resulting
in an increased
potential for bleeding.
High
Bladder outflow
obstruction
Anticholinergics and
antihistamines,
gastrointestinal
antispasmodics, muscle
relaxants, oxybutynin
(Ditropan), flavoxate
(Urispas), anticholinergics,
antidepressants,
decongestants, and
tolterodine (Detrol)
May decrease urinary
flow, leading to urinary
retention.
High
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12.2
2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Considering
Diagnoses or Condition
Disease or
Condition Drug Concern
Severity Rating
(High or Low)
Stress
incontinence
α-blockers (Doxazosin,
Prazosin, and Terazosin),
anticholinergics,
tricyclic antidepressants
(imipramine
hydrochloride, doxepin
hydrochloride, and
amitriptyline
hydrochloride), and
long-acting
benzodiazepines
May produce polyuria and
worsening of
incontinence.
High
Arrhythmias Tricyclic antidepressants
(imipramine
hydrochloride, doxepin
hydrochloride, and
amitriptyline
hydrochloride)
Concern due to
proarrhythmic effects
and ability to produce QT
interval changes.
High
Insomnia Decongestants,
theophylline (Theodur),
methylphenidate
(Ritalin), MAOIs, and
amphetamines
Concern due to CNS
stimulant effects.
High
Parkinson’s
disease
Metoclopramide (Reglan),
conventional
antipsychotics, and
tacrine (Cognex)
Concern due to their
antidopaminergic and
cholinergic effects.
High
Cognitive
impairment
Barbiturates,
anticholinergics,
antispasmodics, and
muscle relaxants. CNS
stimulants:
dextroAmphetamine
(Adderall),
methylphenidate (Ritalin),
methamphetamine
(Desoxyn), and pemolin
Concern due to
CNS-altering effects.
High
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12.2 (continued)
Disease or
Condition Drug Concern
Severity Rating
(High or Low)
Depression Long-term benzodiazepine
use. Sympatholytic
agents: methyldopa
(Aldomet), reserpine,
and guanethidine
(Ismelin)
May produce or exacerbate
depression.
High
Anorexia and
malnutrition
CNS stimulants:
Dextroamphetamine
(Adderall),
methylphenidate
(Ritalin),
methamphetamine
(Desoxyn), pemolin, and
fluoxetine (Prozac)
Concern due to
appetite-suppressing
effects.
High
Syncope or falls Short- to
intermediate-acting
benzodiazepine and
tricyclic antidepressants
(imipramine
hydrochloride, doxepin
hydrochloride, and
amitriptyline
hydrochloride)
May produce ataxia,
impaired psychomotor
function, syncope, and
additional falls.
High
SIADH/
hyponatremia
SSRIs: fluoxetine (Prozac),
citalopram (Celexa),
fluvoxamine (Luvox),
paroxetine (Paxil), and
sertraline (Zoloft)
May exacerbate or cause
SIADH.
Low
Seizure disorder Bupropion (Wellbutrin) May lower seizure
threshold.
High
Obesity Olanzapine (Zyprexa) May stimulate appetite and
increase weight gain.
Low
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12.2
2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Considering
Diagnoses or Condition
Disease or
Condition Drug Concern
Severity Rating
(High or Low)
COPD Long-acting
benzodiazepines:
chlordiazepoxide
(Librium),
chlordiazepoxide-
amitriptyline (Limbitrol),
clidinium-
chlordiazepoxide
(Librax), diazepam
(Valium), quazepam
(Doral), halazepam
(Paxipam), and
chlorazepate (Tranxene).
β-blockers: propranolol
CNS adverse effects. May
induce respiratory
depression. May
exacerbate or cause
respiratory depression.
High
Chronic
constipation
Calcium channel blockers,
anticholinergics, and
tricyclic antidepressant
(imipramine
hydrochloride, doxepin
hydrochloride, and
amitriptyline
hydrochloride)
May exacerbate
constipation.
Low
Abbreviations: CNS: central nervous system; COPD: chronic obstructive pulmonary disease; INR: international normalized
ratio; MAOIs: monoamine oxidase inhibitors; NSAIDs: nonsteroidal anti-inflammatory drugs; SIADH: syndrome of
inappropriate antidiuretic hormone; SSRIs: selective serotonin reuptake inhibitors.
Reprinted with permission from: Fick, D. M., Cooper, F. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003).
Updating the Beers criteria for potentially inappropriate medication use in older adults. Archives of Internal Medicine,
163(22), 2716–2724. Evidence Level VI: Expert Opinion.
Copyright c© 2003, American Medical Association. All rights reserved.
largest number of preventable ADRs occurred at the prescribing or monitoring
stages and included wrong drug choices or dosages, inadequate patient edu-
cation, or a clinically important drug–drug interaction. Monitoring for errors
includes inadequate lab evaluation of a drug and failure to respond to signs,
symptoms (including atypical symptoms), or abnormal lab levels indicative of
toxicity. Assessing lab values and appropriateness of drugs and doses when or-
ders are written and monitoring for signs and symptoms of toxicity comprise
an important role for nurses in preventing ADRs in the hospital setting. These
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researchers suggest provider education and system interventions in health care
settings to reduce ADRs.
Drug-Drug Interactions
Concurrent use of more than one drug simultaneously can result in serious tox-
icities in older adults resulting in synergistic effects, additive effects, or antago-
nistic effects. For example, concurrent use of any two of the following drugs: an-
tiparkinsondrugs, tricyclic antidepressants such as amitriptyline, antipsychotics
(e.g., haldol), anti-arrhythmics (e.g., disopyramide), and OTC antihistamines
(e.g., diphenhydramine, chlorpheniramine) may cause or worsen dry mouth,
gum disease, blurred vision, constipation, urinary retention, and/or delirium
(Merck Manual, 2005 [Level VI]).
Little is known about the epidemiology of drug–drug interactions in clin-
ical practice (Juurlink et al., 2003 [Level III]); however, studies indicate that
drug–drug interactions are a common cause of predictable ADEs (Hansten,
Horn, & Hazlet, 2001 [Level IV]). A case-control study conducted by Juurlink
and colleagues (2003 [Level III]) reported that drug–drug interactions resulted
in serious adverse events among several classes of medications. Of 179,986
older patients treated with glyburide along with cotrimoxazole, 909 patients
became hypoglycemic, 12 patients died, and no control subjects experienced
hypoglycemia. Of 231,257 patients, 1,051 were admitted due to dioxin toxicity
and 33 died while hospitalized. Those with digoxin toxicity were 13 times more
likely to have received clarithromycin 1 week prior to hospitalization, which
suggests that avoidance of concomitant use of digoxin and clarithromycin may
have prevented the digoxin toxicity. In the same study, concomitant prescrib-
ing of ACE inhibitors and potassium-sparing diuretics 1 week before admission
were observed in 622,285 older persons. The researchers estimated that 7.8%
of hospitalizations for hyperkalemia could have been prevented if addition of
potassium-sparing diuretics had been avoided (Juurlink et al., 2003 [Level III]).
In a retrospective review of the National Hospital Ambulatory Medical Care
Survey (NHAMCS), Zhan and colleagues (2005 [Level IV]) reported that older
adults with two or more prescriptions had at least one inappropriate drug–drug
combination present, and 6.6% of patients on warfarin were prescribed a drug
with a potentially harmful interaction. Some other common drug–drug interac-
tions are shown in Table 12.3.
Interactions with OTCs and Herbal Remedies
Interactionswith herbal remedies andOTCmedications, often overlooked,must
also be assessed because older adults commonly use these remedies, consum-
ing 40% of all OTCs (Astin et al., 2000 [Level IV]; Kohn, Corrigan, & Donaldson,
2000 [Level VI]). Hanlon, Fillenbaum, Ruby, Gray, and Bohannon (2001 [Level
V]) reported that community-dwelling older adults in the United States con-
sume approximately 1.8 OTC medications per day. Use varies somewhat with
geographic area and ethnicity; highest use is in the Midwest and Whites with
the lowest use among Hispanic persons. The most common OTC classes used
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12.3 Examples of Common Drug–Drug Interactions
Drug 1 Drug 2 Interaction
Adverse
Effect(ds)
Warfarin
(Coumadin)
Diltiazem1
Verapamil1
Metronidazole1,5
Inhibits drug
metabolism
↑ anticoagulation;
potential
bleeding
Warfarin NSAID* 4,5
ASA4
Sulfa drugs5
Macrolides
Acetaminophen5
combined with narcotic
Fluconazole5
Cipro4
Biaxin4
NSAID ↓ prostaglandin
Increases GI erosion;
↓ platelet aggregation
Unknown
Inhibits metabolism and
clearance
↑ INR
GI bleeding
GI bleeding
↑ effects of
warfarin,
potential
GI bleeding
↑ effects of
warfarin,
potential
GI bleeding
Bleeding
Digoxin Amiodorone1,4
Clarithromycin1,4
Verapamil1,4
↓ renal or nonrenal
clearance of Digoxin
Inhibits renal clearance of
Digoxin
↓ cardiac impulse
conduction & muscle
contraction
Digoxin toxicity
Digoxin toxicity
Potential
bradycardia or
heart block
Levothyroxine T4 Calcium carbonate1 L-thyroxine absorbs
calcium carbonate in
acidic environment
Reduced
absorption of
L-thyroxin
Glyburide Co-trimoxazole4 Potentiates effect of
sulfonylureas
Hypoglycemia
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12.3 (continued)
Drug 1 Drug 2 Interaction
Adverse
Effect(ds)
Ace inhibitors Potassium-sparing4
diuretics4
Unknown Life-threatening
hyperkalemia
Diuretic NSAID*,1 ↓ renal perfusion Renal impairment
Phenytoin4
(Dilantin)
cimetidine, erythromycin,
clarithromycin,
fluconazole
Not specified Increases levels of
phenytoin4
within 1 week
Theophylline Quinolones ↓ liver metabolism of
Theophylline
Theophylline
toxicity
Notes: There are many other common drug–drug interactions; this table is not intended to be all-inclusive. Use of
computer devices is typically the best method for determining drug–drug interactions (see Resources).
*NSAID = non-steroidal anti-inflammatory agents: prescription and over-the-counter such as toradol or ibuprofen,
respectively.
Source: Adapted from:
1 Beers, M. & Berkow, R. (2000). The Merck Manual of Geriatric Clinical Pharmacology, 3rd edition. NJ: Merck Research
Laboratory. [Level VI].
2 Jurrlink, Mamdani, Kopp, Laupacis, & Redelmeier (2003). Drug–drug interactions among elderly patients hospitalized for
drug toxicity. Journal of the American Medical Association, 289 (13), 1652–1658. [Level III].
3 Tatro, D. S., ed. (2001). Drug interactions in Facts in Facts and Comparisons. St. Louis, MO.
4 Feldstein et al. (2006). Reducing warfarin medication interactions. Archives of Internal Medicine, 166, 1009–1015.
[Level III].
5 Ament, P. W., Bertolino, J. G., & Liszewski, J. L. (2000). Clinical pharmacology: Clinically significant drug interactions.
American Family Physician, 61, 1745–1754. Evidence Level VI: Expert Opinion.
are analgesics, laxatives, and nutritional supplements. Herbal or dietary sup-
plement usage (e.g., ginseng, ginkgo biloba extract, and glucosamine) is on the
rise among older adults, increasing from 14% in 1998 to 26% in 2002 (Kaufman,
Kelly, Rosenberg, Anderson, & Mitchell, 2002; Kelly et al., 2005 [both Level IV]).
Use of St. John’s Wart and Echinacea are on the rise and may have now topped
the list. OTC and herbal supplements are typically not reported to medical
providers because most consumers do not consider them medication (Astin
et al., 2000 [Level IV]); the implications for unidentified drug–drug and drug–
disease interactions with OTCs and herbal remedies are astounding.
Medication Adherence
As individuals age, they may encounter difficulties that decrease their ability to
adhere to medication regimens (e.g., vision impairment, arthritis, economics).
Medication adherence with older adults is complex and needs careful nursing
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assessment. There are a number of ways to assess for potential adherence-
related problems (Bergman-Evans, 2006 [Level V]; Edelberg et al., 1999 [Level
IV]), as well as to ascertain adherence (Fulmer, Kim, Montgomery, & Lyder,
2000; Rohay, Dunbar-Jacob, Sereika, Kwoh, & Burke, 1996). An array of de-
vices can assist in enhancing adherence behavior (Fulmer et al., 1999; Haynes
et al., 2005 [Level V]) (see the Resources section in this chapter for further
information).
Reconciliation of Medications
Poor communication of medical information at transition points of care (i.e.,
at admission, transfer, and discharge) often results in medication errors, but
appropriate strategies can reduce the likelihood of errors (Santell, 2006 [Level
VI]).Unfortunately aneffectivemeansof communicatingdrug therapies to other
levels of care upon discharge from the hospital has not been established across
the continuum (Nickerson, MacKinnon, Roberts, & Saulnier, 2005 [Level II]).
MR described in the literature is performed by pharmacists (Gleason et al.,
2004; Nickerson et al., 2005 [Level II]). However, MR can be performed by a
nurse-collaborative team, including pharmacist consultation (Doucette et al.,
2005 [Level V]) or a computer-based program(s); however, studies to date are
equivocal on the use of computer-based programs for reconciliation. The MR
process includes comparison of medications on admission and transfer doc-
uments with medication orders at time of admission and time of transfer to
other units or discharge to other levels of care. Barriers for nurses perform-
ing MR reported in one study included lack of confidence in existing institu-
tional safety systems, inconsistent practices (whether or not pharmacists are
consulted), lack of communication between health professionals, and staffing
concerns (MR is time-consuming) (Chevalier, Parker, MacKinnon, & Sketris,
2006 [Level V]). The Brown Bag method can be used for corroborating medica-
tions (Nathan et al., 1999 [Level IV]) with community dwelling older adults,
when used in conjunction with a good medication admission history (Table
12.4). At discharge, the pharmacist has been involved (or can assist nurses
or the care team) in identifying problems with drug therapy and communi-
cating with the community pharmacy, medical provider, or admitting staff at
the transitional site of care (Hanlon, Fillenbaum, Ruby, Gray, & Bohannon,
2001 [Level V]; Nickerson et al., 2005 [Level II]). A systematic review of multi-
ple randomized controlled trials (RCTs) by Hanlon, Lindblad, and Gray (2004
[Level I]) included many health care settings (all studies were RCTs: five in
the home-health setting, three at hospital discharge with home follow-up, three
clinic-based, one in the community-pharmacy setting, and two in long-term
care) where clinical pharmacist interventions showed a considerable reduction
in drug-related problems as well as reduced morbidity, mortality, and health
care costs. Many hospital pharmacies are now linked electronically to health
care providers and/or local pharmacies but studies are lacking. Discharge edu-
cation and counseling to patients including assessment of factors that might
affect adherence have been shown to reduce ADEs (Nickerson et al., 2005
[Level II]).
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12.4 Complete Medication History∗
Date performed
Patient Name
Medication allergies and type of reaction (e.g., PCN: hives)
Prescription medications – list all including dose, frequency, and route administered
Specifically ask about eye drops, topical creams, B12 injections or other injections (if
given at home or at medical office, how often).
Over-the-Counter Medications (OTCs)
How often do you exceed the recommended dose on package?
Do you read the labels? Why or why not?
Do you ask a pharmacist or your provider about interactions with your prescriptions?
Ask specifically about:
Pain relievers
What have you tried, what works what does not? What pain do you take it for? How often?
Allergy medications – when do you take them year round? What season? Or When
symptoms develop?
Sinus congestion/cold or cough medications (combined products with more than one
ingredient? If so, list ingredients)
Heart burn medications, how often?
Diarrhea or constipation treatments, how often?
Sleeping medications Ask specifically diphenhydramine (Benadryl)
Eye drops – how often what do you take them for?
Herbal remedies (orally or as a tea)
– ginkgo biloba
– ginseng
– glucosamine
– St. John’s Wart
– Echinacea
Nutritional Supplements
Ask how often?
Ask specifically about:
Calcium with Vitamin D, Vitamin E, C, or B’s
Mega Vitamins
Protein supplements such as Ensure, Boost
Vitamin Drinks
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12.4 Complete Medication History
Medications that have been stopped and why? (Did you discontinue or did provider? Why?)
Alcohol (Ask about type/amount per day)
Smoking (what smokes and how much, e.g., cigarettes #packs per day, how many years)
Past or Annual Immunizations, date last received each
Pneumonia vaccine
Flu Vaccine
Other
Regular lab tests – performed to evaluate medications or medication side effects,
e.g., potassium level, INR, digoxin level, liver toxicity, renal function, blood counts etc.
Use of Memory Aides – reminders to take medications, e.g., pill dispenser box
* Use Brown Bag Method in conjunction with Medication history (see assessment tools).
High Risk Medications
Many studies have revealed common high risk medications in older adults.
Nurses should become familiar with high risk medications and medication
classes prescribed for older adults in order to aid in preventing ADEs. Many
tools are available for nurses to use to assess for high risk medications (i.e.,
Beers criteria) and for potential drug–drug, drug–disease, or drug–herbal in-
teractions. Common high risk medications are discussed in the following
sections.
Warfarin
Warfarin is among the highest risk medications taken by older persons; how-
ever, with proper monitoring, the risk of potential adverse sequelae can be sig-
nificantly reduced. In a prospective study, Hanlon and colleagues (2006 [Level
II]) found that warfarin and benzodiazepines were independent risk factors for
ADRs, that ADRs are very common in frail elderly adults after hospitalization,
and that polypharmacy and warfarin use consistently increase the risk of ADRs.
Gaddis and colleagues (2002 [Level IV]) reported that digoxin and warfarin
were the greatest source of drug interactions among 200 outpatients. A prospec-
tive observational study of 18,820 patients found that the drugs most commonly
implicated in causing hospitalization due to ADRs included low-dose aspirin,
diuretics, warfarin, and nonsteroidal anti-inflammatory drugs (NSAIDs), with
the most common reaction being GI bleeding (Pirmohamed et al., 2004 [Level
IV]). In a study of 808 frail older adults discharged from 11 Veteran Affairs
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hospitals to outpatient care, 33% had one or more ADRs for a rate of 1.92 per
1,000 person-days of follow-up and the rate for preventable ADRs being 0.71
per 1,000 person-days of follow-up. Independent risk factors for all ADRs were
number of medications, use of warfarin, and (marginally) the use of benzo-
diazepines (Hanlon et al., 2006 [Level II]). Although herbal remedies are com-
monly used, 58% of older persons do not report use of herbal supplements (Astin
et al., 2000 [Level IV]); herbal remedies (e.g., Ginkgo biloba and garlic) interact
with warfarin to augment its anticoagulant effect andmay lead to serious bleed-
ing problems (Miller, 1998 [Level V]). It is imperative to identify older adults
on warfarin who fall or are at risk for falling (see chapter 9, Preventing Falls in
Acute Care) because their risk of serious injury increases when they are taking
warfarin. Nurses must be vigilant in monitoring for potential drug interactions
& reactions due to warfarin.
Antihypertensive Agents
Hypertension affects approximately two-thirds of individuals older than 65 but
only 27% of people have adequate control. Physiological changes of aging can
produce changes in the pharmacokinetics and pharmacodynamics of cardio-
vascular drugs in older persons (Nolan & Marcus, 2000 [Level VI]). The anti-
hypertensives, as a class, tend to produce various unintended effects, including
orthostatic hypotension (associated with diuretics and alpha-blockers), seda-
tion and depression (associatedwith somebeta-blockers), confusion (associated
with alpha-blockers), impotence and constipation (associated with verapamil, a
calcium channel blocker). Comprehensive and ongoing assessment for poten-
tial adverse effects (e.g., routinely checking orthostatic blood pressure) is key to
monitoring drug efficacy while an older person is hospitalized. Older persons
may also be taught to monitor their blood pressure and orthostatics at home or
in other levels of care.
Dose for dose, water-soluble compounds are more potent in aging persons,
whereas fat-soluble drugs can be expected to have an extended half-life. Be-
cause of changes in fat/lean bodymass that characterize the aging process, older
adults may require fat soluble beta-blocker dosing intervals to be increased.
Fat soluble beta-blockers may be preferable in some cases, such as using pro-
pranolol for tremors. Additionally, changes in central penetration of the drug
that occurs as a result of age-related changes decreases the integrity of the
blood-brain barrier and may predispose older adults to untoward experiences
with alpha agonists as well. Many antihypertensives have a tendency to cause
depression; persons on lipophilic beta-blockers in particular should be mon-
itored for depression using a standard scale such as the GDS (see chapter 5,
Depression).
Orthostatic hypotension is a serious problem that can affect older adults on
continuous antihypertensive therapy. Sustained treatment renders them more
susceptible to diuretic-induced dehydration and orthostatic changes. Orthosta-
sis may also be due to concomitant illness (e.g., infection). The known sequelae
of orthostatic hypotension in older adults include falls—true trauma and amed-
ical emergency in physically frail or functionally compromised older adults. Or-
thostatic hypotension is an independent risk factor for recurrent falls in nursing
home residents (Ooi, Hossain, & Lipsitz, 2000 [Level II]).
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Psychoactive Drugs
Mental disorders are not a part of normal aging. Nearly 20% of people older
than 55 experience mental disorders, with the most common prevalence (in
order) being anxiety, severe cognitive impairment, and mood disorders. Mental
disorders are under-reported and suicide rates are highest among older adults
compared to younger adults. Adults older than 85 have the highest suicide rates
of all—more than twice the national rate. (American Association of Geriatric
Psychiatrists, 2004 [Level VI]).
In the face of prevailing clinical norms, it is recommended that sedative-
hypnotic use for older adults be generally used sparingly and with intensemon-
itoring. Gray and colleagues (2006 [Level II]) reported, in a prospective study of
9,093 patients, that older adults who take benzodiazepines (BZDs) are at greater
risk for mobility problems and ADL disability, and that short-acting BZDs do
not appear to improve safety benefits over long-acting agents. The likelihood
of falls with fractures is more than twice as high for the long-acting BZDs than
short-acting agents (Ray, Thapa, & Gideon, 2000 [Level II]). Likewise, Tamblyn
and colleagues (2005 [Level II]) report 17.7% of older persons given at least one
prescription for BZDs at hospital discharge (greatest risk was with higher dose
BZDs) were treated for at least one injury on a follow-up visit, of which fractures
were the most common. Over-sedation, respiratory depression, confusion, and
other alterations in cognitive capacity, as well as falls, are frequently associated
with sedative-hypnotic drug use.
In addition to the sedative-hypnotic class, psychoactivemedications include
antidepressants (e.g., tricyclics, selective serotonin reuptake inhibitors [SSRIs]),
anxiolytics agents (e.g., diazepam, lorazepam), antipsychotics (previously re-
ferred to as neuroleptics), mood-stabilizing compounds (e.g., lithium), and psy-
choactive stimulants. Mood stabilizers and psychoactive stimulants are known
to have a relatively narrow therapeutic window even in fully functional, younger
adults. Lithium, in particular, requires close monitoring of levels and signs of
toxicity in older adults; it also interacts with many other drugs. Psychoactive
compounds are most frequently prescribed for agitated behaviors, to stabilize
mood, and for therapeutic effects in clinical depression. Older adults are at risk
because of changes in absorption, metabolism, distribution, and excretion of
both parent drug and psychoactive metabolites. Some unintended interactions
maybeprevented if age-related changes are considered and careful surveillance
is part of routine care.
The half-life of psychoactive drugs is prolonged in older adults and, in
general, this class of drugs must be used with extreme caution to avoid in-
ducing delirium, falls, and other traumatic events. Psychotropic medications
are associated with an increased risk for falls. A significant correlation was
made between falls and psychotropic medications in a meta-analysis of stud-
ies in people older than 60 (Leipzig, Cumming, & Tinetti, 1999 [Level I]).
Although antianxiety agents, such as the BZDs and sedative-hypnotics, are
generally over-prescribed for older adults, the antidepressants are generally
considered to be under-prescribed. It is estimated that almost 15% of older
persons living in the community, 5% in primary care, and 15% to 25% in
nursing homes have significant depressive symptoms (Spina & Scordo, 2002
[Level VI]).
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A major deterrent to antidepressant pharmacotherapy in this population
has been the high incidence of anticholinergic side effects that occur with ad-
ministration of tricyclic antidepressants. Anticholinergic side effects such as
drymouth, blurred vision, urinary retention (particularly in the presence of pro-
static enlargement), cognitive alterations, cardiotoxicity, and constipation signal
to the vigilant clinician that the antidepressant profile needs to be reevaluated
and adjusted. Tricyclic antidepressantmedicationswith lowanticholinergic pro-
files include desipramine, nortriptyline, and trazadone; however, the tricyclic
class should now be avoided in the elderly because the SSRIs are generally
much safer.
The SSRIs, as a class of antidepressants, have strikingly different side ef-
fects than other antidepressants. This class does not cause cardiotoxicity or
orthostatic hypotension and does not have anticholinergic effects, except for
paroxetine, which may have mild anticholinergic effects in some elders (Salz-
man, 1998). In general, these drugs tend to be a better choice of antidepres-
sants in older adults. The most common side effects are GI related (i.e., nausea,
anorexia), which may be ameliorated by starting with a low dose (half that for
younger adults; e.g., fluoxetine 5 mg) and slowly increasing (e.g., to 10 mg) af-
ter 1 week. A serious but uncommon sequelae of SSRIs is serotonin syndrome,
which may occur if more than one antidepressant is prescribed with an SSRI
or with concurrent use of St. John’s Wort, a commonly self-administered OTC
herbal remedy for depression.
The antipsychotics are often considered first-line pharmacotherapeutic in-
terventions for people older than 65 presenting with agitation and behav-
ioral problems associated with dementia (Kindermann, Dolder, Bailey, Katz, &
Jeste, 2002 [Level V]). Most are not U.S. Food and Drug Administration (FDA)–
approved for such use and data on their effectiveness for such purposes are
lacking. Antipsychotics must be used with extreme caution in this population,
largely because of the potential for development of abnormal and often ir-
reversible involuntary movements (e.g., extrapyramidal symptoms) associated
with their administration.Thenewer antipsychotics present amuch lower risk of
extrapyramidal movement disorders than conventional antipsychotics. Unlike
conventional antipsychotics, the newer atypical ones (e.g., clozapine, risperi-
done, olanzapine, and quetiapine) apparently provide several advantages with
respect to both efficacy and safety. In 2004, the FDA issued a warning against
off-label use of antipsychotics for dementia-related psychotic symptoms due to
potential adverse effects. The American Association of Geriatric Psychiatrists
(AAGP) does not support the FDA decision and states, “the available evidence of
short-term trials conducted in nursing home patients suggests that risperidone
and olanzapine may be beneficial for some of the noncognitive [behavioral]
symptoms but the decision must be based on individual circumstances” (AAGP,
2005, p. 1). Recent data from the Centers for Medicare and Medicaid (CMS)
indicate that newer atypical antipsychotic medications, compared to older an-
tipsychotics, do not appear to be associated with an increased risk of ventricu-
lar arrhythmias or cardiac arrest (Liperoti et al., 2005 [Level III]). Psychotropic
medications are associated with an increased risk for falls, particularly in the
long term care setting (Gurwitz et al., 2005 [Level II]). Drug–drug interactions
with antipsychotics are common. Finkel (2004 [Level VI]) is a good resource for
drug interactions associated with antipsychotics.
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Anticholinergics
Medications with high anticholinergic properties must be used with great cau-
tion in older adults due to adverse effects such as inability to concentrate to
frank delirium, agitation, hallucinations, blurred vision, slowed GI motility, de-
creased secretions, urinary retention, and constipation (Spina & Scordo, 2002
[Level VI]; Terrell Heard, K., & Miller, 2006; Tune, 2001 [both Level V]). Urinary
retention, resulting from an anticholinergic, can be a lethal side effect in a male
with benign prostatic hypertrophy (BPH) and a history of UTIs; urosepsis and
death may result. Catterson and colleagues (1997) discuss the vicious cycle of
treatment and/or iatrogenesis that may occur with administration of anticholin-
ergic drugs. An illustrative example is an older adult with dementia and BPH
who is administered diphenhydramine (i.e., Benadryl) for sleep and who is also
taking oxybutinin (i.e., Ditropan), both of which have anticholinergic proper-
ties. The additive effects of the two medications may lead to urinary retention
and agitation, which may in turn lead to treatment of the agitation with antipsy-
chotics (which also have anticholinergic effects) and exacerbate the problem
and cascade of events further. Rochon and colleagues (2006) refer to this as the
“prescribing cascade.”
Anticholinergic properties occur not only in antidepressant and antipsy-
chotic medications, as previously mentioned, but are also properties of most
OTC antihistamines and sleep aids, intestinal and bladder relaxants, corticos-
teroids, antihypertensives, anti-arrythmics, and other cardiovascular drugs and
some antibiotics. See Tune (2001 [Level V]) for a complete list of medications
with anticholinergic effects. Additionally, syncopal events and falls are common
sequelae of high anticholinergic drug use, again resulting in increasedmorbidity
and mortality in older adults.
Cardiotonics
Digoxin is useful in treating congestive heart failure (CHF) due to systolic dys-
function in the elderly, but it is not the recommended treatment for CHF from
underlying diastolic dysfunction in older adults. Digoxin toxicity occurs more
frequently in older adults, presents atypically, and may result in death. Juurlink
and colleagues (2003 [Level III]) reported that about 2.3% of cases of digoxin
toxicity could have been prevented in hospitalized older adults. Ahmed, All-
man, and DeLong (2002 [Evidence Level III]) reported that digoxin is often
prescribed inappropriately in hospital patients. Classic symptoms of digoxin
toxicity (i.e., nausea, anorexia, visual disturbance) may occur; however, symp-
tomatic cardiac disturbance and arrhythmias are more common in the elderly
and are not often thought to be due to digoxin toxicity. Older adults may expe-
rience toxicity symptoms even with normal plasma levels of digoxin (Flaherty,
Perry, Lynchard, &Morley, 2000). Many older people will have some reduction in
renal function with aging; therefore, monitoring for symptoms, especially atyp-
ical symptoms of digoxin toxicity, and for renal function and potassium levels is
important.
Particular cautionmust be exercised when digoxin is prescribed with diure-
tics; this combination can cause hypokalemia and exacerbate renal impairment,
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which can potentiate digoxin toxicity. Because the therapeutic window for
digoxin is narrow and because it is water-soluble (e.g., the drug has a smaller
volume of distribution and thus higher plasma concentration), correct and safe
dosing of older adults is challenging. The maximum recommended dose in
older persons for treating heart failure is 0.125 milligram (Beers, 1997; Fick
et al., 2003 [Level VI]); doses for treating atrial fibrillation may be higher.
Digoxin binds to protein and because many debilitated older adults have
low serum albumin levels, higher plasma levels and digoxin toxicity may
result.
Despite the recommendation that ACE inhibitors (ACEI) should be pre-
scribed for all patients with heart failure due to left ventricular/systolic dys-
function and who have normal renal function (Jones, 2000; Packer et al., 1999
[Level II]), Sloane and colleagues (2002 [Level II]) found that 62% of adults in
assisted living residences (n = 2014) were not on an ACE inhibitor. Monitoring
of renal function and serum potassium should continue as the ACEI dose is
titrated up. Rarely do older patients on an ACE inhibitor need potassium sup-
plementation, the combination of which can be lethal. Juurlink and colleagues
(2003 [Level III]) reported that 523 of 1,222,093 patients on ACE inhibitors
were hospitalized with hyperkalemia; of these patients, 21 died while in the
hospital.
OTCs
Self-medication with OTC medications, herbal remedies, and dietary supple-
ments may lead to adverse drug–disease interactions (Astin et al., 2000 [Level
IV]) and drug–drug interactions (Rochon, 2006). Neafsey and Shellman (2001
[Level IV]) found that 86% of a sample of 168 older adults attending a hyper-
tension clinic reported at least two or more self-medication practices that could
result in an adverse drug interaction. In the United States, community-dwelling
older adults take about as many OTC drugs as prescription drugs; among the
OTC medications, analgesics, laxatives, and nutritional supplements are uti-
lized most frequently (Hanlon, Schmader, Ruby, & Weinberger, 2001 [Level V]).
Salicylates, such as aspirin, are a significant concern with regard to ADRs in
older people. In a study of 18,820 patients, Pirmohamed et al. (2004 [Level IV])
found that 18% of all ADRhospital admissions were aspirin-related and lowdose
aspirin was implicated most often. ASA in combination with alcohol, because
of its water solubility, can worsen age-related renal insufficiency and chronic
salicylate intoxication can result. Cold remedies that include alcohol are a signif-
icant source of drug potentiation in aging adults. Indeed, alcohol consumption is
frequently omitted from history-taking of older adults even though it interacts
with OTC and prescription medications in frank and subtle ways to produce
unintended drug harm.
The OTCs most commonly implicated in hospital admissions are low dose
aspirin and NSAIDs (Pirmohamed et al., 2004 [Level IV]). The FDA has been
evaluating OTC ingredients and labeling of OTCs; however, it is a long-range
project and yet to be seen if the FDA will be more specific as to safety issues
that relate to older adults. Astin and colleagues (2000 [Level IV]) reported that
24% of seniors use herbal remedies (the most common being ginkgo biloba and
286 Chapter 12
garlic) and 58% did not report usage to their primary provider. Gingko biloba
and garlic interact with warfarin to augment its anticoagulant effect and may
lead to bleeding (Miller, 1998 [Level V]); the potential adverse consequences
left unaddressed are significant.
Interventions and Nursing Care Strategies
Comprehensive Medication Assessment and Management
Medication management begins with a thorough drug history and medication
assessment obtained from an older adult or a reliable informant. Medication
history errors occur in up to 67% of patients at the time of admission to the
hospital and increase up to 83% when nonprescription drugs were included
(Tam et al., 2005 [Level I]), suggesting, by the authors, a need for a systematic
approach to accurate medication histories at the time of admission. No studies
provide a systematic approach to history taking, although specific aspects of
the medication history and assessment includes the following evidence-based
activities:
■ Obtain a complete medical history and validate that themedication history
is true (Lau, Florax, Porsius, & De Boer, 2000 [Level IV]) ascertaining
the numbers and types of medications typically consumed, as well as an
estimate of how long the older adult has been taking the drug.
■ Nathan and colleagues (1999 [Level IV]) recommend that older adults
bring all their medications to the provider/hospital/other health care set-
ting (using the Brown Bagmethod, this requires bringing all prescription,
OTC, and herbal remedies in a brown bag) in order to document medica-
tion types, instructions for self-administration, dates, and duration of the
drug regimen. This method fosters identification of multiple prescribers
and dispensing pharmacies and can signal polypharmacy and/or possible
substance abuse, particularly with regard to analgesics, anxiolytics, and
sedative-hypnotics.
■ Focused questions by the clinician should address nicotine and alcohol
use, as well as vitamins, herbal remedies, and OTC medications that are
routinely used (Astin et al., 2000; Lau et al., 2000 [both Level IV]). This
information should be included in the medication profile. (See Table 12.4
for a suggested medication history.) Little information is available about
medication history-taking or even education of pharmacists regarding
medication history interviews (Ellington et al., 2002).
■ Ask detailed questions about OTC and “recreational” drugs, alcohol use,
and herbal or other folk remedies. Be specific about the actual amount
and underwhat circumstances these substances are used. Accurate infor-
mation can help explain symptoms that otherwise may not make sense.
Evaluate for duplicate medications, which often occurs due to unrecog-
nized trade names versus generic names and OTCs with the same active
ingredients in them (e.g., acetaminophen) (Astin et al., 2000 [Level IV]).
■ Perform medication reconciliation to verify actual medication regimen
at hospital admission and discharge (Gleason et al., 2004 [Level IV];
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Nickerson et al., 2005 [Level II]) and across the continuum of care (Nick-
erson et al., 2005 [Level II]). The eighth goal of the Joint Commission on
Accreditation of Health Care Organizations (JCAHO) mandates medica-
tion reconciliation across practice sites requiring an accurate and com-
plete reconciliation of medications across the continuum. The intent of
this standard is to ensure that when a person moves from one “setting,
service, practitioner, or level of care within or outside the organization,”
a complete current list of medications will be communicated to the next
provider or service and be reconciled (compared) at the new setting, ser-
vice practitioner, or level of care (JCAHO, 2006, 2007; Tangalos&Zarowitz,
2006 [both Level VI]).
■ Monitor new symptoms and consider the likelihood of their being due to
an ADR (Petrone & Katz, 2005 [Level IV]; Rochon, 2006 [Level V]) prior
to requesting a new medication to treat symptoms; avoid the prescribing
cascade.
■ Attempt a trial of nonpharmacological interventions/treatments prior
to requesting medication for new symptoms. Nurses often make these
recommendations when notifying primary providers for a new prob-
lem/symptom.
■ Continually monitor for possible toxicity to those drugs with high preva-
lence of toxicity (see high risk medications section in this chapter). PDA
technology can help nurses assess high risk medications such as Facts
and Comparisons (see Resources section in this book).
■ When falls occur, always consider medications as a source. Particularly
consider recently added medications that are high risk for causing falls,
such as diuretics (see chapter 9, Preventing Falls in Acute Care).
■ Nurses need to collaborate with the interdisciplinary team to effect
change in reducing the numbers of ADEs and ADRs, many of which are
preventable (Hanlon, et al., 2001 [Level V]). Although many studies de-
scribe and recommend an interdisciplinary approach as the best method
for improving drug-treatment outcomes (Lam & Ruby, 2005; Williams,
et al., 2004 [both Level II]), most do not delineate the specific role or
function of the individual teammembers (other than the pharmacistmak-
ing recommendations to the physician), nor do theymeasure outcomes of
the team. Some recommendations to consider for an interdisciplinary ap-
proach include a medication care team (i.e., nurses, pharmacist, primary
physician, social worker) with specific functions assigned to review med-
ications at admission and discharge utilizing evidence-based recommen-
dations. The following list of discharge interventions may be performed
by various team members, such as:
■ Reminder systems may be instituted by pharmacists in collabora-
tion with nurses as reported effective by Muir, Sanders, Wilkinson, &
Schmader (2001 [Level III]). A visual intervention (medication grid)
was delivered to physicians to see if it could reduce medication-
regimen complexity. Researchers reported that this simple interven-
tion had a significant impact on medication-regimen complexity in
older adults. The pharmacist may also review (preferably using a
computer-based program) the medication list at admission, when new
medications are added, and prior to discharge for potential drug–drug
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interactions, drug–disease interactions, and/or inappropriate medica-
tions for older adults. In a study by Simon et al. (2006 [Level II]), age-
specific alerts sustained the effectiveness of drug-specific alerts to re-
duce potentially inappropriate prescribing in older people, resulting
in a considerably decreased burden of the alerts. Computerized med-
ication order entry has the potential to prevent an estimated 84% of
dose, frequency, and route errors. Anywhere from 28% to 95% of ADEs
can be prevented by reducing medication errors through computer-
izedmonitoring systems (AHRQ, 2001 [Level I]). A study in ambulatory
care using a quasi-experimental design found that medication inter-
action alerts modestly reduced the frequency of coprescribing of in-
teracting medications; however, the study concluded additional efforts
would be required to further reduce rates of inappropriate prescribing
of warfarin with interacting drugs (Feldstein et al., 2006 [Level III]).
The pharmacist may also function as the communicator of the hospi-
tal drug regimen to the community pharmacy, primary care provider,
and/or other levels of care.
■ The social worker may review issues at home such as access to
medications, cost, caregiver support, and barriers to discharge inter-
ventions.
■ Nurses and other interdisciplinary members need to be proactive par-
ticipants in reducing rehospitalization related to ADEs and implement
discharge education and counseling to patients, including:
■ Assess abilities and limitations such as functional ability, including the
ability to read themedication label, open themedication container, and
consumeor self-administer theprescribedmedication as intended (see
chapter 3, Assessment of Function, and chapter 4, Assessing Cognitive
Function) (Curry, Walker, Hogstel, & Burns, 2005 [Level VI]). The care
plan should address actual and potential problems and the need for
reassessment at regular intervals and after major medical events (e.g.,
CVA or delirium).
■ Devices to accommodate some impairments or barriers may be recom-
mended. For example, tamper-proof lids are often difficult for elders
to remove, particularly if there are arthritic changes. A simple request
to the pharmacist to provide a non-childproof lid may improve the safe
and effective use of a prescribed medication.
■ Assess cognitive and affective status to ensure that memory problems
or vegetative symptoms associated with depression are not interfer-
ing with the safe use of prescription drugs (see chapter 4, Assessing
Cognitive Function, and chapter 5, Depression).
■ Assess health literacy (Curry et al., 2005 [Level VI]). Query whether
the older person understands what the drug is to be used for, how
often it is to be taken, circumstances of ingestion (e.g., with food), and
other aspects of drug self-administration that signal intelligent drug
use; use the DRUGS tool (Edelberg et al., 1999 [Level IV]; Hutchison,
Jones, West, & Wei, 2006 [Level IV]).
■ Assess for ability to recognize generic versus brand name medication
and their use (Curry et al., 2005 [Level VI]). Ask the older adult to
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describe circumstances in which the medication was not used or was
used differently than prescribed. If the older adult cannot describe
medication use, consider removing the drug or providewritten instruc-
tion for the home (Muir et al., 2001 [Level III]).
■ Assess beliefs, concerns, and problems related to the medication regi-
men. Ask the older adult if she or he believes that the drug is actually
doing what it is intended to do. If the medication is not useful, not cre-
ating symptom relief, or causing adverse effects, consider removing it
or replacing it with a more acceptable substitute.
■ Discuss the impact of medication expenses. Many medications, particu-
larly those that are new to the market, can be prohibitively expensive,
particularly for people on fixed incomes. Discuss the influence of tele-
vision ads. Ask the older adult what concerns they have about the costs
and risks of administration (Curry et al., 2005 [Level VI]). Also discuss
Medicare part D concerns and confusion. Where economic problems
are identified, generic drugs and other avenues should be explored to
manage the cost issue.
■ Consider instrumental issues related to drug use, such as availability
of family members or other social supports to facilitate medication
adherence, and who monitors the need to change specific medications
dictated by third-party reimbursement andmedication coverage plans.
It is particularly important with Medicare Part D coverage to ensure
that those enrolled understand that after a certain dollar amount is
reached, the older adult will the be required to pay full price for pre-
scriptions, called the “doughnut hole.”
■ Assess factors that might affect adherence (Nickerson et al., 2005 [Level
II]). See the Resources section for literature on adherence.
■ Patients should be given the necessary information and the opportunity
to exercise the degree of control they choose over health care decisions
that affect them and the necessary information to effectuate this. Patients
who are informed and are involved in decision making are less likely to
make decisions that may lead to ADRs, such as abruptly discontinuing
a medication that should be tapered off slowly (National Coordinating
Council for Medication Errors Reporting and Prevention, 2001).
Conclusion
Nurses have the unique opportunity to intervene and to reduce ADEs in older
adults in the hospital setting and at transition to other levels of care. Tradition-
ally, focused on “caring,” nurses have taken the lead in implementing preven-
tive strategies on behalf of the patient. While acute care nurses are not typically
prescribers unless they are advanced practice nurses (APNs) with prescrip-
tive authority, they have always reviewed and confirmed medication orders,
carried them out, and alerted the primary provider of concerns and problems
with medications; nurses have always ensured a culture of safety and must con-
tinue to be proactive in doing so. Nurses are also responsible for identifying
wrong drugs, dosages, and so on prior to administering them. Given that nurses
290 Chapter 12
are at the bedside 24/7, they can make medication suggestions to prescribers
based on their holistic knowledge of the patient and recognition of new symp-
toms. Nurses are in a pivotal position to reduce ADEs in older persons at dis-
charge as well. Nurses are the primary source for providing discharge education
and counseling to older adults at discharge; therefore, they play a key role in
preventingmedication-related consequences after discharge, including preven-
tion of rehospitalization due to medication-related problems. Consulting with
experts on the interdisciplinary team and/or use of computer programs can fa-
cilitate provision of discharge information.
Case Study and Discussion
Mr. R., a 72-year-old retired college professor, is admitted to your preoper-
ative surgery unit for a TURP with a 24-hour anticipated stay. He also has
a history of recurrent UTIs and is admitted with a temperature of 102◦F.
He says he feels confused today and isn’t sure why he is here. He is a wid-
ower with two children and three grown grandchildren; the closest relative
lives 200 miles away. Mr. R. has a history of Parkinson’s disease, osteoarthri-
tis, BPH, constipation, and recent elevated blood pressure readings. On your
admission history, you askMr. R. about OTCs and herbal remedies. You learn
he has been taking Ibuprofen 400 mg four times per day for unrelieved os-
teoarthritis (OA) pain during the past 2 weeks, as well as Benadryl 25 mg
to help him “sleep with the pain” and OTC glucosamine. He also admits to
taking Gingko biloba because, he says, “I’m worried about becoming senile
from the Parkinson’s.”
Because Mr. R. has a history of significant BPH and is scheduled for
TURP, you take a look at his medication list and medical conditions. He is
taking Sinemet, Benadryl, and Vicodin but unclear of dosages. You look up
the medications on your PDA and learn that the three medications taken
together can have an additive effect and cause urinary retention, placing
Mr. R. at risk for urosepsis. You quickly notify the on-call resident of Mr. R.’s
fever and signs of delirium (confusion) (which could indicate impending
urosepsis) and inform her about what you know about the medication in-
teractions andMr. R.’s history. You recommend a stat urinalysis with culture
(along with his preoperative lab work). He is admitted to the medical surgi-
cal floor instead of to surgery that day. Intravenous fluids and the first dose
of antibiotics are initiated after the U/A is collected; his surgery is delayed
until his fever and UTI are resolved. You make a note on his discharge/care
planning form to educate Mr. R. regarding:
■ Benadryl is not recommended in older adults; particularly in com-
bination with the other meds he is taking, Sinemet and Vicodin (a
smooth muscle relaxant which may cause constipation and urinary
retention), which may have led to acute urinary retention as well as
constipation. If he requires Vicodin (or other narcotic analgesia) for
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pain, he will need increased fluids, dietary modification, and possibly
Lactulose (i.e., an osmotic laxative) to prevent/treat constipation.
■ Recent high blood pressure readings may be related to NSAID (i.e.,
Ibuprofen) use. Recommend discontinuance of NSAIDs and monitor
B/P off them during hospitalization. Inform him that OA is not in-
flammatory, and NSAIDs are not recommended for OA and are high
risk for adverse effects in older adults. Also consider a consultation
with the pain service.
■ Educate about the risks of self-medication with OTCs and recom-
mend consultation with primary provider and/or pharmacist before
purchasingOTCs, including herbal remedies. Recommend a complete
medication history once confusion (delirium) clears.
■ Nurses on the other levels of care (e.g., pre- and post-op) need to be
informed of the need for ongoing monitoring of his mental status for
delirium (see chapter 7, Delirium: Prevention, Early Recognition, and
Treatment), blood pressure (due to recent high readings), and pain-
related to OA as well as post-op pain.
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Box 12.1
Nursing Standard of Practice Protocol: Reducing
Adverse Drug Events in Older Adults
I. GOAL: Reduce adverse drug events in older adults.
II. OVERVIEW: Adverse drug events, whether from drug–drug or drug–
disease interactions, inappropriate prescribing, poor adherence, or medi-
cation errors, lead to serious or potentially fatal outcomes for older adults.
More than half of adverse drug events may be preventable (NCC MERP,
2001[Level VI]; Rochon, 2006 [Level V]; Safran et al., 2005 [Level IV]).
III. BACKGROUND
A. Definitions
1. Adverse Drug Event (ADE): Injury occurring during the patient’s
drug therapy, whether resulting from appropriate care or from
unsuitable or suboptimum care. Includes ADEs during normal
use of medicine and any harm secondary to a medication error.
ADEs can have different outcomes: worsening of existing pathol-
ogy or lack of expected health-status improvement (COE, 2005;
p. 1).
2. IatrogenicADEs: Anyundesirable condition in a patient occurring
as the result of treatment by ahealth care professional; pertaining
to an illness or injury resulting from a medication or drug.
3. Adverse drug reaction (ADR): Any noxious or unintended and
undesired effect of a drug that occurs at normal human doses
for prophylaxis, diagnosis, or therapy. According to Committee
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of Experts on Safe Medication Practices, ADEs are preventable
(COE, 2005; p. 2), including medical errors and nonadherence.
4. Medicationnonadherance: Thenumber of dosesnot takenor taken
incorrectly that jeopardizes the patient’s therapeutic outcome
(NCPIE, 1997 [Level VI]).
5. Drug–drug interactions: Changes in a drug’s effects by another
drug taken during the same period. The interactions are basi-
cally pharmacokinetic or pharmacodynamic (Merck Manual of
Diagnosis and Therapy, 2005 [Level VI]).
6. Drug–disease interactions: Undesired drug effects (exacerbation
of a disease or condition by a drug) that occur in patients with
certain disease states (e.g., beta-blocker given to patient with de-
pression, worsens the depression chospasm).
7. Pharmacokinetics: The time course of absorption, distribution
across compartments, metabolism, and excretion of drugs in the
body. The metabolism and excretion of many drugs decrease and
the physiological changes of aging require dosage adjustment for
some drugs (Merck Manual, 2005 [Level VI]).
8. Pharmacodynamics: The response of the body to the drug, which
is affected by receptor binding, postreceptor effects, and chemical
interactions (MerckManual, 2005 [Level VI]). Pharmacodynamic
problems occur when two drugs act at the same or interrelated
receptor sites, resulting in additive, synergistic, or antagonistic
effects. The effects of two or more drugs together can be either
additive (combination of drugs “add up” to increase effect), syner-
gistic (one agent magnifies the effect of the other), or antagonistic
(one medication inhibits the effect of the other).
9. Medication Reconciliation: the process of comparing a patient’s
medication orders to all of the medications that the person has
been taking (Santell, 2006 [Level VI]).
B. Epidemiology
1. It is estimated that themajority of older adults older than 65 (79%)
are on medications, with 39% taking five or more prescription
drugs and up to 90% taking over-the-counter drugs (Hanlon et
al., 2001a [Level V]). People older than 65 consume more than
one-third of all prescription drugs and purchase 40% of all over-
the-counter medicines (Kohn et al., 2000 [Level VI]).
2. In a large study of women 65 years of age and older, 12% took 10
or more medications and 23% took at least five prescribed medi-
cations (Kaufman et al., 2002 [Level IV]).
3. An estimated 35% of older persons experience ADEs and almost
half of these are preventable (Safran et al., 2005 [Level IV]).
4. Prevalence of ADR-related hospitalizations ranges from 5% to
35% (Gurwitz et al., 2003 [Level IV]).
5. Serious ADRs that occur during hospitalization are at 6.7%
and, when extrapolated, are the fourth to sixth leading cause
of in-hospital mortality for all causes of death and likely an
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underestimate because ADRs related to nonadherence or errors
in administration therapeutic failures are not included (Lazarou
et al., 1998 [Level I]).
6. ADEs are estimated to cost the health care system $75 billion to
$85 billion annually (Fick et al., 2003 [Level VI]) and result in
106,000 deaths annually (Lazarou et al, 1998; [Level I]).
C. Etiology
Adults become increasingly susceptible to ADEs as they age. Phys-
iological changes characteristic of aging predispose older adults
to experience ADEs resulting in four times more hospitalizations
in older versus younger persons. People older than 65 experience
medication-related problems for seven major reasons:
1. Age-related physiologic changes that result in altered pharma-
cokinetics and pharmacodynamics (Mangoni & Jackson, 2003
[Level VI]; Rochon, 2006 [Level V]).
2. Multiple medications (i.e., polypharmacy) that are often pre-
scribed by multiple providers (Hanlon, Schmader, Ruby, & Wein-
berger, 2001 [Level V]; Hajjar & Kotchen, 2003 [Level IV])
3. Incorrect doses of medications (over or under a therapeutic
dosage) (Astin et al., 2000 [Level IV]; Hanlon, Schmader, Ruby, &
Weinberger, 2001 [Level V]; Sloane et al., 2002 [Level II]).
4. Medication consumption for the treatment of symptoms that are
not disease-dependent or specific (i.e., self-medication or pre-
scribing cascades) (Neafsey & Shellman, 2001 [Level IV]; Rochon
& Gurwitz, 1997 [Level V]).
5. Iatrogenic causes such as:
a. ADRs: drug–drug or drug–disease interactions (Gurwitz et al.,
2005 [Level II]; Hohl et al., 2005 [Level IV]; Lazarou et al., 1998
[Level I]; Petrone & Katz, 2005 [Level IV])
b. Inappropriate prescribing for older adults (Fick et al., 2003
[Level VI])
6. Problems with medication adherence (Fulmer et al., 1999 (Level
VI]), Haynes et al., 2005 [Level V]).
7. Medication errors (Doucette et al., 2005 [Level V]; National
Council on Patient Information and Education (NCPIE), 1997
[Level VI]).
IV. ASSESSMENT TOOLS AND STRATEGIES
A. Assessment Tools
1. Use appropriate assessment tools as indicated for each individ-
ual’s needs and specific setting:
a. Beers Criteria: 2002 Criteria for Potentially Inappropriate
Medication Use in Older Adults: Independent (see Table 12.1).
2002 Criteria for Potentially Inappropriate Medication Use in
Older Adults: Considering Diagnoses or Condition (see Table
12.2) (Fick et al., 2003 [Level VI]).
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b. CommonDrug–Drug Interactions (seeTable 12.3). List of some
commonly known interactions.
c. Cockroft-Gault Formula: to estimate renal function (see Figure
12.1).
d. Functional Capacity (ADL, IADL, Mini-Cog, or MMSE). See
chapter 3, Assessment of Function, and chapter 4, Assessing
Cognitive Function.
e. Brown Bag Method (Nathan et al., 1999 [Level IV]). Method
used to assess all medications an older adult has at home, in-
cludingprescriptions fromall providers,OTCmedications, and
herbal remedies (all medications are to be brought in a “brown
bag”). Should be used in conjunction with a complete medica-
tion history (see Table 12.4).
f. Drugs Regimen Unassisted Grading Scale (DRUGS) Tool. As-
sessment of self-administration ability (Edelberg, Shallen-
berger, & Wei, 1999 [Level IV]; Hutchinson, Jones, West, &
Wei, 2006 [both level IV]). Typically used at time of transfer
to other levels of care (see Resources section).
B. Assessment Strategies
1. Comprehensive medication assessment should be performed at
admission, discharge, and intervals in between (Petrone & Katz,
2005 [Level IV]; Shekelle et al., 2001). Obtain a detailed medi-
cation history and confirm its accuracy (Lau et al., 2000 [Level
IV]); Tam et al., 2005 [Level I], detailing the type and amount of
prescriptions, OTCs, vitamins, supplements, and herbal remedies
(Hanlon et al., 2001a [Level V]; Kaufman et al., 2002 [Level IV]),
alcohol and illicit drugs, using appropriate assessment tool (e.g.,
Brown Bag method) (Nathan et al., 1999 [Level IV]).
2. Assess renal function using Cockroft-Gault formula for assessing
renal function prior to administering renal-clearing drugs (see
Figure 12.1).
3. Reconciliation of medications ordered at admission and at dis-
charge in consultation with a pharmacist (Gleason et al., 2004
[Level IV]; Santell, 2006 [Level VI]), geriatric expert, or computer-
based program (Joanna Briggs Institute, 2006 [Level I]; Feld-
man, McDonald, Rosati, Murtaugh, Kovner, et al., 2006 [Level
IV]).
4. Review medication list using Beers criteria for potentially inap-
propriate medications, particularly those with high severity and
for potential drug–drug and drug–disease interactions (see Ta-
bles 12.1 and 12.2) (Fick et al., 2003 [Level VI]; Zhan et al., 2005
[Level IV]).
5. At discharge from hospital, use appropriate tools to assess indi-
vidual’s ability to self-administer medications:
a. Assess functional capacity: ADLs, IADLs, Mini-Cog. See chap-
ter 3, Assessment of Function, and chapter 4, Assessing Cogni-
tive Function.
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b. Assess individuals (at admission or initial encounter and at
discharge) who administer their own medicines with DRUGS
tool to identify potential areas of self-administration diffi-
culty (see Resources) (Edelberg et al., 1999; Edelberg, Shal-
lenberger, Hausdorff, & Wei, 2000; Hutchinson, Jones, West, &
Wei, 2006 [all Level IV]).
V. INTERVENTIONS AND NURSING CARE STRATEGIES
A. Reducing ADEs (during and posthospitalization)
1. Patient empowerment. Patients should be given the necessary in-
formation and the opportunity to exercise the degree of control
they choose over health care decisions that affect them. If patients
are involved in decision making, they are less likely to make de-
cisions that may lead to ADRs (NCC MERP, 2001 [Level VI]), such
as abruptly discontinuing a medication that should be tapered
off. (Preventing Medication Errors: Quality Chasm Series (2007)
[Level VI]).
2. Comprehensive Medication Assessment on admission as indicated
in assessment (see Table 12.4).
3. Collaborate with the interdisciplinary team to effect change in re-
ducing the numbers of ADEs and ADRs, many of which are pre-
ventable (Hanlon, Schmader, Ruby,&Weinberger, 2001 [LevelV]).
4. Prescribing Principles. Monitoring for appropriate prescribing
and alerting the prescriber to potential problem areas helps re-
duce medication-related problems. Prescribing a medication is
multifaceted: deciding that a drug is truly indicated; choosing the
best drug; determining appropriate dose for the individual; mon-
itoring for toxicity and effectiveness; and seeking consultation
when necessary (Rochon, 2006 [Level V]). These principles sup-
port recommendations to:
a. Reduce the dose. “Start Low and Go Slow,” or give the lowest
possible dose when starting a medication and slow upward
titration to obtain clinical benefit; many ADEs are dose-related
(Petrone & Katz, 2005 [Level IV]; Rochon, 2006 [Level V]). Pri-
maryprovider should benotified if the dosage ordered is higher
than the recommended starting dose (e.g., digoxin maximum
dose ≤0.125 mg for treatment of CHF) (Fick et al., 2003 [Level
VI]).
b. Discontinue unnecessary therapy. Prescribers are often reluc-
tant to stop medications, especially if they did not initiate the
treatment. This practice increases the risk for an adverse event
(Rochon, 2006 [Level V]).
c. Attempt a trial of nonpharmacological interventions/treatments
prior to requesting medication for new symptoms (Rochon,
2006 [Level V]).
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d. Recommend safer drugs. Avoid drugs that are likely to be asso-
ciated with adverse outcomes (review Beers Criteria) (Petrone
& Katz, 2005 [Level IV]).
e. Assess renal function using Cockroft-Gault formula (for renally
cleared drugs) to determine accurate dosage prior to prescrib-
ing such as many routinely prescribed IV antibiotics. Dosage
recommendations are available based on this formula in PDR
and other common prescribing resources.
f. Optimize drug regimen. When prescribing medications, the
focus should be on risk versus benefit where the ex-
pected health benefit (e.g., relief of agitation in dementia
with psychosis) exceeds the expected negative consequences
(e.g., morbidity and mortality from falls that result in hip
fracture) (Leipzig et al., 1999 [Level I]; Ooi et al., 2000
[Level II]).
g. Initiation of new medication. Assess for potential drug–disease
and drug–drug interactions and correct dosages, themost com-
mon causes of ADRs, before starting new drugs (Doucet et al.,
2002 [Level V]; NCC MERP, 2001 [Level VI]; Petrone & Katz,
2005 [Level IV]).
h. Avoid the prescribing cascade. Avoid the prescribing cascade by
first considering a new symptom as being a consequence of a
current medication prior to adding a new medication (Rochon,
2006 [Level V]; Rochon & Gurwitz, 1997 [Level V]).
i. Avoid inappropriate medications in older persons. Review crite-
ria for potentially inappropriate medications (see Table 12.1)
or drug–disease interactions (see Table 12.2) and potential
drug–drug interactions (see Table 12.3) (Fick et al., 2006
[Level VI]).
B. Specific interventions for prevention of Iatrogenic Adverse Drug Re-
actions (in hospital and after discharge)
1. Consider any new symptom as a possible ADR before requesting/
administering newmedication for the symptom, avoiding the pre-
scribing cascade (example in context) (Gurwitz et al., 2003 [Level
IV]).
2. Monitor medication orders for wrong drug choices (high risk in-
appropriate medications, drug–disease and drug–drug interac-
tions), wrong dosages, or administration errors (Doucette et al.
2005 [Level V]; Gurwitz et al., 2003 [Level IV]; Hanlon et al.,
1997 [Level IV]). Consider use of technological handheld de-
vices such as PDA for quick access to Beers criteria, drug–drug
or drug–disease interactions, and geriatric assessment tools (see
www.ConsultGeriRN.org and Resources section of this chapter).
3. Improve prescribing practices by documenting indication for ini-
tiation of new drug therapy, maintaining a current medication list,
documenting response to therapy, as well as the need for ongo-
ing treatment (Knight & Avorn, 2001 [Level VI]; Merle, Laroche,
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Dantoine, & Charmes, 2005 [Level VI]) and evaluating co-
morbidities (Merle et al., 2005 [Level VI]).
4. Institutional implementation of computer-assisted technology for
medication order entry: has the potential to prevent an esti-
mated 84% of dose, frequency, and route errors; and from 28%
to 95% of ADEs can be prevented by reducing medication er-
rors through computerized monitoring systems (AHRQ, 2001
[Level I]). Identifying and reporting of ADRs can also be per-
formed using computer-assisted National Surveillance system.
Institutions must facilitate a culture of safety to reduce ADRs/
ADEs.
C. Interventions at Discharge
1. Reconciliation of medications at discharge (Gleason et al., 2004
[Level IV]; Nickerson et al., 2005 [Level II]; JCAHO, 2006, 2007
[Level VI]) helps to reduce ADR/ADEs and therefore rehospital-
ization.
2. Assess abilities and limitations and health literacy in self-
administration of medications using appropriate tools at dis-
charge (Curry et al., 2005 [Level VI]) and recognize that self-
administration and nonadherence can induce ADRs (Merle et al.,
2005 [Level VI]).
3. Assess for adherence issues that may develop after discharge,
which can help to reduce ADEs (Nickerson et al., 2005
[Level II]) and rehospitalization (Bergman-Evans, 2006; Edelberg
et al., 1999 [Level IV]; Fulmer et al., 2000). Recommend de-
vices that can assist in enhancing adherence behavior (Fulmer
et al., 1999) and interventions to address cost and other adherence
issues.
4. Patient/Caregiver Education. Provide patient and caregiver edu-
cation using relevant nursing content and principles (Curry et al.,
2005 [Level VI]) including assessment of factors that might affect
adherence. Nurses are the primary source for providing education
to patients at discharge; therefore, their role is key to preventing
medication-related consequences after hospitalization, including
rehospitalization. Discharge education and counseling includes:
a. Education tailored to the age group and needs of the individual
(Bergman-Evans, 2006)
b. Educate the patient/caregiver about benefits and risks
(Shekelle et al., 2001) and potential medication side effects
(Rochon, 2006 [Level V]).
c. Teach safe medication management (Curry et al., 2005 [Level
VI]).
d. Consider an interactive computer program (Personal Educa-
tion Program [PEP]) designed for the learning styles and psy-
chomotor skills of older adults to teach about potential drug
interactions that can result from self-medication with OTC
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agents and alcohol (Neafsey, Strickler, Shellman, & Chartier,
2002 [Level II]).
VI. EXPECTED OUTCOMES
A. Patients will:
1. Experience fewer iatrogenic outcomes from medication-related
events.
2. Understand their medication regimens upon discharge from the
hospital.
B. Health care providers will:
1. Use a range of interventions to prevent, alleviate, or ameliorate
medication problems with older adults.
2. Improve prescribing practices by documenting indication for ini-
tiation of newdrug therapy,maintaining a currentmedication list,
documenting response to therapy, as well as the need for ongoing
treatment (Knight & Avorn, 2001 [Level VI]).
3. Evaluate nature and origins of medication-related problems in a
timely manner.
4. Increase their knowledge aboutmedication safety in older adults.
5. Increase referrals to appropriate practitioners (e.g., geriatrician,
geriatric/gerontological or psychiatric clinical nurse specialist,
nurse practitioner, or consultation-liaison service).
C. Institution will:
1. Provide education to health care providers regarding prevention,
identification, and reporting of ADRs (Gurwitz et al., 2003 [Level
IV]).
2. Make information on ADRs accessible to patients (Gurwitz et al.,
2003 [Level IV]).
3. Enhance surveillance and reporting of ADRs using a National
Surveillance system (Gurwitz et al., 2003 [Level IV]; JCAHO, 2007
[LevelVI]). Consideruse of computerizedphysicianordering sys-
tem (Gurwitz et al., 2003 [Level IV]; Joanna Briggs Institute, 2006
[Level I]).
4. Track and report morbidity and mortality due to medication-
related problems.
5. Provide a system for medication reconciliation and follow-up its
effectiveness with regard to rehospitalization rates due to ADRs.
6. Review for careful documentation of iatrogenic medication and
other iatrogenic events for CQI.
7. Provide ongoing education related to safe medication manage-
ment for physicians and staff.
VII. FOLLOW-UP
A. Health care providers will:
1. Provide consistent and appropriate care and follow-up in pres-
ence of a medication-related problem.
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2. Evaluate with physical exam and laboratory tests (as appropri-
ate) on regular basis to ensure that the older adult is responding
to therapy as expected (Edelberg et al., 2000 [Level IV]).
B. Institutions will:
1. Provide ongoing assessment of staff competence in assessing
and intervening for prevention of ADEs.
2. Embed reduction of ADEs in the culture of safety.
VIII. RELEVANT PRACTICE GUIDELINES
A. Bergman-Evans, B. (2004). Improving medication management for
older adult clients. Iowa City, IA: University of Iowa Gerontologi-
cal Nursing Interventions Research Center, Research Dissemina-
tion Core; 2004 Oct. [Level I]. Available at www.guideline.gov; NGC
Guideline # 003993.
B. Health Care Association of New Jersey (HCANJ). (2006). Medica-
tion management guideline. Hamilton, NJ: Health Care Associa-
tion of New Jersey (HCANJ); Available at www.guideline.gov. Note:
Geared for posthospital institutions for adult patients.
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Educational
Objectives
At the completion of this chapter, the reader should be
able to:
1. discuss transient and established etiologies of
urinary incontinence (UI)
2. describe the core components of a nursing
assessment for UI in hospitalized older adults
3. discuss the importance of nurse collaboration
within the interdisciplinary team in an effort to best
assess and document type of UI
4. develop an individualized plan of care for an older
adult with UI
5. list limited indications for indwelling catheter use
Overview
Persistentmyths regarding urinary incontinence (UI) among lay and health care
providers are captured by the axiom: “You are born wearing diapers . . . you
die wearing diapers.” Despite evidence supporting UI management strategies
(Fantl et al., 1996 [Level I]); International Consultation on Incontinence (ICI),
2000 [Level VI]), nursing staff and laypersons often use containment strategies,
such as diapers, tomanageUI. Individuals with UI erroneously believe that con-
taining UI is a normal consequence of aging (Bush, Castellucci, & Phillips 2001
[Level IV]; Dowd, 1991 [Level IV]; Kinchen et al., 2003 [Level IV]; Milne, 2000
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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[Level IV]; Mitteness, 1987a, 1987b [Level VI]). In addition, incontinent persons
feel that UI is a personal problem, it is difficult to talk about (Bush et al., 2001
[Level IV]), and prefer self-help strategies rather than seeking professional ad-
vice (Milne, 2000 [Level IV]). Personal care strategies are often the result of
information gained through lay media and personal contacts, not necessarily
from health care professionals (Cochran, 2000 [Level VI]; Jeter & Wagner, 1990
[Level IV]; Miller, Brown, Smith, & Chiarelli, 2003 [Level IV]; Milne, 2000 [Level
IV]). Therefore, attitudes and beliefs regarding UI are important for nurses to
consider in an effort to best assess and manage UI.
UI affects more than 17 million adults in the United States and is most often
defined as the involuntary loss of urine sufficient to be a problem (Fantl et al.,
1996 [Level I]; National Association for Continence, 1998 [Level IV]; Resnick &
Ouslander, 1990 [Level VI]). Prevalence and incidence rates of UI are viewed
cautiously due to inconsistencies with definitions and measurements of both
these epidemiological statistics. In addition, variable or poorly articulated UI
definitions (Abrams et al., 2002 [Level V]; Palmer, 1988 [Level V]), as well as
underreporting and underassessment of UI (Schultz, Dickey, & Skoner, 1997
[Level IV]), can render data of questionable reliability. Prevalence of UI in
community-dwelling adult populations ranges from 8% to 38% (Anger, Saigal,
Litwin, & The Urologic Diseases of America Project, 2006 [Level IV]; Diokno,
Brock, Brown, & Herzog, 1986 [Level IV]; Herzog & Fultz, 1990 [Level V]; John-
son et al., 1998 [Level IV]). For individuals with dementia, UI prevalence rates
range from 11% to 90%; higher prevalence rates reflect institutionalized cogni-
tively impaired older adults (Brandeis, Baumann, Hossain, Morris, & Resnick,
1997 [Level IV]; Skelly & Flint, 1995 [Level V]). Although the highest preva-
lence rate occurs in institutionalized older adults, 15% to 53% of homebound
elderly and 10% to 42% of older adults admitted to acute care also suffer from
UI (Dowd & Campbell, 1995 [Level IV]; Fantl et al., 1996 [Level I]; McDow-
ell et al., 1999 [Level II]; Palmer, Bone, Fahey, Mamom, & Steinwachs, 1992
[Level IV]; Schultz et al., 1997 [Level IV]). For example, 36% of older hospi-
talized adults develop acute UI (e.g., new-onset UI, meaning that these indi-
viduals were continent on admission) (Kresevic, 1997 [Level IV]); for patients
undergoing hip surgery, the incidence of acute UI is 19% to 32% (Palmer, Baum-
garten, Langenberg, & Carson, 2002 [Level IV]; Palmer, Myers, & Fedenko, 1997
[Level IV]).
In addition to being a common geriatric syndrome, UI significantly affects
health-related quality of life (HRQOL) (Shumaker, Wyman, Uebersax, McClish,
& Fantl, 1994 [Level IV]). The consequences of UI may be characterized phys-
ically, psychosocially, and economically. An episode of urge UI occurring once
weekly or more frequently is associated with falls or fracture (Brown et al.,
2000a [Level IV]). Other physical consequences associated with UI include skin
irritations or infections, urinary tract infections (UTIs), pressure ulcers, and lim-
itation of functional status (Fantl et al., 1996 [Level I]; Johnson et al., 1998 [Level
IV]). UI is associated with psychological distress (Bogner et al., 2002 [Level IV])
including depression, poor self-rated health, and social isolation or condition-
specific functional loss (Bogner et al., 2002 [Level IV]; Fantl et al., 1996 [Level
I]; Johnson et al., 1998 [Level IV]). Therefore, it is essential that nurses as-
sess and treat UI when addressing other health problems such as depression or
falls.
Urinary Incontinence 311
Although there is conflicting evidence as to UI being a predictor for nursing
home placement, UI has been identified as a marker of frailty in community-
dwelling older adults (Holroyd-Leduc, Mehta, & Covinsky, 2004 [Level I]). The
negative psychosocial impact of UI affects not only the individual but also the
family caregiver(s) (Cassells & Watt, 2004 [Level IV]). Economically, the total
direct cost for all incontinent individuals is estimated to bemore than $16 billion
annually (Wilson, Brown, Shin, Luc, & Subak, 2001 [Level IV]; Wyman, 1997
[Level V]).
Nurses are in a key position to identify and treat UI in hospitalized older
adults. This chapter reviews the etiologies and consequences of UI, with em-
phasis on the most common types of UI encountered in the acute care setting.
Assessment parameters and care strategies for UI are highlighted and a nurs-
ing standard of practice protocol for recognizing and treating UI is presented.
The protocol focuses on comprehensive assessment and management of UI for
hospitalized older adults.
Assessment of The Problem
Adverse physiologic consequences of UI commonly encountered in acute care
facilities include an increased potential for UTIs and indwelling catheter use,
dermatitis, skin infections, and pressure ulcers (Sier, Ouslander, & Orzeck, 1987
[Level IV]). Moreover, UI that results in functional decline predisposes older
individuals to complications associated with bedrest and immobility (Harper &
Lyles, 1988 [Level V]).
Etiologies of Urinary Incontinence
Continence is a complex,multidimensional phenomenon influencedby anatom-
ical, physiological, psychological, and cultural factors (Gray, 2000 [Level V]).
Thus, continence requires intact lower urinary tract function; cognitive and
functional ability to recognize voiding signals and use a toilet or commode; the
motivation to maintain continence; and an environment that facilitates the pro-
cess (Jirovec, Brink, & Wells, 1988 [Level VI]). Physiologically, continence is
a result of urethral pressure being equal to or greater than bladder pressure
(Hodgkinson, 1965 [Level V]), of which angulation of the urethra, supported by
pelvicmuscles, plays a role (DeLancy, 1994 [Level IV]). Continence also requires
the ability to suppress autocontractility of the detrusor (Hodgkinson, 1965 [Level
V]). Micturition (i.e., urination) involves voluntary as well as reflexive control of
the bladder, urethra, detrusor muscle, and urethral sphincter.When the bladder
volume reaches approximately 400 milliliters, stretch receptors in the bladder
wall send a message to the brain and an impulse for voiding is sent back to
the bladder. The detrusor muscle then contracts and the urethral sphincter re-
laxes to allow urination (Gray, Rayome, & Moore, 1995 [Level VI]). Normally,
the micturition reflex can be voluntarily inhibited (at least for a time) until an
individual desires to void or finds an appropriate place for voiding. UI occurs as
the result of a disruption at any point during this process. For a comprehensive
review, Gray (2000 [Level V]) provides a detailed analysis of voiding physiol-
ogy. Common age-associated changes, including a decrease in bladder capacity,
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benign prostatic hyperplasia (BPH) in men, and menopausal loss of estrogen in
women, can affect lower urinary tract function and predispose older individuals
to UI (Bradway & Yetman, 2002 [Level VI]). Despite these aging changes, UI is
not considered a normal consequence of aging.
The Agency for Healthcare Research and Quality (AHRQ) identifies two
types of UI: transient (acute) and established (chronic) (Fantl et al., 1996
[Level I]).
Transient UI is characterized by the sudden onset of potentially reversible
symptoms. Causes of transient UI include delirium, infections (e.g., untreated
UTI), atrophic vaginitis, urethritis, pharmaceuticals, depression or other psy-
chological disorders that affect motivation or function, excessive urine produc-
tion, restricted mobility, and stool impaction or constipation (which creates ad-
ditional pressure on the bladder and can cause urinary urgency and frequency).
Hospitalized older adults are at risk of developing transient UI. Complicated by
shorter hospital stays, these individuals may also be at risk of being discharged
without resolution of transient UI and, thus, urine leakage persists and may
become established UI. However, transient UI is often preventable, or at least
reversible (e.g., transient UI precipitated by a UTI that resolves with successful
treatment, or acute UI related to diuresis therapy for heart failure exacerba-
tion), if the underlying cause for the UI is identified and treated (Fantl et al.,
1996 [Level I]; Palmer, 1996 [Level VI]).
Kresevic (1997 [Level IV]) reported that hospitalized older adults with new-
onset UI were more likely to be on bedrest, restrained, depressed, dehydrated,
malnourished, and dependent in ambulation when compared to their continent
counterparts. Furthermore, the relative risk of developing new-onset UI was
twofold for older adults with depression (OR=2.28), malnutrition (OR=2.29),
and dependent ambulation (OR=2.55). Study participants identified that being
able to walk, having use of a bedpan/commode, and nursing assistance fos-
tered continence (Kresevic, 1997). Likewise, Palmer and colleagues (2002 [Level
IV]) determined that in addition to mobility dependency, other risk factors for
new-onset UI, specific to a hip fracture population, included institutionalization
prior to hospital, the presence of confusion preceding hip fracture, and being
an African American woman.
Established UI has either a sudden or gradual onset and is often present
prior to hospital admission. However, health care providers or family caregivers
may discover it initially during the course of an acute illness, hospitalization, or
abrupt change in environment or daily routine (Palmer, 1996 [Level VI]). Types
of established UI include stress, urge, mixed, overflow, and functional.
Stress UI is defined as an involuntary loss of urine associated with activi-
ties that increase intra-abdominal pressure. Symptomatically, individuals with
stress UI usually present with complaints of small amounts of daytime urine
loss that occurs during physical effort or exertion (e.g., position change, cough-
ing, sneezing) that result in increased intra-abdominal pressure. Stress UI is
more common in women; however, stress UImay also be identified inmen post-
prostatectomy (Abrams et al., 2003 [Level V]; Fantl et al., 1996 [Level I]; Hunter,
Moore, Cody, & Glazener, 2005 [Level I]).
UrgeUI is characterizedby an involuntary urine loss associatedwith a strong
desire to void (i.e., urgency). Individuals with urge UI often complain of being
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unable to hold the urge to urinate and leak on the way to the bathroom. In
addition to urgency, signs and symptoms of urge UI most often include urinary
frequency, nocturia and enuresis, and UI of moderate to large amounts. Bladder
changes common in aging make older adults particularly prone to this type of
UI (Abrams et al., 2003 [Level V]; Fantl et al., 1996 [Level I]). An individual
with an overactive bladder (OAB) may complain of urgency, with or without
UI. Individuals with an OAB also may have urinary frequency and nocturia.
Assessment should focus onpathologic ormetabolic conditions thatmay explain
these symptoms (Abrams et al., 2003 [Level V]).
Mixed UI is defined as involuntary urine loss as a combination of stress UI
and urge UI (Fantl et al., 1996 [Level I]). Symptoms include both urge and stress
UI symptoms.
Overflow UI is an involuntary loss of urine associated with over-distention
of the bladder and may be caused by an under active detrusor muscle or out-
let obstruction leading to over-distention of the bladder and leakage of urine.
Individuals with overflow UI often describe dribbling, urinary retention or hes-
itancy, urine loss without a recognizable urge, an uncomfortable sensation of
fullness or pressure in the lower abdomen, and incomplete bladder empty-
ing. Clinically, suprapubic palpation may reveal a distended or painful blad-
der as a result of urine retention, which may be acute or chronic. A com-
mon condition associated with this type of UI is BPH. Neurological conditions
such as multiple sclerosis and spinal cord injuries or diabetes mellitus (DM),
which result in bladder muscle denervation, may also cause overflow UI
(Abrams et al., 2003 [Level V]; Doughty, 2000 [Level VI]; Fantl et al., 1996
[Level I])
Functional UI is caused by nongenitourinary factors, such as cognitive or
physical impairments, that result in an inability for the individual to be inde-
pendent in voiding. For example, acutely ill hospitalized individualsmaybe chal-
lenged by a combination of an acute illness and environmental changes. This,
in turn, makes the voiding process even more complex, resulting in a functional
type of UI (Fantl et al., 1996 [Level I]).
Assessment Parameters
Nurse continence experts suggest that entry-level nurses demonstrate the abil-
ity to collect and organize data surrounding urine control and implement nurs-
ing interventions that promote continence (Jirovec,Wyman, &Wells, 1998 [Level
VI]). Nurses play a critical role in the basic assessment and management of UI
in hospitalized older adults. Because UI is an interdisciplinary issue, collabo-
ration with other members of the health care team is essential. However, it is
no longer sufficient for nurses to identify and document the presence of UI.
According to incontinence experts, the type of UI should be determined and
documented based on a careful history and focused assessment; urodynamic
tests are not required as part of the initial assessment of UI (ICI, 2000 [Level
VI]). Basic history and examination techniques are presented herein to assist
nurses in identifying the type of UI along with a nursing standard of practice
protocol (see Box 13.1) to guide UI assessment and management.
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History
When a patient is admitted to the hospital, nursing history should include ques-
tions to determine if the individual has pre-existing UI or risk factors (Table
13.1) for UI. Nurses should be alert to the following UI-associated risk factors
specific to the hospital setting: depression, malnourishment, dependent ambu-
lation, being a resident in a long term care institution, confusion, and being an
African American woman (Kresvic, 1997 [Level IV]; Palmer et al., 2002 [Level
IV]). Therefore, nurses should screen for depression, determine body mass in-
dex (BMI), monitor albumin and total protein levels if available, consult with the
dietician, and perform a validated assessment of both cognitive and functional
status.
Nurses should include screening questions such as “Have you ever leaked
urine? If yes, how much does it bother you?” for all older adult patients. Al-
though not validated in the hospital setting, examples of screening instruments
used in other settings include the Urinary Distress Inventory-6 (UDI-6) and the
Male Urinary Distress Inventory (MUDI). The UDI-6 is a self-report symptom
inventory for UI that is reliable and valid for identifying the type of established
UI in community-dwelling females (Lemack & Zimmern, 1999 [Level IV]; Ue-
bersax, Wyman, Shumaker, McClish, & Fantl, 1995 [Level IV]). The MUDI is a
valid and reliable measure of urinary symptoms in the male population (Robin-
son & Shea, 2002 [Level IV]). Determining the degree of “bother” and the effect
on HRQOL is important and should include the perspective of both the patient
and caregiver or significant other. Various instruments for quantifying bother
and HRQOL exist (Abrams et al., 2003 [Level V]; Bradway, 2003 [Level VI];
Robinson & Shea, 2002 [Level IV]; Shumaker et al., 1994 [Level IV]).
Historical questions should focus on the characteristics of UI: time of onset,
frequency, and severity of the problem. Questions also should review past health
history and address possible precipitants of UI such as coughing, uncontrollable
urinary urgency, functional decline, and acute illness (e.g., UTI, hip fracture).
Nurses should inquire about lower urinary tract symptoms such as nocturia,
hematuria, and urinary hesitancy, as well as current management strategies
for UI.
The presence and rationale for an indwelling urinary catheter should be
documented. For example, Tag F315 of the U.S. Centers for Medicare and Med-
icaid (2005) regulate indwelling urinary catheter usage in nursing home set-
tings.Appropriate indications in the nursing home include: (1) urinary retention
unmanageable by other measures (e.g., intermittent catheterization); (2) pre-
vention of urine contamination to stage III or IV pressure ulcers; and (3) se-
vere impairment or terminal illness that makes changing soiled clothes and
repositioning uncomfortable. Therefore, the presence of an indwelling urinary
catheter without one of these appropriate indications must prompt nurses to
evaluate its appropriateness and if necessary, consult with other members of
the health care team with regard to discontinuing the catheter.
A bladder diary or voiding record is the clinical “gold standard” for obtaining
objective information about a patient’s voiding pattern, incontinent episodes,
and UI severity. There are numerous voiding records available; for example,
visit http://kidney.niddk.nih.gov and search for “bladder diary.” Although the
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13.1 Risk Factors Associated with UrinaryIncontinence
Risk Factor Source
Age Holroyd-Leduc & Straus, 2004 [Level I ])
Age was associated with Urge UI, not Stress UI
Caffeine intake Holroyd-Leduc & Straus, 2004 [Level I ])
Immobility/functional
limitations
Fantl et al., 1996 [Level I ]
Holroyd-Leduc & Straus, 2004 [Level I ]
Kresvic, 1997 [Level IV ]
Impaired cognition Fantl et al., 1996 [Level I ]
Medications Fantl et al., 1996 [Level I ]
Obesity Fantl et al., 1996 [Level I ]
Brown et al., 1996 [Level IV ]
Diuretics Fantl et al., 1996 [Level I ]
Smoking Fantl et al., 1996 [Level I ]
Fecal impaction Fantl et al., 1996 [Level I ]
Malnutrition Kresvic, 1997 [Level IV ]
Depression Kresvic, 1997 [Level IV ]
Delirium Fantl et al., 1996 [Level I ]
Pregnancy/vaginal
delivery/episiotomy
Fantl et al., 1996 [Level I ])
Holroyd-Leduc & Straus, 2004 [Level I ]
Low fluid intake Fantl et al., 1996 [Level I ]
Environmental barriers Fantl et al., 1996 [Level I ]
High-impact physical
activities
Fantl et al., 1996 [Level I ]
Diabetes mellitus Fantl et al., 1996 [Level I ])
Holroyd-Leduc & Straus, 2004 [Level I ]
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Risk Factor Source
Parkinson’s disease Holroyd-Leduc & Straus, 2004 [Level I ]
Stroke Fantl et al., 1996 [Level I ])
Holroyd-Leduc & Straus, 2004 [Level I ])
Meijer et al., 2003 [Level I ])
Thomas et al., 2005 [Level I ]
Chronic obstructive
pulmonary disease
Dowling-Castronovo, 2004 [Level VI ]
Holroyd-Leduc & Straus, 2004 [Level I ]
Estrogen depletion Fantl et al., 1996 [Level I ])
Holroyd-Leduc & Straus, 2004 [Level I ]
Hysterectomy Brown, Sawaya, Thom, & Grady, 2000b [Level I ]
Holroyd-Leduc & Straus, 2004 [Level I ]
Pelvic muscle weakness Fantl et al., 1996 [Level I ])
Kegel, 1956 [Level VI ]
DeLanacy, 1994 [Level IV ]
Holroyd-Leduc & Straus, 2004 [Level I ]
Childhood nocturnal
enuresis
Fantl et al., 1996 [Level I ])
Race Fantl et al., 1996 [Level I ]
Holroyd-Leduc & Straus, 2004 [Level I ]: White women
having higher rates of moderate and severe UI than Black
women [Level I ]
Arthritis and/or back
problems
Holroyd-Leduc & Straus, 2004 [Level I ]
Hearing and/or visual
impairment
Holroyd-Leduc & Straus, 2004 [Level I ]
Prostate surgery Hunter, Moore, Cody, & Glazener, 2004 [Level I ]
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7-day voiding record is themost evaluated and recommended tool used to quan-
tify UI and identify activities associated with unwanted urine loss (Jeyaseelan,
Roe, & Oldham, 2000 [Level I]), a 3-day voiding record has been recommended
as more feasible in outpatient and long term care settings (Fantl et al., 1996
[Level I]; ICI, 2000 [Level VI]). A voiding record completed for even 1 day may
help identify patients with bladder dysfunction or those requiring further re-
ferral. Advanced practice nurses or urologic/continence specialists can assist
nursing staff with interpretation and offer suggestions regarding nursing inter-
ventions based on information from the voiding record.
Comprehensive Assessment
A wide variety of medications can adversely affect continence. Diuretics are the
most commonly knownclass ofmedications that contribute toUI due to polyuria,
frequency, and urgency. Anticholinergics may cause mental status changes, uri-
nary retention with or without overflow incontinence, and stool impaction. Var-
ious psychotropic medications (e.g., tricyclic antidepressants, antipsychotics,
sedative-hypnotics) have anticholinergic effects, contribute to immobility, cause
sedation and possibly delirium—each of which negatively affects bladder con-
trol. Alpha-adrenergic blockers may cause urethral relaxation whereas alpha-
adrenergic agonistsmay cause urinary retention. Calcium channel blockers also
may cause urinary retention (Kane, Ouslander, & Abrass, 2004 [Level VI]).
Nurses should document all over-the-counter (OTC), herbal, and prescrip-
tion medications on admission. Additionally, nurses must closely scrutinize new
medications as possible causes if UI suddenly develops during a patient’s hos-
pital stay. Medications that may contribute to iatrogenic (i.e., hospital-caused)
UI include diuretics and sedative-hypnotics. Essentially, when a hospitalized
patient develops transient UI, the nurse must ask the question: Could a new
medication be affecting this patient’s bladder control? If the answer is yes, then
the nurse reviews this finding with the prescribing practitioner to learn if the
contributing medication may be discontinued or modified.
Important components of a comprehensive examination include abdomi-
nal, genital, rectal, and skin examinations. In particular, the abdominal exami-
nation should assess for suprapubic distention indicative of urinary retention.
Inspection of male and female genitalia can be completed during bathing or
as part of the skin assessment. The nurse should observe the patient for signs
of perineal irritation, lesions, or discharge. In women, a Valsalva maneuver (if
not medically contraindicated) or voluntary cough may identify pelvic prolapse
(e.g., cystocele, rectocele, uterine prolapse) or stress UI as a result of increased
intra-abdominal pressure with bearing down (Burns, 2000 [Level VI]). Post-
menopausal women are especially prone to atrophic vaginitis. Significant find-
ings for atrophic vaginitis include perineal inflammation, tenderness (and, on
occasion, trauma as a result of touch), and thin, pale genitalia tissues. During
the genitalia examination, patients should be instructed to cough to determine
if there is urine leakage, again caused by increased intra-abdominal pressure,
which may be attributed to stress UI. Digital rectal and skin examinations are
essential in identifying transient causes of UI such as constipation, fecal im-
paction, and the presence of fungal rashes. The “anal wink” (i.e., contraction of
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Instruct the patient to void. Post-void (ideally within 15 minutes or less) measure the
residual urine remaining in the bladder by either:
• Bladder Sonography (Scan)
Noninvasive ultrasound of the suprapubic area identifies the residual amount of
urine, or
• Sterile catheterization
A PVR of greater than 100cc is considered abnormal and requires further evaluation by
a urology specialist
Adapted from Shinopulos (2000 [Level VI])
13.1
Post Void Residual
(PVR)
the external anal sphincter) indicates intact sacral nerve routes and is assessed
by lightly stroking the circumanal skin. Absence of the “anal wink” may suggest
sphincter denervation (Burns, 2000 [Level VI]) and risk for stress UI. In men,
the prostate gland should be palpated during the rectal examination because
BPH contributes to urge or overflow UI. A normal prostate gland is symmetri-
cally heart-shaped, about the size of a large chestnut, and often described as
“rubbery” or similar to the tip of the nose. When enlarged, as with BPH, the
examiner may palpate symmetrical enlargement. Pain on palpation or asym-
metrical borders may be indicative of prostatitis or prostate cancer, respectively
(Gray & Haas, 2000 [Level VI]).
In some cases, diagnostic testing may provide additional information. The
most common diagnostic testing includes urinalysis, urine culture and sensi-
tivity, and postvoid residual urine (PVR) (ICI, 2000 [Level VI]). Urinalysis and
urine cultures are used to identify the presence of a UTI and bacterial agent
responsible, which may contribute to acute UI. When dealing with a suspected
UTI in a patient with an indwelling urinary catheter, change the entire system
(Wound Ostomy Continence Nurse’s Society, 1996 [Level VI]) prior to obtaining
a urine specimen. A measurement of PVR may reveal incomplete bladder emp-
tying. Twoways to accurately evaluate PVRare bladder sonography and catheter
insertion after the patient has voided (Figure 13.1). An additional diagnostic test
such as a simple bedside urodynamic test, which provides information regarding
detrusor activity,maybewarranted in somecases (Burns, 2000;Weiss, 1998 [both
Level VI]).
A simple bedside urodynamic test is most likely to be performed by an ad-
vance practice nurse or physician. It is done after a PVRhas beenperformed and
measured via the sterile catheterization method. After the bladder is emptied,
the catheter is maintained in the bladder. A 50 mL syringe (without plunger) is
connected to the catheter, with the center of the syringe in alignment with the
symphysis pubis. Sterile water is then instilled to fill the bladder. The fluid level
is monitored for evidence of bladder contractions, which are reflected in move-
ment of the fluid level. UrgeUI is likely if severe urgency or bladder contractions
are noted at less than 300 mL (Weiss, 1998 [Level VI]).
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Functional, environmental, and mental status assessments are essential
components of the UI evaluation in older adults. Nurses should observe the
patient voiding, assess mobility, note any use of assistive devices, and identify
any obstacles that interfere with appropriate use of toilets or toilet substitutes,
such as a bedside commode.
Interventions and Care Strategies
Palmer’s conceptual model for continence management stresses the need for
public education (1996 [Level VI]). Evidence demonstrates that hospital nurses
lack the knowledge necessary for evidence-based incontinence care (Connor
& Kooker, 1998 [Level IV]; Cooper & Watt, 2003 [Level IV]); therefore, adapt-
ing this for the acute care environment includes staff education. A brief unit-
based in-service followed by patient rounds may be instrumental in identifying
patients at risk for UI and those actually experiencing UI. The North Amer-
ican Nursing Diagnosis Association (NANDA), Nursing Interventions Classifi-
cations (NIC), andNursing Outcomes Classification (NOC) provide structure for
planning and evaluating UI assessment and management (Johnson, Bulechek,
McCloskey-Dochterman, Maas, & Moorhead, 2001 [Level VI]). However, there
is no structured guidance for the assessment and management of transient UI.
Nurses are likely to be the first to identify and perhaps prevent transient UI. Re-
search is needed to understand the role nurses play in preventingUI (Sampselle,
Palmer, Boyington, O’Dell, & Wooldridge, 2004 [Level VI]).
Treating Transient and Functional Causes of UI
First, transient causes of UI should be investigated, identified, and treated. In-
dividuals with a history of established UI should have usual voiding routines
and continence strategies immediately incorporated into the acute care plan,
whenever possible. Nurses play an essential role in the initiation of discharge
planning and patient or caregiver teaching regarding all aspects of UI. Teach-
ing and discharge planning should begin at admission as appropriate, reviewed
continually, and revised as necessary.
The environment is vital in managing UI, particularly functional UI.
Incontinent older adults are often dependent on adaptive devices (e.g., walker)
or caregivers for assistance with voiding, making them “dependently continent.”
Call bells should be identified and within easy reach. If limited mobility is
anticipated, nursing staff should consider using an elevated toilet or commode
seat,male or female urinal, or bedpan.Nurses should obtain referrals to physical
and occupational therapy for ambulation aids, gait training, further assessment
of activities of daily living (ADLs) associated with continence, and improved
muscle strength. Physical and chemical restraints should be avoided, including
side rails (see case studies). Patients should be encouraged and assisted to void
before leaving the unit for tests (Fantl et al., 1996 [Level I]; Jirovec, 2000 [Level
VI]; Jirovec et al., 1988 [Level VI]; Palmer, 1996 [Level VI]).
Toileting programs (e.g., individualized, scheduled toileting programs;
prompted voiding) have varied success rates (Colling, Ouslander, Hadley,
Eisch, & Campbell, 1992 [Level II]; Eustice, Roe, & Paterson, 2005 [Level I];
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Ostaszkiewicz, Johnston, & Roe, 2005 [Level I]). A voiding record is essential
for developing an individualized scheduled toileting program, which mimics
the patient’s normal voiding patterns and requires continual assessment and
re-evaluation for successful outcomes. For example, if the initial scheduled toi-
leting time is set for 8 a.m., yet at 6:30 a.m. the patient consistently attempts to
independently void or is noted to be incontinent, then the toileting time should
be adjusted to 6 a.m. Prompted voiding requires the caregiver to ask if the pa-
tient needs to void, offer assistance, and then offer praise for successful voiding
(Eustice et al., 2005 [Level I]; Jirovec, 2000 [Level VI]; Ostaszkiewicz et al., 2005
[Level I]).
Healthy Bladder Behavior Skills
Traditionally, nursing interventions for UI focus on containment strategies by
means of receptacles (e.g., bedpan, urinal, commode, urinary catheters) or by
various absorbent products (e.g., sanitary napkin, adult diaper, incontinent pad)
(Harmer & Henderson, 1955; Henderson & Nite, 1978). Various treatments be-
yond containment strategies include dietary management; pelvic floor muscle
exercises (PFMEs), also known as Kegel exercises (Kegel, 1956 [Level VI]); urge
inhibition and bladder training (retraining) strategies; toileting programs (e.g.,
individualized, scheduled toileting programs, prompted voiding); pharmacolog-
ical therapy; and surgical options (Fantl et al., 1996 [Level I]). These treatments
(excluding pharmacological and surgical options) are viewed as healthy bladder
behavior skills (HBBS). Although the recommendation is to offer HBBS to all
older adults with UI (Fantl et al., 1996 [Level I]; ICI, 2000 [Level VI]); Teunis-
sen, deJonge, van Weel, & Lagro-Janssen, 2004 [Level I]), it is unclear how to
best incorporate HBBS in the care of hospitalized older adults. Despite the fact
that contemporary nursing-practice textbooks list and describe HBBS as nurs-
ing interventions (Kozier, Erb, Berman, & Snyder, 2004; Taylor, Lillis, & LeMone,
2005 [both Level VI]), many of these interventions have not been adequately
examined in the acute care setting, and nurses do not routinely implement these
interventions in the acute care setting (Bayliss, Salter, & Locke, 2003; Schnelle
et al., 2003;Watson, Brink, Zimmer, &Mayer, 2003 [all Level IV]). Recall, under-
reporting, and under-assessment are barriers to optimally addressing UI in the
hospital setting, as reflected in the study by Schultz and colleagues (1997 [Level
IV]), which reported that only 0.1% of medical records captured the problem of
UI present at the time of hospital admission. Accurate assessment and identifi-
cation of type of UI is needed before care strategies are initiated.
Prior to instituting HBBS, nurses need to assess the motivation of a pa-
tient, informal caregiver, and nursing staff because behavior modification is a
premise of HBBS (Palmer, 2004 [Level VI]). Examples of dietary management
strategies include avoiding certain foods and beverages known to be bladder
irritants such as caffeine, acidic foods or fluids, and NutraSweet® (Gray & Haas,
2000 [Level VI]). Some individuals with a BMI greater than 27 may benefit from
a weight-loss program. For example, in one study, a weight loss of 5% to 10%
significantly decreased UI episodes for some obese women (Subak et al., 2005
[Level II]).
If not contraindicated, the nurse recommends adequate fluid intake, specifi-
cally water, and an increased intake of dietary fiber tomaintain bowel regularity.
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It is important to work closely with older adults who fear that unwanted urine
loss is a result of increased fluid intake. Education should focus on the adverse
consequence of inadequate fluid intake, such as volume depletion and potential
for dehydration, and that too little fluid intake may result in concentrated urine,
which, in turn, may cause increased bladder contractions and increased feelings
of urinary urgency. Lastly, tomanage and limit nocturia, patientsmay be advised
to limit fluid intake a few hours before bedtime (Doughty, 2000 [Level VI]; Fantl
et al., 1996 [Level I]; ICI, 2000 [Level VI]). In the hospital setting, nurses must
note the schedule of diuretics. For example, many institutions schedule every
12-hour diuretic dose times at 10 a.m. and 10 p.m. For some patients, it will be
extremely important that nurses navigate organizational processes to resched-
ule diuretic doses to alternate times, such as 6 a.m. and 6 p.m. This simple
strategy may decrease nocturia, which, in turn, will likely decrease risk for falls.
Research that examines which UI interventions best modify fall risk is needed
(Wolf, Riolo, & Ouslander, 2000 [Level VI]).
PFMEs are better than no treatment for stress and urge UI (Bo, Talseth,
& Holme, 1999 [Level II]; Flynn, Cell, & Luisi, 1994 [Level IV]; Hay-Smith &
Dumoulin, 2006 [Level I]; Holroyd-Leduc & Straus, 2004 [Level I]. PFME holds
promise for the primary prevention of UI but requires additional research (Hay-
Smith, Herbison, & Morkved, 2002 [Level I]). PFMEs were developed to aug-
ment the strength, endurance, and coordination of the pelvic muscles, which
play a role in maintaining continence. Integrating PFMEs into the plan of care
requires an assessment of the patient’s baseline understanding of PFMEs to
identify knowledge deficits. Ideally, PFMEs are taught during a vaginal or rec-
tal examination when the clinician manually assists the patient to identify the
pelvic muscles by instructing the patient to squeeze around the gloved ex-
amination finger. This method allows for performance appraisal (Hay-Smith
et al., 2002 [Level I]). Alternately, PFMEs may be verbally taught by instructing
the patient to gently squeeze or contract the rectal or vaginal muscle. Either
teaching method includes instructions to not squeeze the stomach, buttocks,
or thigh muscles (because this only increases intra-abdominal pressure) but
rather to isolate the contraction of the pelvic muscles. Preferably, each exercise
should consist of contracting for 10 seconds and relaxing for 10 seconds. Some
patients may need to start with 3 or 5 seconds and then increase as their mus-
cle gets stronger. There is no set “exercise dose” (DuMoulin, Hammers, Paulus,
Berendsen, & Halfens, 2005 [Level I]); however, it is usual practice to recom-
mend 15 PFMEs three times per day. Patients may notice improvement in 2
to 4 weeks but not immediately. Nurses should reinforce compliance and other
HBBSand initiate a referral for discharge follow-upwith a continence specialist,
if available (Bradway, Hernly, & the NICHE faculty, 1999a [Level VI]).
Urge inhibition is based on behavioral theory and is another recommended
HBBS for treatment of urge UI (ICI, 2000 [Level VI]; Teunissen et al., 2004
[Level I]), although the mechanism of how urge inhibition works is not well
understood (Gray, 2005 [Level VI]; Smith, 2000 [Level VI]). Urge inhibition in-
cludes distraction techniques (e.g., reciting a favorite poem or song), relaxation
techniques, and rapid PFMEs, with the goal being to suppress the urge to void
until desirable (Smith, 2000 [Level VI]).
Bladder training (retraining) is another behavioral technique used to treat
urge UI (ICI, 2000 [Level VI]; Teunissen et al., 2004 [Level I]) and OAB and is
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often used in conjunction with urge-inhibition techniques. Bladder training re-
quires a baseline bladder diary to determine the timing of voids andUI episodes.
If urinary frequency is present, the patient is instructed to lengthen the time be-
tween voids in an effort to retrain the bladder.When a strong urge to void occurs,
the patient is instructed to use urge-inhibition techniques to suppress urinary
urgency. For example, if the patient is not in a position to empty the bladder in a
socially appropriate manner, the nurse instructs the patient to quickly squeeze
and relax pelvic-floor muscles several times to suppress the urge to void. This
technique is sometimes referred to as “quick flicks” (Gray, 2005 [Level VI]).
Relaxation and distraction and urge-inhibition techniques are also beneficial
during bladder training.
In some instances (e.g., for patients experiencing incomplete bladder emp-
tying or overflow UI), patients and staff can use the Crede’s maneuver (i.e.,
deep suprapubic palpation). The Crede’s maneuver is used with caution and re-
quires manual compression over the suprapubic area during bladder emptying.
The Crede’s maneuver should be avoided if vesicoureteral reflux (i.e., abnor-
mal flow of urine from the bladder back up the ureters) or overactive sphincter
mechanisms are suspected because it may dangerously elevate pressure within
the bladder (Doughty, 2000 [Level VI]). In some cases, instructing patients to
double void (i.e., after an initial void, instruct the patient to stand or reposition
for a second void) also facilitates bladder emptying.
Additional Nursing Interventions
Despite the promise of antiseptic urinary catheters (Brosnahan & Kent, 2004
[Level I]), indwelling urinary catheters should be avoided as a treatment for
UI. Dowd and Campbell (1995 [Level IV]) discovered a UTI incidence of 10%
associated with indwelling catheter use. They suggest that unintended infec-
tions may have increased length of hospital stay and decreased opportunities
for nursing staff to identify incontinence as a problem. In addition, a European
study of 141 hospitals demonstrated that catheter-associated UTI was present
in more than 60% of nosocomial UTI cases (Bouza et al., 2001 [Level IV]).
The Wound Ostomy Continence Nurses Society (1996 [Level VI]) recommends
specific indications for indwelling catheter use, including severe acute illness,
urinary retention uncontrollable by other interventions (including medication
management and sterile intermittent catheterization), and UI management for
patients with Stage III–IV pressure ulcers of the trunk, such the sacral or ischial
areas. (see chapter 11, Iatrogenesis: The Nurse’s Role in Preventing Patient Harm)
Sterile intermittent catheterization may result in a lower incidence of infec-
tion (Saint et al., 2006 [Level II]; Terpenning, Allada, & Kauffaman, 1989 [Level
IV]; Warren, 1997 [Level VI]) and may be a feasible alternative to placement of
an indwelling urinary catheter for managing urinary retention with or without
overflow UI. Decisions regarding catheterization require careful consideration
of the benefits and burdens associated with use because it has long been docu-
mented that indwelling urinary catheters are positively associatedwith bacturia,
UTIs, uricemia, urethral erosion, and death (LeBlanc&Christensen, 2005 [Level
V]; Madigan & Neff, 2003 [Level I]; Wong, 1981 [Level VI]; Zimakoff, Stickler,
Pontoppidan, & Larsen, 1996 [Level IV]). One study reported the unjustified use
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of indwelling urinary catheters in 21% of cases; moreover, continued catheteri-
zation was unjustified 47% of the time (Jain, Parada, & Smith 1995 [Level IV]).
Strategies to reduce UTIs associated with indwelling urinary catheter use in
hospital settings include protocols that provide indications for appropriate in-
dwelling urinary catheter use and for discontinuing indwelling urinary catheters
(Reilly et al. 2006 [Level V]). When an indwelling urinary catheter is indicated,
it is recommended that (1) the smallest lumen size catheter be used; (2) ster-
ile water is used to inflate the catheter balloon and balloon volume is assessed
every 2 weeks or as clinically indicated; and, (3) the catheter is secured to the
patient’s thigh. No evidence supports routine collection of urine or routine tim-
ing of catheter changes (The Society of Urologic Nurses and Associates, 2005
[Level VI]).
Although a causal link between UI and skin breakdown has not been ad-
equately supported, maintaining skin integrity is a goal of nursing care. De-
composition of urinary urea by microorganisms releases ammonia and forms
ammonium hydroxide, an alkali. This alkali makes the protective “acid man-
tle” of the skin vulnerable and jeopardizes skin integrity. If UI episodes persist
despite management strategies, perineal skin care interventions should focus
on maintaining the integrity of the protective acid mantle of the skin (Ersser,
Getliffe, Voegeli, & Regan, 2005 [Level I]). Although absorbent products are
commonly used for UI containment, there is little evidence available to guide
product selection and no evidence of how absorbent products may interact with
the acid mantle. Pertaining to reusable versus disposable absorbent products,
there is no demonstrable risk of cross-infection with reusable absorbent prod-
ucts when appropriate laundering protocols are followed, and there are no clear
cost savings with using one versus the other. However, it is reported that the
use of diapers is significantly associated with an increased risk for infection
(Zimakoff et al., 1996 [Level IV]). Although bed pads contain urine, consumer
satisfaction is questionable, and there are no studies on the use of chair pads.
Essentially, there is no clear evidence to suggest one absorbent product be-
ing superior to another. However, the evidence does support pilot testing of
absorbent products according to individual circumstances, including patient,
family, and institutional preferences (Dunn, Kowanko, Patersonk, & Pretty, 2002
[Level I]).
Case Studies and Discussion
CASE #1
A student nurse received a report on Mr. G., an 86-year-old man with a
history of Alzheimer’s dementia who is hospitalized for delirium. The nurse
was told that Mr. G. was “pleasantly confused,” required full assistance with
personal care, and spent most of the day in a Geri-chair. The student nurse
performed an assessment that revealed the following:
Patient sleeping in bed with all siderails up, call bell within reach, no
urinal in sight. PMH-CAD, Mild HTN, Mild osteoarthritis
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PSH: None
Medications: diphenhydramine (Benadryl) 25mg PRN for sleep,
enalapril (Vasotec) 5mg PO OD for HTN, MVI 1 tab PO OD, donepezil
(Aricept) 10 mg PO OD for Alzheimer’s dementia, Vitamin E 400iu PO
BID supplement for Alzheimer’s dementia
VS: 114/60, 72, 14, 98.0F
Alert and oriented to self; sleepy; no focal deficits
Heart Rate: Regular
Breath sounds clear, slightly decreased at the bases
Abdomen: +BS in all quadrants, soft, nontender, no suprapubic tender-
ness; left quadrant slightly dull to percussion; no palpable masses
Dry adult diaper in place
The student nurse learns from the patient’s wife (i.e., the primary care
provider at home) that the patient has experienced occasional urinary leak-
ing in the past but not to the extent of needing “diapers.” He has a history
of chronic constipation. With the nursing instructor’s guidance, the student
nurse assisted Mr. G. to a dangling position at the side of the bed. After
assessing and evaluating that the patient’s muscular strength was strong,
ambulation was attempted. The patient ambulated to the bathroom, the
adult diaper was removed, and Mr. G. was prompted to void. He success-
fully voided and had a bowel movement. He proceeded to wash his hands
and returned to the bedside chair (not the Geri-chair) and enjoyed break-
fast. The adult diaper was left off during the time the student nurse was
there to assist him. During this time, Mr. G. made one attempt to initiate
voiding and was successfully assisted by the student nurse.
The importance of ongoing nursing assessment was stressed as being
vital to quality of care. Had the student nurse just transferred the patient to
the Geri-chair, he may not have effectively emptied his bowel and bladder.
Mr. G.’s constipation was addressed by providing appropriate fluid and fiber
intake and by continuing with an individualized toilet schedule as toler-
ated. The avoidance of diphenhydramine for the elderly was also discussed
because it is known to cause anticholinergic effects including urinary reten-
tion. Diphenhydramine raises concerns about sedation as well, which may
alter Mr. G.’s response to the need to void.
Evidence suggests that prompted voiding and individualized toileting
schedules reduce the number of UI episodes (Eustice et al., 2005 [Level
I]; Ostaszkiewicz et al., 2005 [Level I]). In addition, prompted voiding in
cognitively impaired long term care residents has demonstrated an increase
in self-initiative toileting activities (Holroyd-Leduc & Straus, 2004 [Level
I]). However, these strategies have not been studied in the hospital setting.
Despite this lack of evidence, Case Study #1 demonstrates that these nursing
interventions may also be beneficial for acutely hospitalized older adults.
CASE #2
Ms. W. is a 92-year-old patient hospitalized for an exacerbation of heart
failure (HF). Her past health history is also significant for DM, HTN, CAD,
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and osteoarthritis. Initially, Ms. W. required an indwelling urinary catheter
for accurate fluid management. During that time, the staff utilized wrist
restraints to prevent her from removing intravenous lines and the catheter.
Today is hospital day 5. The nurse receives the shift report that Ms.
W. is ready for discharge. On assessment, the nurse finds Ms. W. lying in
bed with all side rails up and the indwelling urinary catheter has not been
discontinued.
Individuals with acute exacerbations of HF are at high risk for tran-
sient UI and exacerbation of established UI. In addition, these individuals
are prone to postural hypotension and polypharmacy as a result of multi-
ple co-morbid conditions, such as diabetes. During an acute hospital stay,
nursing interventions should focus on diuretic management, such as atten-
tion to increased voiding needs and appropriate use of urinals, a bedside
commode, or other assistive devices. Patients often require careful fluid and
electrolyte management, necessitating the temporary use of an indwelling
urinary catheter; however, nursing care should focus on expedient catheter
removal. These interventions decrease the risk of catheter-associated UTIs
or trauma that may exacerbate UI symptoms (McGann, 2000 [Level VI]).
Summary
Although acute care stays are generally short, UI is a significant health problem
that should not be overlooked. Behavioral and supportive therapies and patient
education should be initiated by nurses if the patient is cognitively, physically,
and emotionally able to participate. Evidence from long term care and com-
munity settings suggests that nurse continence experts play an essential role
in improving the quality of continence care (DuMoulin et al., 2005 [Level I];
McDowell et al., 1999 [Level II]; Watson, 2005 [Level VI]). Therefore, if pa-
tients remain incontinent at discharge, hospital nurses have the responsibility
to design a plan that includes referral to a continence nurse specialist or other
continence expert for follow-up.
Other than identifying UI as a risk for falls, there are no requirements
specific to UI from The Joint Commission (http://www.jointcommission.org/).
Nevertheless, it is recommended that a continuous quality improvement (CQI)
criterion should encompass critical elements in an effective and successful
urinary continence program. For example, quality indicators for UI may in-
clude appropriate documentation of UI, if the UI is transient or established,
if an indwelling urinary catheter was used during hospitalization or on dis-
charge, and evidence of documentation of referrals. In addition, the AHRQ
Guideline for UI (Fantl et al., 1996 [Level I]) or other published guidelines
(e.g., those found at theNationalGuidelineClearinghouse http://www.guideline.
gov/Compare/comparison.aspx?file=INCONTINENCE1.inc) may be used clin-
ically and facility-wide for program development and CQI.
In summary, nurses have a significant role in improving the assessment and
treatment of UI in hospitalized older adults. It is recommended that nurses are
particularly vigilant for patients who are “admitted dry and become wet” during
a hospitalization. These patients will particularly benefit from evidence-based
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assessment and management. Moreover, nurses can help to promote changes
in attitudes toward UI and provide education on individual, facility-wide, com-
munity, and national levels.
Resources
Incontinence Impact Questionnaire Short Version (IIQ-7) http://www.
americangeriatrics.org/education/UItool02.pdf
Urinary Distress Inventory Short Version (UDI-6) http://www.fpminstitute.
com/files/pelvic-floor-distress-inventory.pdf
Wound Ostomy Continence Nurses Society 150 South Coast Highway, Suite 201
Laguna Beach, CA 92651 (888) 224-WOCN http://www.wocn.org An inter-
national society providing a source of networking and research for nurses
specializing in enterostomal and continence care.
National Association for Continence (NAFC) (800) BLADDER http://www.nafc.
org/ A not-for-profit organization dedicated to improving the lives of indi-
viduals with incontinence.
The JohnA.Hartford Institute for Geriatric Nursing http://www.ConsultGeriRN.
org/ This Web site takes the reader to the “Try This” series, which includes
a 2-page UI information sheet to share with hospital staff.
Society of Urologic Nurses and Associates (SUNA) National Headquarters East
Holly Avenue, Box 56 Pitman, NY 08071-0056 (888) TAP-SUNA http://www.
suna.org/ An international organization dedicated to nursing care of indi-
viduals with urologic disorders.
GeroNurseOnline Geriatric Resources and tools www.ConsultGeriRN. Click Re-
sources tab in Urinary Incontinence topic.
Box 13.1
Nursing Standard of Practice Protocol: Urinary
Incontinence (UI) in Older Adults Admitted to
Acute Care
I. GOAL
A. Nursing staff will utilize comprehensive assessments and implement
evidence-based management strategies for patients identified with
UI.
B. Nursing staff will collaborate with interdisciplinary teammembers to
identify and document type of UI.
C. Patients with UI will not have UI-associated complications.
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II. OVERVIEW
UI affects approximately 17 million Americans (Fantl et al., 1996 [Level
I]; National Association for Continence, 1998 [Level IV]; Resnick&Ous-
lander, 1990 [Level VI]). More than 35% of older adults admitted to the
hospital develop UI [Kresvic, 1997 [Level IV]). In addition to medica-
tions, constipation/fecal impaction, low fluid intake, environmental bar-
riers, diabetes mellitus, and stroke (Fantl et al., 1996 [Level I]; Holroyd-
Leduc & Straus, 2004 [Level I]; Meijer et al., 2003 [Level I]; Thomas
et al., 2005 [Level I]), immobility, impaired cognition, malnutrition, and
depression are factors specific to identifying older adults at risk for UI
in the hospital setting (Kresvic, 1997 [Level IV]). Complications of UI
include falls, skin irritation leading to pressure ulcers, social isolation,
and depression (Bogner et al., 2002 [Level IV]; Brown et al., 2000a [Level
IV]; Fantl et al., 1996 [Level I]; Johnson et al., 1998 [Level IV]). Nurses
play a key role in the assessment and management of UI.
III. BACKGROUND
A. Definitions
UI is the involuntary loss of urine sufficient to be a problem (Fantl
et al., 1996 [Level I]). UI may be transient (acute) or established
(chronic). Types of established UI include:
1. Stress UI: defined as an involuntary loss of urine associated with
activities that increase intra-abdominal pressure (Abrams et al.,
2003 [Level V]; Fantl et al., 1996 [Level I]; Hunter et al., 2005
[Level I]).
2. Urge UI: characterized by an involuntary urine loss associated
with a strong desire to void (urgency) (Abrams et al., 2003 [Level
V]; Fantl et al., 1996 [Level I]). An individual with an overactive
bladder (OAB) may complain of urinary urgency, with or without
UI (Abrams et al., 2003 [Level V]).
3. Mixed UI: usually defined as a combination of Stress UI and Urge
UI.
4. Overflow UI: an involuntary loss of urine associated with over-
distention of the bladder and may be caused by an under-active
detrusor muscle or outlet obstruction leading to over-distention
of the bladder and overflow of urine (Abrams et al., 2003 [Level
V]; Doughty, 2000 [Level VI]; Fantl et al., 1996 [Level I]).
5. Functional UI: caused by nongenitourinary factors, such as cog-
nitive or physical impairments that result in an inability for
the individual to be independent in voiding (Fantl et al., 1996
[Level I]).
B. Epidemiology
UI affects approximately 17 million Americans (Fantl et al., 1996
[Level I]; National Association for Continence, 1998 [Level IV];
Resnick & Ouslander, 1990 [Level VI]). UI studies specific to the
hospital setting demonstrate that UI is present in 10% to 42% of older
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adults (Dowd & Campbell, 1995 [Level IV]; Fantl et al., 1996 [Level
I]; Palmer et al., 1992 [Level IV]; Schultz et al., 1997 [Level IV]).
New-onset UI was identified in 35% of one patient sample (Kresvic,
1997 [Level IV]). Therefore, it is essential to assess forUI and imple-
ment a protocol that offers evidence-based management strategies.
IV. Parameters of Assessment
A. Document the presence/absence of UI for all patients on admission
(ICI, 2000 [Level VI]).
B. Document the presence/absence of an indwelling urinary catheter.
1. Determine appropriate indwelling catheter use: severely ill pa-
tients, patient with Stage III–IV pressure ulcers of the trunk, uri-
nary retention unresolved by other interventions (WoundOstomy
Continence Nurse’s Society, 1996 [Level VI]).
C. For patients with presence of UI:
The nurse collaborates with interdisciplinary team members to:
1. Determine whether the UI is transient, established (Stress/Urge/
Mixed/Overflow/Functional), or both and document (Fantl et al.,
1996 [Level I]; ICI, 2000 [Level VI]); Johnson et al., 2001 [Level
VI]).
2. Identify and document the possible etiologies of the UI (Fantl et
al., 1996 [Level I]; ICI, 2000 [Level VI]).
V. Nursing Care Strategies
A. General principles that apply to prevention and management of all
forms of UI:
1. Identify and treat causes of transient UI (ICI, 2000 [Level VI]).
2. Identify and continue successful prehospital management stra-
tegies for established UI.
3. Develop an individualized plan of care using data obtained from
the history and physical examination and in collaboration with
other team members.
4. Avoid medications that may contribute to UI (Kane et al., 2004
[Level VI]).
5. Avoid indwelling urinary catheters whenever possible to avoid
risk for UTI (Dowd & Campbell, 1995 [Level IV]; Bouza et al.,
2001 [Level IV]; Madigan & Neff, 2003 [Level I]; Zimakoff et al.,
1996 [Level IV]; & Wong, 1981 [Level VI]).
6. Monitor fluid intake and maintain an appropriate hydration
schedule.
7. Limit dietary bladder irritants (Gray & Haas, 2000 Level VI]).
8. Consider adding weight loss as a long-term goal in discharge
planning for those with a BMI greater than 27 (Subak et al., 2005
[Level II]).
9. Modify the environment to facilitate continence (Fantl et al., 1996
[Level I]; Jirovec, 2000 [Level VI]; Palmer, 1996 [Level VI]).
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10. Provide patients with usual undergarments in expectation of
continence, if possible.
11. Prevent skin breakdown by providing immediate cleansing after
an incontinent episode and utilizing barrier ointments (Ersser et
al., 2005 [Level I]).
12. Pilot test absorbent products to best meet patient, staff, and in-
stitutional preferences (Dunn et al., 2002 [Level I]), bearing in
mind that diapers have been associated with UTIs (Zimakoff et
al., 1996 [Level IV]).
B. Strategies for specific problems:
Stress UI:
1. Teach PFMEs (Bo et al., 1999 [Level II]; Hay-Smith & Dumoulin,
2006 [Level I]; ICI, 2000 [Level VI]).
2. Provide toileting assistance and bladder training PRN (ICI, 2000
[Level VI]).
3. Consider referral to other team members if pharmacological or
surgical therapies are warranted.
Urge UI:
1. Implement bladder training (retraining) (ICI, 2000 [Level VI]; Te-
unissen et al., 2004 [Level I]).
2. If patient is cognitively intact and is motivated, provide informa-
tion on urge inhibition (Gray, 2005 [Level VI]; Smith, 2000 [Level
VI]).
3. Teach PFMEs to be used in conjunction with #1 (Flynn et al., 1994
[Level IV]).
4. Collaborate with prescribing team members if pharmacologic
therapy is warranted.
5. Initiate referrals for those patients who do not respond to the
previous steps.
Overflow UI:
1. Allow sufficient time for voiding.
2. Discuss with interdisciplinary team the need for determining a
post-void residual (PVR) (ICI, 2000 [Level VI]; Shinoplous, 2000
[Level VI]; Weiss, 1998 [Level VI]) (see Figure 13.1).
3. Instruct patients in double voiding and Crede’s maneuver
(Dougherty, 2000 [Level VI]).
4. Sterile intermittent is preferred over indwelling catheterization
(Saint et al., 2006 [Level II]; Terpenning et al., 1989 [Level IV];
Warren, 1997 [Level VI]) PRN.
5. Initiate referrals to other teammembers for those patients requir-
ing pharmacological or surgical intervention.
Functional UI:
1. Provide individualized, scheduled toileting or prompted void-
ing (Eustice et al., 2005 [Level I]; Jirovec, 2000 [Level VI]; Os-
taszkiewicz et al., 2005 [Level I]).
2. Provide adequate fluid intake.
3. Refer for physical and occupational therapy PRN.
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4. Modify environment to maximize independence with continence
(Fantl et al., 1996 [Level I]; Jirovec, 2000 [Level VI]; Jirovec, Brink,
& Wells, 1988 [Level VI]); Palmer, 1996 [Level VI]).
VI. Evaluation of Expected Outcomes
A. Patients:
1. Will have fewer or no episodes of UI or complications associated
with UI.
B. Nurses:
1. Will document assessment of continence status at admission and
throughout hospital stay. If UI is identified, document and deter-
mine type of UI.
2. Will use interdisciplinary expertise and interventions to assess
and manage UI during hospitalization.
3. Will include UI in discharge planning needs and refer PRN.
C. Institution:
1. Incidence and prevalence of transient UI will decrease.
2. Hospital policies will require assessment and documentation of
continence status.
3. Will provide access to AHRQGuidelines for Managing Acute and
Chronic UI.
4. Staff will receive administrative support and ongoing education
regarding assessment and management of UI.
VII. Follow-up Monitoring of Condition
A. Provide patient/caregiver discharge teaching regarding outpatient
referral and management.
B. Incorporate continuous quality improvement (CQI) criteria into ex-
isting program.
C. Identify areas for improvement and enlist multidisciplinary assis-
tance in devising strategies for improvement
VIII. Relevant Practice Guidelines
National Guideline Clearinghouse Guideline Synthesis: (updated
2007). Evaluation and management of urinary incontinence. http://
www.guideline.gov/Compare/comparison.aspx?file=
INCONTINENCE1.inc
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14MealtimeDifficulties
Elaine J. Amella
Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. assess older adults for critical issues related to
performance at mealtimes: physical and cognitive
functioning, resistance to eating, cultural/religious
factors
2. modify the mealtime environment to one that
promotes adequate intake and normalizes social
interaction
3. educate staff and caregivers to provide
individualized assistance at meals while
preserving the independence and dignity of the
person being assisted
Overview
Most health professionals realize the critical role nutrition plays in maintaining
health and function in older adults; however, issues surrounding the ingestion
of food may be ignored. An older adult’s capacity to consume calories may rest
onmore than the correctmixture ofmacro- andmicro-nutrients, but how, when,
where, and with whom meals are taken may have a very strong influence. Fac-
tors that comprise the mealtime experience may be especially decisive when an
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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individual’s mental status is compromised and/or acute disease is present. This
chapter reviews issues that can lead to mealtime difficulties for older adults and
presents evidence-based strategies to resolve them.
Background
Although maintenance of good nutrition is important throughout the life span,
it is critical during older age, especially if chronic illness is present. A fo-
cus of Healthy People 2010 (U.S. Department of Health and Human Services
[USDHHS], 2000) addresses the need to reduce chronic illness related to nutri-
tionwith objectives related to diabetes and heart disease; increasing the number
of older adults who achieve a healthy weight; and increasing food security—that
is, having adequate access and finances to acquire a healthy diet. Of the top
ten causes of death (Minino, Heron, & Smith, 2006), a lifetime of good nutri-
tion would positively improve nine causes: heart disease, cancer, stroke, chronic
lower respiratory disease, diabetes, Alzheimer’s disease, influenza/ pneumonia,
nephritic syndrome/nephritis, and septicemia, with accidents (fifth in order)
being the outlier (National Center for Health Statistics, 2006). Thus, a focus
on nutrition is certainly warranted in the older population; however, one area
that may be overlooked as a cause for nutritional problems is the process of
how older people choose, prepare, serve, and ingest food, or how others do it for
them—the phenomenon of meals.Meal is defined as “the food served and eaten,
especially at one of the customary, regular occasions for taking food during the
day, as breakfast, lunch, or supper; one of these regular occasions or times for
eating food” (Flexner & Hauck, 1987, p. 1191). Meals are custom-driven and
contextually based; even the time that food is eaten and what is eaten at each
meal can be dictated by culture and habit.
Numerous cultural and religious rituals influence the way that food is con-
sumed; thus, the meaning of food and the way it is shared often supplant the
nutritional value of the calories consumed by individuals. Therefore, examining
mealtime and food as merely an exercise necessary to acquire needed nutri-
ents misses the critical social aspect of meals. However, persons entrusted with
serving or assisting with meals often frame meals only in the context of nu-
tritional requirements, examining those requirements only when an individual
experiences unplanned outcomes, such as weight loss or gain. The professional
nurse has historically played a critical role in the interdisciplinary team to assess
and manage problems with nutrition and hydration for older adults; however,
little attention has been paid to the context of meals and how food and fluid
are presented in a manner that is in keeping with the ideals of individualized
care.
Assessment of Problem
A standardized assessment instrument that evaluates nutrition, such as theMini
Nutritional Assessment (MNA®), which has been validated and is used widely
in the community, institution, and acute care setting, has only one question that
even indirectly deals with meals: “How many full meals does the patient eat
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daily?” The individual is then asked: “Do you normally eat breakfast, lunch, and
dinner?” The following definition of a full meal is given: A full meal is defined
as an eating occasion when the patient “sits down” to eat and consumes more
than two items/dishes (Guigoz, Vellas, & Garry, 1997; MNA, 2005 [Level III]). An
alternative assessment instrument that has been used exclusively in the com-
munity, SCREENII, shows strongpsychometrics but doesnot address contextual
issues (Keller, Goy, & Kane, 2005 [Level III]). Assessment of the entire process
of mealtimes has been compartmentalized by instruments to examine behavior
of persons with dementia when being assisted (Edinburgh Feeding in Dementia
Questionnaire [EdFED-Q], Watson, 1996 [Level III]); food complaints (Mini-
mum Data Set, item K.4.a, Centers for Medicare & Medicaid [CMS], 2006); oral
movements (Scale of Oral Functions in Feeding, Stratton, 1981 [Level III]); iden-
tifying feeding and mealtime behaviors (Screening Tool of Feeding Problems
[STEP], Kuhn & Matson, 2002 [Level IV]); and functional ability during meals
(Eating Behavior Scale; Tulley, Matrakas, Muir, & Musallam, 1997 [Level IV]).
Although the MDS item is the mostly widely used because it administered to
all residents of nursing homes in the United States, it was found to be inac-
curate in 32% of cases (Simmons, Lim, & Schnelle, 2002 [Level IV]). Watson’s
EdFED-Q is the most widely tested in nursing home and community settings
and has strong psychometrics: the ability to correctly measure what it is sup-
posed to and to be consistent over timewith different raters. Older adults should
also be assessed for intake; the Meal Portion method has been shown as a valid
method to estimate calories and protein when comparing estimates by vari-
ous providers and weighing (Berrut et al., 2002 [Level III]). The Meal Portion
method directs the person assisting at meals to break each food item served
into quarters and record whether 0, 1/4, 1/2, or the whole portion is consumed.
Then, using the meal recipes, total calories and nutrients consumed can be cal-
culated. Notable among all these instruments, however, is lack of attention to
the context of meals—that is, attributes of the setting and the persons who are
assisting withmeals. (See “MealtimeDifficulties” at www.ConsultGeriRN.org for
MNA and EdFed. Also see the Resources in this chapter for more information
on these and other assessment tools.)
As an individual ages, the likelihood of functional impairment increases.
With increased frailty, loss of function follows a predictable pattern, with the
ability to feed oneself the last activity of daily living (ADL) to be lost (Katz, Ford,
Moskowitz, Jackson, & Jaffe, 1963 [Level IV]). The most recent national data
on disability showed that 19.7% of all older adults (i.e., 65 years and older) are
chronically disabled, with 3.1% of those living in the community requiring assis-
tancewith five to sixADLs (Federal Interagency ForumonAging-Related Statis-
tics, 2006 [Level IV]). Although self-feeding must be promoted for all persons
for as long as possible, techniques for promotion of independence at mealtimes
are often not used by both formal and informal caregivers, which reinforces
dependence. Assessment of capacity for self-feeding is essential to promote
independence and integrity at meals; referral to an occupational therapist is
essential (see also chapter 3, Assessment of Function).
Different religious beliefs may have strict requirements for preparation
and blessing of food before it can be consumed (Bermudez & Tucker, 2004
[Level IV]). Individualswho follow dietary restrictions for religious reasonsmay
not eat when religious rules have not been observed. In general, most cultures
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promote the washing of hands before meals; this may not be offered in institu-
tional settings.Older adultswhohave serious chronic illness shouldbe consulted
regarding preferences for food and fluid intake. If it is not already documented
in an advance directive, they should be asked about their wishes regarding treat-
ment with artificial nutrition and hydration. If an older adult loses the capacity
for decision making, the proxy for health care decisions should be consulted
rather than the provider assuming responsibility for the management of nu-
tritional care (see chapter 23, Health Care Decision Making, and chapter 24,
Advance Directives).
Interventions and Care Strategies
Nutritional Health
Assessment and management of nutritional health is discussed in chapter 15,
Nutrition; therefore, the reader is referred to that chapter. However, profes-
sional nurses are reminded that nutritional health is best assessed and man-
aged through an interdisciplinary approach because it is a multifaceted issue.
Minimally, the dietician, provider (e.g., physician, nurse practitioner), dentist,
speech and language pathologist, occupational therapist, and patient/caregiver
should be consulted when designing a nutritional plan of care.
Cognitive Impairments
Cognitive deficits impair the ability to eat anddrink. Peoplewith severe cognitive
impairments may develop refuse-like or aversive behavior that affect their abil-
ity to be assisted at meals (Amella, 2002 [Level IV]). Watson (1996) developed
a psychometrically sound instrument, the ED-FedQ, to measure the declining
ability to consume food offered related to resistance. Nurses can use the princi-
ples of this instrument to determine the stage of resistive eating behavior. In the
earlier stages, more active behaviors are displayed (e.g., the individual pushes
food away or turns his or her head away from the feeder). In later stages, pas-
sive behaviors occur, as the patient does not swallow and allows food to fall from
his or her mouth. In late-stage dementia, a primitive and less forceful swallow
pattern may develop. The upper airway is not well protected, making the use
of bottle or syringe-type feeding not only undignified but also ineffective and
unsafe. (See the Resources section for access to this tool.)
Increasing Intake
Obesity is a growing problem among older adults (Centers for Disease Control
and Prevention [CDC], 2003 [Level V]); however, inadequate intake resulting
in undernutrition continues to be a principal concern for clinicians caring for
older adults. Several factors have been shown to influence intake, including
psychosocial causes and context (i.e., where they ate and with whom). Eating
alone or without social engagement decreases intake (Beck & Ovesen, 2003
[Level IV]) along with feeling anxious, mildly depressed, and angry (Paquet,
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St. Arnaud-McKenzie, Kergoat, Ferland, & Dube, 2003 [Level IV]). Taylore and
Barr report that eating smaller, more frequent meals increases intake of flu-
ids; however, it does not increase food intake (2006 [Level IV]), nor does an
exercise and scheduled toileting program (Simmons & Schnelle, 2004 [Level
III]). Eating in the dining room increased total consumption of calories but
did not influence intake of protein, nor did it influence weight gain (Wright,
Hickson, & Frost, 2006 [Level III]). Keller (2006 [Level IV]) reported that a
Meals on Wheels program increased intake as well as decreased self-reported
depression.
Feeding Assistance and Staff Training
Lack of staff assistance and inadequate education of caregivers who are respon-
sible for delivering, serving, and actively assisting at meals have been shown to
place institutionalized older residents at risk for mealtime problems. Mealtimes
are one of the most time-consuming ADLs and is unfortunately not reimbursed
at the required levels. Simmons and Schnelle (2006 [Level IV]) reported in an
observational study that residents with low intake required 35 to 40 minutes of
staff assistance despite their level of dependency, which does not reflect the cur-
rent level of federal funding for this ADL. This issue of reimbursed staff time to
assist with eating may be linked to other institutional findings, such as less con-
sumption of food by nursing home residents who ate in bed, with staffing levels
the most powerful predictor of time in bed (Bates-Jensen, Schnelle, Alessi, Al
Samarri, & Levy-Storm2004 [Level IV]).When surveyed, nursing assistants and
licensed nurses identified lack of time and training, as well as “working short
staffed,” as being related to residents not receiving enough food (Crogan, Shutz,
Adams, & Massey, 2001 [Level IV]). Strategies that produced better mealtime
outcomes included “meal rounds” by a dietician and food-service supervisors
working with unit staff, which allowed for early identification of residents at risk
for nutritional problems and early intervention, especially those with dysphagia
and those needing assistance at meals (Keller, Gibbs-Ward, Randall-Simpson,
Bocock, & Dimou, 2006 [Level IV]). When nursing assistants were trained in
feeding skills and the residents they assisted using those improved strategies
were then evaluated using the EdFED-Q, the residents receiving the new strate-
gies had better eating behavior and were given more time to eat (Chang & Lin,
2005 [Level IV]).
Environment and Interaction
Because of the strong social and cultural components of eating, where one dines
is sometimes as important as what one eats. Nurses should simply ask them-
selves, “Would I want to eat my next meal where this person is eating?” If the
answer is no, then steps should be taken to improve the dining environment.
Small changes in the dining environment may make large improvements in
a patient’s capacity and motivation to eat or be fed. Unfortunately, in institu-
tions, the mealtime experience is often determined more by the living arrange-
ments rather than individual needs (Synder & Fjellstrom, 2005 [Level IV]).
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Gibbs-Ward and Keller (2005 [Level IV]) reiterated this theme in their
grounded-theory approach to discovering what made mealtimes better, find-
ing that several factors emerged as critical to older adults: each mealtime was
seen as a unique process; residents are central to the process through their
actions, not only at meals but also during the time surrounding meals, such
as socializing while waiting; and internal and external influences affect meals,
with the ideal being individualized care. The individualized nature of meals was
reflected in interviews with nursing home residents who described the mean-
ing of food and food service during their lifetime and how that changed once
they were institutionalized. These interviews reflected themes of Remember-
ing our Roots, Relating to Others, and Giving Life, with residents yearning for
personalized attention to preferences and sharing traditional foods (Evans, Cro-
gan, & Shultz, 2005 [Level IV]). When attempting to quantify “appetite,” Wikby
and Fagerskiold (2004 [Level IV]) found that internal factors such as mood and
personal values, as well as external factors regarding the food, environment,
and social interactions, directly affected appetite for residents. External fac-
tors such as decreased noise, increased lighting, and relaxing music at meals
positively influenced residents’ mealtime behavior (Hick-Moore, 2005 [Level
III]; McDaniel, Hunt, Hackes, & Pope, 2001 [Level III]). Using contrasting col-
ors (foreground/ background) in tableware and tablecloths and placing dishes
in similar positions may help persons with low vision be more independent
(Ellexson, 2004 [Level VI]. Proper positioning using an appropriate, support-
ive chair promotes good eating posture (Rappl & Jones, 2000 [Level V]). Family
dining was shown to be an effective way to increase body weight and fine motor
function in a randomized control trial involving 178 residents (Nijs, deGraaf,
Kok, & vanStaveren, 2006 [Level II]) and modestly improved communication
among residents with dementia during meals (Altus, Engelman, & Mathews,
2002 [Level III]). Denmark has modified the living environment within its nurs-
ing homes to a “stay-and-living environment,” where meals are eaten in small
groups—much like family dining, residents assist in choosing the menu and
take part in meal preparation (Kofod & Birkemose, 2004 [Level IV]). Results
of this change in mealtime patterns in four homes were mixed: the Body Mass
Index (BMI) was similar to national norms for the institutionalized age; the at-
tempts at increased socialization and control over food preparation and menu
made little difference to those older adults interviewed, whereas the staff be-
lieved that conditions were much improved. The researchers felt that in this
altered context, it was still the staff responsibility to create the ambience of
shared meals within an institution (Kofod & Birkemose, 2004 [Level IV]). Un-
fortunately, nurses may be unaware of the lack of social interaction between
residents and staff, and this time may become bereft of former patterns that
gave meaning to meals for residents (Pearson, Fitzgerald, & Nay, 2003 [Level
IV]; Stabell, Eide, Solheim, Solberg, & Rustoen, 2004 [Level IV]). Above all,
dining is a shared experience. Successful completion of the meal is depen-
dent on who assists or feeds the patient and the interpersonal process that
person uses to interact with the patient (Amella, 2002, 1999 [both Level IV]).
Caregivers who are able to let the patient set the tempo of the meal and al-
low others to make choices will be more effectual in increasing intake. These
studies point to a need to individualize mealtimes for people in institutions,
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and the responsibility for assuring that that occurs rests with a sensitive and
well-trained staff.
Case Study and Discussion
Mrs. Simpson is an 84-year-old femalewho is admitted to a short-stay skilled
nursingunitwithin ahospitalwith the followingdiagnoses: poorly controlled
Type II diabetes, heart failure (Stage C), and moderate-stage dementia with
deterioration in mental status since admission. Her medications now in-
clude a short-acting oral antidiabetic agent that is given at mealtimes (i.e.,
repaglidine), loop diuretic, ACE inhibitor (i.e., fosinopril), beta-blocker (i.e.,
bisoprolol), and aldosterone antagonist (i.e., spironolactone). Medications
can cause a decrease in appetite, so Mrs. Simpson needs to have a side-
effect profile for all drugs developed by the pharmacologist. Mrs. Simpson’s
appetite declined while hospitalized and she experience two episodes of hy-
poglycemia when she received her oral agent at breakfast and then did not
eat well at lunch and supper. Since then she was placed on repaglinide. She
was placed on this short-stay unit before returning to her daughter’s home so
that a plan of care could be developed for a safe discharge. The staff notes
that Mrs. Simpson tires easily when seated in a chair, so they have been
serving her meals in bed. Her tolerance for any exercise is decreasing as
she becomesmore deconditioned. Additionally, since admission, she ismore
agitated at night and has been getting out of bed calling for her daughter.
During the day, she sleeps and thus shows even less interest in eating. The
physician is considering inserting a PEG tube until her medical condition
stabilizes. Mrs. Simpson is a member of the Seventh Day Adventist church.
Mrs. Simpson has several issues that require close monitoring, first of
which are her two severe chronic illnesses: diabetes and heart failure. Both
conditions must be medically managed before discharge can be attempted.
However, those illnesses in conjunctionwith her dementia are causing her to
have unmet nutritional needs that could be addressed by careful assessment
and interventions.
Initially, the nurse should observe Mrs. Simpson during each meal dur-
ing the course of the day, noting whether her capacity to eat fluctuates
across the day and if shewould benefit fromprogressive assistance. Because
she has dementia, the nurse can quantify her mealtime behaviors with the
EdFED-Q to see if she is resistingmeals or is unable to complete the process
of ingestion without regular cues and prompts. Consultation with the entire
health care team, including the provider, speech and language pathologist,
dietician, dentist, occupational therapist, clergy, and social worker, is war-
ranted to assure that any unmet needs are addressed, such as adequacy
of diet; problems with food consistency and swallowing; requirements for
adaptive equipment; a vegetarian diet that adheres to her religious tenets,
with increasedwhole grains, fruits, andwater instead of fruit juice; adequate
oral health; and assistants who are knowledgeable about the effects of her
illness.
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Daily activities could be structured so that Mrs. Simpson is allowed to
rest beforemeals and then is assisted to get out of bedwhile she eats. Aides to
eatingmight include playing her favoritemusic and having someone present
to assist if her strength wanes and to provide pleasant social interaction.
Staff assisting should be alert for signs of dysphagia such as regular attempts
to “clear” the throat or small coughs. When directly assisting, staff needs to
followMrs. Simpson’s tempo and not rush her. Using the evaluation from the
EdFED-Q, the staff member can offer cues and prompts when needed. En-
couraging familymembers to visit and eat withMrs. Simpsonmay normalize
the meal if there is not excessive distraction or noise. Other staff should also
avoid performing tasks in the room while Mrs. Simpson is eating.
With more attention paid to the environment, the interaction, the vary-
ingneed for assistance based on thepatient’s need at the time, and resolution
of her medical problems, Mrs. Simpson’s intake begins to improve. The fam-
ily and church members bring foods she once enjoyed, and they are more
confident they canmanage hermealtimes and nutritional problems at home.
The consultation order for a PEG tube is rescinded.
Summary
Inadequate use of evidence-based interventions as well as a lack of tested “bun-
dled programs” that address multiple issues confronted during meals (e.g., staff,
environment, food preferences) make recommendations difficult. The studies
to date have methodological flaws and do not account for confounding factors
that may alter results, as noted by Watson and Green (2006 [Level I]) in the
only systematic review published on studies concerning feeding and demen-
tia published between 1993 and 2003. As such, health professionals are left to
examine trends across several studies and to note that certain interventions
seem to make a difference in some settings: family-style dining, music at meals,
and staff interaction with older adults made a difference in various outcomes,
some of which were not robust. Clearly, a diagnosis based on careful assessment
using instruments normed to this population, an interdisciplinary plan of care
based on the lifelong preferences and patterns of the patient and the family, and
the thoughtful training of caregivers, as well as allowing them adequate time to
assist at meals, should be heartily recommended.
Resources
Assessment Tools MNA® Mini-Nutritional Assessment (2005). Retrieved Jan-
uary 20, 2007, from http://www.mna-elderly.com
Edinburgh Feeding in Dementia Questionnaire Watson, R. (1996). The Mokken
scaling procedure (MSP) applied to the measurement of feeding difficulty
in elderly people with dementia. International Journal of Nursing Studies, 33,
385–393.
To obtain copies for the SCREEN, contact: Dr. Heather Keller Family Relations
& Applied Nutrition, University of Guelph hkeller@uoguelph.ca
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Box 14.1
Nursing Standard of Practice Protocol: Assessment
and Management of Mealtime Difficulties
I. GOAL: To maintain or improve nutritional intake at meals and provide
a quality mealtime experience that fosters dignity and pleasure in eat-
ing, as well as respecting cultural and personal preferences, for as long as
possible.
II. OVERVIEW
Guiding Principles
A. The adequate intake of nutrients is necessary to maintain physical
and emotional health.
B. Mealtime is an opportunity not only to ingest nutrients but also to
maintain critical social aspects of life.
C. The social components ofmealswill be observed, includingmealtime
rituals, cultural norms, and food preferences.
D. Persons will be encouraged and assisted to self-feed for as long as
possible.
E. Persons dependent in eating will be assisted with dignity.
F. End-of-life decisions by the individual or his or her proxy regarding
the provision or termination of food and fluid will be respected.
G. The quality of mealtime is an indicator of quality of life and care of
an individual.
III. BACKGROUND
A. Definitions
1. Feeding is “the process of getting the food from the plate to the
mouth. It is a primitive sense without concern for social niceties”
(Katz, Downs, Cash, & Grotz, 1970, p. 21).
2. Eating is “the ability to transfer food from plate to stomach
through the mouth” (Katz et al., 1970, p. 21). Eating involves the
ability to recognize food, the ability to transfer food to the mouth,
and the phases of swallowing.
3. Anorexia is characterized by a refusal to maintain a minimally
normal body weight (American Psychiatric Association, 1994,
p. 539). May have physiological basis in the elderly.
4. Dehydration is “a fluid imbalance caused by too little fluid taken
in or too much fluid lost or both” (Weinberg & Minaker, 1995,
p. 1552).
5. Dysphagia is “an abnormality in the transfer of a bolus from the
mouth to the stomach” (Groher, 1997, p. 1).
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6. Apraxia is an inability to carry out voluntary muscular activities
related to neuromuscular damage. As it relates to eating and feed-
ing, it involves loss of the voluntary stages of swallowing or the
manipulation of eating utensils.
7. Agnosia is the inability to recognize familiar items when sensory
cuing is limited.
B. Etiology
Mealtime difficulties can have multiple causes from both physiolog-
ical and psychological origins. Health professionals need to consider
multiple etiologies and not assume that difficulties are related only
to increased confusion from a cognitive decline.
1. Cognitive/neurological: Parkinson’s disease; amyotrophic lateral
sclerosis; dementia, especially Alzheimer’s disease; stroke
2. Psychological: depression
3. Iatrogenic: lack of adaptive equipment; use of physical restraints
that limit ability to move, position, or self-feed; improper chair
or table surface or discrepancy of chair to table height; use of
wheelchair in lieu of table chair; use of disposable dinnerware,
especially for patients with cognitive or neuromuscular impair-
ments
VI. PARAMETERS OF ASSESSMENT
A. Assessment of Older Adult and Caregivers
1. Rituals used before meals (e.g., handwashing and toilet use);
dressing for dinner.
2. Blessings of food or grace, if appropriate.
3. Religious rites or prohibitions observed in preparation of food or
before meal begins (e.g., Muslim, Jewish, and Seventh-Day Ad-
ventist; consult with pastoral counselor, if available).
4. Cultural or special cues: family history, especially rituals sur-
rounding meals.
5. Preferences as to end-of-life decisions regarding withdrawal or
administration of food and fluid in the face of incapacity, or re-
quest of designated health proxy; ethicist or social worker may
facilitate process.
B. Assessment Instruments:
1. EdFED-Q for personswithmoderate to late-stagedementia (Wat-
son, 1996 [Level III]).
2. Katz Index of ADL for functional status (Katz et al., 1970 [Level
III]).
3. Food diary/Meal Portion method (Berrut et al., 2002 [Level III]).
V. NURSING INTERVENTIONS
A. Environment
1. Dining or patient room: encourage older adult to eat in dining
room to increase intake (Bates-Jensen et al., 2004 [Level IV]),
Mealtime Difficulties 347
personalize dining room, no treatments or other activities occur-
ring during meals, no distractions.
2. Tableware: use of standard dinnerware (e.g., china, glasses, cup
and saucer, flatware, tablecloth, napkin) versus disposable table-
ware and bibs.
3. Furniture: older adult seated in stable arm chair; table-
appropriate height versus eating in wheelchair or in bed (Rappl
& Jones, 2000 [Level V]).
4. Noise level: environmental noise frommusic, caregivers, and tele-
vision is minimal (McDaniel et al., 2001 [Level III]); personal con-
versation between patient and caregiver is encouraged.
5. Music: pleasant, preferred by patient (Hick-Moore, 2005 [Level
III]; Watson & Green, 2006 [Level I]).
6. Light: adequate and nonglare-producing versus dark, shadowy, or
glaring (McDaniel et al., 2001 [Level III]).
7. Contrasting background/foreground: use contrasting background
and foreground colors with minimal design to aid persons with
decreased vision (Ellexson, 2004 [Level IV]).
8. Odor: food prepared in area adjacent to or in dining area to stim-
ulate appetite (Amella, 2004 [Level V]).
9. Adaptive equipment: available, appropriate, and clean; caregivers
and/or older adult knowledgeable in use; occupational therapist
assists in evaluation.
B. Caregiver/Staffing
1. Provide an adequate number of well-trained staff (Chang & Lin,
2005 [Level IV]; Crogan et al., 2001 [Level IV]).
2. Deliver an individualized approach to meals (Gibbs-Ward &
Keller, 2005 [Level IV]; Synder & Fjellstrom, 2005 [Level IV]) in-
cluding choice of food, tempo of assistance.
3. Position of caregiver relative to elder: eye contact; seating so care-
giver faces elder patient in same plane (Amella, 2004 [Level V]).
4. Cueing: caregiver cues elderwheneverpossiblewithwords or ges-
tures (Simmons & Schnelle, 2006 [Level IV]).
5. Self-feeding: encouragement to self-feed with multiple methods
versus assisted feeding to minimize time (Simmons & Schnelle,
2006 [Level IV]).
6. Mealtime rounds: interdisciplinary team to examine multifaceted
process of meal service, environment, and individual preferences
(Keller et al., 2006 [Level IV]).
VI. EVALUATION/EXPECTED OUTCOMES
A. Individual
1. Corrective and supportive strategies reflected in plan of care.
2. Quality of life issues emphasized in maintaining social aspects of
dining.
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3. Culture, personal preferences, and end-of-life decisions regard-
ing nutrition respected.
B. Health Care Provider
1. System disruptions at mealtimes minimized.
2. Family and staff informed and educated to patient’s special needs
to promote safe and effective meals.
3. Maintenance of normalmeals and adequate intake for the patient
reflected in care plan.
4. Competence in diet assessment; knowledge of and sensitivity to
cultural norms and preferences for mealtimes reflected in care
plan.
C. Institution
1. Documentation of nutritional status and eating and feeding be-
havior meets expected standard.
2. Alterations in nutritional status, eating and feeding behaviors as-
sessed and addressed in a timely manner.
3. Involvement of interdisciplinary team (geriatrician, advanced
practice nurse [NP/CNS], dietitian, speech therapist, dentist, oc-
cupational therapist, social worker, pastoral counselor, ethicist)
appropriate and timely.
4. Nutritional, eating, and/or feeding problems modified to respect
individual preferences and cultural norms.
5. Adequate number of well-trained staff who are committed to de-
livering knowledgeable and individualized care.
VII. FOLLOW-UP MONITORING
A. Providers’ competency to monitor eating and feeding behaviors.
B. Documentation of eating and feeding behaviors.
C. Documentation of care strategies and follow-up of alterations in
nutritional status and eating and feeding behaviors.
D. Documentation of staffing and staff education; availability of sup-
portive interdisciplinary team.
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Educational
Objectives
At the completion of this chapter, the reader should be
able to:
1. recognize factors that place an older adult at risk
for malnutrition
2. discuss methods to screen and assess nutritional
status in an older adult
3. utilize appropriate nursing interventions in a
hospitalized older adult who is either at risk for
malnutrition or has malnutrition
Overview
Nutritional status is the balance of nutrient intake, physiological demands, and
metabolic rate (DiMaria-Ghalili, 2002 [Level IV]). Nutrition-related conditions
in older adults include obesity and malnutrition. Recent data from the Health of
the United States indicate that of the older adults sampled, 71% of women and
76% of men aged 65 to 74 and 60% of women and 67% of men aged 75 and older
have a body mass index (BMI) greater than or equal 25 and are considered
overweight (National Center for Health Statistics, 2005 [Level V]). Although
obesity is a problem in older adults, malnutrition is of greater concern because
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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it can often be unrecognizable and impacts morbidity, mortality, and quality of
life (Chen, Schilling, & Lyder, 2001 [Level V]). Malnutrition is also a precursor
for frailty in older adults. Malnutrition in the elderly is defined as “faulty or
inadequate nutritional status; undernourishment characterized by insufficient
dietary intake, poor appetite, muscle wasting, and weight loss” (Chen et al.,
2001 [Level V]). In older adults, malnutrition exists along the continuum of care
(Furman, 2006 [Level VI]) because the prevalence of malnutrition is found in
older adults in the community, acute care, and long term care settings. Older
adults admitted to acute care settings from either the community or long term
care settingsmay already bemalnourished ormay be at risk for the development
ofmalnutrition during hospitalization. Therefore, it is imperative that acute care
nurses carefully assess and monitor the nutritional status of older adults to
identify the risk factors for malnutrition so that appropriate interventions are
instituted in a timely fashion. The focus of this geronursing protocol is aimed at
the discussion of nutrition in aging as it relates to risk factors, implications, and
interventions for malnutrition in older adults. See standard of practice protocol
Box 15.1.
Background and Statement of Problem
In the United States, 40% to 60% of hospitalized older adults are malnourished
or at risk for malnutrition (Nutrition Screening Initiative, 2002 [Level V]). Mal-
nutrition is also a global problem for the elderly in industrialized nations. For
example, one in every five older adults admitted to the hospital in England was
found to be malnourished (The Malnutrition Prevalence Group, 2000 [Level
IV]). The major type of malnutrition in the elderly is protein-energy under nu-
trition,which is characterizedby thepresence of clinical (i.e., physical signs such
as wasting, low BMI) and biochemical (i.e., albumin or other serum protein) evi-
dence of insufficient intake (Beers, 2005 [LevelVI]).Marasmus andkwashiorkor
are two forms of protein-energy under nutrition. Marasmus is characterized by
a marked depletion of muscle mass and fat stores; however, visceral protein
levels and organ function are normal (Beers, 2005 [Level VI], Chen et al., 2001
[LevelV]).Marasmic individuals lookmalnourished and cachetic andoftenhave
ahistory ofweight loss.However, they have adapted to decreasednutrient intake
and may be able to function fairly well unless exposed to additional metabolic
stress. Due to their limited nutritional reserve, they can rapidly develop hy-
poalbuminemic malnutrition. Kwashiorkor is referred to more commonly as
hypoalbuminemic malnutrition and is characterized by a loss of visceral pro-
tein (e.g., albumin, transferring, and prealbumin) and is often associated with
edema. Patients with hypoalbuminemic malnutrition may look well nourished
and not report a history of weight loss. This type of malnutrition typically devel-
ops when there is inadequate protein intake relative to the body’s needs during
a hypermetabolic state, such as in injury, infection, and draining wounds.
The risk factors for malnutrition in older adults are multifactorial and
include dietary, economic, psychosocial, and physiological factors (DiMaria-
Ghalili & Amella, 2005 [Level VI]). Dietary factors include little or no ap-
petite (Carlsson, Tidermark, Ponzer, Soderqvist, & Cederholm, 2005 [Level II];
Reuben, Hirsch, Zhou, & Greendale, 2005 [Level II]; Saletti et al., 2005
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[Level IV]), problems with eating or swallowing, eating inadequate servings
of nutrients (Margetts, Thompson, Elia, & Jackson, 2003 [Level IV]), and eating
fewer than two meals a day (Saletti et al., 2005 [Level IV]). Limited income may
cause restriction in the number of meals or dietary quality of meals eaten per
day (Souter&Keller, 2002 [Level IV]). Isolation is also a risk factor because older
adultswho live alonemay lose their desire to cook due to loneliness, and appetite
often decreases after the loss of a spouse (Shahar, 2001 [Level IV]). Impairment
in functional status can place the elderly at risk for malnutrition because ade-
quate functioning is needed to secure and prepare food. Difficulty in cooking is
related to disabilities (Souter & Keller, 2002 [Level IV]) and disabilities can hin-
der the ability to prepare or ingest food (Saletti et al., 2005 [Level IV]). Chronic
conditions can negatively influence nutritional intake (Margetts et al., 2003)
as can cognitive impairment (Kagansky et al., 2005 [Level IV]). Psychological
factors are known risk factors for malnutrition. For example, depression is re-
lated to unintentional weight loss (Morley, 2001 [Level V]; Thomas et al., 2002
[Level IV]). Furthermore, poor oral health (Saletti et al., 2005 [Level IV]) and xe-
rostomia (i.e., dry mouth due to decreased saliva) can impair the ability to lubri-
cate, masticate, and swallow food (Saletti et al., 2005). Antidepressants, antihy-
pertensives, and bronchodilators can contribute to xerostomia (DiMaria-Ghalili
& Amella, 2005 [Level VI]). Change in taste (e.g., frommedications, nutrient de-
ficiencies, or tastebud atrophy) can also alter nutritional intake (DiMaria-Ghalili
& Amella, 2005).
Body composition changes in normal aging include increase in body fat,
including visceral fat stores (Hughes et al., 2004 [Level IV]), and a decrease
in lean body mass (Janssen, Heymsfield, Allison, Kotler, & Ross, 2002 [Level
IV]). Furthermore, the low skeletal musclemass associated with aging is related
to functional impairment and physical disability (Janssen, Heymsfield, & Ross,
2002 [Level IV]).
The impact of malnutrition on the health of hospitalized older adults is
well documented. In this population, malnutrition is related to prolonged hos-
pital stay (Pichard et al., 2004 [Level IV]), increased risk for poor health
status, recent hospitalization, and institutionalization (Margetts et al., 2003
[Level IV]). Additionally, low Mini Nutritional Assessment (MNA) scores are
predictors of prolonged hospital stays and mortality (Kagansky et al., 2005
[Level IV]).
Assessment of Problem
Areas of nutritional status assessment in hospitalized older adults should fo-
cus on identification of malnutrition and risk factors for malnutrition. TheMNA
(Guigoz, Lauque, &Vellas, 2002 [Level V]) is a comprehensive two-level tool that
can be used to screen and assess an older hospitalized patient for malnutrition
by evaluating the presence of risk factors for malnutrition in this age group. The
validity and reliability of the MNA for use in hospitalized older adults is well
documented (Salva et al., 2004 [Level V]). If a patient scores less than 11 on the
screen, then the assessment section should be completed in order to compute
the Malnutrition Indicator Score. The screening section of the MNA is easy to
administer and consists of six questions. The assessment section requires mea-
surement of mid-arm muscle circumference and calf circumference. Although
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these anthropometric measurements are relatively easy to obtain using a tape
measure, nurses may first require training in these procedures prior to incor-
porating the MNA as part of a routine nursing assessment. Protocols should
be established to identify interventions to be implemented once the screening
and assessment data are obtained, including consultation with a dietitian. (See
www.ConsultGeriRN.org, Assessing nutrition in older adults [PDF file] for MNA,
Nutrition topic; and Resources in this chapter.)
Additional assessment strategies include propermeasurement of height and
weight and a detailed weight history. Height should always be directly mea-
sured and never recorded via patient self-report. An alternative way to measur-
ing standing height is knee-height (Salva et al., 2004 [Level V]). Knee-height
calipers are relatively inexpensive to purchase and can be used for many pa-
tients. To obtain a knee-height measure, the patient must be supine and the left
knee positioned at a 90-degree angle. Using the calipers, the measurement is
taken from the heel to the anterior surface of thigh. Estimated height is then
made by using the following formulas (Rombeau, Caldwell, Forlaw, & Guenter,
1989 [Level VI]):
Men (cm) = 6, 419 − (0.04 × age) + (2.02 × knee height in cm)
Women (cm) = 84.88 − (0.24 × age) + (1.83 × knee height in cm)
Because this method to measure height in older adults is not frequently used
in clinical practice, nurses would require training in the use of knee-height
calipers. A calorie count or dietary intake analysis is a good way to quantify the
type and amount of nutrients ingested during hospitalization (DiMaria-Ghalili
& Amella, 2005 [Level VI]). Laboratory indicators of nutritional status include
measures of visceral proteins such as serum albumin, transferrin, and preal-
bumin (DiMaria-Ghalili & Amella, 2005 [Level VI]). However, these visceral
proteins are also negative acute-phase reactants and are decreased during a
stressed state, limiting the ability to predict malnutrition in an acutely ill hos-
pitalized patient. Nonetheless, albumin is a strong prognostic marker for mor-
bidity and mortality in older hospitalized patients (Sullivan, Roberson, & Bopp,
2005 [Level IV]).
Interventions and Care Strategies
The nursing interventions outlined in the protocol focus on enhancing or pro-
moting nutritional intake and range in complexity, frombasic fundamental nurs-
ing care strategies to the administration of artificial nutrition via parenteral or
enteral routes. Prior to initiating targeted nutritional interventions in a hos-
pitalized older adult, it must first be determined if the older adult can’t eat,
shouldn’t eat, or won’t eat (American Society for Parenteral and Enteral Nutri-
tion, 2002). One factor to consider is whether the gastrointestinal tract (starting
with the mouth) is working properly without any functional, mechanical, or
physiological alterations that would limit the ability to adequately ingest, di-
gest, and/or absorb food. Also, it needs to be determined whether older adults
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have any chronic or acute health condition in which the normal intake of food
is contraindicated or are they simply not eating or is their appetite decreased?
If the gastrointestinal tract is functional and can be used to provide nutrients,
then nutritional interventions should be targeted at promoting adequate oral
intake.
Nursing care strategies focus on ways to increase food intake as well as
ways to enhance and manage the environment to promote increased food in-
take. When functional or mechanical factors limit the ability to take in nutri-
ents, nurses should obtain interdisciplinary consultations from speech ther-
apists, occupational therapists, physical therapists, psychiatrists, and/or di-
etitians to collaborate on strategies that would enhance the ability of older
adults to feed themselves or to eat. Oral nutritional supplementation has been
shown to improve nutritional status in malnourished hospitalized older pa-
tients (Milne, Avenell, & Potter, 2006 [Level I]) and should be considered in
those who are malnourished or at risk for malnutrition. When used, oral liq-
uid nutritional supplements should be given at least 60 minutes prior to meals
(Wilson, Purushothaman, & Morley, 2002 [Level IV]). Specialized nutritional
support should be reserved for select situations. If the provision of nutrients
via the gastrointestinal tract is contraindicated, then parenteral nutrition via
the central or peripheral route should be initiated (American Society for Par-
enteral and Enteral Nutrition, 2002). If the gastrointestinal tract can be utilized,
then nutrients should be delivered via enteral tube feeding (American Soci-
ety for Parenteral and Enteral Nutrition, 2002). The exact location of the tube
and type of feeding tube inserted depend on the disease state, length of time
tube feeding is required, and risk for aspiration. Patients started on special-
ized nutritional support should be routinely reassessed for its continued need
and transitioned to oral feeding when feasible. Also, advance directives, if not
completed, should be addressed prior to initiating specialized nutritional sup-
port (see chapter 23, Health Care Decision Making, and chapter 24, Advance
Directives).
Case Study and Discussion
Mrs. V. H. is a 75-year-old female admitted to the hospital with a myocardial
infarction and is on a telemetry unit for further workup prior to coronary
artery bypass grafting surgery. On admission, her standing height is 5 feet
8 inches and she weighs 140 pounds. Her BMI is 21.33. Her past medical
history is significant for osteoarthritis. She describes herself as generally in
good health up until she was admitted to the hospital. Medications include
400mg of ibuprofen q 6 hours, prn.Mrs. V. H. is the primary caregiver for her
80-year-old husband, who has altered cognitive functioning and is bedrid-
den after a stroke 3 years ago. She administers her husband’s gastrostomy
tube feedings and turns and positions her husband to prevent decubitus ul-
cers. She receives assistance from three times a week when a home health
aide visits for 4 hours each visit. During this time, she is able to go shopping
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and run errands. She complained of being tired and lacking energy prior
to admission. Her weight history is significant for a 10-pound weight loss
in the past 3 months. Mrs. V. H. said she started taking oral energy drinks
because she was often too tired to cook a complete dinner for herself and
lacked energy and was concerned about weight loss. She reported regaining
2 pounds after taking three cans of an oral nutritional supplement per day
for about 4 weeks. She reported having more strength after regaining some
of her weight back. Although she is married and lives with her husband, she
is isolated because she does not have any social support systems on which
to rely. Her only living relative is a cousin who is 70 years old, lives 60 miles
away, and visits twice a month. During the assessment, Mrs. V. H. continu-
ally complained of being physically exhausted from caring for her husband
at home and being too tired to eat or cook a nutritious meal for herself. She
is worried about how she will care for her husband upon discharge from
surgery and hopes that she can recover in the same nursing home to which
her husband was admitted.
Although Mrs. V. H. does not have any chronic conditions or functional
limitations that may place her at risk for malnutrition, her social history is
significant for risk. As the sole caregiver for her disabled husband, she is
isolated and tired and has a decreased appetite. She reports a history of
unintentional loss of 10 pounds in 3 months. Her MNA score of 7 is based
on moderate loss of appetite, weight loss greater that 6.6 pounds during
the last 3 months, goes out, has suffered an acute disease, no psychologi-
cal problems, and has a BMI of 21.33. Because her score is below 11, she
is at risk or malnutrition, and a complete assessment level of the MNA is
performed. Her total MNA assessment score is 17.5, based on an assess-
ment score of 10.5 and a screening score of 7.0, indicating that she is at risk
for malnutrition. Her serum albumin on admission is within normal lim-
its. Although she is on a regular diet, she only takes in about 50% of her
meals. Oral nutritional supplements are ordered twice daily between meals.
Consultations are obtained from the social worker, dietitian, and physical
therapist.
Conclusion
Hospitalized older adults are at risk for malnutrition. Nurses should carefully
assess and monitor the nutritional status of older hospitalized patients so that
appropriate nutrition-related interventions can be implemented in a timely
fashion.
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■ Centers for Medicare and Medicaid Services
http://www.medicare.gov/Nursing/Campaigns/NutriCareAlerts.asp
■ Practicing Physician Education in Geriatrics
http://www.gericareonline.net/
■ National Conference of Gerontological Nurse Practitioners: Home Page
http://www.ncgnp.org
■ National Gerontological Nursing Association: Home Page
http://www.ngna.org/
■ National Institutes of Health
http://www.nlm.nih.gov/medlineplus/nutritionforseniors.html
■ The Gerontological Society of America: Home Page
http://www.geron.org/
■ U.S. Department of Health and Human Services: Home Page
http://www.hhs.gov/
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Box 15.1
Nursing Standard of Practice Protocol: Nutrition in
Aging
I. GOAL: Improvement in indicators of nutritional status in order to opti-
mize functional status and general well-being and promote positive nutri-
tional status.
II. OVERVIEW: Older adults are at risk for malnutrition, with 40% to
60% of hospitalized older adults malnourished or at risk for malnutrition.
III. BACKGROUND
A. Definitions:
1. Malnutrition: Any disorder of nutritional status, including disor-
ders resulting from a deficiency of nutrient intake, impaired nu-
trient metabolism, or overnutrition.
2. Protein-energy under-nutrition: The presence of clinical (i.e.,
physical signs such as wasting, low body mass index [BMI]) and
biochemical (i.e., albumin or other serum protein) evidence of
insufficient intake.
B. Etiology and/or Epidemiology. Older adults are at risk for under-
nutrition due to dietary, economic, psychosocial, and physiological
factors (DiMaria-Ghalili & Amella, 2005 [Level VI]).
1. Dietary intake
a. Little or no appetite (Carlsson et al., 2005 [Level II]; Reuben
et al., 2005 [Level II]; Saletti et al., 2005 [Level IV])
b. Problems with eating or swallowing (Margetts et al., 2003
[Level IV])
c. Eating inadequate servings of nutrients (Margetts et al., 2003
[Level IV])
d. Eating fewer than two meals a day (Saletti et al., 2005 [Level
IV])
2. Limited income may cause restriction in the number of meals
eaten per day or dietary quality of meals eaten (Souter & Keller,
2002 [Level IV])
3. Isolation
a. Older adults who live alone may lose desire to cook because of
loneliness (Shahar, 2001 [Level IV]).
b. Appetite of widows decreases (Shahar, 2001 [Level IV]).
c. Difficulty cooking due to disabilities (Souter & Keller, 2002
[Level IV]).
d. Lackof access to transportation to buy food (DiMaria&Amella,
2005 [Level VI]).
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4. Chronic Illness
a. Chronic conditions can affect intake (Margetts et al., 2003
[Level IV]).
b. Disability can hinder ability to prepare or ingest food (Saletti
et al., 2005 [Level IV]).
c. Depression can cause decreased appetite (Thomas et al., 2002
[Level IV]; Morley, 2001 [Level V]).
d. Poor oral health (e.g., cavities, gum disease, andmissing teeth)
andxerostomia, or drymouth, impairs ability to lubricate,mas-
ticate, and swallow food (Saletti et al., 2005 [Level IV]).
e. Antidepressants, antihypertensives, and bronchodilators can
contribute to xerostomia (dry mouth) (DiMaria-Ghalili &
Amella, 2005 [Level VI]).
5. Physiological changes
a. Decrease in leanbodymass and redistribution of fat around in-
ternal organs lead to decreased caloric requirements (Hughes
et al., 2004 [Level IV]; Janssen et al., 2002 [Level IV]).
b. Change in taste (from medications, nutrient deficiencies, or
tastebud atrophy) can also alter nutritional status (DiMaria-
Ghalili & Amella, 2005 [Level VI]).
VI. PARAMETERS OF ASSESSMENT
A. General: During routine nursing assessment, any alterations in gen-
eral assessment parameters that influence intake, absorption, or di-
gestion of nutrients should be further assessed to determine if an
older adult is as nutritional risk. These parameters include the fol-
lowing:
1. Subjective assessment, including present history, assessment of
symptoms, past medical and surgical history, and co-morbidities
(University of Texas, School of Nursing, 2006, guideline)
2. Social history(University of Texas, School of Nursing, 2006,
guideline).
3. Drug–nutrient interactions: Drugs can modify the nutrient needs
and metabolism of older people. Restrictive diets, malnutrition,
changes in eating patterns, alcoholism, and chronic disease with
long-term drug treatment are some of the risk factors in elderly
that place them at risk for drug–nutrient interactions (Boullata,
2004 [Level VI]). TheU.S. Food andDrugAdministration andNa-
tional Institutes for Health have Internet resources for common
drug–nutrient interactions.
4. Functional limitations (Salva et al., 2004 [Level V]).
5. Psychological status (Salva et al., 2004 [Level V]).
6. Objective assessment: physical examination with emphasis on
oral exam (see chapter 17,OralHealth Care), loss of subcutaneous
fat, muscle wasting, BMI (University of Texas, School of Nursing,
2006, guideline) and dysphagia.
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B. Dietary Intake: in-depth assessment of dietary intake during hos-
pitalization may be documented with a 3-day calorie count (dietary
intake analysis) (DiMaria-Ghalili & Amella, 2005 [Level VI]).
C. Risk Assessment Tool: The MNA should be administered to de-
termine if an older hospitalized patient is either at risk for mal-
nutrition or has malnutrition. The MNA determines risk based
on food intake, mobility, BMI, history of weight loss, psychologi-
cal stress, or acute disease and dementia or other psychological
conditions. If the score is 11 points or less, the in-depth MNA
assessment should be administered (DiMaria-Ghalili & Amella,
2005 [Level VI]; Salva et al., 2004 [Level V]). See the Resources
section for the MNA tool or www.ConsultGeriRN.org, Nutrition
topic.
D. Anthropometry
1. Obtain an accurate weight and height through direct measure-
ment. Do not rely on patient recall. If patient cannot stand
erect to measure height, then knee-height measurements should
be taken to estimate height using special knee-height calipers.
Height should never be estimated or recalled, due to shortening
of the spine with advanced age; self-reported height may be off
by as many as 2.4 cm (DiMaria-Ghalili & Amella, 2005 [Level VI];
Salva et al., 2004 [Level V]).
2. Weight history: A detailed weight history should be obtained
along with current weight. Detailed history should include a his-
tory of weight loss, whether theweight loss was intentional or un-
intentional, and during what period. A loss of 10 pounds during
a 6-month period, whether intentional or unintentional, is a crit-
ical indicator for further assessment (DiMaria-Ghalili & Amella,
2005 [Level VI]; National Collaborating Centre for Acute Care,
2005, guideline).
3. Calculate BMI to determine if weight for height is within the nor-
mal range of 22–27. A BMI below 22 is a sign of under-nutrition.
(National Collaborating Centre for Acute Care, 2005, guideline;
Nutrition Screening Initiative, 2002 [Level V]).
E. Visceral Proteins. Serum albumin, transferrin, and prealbumin are
visceral proteins commonly used to assess and monitor nutritional
status (DiMaria-Ghalili & Amella, 2005 [Level VI]). However, these
proteins are negative acute-phase reactants; therefore, during a
stress state, production is usually decreased. In an older hospital-
ized patient, albumin levels may be a better indicator of prognosis
than nutritional status (Sullivan et al., 2005 [Level IV]).
V. NURSING CARE STRATEGIES
(DiMaria-Ghalili & Amella, 2005 [Level VI]
A. Collaboration
1. Refer to dietitian if patient is at risk for or has under-nutrition.
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2. Consult with pharmacist to review patient’s medications for pos-
sible drug–nutrient interactions.
3. Consult with a multidisciplinary team specializing in nutrition.
4. Consult with social worker, occupational therapist, and speech
therapist as appropriate.
B. Alleviate Dry Mouth
1. Avoid caffeine; alcohol; tobacco; and dry, bulky, spicy, salty, or
highly acidic foods.
2. If patient does not have dementia or swallowing difficulties, offer
sugarless hard candy or chewing gum to stimulate saliva.
3. Keep lips moist with petroleum jelly.
4. Encourage frequent sips of water.
C. Maintain adequate nutritional intake:
1. Daily requirements for healthy older adults include 30 kcal per kg
of body weight and 0.8 to 1 g/kg of protein per day, with no more
than 30% of calories from fat. Caloric, carbohydrate, protein, and
fat requirements may differ depending on degree of malnutrition
and physiological stress.
D. Improve oral intake
1. Mealtime rounds to determine how much food is consumed and
whether assistance is needed.
2. Limit staff breaks to before or after patient mealtimes to ensure
adequate staff are available to help with meals.
3. Encourage family members to visit at mealtimes.
4. Ask family to bring favorite foods from home when appropriate.
5. Ask about and honor patient food preferences.
6. Suggest small frequent meals with adequate nutrients to help pa-
tients regain or maintain weight.
7. Provide nutritious snacks.
8. Help patient with mouth care and placement of dentures before
food is served.
E. Provide conducive environment for meals
1. Remove bedpans, urinals, and emesis basin from room before
mealtime.
2. Administer analgesics and antiemetics on a schedule that will di-
minish the likelihood of pain or nausea during mealtimes.
3. Serve meals to patients in a chair if they can get out of bed and
remain seated.
4. Create a more relaxed atmosphere by sitting at the patient’s eye
level and making eye contact during feeding.
5. Order a late food tray or keep food warm if patients are not in their
room during mealtime.
6. Donot interrupt patients for round andnonurgent procedures dur-
ing mealtimes.
F. Specialized nutritional support (American Society for Parenteral and
Enteral Nutrition, 2002, guidelines)
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1. Start specialized nutritional supportwhen a patient cannot, should
not, or will not eat adequately and if the benefits of nutrition out-
weigh the associated risks.
2. Prior to initiation of specialized nutritional support, review the pa-
tient’s advanced directives regarding the use of artificial nutrition
and hydration.
G. Provide oral supplements
1. Supplements should not replace meals but rather be provided be-
tween meals but not within the hour preceding a meal and at bed-
time (Wilson et al., 2002 [Level IV]). See National Collaborating
Centre for Acute Care Clinical Guideline (2006) for algorithm for
use of oral supplements.
H. N.P.O. orders
1. Schedule older adults for test or procedures early in the day to
decrease the length of time they are not allowed to eat and drink.
2. If testing late in the day is inevitable, ask physician whether the
patient can have an early breakfast.
3. See American Society of Anesthesiologists practice guideline re-
garding recommended length of time patients should be kept n.p.o.
for elective surgical procedures.
VI. EVALUATION AND EXPECTED OUTCOMES
A. Patient:
1. Will experience improvement in indicators of nutritional status.
2. Will improve functional status and general well-being.
B. Provider:
1. Should ensure that care provides food and fluid of adequate
quantity and quality in an environment conducive to eating, with
appropriate support (e.g., modified eating aids) for people who
can potentially chew and swallow but are unable to feed them-
selves (National Collaborating Center for Acute Care, 2006).
2. Should continue to reassess patients who are malnourished or
at risk for malnutrition (National Collaborating Center for Acute
Care, 2006).
3. Should monitor for refeeding syndrome (National Collaborating
Center for Acute Care, 2006).
C. Institution:
1. Will ensure that all health care professionals who are directly in-
volved in patient care receive education and training on the im-
portance of providing adequate nutrition (National Collaborating
Center for Acute Care, 2006).
D. QA/QI
1. Establish QA/QI measures surrounding nutritional management
in aging patients.
E. Educational
1. Provider education and training includes the following:
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a. nutritional needs and indications for nutrition support
b. options for nutrition support (oral, enteral, and parenteral)
c. ethical and legal concepts
d. potential risks and benfits
e. when and where to seek expert advice
f. (National Collaborating Center for Acute Care, 2006)
2. Patient and/or caregiver education includes how to maintain or
improve nutritional status, as well as how to administer, when ap-
propriate, oral liquid supplements, enteral tube feeding, or par-
enteral nutrition.
VII. FOLLOW-UP MONITORING
(National Collaborating Centre for Acute Care, 2006)
A. Monitor for gradual increase in weight over time.
1. Weigh patient weekly to monitor trends in weight.
2. Daily weights are useful for monitoring fluid status.
B. Monitor and assess for refeeding syndrome.
1. Carefullymonitor and assess patients thefirstweek of aggressive
nutritional repletion.
2. Assess and correct the following electrolyte abnormalities:
Hypophosphatemia, hypokalemia, hypomagnesemia, hyper-
glycemia, and hypoglycemia.
3. Assess fluid status with daily weights and strict intake and
output.
4. Assess for congestive heart failure in patients with respiratory
or cardiac difficulties.
5. Ensure caloric goals will be reached slowly during 3 to 4 days to
avoid refeeding syndrome when repletion of nutritional status is
warranted.
6. Be aware that refeeding syndrome is not exclusive to patients
started on aggressive artificial nutrition but may also be found
in elderly individuals with chronic co-morbidmedical conditions
and poor nutrient intake started with aggressive nutritional re-
pletion via oral intake.
VIII. RELEVANT GUIDELINES
A. American Society of Anesthesiologists (1999). Practice guidelines
for preoperative fasting and the use of pharmacologic agents to
reduce the risk of pulmonary aspiration: Application to health pa-
tients undergoing elective procedures. Anesthesiology, 90, 896–905.
B. National Collaborating Centre for Acute Care (2006).Nutrition sup-
port in adults: Oral nutrition support, enteral tube feeding and par-
enteral nutrition. London, UK: National Institute for Health and
Clinical Excellence (NICE). Clinical guideline no. 32. Electronic
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copies: Available in PDF format from that National Institutes for
Health and Clinical Excellence (NICE) Web site.
C. American Society for Parenteral and Enteral Nutrition (2002).
Guidelines for the use of parenteral and enteral nutrition in
adult and pediatric patients. Journal of Parenteral and Enteral Nu-
trition, 26, 1SA–138SA. (Note: These guidelines are undergoing
revision.)
D. University of Texas, School of Nursing (2006).Unintentional weight
loss in the elderly. Austin, TX: University of Texas, School of Nurs-
ing. (Note: These guidelines are located at www.guidelines.gov.
However, the companion document with full bibliography is not
in the public domain.)
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16Managing OralHydration
Janet C. Mentes
Educational
Objectives
After completion of this chapter, the reader will be
able to:
1. describe older adults at risk for dehydration
2. identify keys aspects of a hydration assessment
3. list specific interventions to promote hydration in
older adults across care settings
4. identify outcomes of a hydration-management
program
Overview
A recent study using markers (i.e., serum sodium, osmolality, and BUN/creat-
inine ratio) for dehydration and volume depletion from the Established Popu-
lations for Epidemiologic Studies of the Elderly (EPESE) found that the preva-
lence for these conditions in community-dwelling elders could range from 0.5%
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
NOTE: Portions of this chapter were adapted with permission from J. C. Mentes and the Iowa Veterans Affairs
Nursing Research Consortium (2004). Evidence-based protocol: Hydration management. In M.G. Titler (Series
Ed.), Series on evidence-based practice for older adults. Iowa City, IA: University of Iowa College of Nursing
Gerontological Nursing Interventions Research Center, Research Translation and Dissemination Core.
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to 60% depending on the markers used (Stookey, Pieper, & Cohen, 2005 [Level
IV]). Another study of dehydration in older adults found that 48% of elders
presenting with dehydration at an ER unit were from the community (Ben-
nett, Thomas, & Riegel, 2004 [Level IV]). Maintaining adequate fluid balance
is an essential component of health across the life span; older adults are more
vulnerable to shifts in water balance—both over-hydration and dehydration—
because of age-related changes and increased likelihood that they have sev-
eral medical conditions. Dehydration is the more frequent occurrence in elders
(Warren et al., 1994 [Level IV]; Xiao, Barber, & Campbell, 2004 [Level IV]). In
fact, avoidable hospitalizations for dehydration in older adults have increased
by 40% from 1990 to 2000, at a cost of 1.14 billion dollars (Xiao et al., 2004
[Level IV]).
Consequences of dehydration can cause further morbidity, including con-
stipation, increased falls, medication toxicity, increased infections (i.e., urinary
and respiratory) (Mukand, Cai, Zielinski, Danish, & Berman, 2003 [Level IV]),
and decreased risk of bladder cancer in men (Michaud et al., 1999 [Level
IV]). High daily intakes of water (i.e., five or more 8-ounce glasses) com-
pared with low intakes (two or fewer glasses), but not other types of fluid,
were associated with decreased fatal coronary heart disease in middle-aged
and older adults (Chan, Knutsen, Blix, Lee, & Fraser, 2002 [Level IV]). Fi-
nally, consuming 16 ounces of tepid water before a meal significantly in-
creased healing time, especially for pressure ulcers, and decreased likeli-
hood of delirium (Mentes & Culp, 2003 [Level III]; Weinberg, Minaker, & The
Council on Scientific Affairs, AMA,1995 [Level I]). Dehydration in elders with
multiple co-morbid conditions can precipitate an emergency hospitalization
and increase the risk for repeated hospitalizations (Gordon, An, Hayward, &
Williams, 1998 [Level IV]; Xiao et al., 2004 [Level IV]). The most serious conse-
quence of dehydration is an increased 1-year mortality rate, which was doc-
umented in 50% of older Medicare beneficiaries admitted for a hospitaliza-
tion with a primary or secondary diagnosis of dehydration (Warren et al., 1994
[Level IV]).
Conversely, adequate fluid consumption has been associatedwith decreased
falls, decreased constipation, and decreased use of laxatives (Robinson &
Rosher, 2002 [Level IV]). Adequate hydration may have even more far-reaching
positive effects, such as better rehabilitation outcomes in older orthopedic pa-
tients (Mukand et al., 2003 [Level IV]) and improved postprandial orthostatic
hypotension in older individuals with autonomic failure (Shannon et al., 2002
[Level IV]).
Oral hydration of older adults is particularly complex for various reasons.
In this chapter, issues of age-related changes, risk factors, assessment mea-
sures, and nursing strategies for effective interventions for dehydration are
addressed.
Background and Statement of Problem
Water is an essential component of body composition. Intricate cellular func-
tions, such as gene expression, protein synthesis, and uptake andmetabolism of
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nutrients, are affected by hydration status. Organ systems, specifically the car-
diovascular and renal systems, are particularly vulnerable to fluctuating levels
of hydration (Metheny, 2000 [Level VI]).
Fluid is found in different compartments in the body. Two basic compart-
ments are the intracellular, or water within the cell, and extracellular, or water
outside the cells. The extracellular compartment can be further categorized into
the interstitial compartment, or the water between cells, and the intravascu-
lar compartment, or fluid in the blood vessels. Of course, when thinking about
where water can be found in the body, it is realized that water serves as a sol-
vent for many essential elements, such as the electrolytes sodium, potassium,
and others. Fluid with these elements moves between the compartments in an
orchestrated manner, guided by electrochemical forces that are exerted by elec-
trolytes, by large molecules such as glucose, and by the colloidal osmotic pres-
sure of proteins contained in the blood. Cellular factors, such as cell permeability
and transport of elements and nutrients across this membrane, also contribute
to the pattern of fluid distribution in the body. Therefore, hydration problems
rarely involve body water alone but rather are a water and electrolyte problem
(Metheny, 2000 [Level VI]).
Older individuals are at increased risk for hydration problems for vari-
ous reasons. First, as individual’s age, total body water decreases from 50%–
70% to 40%–50% of body weight. For example, a female weighing 60 kg (132
pounds) at age 35 with 55%, or 33 kg, of body weight as water would have
significantly less body weight as water at age 75, assuming that she weighed
the same and that only 45%, or 27 kg, was water (Metheny, 2000 [Level VI]).
Second, older individuals tend to lose muscle cells, which increases the pro-
portion of fat cells to muscle cells. Fat cells are known to contain less water
than muscle cells, which decreases overall intracellular fluids (Metheny, 2000
[Level VI]). Third, the risk of hydration problems is further increased with
another age-related change involving the hormonally regulated thirst mech-
anism. Although not completely understood, elderly individuals do not experi-
ence thirst as intensely as younger individuals; in fact, their thirst is not pro-
portional to metabolic needs in response to dehydrating conditions (Kenney &
Chiu, 2001 [Level V]; Mack et al., 1994 [Level III]; Miescher & Fortney, 1989
[Level III]; Phillips et al., 1984 [Level III]; Phillips, Bretherton, Johnson, & Gray,
1991 [Level III]). Therefore, a major hydration management mechanism is im-
paired with age. Fourth, renal efficiency as measured by creatinine clearance
decreases with age. In studying healthy older adults who had no renal or uri-
nary tract disease, were normotensive, and did not use diuretics or antihyper-
tensive drugs, Lindeman and colleagues (1985 [Level IV]) found that creati-
nine clearance decreased on average by 0.75 mL/min per year starting at age
40. It is important to note that one-third of study participants had no decrease
in renal function. However, in general, older individuals lose their water re-
serves through loss of fluid-rich muscle cells, impaired renal conservation of
water, and decreased fluid replacement due to lack of thirst. Finally, myriad
other clinical factors that are more likely to occur as one ages but are not a
direct effect of aging also contribute to increased risk, including cardiovascu-
lar disease, diabetes, multiple medical problems, malnutrition, and medication
usage.
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Definitions
Hydration Management
Hydration management is the promotion of adequate fluid balance that pre-
vents complications resulting from abnormal or undesired fluid levels (see both
Fluid Management and Fluid Monitoring nursing interventions in McCloskey-
Dochterman & Bulechek, 2004, pp. 348–349, 352).
Dehydration
Dehydration is depletion in total body water content due to pathologic fluid
losses, diminished water intake, or a combination of both. It results in hyperna-
tremia (greater than 145mEq/L) in the extracellular fluid compartment, which
draws water from the intracellular fluids. The water loss is shared by all body-
fluid compartments and relatively little reduction in extracellular fluids occurs.
Thus, circulation is not compromised unless the loss is very large. This is also
known as intracellular or hypernatremic dehydration (Na+ greater than or equal
to145mEq/L).
Volume Depletion
Dehydration and volume depletion are often used synonymously to refer to
dehydration; however, there are differences in symptoms and in emergency
management between the two conditions. Volume depletion is the loss of both
sodium and water with greater losses of sodium resulting in extracellular fluid
loss and a reduction in intravascular volume (Mange et al., 1997 [Level V]).
Major causes of volume depletion include blood loss, diarrhea, and vomiting,
with individuals experiencing lightheadedness and orthostatic blood pressure
changes.
Risk Factors for Dehydration
Community-Dwelling Elders
From findings of two recent studies, healthy community-dwelling older adults
have no apparent changes in hydration status (Bossingham, Carnell, & Camp-
bell, 2005 [Level II];Morgan,Masterson, Fahlman, Topp, &Boardley, 2003 [Level
IV]). Bossingham and colleagues (2005 [Level II]) studied older and younger
adults using a controlled diet study. Total water intake, water output, and mark-
ers of hydration status (i.e., specific gravity and plasma osmolality) were not
different between younger and older adults and fell within accepted clinical
ranges. They did find normal age-related changes in body composition, specif-
ically decreased fat-free body mass. Morgan and colleagues (2003 [Level IV])
also found that older adults who fasted for 12 hours exhibited normal values for
the clinical markers of hydration, including specific gravity, serum osmolality,
serum sodium, hematocrit, and hemoglobin. Only urine osmolality values were
higher than normal.
Managing Oral Hydration 373
These studies suggest an important consideration for risk of dehydration.
Older adults, under normal conditions, maintain adequate hydration; however,
when stressed by physical or emotional illness, surgery, or trauma, they are at
increased risk for dehydration (Bossingham et al., 2005 [Level II]; Luckey &
Parsa, 2003 [Level IV]; Morgan et al., 2003 [Level IV]). Therefore, a change in
health status in a healthy older adult is an important risk factor for dehydration.
Institutionalized Older Adults
Risk for dehydration in ill or frail older adults across care settings has beenmore
frequently studied. Although there is no one outstanding risk factor for dehy-
dration, age, gender, ethnicity, class and number of medications taken, level of
ADL dependency, presence of cognitive impairment, presence of medical con-
ditions such as infectious processes, and a prior history of dehydration all have
been associated with dehydration in older adults (Mentes & The Iowa Veterans
Affairs Nursing Research Consortium, 2004 [Level I]).
Increasing age is associated with increased likelihood of dehydration
(Ciccone, Allegra, Cochrane, Cody, & Roche, 1998 [Level IV]; Lavisso-Mourey,
Johnson, & Stolley, 1988 [Level IV]; Warren et al., 1994 [Level IV]). Ciccone
and colleagues (1998 [Level IV]) found that adults 85 years and older were
three times more likely to have a diagnosis of dehydration on admission to an
emergency department than adults ages 65 to 74 years. Older African Ameri-
can adults have higher prevalence rates of dehydration on hospitalization than
White adults (Lancaster, Smicklas-Wright, Heller, Ahern, & Jensen, 2003 [Level
IV];Warren et al., 1994 [Level IV]). Female gender has been associated with risk
for dehydration in nursing home residents (Lavisso-Mourey et al., 1988 [Level
IV]); however, male hospitalized patients had an increased risk for dehydration
(Warren et al., 1994 [Level IV]) and, more recently, no gender differences were
detected in a large database study (Xiao et al., 2004 [Level IV]).
In general, individuals in long term care (LTC) settings are considered at
increased risk, with one-third of residents experiencing a dehydration episode
in a 6-month period (Mentes, 2006a [Level IV]). Specific factors that have been
studied in LTC residents include the following:
■ older than 85 years of age (Gaspar, 1999 [Level IV]; Lavisso-Mourey et al.,
1988 [Level IV])
■ female (Gaspar, 1988 [Level IV]; Lavisso-Mourey et al., 1988 [Level IV])
■ functionally semidependent (e.g., those individuals who are cognitively
unaware of their needs yet have mobility and those who are physically
unable to meet their needs but who can express them) (Gaspar, 1988
[Level IV])
■ functionally more independent (Gaspar, 1999 [Level IV]; Mentes & Culp,
2003 [Level III])
■ semidependent with eating (Gaspar, 1999 [Level IV])
■ Alzheimer’s disease or other dementias (Albert, Nakra, Grossberg, &
Caminal, 1989; 1993 [both Level III])
■ four or more chronic conditions (Lavisso-Mourey et al., 1988 [Level IV])
■ more than four medications (Lavisso-Mourey et al., 1988 [Level IV])
■ fever (Pals et al., 1995 [Level IV]; Weinberg et al., 1994 [Level IV])
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■ few fluid ingestion opportunities (Gaspar, 1988; 1999 [both Level IV])
■ inadequate nutrient intake (Gaspar, 1999 [Level IV])
■ inadequate staff and professional supervision (Kayser-Jones, Schell,
Porter, Barbaccia, & Shaw, 1999 [Level IV])
Special Populations
Several groups of patients, based on medical diagnosis, are at increased risk for
dehydration, including chronically mentally ill, surgical, stroke, and end-of-life
(EOL) patients.
Chronically Mentally Ill Patients
Special consideration should be given to chronic mentally ill elders (e.g., in-
dividuals with schizophrenia, bipolar disorder, obsessive-compulsive disorder)
because they may be at risk for hydration problems. Their antipsychotic med-
ications may blunt their thirst response and put them at increased risk in hot
weather for dehydration and heat stroke (Batscha, 1997 [Level V]). In addition,
even small increases in their antipsychotic medications may predispose them
to neuroleptic malignant syndrome (NMS), of which hyperthermia and dehy-
dration are prominent features (Bristow & Kohen, 1996 [Level V]; Jacobs, 1996
[Level V]; Sadev,Mason, &Hadzi-Pavlovic, 1997 [Level V]). In these individuals,
risks for over-hydration stem from a combination of the drying side effects of
prescribed psychotropic medications and the individual’s compulsive behaviors
that result in excessive fluid intake (Cosgray, Davidhizar, Giger, & Kreisl, 1993
[Level V]).
Stroke Patients
There is increasing evidence that people who suffer from dysphagia as a result
of stroke are at increased risk for dehydration (Whelan, 2001 [Level II]). This
appears to be related not only to the dysphagia resulting from the stroke but
also the poor palatability of the thickened fluids offered to patients to prevent
aspiration.
Surgical Patients
Prolonged nothing by month (NPO) status prior to elective surgery has been
linked to increased risk of dehydration and adverse effects such as, thirst,
hunger, irritability, headache, hypovolemia, and hypoglycemia in surgical pa-
tients (Smith, Vallance, & Slater, 1997 [Level II]; Yogendran, Asokumar, Cheng,
& Chung, 1995 [Level II]). Crenshaw and Winslow have found that de-
spite the formulation of national fasting guidelines (available at www.asahq.
org/publicationsAndServices/NPO.pdf), patients were still being instructed to
fast too long prior to surgery (Crenshaw & Winslow, 2002 [Level IV]). In fact,
patients may safely consume clear liquids up to 2 hours prior to elective surgery
using general anesthesia, regional anesthesia, or sedation anesthesia.
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EOL Patients
Maintaining orwithholding fluids at the end of life remains a controversial issue.
Proponents suggest that dehydration in the terminally ill patient is not painful
and lessens other noxious symptoms of terminal illness, such as excessive pul-
monary secretions, nausea, edema, and pain (i.e., dehydration acts as a natural
anesthetic) (Dalal & Bruera, 2004 [Level I]). Opponents to this position suggest
that associated symptoms of dehydration, such as acute confusion and delir-
ium, are stressful and reduce the quality of life for a terminally ill elder (Bruera,
Belzile, Wantantabe, & Fainsinger, 1996 [Level IV]).
Most research has been done with terminally ill cancer patients and has
examined discomforts of dehydration, including thirst, dry mouth, and agitated
delirium. However, research has not demonstrated a link between biochemical
markers of dehydration and these various symptoms in terminally ill patients
(Burge, 1993 [Level IV]; Ellershaw, Sutliffe, & Saunders, 1995 [Level IV]; Morita,
Tei, Tsunoda, Inoue,&Chihara, 2001 [Level IV]). It is suggested that several con-
founding factors influence the uncomfortable dehydration-like symptoms that
accompany the end of life, including use and dosage of opiates, type and loca-
tion of cancer, hyperosmolality, stomatitis, and oral breathing (Morita et al., 2001
[Level IV]). On the other hand, Bruera et al. (1996 [Level IV]) have determined
that small amounts of fluids delivered subcutaneously via hypodermoclysis plus
opioid rotation were effective in decreasing delirium and antipsychotic use and
did not cause edema in terminally ill patients. Therefore, it is recommended
that maintaining or withholding fluids at the end of life is an individual decision
that should be based on the etiology of illness, use of medications, presence of
delirium, and family and patient preferences (Dalal & Bruera, 2004 [Level I];
Morita et al., 2001 [Level IV]).
Assessment of Hydration Status
Hydration Habits
Hydration habits may indicate level of risk for dehydration in older adults. Some
hydration habits may have developed during a lifetime and others are adap-
tations to current health status. Four major categories of hydration habits in
nursing home residents have been identified (Mentes, 2006a [Level IV]). The
categories include those elders who “can drink,” “can’t drink,” “won’t drink,”
and those who are at the “end of life.” For example, older adults who “can drink”
are those who are functionally capable of accessing and consuming fluids but
who may not know what is an adequate intake or may forget to drink secondary
to cognitive impairment. Elders who “can’t drink” are those who are physically
incapable of accessing or safely consuming fluids related to physical frailty or
difficulty swallowing Elders who “won’t drink” are those who are capable of
consuming fluids safely but who do not because of concerns about being able
to reach the toilet with or without assistance or who relate that they have never
consumed many fluids. Elders who are terminally ill comprise the EOL cate-
gory. Understanding hydration habits of older adults can help nurses to plan
appropriate interventions to improve or ensure adequate intake (Mentes, 2006a
[Level IV]).
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Indicators of Hydration Status
Apriority for nursing, regardless of clinical setting, is the prevention of dehydra-
tion. Unfortunately, many of the standard tests for detection of dehydration only
confirm a diagnosis of dehydration after it is too late to prevent the episode. In
fast-paced nursing environments, it is difficult to monitor the fluid intake of all
older patients. Although controversial, the use of urine color and specific gravity
has been shown to be a reliable indicator of hydration status (not dehydration)
in older individuals in nursing homes and a Veterans Administration Medical
Center with adequate renal function (Culp, Mentes, & Wakefield, 2003; Mentes,
Wakefield, & Culp, 2006 [both Level IV]). Specifically, the use of urine color, as
measured by a urine color chart, can be helpful in monitoring hydration status
(Armstrong et al., 1994 [Level IV]; Mentes & The Iowa Veterans Affairs Nursing
Research Consortium, 2004 [Level I]). The urine color chart has eight standard-
ized colors ranging from pale straw (number 1) to greenish brown (number 8),
approximating urine specific gravities of 1.003 to 1.029 (Armstrong et al., 1994
[Level IV]). The color chart is most effective when an individual’s average urine
color is calculated during several days for an individual referent value. If an
older person’s urine becomes darker from his or her average color, further as-
sessment into recent intake and health status can be conducted and fluids can
be adjusted to improve hydration status before dehydration occurs. Limitations
in using urine indices to estimate specific gravity include (1) certainmedications
and foods can discolor the urine (Wakefield, Mentes, Diggelmann, & Culp, 2002
[Level IV]; Mentes, 2006a [Level IV]); (2) people must be able to give a urine
specimen for a color evaluation; and (3) best results in the use of urine color as
an indicator have been documented in older adults with adequate renal function
(Mentes et al., 2006 [Level IV]).
Bioelectrical impedance analysis (BIA) is ameasurement that has been used
mostly in the fitness industry to estimate body composition, including bodymass
index (BMI), total body water (TBW), and intracellular and extracellular water.
Several nursing studies have used impedance measurements to estimate TBW,
intracellular and extracellular water (Culp, Mentes, & Wakefield, 2003 [Level
IV]; Culp et al., 2004 [Level II]). Although mostly used in research, BIA is a
noninvasive, reliable method to estimate body water (Ritz, 2001 [Level IV]). Be-
causeTBWisweight andbody compositiondependent, thismeasure is best used
after a baseline value of TBW, intracellular, and extracellular fluid in liters has
been documented, then deviations from the individual baseline can be noted.
Dehydration
Dehydration is the loss of body water from intracellular and interstitial
fluid compartments that is associated with hypertonicity (Mange et al., 1997
[Level V]). Therefore, the most reliable indicators of dehydration are elevated
serum sodium, serum osmolality, and BUN/creatinine ratio (Table 16.1). The
most common clinical assessments of dehydration include the presence of
dry oral mucous membranes, tongue furrows, decreased saliva, sunken eyes,
decreased urine output, upper-body weakness, and a rapid pulse (Gross et
al., 1992 [Level IV]). Decreased axillary sweat production as a clinical sign
of dehydration has produced contradictory results, making it an unreliable
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16.1 Approximate Ranges of Laboratory Testsfor Hydration Status
Value Ranges for
Test Impending Dehydration Dehydration
BUN/creatinine ratio 20–24 >25
Serum osmolality normal 280–300 mmol/kg >300 mmol/kg
Serum sodium >150 meq/L
Urine osmolality >1,050 mmol/kg
Urine specific gravity 1.020–1.029 >1.029
Urine color dark yellow greenish-brown
Amount of urine 800–1,200 cc/day <800 cc/day
Armstrong et al., 1994, 1998; Mentes, Culp, & Wakefield, 2006 [all Level IV]; Metheny, 2000
[Level VI]; Wakefield et al., 2002; Wallach, 2000 [both Level IV].
Source: Adapted with permission from J. C. Mentes and The Iowa Veterans Affairs Nursing Research
Consortium (2004). Evidence-based protocol: Hydration management. In M. G. Titler (Series ed.), Series on
evidence-based practice for older adults. Iowa City, IA: The University of Iowa College of Nursing
Gerontological Nursing Interventions Research Center, Research Translation and Dissemination Core.
indicator of dehydration (Eaton, Bannister,Mulley, &Connolly, 1994; Gross et al.,
1992 [both Level IV]). Assessment of sternal skin turgor as a sign of dehydration
has been amainstay in nursing practice; however, it is not a reliable indicator for
dehydration in older individuals because of age-related changes in skin elastic-
ity (Gross et al., 1994 [Level IV]).
Interventions
The hydration management intervention is an individualized daily plan to pro-
mote adequate hydration based on risk-factor identification that is derived from
a comprehensive assessment. The intervention is divided into two phases: risk
identification and hydration management.
Risk Identification
Based on the collected assessment data, a risk appraisal for hydration prob-
lems is completed using the Dehydration Risk Appraisal Checklist (DRAC)
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16.1
Dehydration Risk Appraisal Checklist
Patient ID______________
The greater the number of characteristics present, the greater the risk for hydration problems. Please
check all that apply.
>85 years BMI <21 or >27
Female [BMI = weight(kg)/height(m)2]
Significant Health Conditions
Dementia/ + screen for cognitive impairment Renal Disease
Depression/ +screen for depression Cardiac Arrhythmias
CVA Malnutrition
Diabetes History of dehydration
Urinary Incontinence History of repeated infections
Medications
>4 medications Diuretics
Laxatives Psychotropics: Antipsychotics,
Steroids Antidepressants, Anxioytics
ACE Inhibitors
Intake Behaviors
Requires assistance to drink Semi-dependent with feeding
Has difficulty swallowing/Chokes Fluid intake of <1,500ml/day
Can drink independently but forgets Spills
Poor eater (eats <50% of food) Receives tube feedings
Laboratory Indicators
Urine specific gravity >1.020 BUN/Creatinine >20:1
Urine Color dark yellow
Reprinted with permission from J. C. Mentes and The Iowa Veterans Affairs Nursing Research Consortium
(2004). Evidence-based protocol: Hydration management. In M. G. Titler (Series ed.), Series on evidence-
based practice for older adults. Iowa City, IA: The University of Iowa College of Nursing Gerontological
Nursing Interventions Research Center, Research Translation and Dissemination Core.
DEHYDRATION RISK APPRAISAL CHECKLIST
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(Figure 16.2). The DRAC was developed from an extensive literature review of
risk factors for dehydration in older adults residing in LTC settings. The orig-
inal 42-item checklist has been reduced to 31 items including health condi-
tions, medications, intake behaviors, functional status, and laboratory values
that have been linked to dehydration. These items can be collected during an
admission/baseline assessment and can be linked to Minimum Data Set (MDS)
data. The presence of a higher number of items implies greater risk for dehy-
dration (Mentes, 2006b [Level V]). The checklist is currently being evaluated
for validity and reliability.
Hydration Management
Managing fluid intake for optimal fluid balance consists of acute management
of oral intake and ongoing management of oral intake.
Acute Management of Oral Intake
Any individual who develops a fever, vomiting, diarrhea, or a nonfebrile infec-
tion should be closely monitored by implementing intake and output records
and provision of additional fluids as tolerated (Weinberg et al., 1994 [Level I]).
Individuals who are required to be NPO for diagnostic tests should be given
special consideration to shorten the time and should be provided with adequate
amounts of fluids and food when they have completed their tests. For many
procedures, a 2-hour fluid fast is recommended (American Society of Anesthe-
siology Task Force on Preoperative Fasting, 1999 [Level I]).
Any individual who develops unexplained weight gain, pedal edema, neck-
vein distension, or shortness of breath should be evaluated and closely mon-
itored for over-hydration. Fluids should be temporarily restricted and the in-
dividual’s primary care provider notified. Specific attention should be focused
on individuals who have renal disease or congestive heart failure. Older adults
taking selective serotonin reuptake inhibitors (SSRIs) should have their serum-
sodium levels and their hydration status monitored carefully because they are
at risk for hyponatremia and increasing fluid intake may aggravate an evolving
hyponatremia (Movig, Leufkens, Lenderlink, & Egberts, 1992 [Level IV]).
Ongoing Management of Oral Intake
Ongoing management of oral intake consists of the following five components:
1. Calculate a daily fluid goal.
All older adults should have an individualized fluid goal determined by a
documented standard for daily fluid intake. There is preliminary evidence
that the standard suggested by Skipper (1993) of 100 mL/kg for the first 10 kg
ofweight, 50mL/kg for thenext 10 kg, and 15mL for remaining kg is preferred
(Chidester & Spangler, 1997 [Level IV]).
Because this standard reflects fluid from all sources, to calculate a stan-
dard for fluids alone, 75% of the total calculated from the formula can be
used. This formula allows for at least 1,500mL of fluid per day as aminimum,
which has been shown to be well tolerated in older men ages 55 to 75 (Spigt,
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16.2
Examples of Daily Fluid Goal
Examples
70-kg (154-lb.) resident would have a fluid goal of 2,250 mL/day.
60-kg (132-lb.) resident would have a fluid goal of 2,100 mL/day.
50-kg (110-lb.) resident would have a fluid goal of 1,950 mL/day.
Knottnerus,Westerterp, Olde-Rikkert, & van Schayck, 2006 [Level II]). Other
standards include the following:
■ 1,600 mL per m2 of body surface/day (Butler & Talbot, 1948 [Level VI];
Gaspar, 1988 [Level IV]) or, more recently, Gaspar (1999 [Level IV]) rec-
ommended 75% of this standard
■ 30mL/kg body weight with 1,500 mL/dayminimum (Chernoff, 1994 [Level
VI])
■ 1mL/kcal fluid for adults (FoodandNutritionBoard, 1989 [LevelVI: Expert
Opinion])
■ 1,600 mL/day (Hodgkinson, Evans, & Wood, 2003 [Level I])
2. Compare individual’s current intake to the amount calculated from applying
the standard to evaluate the individual’s hydration status.
3. Provide fluids consistently throughout the day (Ferry, 2005 [Level V]).
a. Plan fluid intake as follows: 75% to 80% delivered at meals and 20% to 25%
delivered during nonmeal times, such as medication times and planned
nourishment times (Simmons, Alessi, & Schnelle, 2001 [Level II]).
b. Offer a variety of fluids, remembering the individual’s previous intake
pattern (Zembrzuski, 1997 [Level V]). Alcoholic beverages, which exert
a diuretic effect on the patient, should not be counted toward the fluid
goal. Caffeinated beverages may be counted toward the fluid goal based
on individual assessment because there is evidence that in individuals
who are regular users, there are no untoward effects on fluid balance and
that recommendations to refrain from moderate amounts of caffeinated
beverages (250 to 300 mg, equivalent of two to three cups of coffee or five
to eight cups of tea) may adversely affect fluid balance in older adults
(Maughan & Griffin, 2003 [Level I]).
c. Fluid with medication administrations should be standardized to a pre-
scribed amount (e.g., at least 180 mL or 6 oz.) per administration time.
4. Plan for at-risk individuals
For residents who are at risk of under-hydration because of poor intake, the
following strategies can be implemented based on time, setting, and formal
or informal caregiver issues:
a. Fluid rounds mid-morning and late afternoon, where caregiver provides
additional fluids (Robinson & Rosher, 2002 [Level IV]).
b. Provide two 8-ounce glasses of fluid in morning and evening (Robinson &
Rosher, 2002 [Level IV]).
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c. “Happy Hours” in the afternoon, where residents can gather together for
additional fluids and socialization (Musson et al., 1990 [Level V]).
d. “Tea Time” in the afternoon, where residents come together for fluids,
nourishment, and socialization (Mueller & Boisen, 1989 [Level V]).
e. Use ofmodified fluid containers based on resident’s intake behaviors (e.g.,
ability to hold cup and swallow) (Mueller & Boisen, 1989 [Level V]).
f. Offer a variety of fluids and encourage ongoing intake throughout the
day for cognitively impaired residents; offer fluids that resident prefers
(Simmons et al., 2001 [Level II]).
5. Fluid regulation and documentation
a. Individualswho are cognitively intact, visually capable, andhave adequate
renal function can be taught how to regulate their intake through the use
of a color chart to compare to the color of their urine (Armstrong et al.,
1994 [Level IV]; Armstrong, Herrera-Soto, Hacker, Kavouras, & Maresh,
1998 [Level IV]; Mentes, Culp, & Wakefield, 2006 [Level IV]). For those
individuals who are cognitively impaired, caregivers can be taught how to
use the color chart.
b. Frequency of documentation of fluid intake will vary among settings and
is dependent on an individual’s condition. However, in most settings, at
least one accurate intake and output recording should be documented,
including the amount of fluid consumed, intake pattern, difficulties with
consumption, and urine specific gravity and color (Mentes & The Iowa
Veterans Affairs Nursing Research Consortium, 2004 [Level I]).
c. Accurate calculation of intake requires knowledge of the volumes of con-
tainers used to serve fluids, which should be posted in a prominent place
on the care unit, because a study by Burns (1992 [Level IV]) suggested
that nurses over- or under-estimated the volumes of common vessels.
Evaluation
Adherence to the hydration-management guideline can be monitored by the
frequency of monitoring (to be determined by setting), as follows:
■ Urine specific-gravity checks, preferably a morning specimen (Arm-
strong et al., 1994, 1998 [both Level IV]; Wakefield et al., 2002 [Level IV]).
A value greater than or equal to 1.020 implies an under-hydrated state
and requires furthermonitoring (Mentes et al., 2006 [Level IV]; Kavouras,
2002 [Level IV]).
■ Urine color chartmonitoring, preferably amorning specimen (Armstrong
et al., 1994, 1998 [both Level IV]; Wakefield et al., 2002 [Level IV]).
■ 24-hour intake recording (output recording may be added; however, in
settings where individuals are incontinent of urine, an intake recording
should suffice).
Expected improved health outcomes of consistent application of a hydra-
tion management plan include the following:
■ maintenance of body hydration (Mentes & Culp, 2003 [Level III]; Robin-
son & Rosher, 2002 [Level IV]; Simmons et al., 2001 [Level II])
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■ decreased infections, especially urinary tract infections (McConnell, 1984
[Level III]; Mentes & Culp, 2003 [Level III]; Robinson & Rosher, 2002
[Level IV])
■ improvement in urinary incontinence (Spangler, Risley, & Bilyew [Level
III])
■ lowered urinary pH (Hart & Adamek, 1984 [Level III])
■ decreased constipation (Robinson & Rosher, 2002 [Level IV])
■ decreased acute confusion (Mentes, Culp,Maas, &Rantz, 1999 [Level IV])
Case Study and Discussion
Mrs. Chung is an 87-year-old Chinese American woman who has resided in
Sunny Days Assisted Living Facility for the past month. She is fiercely in-
dependent despite recently experiencing some declines in her health. Her
medical diagnoses include hypertension, for which she receives atenolol
25 mg daily and enalapril 20 mg daily; status post-mild CVA with resid-
ual left-sided weakness, for which she is taking 80 mg of aspirin daily;
osteoarthritis, for which she takes Tylenol extra strength twice daily; and
cataracts, for which she is reluctant to have surgery. She is cognitively intact
and requires only minor assistance with bathing.
Recently, Mrs. Chung has becomemorewithdrawn and concerned about
her health. Her family has noticed that she has altered some of her daily
routines. For example, she has eliminated her daily tea because she finds
it difficult to use the new microwave at the assisted care facility (ACF) to
heat her water because of unfamiliarity. She stays in her bed much of the
day, complaining that she doesn’t have any energy. When questioned, she
reluctantly admits that she has been having more problems with her long-
standing urinary incontinence and she is afraid to leave her room because
she is fearful that she won’t be able to make it to a bathroom on time. Con-
sequently, she has further restricted the amount of fluid that she consumes
on a daily basis.
Mrs. Chung is at high risk for dehydration given that she has recently
begun to restrict her fluids due to unfamiliarity with the microwave to heat
her water for tea. Elders from different cultures may wish to have their bev-
erages served at different temperatures. Especially when ill, ethnic elders
may prefer to have warmed beverages. In addition, Mrs. Chung is “treating”
her urinary incontinence by restricting her fluids, which places her at risk
for dehydration and urinary tract infections. This scenario is not uncom-
mon in older adults struggling to maintain independence. One of the major
reasons for admission to a nursing home is the presence of urinary inconti-
nence. Finally, there is some evidence that Mrs. Chung is depressed, which
would also place her at risk for dehydration often secondary to decreased
food and fluid intake. Additional risk factors include her age, gender, and
use of an ACE-inhibitor, which acts on the renin angiotension aldosterone
(RAA) system.
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Interventions to prevent dehydration inMrs. Chung would include eval-
uating her for a urinary tract infection and offering her an evaluation for her
urinary incontinence, which could include use of medications, if indicated;
use of behavioral strategies, including urge inhibition; and/or Kegel exer-
cises. Education around the importance ofmaintaining adequate fluid intake
to minimize urinary incontinence is indicated, which should include a dis-
cussion about the amount of daily fluids required and theprovision of a grad-
uated cup to help her ascertain appropriate amounts. Helping her simplify
theuseof themicrowaveand/or attendance at social events at theACFwhere
fluids are provided could be implemented. Lastly, an evaluation for depres-
sionmaybe indicated if the previous interventions donot improve hermood.
Conclusions
Dehydration in older adults is a costly yet preventable health problem. Best
practices for hydrationmanagement have been identified primarily in the nurs-
ing home population, including providing access to fluids at all times, regularly
offering fluids throughout the day, assessing fluid preferences and providing the
fluid of choice, and appropriate supervision of personnel who will be providing
the fluids. Access to fluids means that fasting times for older adults are limited
to the shortest period, fluids are available at all times, and nursing personnel
assess the ability to self-manage hydration in older individuals. Regularly offer-
ing fluids through fluid rounds, a beverage cart, or other novel means such as
teatime is another principle of good hydration practices. Accommodating older
peoples’ preferences for type and appropriate temperature of beveragehas been
shown to increase fluid intake. Last, appropriate supervision of how much fluid
per day is required and how assistance is given to elders who are not capable
of drinking themselves to ensure that required amounts are consumed is also
key in maintaining adequate hydration. The hydration practices of healthier,
community-dwelling older adults is less well known and requires further study.
Box 16.1
Nursing Standard of Practice Protocol:
Oral Hydration Management
I. GOAL: To minimize episodes of dehydration in older adults.
II. OVERVIEW: Maintaining adequate fluid balance is an essential compo-
nent of health across the life span; older adults are more vulnerable to
shifts in water balance, both over-hydration and dehydration, because
of age-related changes and increased likelihood that they have several
medical conditions. Dehydration is the more frequently occurring prob-
lem.
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III. BACKGROUND AND STATEMENT OF PROBLEM
A. Definitions
1. Hydration management is the promotion of adequate fluid bal-
ance that prevents complications resulting from abnormal or
undesired fluid levels. (See both Fluid Management and Fluid
Monitoring nursing interventions in McCloskey-Dochterman &
Bulechek, 2004).
2. Dehydration is depletion in TBW content due to pathologic fluid
losses, diminished water intake, or a combination of both. It re-
sults in hypernatremia (>145 mEq/L) in the extracellular fluid
compartment, which draws water from the intracellular fluids.
The water loss is shared by all body fluid compartments and rel-
atively little reduction in extracellular fluids occurs. Thus, circu-
lation is not compromised unless the loss is very large. This is also
known as intracellular dehydration or hypernatremic dehydration
(Na > 145 mE/L).
3. Volume depletion is the loss of both sodium andwaterwith greater
losses of sodium resulting in extracellular fluid loss and a reduc-
tion in intravascular volume (Mange et al., 1997 [Level V]). Also
called hypotonic dehydration.
B. Etiologic factors associated with dehydration
1. Age-related changes in body compositionwith resulting decrease
in TBW (Metheny, 2000 [Level VI]).
2. Decreasing renal function (Lindeman et al., 1985 [Level IV])
3. Lack of thirst (Kenney & Chiu, 2001 [Level V]; Mack et al., 1994
[Level III]; Miescher & Fortney, 1989 [Level III]; Phillips et al.,
1984, 1991 [both Level III])
C. Risk Factors
1. Individuals older than 85 (Ciccone et al., 1998 [Level IV]; Lavisso-
Mourey et al., 1988 [Level IV]; Warren et al., 1994 [Level I]).
2. Individuals who are institutionalized (Mentes, 2006a [Level IV])
3. Individuals with ADL dependencies, specifically feeding and eat-
ing (Gaspar, 1999 [Level IV])
4. Individuals with a diagnosis of dementia (Albert et al., 1989, 1993
[both Level III])
5. Individuals with infections (Warren et al., 1994 [Level IV])
6. Individuals who have had prior episodes of dehydration (Mentes,
2006a [Level IV])
IV. PARAMETERS OF ASSESSMENT
(Mentes & The Iowa Veterans Affairs Nursing Research Consortium,
2004 [Level I])
A. Health history
1. Specific disease states: dementia, congestive heart failure, chr-
onic renal disease, malnutrition, and psychiatric disorders such
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as depression (Albert et al., 1989, 1993 [both Level III]; Warren
et al., 1994 [Level IV])
2. Presence of co-morbidities: more than four chronic health con-
ditions (Lavisso-Mourey et al., 1988 [Level IV])
3. Prescription drugs: number and types (Lavisso-Mourey et al.,
1988 [Level IV])
4. Past history of dehydration, repeated infections (Mentes, 2006a
[Level IV])
B. Physical Assessments (Mentes&The IowaVeteransAffairsNursing
Research Consortium, 2004 [Level I])
1. Vital signs
2. Height and weight
3. BMI
4. Review of systems
5. Indicators of hydration
C. Laboratory Tests
1. Urine specific gravity (Wakefield et al., 2002; Mentes et al., 2006
[both Level IV])
2. Urine color (Wakefield et al., 2002; Mentes et al., 2006 [both Level
IV])
3. BUN/creatinine ratio
4. Serum sodium
5. Serum osmolality
D. Individual fluid intake behaviors (Mentes, 2006a [Level IV])
V. NURSING CARE STRATEGIES
A. Risk Identification (Mentes & The Iowa Veterans Affairs Nursing
Research Consortium, 2004 [Level I]).
1. Identify acute situations: vomiting, diarrhea, or febrile episodes
2. Use a tool to evaluate risk: Dehydration Appraisal Checklist
B. Acute Hydration Management
1. Monitor input and output (Weinberg et al., 1994 [Level I]).
2. Provide additional fluids as tolerated (Weinberg et al., 1994 [Level
I]).
3. Minimize fasting times for diagnostic and surgical procedures
(American Society of Anesthesiology Task Force on Preoperative
Fasting, 1999 [Level I]).
C. Ongoing Hydration Management
1. Calculate a daily fluid goal (Mentes & The Iowa Veterans Affairs
Nursing Research Consortium, 2004 [Level I]).
2. Compare current intake to fluid goal (Mentes&The IowaVeterans
Affairs Nursing Research Consortium, 2004 [Level I]).
3. Provide fluids consistently throughout the day (Ferry, 2005 [Level
V]; Simmons et al., 2001 [Level II]).
4. Plan for at-risk individuals
a. Fluid rounds (Robinson & Rosher, 2002 [Level IV]).
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b. Provide two 8-oz. glasses of fluid, one in the morning and the
other in the evening (Robinson & Rosher, 2002 [Level IV])
c. “Happy Hours” to promote increased intake (Musson et al.,
1990 [Level V]).
d. “Tea time” to increase fluid intake (Mueller & Boisen, 1989
[Level V]).
e. Offer a variety of fluids throughout the day (Simmons et al.,
2001 [Level II]).
5. Fluid regulation and documentation
a. Teach able individuals to use a urine color chart to monitor
hydration status (Armstrong et al., 1994, 1998; Mentes et al.,
2006 [all Level IV]).
b. Document a complete intake recording including hydration
habits (Mentes & The Iowa Veterans Affairs Nursing Research
Consortium, 2004 [Level I]).
c. Know volumes of fluid containers to accurately calculate fluid
consumption (Burns, 1992 [Level IV]; Hart & Adamek, 1984
[Level III]).
d. d. Maintenance of body hydration (Mentes & Culp, 2003 [Level
III]; Robinson & Rosher, 2002 [Level IV]; Simmons et al., 2001
[Level II]).
VI. EVALUATION AND EXPECTED OUTCOMES
A. Decreased infections, especially urinary tract infections (Mc-
Connell, 1984; Mentes & Culp, 2003; [both Level III]; Robinson &
Rosher, 2002 [Level IV])
B. Improvement in urinary incontinence (Spangler et al., 1984 [Level
III])
C. Normal urinary pH (Hart & Adamek, 1984 [Level III])
D. Decreased constipation (Robinson & Rosher, 2002 [Level IV])
E. Decreased acute confusion (Mentes et al., 1999 [Level IV])
VII. FOLLOW-UP MONITORING OF CONDITION
A. Urine color chart monitoring in residents with better renal function
(Armstrong et al., 1994, 1998; Wakefield et al., 2002 [all Level IV]).
B. Urine specific-gravity checks (Armstrong et al., 1994, 1998; Wake-
field et al., 2002 [all Level IV]).
C. 24-hour intake recording (Metheny, 2000 [Level VI]).
VIII. RELEVANT PRACTICE GUIDELINES
A. Hydration-Management Evidence-Based Protocol available from
The University of Iowa College of Nursing Gerontological Nursing
Interventions Research Center Research Dissemination Core. Au-
thor: Janet Mentes, revised 2004. Access at www.nursing.uiowa.edu/
centers/gnirc/protocols.htm
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17Oral HealthCare
Linda J. O’Connor
Educational
Objectives
At the completion of this chapter, the reader will be
able to:
1. discuss the consequences of poor oral health
2. describe a thorough oral assessment in an older
adult
3. describe the oral hygiene plan of care for
nonintubated older adults
4. discuss nursing interventions for oral care
Background
Poor oral health is associated with malnutrition, dehydration, brain abscesses,
valvular heart disease, joint infections, cardiovascular disease, pneumonia, as-
piration pneumonia, and poor glycemic control in Type I and II diabetes (Abe,
Ishihara, & Okuda, 2001 [Level IV]; Coleman, 2002 [Level III]; Fowler, 2001
[Level V]; Imsand, Janssens, Auckenthaler, Mojon, & Budtz-Jorgensen, 2002
[Level V]; Mojon, 2002 [Level V]; Scannapieco, 1999 [Level V]; Taylor, Loesche,
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
Adapted from L. J. O’Connor & J. A. Ship (September 2005). Oral Health Care in Aging.
www.ConsultGeriRN.org
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& Terpenning, 2000 [Level IV]; Terpenning et al., 2001 [Level IV]; Yoneyama
et al., 2002 [Level II]). Oral health also affects nutritional status, ability to speak,
self-esteem, mental wellness, and overall well-being. Despite oral health being
essential to overall health status and quality of life, more than a quarter of older
adults have not seen a dental professional in the past 5 years (Ship, 2002 [Level
V]). Many oral diseases are not part of the natural aging process but rather side
effects of medical treatment and medications.
Plaque retention is a problem in elderly people who have difficulty in me-
chanically removing plaque due to diminished manual dexterity, impaired vi-
sion, or chronic illness (Simons, Brailsfords, Kidd, & Beighton, 2001 [Level IV];
Simons, Kidd, & Beighton, 1999 [Level III]). The functional ability and cogni-
tive status of older adults affect their ability to perform oral care and denture
care. Lack of good oral hygiene increases the risk for development of secondary
infections, extended hospital stays, and significant negative health outcomes.
Multiple medications produce side effects that affect the oral cavity. Cardiac
medications can cause salivary dysfunction, gingival enlargement, and lichenoid
mucosal reactions (Cianco, 2004 [Level V]; Ship, 2000 [Level V]). Steroid treat-
ment can predispose a patient to oral candidiasis, and cancer treatments can
cause a plethora of oral conditions such as stomatitis, salivary hypofunction, mi-
crobial infections, and xerostomia. Xerostomia is complaints of dry mouth and
objective evidence of salivary dysfunction; it is probably not the result of the ag-
ing process and therefore requires intervention and prevention. Its prevalence
in the elderly is 25% to 40+ %. Some causes are multiple medications, several
medical conditions, head and neck radiation, and chemotherapy.
Themouth reflects the culmination of multiple stressors over the years and,
as the mouth ages, it is less able to tolerate these stressors. With an increase in
chronic disease and medication usage as a person ages, the prevalence of root
caries, tooth loss, oral cancers, soft-tissue lesions, and periodontal problems
increases significantly (Al-Shammari, Al-Khabbaz, Al-Ansari, Neiva, & Wang,
2005; Shimazaki, Soh, Koga, Miyazaki, & Takehara, 2003 [both Level IV]). Many
of the oral health problems in the elderly could be avoided with routine pre-
ventive care. Many older adults believe in the myth that a decline in their oral
health is a normal part of aging.
Assessment
Physical Assessment
The promotion of oral health through assessment and good oral hygiene is an
essential of nursing care. The oral assessment is part of a nurse’s head-to-toe
assessment of an older adult and is done on admission and at the beginning
of each shift. Nurses assess the condition of the oral cavity (i.e., lips, oral mu-
cosa, and tongue); the presence of or absence of natural teeth and/or dentures;
the ability to function with or without natural teeth and/or dentures; and the
patient’s ability to speak, chew, and swallow. The oral cavity should be pink,
moist, and intact. Natural teeth should be intact and dentures (partial or full)
should fit comfortably and not be moving when the older adult is speaking.
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Any abnormal findings such as dryness, swelling, sores, ulcers, bleeding, white
patches, broken or decayed teeth, halitosis, ill-fitting dentures, difficulty swal-
lowing, signs of aspiration, and pain are documented by the nurse and the health
care team is informed. Poorly fitting dentures can cause ulcerations, candidiasis
(i.e., oral fungal infection), masses, and denture stomatitis. Denture stomatitis
presents as red, inflamed tissue beneath dentures, caused by fungal infections
and insufficient oral hygiene. Some oral mucosal diseases that nurses may see
are angular cheilitis (i.e., red and white cracked lesions in the corners of the
mouth, caused by inflammation and a fungal infection), cicatrical pemphigoid
(i.e., produces red, inflamed lesions on the gingival, palate, tongue, and cheek
tissues), lichen planus (i.e., most common form presents as a lacy white appear-
ance on the tongue and/or cheeks; a less common but more painful form pro-
duces red and white ulcerated lesions), and Pemphigus vulgaris (i.e., red, bleed-
ing tissues resulting from trauma but heal without scarring). Untreated lesions
can develop into large, infected regions that require immediate medical atten-
tion: recurrent aphthous stomatitis (canker sores; that is, well-circumscribed
lesions that develop under the tongue, inside the lips and cheeks, and most
commonly heal within 7 to 10 days). Dental professionals diagnose oral mucosal
diseases, but nurses need to be aware of any abnormal findings and report them
immediately.
Nurses also need to assess patients for their functional ability and manual
dexterity to provide oral hygiene. Nurses need to observe older adults providing
their oral hygiene to ensure that it is effective. The primary focus for nurses
is to maintain older adults’ function so that they may participate in their own
daily care. Once older adults provide their oral hygiene, nurses must follow-up
as appropriate to complete the oral hygiene.
Assessment Tools
The Oral Health Assessment Tool (OHAT) is an eight-category screening tool
that can be used with cognitively intact or impaired older adults. The OHAT
provides an organized, efficient method for nurses to document their oral as-
sessment. Theeight categories (i.e., lips, tongue, gumsand tissues, saliva, natural
teeth, dentures, oral cleanliness, and dental pain) are scored from 0 (healthy) to
2 (unhealthy). Total scores range from 0 to 16; the higher the score, the poorer
the older adult’s oral health (Chalmers, King, Spencer, Wright, & Carter, 2005
[Level III]). The OHATmay be implemented in any health care setting. (See the
Resources for access to this tool.)
Intervention and Care Strategies
The “gold standard” for providing oral hygiene is the toothbrush. Toothbrushes
should have soft nylon bristles (Fischman, 1997 [Level V]). It is the mechanical
action of the toothbrush that is important for plaque removal, and research has
shown that the manual toothbrush remains the primary method of maintaining
good oral hygiene. If older adults have any decrease in their function or man-
ual dexterity, the nursing staff needs to assess their ability to provide effective
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oral hygiene and provide assistance as needed. Foam swabs are available in nu-
merous facilities to provide oral hygiene. Research has shown that foam swabs
cannot remove plaque as well as toothbrushes (Pearson & Hutton, 2002 [Level
II]). Foam swabs may be used for cleaning the oral mucous of an edentulous
older adult.
Lemon glycerin swabs/swabsticks are drying to the oral mucosa and cause
erosion of the tooth enamel. Combined with decreased salivary flow and an
increased rate of xerostomia in older adults, use of potentates the corrosive ef-
fect of lemon-glycerin swabs (Meurman et al., 1996 [Level II]). Lemon glyc-
erin swabs/swabsticks are detrimental to the older adult and are never to
be used.
Commercial mouth rinses that contain alcohol are very trying to the oral
mucosa. If an older adult is using a commercial mouth rinse with alcohol, a half
commercial mouthwash/half water mixture is recommended. Toothpaste with
fluoride is currently recommended by the American Dental Association (ADA)
to reduce cavities and can also help reduce periodontal disease (Fischman, 1997
[Level V]).
The use of chlorhexidine in postoperative cardiac patients has been sup-
ported by scientific research for several years. It has also been shown to be
effective against gram-positive bugs associated with dental caries and against
fungal organisms, and it is currently recommended only for debilitated patients
at risk for oral fungal infections, dental decay, and gingivitis (J. A. Ship, personal
communication, February 26, 2007). The use of chlorhexidine in geriatric pa-
tients is determined by the dentist. There are some side effects of chlorhexidine
(i.e., bitter taste; change in the taste of food; mouth irritation; and staining of
teeth, mouth, fillings, and dentures) that may have negative outcomes for older
adults. A good oral assessment by nurses on each shift is essential for geriatric
patients on chlorhexidine and monitoring of their nutritional intake.
Education of the nursing staff is imperative. Two of the major barriers cited
by nursing staff are (1) inadequate knowledge of how to assess and provide care,
and (2) lack of appropriate supplies. Implementation of evidence-based proto-
cols combined with educational training sessions have been shown to have a
positive impact on oral care being provided and on the oral health status of
older adults (Chalmers & Pearson, 2005 [Level III]; Coleman & Watson, 2006
[Level IV]; Fitch, Munro, Glass, & Pelligrini, 1999 [Level V]; Frenkel, Harvey, &
Newcombe, 2001 [Level II]; Isaksson, Paulsson, Fridlund, & Nederferos, 2000
[Level III]; Nicol et al., 2005 [Level V]; Stiefel, Damron, Sowers, & Velez, 2000
[Level V]). Staff needs to be instructed on oral hygiene and the proper care
of different appliances. Dentures should be brushed before placing them in a
denture cup. Dentures should be removed at night; however, some elders prefer
to keep their dentures in continuously. It therefore becomes even more im-
portant for nurses to perform an assessment of the oral mucosa. In the acute
care and long term care settings, older adults may not have dental adhesive
and, therefore, there is a high risk for food particles to get caught underneath
their dentures. It is important for staff to remember to take the dentures out
after each meal, rinse them and the patient’s mouth, and place the dentures
back in. Complete denture care should be given morning and night and as
needed.
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Patients on gastrostomy tubes require more frequent mouth care. Although
no research studies were found specifically related to oral hygiene/oral health
and patients with gastrostomy tubes, anecdotally it has been reported that pa-
tients with gastrostomy tubes tend to have an increased buildup of mucus that
forms on the tongue. This causes a coating on the tongue that, if not frequently
cleared off, can build up and lead to poor oral health and even respiratory dis-
tress. Therefore, it is recommended that more frequent mouth care be given to
patients with gastrostomy tubes. There is no research focused on the frequency
at which the care should be done; however, anecdotally, it is been found that
providing oral hygiene to these patients a minimum of every 4 hours or twice in
an 8-hour shift appears to prevent this buildup of mucus on the tongue.
Education of nursing staff, older adults, and families is imperative. Nurses
need to be educated in oral assessment and nursing assistants need to be edu-
cated in observation of the oral cavity and what to report to nurses. Both nurses
and nursing assistants need to be educated in the proper techniques for pro-
viding oral hygiene and caring for oral appliances. Patients and families need
to be educated in the importance of good oral health and hygiene dispel the
oral-health myths that exist about oral health and aging in general.
Education focused on the importance of good oral health and hygiene in
older adults, the myths about oral health and aging, evidence-based practice
protocols, implementing these protocols, and the appropriate products for pro-
viding oral hygiene to patients and residentsmust be provided to administrators.
Without the proper supplies, it is impossible for nursing staff to provide the oral
hygiene care that older adults need and to properly implement evidence-based
protocols for oral health and hygiene.
Case Study and Discussion
Mrs. Smith, an 84-year-old femalewith a history of Alzheimer’s type demen-
tia, was admitted for recent decreased oral intake and percutaneous endo-
scopic gastrostomy (PEG) placement (a feeding tube placed into the stom-
ach through the abdominal wall). Mrs. Smith was alert and oriented to her-
self, pleasant, cooperative with care, and able to follow simple directions.
She lived at home with her family and received care from a home health
aide. The initial oral assessment, done on day 2 of admission, found up-
per dentures and lower natural teeth, both covered with food particles. The
oral mucosa was noted to be dry. The upper dentures were difficult to re-
move and caused pain to Mrs. Smith. The upper denture was being “kept
in place” by a collection of old food that was found upon removal. The oral
mucosa under the upper denture was covered with sores and ulcers and
was bleeding, infected, and very painful. The health team was notified, a
dental consultation was called, and an oral hygiene plan of care was im-
plemented. Mrs. Smith’s diet was changed to pureed foods while her oral
mucosa was healing and the PEG placement was put on hold. Upon inquiry,
it was learned from the family that their long-time aide hadmoved away and
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the new aide had been with them only a few months. It was during this time
that they noticed the decline in Mrs. Smith’s nutritional intake. The family
chose to hire a new aide, and both the family and the new aidewere educated
on proper oral hygiene for Mrs. Smith. Once Mrs. Smith’s oral mucosa had
healed, the upper denture was replaced and she was returned to her regular
diet. Mrs. Smith’s oral intake returned to baseline and a PEG was no longer
required.
This case study illustrates how poor oral care often goes undetected, the
importance of good oral care, the need for physical assessment by nurses,
and the need for staff and family education. This patient was being admitted
for an invasive procedure secondary to poor oral health caused by poor oral
care. Although the family was involved in Mrs. Smith’s care (she had no
contractures or skin breakdown), her lack of oral care had gone unnoticed by
them. The admitting nurse documented that the patient had dentures on the
admission form but did not do a physical oral assessment. The nurse caring
for the patient on day 2 had attended an oral health seminar and included
the physical oral assessment in her morning rounds. She also followed up
with the nursing assistants to ensure that oral care had been provided to the
patient after each meal. The implementation of an oral hygiene plan of care
and the education of nursing staff, family, and home care staff ensured that
Mrs. Smith received the oral care required for her oral mucosa to heal and
her nutritional status to return to baseline, and prevented the unnecessary
placement of a PEG.
Summary
As previously stated, many of the oral-health problems in the elderly could
be avoided with routine preventive care, but many older adults believe in the
myth that a decline in their oral health is a normal part of aging (Andersson,
Hallberg, & Renvert, 2003 [Level IV]; Meurman & Hamalainen, 2006 [Level
V]; Peltola, Vehkalahti, & Wuolijoka-Saaristo, 2004 [Level IV]; Reed, Broder,
Jenkins, Spivack, & Janal, 2006 [Level IV]). To dispel this myth and improve
the oral health of older adults, it is imperative that health care professionals
provide continuing education to patients and families, advocate for oral health
prevention, and provide oral care to older adults in all settings. Well-developed,
evidence-based oral-care protocols and educational training sessions have been
shown to have a positive impact on the oral-health status of older patients
(Fitch et al., 1999 [Level V]; Isakasson et al., 2000 [Level III]; Stiefel et al., 2000
[Level V], see Box 17.1).
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Resources
Assessment Tools
Chalmers, J. M., King, P. L., Spencer, A. J., Wright, F. A. C., & Carter, K. D. (2005).
The oral health assessment tool: validity and reliability. Australian Dental
Journal, 50(3), 191–199. Evidence Level III.
Evidence-Based Protocols
Oral Health Care in Aging www.ConsultGeriRN.org
Johnson, V., Chalmers, J., & Titler, M. (2002). Evidence-based protocol: Oral hy-
giene for functionally dependent and cognitively impaired older adults. Iowa:
University of Iowa Gerontological Nursing Interventions Research Center.
www.nursing.uiowa.edu/centers/gnirc/protocols.htm
Related Professional Organizations
Academy of General Dentistry www.agd.org
American Dental Association www.ada.org
American Geriatrics Society www.americangeriatrics.org
The University of Iowa Gerontological Nursing Interventions Research Center
www.nursing.uiowa.edu/centers/gnirc/disseminatecore.htm
Government Information Agencies
National Institutes on Aging www.niapiblications.org
National Oral Health Information Clearinghouse www.health.gov/NHICscripts/
entry.cfm?HRCode=HR2457
National Institute of Dental and Craniofacial Research www.nidcr.nih.gov
NationalCenter forChronicDiseasePrevention andHealthPromotionwww.cdc.
gov/nccdphp/bb oralhealth/index.htm
Centers for Disease Control www.cdc.gov/oralhealth/index.htm
Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov/browse/
dental.htm
Regulatory/Authoritative Sites
National Institute of Dental and Craniofacial Research www.nidcr.nih.gov
American Dental Association www.ada.org
The University of Iowa Gerontological Nursing Interventions Research Center
www.nursing.uiowa.edu/centers/gnirc/disseminatecore.htm
Oral Health in America: A Report of the Surgeon General www2.nidcr.nih.gov/
sgr/sgrohweb/home.htm
Continuing Education Opportunities
CE284bLet’s talk teeth:Dental health in older adultswww.nursingspectrum.com
www.ConsultGeriRN.org
Patient and Family Resources
American Dental Association www.ada.org
National Institute of Dental and Craniofacial Research www.nidcr.nih.gov
U.S. National Library of Medicine/National Institutes of Health www.nlm.nih.
gov/medlineplus/dentalhealth.html
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Box 17.1
Nursing Standard of Practice Protocol: Providing Oral
Health Care to Older Adults
This standard of care protocol is based on evidence in multicomponent
oral health care studies (Chalmers & Pearson, 2005 [Level IV]); Coleman
&Watson, 2006 [Level IV]; Fitch,Munro, Glass, & Pelligrini, 1999 [Level V];
Frenkel, Harvey, & Newcombe, 2001 [Level II]; Isaksson, Paulsson, Frid-
lund, & Nederferos, 2001 [Level III]; Nicol et al., 2005 [Level V]; Stiefel,
Damron, Sowers, & Velez, 2000 [Level V]).
I. OVERVIEW
The promotion of oral health through good oral hygiene is an essen-
tial of nursing care. The RN or designee provides regular oral care for
functionally dependent and cognitively impaired older adults.
II. BACKGROUND
(Coleman, 2002 [Level III]; Taylor, Loesche, & Terpenning, 2000 [Level
IV]; Imsand, Janssens, Auckenthaler, Mojon, & Budtz-Jorgensen, 2002
[LevelV]; Terpenning et al., 2001 [Level IV]; Yoneyamaet al., 2002 [Level
II]; Abe, Ishara, & Okuda, 2001 [Level IV]; Mojon, 2002 [Level V]; Scan-
napieco, 1999 [Level V]; Fowler, 2001 [Level V])
A. Oral hygiene is directly linked with systemic infections, cardiac dis-
ease, CVA, acute MI, glucose control in diabetes, nutritional intake,
comfort, ability to speak, and a patient’s self-esteemand overall well-
being.
B. Statistics (Ship, 2004, 2005; Ship&Ghezzi, 2005; Ship, Phelan,&Kerr,
2003)
1. More than one-half of the elderly dentate population has new or
recurrent dental caries.
2. More than two-thirds of the older dentate populationhas evidence
of gingivitis.
3. More than three-quarters of the older dentate population has ex-
perienced some form of periodontal attachment loss.
C. Definitions
1. Oral: refers to the mouth (natural teeth, gingival and supporting
tissues, hard and soft palate, mucosal lining of the mouth and
throat, tongue, salivary glands, chewingmuscles, upper and lower
jaw, lips)
2. Oral cavity: includes cheeks, hard and soft palate
3. Oral hygiene: the prevention of plaque-related disease, the de-
struction of plaque through the mechanical action of toothbrush-
ing and flossing or use of other oral hygiene aides
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4. Edentulous: natural teeth removed
III. PATIENT ASSESSMENT
(Chalmers, King, Spencer, Wright, & Carter, 2005 [Level III])
A. An RN conducts an oral assessment/evaluation on admission and
every shift.
1. A nurse assesses the condition of:
2. The oral cavity (lips, oral mucosa, and tongue): The oral cavity
should be pink, moist, and intact.
3. The presence or absence of natural teeth and/or dentures: Natu-
ral teeth should be intact and dentures (partial or full) should fit
comfortably and not be moving when the older adult is speaking.
4. Ability to function with or without natural teeth and/or dentures.
5. The patient’s ability to speak, chew, and swallow.
6. Any abnormal findings, such as dryness, swelling, sores, ulcers,
bleeding, white patches, broken or decayed teeth, halitosis, ill-
fitting dentures, difficulty swallowing, signs of aspiration, and
pain are documented by the nurse and the health care team is
informed.
B. Assessment Tool: The Oral Health Assessment Tool (OHAT). See
the Resources for information about this tool.
IV. NURSING CARE STRATEGIES
(Fischman, 1997 [Level V]; Meurman et al., 1996 [Level II]; Pearson &
Hutton, 2002 [Level II])
A. Oral Hygiene Plan of Care: Dependent Mouth Care of the Edentu-
lous Patient
1. Oral care is providedduringmorning care, evening care, andPRN.
2. Wash hands and don gloves.
3. Remove dentures by pulling the lower plate down and lift forward
and out. Pull the upper plate up and forward to dislodge and
remove it. Place dentures in emesis basin and proceed to the
sink.
4. Brush dentures with toothbrush/toothpaste using up and down
motion.
5. Clean the grooved area, which fits against the gumwith the tooth-
brush. Rinse with cool water.
6. Brush the patient’s tongue.
7. Reinsert dentures.
8. Apply lip moisturizer.
B. Dependent Mouth Care: Patient with Teeth or Partial Dentures
1. Oral care is providedduringmorning care, evening care, andPRN.
2. Wash hands and don gloves.
3. Place soft toothbrush at an angle against the gum line. Gently
brush teeth in an up and down motion with short strokes using
the toothbrush.
4. Brush the patient’s tongue.
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5. Apply lip moisturizer.
For partial dentures, follow procedure for full denture cleaning and
insertion.
C. Assisted/Supervised Care
1. Oral care is providedduringmorning care, evening care, andPRN.
2. Assess what a patient can do and provide assistance as needed.
3. Set up necessary items.
V. EVALUATION OF EXPECTED OUTCOMES
A. Patient
1. Will receive oral hygiene a minimum of once every 8 hours while
in the acute care, long term care, or home setting.
2. With gastrostomy tubes and is not unresponsive, will receive
mouth care a minimum of every 4 hours while awake.
3. With gastrostomy tubes and is unresponsive, will receive mouth
care a minimum of every 4 hours.
4. Patients and families will be referred to dental services for follow-
up treatment.
5. Patients and families will be educated on the importance of good
oral hygiene and follow-up dental services.
B. Professional Caregiver/RN will:
1. Conduct an assessment/evaluation of the oral cavity on admission
and every shift.
2. Notify the physician and dentist of any abnormalities present in
the oral cavity.
3. Assess what each a patient can do independently.
4. Observe aspiration precautions while providing care.
5. Provide oral care and dental care education to patients and fami-
lies.
C. Institution
1. Will provide access to dental services as appropriate.
2. Will provide ongoing education to health care providers.
3. Will provide a yearly oral health and dental care in-service to
health care providers.
VI. OTHER CLINICAL GUIDELINES
A. Oral Health Care in Aging www.ConsultGeriRN.org
B. Johnson, V., Chalmers, J., & Titler, M. (2002). Evidence-based proto-
col: Oral hygiene for functionally dependent and cognitively impaired
older adults. Iowa: University of Iowa Gerontological Nursing Inter-
ventions Research Center. www.nursing.uiowa.edu/centers/gnirc/
protocols.htm
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Preventing
Pressure Ulcers
and Skin Tears
Elizabeth A. Ayello
R. Gary Sibbald
Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. complete a pressure ulcer risk assessment
2. assess risk factors associated with pressure ulcer
development
3. interpret the meaning of an individual’s risk
assessment score
4. develop a comprehensive, holistic plan to prevent
pressure ulcers in individuals at risk
5. identify elders at risk for skin tears
6. classify skin tears and develop a plan to prevent
and treat skin tears
The skin is the largest external organ so preserving its integrity is an important
aspect of nursing care. Florence Nightingale (1859) identified a link between
skin injury (specifically, pressure ulcers) and nursing. Performing a risk assess-
ment and implementing a consistent prevention protocol may prevent some
types of skin injuries, including pressure ulcers or skin tears. Although pressure
ulcers and skin tearsmay look similar, they are different types of skin injury: skin
tears are acute traumatic wounds whereas pressure ulcers are chronic wounds.
It is important, therefore, to assess the wound and to determine the correct
etiology so that the proper individualized treatment plan can be implemented.
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
403
404 Chapter 18
Pressure Ulcers
Pressure ulcers are a significant health care problem worldwide. In February
2007, the National Pressure Ulcer Advisory Panel (NPUAP) revised the clas-
sic 1989 pressure ulcer definition (NPUAP, 1989) to be as follows: “A pressure
ulcer is a localized injury to the skin and/or underlying tissue usually over a
bony prominence, as a result of pressure, or pressure in combination with shear
and/or friction. A number of contributing or confounding factors are also associ-
ated with pressure ulcers; the significance of these factors is yet to be elucidated
(Black et al., 2007 [Level IV]; NPUAP, 2007 [Level IV]). Most pressure ulcers are
found on the sacrum, with heels being the secondmost common site (Cuddigan,
Ayello, & Sussman, 2001 [Level I]). In hospice patients, in addition to sacrum
and heels, elbows were a common site for ulcers; most ulcers occurred within
2 weeks of death (Hanson et al., 1991 [Level IV]). Following an extensive re-
view of the data, the NPUAP concluded that the prevalence of pressure ulcers
in acute care in the United States ranged from 10% to 18%, with the best current
estimate of prevalence being 15% (Cuddigan et al., 2001 [Level I]). The pres-
sure ulcer prevalence in long term care ranged from 2.3% to 28%, whereas in
home care it was 0% to 29% (Cuddigan et al., 2001 [Level I]). Incidence, or the
number of new cases that develop in the particular agency during a specified
period, ranged from 0.4% to 38% in acute care, with 7% being the best average
(Cuddigan et al., 2001 [Level I]). A study of 20 hospitals of patients waiting for
surgery determined a higher incidence of pressure ulcers for longer surgery
waiting times or time in an intensive care unit (Baumgarten et al., 2003 [Level
IV]). The less time patients waited to go to the operating room (OR) for repair of
hip fracture resulted in fewer pressure ulcers (Hommel, Ulander, & Thorngren,
2003 [Level IV]). Length of time on the OR table also increased risk for pressure
ulcers in hip-fracture patients (Houwing et al., 2004 [Level IV]). In one study
of 84 surgical patients, most pressure ulcers occurred within the first 3 days
post-op (Karadag & Gumuskaya, 2006 [Level IV]).
In long term care (LTC), the incidence ranged from 2.2% to 23.9%, whereas
in home care it ranged from 0% to 17% (Cuddigan et al., 2001 [Level I]). In a
retrospective study of more than 2,400 residents in LTC, pressure ulcers were
more likely to develop in residents whowere female, older, cognitively impaired,
and immobile (Horn et al., 2002 [Level III]). Conversely, Horn& colleagues (2004
[Level III]) found that residents with nutritional intervention, antidepressant
use, use of disposable briefs for more than 14 days, care by registered nurse of
at least 0.25 hour per day (or at least 2 hours per day by a nurse’s aide), or in
facilities with an LPN turnover rate of less than 25% were less likely to develop
pressure ulcers. A lower incidence of admission with a pressure ulcer to LTC
was associated with White individuals; a higher incidence was associated with
being chair or bed-bound, underweight, or in the presence of fecal incontinence
(Baumgarten et al., 2003 [Level IV]).
Pressure ulcers are associated with complications including cellulitis, os-
teomyelitis, sepsis, increased length of stay, and financial and emotional costs
(Agency for Health Care Policy and Research [AHCPR], now Agency for
Healthcare Research and Quality [AHRQ], 1992 [Level I]). The Wound, Os-
tomy and Continence Nurses Society [WOCN] has since updated the guide-
line (2003 [Level I]) after a review of the literature. These ulcers occur from a
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combination of intensity and duration of pressure, as well as from tissue tol-
erance (Bergstrom, Braden, Laguzza, & Holman, 1987 [Level III]; Braden &
Bergstrom, 1987 [Level II]; Braden & Bergstrom, 1989 [Level III]). Immobility as
seen in bed- or chair-bound patients and those unable to change positions, un-
dernourishment or malnutrition, incontinence, friable skin, impaired cognitive
ability, and decreased ability to respond to one’s environment are some of the
important identified risk factors for pressure ulcers (Braden, 1998). Berlowitz
and colleagues (2001 [Level IV]) found 17 characteristics of residents in LTC that
were associated with pressure ulcer development, including dependence inmo-
bility and transferring, diabetesmellitus, urinary incontinence, lower bodymass
index (BMI), and end-stage disease. No one single factor puts a patient at risk
for pressure ulcer skin breakdown. A home care study identified increased risk
of pressure ulcer development with being in bed with limited activity, depen-
dence for putting on clothes, assistance for transfers, and urinary incontinence
as predictors of stage 1 pressure ulcer occurrence (Bergquist, 2003 [Level IV]).
For stage 2 or higher levels, there were other predictors, including oxygen use
and the presence of a bone fracture.
Recent regulatory and government initiatives continuously support the im-
portance of pressureulcer prevention.Anobjective inHealthyPeople 2010man-
dates the reduction of pressure ulcer incidence rates (Health Care Financing
Administration [HCFA], 2000). The Centers for Medicare and Medicaid Ser-
vices (CMS) released revised guidance for surveyors for Federal Regulation Tag
F-314 regarding prevention of pressure ulcers in LTC in 2004. The federal reg-
ulation to prevent pressure ulcers from occurring or from existing ulcers be-
coming worse did not change, but the interpretation for surveyors did change.
A 40-page document is provided for surveyors, but its content is based on a
comprehensive review of the literature (CMS, 2004 [Level V]) and it does pro-
vide recommendations and direction for clinicians to prevent and treat pressure
ulcers. Data from the Healthcare Cost and Utilization Project (HCUP) statisti-
cal review reveals that during the period 1993–2003, pressure ulcers increased
in hospitalized patients by 63% even though the number of hospitalizations
only increased by 11% (Russo & Elixhauser, 2006 [Level IV]). In the state of
New Jersey, stage 3 or 4 pressure ulcers are now reportable in acute care (New
Jersey Department of Health and Senior Services, 2004). Pressure ulcers are
one of the 12 targeted areas to reduce harm to hospitalized patients in the
United States as part of the Institute for Healthcare Improvement “5 Million
Lives Saved Campaign” launched in December 2006 (Institute for Healthcare
Improvement [IHI], 2006 [Level V]). Thus, at the beginning of the 21st century,
appropriate risk assessment and preventative care take on even more impor-
tant meaning. Nurses will find the NPUAP competencies for registered nurses
on pressure ulcer prevention helpful in guiding their professional practice
(Table 18.1).
Risk Assessment
When to Do an Assessment
Assessing relative risk is the first step of any individual patient or health
care system plan for pressure ulcer prevention. Some pressure ulcer clinical
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18.1 National Pressure Ulcer Advisory Panel
Purpose:
To prepare registered nurses with the minimum competencies for pressure ulcer
prevention.
Competencies:
1 Identify etiologic factors contributing to pressure ulcer occurrence.
2 Identify risk factors for pressure ulcer development.
3 Recognize the presence of factors affecting tissue tolerance.
4 Conduct risk assessment using a valid and reliable tool.
5 Conduct a thorough skin assessment considering the individual’s uniqueness.
6 Develop and implement an individualized program of skin care.
7 Demonstrate proper positioning to decrease pressure ulcer occurrence.
8 Select and use support surfaces as indicated by risk status.
9 Use nutritional interventions as appropriate to prevent incident pressure ulcers.
10 Accurately document results of risk assessment, skin assessment, and prevention
strategies.
11 Apply critical-thinking skills to clinical decision making regarding the impact of changes
in the individual’s condition on pressure ulcer risk.
12 Make referrals to other health care professionals based on client assessment.
c©Copyright 2001: National Pressure Ulcer Advisory Panel, used with permission.
Source: National Pressure Ulcer Advisory Panel. (2001). Pressure ulcer prevention: A competency-based
curriculum. Retrieved April 21, 2007, from www.npuap.org/prevwrr.pdf
guidelines recommend that patients be assessed for pressure ulcer develop-
ment on admission to a facility, on discharge, whenever the patient’s condition
changes, and then reassessed periodically (AHCPR, 1992; WOCN, 2003 [both
Level I]). Although some clinicians have suggested reassessment intervals of
every 48 hours in acute care (Ayello & Braden, 2001, 2002 [both Level V]), the
IHI recommends daily pressure ulcer risk assessment (IHI, 2006 [Level V]). In
LTC, research has shown that most pressure ulcers occur soon after admission
(Bergstrom & Braden, 1992 [Level III]); as a result, it is recommended that LTC
patients be reassessed weekly for the first 4 weeks, then at least monthly to
quarterly or whenever the patient’s condition changes. The best interval to do
pressure ulcer risk assessment in home care has yet to be determined. In home
care, reassessment for pressure ulcer risk may occur as often as at each nursing
visit (Ayello & Braden, 2001, 2002 [both Level V]). Bergquist and Frantz (2001
[Level IV]) found that in 1,711 home care patients, risk assessment should be
done on admission, weekly for the first 4 weeks, and then every other week. Re-
search by Bergstrom and Braden (1992 [Level III]) found no difference in risk
assessment scores performed at different times of day in the acute-care and
LTC setting. Risk assessment can be done on either the day or evening shift,
depending on which works best for the facility.
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Pressure Ulcer Risk Assessment Tools
The AHRQ Panel Guidelines (AHCPR, 1992 [Level V]) recommend that an as-
sessment for pressure ulcer risk be done using a valid and reliable assessment
tool. Although there are several risk assessment scales available, research sup-
ports only the reliability and validity of the Braden (Pancorbo-Hidalgo, Garcia-
Fernandez, Lopez-Medina, & Alvarez-Nieto, 2006 [Level I]) and Norton Scales
(Norton, McLaren, & Exton-Smith, 1962); therefore, they are the only scales
mentioned in the 1992 AHRQ prevention guidelines. A recent study of 429 pa-
tients in acute care found the modified Braden scale to be a better predictor
than the Norton Scale (Kwong et al., 2005 [Level IV]). Although there are some
concerns about methodology, one study found the Gosnell Scale to have bet-
ter predictive validity than the Braden, Norton, and Waterlow to which it was
compared (Jalali & Rezaie, 2005 [Level IV]).
The Braden Scale was created in 1987 as part of a research study (Bergstrom
et al., 1987 [Level III]) and is the most widely used in the United States. Each
of its six factors assesses the etiologic factors in pressure ulcer development.
Sensory perception, mobility, and activity address clinical situations that pre-
dispose the patient to intense and prolonged pressure. Moisture, nutrition, and
friction/shear address factors that alter tissue tolerance for pressure. Each of
the six categories is ranked with a numerical score, with 1 representing the low-
est possible subscore with the greatest risk. The sum of the six subscores is the
final Braden score, which can range from 6 to 23. Braden Scale scores are as
follows: 1 = highly impaired, 3–4 = moderate to low impairment, total points
possible = 23, risk-predicting score = 16 or less.
A low Braden Scale score indicates that a patient is at risk for pressure
ulcers. The increased risk score for the development of a pressure sore on the
Braden Scale was originally determined to be 16 (Bergstrom et al., 1987 [Level
III]). Further research in older adults (Bergstrom & Braden, 1992 [Level III])
and in people with darkly pigmented skin (Lyder et al., 1998, 1999 [both Level
IV]) indicates that a risk score of 18 should be used in patients from these
populations. The prevention protocols should be initiated for patients whose
BradenScale score is at or below the risk score. Bergquist (2001 [Level IV]) found
that whereas the Braden Scale subscores of friction/shear, limited mobility, and
moisture were most predictive of pressure ulcer occurrence in 1,684 home care
patients, the summative score was most strongly related to the development
of pressure ulcers. Interesting research by Chan, Tan, Lee, & Lee (2005 [Level
IV]) also found that the total Braden Score was the only significant predictor of
pressure ulcers in hospitalized patients.
However, in direct contrast, it is not just about the total score as far as regu-
latory agencies are concerned. CMS recommends that prevention protocols be
implemented for low scores in any of the subscales in the Braden Scale (CMS,
2004 [Level V]). The use of prevention protocols has shown a 60% drop in pres-
sure ulcer incidence as well as a decrease in severity of ulcers and cost of care
(Braden & Bergstrom, 1989 [Level III]). Unfortunately, in another study, the use
of an AHRQ prevention protocol demonstrated that the decrease in pressure
ulcer incidence and the increase in length of time before a pressure ulcer devel-
oped was not sustained over time (Xakellis, Frantz, Lewis, &Harvey, 2001 [Level
IV]). Frantz and Baranoski (2001 [Level V]) summarized studies from 1990–2000
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assessing the effectiveness of pressure ulcer prevention in various settings. The
prevention programs included risk assessment, pressure-reduction interven-
tions, and staff education. Pressure ulcer incidence declined in all studies re-
gardless of setting. A decrease in incidence in the four LTC studies ranged from
3.5% to 24%, which was more variable than the range in the five acute-care
studies of 11% to 16%. A process for implementing prevention guidelines using
a systems approach was suggested by Bryant and Rolstead (2001 [Level V]). Au-
rigemma (2005 [Level III]) found a lower incidence of pressure ulcers (3%) for
hospitalized LTC residents who participated in a monitored order system and
prevention program as compared to 34% in those who did not participate in the
program.
Does Race Make a Difference?
When it comes to severity of pressure ulcers, racemaymake a difference. Ayello
and Lyder (2001 [Level V]) analyzed and summarized the existing data about
pressure ulcers across the skin-pigmentation spectrum. Lyder (1991, 1996 [both
Level IV]) pioneered research about incidence rates and stage I pressure ulcers
in Blacks and Latinos. One study by Bergstrom and Braden (2002 [Level IV])
found no difference in risk between Blacks and Whites in a multisite study of
the predictive validity of the Braden Scale in nursing homes. Blacks have the
lowest incidence (19%) of superficial tissue damage classified as stage I pres-
sure ulcers, and Whites have the highest at 46% (Barczak, Barnett, Childs, &
Bosley, 1997 [Level IV]). The more severe tissue injury seen in stages II–IV
pressure ulcers is higher in persons with darkly pigmented skin (Barczak et al.,
1997; Meehan, 1990, 1994 [all Level IV]). Three national surveys showed that
Blacks had 39% (Barczak et al., 1997 [Level IV]), 16% (Meehan, 1990 [Level
IV]); and 41% (Meehan, 1994 [Level IV]) higher incidence of stage II pres-
sure ulcers. Subsequent studies by Lyder and colleagues (1998, 1999 [both
Level IV]) continue to support a higher incidence of pressure ulcers in per-
sons with darkly pigmented skin. Baumgarten et al. (2004 [Level IV]) found a
significantly high incidence of pressure ulcers for Black residents compared to
White residents in nursing homes. Therefore, early identification of stage I pres-
sure ulcers in this population is critical to identify early damage prior to skin
breakdown.
The clinician assessment of Black skin may lack the sensitivity and speci-
ficity by clinicians assessing patients with darkly pigmented skin and may con-
tribute to the increased severity and incidence of higher stage pressure ulcers
(Barczak et al., 1997; Henderson et al., 1997; Lyder et al., 1998, 1999 [all Level
IV]). Inadequate detection of stage I pressure ulcers in persons with darkly pig-
mented skin may be because clinicians erroneously believe that dark skin tol-
erates pressure better than light skin (Bergstrom, Braden, Kemp, Champagne,
& Ruby, 1996) or that only color changes (see Table 18.2 on NPUAP stage I def-
initions) indicate an ulcer (Barczak et al., 1997 [Level IV]; Bennett, 1995 [Level
V]; Henderson et al., 1997 [Level IV]; Lyder, 1996 [Level IV]; Lyder et al., 1998,
1999 [both Level IV]). Bennett (1995, p. 35 [Level V]) defined darkly pigmented
skin as “the obvious color of intact dark skin which remains unchanged when
pressure is applied over a bony prominence.” In 1998, the NPUAP approved a
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18.2 2007 NPUAP Pressure Ulcer StagingSystem
Pressure Ulcer Definition
A pressure ulcer is a localized injury to the skin and/or underlying tissue usually over a
bony prominence, as a result of pressure, or pressure in combination with shear and/or
friction. A number of contributing or confounding factors are also associated with
pressure ulcers; the significance of these factors is yet to be elucidated.
Pressure Ulcer Stages
Suspected deep-tissue injury
Purple or maroon localized areas of discolored intact skin or a blood-filled blister due to
damage of underlying soft tissue from pressure and/or shear. The area may be preceded
by tissue that is painful, firm, mushy, boggy, warmer, or cooler as compared to adjacent
tissue.
Further description
Deep-tissue injury may be difficult to detect in individuals with dark skin tones. Evolution
may include a thin blister over a dark wound bed. The wound may further evolve and
become covered by thin eschar. Evolution may be rapid, exposing additional layers of
tissue even with optimal treatment.
Stage I:
Intact skin with non-blanchable redness of a localized area usually over a bony
prominence. Darkly pigmented skin may not have visible blanching: its color may differ
from the surrounding area.
Further description:
The area may be painful, firm, soft, warmer, or cooler as compared to adjacent tissue.
Stage I may be difficult to detect in individuals with dark skin tones. May indicate “at risk”
persons (a heralding sign of risk)
Stage II:
Partial thickness loss of dermis presenting as a shallow open ulcer with a red-pink wound
bed, without slough. May also present as an intact or open/ruptured serum-filled blister.
Further description:
Presents as a shiny or dry shallow ulcer without slough or bruising.* This stage should not
be used to describe skin tears, tape burns, perineal dermatitis, maceration, or excoriation.
*Bruising indicated suspected deep-tissue injury.
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18.2 2007 NPUAP Pressure Ulcer StagingSystem
Stage III:
Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, or muscle is
not exposed. Slough may be present but does not obscure the depth of tissue loss. May
include undermining and tunneling.
Further description:
The depth of a stage III pressure ulcer varies by anatomical location. The bridge of the
nose, ear, occiput, and malleolus do not have subcutaneous tissue and stage III ulcers can
be shallow. In contrast, areas of significant adiposity can develop extremely deep stage III
pressure ulcers. Bone/tendon is not visible or directly palpable.
Stage IV:
Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be
present on some parts of the wound bed. Often include undermining and tunneling.
Further description:
The depth of a stage IV pressure ulcer varies by anatomical location. The bridge of the
nose, ear, occiput, and malleolus do not have subcutaneous tissue and these ulcers can
be shallow. Stage IV ulcers can extend into muscle and/or supporting structures (e.g.,
fascia, tendon, or joint capsule) making osteomyelitis possible. Exposed bone/tendon is
visible or directly palpable.
Unstageable:
Full thickness tissue loss in which the base of the ulcer is covered by slough (yellow, tan,
gray, green, or brown) and/or eschar (tan, brown, or black) in the wound bed.
Further description:
Until enough slough and/or eschar is removed to expose the base of the wound, the true
depth and, therefore, stage cannot be determined. Stable (dry, adherent, intact without
erythema or fluctuance) eschar on the heels serves as “the body’s natural (biological)
cover” and should not be removed.
See NPUAP Web site www.npuap.org; Black et al., 2007
c©Copyright 2007: National Pressure Ulcer Advisory Panel, used with permission.
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revised definition of a stage I pressure ulcer to include assessment variables
other than color—specifically, skin temperature, skin consistency, and sensation
(NPUAP, 1998 [Level V]).
Research has begun to validate these assessment characteristics in the stage
I definition. Lyder and colleagues (2001 [Level III]) reported a higher diagnostic
accuracy rate of 78% using the revised definition compared with 58% using the
original definition. Sprigle, Linden, McKenna, Davis, and Riordan (2001 [Level
IV]) found changes in skin temperature, in particular, that warmth, then cool-
ness, accompanied most stage I pressure ulcers.
Clinicians should pay careful attention to a variety of factors when assessing
a client with darkly pigmented skin for stage I pressure ulcers. Differences in
skin over bony prominences (e.g., the sacrum and the heels) as compared with
surrounding skin may be indicators of a stage I pressure ulcer. The skin should
be assessed for alterations in pain or local sensation. Also, a change of skin color
should be noted by being familiar with the range of skin pigmentation that is
normal for a particular patient (Bennett, 1995 [Level V]; Henderson et al., 1997
[Level IV]). The correct lighting source is important to accurately perform the
skin assessment; where possible, natural or halogen light should be used when
performing the assessment (Bennett, 1995 [Level V]). Fluorescent light should
be avoided because it casts a bluish hue to the skin (Bennett, 1995 [Level V]).
Clinicians may find the application of the limited studies and expert opinion
helpful in the early detection of skin injury as seen in stage I pressure ulcer
clients across the skin- pigment continuum.
Interventions Aimed at Prevention
Determining a patient’s risk for developing a pressure ulcer is only the first step
in providing best practice care.Once risk is identified, implementing a consistent
protocol to prevent the development of a pressure ulcer is essential. A nursing
standard of practice protocol for pressure ulcer prevention is presented to fa-
cilitate proactive interventions to prevent pressure ulcers (Box 18.1). A change
in attitude of health care professionals may be required to get them to act on
prevention modalities (Buss, Halfens, Abu-Saad, & Kok, 2004 [Level III]). Sev-
eral clinical guidelines on preventing and treating pressure ulcers exist. Most
are based on the AHRQ (now AHCPR) Panel for Prediction and Preventions
(1992 [Level V]; Bergstrom & the AHCPR Treatment of Pressure Ulcers Guide-
line Panel, 1994 [Level 1]) guidelines, with WOCN (2003 [Level I]) guidelines
being the most recently evidenced updated nursing guidelines. Components of
a pressure ulcer prevention protocol should minimally include interventions
targeting skin care, pressure redistribution, repositioning, and nutrition.
Skin Care
Skin that is too dry or too wet has been associated with pressure ulcers. Frantz,
Xakellis, Harvey, & Lewis (2003 [Level IV]) found that pressure ulcer rates were
decreased when appropriate interventions were implemented to treat inconti-
nence in residents in a nursing home. Although there is limited research, dry
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skin is believed to predispose ulcer formation (Allman, Goode, Patrick, Burst
& Bartolucci, 1995 [Level IV]). One quasi-experimental study demonstrated a
reduction in incidence of stages I and II pressure ulcers through a combination
of using body wash and skin-protectant products along with proper education
of the staff (Thompson, Langemo, Anderson, Hanson, & Hunter, 2005 [Level
III]). After implementation of an early prevention protocol for skin prevention
in two nursing homes, stage I and stage II pressure ulcer incidence decreased
from 19.9% to 8.1% (Hunter et al., 2003 [Level III]). In Australia, where real med-
ical sheepskin is available, one study that had some questionable methodology
found that patients randomly assigned to the real sheepskin mattress overlay
during their hospital stay had a 9.6% incidence risk of pressure ulcers compared
to the control group that had 16.6% (Jolley et al., 2004 [Level II]).
Pressure Redistribution
Because immobility is a risk factor in the development of pressure ulcers in
hospitalized patients (Lindgren, Unosson, Fredrikson, & Ek, 2004 [Level VI]),
efforts must be made to address pressure. Although turning and repositioning
patients is a key intervention to redistribute the pressure and prevent pressure
ulcers, the best frequency for turning and repositioning, aswell aswhich support
surface to use, remains a challenge (De Floor, De Bacquer & Grypdonck, 2005
[Level III]; Norton,McLaren&Exton-Smith, 1975 [Level IV]; Young, 2004 [Level
IV]). Redistributing pressure is a key component of preventing pressure ulcers.
Hampton and Collins (2005 [Level II]) found a reduction in pressure ulcers
when visco-elastic mattresses or cushions were used for residents in a nursing
home. When compared to alternating pressure overlays, alternating pressure
mattresses reduced length of stay for hospitalized patients, thereby decreasing
costs, as well as the added benefit of delaying the time to when a pressure
ulcer appeared (Iglesias et al., 2006 [Level II]; Nixon et al., 2006 [Level II]). The
incidence of heel pressure ulcers has been decreased when the appropriate
heel-suspending device has been used to relieve pressure (Gilcreast et al., 2005
[Level II]). Attention to pressure redistribution also needs to be brought into
the OR.
Nutrition
There is lack of consensus about the best way to assess nutritional impairment.
Cavalcanti-Cordeiro and colleagues (2005 [Level IV]) found that decreased con-
centrations of ascorbic acid and alpha-tocopherol were significantly decreased
in patientswith pressure ulcers or infection. In a randomized double-blind study
on the effect of a daily supplement with protein, arginine, zinc, and antioxidants
versus awater-basedplacebo supplement inpatientswithhip fractures, the inci-
dence of stage II pressure ulcers showed a 9% difference between the nutrition-
ally supplemented group and the placebo group (Houwing, Rozendaal,Wouters-
Wessling, Beulens, & Buskens, 2003 [Level II]). The Cochrane Database review
of the role of nutrition in pressure ulcer prevention and treatment concluded
that due to the lack of high-quality trials, no firm conclusions of the effect of
the provision of enteral or parenteral nutrition could be determined (Langer,
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Schloemer, Knerr, Kuss, & Behrens, 2003 [Level I]). When and how patients
should be nutritionally supplemented to prevent pressure ulcers remains un-
clear (Haalboom, 2003 [Level II]; Reddy, Gill, & Rochon, 2006 [Level I]; Stratton
et al., 2005 [Level I]); at times the literature is contradictory.
Skin Tears
Skin tears are traumatic wounds caused by shear and friction (O’Regan, 2002
[Level V]). This skin injury occurs when the epidermis is separated from the
dermis (Malone, Rozario, Gavinski, & Goodwin, 1991 [Level IV]). Because ag-
ing skin has a thinner epidermis, a flatter dermal–epidermal junction, and de-
creased dermal collagen, older persons are more prone to skin injury from me-
chanical trauma (Baranoski, 2000 [Level V]; Payne & Martin, 1993 [Level IV];
White, Karam, & Cowell, 1994 [Level IV]). Therefore, skin tears are common in
older adults, with more than 1.5 million occurring annually in institutionalized
adults in the United States (Thomas, Goode, LaMaster, Tennyson, & Parnell,
1999 [Level III]). Skin tears are frequently located at areas of age-related pur-
pura (Malone et al., 1991 [Level IV]; White et al., 1994 [Level IV]).
Assessment of Skin Tears
The following areas shouldbe assessed for skin tears: shins, face, dorsal aspect of
hands, and plantar aspect of the foot (Malone et al., 1991 [Level IV]). In addition
to elders, others with thinning skin who are at risk for skin tears are patients on
long-term steroid therapy, women with decreased hormone levels, people with
peripheral vascular disease or neuropathy (i.e., the decreased sensationmaking
them more susceptible to injury), and those with inadequate nutritional intake
(O’Regan, 2002 [Level V]).
The three-group risk assessment tool, developed during a research study
by White and colleagues (1994 [Level IV]), may be employed to assess for risk
of skin tears. Within the tool, there are three groups delineated by level of risk:
groups I, II, and III. Group I refers to a positive history of skin tears within the
last 90 days or skin tears that are already present. A positive score in this group
requires that the patient be put on a skin tear prevention protocol. Group II
requires four of the next six criteria to identify an increased risk-related items:
(1) decision-making skills are either impaired or slightly impaired, or extensive
assistance/total dependence for activities of daily living (ADLs) is noted; (2)
wheelchair assistance needed; (3) loss of balance; (4) bed or chair confined; (5)
unsteady gait; and (6) bruises. If a patient has a score of four or more items in
Group II, then implement a skin tear prevention protocol. Group III includes the
following 14 items, requiring any 5 for an increased risk: (1) physically abusive;
(2) resists ADL care; (3) agitation; (4) hearing impaired; (5) decreased tactile
stimulation; (6) wheels self; (7) manually/mechanically lifted; (8) contractures
of arms, legs, shoulders, and/or hands; (9) hemiplegia/hemiparesis; (10) trunk,
partial, or total inability to balance or turn body; (11) pitting edema of legs; (12)
open lesions on extremities; (13) three or four discrete senile purpura lesions on
extremities; and (14) dry, scaly skin. An increased risk has also been identified
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in individuals with a combination of three items in group II and three items in
group III. Positive responses to five or more items in group III or three items
in both groups II and III should also trigger the implementation of a skin tear
prevention protocol.
Several authors have suggested protocols to prevent skin tears (Baranoski,
2000 [Level V]; Mason, 1997 [Level IV]; O’Regan, 2002 [Level V]; White et al.,
1994 [Level IV]). Some nursing home research supports the value of skin ulcer
care protocols to reduce the incidence of skin tears (Bank, 2005 [Level IV]; Birch
& Coggins, 2003 [Level IV]; Hanson, Anderson, Thompson, & Langemo, 2005
[Level III]). After changing to a no-rinse, one-step bed product from bathing
with soap and water, skin tears declined from 23.5% to 3.5% in one nursing
home (Birch & Coggins, 2003 [Level IV]). Hanson and colleagues (2005 [Level
III]) also found that skin tears could be reduced in two different nursing homes
when staff were educated in appropriate skin cleaning and protection strategies.
Using longer-lasting moisturizer-lotion sleeves to protect the arms and padded
side rails yielded a reduction in the monthly average of skin tears from 18 to 11
in another nursing home study (Bank, 2005 [Level IV]). A protocol of guidelines
is presented for high risk patients with skin tears (Table 18.2).
Interventions for Skin Tears
If a skin tear does occur, it is important to correctly identify it and begin an
appropriate plan of care. The Payne and Martin (1993 [Level IV]) classification
systemmay be used to describe skin tears. The three categories are as follows:
■ Category I: a skin tear without tissue loss
■ Category II: a skin tear with partial tissue loss
■ Category III: a skin tear with complete tissue loss, where the epidermal
flap is absent
The usual healing time for skin tears is 3 to 10 days (Krasner, 1991 [Level
VI]). Although skin tears are prevalent in the elderly, there is no consistent
approach to managing these skin injuries (Baranoski, 2000 [Level V]; O’Regan,
2002 [Level V]). Research is just beginning to provide evidence as to which
dressing is best to use for skin tears. One study (Edwards, Gaskill, & Nash, 1998
[Level III]) compared the use of four different types of dressings in treating skin
tears in a nursing home: three occlusive (i.e., transparent film, hydrocolloid, and
polyurethane foam) and one nonocclusive dressing of steri-strips covered by a
nonadhesive cellulose-polyestermaterial. The nonocclusive dressing facilitated
healing at a faster rate than the occlusive dressings. Another study by Thomas
and colleagues (1999 [Level III]) studied older-adult skin tears in three nursing
homes and determined that a higher rate of complete healing occurred with
foam dressings compared to transparent films.
Goals of care for skin tears include retaining the skin flap, if present; provid-
ing a moist, nonadherent dressing; and protecting the site from further injury
(O’Regan, 2002 [Level V]). A consensus protocol for treating skin tears based
on suggested plans of care has been developed by several authors (Baranoski,
2000 [Level V]; Edwards et al., 1998 [Level III]); O’Regan, 2002 [Level V]) and
is in Table 18.2.
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Case Study 1 and Discussion
Randy Gonnagetawound, age 70, has diabetes mellitus with several micro-
and macro-vascular complications. He was admitted to the hospital after a
right-sided cerebral vascular accident. Past history includes retinal hemor-
rhages, a previous myocardial infarction, peripheral vascular disease, and
a neuro-ischemic foot ulcer (healed after a left femoral-popliteal bypass,
intravenous antibiotics, and plantar pressure redistribution with deep-toed
shoes and orthotics). He is incontinent of feces and urine and responds by
nodding to verbal commands. The left arm and leg are paralyzed. He has a
gag reflex but cannot swallow. His Braden score is 10.
Current Data
Physical exam: There is an area of persistent erythema with bruising on the
left buttock alongwith a number of superficial nonpalpable purpuric lesions
on the arms and legs.
Physical Assessment and Pertinent Admission History
General: Responds to verbal questioning, but he cannot move his left side.
In the past 3 days he has been increasingly fatigued, completely bedridden.
He can change position only with movement of the right side.
Vital signs: Temperature = 39.2◦C
Respiration: 10 per minute and regular
Pulse: 88 and irregular
Blood pressure: 162/94
Weight: 195 pounds
Height: 5 feet, 9 inches
Abdominal: Intake has been limited to half a bowl of cereal twice a day and
a piece of toast and tea for lunch for the past 3 days. Last bowel movement
was 3 days ago; + bowel sounds.
Cardiovascular: Irregular heart beat, No S3S4 at apex, +1 pedal edema,
faintly palpable pedal pulses; capillary refill prolonged at 8 seconds
Respiratory: Crackles over right lower lobe, coughing periodically, nonpro-
ductive of mucous
Renal: Episodes of urinary incontinence for the past 3 days prior to admis-
sion
Integumentary: Skin is warm, dry, translucent; tenting noted
Laboratory data: Hg 10, HCT 28, RBC: 3.2, WBC: 11,000 shift to the left.
Albumin 3.0 g/dL, K: 3.1, BUN: 32 mg/100 mL, glucose and/or HbA1c not
available
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Medical Orders
D51/2NS with 10 mEq KCL at 100 cc/h
Colace 100 mg PO tid
Pulse oximetry monitoring continuously
Metamucil 1 package QD
Bedrest
Multivitamin 1 tablet QD
Daily weights
Soft diet as tolerated
Mr. Gonnagetawound is a prime candidate for developing a pressure
ulcer. His low numerical score on the Braden Scale (10) puts him at high
risk. Immediate strategies to prevent the occurrence of an ulcer are needed.
Immobility is a leading risk factor for pressure ulcer development, so amajor
part of his plan of care needs to first be directed to get him moving as much
as possible. A physiotherapy consult is needed to evaluate and recommend
a plan of progressive exercise and activity. The plan should be to get him out
of bed and moving within the constraints of his limitations from the stroke,
as well as being in the chair rather than the bed.When in the chair, he needs
to be sitting on a gel cushion. He will need to be repositioned every hour
when in the chair. A group II, alternating low-air-loss mattress needs to be
placed on his bed. For the limited time when he is in bed, he needs to be
turned and positioned. His skin should be assessed every shift to evaluate
signs for early skin injury.
A consult to a speech therapist is essential. A swallowing study is
warranted to determine his ability to safely take an oral diet. A nutri-
tional consult with a dietician will address his needs for appropriate calo-
ries, protein, and vitamins and minerals. A toileting regimen needs to
be implemented to address the fecal and urinary incontinence. A dis-
cussion with the prescribing health care provider can explore whether
he should continue on the colace and Metamucil. His skin needs cleans-
ing after each episode of incontinence. Use of a no-rinse bathing sys-
tem is preferred rather than soap and water. This vulnerable skin needs
protection by using one of the many skin barriers available on the
market.
Both Mr. Gonnagetawound and his family need instruction as to why it
is so important to get him moving and why nutrition, skin care, turning, and
positioning are so critical to his skin health.
Considering his general health, low hemoglobin, possibility of sepsis,
and increased capillary refill must be also be monitored and addressed. It
would be beneficial to know the HbA1C to determine blood sugar control
and prevent long-term complications.
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Case Study 2 and Discussion
Mrs. Keri Sight, 88-year-old, presents with a diagnosis of senile dementia of
the Alzheimer’s type with impaired communication skills. She has a history
of congestive heart failure and osteoporosis. She spends most of the day in
a wheelchair and needs two-person assistance for ambulation. Her skin is
thin and dry, resembling an onion; each arm and leg has a purpura area.
She is 15 pounds below her ideal body weight and has difficulty swallowing.
Laboratory values are total protein 5.5 g/dL, albumin 2.6 g/dL, and BUN 28.
She is verbally aggressive to the staff on whom she depends for assistance
for ADLs.
Assessment of Mrs. Sight on admission to the LTC facility needs to be
done. Because she has four of the criteria from group II of the Skin Tear Risk
Assessment Tool developed by White and colleagues (1994 [Level IV]) (i.e.,
impaired decision-making skills due to senile dementia, dependence for
ADLs, wheelchair/bed confined, unsteady gait), she is at risk for developing
skin tears. Other factors that would put her at risk are her thin, dry skin with
four purpura present and poor nutritional status. Her dependence on staff
for ADLs and assistance coupled with her dementia predispose her to skin
injury during bathing and other ADLs.
A skin tear prevention protocol needs to be immediately implemented
for Mrs. Sight. To achieve a safe environment for her, the staff must know
how to approach her with her dementia. To address her nutrition and hydra-
tion risk factors, a dietary consultation should be performed. Her ability to
safely swallow needs to be evaluated by a speech therapist. After the swal-
lowing evaluation, a plan to encourage frequent fluids and assist with eating
should be implemented. To protect Mrs. Sight’s skin from additional injury,
avoid using hot water to bathe her and instead use one of the nonrinse soap-
less bathing products. Her family can be asked to bring in a soft fleece jog-
ging suit for her to wear. The purpura areas on her arms and legs should be
covered with stockinette or some other soft, nonadherent dressing or prod-
uct to further protect these areas. Her bedrails and the arms and legs of her
wheelchair should be padded. Staff should use the palm of their hands and a
turn sheet when repositioningMrs. Sight in bed. Lotion can be applied twice
a day to her dry skin. Daily assessment of her skin including the fiveminimal
characteristics proposed by CMS should be done (CMS, 2004 [Level V]).
Summary
Skin is the largest organ, so pay attention to it. Although the research into pre-
vention strategies is limited, there is support for doing the appropriate risk as-
sessment for these two types of skin injuries, assessing the skin for breakdown,
protecting the skin by using appropriate bathing techniques and products to
minimize the effects of friction and shear on the skin, and paying attention to
nutritional status. In the case of pressure ulcers, redistributing the pressure by
turning and repositioning and appropriate use of support surfaces are also crit-
ical. Immediate initiation of prevention protocols after risk identification is key.
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By doing so, skin integrity problems such as tears and pressure ulcers can be
prevented and treated.
Resources
Tools
Ayello, E. A. (Updated 2007). Try this: Predicting pressure ulcer risk, Issue #5
(PDF). Access at the The Hartford Institute for Geriatric Nursing, College
of Nursing, New York University Web site.
http://www.ConsultGeriRN.org/publications/trythis/issue05.pdf
Braden, B., & Bergstrom, N. (1988). Braden Scale for predicting pressure ulcer
risk.
http://www.bradenscale.com/braden.PDF
Authoritative Sites
Agency for Health Research and Quality (AHRQ, formerly AHCPR) USDHHS
supported Clinical Guidelines: Pressure Ulcers. Retrieved May 5, 2007, at
www.guideline.gov
National Pressure Ulcer Advisory Panel (NPUAP)
Pressure ulcer prevention and treatment, research, and policy information.
http://npuap.org/
Wound, Ostomy, and Continence Nursing Society (WOCN)
Guidelines, position statements, best practices, and much more.
http://www.wocn.org/
Other Related Professional Organizations
European Pressure Ulcer Advisory Panel (EPUAP)
http://www.epuap.org/
World Council of Enterostomal Therapists (WCET)
http://www.wcetn.org/
Wound Healing Society (WHS)
http://www.woundheal.org/
American Professional Wound Care Association (APWCA)
http://www.apwca.org/
World Union of Wound Healing Societies (WUWHS)
http://www.wuwhs.org/
These data retrieved May 4, 2007.
Box 18.1
Nursing Standard of Practice Protocol: Pressure
Ulcer Prevention
I. GOALS
A. Prevention of pressure ulcers (PU)
B. Early recognition of PU development/skin changes
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II. BACKGROUND AND STATEMENT OF PROBLEM
A. Prevalence: 15% (Cuddigan et al., 2001 [Level I])
1. Acute-care range: 10% to 18%
2. Long term care range: 2.3% to 28%
3. Home care range: 0% to 29%
B. Incidence: 7%
1. acute-care range: 0.4% to 38%
2. long term care range: 2.2% to 23.9%
3. home care range: 0% to 17%
C. Healthy People 2010 Objective: Reduce the proportion of nursing
home residents with a current diagnosis of pressure ulcers.
D. A sentinel event in long term care (HCFA, 2000)
E. Etiology and/or epidemiology
1. Risk factors (immobility, under or malnutrition, incontinence, fri-
able skin, impaired cognitive ability)
2. Higher incidence stage II and higher in persons with darkly pig-
mented skin
III. PARAMETERS OF ASSESSMENT
A. Assess for intrinsic and extrinsic risk factors
B. Braden Scale risk score
1. 18 or below for elderly and persons with darkly pigmented skin
2. 16 or below for other adults
IV. NURSING CARE STRATEGIES AND INTERVENTIONS
A. Risk assessment documentation
1. On admission to a facility
2. Reassessment intervals whenever the client’s condition changes
and based on patient care setting:
a. acute care: every 48 hours
b. long term care: weekly for first 4 weeks, then monthly/
quarterly
c. home care: every nursing visit
3. Use a reliable and standardized tool for doing a risk assessment,
such as the Braden Scale (available at http://www.bradenscale.
com/braden.PDF).
4. Document risk assessment scores and implement prevention
protocols based on cut score.
B. General Care Issues and Interventions
1. Culturally sensitive early assessment for stage I pressure ulcers
in clients with darkly pigmented skin.
a. Use a halogen light to look for skin color changes—may be
purple hues
b. Compare skin over bony prominences to surrounding skin—
may be boggy or stiff, warm or cooler
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2. AHCPR (1992) prevention recommendations:
a. Assess skin daily.
b. Clean skin at time of soiling; avoid hot water and irritating
cleaning agents.
c. Use moisturizers on dry skin.
d. Do not massage bony prominences.
e. Protect skin of incontinent clients from exposure to moisture.
f. Use lubricants, protective dressings, and proper lifting tech-
niques to avoid skin injury from friction/shear during trans-
ferring and turning of clients.
g. Turn and position bed-bound clients every 2 hours if consis-
tent with overall care goals.
h. Use a written schedule for turning and repositioning clients.
i. Use pillows or other devices to keep bony prominences from
direct contact with each other.
j. Raise heels of bed-bound clients off the bed; do not use donut-
type devices (Gilcrest, Warren, & Yoder, 2005 [Level II]).
k. Use a 30-degree lateral side lying position; do not place clients
directly on their trochanter.
l. Keep head of the bed at lowest height possible.
m.Use lifting devices (trapeze, bed linen) to move clients rather
than dragging them in bed during transfers and position
changes.
n. Use pressure-reducing devices (static air, alternating air, gel
or water mattresses) (Iglesias et al., 2006 [Level II]; Hampton
& Collins, 2005 [Level II]).
o. Reposition chair- or wheelchair-bound clients every hour. In
addition, if client is capable, have him or her do small weight
shifts every 15 minutes.
p. Use a pressure-reducing device (not a donut) for chair-bound
clients.
3. Other care issues and interventions
a. Keep the patient as active as possible; encouragemobilization.
b. Do not massage reddened bony prominences.
c. Avoid positioning the patient directly on his or her trochanter.
d. Avoid using donut-shaped devices.
e. Avoid drying out the patient’s skin; use lotion after bathing.
f. Avoid hot water and soaps that are drying when bathing el-
derly. Use body wash and skin protectant (Hunter et al., 2003
[Level III]).
g. Teach patient, caregivers, and staff the prevention proto-
cols.
h. Manage moisture:
i. Manage moisture by determining the cause; use absorbent
pad that wicks moisture.
ii. Offer a bedpan or urinal in conjunction with turning sched-
ules.
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i. Manage nutrition:
Consult a dietitian, and correct nutritional deficiencies in-
crease
i. protein and calorie intake and A, C, or E vitamin supple-
ments as needed (Houwing et al., 2003 [Level II]; CMS, 2004
[Level V]).
ii. Offer a glass ofwaterwith turning schedules to keeppatient
hydrated.
j. Manage friction and shear:
i. Elevate the head of the bed no more than 30 degrees.
ii. Have the patient use a trapeze to lift self up in bed.
iii. Staff should use a lift sheet or mechanical lifting device to
move patient.
iv. Protect high risk areas such as elbows, heels, sacrum, and
back of head from friction injury.
C. Interventions Linked to Braden Risk Scores (Adapted from Ayello
& Braden, 2001)
Prevention protocols linked to Braden risk scores are as follows:
1. At risk: score of 15–18
a. Frequent turning; consider q 2 h schedule; use a written
schedule.
b. Maximize patient’s mobility.
c. Protect patient’s heels.
d. Use a pressure-reducing support surface if patient is bed- or
chair-bound.
2. Moderate risk: score of 13–14
a. Same as above, but provide foamwedges for 30-degree lateral
position.
3. High risk: score of 10–12
a. Same as above, but add the following.
i. Increase the turning frequency.
ii. Do small shifts of position.
4. Very high risk: score of 9 or below
a. Same as above, but use a pressure-relieving surface.
b. Manage moisture, nutrition, and friction/shear.
V. EVALUATION AND EXPECTED OUTCOMES
A. Patient
1. Skin will remain intact.
2. Pressure ulcer will heal.
B. Provider/Nurse
1. Nurses will accurately perform PU risk assessment using stan-
dardized tool.
2. Nurses will implement PU prevention protocols for clients inter-
preted as at risk for PU.
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3. Nurses will perform a skin assessment for early detection of pres-
sure ulcers.
C. Institution
1. Reduction in development of new pressure ulcers.
2. Increased number of risk assessments performed.
3. Cost-effective prevention protocols developed.
VI. FOLLOW-UP MONITORING OF CONDITION
A. Monitor effectiveness of prevention interventions.
B. Monitor healing of any existing pressure ulcers.
Box 18.2
Nursing Standard of Practice Protocol:
Skin Tear Prevention
I. GOALS
A. Prevent skin tears in elderly clients.
B. Identify clients at risk for skin tears (White et al., 1994 [Level IV]).
C. Foster healing of skin tears by
1. Retaining skin flap
2. Providing a moist, nonadherent dressing (Edwards et al., 1998
[Level III]; Thomas et al., 1999 [Level III])
3. Protecting the site from further injury
II. BACKGROUND AND STATEMENT OF PROBLEM
A. Traumatic wounds from mechanical injury of skin.
B. Need to clearly differentiate etiology of skin tears from pressure ul-
cers.
C. Common in the elderly, especially over areas of age-related pur-
pura.
III. PARAMETERS OF ASSESSMENT
A. Use the three-group risk assessment tool (White et al., 1994 [Level
IV]) to assess for skin tear risk.
B. Use the Payne and Martin (1993 [Level IV]) classification system to
assess clients for skin tear risk.
1. Category I: a skin tear without tissue loss
2. Category II: a skin tear with partial tissue loss
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3. Category III: a skin tear with complete tissue loss, where the
epidermal flap is absent
IV. NURSING CARE STRATEGIES AND INTERVENTIONS
(Baranoski, 2000 [Level V])
A. Preventing Skin Tears
1. Provide a safe environment:
a. Do a risk assessment of elderly patients on admission.
b. Implement prevention protocol for patients identified as at
risk for skin tears.
c. Have patients wear long sleeves or pants to protect their ex-
tremities (Bank, 2005 [Level IV]).
d. Have adequate light to reduce the risk of bumping into furni-
ture or equipment.
e. Provide a safe area for wandering.
2. Educate staff or family caregivers in the correct way of handling
patients to prevent skin tears. Maintain nutrition and hydration:
a. Offer fluids between meals.
b. Use lotion, especially on dry skin on arms and legs, twice daily
(Hanson et al., 2005 [Level III]).
c. Obtain a dietary consultation.
3. Protect from self-injury or injury during routine care:
a. Use a lift sheet to move and turn patients.
b. Use transfer techniques that prevent friction or shear.
c. Pad bedrails, wheelchair arms, and leg supports (Bank, 2005
[Level IV]).
d. Support dangling arms and legs with pillows or blankets.
e. Use nonadherent dressings on frail skin.
i. Apply petroleum-based ointment, steri-strips, or a moist
nonadherent wound dressing such as hydrogel dressing
with gauze as a secondary dressing. Telfa type dressings
are also used.
ii. If youmust use tape, be sure it ismade of paper, and remove
it gently. Also, you can apply the tape to hydrocolloid strips
placed strategically around the wound rather than tap-
ing directly onto fragile surrounding skin around the skin
tear.
f. Use gauze wraps, stockinettes, flexible netting, or other wraps
to secure dressings rather than tape.
g. Use no-rinse soapless bathing products (Birch & Coggins,
2003 [Level IV]; Mason, 1997 [Level IV]).
h. Keep skin from becoming dry, apply moisturizer (Hanson et
al., 2005 [Level III]; Bank, 2005 [Level IV]).
B. Treating Skin Tears (Baranoski & Ayello, 2004 [Level V])
1. Gently clean the skin tear with normal saline.
2. Let the area air dry or pat dry carefully.
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3. Approximate the skin tear flap.
4. Use caution if using film dressings because skin damage can oc-
cur when removing dressings.
5. Consider putting an arrow to indicate the direction of the skin
tear on the dressing to minimize any further skin injury during
dressing removal.
a. Skin sealants, petroleum-based products, and other water-
resistant product such as protective barrier ointments or liq-
uid barriers may be used to protect the surrounding skin from
wound drainage or dressing/tape removal trauma.
b. Always assess the size of the skin tear; consider doing awound
tracing.
c. Document assessment and treatment findings.
V. EVALUATION AND EXPECTED OUTCOMES
A. No skin tears will occur in at-risk clients.
B. Skin tears that do occur will heal.
VI. FOLLOW-UP MONITORING OF CONDITION
A. Continue to reassess for any new skin tears in older adults.
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Educational Objectives
On completion of this chapter, the reader should be
able to:
1. describe the structural and functional changes that
occur during the normal aging process in the
cardiovascular, pulmonary, renal, genitourinary,
oropharyngeal, gastrointestinal, musculoskeletal,
and nervous systems
2. understand the clinical significance of these
age-related changes with regard to the health and
disease risks of older adults
3. discuss the components of a nursing assessment
for older adults in light of the manifestations of
normal aging
4. with consideration of age-dependent changes,
identify care strategies to promote successful
aging in elders
The process of normal aging, independent of disease, is accompanied by myr-
iad changes in body systems. As evidenced by longitudinal studies such as the
Baltimore Longitudinal Study of Aging (Baltimore Longitudinal Study of Ag-
ing, 2005), modifications occur in both structure and function of organs and are
most pronounced in advanced age of 85 years or older (Hall, 2002). Many of
these alterations are characterized by a decline in physiological reserve so that,
although baseline functionality is preserved, organ systems become progres-
sively less capable of maintaining homeostasis in the face of stresses imposed
by the environment, disease, or medical therapies (Miller, 2003). Age-related
changes are strongly impacted by genetics (Wang, 2003) as well as by long-term
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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lifestyle factors including physical activity, diet, alcohol consumption, and to-
bacco use (Taffet & Lakatta, 2003). Further, great heterogeneity occurs among
older individuals; clinical manifestations of aging can range from stability to
significant decline in function of specific organ systems (Beck, 1998).
The clinical implications of these gerontological alterations are critically im-
portant in nursing assessment and care of older adults for several reasons. First,
changes associated with normal aging must be differentiated from pathological
processes in order to develop appropriate interventions (Levelser & Shakoor,
2003). Manifestations of aging can also adversely impact the health and func-
tionality of elders and require therapeutic strategies to correct (Matsumura &
Ambrose, 2006). Age-associated changes predispose older persons to selected
diseases (Taffet & Lakatta, 2003); therefore, nurses’ understanding of these risks
can serve to develop more effective approaches to assessment and care. Finally,
aging and illness may interact reciprocally, resulting in altered presentation of
illness, response to treatment, and outcomes (Hall, 2002).
This chapter describes age-dependent changes for the cardiovascular, pul-
monary, renal, genitourinary, oropharyngeal, gastrointestinal, musculoskeletal,
andnervous systems.Clinical implications of these alterations for eachbody sys-
tem, including associated disease risks, are then discussed, followed by nursing
assessment and care strategies related to these changes, and a clinical practice
protocol, see Box 19.1.
Cardiovascular System
Cardiac reserve declines in normal aging. This alteration does not affect car-
diac function at rest and resting heart rate, ejection fraction, and cardiac out-
put remain virtually unchanged with age; however, under physiological stress
with increased cardiac demand, such as physical activity or infection, the abil-
ity of an older adult’s heart to increase rate and cardiac output is compromised
(Lakatta, 2000). Such diminished functional reserve results in reduced exercise
tolerance, fatigue, shortness of breath, slow recovery from tachycardia (Watters,
2002 [Level V]), and intolerance of volume depletion (Mick & Ackerman, 2004
[Level V]). Further, because of the decreasedmaximal attainable heart rate with
aging, a rapid heart rate of more than 90 beats per minute in an older adult in-
dicates significant physiological stress (Taffet & Lakatta, [Level VI] 2003).
Age-dependent changes in both the vasculature and the heart contribute
to the impairment in cardiac reserve. An increase in the wall thickness and
stiffness of the aorta and carotid arteries results in diminished vessel compli-
ance and greater systemic vascular resistance (Tully, 2002). Elevated systolic
blood pressure with constant diastolic pressure follows, increasing the risk of
isolated systolic hypertension andwidened pulse pressure (Joint National Com-
mittee [JNC], 2004). Strong arterial pulses, diminished peripheral pulses, and
increased potential for inflamed varicosities occur commonly with age. Reduc-
tions in capillary density restrict blood flow in the extremities, producing cool
skin (Mick & Ackerman, 2004 [Level V]).
As an adaptive measure to increased workload against noncompliant arter-
ies, the left ventricle and atrium hypertrophy and become rigid. The ensuing
impairment in relaxation of the left ventricle during diastole places greater de-
pendence on atrial contractions to achieve left ventricular filling (Lakatta, 2000).
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In addition, sympathetic response in the heart is blunted due to diminished
β-adrenergic sensitivity, resulting in decreased myocardial contractility (Tully,
2002).
Additional age-related changes include sclerosis of atrial and mitral valves,
which impairs their tight closure and increases the risk of dysfunction. The
ensuing leaky heart valves may result in aortic regurgitation or mitral steno-
sis, presenting on exam as heart murmurs (Santinga, 2003). Loss of pacemaker
and conduction cells contributes to changes in the resting electrocardiogram
of older adults (Saksena & Reddy, 2003). Isolated premature atrial and ventric-
ular complexes are common arrhythmias and the risk of atrial fibrillation is
increased (Hebbar & Hueston, 2002a, 2002b). Due to atrial contractions in di-
astole, S4 frequently develops as an extra heart sound (Schretzman & Strumpf,
2002).
Baroreceptor function, which regulates blood pressure, is impaired with
age, particularly with change in position. Postural hypotension with ortho-
static symptoms may follow (Mukai & Lipsitz, 2002), especially after prolonged
bedrest, dehydration, or cardiovascular drug use, and can cause dizziness and
potential for falls (Kenny, 2003 [Level V]).
Cardiac assessment of an older adult includes performing an electrocardio-
gram (ECG) (Saksena & Reddy, 2003 [Level V]) and monitoring heart rate (40 to
100 bpmwithin normal limits), rhythm (noting whether it is regular or irregular)
(Docherty, 2002 [Level I]), heart sounds (S1, S2, or extra heart sounds S3 in heart
disease or S4 as a common finding), and murmurs (noting location where loud-
est). The apical impulse is displaced laterally. In palpation of the carotid arteries,
asymmetric volumes and decreased pulsations may indicate aortic stenosis and
impaired left cardiac output, respectively. Auscultation of bruit potentially sug-
gests occlusive arterial disease. Peripheral pulses should be assessed bilaterally
at aminimumof onepulsepoint in eachextremity.Assessmentmay reveal asym-
metry in pulse volume, suggesting insufficiency in arterial circulation (Seidel,
Ball, Dains, &Benedict, 2003 [Level VI]). Examine lower extremities for varicose
veins and note dilation or swelling (Bickley, 2003 [Level VI]). Evaluate for dys-
pnea with exertion and exercise intolerance (Mahler, Fierro-Carrion, & Baird,
2003 [Level V]).
Blood pressure should be measured at least twice (Kestel, 2005 [Level V])
on an older adult and performed in a comfortably seated position with back
supported and feet flat on the floor. The B/P should then be repeated after 5
minutes of rest. Measurements in both supine and standing positions evaluate
postural hypotension (Kenny, 2003 [Level V]) and should be performed on all
older adults.
Nursing-care strategies include referrals for older adults who have irreg-
ularities of heart rhythm and decreased or asymmetric peripheral pulses. The
risk of postural hypotension emphasizes the need for safety precautions (Kenny,
2003 [Level V]) to prevent falls. These include avoiding prolonged recumbency
or motionless standing and encouraging the older adult to rise slowly from lying
or sitting positions and wait 1 to 2 minutes after a position change to stand or
transfer. Overt signs of hypotension such as a change in sensorium or mental
status, dizziness, or orthostasis should be monitored and fall-prevention strate-
gies should be instituted. Sufficient fluid intake is advised to ensure adequate
hydration and prevent hypovolemia for optimal cardiac functioning (Docherty,
2002 [Level I]; Watters, 2002 [Level V]).
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Older adults should be encouraged to adopt lifestyle practices for cardiovas-
cular fitness with the aim of a healthy body weight (i.e., BMI 18.5 to 24.9 kg/m2)
(Lewington, Clarke, Qizilbash, Peto, & Collins, 2002; Lichtenstein et al., 2006
[both Level I]) and normal blood pressure (JNC, 2004 [Level I]). These prac-
tices involve a healthful diet (Knoops et al., 2004 [Level II]; Sacks et al., 2001
[Level II]), physical activity appropriate for age and health status (Fogelholm
& Kukkonen-Harjula, 2000; Netz, Wu, Becker, & Tenenbaum, 2005 [both Level
I]), and elimination of the use of and exposure to tobacco products (Barnoya &
Glantz, 2005; U.S. Department of Health andHuman Services [USDHHS], 2004b
[both Level I]).
Pulmonary System
Respiratory function slowly and progressively deteriorates with age. This de-
cline in ventilatory capacity seldom affects breathing during rest or customary
limited physical activity in healthy older adults (Zeleznik, 2003 [Level V]); how-
ever, with greater-than-usual exertional demands, pulmonary reserve against
hypoxia is readily exhausted and dyspnea occurs (Seidel et al., 2003 [Level VI]).
Several age-dependent anatomic and physiologic changes combine to im-
pair the functional reserve of the pulmonary system. Respiratory muscle
strength and endurance deteriorate to restrict maximal ventilatory capacity
(Kelley, 2002 [Level V]). Secondary to calcification of rib-cage cartilage, the chest
wall becomes rigid (Schretzman & Strumpf, 2002 [Level VI]), limiting thoracic
compliance. Loss of elastic fibers reduces recoil of small airways that can col-
lapse and cause air-trapping, particularly in dependent portions of the lung.
Decreases in alveolar surface area, vascularization, and surfactant production
adversely affect gaseous exchange (Zeleznik, 2003 [Level V]).
Additional clinical consequences of aging include an increased anteropos-
terior chest diameter due to skeletal changes (Seidel et al., 2003 [Level VI]).
An elevated respiratory rate of 12 to 24 breaths per minute accompanies re-
duced tidal volume for rapid, shallow breathing. Limited diaphragmatic excur-
sion and chest/lung expansion can result in less effective inspiration and ex-
piration (Mick & Ackerman, 2004 [Level V]). Due to decreased cough reflex
effectiveness and deep-breathing capacity, mucus and foreign matter clearance
is restricted, predisposing to aspiration, infection, and bronchospasm (Watters,
2002 [Level V]). Further elevating the risk of infection is a decline in ciliary and
macrophage activities and drying of the mucosal membranes with more diffi-
cult mucous excretion (Kelley, 2002 [Level V]). With the loss of elastic recoil
comes the potential for atelectasis. Due to reduced respiratory-center sensitiv-
ity, ventilatory responses to hypoxia and hypercapnia are blunted (Imperato &
Sanchez, 2006), putting an elder at risk for development of respiratory distress
with illness or administration of narcotics (Zeleznik, 2003 [Level V]).
The modifications in ventilatory capacity with age are reflected in changes
in pulmonary-function tests measuring lung volumes, flow rates, diffusing ca-
pacity, and gas exchange. Whereas total lung capacity remains constant, vital
capacity is reduced and residual volume is increased. Reductions in all mea-
sures of expiratory flow (i.e., FEV1, FVC, FEV1/FVC, PEFR) quantify a decline
in useful air movement (Imperato & Sanchez, 2006). Due to impaired alveolar
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function, diffusing capacity (DLCO) declines as does arterial oxygen tension
(PaO2), indicating impaired oxygen exchange; however, arterial pH and carbon
dioxide tension (PaCO2) remain constant (Enright, 2003). Reductions in arterial
oxygen saturation and cardiac output restrict the amount of oxygen available
for use by tissues, particularly in the supine position, although arterial blood
gas seldom limits exercise in healthy subjects (Zeleznik, 2003).
Respiratory assessment includes determination of breathing rate, rhythm,
regularity, volume (hyper/hypoventilation), depth (shallow, deep) (Docherty,
2002 [Level I]), and effort (dyspnea) (Mahler et al., 2003 [Level V]). Auscultation
of breath sounds throughout the lung fields may reveal decreased air exchange
at the lung bases (Mick & Ackerman, 2004 [Level V]). Thorax and symmetry of
chest expansion should be inspected. A history of respiratory disease (tubercu-
losis, asthma), tobacco use (expressed as pack years), and extended exposure
to environmental irritants through work or avocation is contributory (Seidel
et al., 2003 [Level VI]).
Subjective assessment of cough includes questions on quality (produc-
tive/nonproductive), sputum characteristics (note hemoptysis; purulence indi-
cating possible infection), and frequency (during eating or drinking, suggest-
ing dysphagia and aspiration) (Smith & Connolly, 2003 [Level V]). Evaluation
for pneumococcal pneumonia includes monitoring for typical symptoms such
as productive cough, fever, and dyspnea as well as insidious, atypical symp-
toms including tachypnea, lethargy (Bartlett et al., 2000 [Level I]), weakness,
falls, decline in functional status, or increased/new-onset confusion with ab-
sent high fever and elevated white blood cell count. Decreased appetite and
dehydration may be the only initial symptoms in an older adult (Kelley, 2002
[Level V]).
Secretions and decreased breathing rate during sedation can reduce ven-
tilation and oxygenation (Watters, 2002 [Level V]). Oxygen saturation can be
followed through arterial blood gases and pulse oximetry (Zeleznik, 2003 [Level
V]) and breathing rate (greater than 24 bpm), accessory muscle use, and skin
color (cyanosis, pallor) should also be monitored (Docherty, 2002 [Level I]). The
inability to expectorate secretions, dyspnea, and decreased SaO2 levels sug-
gests the need for suctioning to clear airways (Smith & Connolly, 2003 [Level
V]). Optimal positioning to facilitate respiration should be regularly monitored
with use of upright positions (Fowler’s or orthopneic position) recommended
(Docherty, 2002 [Level I]; Watters, 2002 [Level V]). Pain assessment may be
necessary to allow ambulation and deep breathing (Mick & Ackerman, 2004
[Level V]).
Nursing-care strategies useful in facilitating respiration and maintaining
patent airways in older adults include positioning to allow maximum chest
expansion through the use of semi- or high-Fowler’s or orthopneic position
(Docherty, 2002 [Level I]). Additionally, frequent repositioning in bed or en-
couraging ambulation, if mobility permits, is advised (Watters, 2002 [Level V]).
Hydration is maintained through fluid intake (six to eight 8-ounce glasses
per day) and air humidification, which prevent desiccation of mucous mem-
branes and loosen secretions to facilitate expectoration (Suhayda&Walton, 2002
[Level V]). Suctioning may be necessary to clear airways of secretions (Smith &
Connolly, 2003 [Level V]) while oxygen should be provided as needed (Docherty,
2002 [Level I]). Incentive spirometry, with use of sustained maximal inspiration
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devices (SMIs), can improve pulmonary ventilation, mainly inhalation, as well
as loosen respiratory secretions, particularly in older adults who are unable to
ambulate or declining in function (Dunn, 2004 [Level V]).
Medications for respiratory problems include bronchodilators (β2 agonists,
xanthines), which reduce bronchospasm, open congested airways, and facilitate
ventilation (National Heart, Lung, and Blood Institute, 1996 [Level I]). Anal-
gesics may be necessary for ambulation and deep breathing (Mick & Ackerman,
2004 [Level V]).
Deep-breathing exercises, such as abdominal (diaphragmatic) and pursed-
lip breathing, in addition to controlled and huff coughing, can further facilitate
respiratory function. Techniques for healthy breathing, including sitting and
standing erect, nose breathing (Dunn, 2004 [Level V]), and regular exercise
(Netz et al., 2005 [Level I]) should be promoted. For individuals older than 65,
immunization is recommended against pneumococcal infections every 5 years
(Centers for Disease Control and Prevention [CDC], 1997 [Level I]) and against
influenza annually (CDC, 2000 [Level I]). Education on eliminating the use of
and exposure to tobacco products should be emphasized (Barnoya & Glantz,
2005 [Level I]; USDHHS, 2004b [Level I]).
Renal and Genitourinary Systems
In normal aging, the mass of the kidney declines with a loss of functional
glomeruli and tubules in addition to a reduction in blood flow. Concomitantly,
changes occur in the activity of the regulatory hormones, vasopressin (antidi-
uretic hormone), atrial natriuretic hormone, and renin-angiotensin-aldosterone
system (Miller, 2003 [Level V]). These alterations combine to result in dimin-
ished glomerular filtration rate (GFR), with a 10% decrement per decade start-
ing at age 30, as well as impaired electrolyte and water management (Beck, 1998
[Level V]).
Despite these changes, older adults maintain the ability to regulate fluid
balance under baseline conditions; however, with age, the renal system is more
limited in its capacity to respond to externally imposed stresses. This reduced
functional reserve increases vulnerability to disturbances in fluid homeostasis
as well as to renal complications and failure (Miller, 2003 [Level V]), particu-
larly fromfluid/electrolyte overload and deficit,medications, or illness (Wiggins,
2003 [Level VI]).
The decline in functional nephrons emphasizes the risk from nephrotoxic
agents including NSAIDs, β-lactam antibiotics, and radiocontrast dyes (Bailey
& Sands, 2003 [Level VI]). Reduced GFR impairs an older adult’s ability to ex-
crete renally cleared medications such as aminoglycoside antibiotics (e.g., gen-
tamycin) and digoxin, increasing the risk of adverse drug reactions. Dosages
should be based on GFR estimated by the Cockcroft-Gault equation for creati-
nine clearance rather than by serum creatinine concentration (Beyth & Shorr,
2002 [Level V]). Values of serum creatinine remain unchanged despite an age-
associated decline in GFR because of the parallel decrease in both elders’ skele-
tal musclemass, which produces creatinine, andGFR for creatinine elimination.
Thus, serum-creatinine levels overestimateGFR to result in potential drug over-
dose (Beck, 1998 [Level V]).
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Increased risk of electrolyte imbalances can result from an age-dependent
impairment in the excretion of excessive sodium loads, particularly in heart
failure and with NSAID use, leading to intravascular volume overload. Clin-
ical indicators include weight gain (>2%); intake>output; edema; change in
mental status; tachycardia; bounding pulse; pulmonary congestion with dys-
pnea, rales, SOB (Beck, 1998 [Level V]); increased B/P and CVP; and distended
neck/peripheral veins (Kozier, Erb, Berman, & Burke, 2000 [Level VI]).
Conversely, sodium wasting, or excess sodium excretion when maximal
sodium conservation is needed, can occur with diarrhea. Hypovolemia and de-
hydration may ensue (Stern, 2006 [Level V]), manifesting as acute change in
mental status (possible initial symptom), weight loss (>2%), decreased tissue
turgor, dry oral mucosa, tachycardia, decreased B/P, postural hypotension, flat
neck veins, poor capillary refill, oliguria (<30 mL/h), increased hematocrit and
specific gravity of urine, BUN:plasma creatinine ratio >20:1, and serum osmo-
lality >300 mOsm/kg (Mentes, 2006 [Level V]).
Impaired potassium excretion puts an elder at risk for hyperkalemia, par-
ticularly in heart failure and with use of potassium supplements, potassium-
sparing diuretics, NSAIDs, and ACE inhibitors (Mick & Ackerman, 2004 [Level
V]). Clinical indicators include diarrhea, change in mental status, cardiac dys-
rhythmias or arrest,muscleweakness and areflexia, paresthesias andnumbness
in extremities, ECG abnormalities, and serum potassium >5.0 mEq/L (Beck,
1998 [Level V]; Kozier et al., 2000 [Level VI]).
Limited acid excretion capability can cause metabolic acidosis during acute
illness in an older adult (Beck, 1998 [Level V]). This condition presents as Kuss-
maul’s respirations, change in mental status, nausea, vomiting, arterial blood
pH<7.35, serum bicarbonate <22 mEq/L, and PaCO2<38 mm Hg with respira-
tory compensation (Kozier et al., 2000 [Level VI]).
Causes of abnormal water metabolismwith age include diminution inmaxi-
mal urinary concentrating ability, which, in concert with blunted thirst sensation
and total body water, can result in hypertonic dehydration and hypernatremia
(Mentes, 2006 [Level V]). Often associated with insensible fluid loss from fever
(Miller, 2003 [Level V]), hypernatremia presents with thirst; dry oral mucosa;
dry, furrowed tongue; postural hypotension; weakness; lethargy; serum sodium
>150 mEq/L; and serum osmolality >290 mOsm/kg. Disorientation, seizures,
and coma occur in severe hypernatremia (Suhayda & Walton, 2002 [Level V]).
Impaired excretion of a water load, exacerbated by ACE inhibitors, thiazide
diuretics (Miller, 2003), andSSRIs (Mentes, 2006 [LevelV]), predisposes an elder
to water intoxication and hyponatremia (Beck, 1998 [Level V]). Clinical indica-
tors involve lethargy, nausea, muscle weakness and cramps, serum sodium<135
mEq/L, and serumosmolality<290mOsm/kg. Confusion, coma, and seizures are
seen in severe hyponatremia (Suhayda & Walton, 2002 [Level V]).
Changes in the lower urinary tract with age include reduced bladder elas-
ticity and innervation, which contribute to decreases in urine flow rate, voided
volume, and bladder capacity, as well as increases in postvoid residual and in-
voluntary bladder contractions (Kevorkian, 2004). A delayed or decreased per-
ception of the signal from the bladder to void translates into urinary urgency
(Bradway & Yetman, 2002 [Level V]). Increased nocturnal urine flow, which
results from altered regulatory hormone production, impaired ability to con-
centrate urine, and bladder-muscle instability, can lead to nocturnal polyuria
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(Miller, 2003 [Level V]). In older men, benign prostatic hyperplasia (BPH) can
result in urinary urgency, hesitancy, and frequency. All these changes combine to
increase the risk of urinary incontinence in an older adult, whereas increased
risk of falls accompanies urgency and nocturia. Changes in the physiology of
the urinary tract also contribute to development of bacteriuria, with potential
for urinary tract infection (UTI) (Stern, 2006 [Level V]).
Renal assessment includes monitoring for renal function, based on creati-
nine clearance, particularly in acute and chronic illness (Beck, 1998 [Level V]).
The choice, dose, need, and alternatives for nephrotoxic and renally excreted
agents should be considered (Beyth & Shorr, 2002 [Level V]).
Dehydration, volume overload, and electrolyte status are assessed first by
screening for risk of fluid/electrolyte imbalances based on an older adult’s age,
medical and nutritional history, medications, cognitive and functional abilities,
psychosocial status, and bowel and bladder patterns. Data on fluid intake and
output, daily weights, and vital signs, including orthostatic blood pressure mea-
surements, are needed. Heart rate is a less reliable indicator for dehydration
in older adults due to the effects of medications and heart disease (Suhayda &
Walton, 2002 [Level V]).
Physical assessment for fluid/electrolyte status focuses on skin for edema
and turgor. Note that turgor in older adults is a less reliable indicator for de-
hydration due to poor skin elasticity, and assessment over the sternum or in-
ner thigh is recommended. Additional assessment involves the oral mucosa for
dryness as well as cardiovascular, respiratory, and neurologic systems. Acute
changes in mental status, reasoning, memory, or attention may be initial symp-
toms of dehydration (Suhayda & Walton, 2002 [Level V]). Pertinent laboratory
tests include serum electrolytes, serum osmolality, CBC, urine pH and specific
gravity, BUN, hematocrit (Mentes, 2006 [Level V]), and arterial blood gases
(Beck, 1998 [Level V]).
Regarding the lower urinary tract, evaluations of urinary incontinence, UTI,
and nocturnal polyuria using a 72-hour voiding diary are recommended. UTI in
older adultsmaypresentwith classical symptoms of dysuria, flank or suprapubic
discomfort, hematuria, and urinary frequency and urgency, or atypical symp-
toms of new-onset/worsening incontinence, anorexia, confusion, nocturia, or
enuresis. A voiding history and rectal examare required to diagnose BPH (Brad-
way & Yetman, 2002 [Level V]). Fall risk should be addressed when nocturnal
or urgent voiding is present (see chapter 9, Preventing Falls in Acute Care).
Ongoing care involves monitoring for renal function by creatinine clear-
ance calculation and for levels of nephrotoxic and renally cleared drugs (Beyth
& Shorr, 2002 [Level V]). Maintenance of fluid/electrolyte balance is paramount
(Beck, 1998 [Level V]). To prevent dehydration, older adults weighing between
50 and 80 kg are advised to have a minimum fluid intake of 1,500 to 2,500
ml/day (unless contraindicated by medical condition) (Suhayda & Walton, 2002
[Level V]) from both fluids and food sources including fruits, vegetables, soups,
and gelatin with avoidance of high salt and caffeine. Education on appropriate
food choices and encouragement to follow recommendations should be pro-
vided (Mentes, 2006 [Level V]). Simmons and colleagues (2001 [Level II]) found
that verbal prompting and complying with beverage preferences increased fluid
intake among nursing-home residents.
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Referrals to specialists in incontinence and urology should be provided for
management of voiding problems. Incontinence care and exercise can improve
performance, including reduced incontinence, of nursing-home residents, as
demonstrated by Schnelle and colleagues (2002 [Level II]). Behavioral inter-
ventions recommended for nocturnal polyuria include limited fluid intake in
the evening, avoidance of caffeine and alcohol, and prompted voiding schedule
(Miller, 2003 [Level V]). Institution of safety precautions and fall-prevention
strategies are needed in nocturnal or urgent voiding (see chapter 9, Preventing
Falls in Acute Care).
Oropharyngeal and Gastrointestinal Systems
Age-specific alterations in the oral cavity can adversely affect an older adult’s
nutritional status. Deterioration in the strength ofmuscles ofmastication as well
as potential for tooth loss and xerostomia due to dehydration or medications
may reduce food intake (Jensen, McGee, & Binkley, 2001). Contributing to poor
appetite are an altered taste perception and a diminished sense of smell (Ritchie,
2002) (see chapter 17, Oral Health Care).
Changes in the esophagus with age include delayed emptying in addition
to decreases in upper and lower esophageal sphincter pressures, sphincter re-
laxation, and peristaltic contractions. Although these alterations rarely impair
esophageal function and swallowing sufficiently to cause dysphagia or aspira-
tion in normal aging, such conditions can develop in conjunction with disease or
medication side effects in older adults (Achem & DeVault, 2005; Shaker & Staff,
2001 [Level V]). Diminished gastric motility with delayed emptying contributes
to altered oral drug passage time and absorption in the stomach; elevated risk of
gastroesophageal reflux disease (GERD) (Hall, 2003); and decreased postpran-
dial hunger, leading to diminished food intake and possiblemalnutrition (Blech-
man & Gelb, 1999). Reduced mucin secretion impairs the protective function of
the gastric mucosal barrier and increases the incidence of NSAID-induced gas-
tric ulcerations (Hila & Castell, 2003). Although themotility andmost absorptive
functions of the small intestine arepreservedwith age, absorptionof vitaminB12,
folic acid, and carbohydrates declines (Holt, 2001). In addition, malabsorption
of calcium and vitamin D contributes to the risk of osteoporosis. Supplementa-
tion with calcium and vitamins D and B12 is now recommended for older adults
(Institute of Medicine, 1997; USDHHS, 2005).
Age-dependent weakening of the large intestine wall predisposes older
adults to diverticulosis andmay lead to diverticulitis (Hall, 2003). Becausemotil-
ity of the colon appears to be preserved with age, increased self-reports of con-
stipation in older adults may be attributed instead to altered dietary intake,
medications, inactivity, or illness (Jensen et al., 2001). Diminished rectal elas-
ticity, internal anal sphincter thickening, and impaired sensation to defecate
contribute to the risk of fecal incontinence in elders (Tariq, 2004 [Level V]),
although this condition is primarily found in combination with previous bowel
surgery or disease and not in normal aging (Schiller, 2001).
Pancreatic exocrine output of digestive enzymes is preserved to allow
normal digestive capacity with aging. An age-related decrease in gallbladder
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function increases the risk of gallstone formation (Ross & Forsmark, 2001). Al-
though liver size and blood flow decline with age, reserve capacity maintains
adequate hepatic function and values of liver-function tests remain stable; how-
ever, the liver is more susceptible to damage by stressors including alcohol and
tobacco. Associated with changes in the hepatic and intestinal cytochrome P450
system (Hall, 2003), clearance of a range of medications, including many benzo-
diazepines, declines to result in increased potential for dose-dependent adverse
reactions to these drugs (Regev & Schiff, 2001).
Decreased immune response of the gastrointestinal tract with age con-
tributes to a high risk for infectious and inflammatory diseases of this system
(Blechman&Gelb, 1999). Further, impaired enteric neuronal functionmayblunt
an older adult’s reaction to inflammation and infection and result in atypical pre-
sentation with symptoms such as confusion and fatigue rather than the typical
rigidity of peritonitis (Hall, 2002 [Level V]).
In the gastrointestinal evaluation, the abdomen and bowel sounds are as-
sessed. Liver size as well as reports of pain, anorexia, nausea, vomiting, and
altered bowel habits should be noted (Edwards, 2002 [Level V]). Assessment of
the oral cavity includes dentition and chewing capacity (see chapter 17, Oral
Health Care).
Weight is monitored with calculation of body mass index (BMI) and com-
pared to recommended values (Lichtenstein et al., 2006 [Level I]). Deficiencies
in diet can be identified through comparisons of dietary intake, using a 24- to
72-hour food intake record, with nutritional guidelines (Roberts & Dallal, 2005
[Level I]; USDHHS, 2000, 2005 [both Level I]). In addition, laboratory values of
serum albumin, prealbumin, and transferrin are useful nutritional indicators.
Low albumin concentration can also affect efficacy and potential for toxicity
of selected drugs, including digoxin and warfarin (Beyth & Shorr, 2002 [Level
V]). Several instruments for screening the nutritional status, eating habits, and
appetite of elders are available (McGee & Jensen, 2000 [Level V]) (see the Re-
sources and chapter 15, Nutrition).
Signs of dysphagia such as coughing or choking with solid or liquid food
intake should be reported for further evaluation (Shaker & Staff, 2001 [Level
V]). If aspiration from dysphagia is suspected, the lungs must be assessed for
the presence of infection, typically indicated by uni- or bilateral basilar crack-
les in the lungs, dyspnea, tachypnea, and cough (Seidel et al., 2003 [Level VI]).
A decline in function or change in mental status may signal atypical presenta-
tion of respiratory infection from aspiration (Kelley, 2002 [Level V]). Evaluation
of GERD is based on typical presenting symptoms of heartburn (pyrosis) and
acid regurgitation and atypical symptoms in older adults of dysphagia, chest
pain, hoarseness, vomiting, chronic cough, or recurrent aspiration pneumonia
(Edwards, 2002 [Level V]).
To assess constipation or fecal incontinence, a careful history with a 2-week
bowel log noting laxative use is needed (Tariq, 2004 [LevelV]). Fecal impaction is
assessed by digital examination of the rectumas ahardenedmass of feces, which
can be palpated. The impaction may also be palpated through the abdomen
(Kozier et al., 2000 [Level VI]).
For continuing care, referrals should be provided to a registered dietician
for poor food intake, unhealthy BMI (healthy BMI: 18.5–24.9 kg/m2; overweight:
25–29.9kg/m2; obesity: >30kg/m2) (Lichtenstein et al., 2006 [Level I]), and
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unintentional weight loss of >10% in 6 months (Hark, Bowman, & Bellini, 1999
[Level VI]); to a dentist for dentition and problems of the oral cavity; and to a
speech pathologist for dysphagia. Drug levels and liver-function tests are mon-
itored if drugs are metabolized hepatically (Beyth & Shorr, 2002 [Level V]). Ed-
ucation on lifestyle modifications and over-the-counter medications is valuable
in treatment of GERD (Edwards, 2002 [Level V]). Explanation of normal bowel
frequency, the importance of diet and exercise, and recommended types of laxa-
tives addresses constipation problems (Harari, 2003 [Level V]). Mobility should
be encouraged to prevent constipation and prophylactic laxatives should be pro-
vided if constipating medications such as opiates are prescribed (Stern, 2006
[Level V]). Community-based food and nutrition programs (Krassie & Roberts,
2001 [Level V]) and education on healthful diets utilizing the food pyramid for
elders may be useful in improving dietary intake (JNC, 2004 [Level I]; USDHHS,
2000, 2005 [both Level I]) (see chapter 15, Nutrition). Screening for colorectal
cancer is effective in reducing mortality from colorectal cancer and should be
encouraged (Takahashi, Okhravi, Lim, &Kasten, 2004 [Level V]; U.S. Preventive
Services Task Force [USPSTF], 2002 [Level I]).
Musculoskeletal System
Musculoskeletal tissues undergo age-associated changes that cannegatively im-
pact function in older adults (Levelser & Shakoor, 2003). In sarcopenia, or the
loss of muscle mass and strength, a decline in the size, number, and quality
of skeletal muscle fibers occurs with aging. Lean body mass is replaced by fat
and fibrous tissue (Levelser & Delbono, 2003) so that by age 75, only 15% of
the total body mass is muscle compared to 30% in a young, healthy adult (Mat-
sumura & Ambrose, 2006). These alterations result in diminished contractile
muscle force with increased weakness and fatigue plus poor exercise tolerance
(Fried & Walston, 2003). Age-specific physiological alterations contributing to
sarcopenia include reductions in muscle innervation, insulin activity, and sex-
steroid (i.e., estrogen, testosterone) and growth-hormone levels. Additionally,
individual factors such as weight loss, protein deficiency, and physical inactivity
can accelerate development of this condition to progress to a clinically signifi-
cant problem. Sarcopenia has been documented to adversely affect function in
older adults by increasing the risk of disability, falls, unstable gait, and need for
assistive devices. Physical activity, particularly strength training, and adequate
intake of energy and protein can prevent or reverse sarcopenia (Roubenoff &
Hughes, 2000).
Age-dependent bone loss occurs in both sexes and at all sites in the skeleton.
Whereas bone mass peaks between ages 30 and 35 (USDHHS, 2004a), density
decreases thereafter at a rate of 0.5% per year. This decrement, due to reduced
osteoblast activity in the deposition of new bone, is accompanied by deteri-
oration in bone architecture and strength. Further, for 5 to 7 years following
menopause during estrogen decline, bone loss in women accelerates to a 3%
to 5% annual rate (Simon, 2005). This loss, resulting from osteoclast activation
with elevated bone breakdown or resorption, occurs mainly in cancellous or
trabecular bone such as the vertebral body and may develop into Type I os-
teoporosis in women ages 51 to 75 who risk vertebral fractures. Following this
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postmenopausal period, bone loss slows again in women and involves cortical
bone in the long bones of the extremities (Dempster, 2003). With aging, both
women and men may develop Type II osteoporosis and are susceptible to hip
fractures and kyphosis from vertebral compression fractures in later life (Prest-
wood & Duque, 2003).
An age-associated decline in the strength of ligaments and tendons, which
are integral to normal joint function, predisposes to increased ligament and
tendon injury, more limited joint range of motion, and reduced joint stability,
leading to osteoarthritis (Levelser & Shakoor, 2003). Degeneration of interver-
tebral discs, due to dehydration and poor nutrient influx, elevates the risk of
spinal osteoarthritis, spondylosis, and stenosis with aging (Levelser & Delbono,
2003).
Gerontological changes in articular cartilage, which covers the bone end-
ings in joints to allow smooth movement, involve increased dehydration, stiff-
ening, crystal formation, calcification, and roughening of the cartilage surface.
Although these alterations have a minor effect on joint function under baseline
conditions, the aging joint is less capable ofwithstandingmechanical stress such
as caused by obesity or excess physical activity and is also more susceptible to
disease including osteoarthritis (Levelser & Delbono, 2003).
Age-dependent changes in stature include dorsal kyphosis, reduction in
height, flexion of the hips and knees, and a backward tilt of the head to compen-
sate for the thoracic curvature (Seidel et al., 2003 [Level VI]). A shorter stride,
reduced velocity, and broader base of support with feet more widely spaced
characterize modifications in gait with age (Sudarsky, 2001).
The musculoskeletal assessment includes inspection of posture, gait, bal-
ance, symmetry of body parts, and alignment of extremities. Kyphosis, bony
enlargements, or other abnormalities should be noted. Palpate bones, joints,
and surrounding muscles. Evaluate muscle strength on a scale of 0/5, symmetry,
and signs of atrophy of major upper and lower extremity muscle groups. Assess
active and passive range of motion for major joints and report pain, limitation
of range of motion (ROM), and joint laxity. Joint stabilization and slow move-
ments in ROM examinations are advised to prevent injury (Seidel et al., 2003
[LevelVI]). Functionality,mobility, fine and grossmotor skills, balance (Robbins,
Waked, & Krouglicof, 1998 [Level II]), and fall risk (Baum, Capezuti, & Driscoll,
2002 [Level V]) should be assessed (see chapter 3, Assessment of Function, and
chapter 9, Preventing Falls in Acute Care).
For continuing care, referrals to physical or occupational therapy may be
needed. Increased physical activity, including exercises for ROM (Netz et al.,
2005 [Level I]) and muscle strengthening and power (Fielding et al., 2002 [Level
II]) are recommended tomaintainmaximal function. Several interventions have
been evaluated to promote such behavior in elders and involve health educa-
tion, goal setting, and self-monitoring (Conn, Minor, Burks, Rantz, & Pomeroy,
2003; Conn, Valentine, & Cooper, 2002 [both Level I]). Painmedication should be
provided if needed to enhance functionality (see chapter 10, Pain Management).
Strategies to prevent falls (Carter, Kannus, & Kahn, 2001 [Level I]; see chap-
ter 9, Preventing Falls in Acute Care) and avoid physical restraints (see chapter
22, Physical Restraints and Side Rails in Acute and Critical Care Settings: Legal,
Ethical and Practice Issues) are appropriate.
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To prevent and treat osteoporosis, adequate daily intake of calcium (i.e.,
1,200 mg for women aged 50 and older) and vitamin D (400 IU for women aged
50 to 70 and 600 IU for women aged 71 and older) (USDHHS, 2004a [Level I]),
physical exercise, and smoking cessation are recommended (USDHHS, 2004b
[Level I]; USPSTF, 1996 [Level I]). In addition, routine bone-mineral density
screening for osteoporosis is advised for women 65 years and older as well as
women 60 to 64 years at increased risk of osteoporotic fractures (USPSTF, 2002
[Level I]).
Nervous System and Cognition
Gerontological alterations in the nervous system can affect function and cogni-
tion in elders. Changes include a reduced number of cerebral (Seidel et al., 2003
[Level VI]) and peripheral neurons (Hall, 2002 [Level V]), modifications in den-
drites and glial support cells in the brain, and loss and remodeling of synapses.
Decreased levels of neurotransmitters, particularly dopamine, as well as deficits
in systems that relay signals between neurons and regulate neuronal plasticity,
also occur with aging (Mattson, 2003 [Level V]).
Combined, these neurological changes contribute to impairments in general
muscle strength; deep-tendon reflexes; sensation of touch, pain, and vibration;
and nerve conduction velocity (Hall, 2002 [Level V]), which result in slowed
coordinated movements and increased response time to stimuli (Matsumura &
Ambrose, 2006). These clinical consequences, although relatively mild in nor-
mal aging, cause an overall slowing of motor skills with potential deficits in bal-
ance, gait, coordination, reaction time, and agility (Pakkar & Cummings, 2003
[Level VI]). Such decline in function can adversely affect an elder’s daily activ-
ities, notably ambulation and driving, and predispose to falls and injury (Craft,
Cholerton, & Reger, 2003 [Level V]).
Neurological changes, along with thinning of the skin, compromise ther-
moregulation in older adults, resulting in decreased sensitivity to ambient tem-
perature aswell as impaired heat conservation, production, and dissipationwith
predisposition to hypothermia and hyperthermia (Abrass, 2003). In addition,
febrile responses to infection may be blunted, particularly in the very old, frail,
or malnourished elder (Watters, 2002 [Level V]).
With age, the speed of cognitive processing slows (Bashore & Ridderinkhof,
2002 [Level I]) and somedegree of cognitive decline is common (Park,O’Connell,
& Thomson, 2003 [Level I]) but not universal in the elder population (Stewart,
2004). Older adults demonstrate significant heterogeneity in cognitive perfor-
mance, which may be positively impacted by education, good health, and phys-
ical activity (Christensen, 2001; Colcombe & Kramer, 2003 [Level I]).
Specific cognitive abilities exhibit differing levels of stability or decline with
age. For example, crystallized intelligence, or the information and skills acquired
from experience, remains largely intact, whereas fluid intelligence, or creative
reasoning and problem-solving, declines (Christensen, 2001). Sustained atten-
tion is unaffected by aging, although divided attention, or the ability to con-
centrate on multiple tasks concurrently, appears to deteriorate. The mild de-
cline in executive function, which includes the capability of directing behavior,
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making appropriate decisions, completing multistep tasks, and solving complex
problems, usually has minimal impact on an older adult’s ability to manage
daily activities. Although language abilities and comprehension appear stable,
spontaneous word finding may deteriorate and is often a complaint of older
adults (Craft et al., 2003). Remote memory, or recalling events in the distant
past, and procedural memory, or remembering ways to perform tasks, remain
intact, but declarative memory, or learning new information, is slowed (Bopp &
Verhaeghen, 2005). However, despite some deficits, memory functions are ade-
quate for normal life in successful aging (Henry, MacLeod, Phillips, & Crawford,
2004 [Level I]).
Changes in the nervous system increase the risk of sleep disorders (Floyd,
2002 [Level I]) and delirium in older adults, especially in acute care (see
chapter 7, Delirium: Prevention, Early Recognition, and Treatment). In addi-
tion, age-specific alterations predispose neurons to degeneration, contributing
to Alzheimer’s disease (Charter & Alekoumbides, 2004), Parkinson’s disease,
and Huntington’s disease, although neurotropic factors, including insulin-like
growth factor (Arwert, Deijen, & Drent, 2005), can counteract such neurodegen-
eration (Mattson, 2003 [Level V]).
Assessment, with periodic reassessment, of baseline functional status (see
chapter 3, Assessment of Function) should include evaluation of fall risk, gait,
and balance (see chapter 9, Preventing Falls in Acute Care) as well as basic,
instrumental, and advanced ADLs. During acute illness, functional status and
symptoms of delirium (see chapter 7, Delirium: Prevention, Early Recognition,
and Treatment) should be monitored. Evaluation of baseline cognition with pe-
riodic reassessment (see chapter 4, Assessing Cognitive Function) and sleep dis-
orders (Floyd, 2002 [Level I]) is warranted. The impact of physical and cognitive
changes of aging on an older adult’s level of safety and attentiveness in daily
tasks, such as driving, should be determined (Bashore & Rudderinkhof, 2002
[Level I]; Craft et al., 2003 [Level V]; Henry et al., 2004 [Level I]; Park et al.,
2003 [Level I]). Temperature indicating hypothermia (<35◦C) or hyperthermia
(>40.6◦C) must be closely watched (Abrass, 2003 [Level V]), whereas symptoms
of infection may present atypically with the absence of fever. Common symp-
toms to bemonitored (Watters, 2002 [Level V]) include fatigue (Hall, 2002 [Level
V]), decline in function, increased/new-onset confusion, and decreased appetite
(Kelley, 2002 [Level V]).
For care of an older adult, fall-prevention strategies should be implemented
(see chapter 9, Preventing Falls in Acute Care). If delirium is identified, nurs-
ing interventions for its treatment are needed (see chapter 7, Delirium: Preven-
tion, Early Recognition, and Treatment). Particularly during surgery, procedures
such as the use of warmed intravenous fluids and humidified gases should be
instituted to maintain normal temperatures and prevent hypothermia in the
older patient (Watters, 2002 [Level V]). Several lifestyle modifications are rec-
ommended to improve cognitive function and include regular physical exercise,
particularly aerobic fitness training for executive function (Colcombe&Kramer,
2003 [Level I]), intellectual stimulation (Mattson, 2003 [LevelV]), and ahealthful
diet (JNC, 2004 [Level I]; USDHHS, 2000 [Level I]). Reaction time training and
safe driving courses can serve to improve safety in the older adult (Craft et al.,
2003 [Level V]). Behavioral interventions for sleep disorders may be warranted
(Irwin, Cole, & Nicassio, 2006 [Level I]).
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Case Study and Discussion
Ms.M. is an 89-year-old woman presenting with productive cough, dyspnea,
fatigue, and increased confusion during the past week. Her vital signs are
pulse, 96 bpm; temperature, 98.6◦F; respirations, 31 bpm; and B/P 110/55. A
chest radiograph showsmultilobe infiltrates with a diagnosis of pneumonia.
How severe is her pneumonia?
Ms.M.’s symptomsof a respiratory rate of greater than 30 bpm,multilobe
infiltrates on a chest radiograph, and diastolic blood pressure of less than
60 mm Hg characterize her pneumonia as severe (Bartlett et al., 2000) and
she is likely to require admission to an intensive care unit. However, sev-
eral age-related changes affect her symptoms of pneumonia. Pneumonia
may present in an older adult with typical symptoms of productive cough,
fever, and dyspnea or with more insidious, atypical symptoms of tachypnea,
lethargy (Bartlett et al., 2000), weakness, falls, decline in functional status,
or increased/new-onset confusion.Decreased appetite anddehydrationmay
be the only initial symptoms (Kelley, 2002 [Level V]).
Because of reduced sympathetic innervation of the heart with age, the
heart rate of an older adult does not increase in response to stress com-
parable to that of a younger individual (Taffet & Lakatta, 2003 [Level VI]).
Thus, 96 bpm in an 89-year-old person is tachycardic and indicates a severe
stress reaction. Further, because of a blunted febrile response to infection
particularly in a very old, frail, or malnourished adult (Watters, 2002 [Level
V]), a fever or elevated WBC count may not be a presenting symptom/sign
even with severe infection.
Conclusion
Changes that occurwith age strongly impact the health and functionality of older
adults. Thus, recognition of and attention to these alterations are critically im-
portant in nursing assessment and care. Armed with knowledge of age-related
changes and utilizing the clinical protocol described in this chapter, nurses can
play a vital role in improving geriatric standards of practice. Designing inter-
ventions that consider gerontological changes, educating patients and family
caregivers on these alterations, and sharing information with professional col-
leagues all serve to ensure optimal care of older adults.
Resources
Agency forHealthcare Research andQuality, AHRQ, part of theU.S. Department
of Health and Human Services, provides evidence-based clinical practice
guidelines including U.S. Preventive Services Task Force recommendations.
Http://www.ahrq.gov
Administration onAgingTheAdministration onAging, an agency in theU.S.De-
partment of Health and Human Services, develops comprehensive systems
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of long-term care for older adults in the community.Web-based information
for professionals is available. http://www.aoa.gov
National Institute on Aging Part of the U.S. National Institutes of Health, the
NIA maintains a Web site with information on aging research as well as
links to other government Web sites on aging. http://www.nia.nih.gov
Health and Age Foundation HAF is an independent nonprofit organization pro-
vidingWeb-based information on health care for older adults for the general
public and health care professionals. http://www.healthandage.org
American Federation of Aging Research The Web site of AFAR, a nonprofit
organization that supports research on aging, contains information on the
biology of aging and approaches for successful aging. http://www.afar.org
Alliance for Aging Research The Web site of this nonprofit organization that
supports aging research has a searchable database on information pertain-
ing to aging. http://www.agingresearch.org
Smith-Kettlewell Eye Research Institute This nonprofit institute conducted a
longitudinal study of vision in older adults. http://www.ski.org
CRONOS The goal of the CRONOS (Cross-cultural Research on the Nutrition of
Older Subjects) project is to develop protocols to study the interaction of nu-
trition and aging. Gross, R., Solomons, N. W., Barba, C. V., de Groot, L., & Lin
Khor, G. (September 1997). Food and Nutrition Bulletin 18(3). Tokyo: United
Nations University Press. Retrieved on February 13, 2007, from http://www.
unu.edu/unupress/food/V183e/begin.htm
National Council on Aging (NCOA) This nonprofit organization with a national
network of more than 14,000 organizations and leaders from senior centers,
area agencies on aging, adult day service centers, faith-based service orga-
nizations, senior housing facilities, employment services, consumer groups,
and leaders from academia, business, and labor has information to help
older people remain healthy and independent, find jobs, increase access to
benefits programs, and discover meaningful ways to continue contributing
to society. http://www.ncoa.org/index.cfm
TheNationalGerontologicalNursingAssociation (NGNA)This national nursing
organization is dedicated to the clinical care of older adults across diverse
care settings. http://www.ngna.org/all.php
The National Conference of Gerontological Nurse Practitioners (NCGNP)
NCGNP represents nearly 3,500 certified GNPs in the country and a multi-
tude of family and adult NPs in geriatric practice. NCGNP has become the
organization of choice for NPs who want to pursue continuing education
in geriatric care and who seek peer support from experienced clinicians.
The Web site has information on regulatory and practice issues, continuing
education, and links to other sites. http://www.ncgnp.org/
The American Geriatrics Society (AGS) This is a not-for-profit organization
of 7,000 health professionals devoted to improving the health, indepen-
dence, and quality of life of all older people. The Society provides lead-
ership to health care professionals, policy makers, and the public by
implementing and advocating for programs in patient care, research, pro-
fessional and public education, and public policy. Information on clini-
cal practice guidelines for older adult care is available at the Web site.
http://www.americangeriatrics.org/
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Box 19.1
Nursing Standard of Practice Protocol: Age-Related
Changes in Health
I. GOAL: To identify anatomical and physiological changes, which are at-
tributed to the normal aging process.
II. OVERVIEW: Age-associated changes are most pronounced in advanced
age of 85 years or older, may alter the older person’s response to illness,
showgreat variability among individuals, are often impactedby genetic and
long-term lifestyle factors, and commonly involve a decline in functional
reserve with reduced response to stressors.
III. STATEMENT OF PROBLEM: Gerontological changes are important in
nursing assessment and care because they can adversely affect health
and functionality and require therapeutic strategies;must be differentiated
frompathological processes to allow development of appropriate interven-
tions; predispose to disease, thus emphasizing the need for risk evaluation
of the older adult; and can interact reciprocally with illness, resulting in
altered disease presentation, response to treatment, and outcomes.
IV. AGE-ASSOCIATED CARDIOVASCULAR CHANGES
A. Definition:
Isolated systolic hypertension: systolic BP >140 mm Hg and diastolic
BP <90 mm Hg.
B. Etiology
1. Arterial wall thickening and stiffening, decreased compliance.
2. Left ventricular and atrial hypertrophy.
3. Sclerosis of atrial and mitral valves.
4. Strongarterial pulses, diminishedperipheral pulses, cool extrem-
ities.
C. Implications
1. Decreased cardiac reserve.
a. At rest: No change in heart rate, cardiac output.
b. Under physiological stress and exercise: Decreased maximal
heart rate and cardiac output, resulting in fatigue, SOB, slow
recovery from tachycardia.
c. Risk of isolated systolic hypertension; inflamed varicosities.
d. Risk of arrhythmias, postural and diuretic-induced hypoten-
sion. May cause syncope.
V. PARAMETERS OF CARDIOVASCULAR ASSESSMENT
A. Cardiac assessment: ECG; heart rate, rhythm, murmurs, heart
sounds (S4 common, S3 in disease) (Seidel et al., 2003 [Level VI]).
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B. Assess BP (lying, sitting, standing) and pulse pressure (Kenney, 2003
[Level V]).
C. Palpate carotid artery & peripheral pulses for symmetry (Seidel et
al., 2003 [Level VI]).
VI. AGE-ASSOCIATED CHANGES IN THE PULMONARY SYSTEM
A. Etiology
1. Decreased respiratory muscle strength; stiffer chest wall with re-
duced compliance.
2. Diminished ciliary & macrophage activity, drier mucus mem-
branes. Decreased cough reflex.
3. Decreased response to hypoxia and hypercapnia.
B. Implications
1. Reduced pulmonary functional reserve.
a. At rest: No change.
b. With exertion: Dyspnea, decreased exercise tolerance.
2. Decreased respiratory excursion and chest/lung expansion with
less effective exhalation. Respiratory rate 12 to 24 bpm.
3. Decreased cough and mucus/foreign matter clearance.
4. Increased risk of infection and bronchospasm with airway ob-
struction.
VII. PARAMETERS OF PULMONARY ASSESSMENT
A. Assess respiration rate, rhythm, regularity, volume, depth
(Docherty, 2002 [Level I]), exercise capacity (Mahler et al.,
2003 [Level V]). Ascultate breath sounds throughout lung fields
(Mick & Ackerman, 2004 [Level V]).
B. Inspect thorax appearance, symmetry of chest expansion. Obtain
smoking history (Seidel et al., 2003 [Level VI]).
C. Monitor secretions, breathing rate during sedation, positioning
(Docherty, 2002 [Level I]; Watters, 2002 [Level V]), arterial blood
gases, pulse oximetry (Zeleznik, 2003 [Level V]).
D. Assess cough, need for suctioning (Smith & Connolly, 2003
[Level V]).
VIII. NURSING-CARE STRATEGIES
A. Maintain patent airways through upright positioning/repositioning
(Docherty, 2002 [Level I]), suctioning (Smith & Connolly, 2003
[Level V]), bronchodilators (National Heart, Lung, and Blood In-
stitute, 1996 [Level I]).
B. Provide oxygen as needed (Docherty, 2002 [Level I]).
C. Incentive spirometry as indicated, particularly if immobile or de-
clining in function (Dunn, 2004 [Level V]).
D. Maintain hydration and mobility (Watters, 2002 [Level V]).
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E. Education on cough enhancement (Dunn, 2004 [Level V]), smoking
cessation (USDHHS, 2004b [Level I]).
IX. AGE-ASSOCIATED CHANGES IN THE RENAL AND GENITOURINARY
SYSTEMS
A. Definitions:
Cockcroft-Gault Equation: Calculation of creatinine clearance in
older adults:
For Men
Creatinine clearance
(mL/min) =
(140 − age in years) × (body weight in kg)
72 × (serum creatinine, mg/dL)
For women, the calculated value is multiplied by 85% (0.85).
B. Etiology
1. Decreases in kidney mass, blood flow, glomerular filtration rate
(10% decrement/decade after age 30). Decreased drug clearance.
2. Reduced bladder elasticity, muscle tone, capacity.
3. Increased postvoid residual, nocturnal urine production.
4. In males, prostate enlargement with risk of benign prostatic hy-
perplasia (BPH).
C. Implications
1. Reduced renal functional reserve; risk of renal complications in
illness.
2. Risk of nephrotoxic injury and adverse reactions from drugs.
3. Risk of volume overload (in heart failure), dehydration, hy-
ponatremia (with thiazide diuretics), hypernatremia (associated
with fever), hyperkalemia (with potassium-sparing diuretics).
Reduced excretion of acid load.
4. Increased risk of urinary urgency, incontinence (not a normal
finding), UTI, nocturnal polyuria. Potential for falls.
X. PARAMETERS OF RENAL AND GENITOURINARY ASSESSMENT
A. Assess renal function (creatinine clearance) (Beck, 1998 [Level V]).
B. Assess choice/need/dose of nephrotoxic agents and renally cleared
drugs (Beyth & Shorr, 2002 [Level V]) (see chapter 12, Reducing
Adverse Drug Events).
C. Assess for fluid/electrolyte and acid/base imbalances (Suhayda &
Walton, 2002 [Level V]).
D. Evaluate nocturnal polyuria (Miller, 2003 [Level V]), urinary in-
continence, BPH. Assess UTI symptoms (Bradway & Yetman, 2002
[Level V]).
E. Assess fall risk if nocturnal or urgent voiding (see chapter 9, Pre-
venting Falls in Acute Care)
XI. NURSING-CARE STRATEGIES
A. Monitor nephrotoxic and renally cleared drug levels (Beyth & Shorr,
2002 [Level V]).
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B. Maintain fluid/electrolyte balance. Minimum 1,500–2,500 mL/day
from fluids and foods for 50 to 80 kg adults to prevent dehydration
(Suhayda & Walton, 2002 [Level V]).
C. For nocturnal polyuria: limit fluids in evening, avoid caffeine, use
prompted voiding schedule (Miller, 2003 [Level V]).
D. Fall prevention for nocturnal or urgent voiding (see chapter 9, Pre-
venting Falls in Acute Care).
XII. AGE-ASSOCIATED CHANGES IN THE OROPHARYNGEAL AND
GASTROINTESTINAL SYSTEMS
A. Definition:
BMI: Healthy: 18.5–24.9 kg/m2; overweight: 25–29.9 kg/m2; obesity:
>30 kg/m2.
B. Etiology
1. Decreases in strength of muscles of mastication, taste, and thirst
perception.
2. Decreased gastric motility with delayed emptying. Atrophy of
protective mucosa.
3. Malabsorption of carbohydrates, vitamins B12 and D, folic acid,
calcium.
4. Impaired sensation to defecate.
5. Reduced hepatic reserve. Decreased metabolism of drugs.
C. Implications
1. Risk of chewing impairment, fluid/electrolyte imbalances, poor
nutrition.
2. Gastric changes: altered drug absorption, increased risk of gas-
troesophageal reflux disease (GERD), maldigestion, NSAID-
induced ulcers.
3. Constipation not a normal finding. Risk of fecal incontinence
with disease (not in healthy aging).
4. Stable liver function tests. Risk of adverse drug reactions.
XIII. PARAMETERS OF OROPHARYNGEAL AND GASTROINTESTINAL
ASSESSMENT
A. Assess abdomen, bowel sounds (Edwards, 2002 [Level V]).
B. Assess oral cavity (see chapter 17, Oral Health Care); chewing and
swallowing capacity, dysphagia (coughing, choking with food/fluid
intake) (Shaker & Staff, 2001 [Level V]). If aspiration, assess lungs
(rales) for infection and typical/atypical symptoms (Bartlett et al.,
2000 [Level I]; Kelley, 2002 [Level V]).
C. Monitor weight, calculate BMI, compare to standards (Lichten-
stein et al., 2006 [Level I]). Determine dietary intake, compare to
nutritional guidelines (USDHHS, 2005 [Level I]) (see chapter 15,
Nutrition).
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D. Assess for GERD (Edwards, 2002 [Level V]); constipation and fecal
incontinence; fecal impaction by digital examination of rectum or
palpation of abdomen (Tariq, 2004 [Level V]).
XIV. NURSING-CARE STRATEGIES
A. Monitor drug levels and liver function tests if on medications me-
tabolized by liver. Assess nutritional indicators (McGee & Jensen,
2000 [Level V]).
B. Educate on lifestyle modifications and OTC medications for GERD
(Edwards, 2002 [Level V]).
C. Educate on normal bowel frequency, diet, exercise, recommended
laxatives. Encourage mobility, provide laxatives if on constipating
medications (Harari, 2003 [Level V]).
D. Encourage participation in community-based nutrition programs
(Krassie&Roberts, 2001 [Level V]); educate on healthful diets (US-
DHHS, 2000, 2005 [both Level I]).
XV. AGE-ASSOCIATED CHANGES IN THE MUSCULOSKELETAL SYSTEM
A. Definition:
Sarcopenia: Decline in muscle mass and strength associated with
aging.
B. Etiology
1. Sarcopenia with increased weakness and poor exercise toler-
ance.
2. Lean body mass replaced by fat with redistribution of fat.
3. Bone loss in women and men after peak mass at 30 to 35 years.
4. Decreased ligament and tendon strength. Intervertebral disc de-
generation. Articular cartilage erosion. Changes in stature with
kyphosis, height reduction.
C. Implications
1. Sarcopenia: increased risk of disability, falls, unstable gait.
2. Risk of osteopenia and osteoporosis.
3. Limited ROM, joint instability, risk of osteoarthritis.
XVI. NURSING-CARE STRATEGIES
A. Encourage physical activity through health education and goal set-
ting (Conn et al., 2003 [Level I]; Conn et al., 2002 [Level I]) to
maintain function (Fielding et al., 2002 [Level II]; Netz et al., 2005
[Level I]).
B. Pain medication to enhance functionality (see chapter 10, Pain
Management). Implement strategies to prevent falls (Carter et al.,
2001 [Level I]) (see chapter 9, Preventing Falls in Acute Care, and
chapter 22, Physical Restraints and Side Rails in Acute and Critical
Care Settings: Legal, Ethical, and Practice Issues).
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C. Prevent osteoporosis by adequate daily intake of calcium and vi-
tamin D (USDHHS, 2004a [Level I]), physical exercise, smoking
cessation (USDHHS, 2004b [Level I]; USPSTF, 1996 [Level I]).
Advise routine bone-mineral density screening (USPSTF, 2002
[Level I]).
XVII. AGE-ASSOCIATED CHANGES IN THE NERVOUS SYSTEM AND
COGNITION
A. Etiology
1. Decrease in neurons and neurotransmitters.
2. Modifications in cerebral dendrites, glial support cells,
synapses.
3. Compromised thermoregulation.
B. Implications
1. Impairments in general muscle strength; deep-tendon reflexes;
nerve conduction velocity. Slowed motor skills and potential
deficits in balance and coordination.
2. Decreased temperature sensitivity. Blunted febrile response to
infection.
3. Slowed speed of cognitive processing. Some cognitive decline
is common but not universal. Most memory functions adequate
for normal life.
4. Increased risk of sleep disorders, delirium, neurodegenerative
diseases.
XVIII. PARAMETERS OF NERVOUS SYSTEM AND COGNITION
ASSESSMENTS
A. Assess, with periodic reassessment, baseline functional status
(Craft et al., 2003 [LevelV]) (see chapter 3,Assessment of Function,
and chapter 9,Preventing Falls inAcute Care). During acute illness,
monitor functional status and delirium (see chapter 7, Delirium:
Prevention, Early Recognition, and Treatment).
B. Evaluate, with periodic reassessment, baseline cognition (see
chapter 4, Assessing Cognitive Function) and sleep disorders
(Floyd, 2002 [Level I]) (see chapter 20; Excessive Sleepiness).
C. Assess impact of age-related changes on level of safety and atten-
tiveness in daily tasks (e.g., driving) (Henry et al., 2004 [Level I];
Park et al., 2003 [Level I]).
D. Assess temperature during illness or surgery (Abrass, 2003 [Level
V]). Monitor atypical symptoms of infection, absent fever.
XIX. NURSING-CARE STRATEGIES
A. Institute fall preventions strategies (see chapter 9, Preventing Falls
in Acute Care).
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B. Tomaintain cognitive function, encourage lifestyle practices of reg-
ular physical exercise (Colcombe & Kramer, 2003 [Level I]), intel-
lectual stimulation (Mattson, 2003 [Level V]), and healthful diet
(Joint National Committee, 2004 [Level I]).
C. Recommend reaction time training and safe driving courses to im-
prove safety (Craft et al., 2003 [Level V]).
D. Recommend behavioral interventions for sleep disorders (Irwin et
al., 2006 [Level I]).
XX. EVALUATION AND EXPECTED OUTCOMES (FOR ALL SYSTEMS)
A. Older adult will experience successful aging through appropriate
lifestyle practices and health care.
B. Health care provider will:
1. Identify normative changes in aging and differentiate these from
pathological processes.
2. Develop interventions to correct for adverse effects associated
with aging.
C. Institution will:
1. Develop programs to promote successful aging.
D. Will provide staff education on age-related changes in health.
XXI. FOLLOW-UP MONITORING OF CONDITION
A. Continue to reassess effectiveness of interventions.
B. Incorporate continuous quality improvement criteria into existing
programs.
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Educational Objectives
On completion of this chapter, the reader should be
able to:
1. identify the signs and symptoms of excessive
sleepiness and quantify them using a standardized
scale
2. describe the signs, symptoms, and usual
treatments for the most primary sleep disorders
causing excessive sleepiness in older adults:
obstructive sleep apnea, restless leg syndrome,
and insomnia
3. discuss the implications of chronic illness and
medications on sleep
4. plan appropriate sleep hygiene interventions for
the patient with excessive sleepiness
5. provide nursing care that incorporates sleep
hygiene measures and provides consistent
ongoing treatment for existing sleep disorders
6. educate patients and families about sleep
disorders and sleep hygiene measures
Excessive sleepiness, sometimes called excessive daytime sleepiness, is com-
mon in the elderly. Distinct from fatigue, which manifests as difficulty in sus-
taining a high level of performance, excessive sleepiness refers to the inability to
maintain alertness, with characteristic hypersomnolence. Causes for excessive
sleepiness include age-related changes in chronobiology and sleep disorders, as
well as other medical and psychological disorders, medications, environmental
factors, and lifestyle factors. In older adults, the most common primary sleep
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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disorders are obstructive sleep apnea (OSA), restless leg syndrome, and insom-
nia. The extent to which changes in sleep patterns experienced by older adults
are due to normal physiological alterations, pathological events, sleep disorders,
or poor sleep hygiene remains unclear. The cause of excessive sleepiness may
also be a chronic health condition that interferes with sleep quality or quan-
tity. Thus, the problem of excessive sleepiness can be more complicated than a
straightforward diagnosis and treatment. There are many effective treatments
for sleep disorders, but the first step is to identify the cause of excessive day-
time sleepiness and to quantify and aggressively treat this condition in the older
adult. The primary purpose of this chapter is to provide a brief summary of sleep
disorders common in older adults becausemanypracticing nurses havenoback-
ground in the science of sleep (see Box 20.1 for clinical practice protocol).
Daytime sleepiness is viewed as normal or unpreventable behavior in older
adults. This misperception prevents many older adults from seekingmedical at-
tention and also reduces the likelihood that health care providers will evaluate,
treat, or refer patients who present with clear symptoms of excessive sleepiness.
However, this symptom should not be dismissed as an insignificant condition.
Additionally, the disorder underlying the excessive sleepiness can have signifi-
cant health effects. OSA, for example, is associated with cardiovascular disease
anddiabetes. TheSleepHeartHealth Study showed thatmild tomoderate sleep-
disordered breathing is associated with cardiovascular disease (Newman et al.,
2000 [Level III]; Nieto et al., 2000 [Level III]) and reduced vitality, and severe
sleep-disordered breathing ismore broadly associatedwith poorer quality of life
(Baldwin et al., 2001 [Level III]). In addition, car crashes (George, 2001 [Level
III]) and falls (Brassington, King, & Bliwise, 2000 [Level III]) are some of the
obvious consequences of sleepiness. Further, in acute care settings, the care of
patients with excessive sleepiness become more complicated when either the
underlying causes of sleepiness are not yet diagnosed or the plan of care does
not reflect maintenance of ongoing treatments for excessive sleepiness.
Background
The Institute ofMedicine (IOM) (Colten&Altevogt, 2006) reports that 50million
to 70 million Americans are affected by chronic disorders of sleep and wake-
fulness. These conditions are among the most common health problems, yet
health care providers frequently overlook them. The combined effects of undi-
agnosed and untreated sleep disorders along with sleep deprivation constitute
an unmet public health problem. For example, according to the 2002 “Sleep in
America” survey (National Sleep Foundation, 2002 [Level III]), 27% of Amer-
icans categorize their sleep as fair or poor. Of the 1,010 subjects polled, 37%
reported symptoms of sleepiness (i.e., 7% daily or almost daily; 9%, a few days a
week; and 20%, a few days a month). However, far fewer of those surveyed had
been diagnosed with the most common causes of sleepiness, such as insomnia
(6%), sleep apnea (4%), or restless legs syndrome (4%), and even fewer had been
treated for these conditions (4%, 2%, and 1%, respectively). The Cardiovascular
Health Study documented excessive sleepiness in 20% of 4,578 subjects older
than age 65 (Whitney et al., 1998 [Level III]). It is not surprising that excessive
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daytime sleepiness and sleep disorders are more common in patients in acute-
and chronic-care settings. For example, among persons older than 65, Ancoli-
Israel and colleagues (1991 [Level IV], 1987 [Level IV]) found undiagnosed OSA
in 24% of those living independently, in 33% of those in acute care settings, and
in 42% of older adults in nursing home settings.
Consequences of Excessive Sleepiness
The primary consequences of sleepiness are decreased alertness, delayed reac-
tion time, and reduced cognitive performance. Decreased reaction time and lack
of sustained attention can contribute to accidental and work-related injuries.
For example, approximately 56,000 car crashes per year are attributed to falling
asleep at thewheel (Knipling&Wang, 1994 [Level IV]). Furthermore, the effects
of sleepiness can be long-lasting. Recent studies show that daytime sleepiness
is significantly associated with declining cognitive function (Cohen-Zion et al.,
2001 [Level III]), falls (Brassington et al., 2000 [Level III]), and cardiovascular
events (Whitney et al., 1998 [Level III]). In the Cardiovascular Health Study,
daytime sleepiness was the only sleep symptom associated with mortality, in-
cident cardiovascular disease morbidity and mortality, myocardial infarction,
and congestive heart failure, particularly among women (Newman et al., 2000
[Level III]). Thus, sleep loss or sleep disorders may play a part in accidental
or workplace injury, cardiovascular morbidity, or cognitive impairment among
older adults with excessive sleepiness.
Physiological Changes in Sleep That Accompany Aging
Normal changes in sleep that occur as part of humandevelopment should be dif-
ferentiated from pathological sleep conditions that increase in prevalence with
aging. Although older adults require as much sleep as younger adults, older
adults may divide their sleep between nighttime slumber and daytime naps,
rather than a single consolidated period at night. The endogenous circadian
pacemaker located in the suprachiasmatic nucleus, along with exogenous en-
vironmental cues and a homeostatic need for sleep, mediate the normal wake
and sleep pattern. With aging, the circadian pattern for sleep–wake decreases
in amplitude, possibly in association with less robust changes in core body tem-
perature (Richardson, Carskadon, &Orav, 1982). Comparedwith younger adults,
healthy older adults have amore pronounced biphasic pattern of sleepiness dur-
ing the afternoon hours (about 2 p.m. to 6 p.m.) and a phase advancement of
nighttime sleepiness earlier in the evening (Roehrs, Turner, & Roth, 2000 [Level
IV]).
Changes in sleep architecture associated with normal aging include an in-
crease in transient arousals, an increase in time until sleep onset as well as stage
1 sleep, and a decrease in the quantity and amplitude of restorative slow-wave
sleep (stages 3 and 4). Although older women report more sleep disturbances
than older men; studies indicate that their sleep is less disturbed than that of
men (Rediehs, Reis, & Creason, 1990 [Level I]).
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Primary Causes of Excessive Daytime Sleepiness
Obstructive Sleep Apnea
OSA is a condition in which intermittent pharyngeal obstruction causes cessa-
tion of respiratory airflow (for at least 10 seconds) and often oxygen desatura-
tion. This results in an arousal that restores upper-airway patency, permitting
breathing and airflow to resume. According to the American Academy of Sleep
Medicine Task Force (1999 [Level I]), OSA is diagnosedwhen these events occur
at a rate of greater than five per hour of sleep and is accompanied by snoring,
gasping, daytime sleepiness, and impaired daytime functioning. However, it is
common for patients with severe symptoms to experience multiple arousals
during the night, which severely fragmented sleep, preventing the deep sleep
(stages 3 and 4) and rapid eye movement (REM) sleep necessary for healthy
mental and physical functioning.
OSA is both an age-related and an age-dependent condition, with an over-
lap in both distributions in the 60- to 70-year-old age range (Bliwise, King, &
Harris, 1994). Age-related risk factors for OSA in older adults include an in-
creased prevalence of overweight and obesity; age-dependent risk factors with
old age are increased collapsibility of the upper airway, decreased lung capacity,
altered ventilatory control, decreased muscular endurance, and altered sleep
architecture (Brassington et al., 2000 [Level III]).
Treatments for sleep apnea depend on the contributing pathology and pa-
tient preference and include nocturnal positive airway pressure, surgical proce-
dures (i.e., palatoplasty to reduce airway encroachment), and other techniques
designed to increase the posterior pharyngeal area, oral appliances, and weight
reductionwhenobesity is a contributing factor.Nasal continuous positive airway
pressure (CPAP) therapy is currently the “gold standard” for treating OSA and is
highly effective when individually titrated to eliminate apneas and hypopneas
(Morgenthaler et al., 2006 [Level I]). Older adults tolerate CPAP therapy, with
patterns of compliance similar to that ofmiddle-aged adults (Weaver &Chasens,
2007 [Level I]).
Insomnia
Insomnia can be defined as delayed sleep onset, premature waking, and/or very
early arousals that result in nonrestorative sleep (Ancoli-Israel & Ayalon, 2006
[Level I]). Although it remains unclear whether insomnia is an organic, psycho-
logical, pharmacological, chronobiological or behavioral problem and is associ-
ated with cardiovascular, respiratory, gastrointestinal, renal, and musculoskele-
tal disorders. Insomnia can be transient or chronic, and the perception of sleep
duration may not correspond to objective assessment. The frequent awaken-
ings suggestive of insomnia may be a conditioned arousal response due to envi-
ronmental (e.g., noise or extremes of temperature) or behavioral cues. Anxiety
associated with emotional conflict, stress, recent loss, feeling insecure at night,
or change in living arrangements can also produce insomnia (Ancoli-Israel &
Ayalon, 2006 [Level I]). The general anxiety and conditioned arousal response
at sleep onset associated with insomnia may prompt frequent use of hypnotic
medication, a common treatment for insomnia. Although the use of hypnotics
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may produce temporary symptom relief, they also affect sleep architecture and
consequently lead to deterioration in the quality of sleep. A cycle of dependency
and abuse can occur and is a potential problem in this age group (see chapter 12,
Reducing Adverse Drug Events).
Research has shown the negative effects of continued hypnotic use in the
elderly; however, recent data suggest otherwise. Avidan et al. (2005 [Level I])
examined the effects of hypnotic use and insomnia as predictors of falls in the
elderly in more than 34,000 residents of Michigan nursing homes. They found
that insomnia was a predictor of falls but hypnotic use was not a significant indi-
cator. Thus, there is an ongoing debate regarding insomnia, the use of hypnotics,
and falls among nursing home residents. At this time, the general recommenda-
tion is that when hypnotics are indicated that the most short-acting drug should
be selected and, optimally, used in conjunction with an appropriate behavioral
intervention (Ancoli-Israel, 2000 [Level I]).
The cause and duration of insomnia should be the primary determinant
of the most appropriate treatment. For example, insomnia associated with a
psychological origin, such as depression or anxiety, is best treated from that
perspective. If pain is affecting sleep adjustment, pain medication should be
attempted first and strategies to promote sleep onset should be added to the
pain-management plan. If insomnia is of recent onset, then short-term phar-
macotherapy is suitable for transient symptoms. Where insomnia is “learned”
and this maladaptation interferes with the initiation of sleep, behavioral inter-
ventions are most appropriate. The American Academy of Sleep Medicine has
published a comprehensive review of nonpharmacologic treatments used for
chronic insomnia (Morin et al., 1999 [Level I]). Their findings indicate that 70%
to 80% of patients benefit from behavioral therapies and that improvement in
sleep is sustained for a minimum of 6 months after treatment. The three treat-
ments that meet the American Psychological Association criteria for empirically
supported effectiveness for insomnia are stimulus control, progressive muscle
relaxation, andparadoxical intention. In addition, sleep restriction, biofeedback,
and multifaceted cognitive-behavior therapy meet their criteria for “probable”
effectiveness.
Restless Legs Syndrome
Restless legs syndrome is a disorder characterized by an almost irresistible
urge to move the limbs, usually associated with disagreeable leg sensations that
are worse during inactivity and often interferes with initiating and maintain-
ing sleep. As a secondary condition, this movement disorder can be caused by
iron-deficiency anemia, uremia, neurological lesions, diabetes, Parkinson’s dis-
ease, or rheumatoid arthritis, or it can be a side effect of certain drugs (e.g., tri-
cyclic antidepressants, serotonin reuptake inhibitors, lithium, dopamine block-
ers, xanthines). Periodic leg movement disorder is a similar chronic condition
also known as nocturnal myoclonus. This condition is characterized by invol-
untary flexion of the leg and foot that produces micro-arousals or full arousals
from sleep, which fragment sleep and interfere with achieving and maintain-
ing restorative slow-wave sleep (i.e., stages 3 and 4). Although the etiology
and associated mechanism of this specific movement disorder are not well de-
fined, these movements have been linked to metabolic, vascular, and neurologic
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20.1 The Epworth Sleepiness Scale
Instructions to the patient: The following questionnaire will help you measure your
general level of daytime sleepiness. It asks you to rate the likelihood that you will doze off
or fall asleep during various routine daytime situations. How likely are you to doze off or
fall asleep in the following situations, in contrast to just feeling tired? Even if you haven’t
done some of these things recently, think about how they would have affected you.
Use the following scale to choose the most appropriate number for each situation:
0 = would never doze
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing
Situation Circle your score for each item
Sitting and reading 0 1 2 3
Watching television 0 1 2 3
Sitting inactive in a public place, for example, a
theater or meeting
0 1 2 3
Riding as a passenger in a car for an hour without
a break
0 1 2 3
Lying down to rest in the afternoon 0 1 2 3
Sitting and talking to someone 0 1 2 3
Sitting quietly after lunch (when you’ve had
no alcohol)
0 1 2 3
In a car, while stopped in traffic 0 1 2 3
Score Results:
1–6
7–8
9–16
≥17
Getting enough sleep
Tends to be sleepy but is average
Very sleepy and should seek medical advice
Dangerously sleepy
Printed with permission: Johns, M. W. (1991). A new method for measuring daytime sleepiness: The
Epworth Sleepiness Scale. Sleep, 14, 540–545.
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causes. Dopaminergic drugs are the most effective agents for treating restless
legs syndrome and periodic leg movement disorder. Other drugs, including opi-
oids, benzodiazepines, anticonvulsants, adrenergics, and iron supplements, are
also used to treat these disorders. However, their efficacy for long-term treat-
ment in older adults has not been sufficiently evaluated (Ancoli-Israel &Ayalon,
2006 [Level I]; Gamaldo & Earley, 2006 [Level I]).
Secondary Causes of Excessive Daytime Sleepiness
Medical and psychiatric illness can also disturb sleep or interfere with sleep
quality and quantity. For example, psychiatric illnesses such as depression or
anxiety can cause insomnia. Also, painful chronic conditions, such as arthritis,
reduce sleep efficiency by causing the elder to wake frequently due to the pain
caused by simply changing body position during sleep. Likewise, because older
adults frequently have multiple medical conditions, they are also more likely
to take over-the-counter (OTC) and prescription medications to manage their
symptoms. However, many medications and nonprescription drugs (e.g., pseu-
doephedrine, alcohol, caffeine, and nicotine) interfere with sleep. Thus, health
care providers must be acutely aware of the role that illness and OTC medica-
tions may play in contributing to sleep disturbances. Both symptom manage-
ment and prevention of polypharmacy are important aspects of care of older
adults to protect and promote sleep in this high risk group (Ancoli-Israel, 2005
[Level I]).
Assessment of Excessive Sleepiness
Several valid and reliable measures are useful to screen for sleepiness. One
of the most commonly used instruments is the Epworth Sleepiness Scale (Ta-
ble 20.1) (Johns, 1991 [Level IV]), which has been widely disseminated on the
Internet in recent years. The likelihood of having OSA can be determined us-
ing the Multivariable Apnea Prediction Index (Maislin et al., 1995 [Level IV]).
The Functional Outcomes of Sleep Questionnaire (Weaver et al., 1997 [Level
IV]) evaluates the impact of daytime sleepiness on functional status, and the
Pittsburgh Sleep Quality Scale (Buysse, Reynolds, Monk, Berman, & Kupfer,
1989 [Level IV]) quantifies sleep quality over the past month (see Sleep topic
at www.ConsultGeriRN.org). Because it is so readily available, many sleep clin-
icians use the Epworth Sleepiness Scale to track sleepiness over the previous
week that may occur during common activities, such as sitting and reading,
watching TV, or riding in a car. It is easy to administer and to score, and it has
scoring parameters to indicate when sleepiness clearly warrants a more com-
plete evaluation by a sleep specialist. A brief sleep history can be obtained by
using the questionnaire in Table 20.2. Table 20.3 presents the criteria for grad-
ing the severity of sleepiness developed by the American Academy of Sleep
Medicine Task Force (1999 [Level I]). In a sleep laboratory, quantitation of
sleep parameters is done using polysomnography. Additional electrophysiologi-
cal tests, such as theMultiple Sleep Latency Test, are also used to assess daytime
sleepiness. Most important in the assessment of sleepiness is an evaluation of
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20.2 Sleep History
Basic Sleep History
Questions Follow-Up Questions
Sleep Disorders to
Consider
■ Do you have any difficulty
falling asleep?
■ Are you having any difficulty
sleeping until morning?
■ Are you having difficulty
sleeping throughout the
night?
■ Have you or anyone else
ever noticed that you snore
loudly or stop breathing in
your sleep?
■ Do you find yourself falling
asleep during the day when
you don’t want to?
■ What time do you usually go to
bed?
■ Fall asleep?
■ What prevents you from falling
asleep?
■ Review intake of alcohol,
nicotine, caffeine, all
medications.
■ Review of depressive
symptoms; weight loss,
sadness, or recent losses.
■ How often do you waken?
■ How long are you awake?
■ Do you have any pain,
discomfort, or shortness of
breath during the night?
■ What prevents you from falling
back to sleep?
■ Are you sleepy or tired during
the day?
■ Review risk factors (e.g.,
obesity, arthritis, poorly
controlled illnesses).
■ If you laugh or get angry, do you
feel weak (as if you might fall
down or drop what you are
holding)?
■ Do your legs kick or jump
around while you sleep?
■ Shift work/sleep schedule
disorders
■ Psychophysiologic insomnia
■ Restless legs syndrome
■ Psychiatric disorders
■ Substance/medications-
related
disorders
■ Depression
■ Insomnia
■ Medical causes of sleep
disturbance
■ Obstructive sleep apnea
■ Functional impairment
resulting from sleep disorder
■ Narcolepsy
■ Periodic leg movement
disorders
Source: Adapted from Avidan (2005) and National Center on Sleep Disorders Research Working Group (1999).
the patient’s knowledge and application of sleep-hygiene measures (Table 20.4)
to complement clinical findings and as simple behavioral strategies to consoli-
date sleep, as well as to promote and protect sleep.
Interventions and Care Strategies
The first line of defense against excessive sleepiness is a lifestyle that promotes
and ensures adequate sleep and rest. Although there is a natural drive to sleep,
environment andhabituation—that is, sleephygiene—plays an important part in
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20.3 Severity Criteria for Sleepiness
Mild Episodes of unwanted sleepiness or involuntary sleep occur only during
activities that require little attention, such as watching television, reading, or
traveling as a passenger in a moving vehicle.
Moderate Episodes of unwanted sleepiness or involuntary sleep occur during
activities that require some attention.
Sleepiness causes moderate impairment of social and occupational
function.
Occurs during activities such as attendance at concerts, presentations, and
meetings.
Severe Episodes of unwanted sleepiness or involuntary sleep occur when more
active attention is required, such as while eating, walking, standing, driving,
or even during conversations or sex.
Sleepiness markedly impairs social and occupational function.
Source: Adapted from American Academy of Sleep Medicine Task Force, 1999.
20.4 Sleep Hygiene Measures
■ Use the bed only for sleeping or sex.
■ Develop consistent and rest-promoting bedtime routines.
■ Maintain the same bedtime and waking time every day.
■ Exposure to bright sunlight is desirable upon awakening but should be avoided just
before bedtime.
■ Upon awakening, get out of bed slowly, no matter what time it is, to prevent postural
hypotension.
■ If awakened during the night, avoid looking at the clock; frequent time checks may
heighten anxiety and hinder sleep onset.
■ Avoid naps entirely or limit naps to 10 to 15 minutes’ duration.
■ Sleep in a cool, quiet environment.
■ If you cannot fall asleep after 15 or 20 minutes in bed, get up and go into another room,
read, or do a quiet activity, using dim lighting, until you are sleepy again. (Avoid
watching television because it emits a bright light.)
■ Sleeping alone is more restful than sleeping with another person or pets. If pets or bed
partners add to the problem, move to the couch for a couple of nights, and restrict pets
from sharing the bed.
■ Before bedtime, avoid the following:
■ caffeine and nicotine after noon
■ alcohol intake (more than 3 drinks)
■ large meals or exercise 3 to 4 hours before bedtime
■ emotional upset or emotionally charged activities
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being able to obtain quality sleep. Sleep hygiene hasmany components and each
bears review and reinforcement over time. Regardless of health status, sleep-
hygiene measures are as important for older adults as they are for children,
adolescents, and other adults.
It bears repeating that excessive daytime sleepiness is only the general
symptom of a more specific problem. Consequently, individualized plans of care
must include treatment of known sleep disorders, and nurses in acute care set-
tings must be able to identify sleep disorders in their patients. Sleep disorders
are not just bothersome, they can complicate care and pose important risks if
they are not diagnosed and treated.
Case Study and Discussion
Scenario
Mrs. M. complained to her friends that her husband snores “loud enough
to wake the dead” and “stops breathing for maybe 30 seconds or so,” which
keeps her awake at night. She relates that they “don’t have sex very often,”
he had difficulty with “doing it,” they are both too tired to be “in the mood,”
and she has started sleeping in another room. Her friends have urged her
to have her husband report the history and symptoms to his primary-care
physician.
History
Mr. M. is a 62-year-old man who is obese (height, 6’2”; weight, 260 lbs.; BMI,
33.4). He is hypertensive (sitting blood pressure, 154/98 mm Hg) and takes
several medications to control his blood pressure (i.e., amlodipine, digoxin,
hydrochlorothiazide, lisinopril, pravastatin, enteric-coated aspirin). He was
diagnosed with Type II diabetes almost 10 years ago (HgbA1c, 8.2%) and is
on metformin 1,000 mg BID and glimepiride 2 mg daily.
Symptoms
Mr. M. says, “I have no energy. I can sleep anytime and anywhere, but I am
tired all the time. I went to the Diabetic Educator and learned what I need to
do with exercise and diet but, usually, I am so tired I just grab some fast food
and want to sit down and do nothing when I get home.” He reports that he
wakes unrefreshed, has morning headaches, and that his sleep is disturbed
by nocturia four times per night. He also says that he has heartburn at night
andhis legs jerkduring sleep.He says that hehas loss of energy, hasdifficulty
staying awake, has difficulty in driving long distances because of extreme
sleepiness, and cannot attend church or movies without falling asleep. He
also takes frequent naps, consumes more than six cups of coffee per day,
and drinks one or two alcoholic beverage in the evenings before bedtime.
He has a history of snoring (more than 20 years) and was a smoker until 12
years ago.
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20.5 Results of Overnight Polysomnography
Total recording time 368 min REM sleep 0
Total sleep time 256 min Stage 1 sleep 92%
Sleep efficiency 70% Stage 2 sleep 8%
Lowest O2 saturation 65% Stages 3 & 4 sleep 0
Apnea/Hypopnea Index 56/hour of sleep Longest apnea 39 sec
Assessment
The patient has severe daytime excessive sleepiness and symptoms of OSA.
Sleep hygiene habits are poor. He self-medicates with caffeine as a daytime
stimulant and uses alcohol as a hypnotic. He is obese, and obesity is a prime
risk factor for both OSA and Type II diabetes. Although nocturia can result
from an osmotic diuresis secondary to a blood glucose that is higher then
the renal threshold of 180 mg/dL, it is also an important symptom of un-
diagnosed and untreated OSA. Clearly, this patient is a driving risk, even
during daylight hours. Although depression can cause sleep disruption, this
patient’s medical history and symptoms are compelling indicators of exces-
sive sleepiness andwarrant a referral to a sleep specialist for evaluation and
treatment.
Interventions
The immediate intervention was referral to a sleep specialist, who ordered
an overnight polysomnography to assess for OSA (Table 20.5). Intermediate
interventions include a referral to the dietician for assistance in maintain-
ing his diabetic diet and weight loss, instruction on sleep-hygienemeasures,
avoidance of sedating OTC drugs (i.e., alcohol), which can exacerbate OSA
symptoms, and avoidance of driving long distances, especially alone or at
night, until treatment of OSA has begun. If the patient does go on to receive
treatment by positive airway pressure and is compliant, hemay bemore suc-
cessful at weight loss, which can improve hypertension and glucose control.
In addition, effective treatment of OSA often improves nighttime symptoms
of nocturia.
Diagnosis
Severe Obstructive Sleep Apnea.
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Treatment
Due to the obstructive character of the patient’s sleep-related breathing dis-
order, continuous positive airway pressure (CPAP) at 14 cm water pressure.
Outcome
Sixmonths after startingCPAP:Mr.M.has lost 30 lbs andhisCPAPpressures
and antihypertensivemedications already have been titrated downward.His
blood pressure has dropped to 132/88 mm Hg, his HgbA1c has improved
(7.6%), and he seldom has nocturia or takes naps. The patient reduced his
caffeine intake to one or two cups of coffee per day and stopped using
OTC products or alcohol as a sleeping aid. He no longer feels tired and
has driven his car on several car trips without feeling sleepy. Mr. M. also
states that he has started to walk with his wife for 30 minutes at least four
times a week. He reports, “I did not know how tired I was until I started on
this breathing machine at night. I will admit, a few nights I haven’t used it.
But, the next day, I always know that I made a mistake by skipping the night
before.”
Summary
Nurses must be able to identify, screen, and refer patients for sleep disorders.
Nurses see patients sleep more than other health care providers do, and sleep
disorders can affect patient outcomes on a daily basis. Sleep medicine is a rel-
atively new specialty and many health care providers have had no background
in sleep disorders. Nurses also must incorporate sleep-hygiene measures and
ongoing treatment of existing sleep disorders into the plan of care for older
adults to ensure adequate, restful sleep in all settings: acute care, primary care,
and at home. Failing to identify, diagnose, or treat excessive sleepiness and its
underlying cause(s) can adversely affect the health and longevity of older adults.
Web Resources for Nurses and Consumers
Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem
This report was issued by the Institute of Medicine in April 2006 to increase
public and health-professional awareness of the personal and economic
consequences of sleep disorders and sleep loss. It is a valuable resource
for understanding the current status of the science of sleep and sleep re-
search. The report outlines the impact of sleep loss in America and provides
recommendations to improve the recognition and treatment of sleep disor-
ders. This publication is available online from National Academies Press at
http://www.nap.edu/catalog/11617.html.
National Institutes of Health, National Center on Sleep Disorders Research
This site includes brochures that may be downloaded or printed for distribution
to patients or for the education of other health care providers.
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For patients and the general public: http://www.nhlbi.nih.gov/health/public/
sleep/index.htm
Forhealth careprofessionals: http://www.nhlbi.nih.gov/health/prof/sleep/index.
htm
Sleep Research Society
This professional organization fosters scientific investigation, professional ed-
ucation, and career development in sleep research and academic sleep
medicine. It is an excellent resource for nurses who are interested in study-
ing issues of sleep and circadian processes.
http://www.sleepresearchsociety.org/
Society for Research on Biological Rhythms
This is a professional group formed to promote the advancement of basic and
applied research in all aspects of biological rhythms and to disseminate
the important results of that research among scientists, agencies that fund
research, and the general public.
http://www.srbr.org/
American Academy of Sleep Medicine (AASM)
This organization for sleep professionals is also a great source of information
for the public and for practice guidelines for professionals.
http://www.aasmnet.org/
Narcolepsy Network
The primary focus of this national nonprofit, patient-support organization is
to improve the lives of those with the lifelong neurological sleep disorder
narcolepsy.
http://www.narcolepsynetwork.org
Restless Legs Syndrome Foundation
This organization is dedicated to improving the lives of the men, women, and
children who live with this often-devastating disease. The organization’s
goals are to increase awareness of RLS, to improve treatments, and, through
research, to find a cure.
http://www.rls.org
Basics of Sleep Guide
This Sleep Research Society publication is designed for students, sleep re-
searchers and non-sleep professionals interested in studying sleep across
the life cycle, sleep deprivation/restriction, and sleep physiology. Informa-
tion about this publication and how to order it can be found on the Sleep
Research Society Web site.
http://www.sleepresearchsociety.org/AnnouncementDetails.aspx?id=14
New Abstracts and Papers in Sleep
This free online subscription service is an excellent resource for professionals
to find the most recent research on sleep disorders and their treatments on
a regular basis. Services include weekly personalized e-mail alerts of new
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citations, author abstracts, a compilation of the current week’s literature
in sleep, an archive of the current year’s literature in sleep, search-and-
retrieval capabilities customized for sleep, computer-generated reprint re-
quest forms, and notification of topical information pertaining to particular
areas of interest.
http://www.websciences.org/bibliosleep/NAPS/
Box 20.1
Nursing Standard of Practice Protocol:
Excessive Sleepiness
I. GOAL: Older adults will maintain an optimal state of alertness while
awake and optimal quality and quantity of sleep during their preferred
sleep interval.
II. BACKGROUND
A. Definition
Excessive sleepiness: somnolence, hypersomnia, excessive daytime sle-
epiness, subjective sleepiness. Sleepiness is a ubiquitous phenomenon,
experienced not only as a symptom in a number of medical, psychiatric,
and primary sleep disorders but also as a normal physiological state by
most individuals over any given 24-hour period. Pathology is inferred
both when its presence becomes pervasive (as in narcolepsy) or in its
absence (as in insomnia). Alternatively, sleepiness can be considered
abnormal when it occurs at inappropriate times or does not occur when
desired (Shen, Barbera, & Shapiro, 2006).
III. ETIOLOGY AND EPIDEMIOLOGY
A. Excessive sleepiness may be due to difficulty initiating sleep, im-
paired sleep maintenance, waking prematurely and not being able
to return to sleep, or sleep fragmentation.
B. There are many types of sleep diagnoses; the most common disor-
ders reported by older adults are obstructive sleep apnea, insomnia,
and restless legs syndrome.
C. Many sleepdisorders share excessive sleepiness as a common symp-
tom, but this symptom is often not evaluated or treated because
health care providers are uninformed about the nature of sleep dis-
orders, the symptoms of these disorders, and the many effective
treatments available for these conditions.
IV. PARAMETERS OF ASSESSMENT
A. A sleep history (see Table 20.2) should include information from
both the patient and family members. People who share living and
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sleeping spaces can provide important information about sleep be-
havior that the patient may not be able to convey.
B. The Epworth Sleepiness Scale (Johns, 1991 [Level IV]; Avidan, 2005
[Level I]; National Center on Sleep Disorders Work Group, 1999
[Level VI]) (Table 20.1) is a brief instrument to screen for severity
of daytime sleepiness in the community setting. It can also be found
under Resources at http://www.ConsultGeriRN.org.
C. Table 20.3 outlines key points in obtaining salient information from
older patients and their family members as well as gauging severity
of symptoms (American Academy of Sleep Medicine Task Force,
1999 [Level I]).
D. The Pittsburgh Sleep Quality Index (Buysse et al., 1989 [Level IV])
is useful to screen for sleep problems in the home environment and
to monitor changes in sleep quality. This instrument can be found
under Resources at http://www.ConsultGeriRN.org.
V. NURSING CARE STRATEGIES
A. Vigilance by nursing staff in observing patients for snoring, apneas
during sleep, excessive leg movements during sleep, and difficulty
staying awake during normal daytime activities (Ancoli-Israel & Ay-
alon, 2006 [Level I]; Avidan, 2005 [Level I]).
B. Management of medical conditions, psychological disorders, and
symptoms that interfere with sleep, such as depression, pain, hot
flashes, anemia, or uremia (Ancoli-Israel & Ayalon, 2006 [Level I];
Avidan, 2005 [Level I]).
C. For patients with a current diagnosis of a sleep disorder, ongo-
ing treatments such as CPAP should be documented, maintained,
and reinforced through patient and family education (Avidan, 2005
[Level I]). Nursing staff should reinforce patient instruction in
cleaning and maintaining positive airway pressure equipment and
masks.
D. Instruction for patients and families regarding sleep-hygiene tech-
niques to protect and promote sleep among all family members (see
Table 20.4) (Avidan, 2005 [Level I]).
E. Review and, if necessary, adjustment of medications that interact
with one another or whose side effects include drowsiness or sleep
impairment (Ancoli-Israel & Ayalon, 2006 [Level I]).
F. Referral to a sleep specialist for moderate or severe sleepiness
or a clinical profile consistent with major sleep disorders such as
obstructive sleep apnea or restless legs syndrome (Avidan, 2005
[Level I]).
G. Aggressive planning, monitoring, and management of patients with
obstructive sleep apnea when sedative medications or anesthesia
are given (Avidan, 2005 [Level I]).
H. Ongoing assessment of adherence to prescriptions for sleep hygiene,
medications, and devices to support respiration during sleep (Avi-
dan, 2005 [Level I]).
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VI. EVALUATION AND EXPECTED OUTCOMES
A. Quality Assurance Actions
1. Provide staff education on the major causes of excessive sleepi-
ness (i.e., obstructive sleep apnea, insomnia, restless legs syn-
drome).
2. Provide staff with in-services on how to use and monitor CPAP
equipment.
3. Have individual nursing units conduct environmental surveys
regarding noise level during the night hours and then develop
strategies to reduce sleep disruption due to noise and care pat-
terns.
4. Add sleepas aparameter of the admissionassessment for patients
and provide written instructions for patients using CPAP at home
to always bring the equipment with them to the hospital. Include
sleep quality (e.g., see PSQI tool, www.ConsultGeriRN.org.)
5. Include sleep quality (e.g., Pittsburgh Sleep Quality Index)
(Buysse et al., 1989) to posthospital surveys of patient satisfaction
and provide feedback for nursing staff (see www.ConsultGeriRN.
org, Sleep topic).
B. Quality Outcomes: Improved quality and/or quantity of sleep during
normal sleep intervals as reported by patients and staff.
VII. FOLLOW-UP MONITORING
A. Depending on the diagnosis, follow-up may include long-term rein-
forcement of the original interventions along with support for ad-
hering to treatments prescribed by a sleep specialist. For example,
patient compliance with CPAP therapy for OSA is critical to its ef-
ficacy and should be assessed during the first week of treatment
(Weaver et al., 1997 [Level IV]). All patients benefit from positive
reinforcement while trying to acclimate to nightly use of a positive
airway pressure device.
B. CPAP masks may require minor adjustments or refitting to find the
most comfortable fit.Most such changes are needed during the accli-
mation period, but patients should be encouraged to seek assistance
if mask problems develop (Weaver et al., 1997 [Level IV]). In the ac-
ute care setting, respiratory-care technicians are valuable in-house
resources when staff from a sleep center are not readily available.
C. During the initial treatment phase of insomnia, sleep deprivation
may cause rebound sleepiness, which should subside over time.
Follow-up should include ongoing assessment of napping habits and
sleepiness to track treatment effectiveness (Avidan, 2005 [Level I]).
D. If obesity has been a complicating health factor, weight loss is a
desirable long-term goal. With reduction in daytime sleepiness, the
timing is ripe for increasing the activity level. Treatment of sleep dis-
orders should include planning for strategic changes in lifestyle that
include regular exercise, which is also consistent with cardiovascu-
lar health and long-term diabetes control (Ancoli-Israel & Ayalon,
2006 [Level I]; Avidan, 2005 [Level I]).
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21SensoryChanges
Pamela Z. Cacchione
Educational
Objectives
At the completion of this chapter, the reader will be
able to:
1. describe the normal changes of aging that affect
the senses in older adults
2. identify common sensory disorders that impact the
senses in older adults
3. determine how best to assess sensory status in
older adults
4. identify nursing strategies to manage sensory
impairment in older adults
5. recognize interprofessional team members who
can assist older adults with sensory impairment
Background and Statement of Problem
Individuals interact with their environment through their senses. Vision, hear-
ing, smell, taste, and peripheral sensation allow us to experience the world
around us. As people age, they often experience changes in their sensory func-
tion (i.e., vision, hearing, smell, taste, and peripheral sensation). These sensory
changes can negatively impact older adults’ ability to interact with their envi-
ronment, decreasing their quality of life. For example, changes in hearing can
impact an older person’s communication skills; changes in vision can impact the
ability to take medications safely. Healthy People 2010 stresses the importance
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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of vision and hearing ability as essential to language, whether spoken, signed,
or read (USDHHS, 2000 [Level VI]). Decreases in sense of smell can interfere
with an older adult’s ability to smell smoke in a fire or recognize spoiled food.
Many adults report a decrease in taste that impacts their desire to eat. Decreased
peripheral sensation sets up an individual for falls.
Understanding how to assess the senses as well as manage sensory deficits
is essential to holistic nursing. A goal of Healthy People 2010 is to improve
the visual and hearing health of the nation through prevention, early detec-
tion, treatment, and rehabilitation (USDHHS, 2000 [Level VI]). This chapter on
sensory changes addresses common changes with the senses that occur with
advancing age, as well as disease states and injuries to the senses that occur
more commonly with aging. Nursing care related to the Healthy People 2010
goals regarding sensory changes are also addressed.
Normal Changes of Aging Senses
Almost all the senses change with aging, usually presenting with a slowing of
function. Table 21.1 describes the changes that occur and the functional out-
comes for each sense.
Vision
There are several changes that occur with vision as people age. The eyelids
start to lag, the pupil takes longer to dilate and contract, and presbyopia is
widespread.
Presbyopia
A loss of elasticity in the lens of the eye leads to a decrease in the eyes’ ability
to change the shape of the lens to focus on near objects, such as fine print, and
a decrease in the ability to adapt to light (Warnat & Tabloski, 2006; Whiteside,
Wallhagen, & Pettengill, 2006 [both Level VI]).
Hearing
Normal changes of aging impacting hearing include the decrease in function
of the hair fibers in the ear canal that normally aid in the natural removal of
cerumen and the protection of the ear canal from external elements.
Presbycusis
Presbycusis is themost common formof hearing loss in theUnited States (Bagai,
Thavendiranathan,&Detsky, 2006 [Level I]). This high-frequency sensorineural
hearing loss is a multifactorial process that varies in severity and is associated
with aging (Gates & Mills, 2005 [Level V]). Presbycusis usually has a bilateral
progressive onset and is due to gradual loss of hair cells and fibrous changes
in the small blood vessels that supply the cochlea. Presenting symptoms are
difficulty hearing high-pitched sounds such as t, s, z, sh, and ch (Wallhagen,
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21.1 Normal Changes of Aging
Sense Change of Aging Functional Outcome
Vision ■ Decreased dark adaptation
■ Decreased upward gaze
■ Eyes become drier and produce fewer
tears
■ Cornea becomes less sensitive
■ Pupils decrease in size
■ Visual fields become smaller
■ Increased safety risk in changing
environmental light
■ Decreased field of vision
■ Dry irritated eyes
■ Slow to recognize injury to the cornea
■ Inability to adjust to glare and change in
lighting conditions
■ Safety risk for driving and maneuvering
in the environment
Hearing ■ Eardrum thickens
■ Loss of high frequency hearing acuity
■ Decreased ability to process sounds after
age 50
■ Increased cerumen impactions
■ Thickened eardrum decreases sound
moving across the ear canal
■ Decreased ability to hear sounds such as
p, w, f, sh, and women’s and children’s
voices
■ Requires more time to process and
respond to auditory stimuli
■ Decreased hearing due to blockage of
sound
Smell ■ Decreased ability to identify odors
■ Impacts ability to taste
■ Inability to identify spoiled food or smoke
■ Limits enjoyment in eating
Taste ■ Decreased number of tastebuds
■ Limited decrease in taste supported by
studies
■ Less saliva production
■ Decreased sensitivity to flavors
■ Dry mouth affecting ability to swallow
Sensation ■ Decreased vibratory sense
■ Decreased two-point discrimination
■ Decreased temperature sensitivity
■ Decreased balance
■ Decreased Proprioception
■ Changed pain sensation
■ Increases risk for injury
■ Decreased ability to sense pressure
■ Decreased protective response to
withdraw from hot objects
■ Risk of falls
■ Risk of falls
■ Decreased protective mechanism
Source: Adapted from Bromley, 2000 [Level VI]; Linton, 2007 [Level V]; Murphy et al., 2002 [Level III]; Schiffman, 1997
[Level V]; Seilberling & Conley, 2004 [Level V]; Wallhagen et al., 2006 [Level VI]; Whiteside et al., 2006 [Level V].
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Pettengill, & Whiteside, 2006 [Level VI]). Background noise further aggravates
this hearing deficit.
Smell
Changes in smell are common as people age but are not considered a normal
part of aging. Changes in the sense of smell have been found to correlate with
neurological conditions such as Parkinson’s disease and Alzheimer’s disease
(Albers, Tabert, & Devanand, 2006 [Level I]; Hummel & Nordin, 2003 [Level
VI]; Wilson, Arnold, Schneider, Tang, & Bennett, 2007 [Level II]).
Taste
Common changes in taste include a decreased ability to detect the intensity of
tastes, when compared to younger adults (Schiffman, 1997 [Level V]). However,
changes in taste are more often related to dental concerns and medications.
Peripheral Sensation
Peripheral nerve function that controls the sense of touch declines slightly with
age. Two-point discrimination and vibratory sense both decrease with age. The
ability to perceive painful stimuli is preserved in aging. However, there may be
a slowed reaction time for pulling away from painful stimuli with aging (Linton,
2007 [Level V]).
Epidemiology of Sensory Impairment in Older Adults
Vision
The prevalence of visual impairment increases with age and the settings in
which older adults live. Older adults comprise 12.8% of the U.S. populationbut
account for 30% of all visually impaired individuals (Desai, Pratt, Lentzer, &
Robinson, 2001 [Level V]). Of adults older than the age of 70, 19% are visually
impaired (Desai et al., 2001 [Level V]). Studies evaluating older adults in long
term care settings demonstrate a prevalence rate of visual impairment of 40%
to 54% (Bron & Caird, 1997 [Level VI]; Cacchione, Culp, Dyck, & Laing, 2002
[Level III]). More than 90% of older adults report that they wear eyeglasses
(Campbell, Crews, Moriarty, Zack, & Blackman, 1999 [Level II]). Uncorrected
refractive error was also found to be common in visually impaired older adults.
Of the 8.8% of the older adults found to be visually impaired, 59% of those were
impaired due to an uncorrected refractive error (Vitale, Cotch, & Sperduto, 2006
[Level III]). Leading causes of visual impairment include cataracts, macular
degeneration, and glaucoma (Congdon et al., 2004 [Level III]). Cataracts, one of
the leading causes of blindness, are the fifth most common chronic condition in
adults older than 75 (NAAS, 1999 [Level II]). The definition of visual impairment
varies by different groups and by country (AHRQ, 2004 [Level VI]). The United
States defines low vision as best corrected visual acuity:
■ Normal vision: visual acuity of 20/20 or better
■ Mild vision impairment: 20/25 to 20/50
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21.2 Vision History Questions
■ When was your last eye exam?
■ How would you describe your eyesight?
■ Any change in your eyesight?
■ When did you notice this change?
■ Are you experiencing any blurred vision?
■ Are you having any double vision?
■ Are you bothered by glare?
■ Are you experiencing any eye pain?
■ Are you using any eye drops for any reason?
■ Any history of trauma or injury to your eyes?
■ Have you had any eye surgeries?
■ Do you have cataracts?
■ Any family history of eye problems?
Source: Adapted from Cacchione, 2007, and Whiteside et al., 2006 [both Level VI].
■ Moderate visual impairment: 20/60 to 20/160
■ Severe visual impairment (legally blind): 20/200 to 20/400
■ Profound vision impairment: 20/400 to 20/1000
■ Near-total vision loss: less than or equal to 20/1250
■ Total blindness: no light perception (AHRQ, 2004)
Low vision can also be defined based on visual-field limitations. Severe
visual impairment is defined as best corrected field less than or equal to 20
degrees (i.e., legal blindness). Profound visual impairment is defined as visual
field less than or equal to 10 degrees (AHRQ, 2004 [Level VI]).
Nursing Assessment of Vision
The health history is an essential part of vision assessment. Several health con-
ditions predispose older adults to visual impairment. Diabetes is one of the lead-
ing causes of disease-related blindness related to diabetic retinopathy (Baker,
2003 [Level I]; Munoz et al., 2000 [Level II]; Tielsch, Sommer, Witt, Katz, &
Royall, 1990 [Level II]). Hypertension carries with it the risk of hypertensive
retinopathy. Ascertaining a thorough baseline health history with yearly re-
views and updates is essential in maintaining visual health. Health questions
related to visual health are detailed in Table 21.2 (Cacchione, 2007; Whiteside,
Wallhagen & Pettengill, 2006 [both Level VI]).
Examination of the Eye
The external structures can cause decreased vision if the lids lag due to laxity
of the skin of the upper eyelid. Lid lag can interfere with visual acuity and fields
andmay require surgery. Cataracts in severe cases can be visible with the naked
eye and appear as a whitish-gray pupil instead of black. Cloudiness of the whole
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cornea of the eye is indicative of a corneal problem, not a cataract. If the person
has had cataract surgery, the lens implant may be visible on close inspection.
Fundus Exam. Using an ophthalmoscope, a nurse can visualize the red reflex
and, with experience and practice, the fundus of the eye. This is often diffi-
cult with small pupils. Darkening the room may help to dilate the pupils. Op-
tometrists and ophthalmologists dilate the pupils to allow for a better view of
the fundus. Cataracts will appear as dark shadows in the anterior portion of the
lens in front of the retina.
Vision Testing. Vision testing should be completed before the eyes are dilated
and completed with both uncorrected and corrected (i.e., with glasses) vision.
Distance Vision. The “gold standard” in eye charts, the Snellen Chart, is one of
the most commonly used to assess distance vision. Visual acuity is tested at 20
feet. The individual is asked to read the letters on the chart until they miss more
than two on a line of acuity. Acuity equals the line above the line with more than
two errors. Acuity measures range from 20/10 to 20/800 on the Snellen Chart.
ETDRS. The Early Treatment of Diabetic Retinopathy Study (ETDRS) (Ferris,
Kassoff, Bresnick, & Bailey, 1982 [Level III]) eye chart is also used frequently
and can be used at a distance of 4 meters. At this distance, the greatest visual
acuity measured is 20/200—the equivalent of legal blindness.
Pin-Hole Test. With best vision with or without glasses, a card with a small pin
hole in the center is placed in front of the eye, and the vision is tested at the last
line that the individual is able to read. If individuals can read farther down the
chart with the pin hole, their vision may be improved with better refraction of
their eyeglasses or, if they do not have glasses, with eyeglasses.
Near Vision. Near vision is important for health literacy, especially in regard
to reading food or medication labels. There are several ways to assess near
vision. Two commonly used tools are the Rosenbaum Pocket Eye Screener and
the Lighthouse for the Blind Near Vision Screener. The Rosenbaum Pocket Eye
Screener, a non-copyrighted tool based on the Snellen test, can be useful in
assessing near vision in acute- and primary-care settings. It is true to scale
when compared with the Snellen Chart at the 20/200, 20/400, and 20/800 acuity
levels. However, the other levels are slightly too large, causing an overestimation
of visual acuity (Horton & Jones, 1997 [Level VI]).
Light House for the Blind Near Vision Screener (Light House for the Blind):
This handheld vision screener has a cord that can be used at 40 and 20 centime-
ters to measure the proper distance for testing near vision. This near-vision
screener mimics the ETDRS eye chart in a smaller version but is not pocket
size. It does not, however, have the questions about matching scale of the ET-
DRS distance acuity level. For research purposes, it has the added feature of the
cord for measuring a consistent distance.
Contrast Sensitivity. Contrast sensitivity is often compromised by aging and
diseases or conditions of the eye. Decreases in contrast sensitivity occur with
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cataracts, glaucoma, and retinopathies (Mantyjarvi & Laitinen, 2001; Wilensky
& Hawkins, 2001 [both Level III]). Contrast sensitivity provides information on
how well an individual may perform in real-life conditions. Decline in contrast
sensitivity impacts the ability to distinguish when one step ends and another
begins, identify light switches on the wall, read materials not printed in high
contrast font, and identify the buttons on the remote control. Intact contrast
sensitivity is important for day-to-day functioning within the environment.
The Pelli–Robson Contrast Sensitivity Chart (Pelli, Robson, & Wilkins, 1988
[Level III]) is read at the 1- or 3-meter distance. All letters are presented at
the 20/200 acuity level but in decreasing shades of black to gray. The Pelli–
Robson Contrast Sensitivity Chart is widely used in practice and works well
for older adults who are experienced in recognizing letters (Hirvela, Koskela, &
Laatikainen, 1995 [Level III]; Morse & Rosenthal, 1997 [Level VI]).
The Vistech Contrast Sensitivity Test, another contrast sensitivity measure,
has four patches of gray circles with lines in different directions (Kennedy &
Dunlap, 1990 [Level II]). The person being examined points to the direction the
lines within the circle are pointed (Morse & Rosenthal, 1997 [Level VI]).
Visual Fields. Fields of vision refers to the area of peripheral vision visible when
an individual is focusing straight ahead (Cassin, 2001 [Level IV]). The vision in
visual fields can be affected by many eye conditions, as well as neurological dis-
orders that inhibit eye movement or affect the blood supply to the optic nerve.
Intact visual fields are important to function safely in the environment. In as-
sessing visual fields by confrontation, a gross clinical measure of visual fields,
the examiner faces the patient and determines if the patient can identify the
examiner’s moving fingers as they are moving into their field of view (Seidel,
Dains, Ball, & Benedict, 2003 [Level IV]). Although subjective and dependent
on the examiner having normal fields of vision, the confrontation test is useful
in quickly identifying large losses in visual fields.
The Humphrey Visual Field Test is completed by an ophthalmologist and
assesses visual fields using a static type of perimetry (Gianutsos & Suchoff, 1997
[Level VI]). This measure provides a more reliable measure of functional visual
fields. The Goldman VI4e kinetic perimetry visual field testing, on the other
hand, assesses kinetic type of functional visual fields (Gillmore, 2002 [Level
VI]). Kinetic perimetry entails the introduction of a moving stimulus moving
from a nonvisible area toward the fixed point of view. The Goldman perimeter
visual field testing is difficult to standardize because it is operator-dependent
(Gillmore, 2002 [LevelVI]); therefore, automatedmethods aremorewidely used.
The location of the visual field deficit may clue the examiner as to the type of
eye condition. For example, unilateral visual field deficits may be related to a
cerebral vascular accident, glaucoma affects the peripheral fields, and macular
degeneration has associated central field of vision loss.
Conditions of the Eye
Diseases That Alter Vision Seen More Frequently as People Age
Cataracts. Clouding of the crystalline lens that presents as a painless, progres-
sive loss of vision can be unilateral or bilateral (NIA, 2005 [Level VI]). Cataracts
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can be hereditary, injury-related, or related to medications. The management
of cataracts includes early identification and monitoring followed by surgical
extraction and lens implantation once vision is affected.
Macular Degeneration. The development of drusen deposits in the retinal pig-
mented epithelium is the leading cause of central vision loss and legal blindness
in older adults. Macular degeneration is more common in fair-haired, blue-eyed
individuals. Other risk factors include smoking and excessive sunlight exposure.
There arewet and dry forms ofmacular degeneration. Thewet form ismore eas-
ily treated than the dry form. Newer treatments of expensive injectable medi-
cations are available to slow the progression of dry macular degeneration.
Glaucoma. Glaucoma is a progressive, serious form of eye disease. Primary
Open Angle Glaucoma is the most common form (Linton, 2007 [Level V]). In-
creased intraocular pressure causes atrophy and cupping of the optic nerve
head, leading to visual field deficits that can progress to blindness. Vision
changes include loss of peripheral vision, intolerance to glare, decreased per-
ception of contrast, and decreased ability to adapt to the dark.
Diabetic Retinopathy. This results from end-organ damage from diabetes caus-
ing retinopathy and spotty vision. Risk can be reduced by strict blood-sugar
control. Almost 6% of diabetics aged 65 to 74 develop diabetic retinopathy (NEI,
2004 [Level VI]). Diabetic retinopathy that starts as nonproliferative and pro-
gresses to proliferative should be treated with laser photocoagulation.
HypertensiveRetinopathy. This is causedby end-organdamage frompoorly con-
trolled hypertension causing background and eventual proliferative retinopa-
thy. Hypertensive retinopathy is usually treatedwith laser photocoagulation and
strict blood pressure control.
Temporal Arteritis. This is an autoimmune disorder that causes inflammation
of the temporal artery, also known as giant cell arteritis. It presents as malaise,
scalp tenderness, unilateral temporal headache, jaw claudication, and sudden
vision loss (usually unilateral). This vision loss is amedical emergency but is po-
tentially reversible if identified immediately. If symptoms develop, an individual
should see an ophthalmologist or go immediately to the emergency room.
Detached Retina. This is a condition that can occur in patients with cataracts or
recent cataract surgery, trauma, or spontaneously. A detached retina presents
as a curtain coming down across a patient’s line of vision. An individual experi-
encing this should see an ophthalmologist or immediately go to the emergency
room. Table 21.3 lists the implications of vision changes on an older adult’s
function.
Nursing-Care Strategies
Vision
Nurses should obtain a past medical history to avoid disruption in the man-
agement of chronic eye conditions, assuring continuation of ongoing regimens
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21.3 Implications of Vision Changes in OlderAdults
Impact on Safety
Inability to read medication labels
Difficulty navigating stairs or curbs
Difficulty driving
Difficulty crossing streets
Impact on Quality of Life
Reduces ability to remain independent
Difficulty or unable to read
Falls
such as eye drops for glaucoma. Without the continuation of an individual’s eye
drops, eye pressures could precipitously increase causing an acute exacerbation
of the glaucoma, potentially dramatically limiting vision. If an acute change in
an individual’s vision occurs, the primary-care provider should be notified im-
mediately. Depending on the signs and symptoms present, the individual may
need to see an ophthalmologist or go to the emergency room to receive treatment
to restore the vision or limit the deterioration.
Lighting is important in an individual’s environment. Too little light can
limit vision. Too much light, depending on an individual’s eye condition such
as cataracts, may cause eye pain and glare. It is important to ascertain whether
an individual is sensitive to light. If so, indirect light and night lights may be
helpful to provide a safe environment. The majority of older adults benefit from
improved lighting. To avoid glare, directing incandescent lamps directly on a
task, such as sewing or reading, often improves visual acuity and is well tol-
erated. Glare occurs when a light shines directly into the eye or reflects off a
shiny surface. Low-vision specialists recommend trying different positions and
wattage of lighting to find what works best for each individual (Community Ser-
vices for the Blind and Partially Sighted, 2004 [Level VI]).
Encourage the use of the person’s eyeglasses. Older adults’ eyeglasses
should be labeled with their name so they can be reconnected to their owner
if they are set down and left behind. Even with eyeglasses, magnification may
be helpful. Have family provide lighted magnification if needed (large lighted
magnifiers are available at low-vision centers).
Contrast sensitivity is a problem with several eye conditions, including
cataracts, glaucoma, and macular degeneration. Adding contrast to the fixtures
in the home if light switches blend into the wall or faucets blend into the sink
can create a safer and more functional environment.
Nurses should encourage an annual dilated-eye examination with either an
optometrist or an ophthalmologist. This is crucial in peoplewhohave a diagnosis
of diabetes or hypertension. Nurses are members of the interprofessional team
responsible for preventing unnecessary disability. Therefore, nurses should en-
sure that there is amechanism in place to trigger these visits on an annual basis.
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Hearing Impairment
Hearing impairment is the third leading chronic condition affecting adults older
than 75 (NAAS, 1999 [Level I]).More than 50%of adults older than 75 are hearing
impaired. For older adults in nursing homes, the estimates run as high as 90%
(Lewis-Culinan & Janken, 1990 [Level II]; Newman, 1990 [Level III]). Hearing
loss is greater in men than women (NIDCD, 2007 [Level VI]). The American
Academy of Audiology defines hearing loss based on decibels or loudness and
the Hertz or the pitch of sound. Normal speech is in the 0 to 25 dB level andmild
hearing loss is defined as hearing in the 25- to 40-dB level. Hearing between 40
and 70 dBs is considered moderate hearing loss; severe hearing loss is between
70 and 90 dBs. Greater than 90 dBs is considered profound hearing loss (Mehr,
2007 [Level IV]). Aging impairs hearing of the sounds in the higher frequencies
or pitch, which are often more difficult to hear.
Assessment of Hearing
It is easy to determine when older adults are hard of hearing just from having a
conversation with them. The older adult may lean closer in an attempt to hear
better, turn their head to their “good ear,” or cup their hand behind their ear.
Older adults may have to ask for things to be repeated, and often have trouble
hearing their grandchildren’s or other’s high-pitched voices. Older adults often
complain that people are mumbling. Any or all of these signs may be present.
Regardless of whether any of these signs are present, all older adults should
have their hearing screened annually at their primary-care visit (Bagai et al.,
2006 [Level I]). Methods of screening are described herein.
Hearing Handicap for the Elderly-Screen
The Hearing Handicap for the Elderly- Screen (HHIE-S) (Ventry & Weinstein,
1983 [Level III]) is a 10-item scale to determine how hearing impacts an older
adult’s daily life and to assist in identifying who might benefit from a hear-
ing aid and an audiologic referral. The scale takes approximately 5 minutes
to complete and is targeted for community-dwelling older adults. This scale
is available online through the Hartford Institute for Geriatric Nursing Try
This Best Practices in Care for Older Adults (Demers, 2001 [Level V]) (access
at www.ConsultGeriRN.org). The HHIE-S has reported excellent sensitivity and
specificity for severe hearing loss, but the sensitivity and specificity decreases
as the level of hearing impairment lessens (Sindhusake et al., 2001 [Level II]).
Whisper Test
Thewhisper test involves covering or rubbing one ear canal and, from a distance
of 2 feet, whispering a three-syllable word on an exhale that the patient either
correctly or incorrectly repeats back. An incorrect response triggers a repeat
attempt to see if the older adult can identify a different three-syllable word.
The consistency of the level of the whispered word makes this test difficult to
compare among examiners. However, despite this difficulty, it has been found
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to be a valid and reliable test to screen for hearing loss (Pirozzo, Papinczak, &
Glasziou, 2003 [Level I]).
Finger-Rubbing Test
The finger-rubbing test is less dependent on volume of the whispered three-
syllable word. It entails having the examiner rub the thumb and first two fingers
together, starting at 2 inches from the patient’s ear, and then slowly moving the
fingers away from the ear. The patient reports when they can no longer hear the
fingers rubbing together on each side. The sensitivity and specificity has been
reported as 80% and 49%, respectively, at 6 to 8 in, and 90% sensitivity and 85%
specificity at 3 inches (Patterson, 1994 [Level V]).
Handheld Audioscope
The handheld audioscope is a device developed to specifically screen for hear-
ing impairment. It has a test tone that is presented at the 60-dB level. The
decibel levels that may be tested include the 20-, 25-, and 40-dB levels at the
500-, 1,000-, 2,000-, and 4,000-Hz levels. The audioscope has an otoscope that
allows for the visualization of the tympanic membrane or cerumen impactions,
which can result in conductive hearing loss present in up to 30% of older adults
(Lewis-Culinan & Janken, 1990 [Level II]). Testing using the audioscope should
be performed in a quiet setting and may not be as useful in the long term care
environment with high noise levels.
Pure Tone Audiometry
This is the “gold standard” of hearing testing, particularly if completed in a
soundproof booth with 92% sensitivity and 94% specificity in detecting sen-
sorineural hearing loss (Frank & Petersen, 1987 [Level II]). Pure tone audiom-
etry allows for testing of a wide range of decibels and Hertz levels, or loudness
and pitch or frequencies, allowing for testing at the 5- to 120-dB level and 250
to 4,000 Hz. Portable pure tone audiometers with noise-reduction earphones
are available and can be used in the community, outpatient, and long term care
settings when access to an audiologist is limited. The wide range of tones allows
for a better understanding of an individual’s functional hearing. Pure tone au-
diometry by an audiologist is the next step after screening identifies a hearing
deficit (Yueh, Shapiro, MacLean, & Shekelle, 2003 [Level I]).
Tuning Fork Tests
Two tuning fork tests have been used in hearing screenings, although a recent
systematic review discouraged their use because they were found to be unreli-
able with limited accuracy (Bagai et al., 2006 [Level I]). The tuning fork should
be either 256 or 512 Hz (Wallhagen, et al., 2006 [Level VI]). The Rinne Test is
meant to differentiate whether an older adult hears better by bone or air con-
duction and can help determine if an individual had sensorineural or conductive
hearing loss. The Weber Test is used to help identify unilateral hearing loss.
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Hearing Changes Common in Older Adults
Conductive hearing loss involves the outer and/or middle ear including the ear
canal, tympanic membrane, and bones in the outer and middle ear (Marcincuk
& Roland, 2002 [Level VI]). Causes of conductive hearing impairment include
cerumen impactions or foreign bodies, ruptured eardrum, otitis media, and oto-
sclerosis (Wallhagen et al., 2006 [Level VI]).
Sensorineural hearing loss, the most common form of hearing loss in older
adults (Linton, 2007 [Level V]), involves damage to the inner ear, the cochlea,
or the fibers of the eighth cranial nerve. Causes of sensorineural hearing
loss include hereditary causes, viral or bacterial infections, trauma, tumors,
noise exposure, cardiovascular conditions, ototoxic drugs, and Meniere’s dis-
ease (Wallhagen et al., 2006 [Level VI]).
Central auditory processing disorder is an uncommon disorder that includes
an inability to process incoming signals and is often found in stroke patients
and older adults with neurological conditions such as Alzheimer’s dementia and
Parkinson’s disease (Pekkonen et al., 1999 [Level II]). The person’s hearing is
intact but the ability to process the sound is impaired.
Tinnitis, which is otherwise known as ringing in the ear, is of two types:
subjective and objective. Subjective tinnitus is a condition in which there is per-
ceived sound in the absenceof acoustic stimulus (Ahmad&Seidman, 2004 [Level
VI]; Lockwood, Salvi, & Burkard, 2002 [Level V]). Objective tinnitus is consid-
ered rare and presents as ringing in the ear that is audible by the individual and
others. It is thought to have a vascular or neurological condition or Eustachian-
tubedysfunction (Crummer&Hassan, 2004 [LevelVI]). Subjective ringing in the
earsmay fluctuate and can be due to damage to the hair receptors of the cochlear
nerve and age-related changes in the organs of hearing and balance. Patients
with tinnitis should be referred to an ear, nose, and throat (ENT) specialist.
Meniere’s disease is characterized by fluctuating hearing loss, dizziness, ver-
tigo, tinnitus, and a sensation of pressure in the affected ear (NIDCD, 2001 [Level
VI]). Unfortunately, the fluctuating hearing loss can become permanent hear-
ing loss over time. Possible causes of Meniere’s disease include hypothyroidism,
diabetes, and neurosyphillis.
Implications of Hearing Changes
Older adults who have hearing impairment experience a decreased quality of
communication, social isolation, low self-esteem, and generally lower quality
of life. Decreased hearing impacts an individual’s word recognition, decreasing
the ability to communicate. This in turn can lead to significant safety issues.
For example, if patient education about medication administration is provided
only verbally, key information can be misheard and misinterpreted. Difficulty
understanding the spokenword can lead to fatigue and speech paucity of friends
and loved ones.
Speech paucity is described as decreased attempts to have meaningful con-
versations due to the difficulty in getting the message through to a hearing-
impaired loved one. Speech paucity (Wallhagen, 2006 [Level VI]) leads to
social isolation of the hearing impaired because only the necessary informa-
tion is transferred and no everyday social information is shared (Wallhagen,
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Strawbridge, Shema, & Kaplan, 2004 [Level III]). This can lead to depression
and low self-esteem in a hearing-impaired individual and the partner. Other
factors that lead to social isolation in hearing-impaired older adults include the
inability to hear the telephone or the doorbell ringing or knocking at the door.
Ideally, an older adult who develops hearing loss will see an audiologist and
obtain unilateral or bilateral hearing aids to improve the ability to communi-
cate with the people around them. Unfortunately, the stigma, cost, and delay
in pursuing hearing aids are barriers to their success. Hearing aids should be
pursued early in the course of hearing impairment. For example, hearing aids
can be very helpful when hearing is impaired to the point that background noise
interferes with understanding the spoken word. Success in using hearing aids
at this level of hearing improves the chance that older adults will continue with
hearing aids. Once older adults become used to the silence, it is difficult to adapt
to the increased ambient noise heard with hearing aids. Often, older adults re-
quire extensive coaching from an audiologist to get through the transition phase
of wearing hearing aids. Technology has improved to the point of analog hearing
aids that can be finely tuned to the individual’s needs (Wallhagen et al., 2006
[Level VI]). In one intervention group of older adults fitted with hearing aids,
98% experienced benefit and their caregivers perceived significant benefit as
well (Tolson, Swan, & Knussen, 2002 [Level II]). University settings are often
themost cost-effective locations to pursue hearing aids. The cost of hearing aids
is an important factor becausemost insurance plans, includingMedicare, do not
cover hearing aids.
Cochlear implants are another technological advancement that has demon-
strated positive outcomes in older adults in the areas of speech recognition. A
cochlear implant works by bypassing the damaged parts of the ear and stimulat-
ing the auditory nerve. These impulses are sent to the brain through the auditory
nerve and the brain recognizes them as sound (NIDCD, 2006 [Level VI]). Severe
hearing impairmentmust be present unilaterally or bilaterally before this surgi-
cal intervention will be considered. Cochlear implants were found in one study
to improve word recognition and health-related quality of life (Francis, Chee,
Yeagle, Cheng, & Niparko, 2002 [Level III]). Despite these improvements, rela-
tively few adults have received this new technology. According to the U.S. Food
and Drug Administration, nearly 22,000 adults have received cochlear implants
(NIDCD, 2006 [Level VI]). Technological advances will continue to improve the
options for hearing-impaired older adults.
Smell and Taste
Smell and taste are two senses that are difficult to separate because they overlap,
particularly when food is involved. Both these senses depend on chemosensa-
tion, the ability of the nose, mouth, and throat to identify tastes and smells based
on chemical reactions that occur when odors or tastes are present in the envi-
ronment (AAO-HNS, 2007 [Level VI]). The sense of smell and ability to identify
odors decrease due to normal changes in aging. Up to 50% of octogenarians have
smell disorders (Murphy et al., 2002 [Level III]). This can be problematic for
safety reasons. An inability to smell smoke, for instance, could put an older adult
at risk. Studies have also linked the loss of smell to Alzheimer’s dementia and
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Parkinson’s disease (Mesholam, Moberg, Mahr, & Doty, 1998 [Level I]; Muller,
Reichmann, Livermore, & Hummel, 2002 [Level II]).
Changes in Smell and Taste Common to Older Adults
There are four medical terms used when describing olfactory disorders: (1) hy-
posmia is the reduction of the sense of smell; (2) parosmia is the distortion in
the sense of smelling the presence of an odor; (3) anosmia is no sense of smell;
and (4) phantosmia is the perception of an odor when no odor source is present
(Hummel&Nordin, 2003 [Level VI]). Olfactory disorders impact quality of life in
older adults. Common complaints from people with olfactory disorders include
difficulty with cooking, decreased appetite, eating spoiled food, too little percep-
tion of body odor, and inability to detect gas leaks or smoke (Miwa, et al., 2001
[Level II]; Temmel, Quint, Schickinger-Fischer, & Hummel, 2005 [Level III]).
Because of the impact on quality of life, it is important to take a complete
history and physical with older adults, asking questions regarding the olfactory
system. A thorough cranial nerve exam and head and neck examination should
be included. If an olfactory disorder is identified, the individual should be re-
ferred to an otorhinolaryngologist (ENT) (Hummel & Nordin, 2005 [Level VI]).
Most changes in taste are thought to occur due to an oral condition, xe-
rostomia (i.e., dry mouth), decreased sense of smell, medications, diseases, and
tobacco use (Seiberling &Conley, 2004 [Level V]). Dysgeusias, or taste disorders,
may resolve spontaneously. However, due to the poor outcomes for older adults
with taste disorders, referral for treatment is indicated either to an otolaryn-
gologist, neurologist, or subspecialist at a smell and taste center (Bromley, 2000
[Level VI]).
As with olfactory disorders, disorders of taste are often identified on history,
not by physical exam. There are few tests to assess for taste disorders. There-
fore, the history is essential. Substance abuse including tobacco, alcohol, and
cocaine should be reviewed. The individual’s dietary habits should be reviewed.
Questions regarding recent dental work or procedures should also be asked.
Ascertaining whether an individual has a history of gastric reflux could surface
manageable conditions impacting taste. A thorough review of medications is
fundamental in the evaluation of a taste disorder (Bromley, 2000 [Level V]).
Diseases That Alter Taste Seen More Frequently
as People Age
Burning Mouth Syndrome
This is a sensation that the tongue is tingling or burning. There may be sev-
eral contributing factors: Vitamin B deficiencies, local trauma, gastrointestinal
disorders causing reflux, allergies, salivary dysfunction, and diabetes.
Xerostomia
Dry mouth is common with many medications used to treat disorders
common to older adults, including anticholinergic medications, antidepres-
sants, antihistamines, ACE-inhibitors, lipid-lowering agents, antiparkinsonian
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medications, and anticonvulsants to name a few (Bromley, 2000 [Level VI];
Seiberling & Conley, 2004 [Level V]).
Implications of Taste and Smell Changes
Inability to smell limits some of the pleasures of everyday life. The smell of a
spring rain, a Christmas tree, flowers, or coffee brewing may not be detectable.
Taste is diminished due to inability to smell. Of significant concern in older
adults who have smell and taste disorders is malnutrition. Appetite is detri-
mentally affected due to inability to smell and taste the food. Inability to smell
is a safety hazard due to the inability to smell smoke in a fire or a gas leak.
Decreased sense of taste may also result in inability to recognize spoiled food,
resulting in nausea, vomiting, or infectious diarrhea.
Peripheral Sensation
Peripheral neuropathy is one of the most common neurological disorders en-
countered in a generalmedical practice, with estimates of 2% to 7% of all patients
having symptoms of neuropathy (Smith & Singleton, 2004 [Level II]). An as-
sessment of 894 participants in the Women’s Health and Aging Study indicated
that 58% of women showed evidence of neuropathy by age 65 (Resnick, Vinik,
Heimovitz, Brancati, & Guralnik, 2001 [Level II]).
Changes in peripheral sensation common to older adults
Diseases that alter peripheral sensation are seen more frequently as people age
and include peripheral neuropathy, diabetic neuropathy, phantom limb pain,
and acute sensory loss.
Peripheral neuropathy. This is nerve pain in the distal extremities related to
nerve damage from circulatory problems or vitamin deficiencies. Common vi-
tamin deficiencies that impact peripheral nerves include B6, B12, and folate.
Diabetic neuropathy. This is end-organ damage to the peripheral nerves from
microvascular changes that occurwith diabetes. It often leads to loss of sensation
in the feet of diabetics, contributing to undetected trauma to the extremities and
subsequent refractory infections due to poor vascular supply to the extremity.
It is extremely important to teach diabetics and patients with peripheral neu-
ropathy to provide special care to their feet.
Phantom-limb pain. This is the experience of pain that can range from dull ache
to crushing pain where an amputated limb once was. The sensory cortex of the
brain has influence in this mechanism. This pain is often chronic and requires
special interventions to control and manage it, including electronic prosthetics,
analgesics, and psychosocial support.
Acute sensory loss. Acute sensory loss may be due to a stroke, acute nerve en-
trapment in the spine, or compartment syndrome due to trauma to a limb. It
presents with acute onset of numbness, tingling, or lack of sensation and func-
tion in the affected extremity.
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Implications of Peripheral Sensation Changes
The inability to recognize position sense, pressure, or ascertain where the feet
are on the floor can lead to falls, burns, lacerations, calluses, and pressure ulcers.
Intact peripheral sensation is essential for keeping safe in the environment.
Nursing Assessment and Care Strategies
of Peripheral Sensation
Nurses should take appropriate health histories to ascertain the presence of de-
creased sensations in limbs. Physical exams should always include a thorough
inspection of an individual’s feet (Hellman, 2002 [Level VI]). Diabetics and peo-
ple known to have peripheral neuropathy should have a thorough neurological
exam including vibratory sense with a tuning fork over bony prominences and
Semmes-Weinstein monofilament testing of the feet and proprioception (Boike
& Hall, 2002 [Level VI]).
Semmes-Weinstein Monofilament Test
This inexpensive and simple procedure is used to screen for decreased sensation
in several plantar sites on the foot. Themonofilament is placed against the sole of
the foot in eight different areas. The individual is asked to report any sensations
(Boike & Hall, 2002 [Level VI]). The Semmes-Weinstein nylon monofilament
5.04 gauge buckles at a pressure of 10 grams. Loss of sensation at this level
of pressure indicates a risk for ulcer development. Identification of this risk is
important for improving the vigilance of foot care (Armstrong & Lavery, 1998
[Level VI]).
Vibratory Sense
This is assessed by using a 128-Hz vibrating tuning fork on lower extremity
bony prominences and asking individuals if they feel any vibration (Boike &
Hall, 2002 [Level VI]). Older adults should be able to feel the vibration.
Proprioception
This is the ability for an individual to determine where they are in space. To
assess for deficits in proprioception in the feet that may set up an older adult
for falls and local trauma, ask the individual to close his or her eyes. Then hold
the large toe on the sides and move the foot up or down. Ask the individual to
identify which direction the toe was moved. Inability to correctly identify the
direction is an indication of decreased proprioception.
Individualized Sensory Enhancement of the Elderly (I-SEE)
The Individualized Sensory Enhancement of the Elderly (I-SEE) program was
developed to tailor nursing interventions to the type and level of sensory im-
pairment experienced by older adults (Cacchione, 2007 [Level VI]). Originally
developed to address hearing and visually impaired older adults, the I-SEE can
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logically be extended to address sensory impairment in smell, taste, and pe-
ripheral sensation. There are three levels to the I-SEE program: nursing as-
sessments, nursing actions, and nursing referrals.
Case Study and Discussion
Mr. Sweets is a 75-year-old African American male living by himself in
the community. He lives in a senior apartment building where he receives
housekeeping services and can participate in a meal plan. He arrives on the
Ace Unit in your hospital with a diagnosis of hyperglycemia and a urinary
tract infection. He also has a history of hypertension, hyperlipidemia, and
osteoarthritis of the left hip. He is widowed and has three children: two live
in the area, the other lives out of state. Hismedications include Amaryl 6mg,
which was recently increased from 4 mg; Zocor, 40 mg p.o. daily; Lisinopril,
20 mg daily; HCTZ, 25 mg daily; and Tylenol ES 1,000 mg, three times a day
for his hip discomfort. He is a retired aeronautical engineer.
In the admission assessment, you determine that he remembers receiv-
ing verbal instructions to cut his diabetic pills in half. Therefore, since that
appointment, he has only been taking 2 mg of Amaryl rather than 6 mg. His
primary-care provider had instructed him to take 11/2 tabs of his Amaryl,
not just a 1/2 tab. You are not sure if it was just a misunderstanding or if Mr.
Sweets has difficulty hearing. You are also concerned that his vision may be
a problem as well due to his 5-year history of known diabetes.
After you complete your history taking, you gather your supplies to com-
plete your physical exam, including an audioscope, Lighthouse for the Blind
near-vision screener, three plastic bags—one each of coffee, baby powder,
and peppermint candies—tuning fork, and a Semmes-Weinstein Monofila-
mentTest. The audioscope reveals thatMr. Sweets’ ear canals are completely
occluded with cerumen and he can only hear the test tone that is delivered
at the 60-dB level. On the near-vision screener, he scored 20/125 in both
eyes with his dirty glasses. Unfortunately, because his blood sugar is and
has been elevated, it is unclear how much of the decreased vision is related
to that and how much to possible diabetic retinopathy. Mr. Sweets was able
to correctly identify each scent in the plastic bags. When you examine his
feet, you identify that he has significant sensation loss on the bottom of his
feet. He has intact vibratory sense in the ankle but it is decreased in both
toes. His feet are free of any calluses, deformities, or open wounds. He does
have some thickened toenails.
These assessments impact the care plan for Mr. Sweets. His sensory
deficits most likely precipitated his hospital admission. Written instructions
may have helped prevent this, but his near vision may have interfered with
the understanding of the written directions as well. He should have writ-
ten instructions in large font, ideally in 24-point font. Due to the bilateral
cerumen impactions, he will need cerumen-softening drops started and the
cerumen removed with a cerumen spoon after a few days. If this is not suc-
cessful, he may need to be seen by an otolaryngologist (ENT) to have the
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wax removed. If his hearing is still impaired after the cerumen is removed,
Mr. Sweets should see an audiologist.
If his vision does not improve with blood-sugar control, he should be
seen by an ophthalmologist to determine any treatments for his diabetic
retinopathy. He also should see an ophthalmologist if he has not been to one
in a year. He would qualify for low-vision services if his acuity remained at
20/125. He also would benefit from increased contrast, which older adults
with diabetic retinopathy often need. This can be achieved by adding red or
white to light fixtures, remote controls, and other electrical devices that are
usually solid colors with limited contrast. A low-vision specialist could help
to make his home environment more safe and user-friendly.
Mr. Sweets should be evaluated by a diabetic foot nurse to have his
nails trimmed and to learn more about foot care. He will need to learn how
to complete daily foot inspections as well as assistance in learning what
type of footwear is appropriate for his feet. His hip may cause him some
difficulty in reaching his feet. It will be important for him to use mirrors
and palpation to assist him in his self-care. A diabetic nurse educator can
assist him with further information on the management of the disease and
empower him to ask more questions and clarify when information does not
appear compatible with his symptoms.
Mr. Sweets was discharged from the hospital after 4 days. His Amaryl
was increased to 6 mg; he is afebrile and discharged on oral antibiotics for
his urinary tract infection. He had his ears cleaned during those 4 days so
his hearing improved to where he can hear at the 40-dB level. He has an ap-
pointment with an audiologist as well as with an ophthalmologist. Follow-up
appointments have also been made with the endocrinologist, diabetic nurse
educator, and diabetic foot nurse on the same visit. These appointments
were written out on a 4-x -6-inch index card with a black marker that he
could read with his glasses.
Sensory impairment is an interprofessional health care problem. Good
communication among disciplines is essential in maintaining Mr. Sweets’s
functional status and ability to stay in the community. Nurses are best pre-
pared to help Mr. Sweets navigate and coordinate visits to the other disci-
plines. Screening completed by nurses either in the community, acute care,
or long term care settings can identify problems that have often been passed
off by an older adult as just getting older.
Related Professional Organizations and Informational
Web Sites
Administration on Aging
http://www.aoa.gov/prof/notes/notes low vision.asp
American Speech-Language-Hearing Association
www.asha.org
Assisted Listening Devices: Summary of available assisted listening devices
www.entcolumbia.org/acd.htm
Cochlear Implants: General information including video on cochlear implants
www.fda.gov/cdrh/cochlear
Sensory Changes 495
Hear Now: 1(800) 648-HEAR (4327)
Will accept donated hearing aids to refit for the under-served
Lighting Research Center: Consumer, Builders, and Health Professional infor-
mation on lighting
www.lrc.rpi.edu/programs/lightHealth/AARP/index.asp
The Lighthouse for the Blind: Consumer and health professional information
on visual impairment and dual impairment
www.lighthouse.org
National Institute on Aging Information Center
www.nia.nih.gov
National Institute on Deafness and Other Communication Disorders. Contains
information for health care providers and consumers
www.nidcd.nih.gov
The National Eye Institute: Contains health information for consumers and
health professionals. Also has images of eye diseases and eye charts.
www.nei.nih.gov
Talking Tapes: Access to talking books for visually impaired elders
www.talkingtapes.org
Patient and Family Resources
Aging in the Know: Your gateway to health and aging resources on the Web.
Created by the American Geriatrics Society Foundation for Health in Aging
(FHA)
www.healthinaging.org/agingintheknow/
League for Hard of Hearing
www.lhh.org/
Prentis Care Networks Project. Care Networks for Formal and Informal Care-
givers of Older Adults
http://caregiving.case.edu
Box 21.1
Nursing Standard of Practice Protocol:
Nursing Sensory Assessments
I. HISTORY
A. Ask questions about changes in hearing, vision, and senses of smell
and taste, as well as any numbness and tingling in extremities.
B. Review medications that may be exacerbating the sensory prob-
lem, such as anticholinergic medications, antibiotics, aminoglyco-
sides, and high-dose aspirin.
C. Determine if symptoms occurred suddenly or gradually.
D. Clarify if symptoms are unilateral or bilateral.
E. Inquire whether the individual has had any prior treatment for sen-
sory conditions.
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F. Ascertain if sensory conditions interfere with daily function.
G. Ask about the ability to drive. Driving can be affected by vision, hear-
ing, and the peripheral nervous system.
H. Determine interest in receiving treatment for these conditions.
For each positive symptom reported, gather more information by asking
about the character, associated symptoms, radiation, location, intensity,
and duration, as well as what makes it better; which medications the in-
dividual has tried for these symptoms; and what makes it worse. These
questions can be easily remembered by using the acronymCAR LID BMW.
These questions provide a better understanding of the individual’s con-
cerns.
II. PHYSICAL EXAM FOR ALL SYSTEMS
A. Inspect the external structures of the eyes and ears, and examine the
ear canal for cerumen using an otoscope.
B. Check visual acuitywith a near-vision screener, distance-acuitymea-
sure, and contrast sensitivity.
C. Perform a whisper test to assess rough hearing, If available in your
setting, use a handheld audioscope to assess up to a 40-dB hearing.
If a greater range of hearing testing is needed, use a portable au-
diometer with noise-reduction earphones. A referral to an audiology
professional may be indicated.
D. Assess the nares and determine if they are patent using the otoscope.
E. Inspect the mouth and tongue for any obvious lesions or deviations
from normal.
F. Perform a neurosensory exam of the extremities including amonofil-
ament test. Complete a monofilament test on all diabetics. This test
quantifies the level of sensory impairment in the feet of diabetic pa-
tients.
G. Assess vibratory sense of the extremities with a tuning fork and pro-
prioception.
III. NURSING ACTIONS
A. Vision
1. Avoid disruption in the management of chronic eye conditions
by obtaining past history and assuring continuation of ongoing
regimens, such as eye drops for glaucoma.
2. Notify the primary-care provider of any acute change in vision.
3. Encourage the use of good lighting in patient rooms. Avoid glare
whenever possible.
4. Encourage theuse of thepatient’s eyeglasses.Have family provide
lighted magnification if needed (i.e., large magnifiers with a light
attached available at low-vision centers).
5. Add contrast to the fixtures and electronics in the room if light
switches blend into the wall or faucets blend into the sink. Other
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low-contrast items in the environment include remote controls,
television sets, and radios.
6. Encourage annual eye exams with either an optometrist or an
ophthalmologist.
7. Schedule an annual dilated-eye exam for patients with diabetes
and hypertension by an ophthalmologist.
B. Hearing
1. Assess for cerumen impactions. Request cerumen-softening
drops followed by cerumen removal or ENT consultation.
2. Get the person’s attention and face them before speaking to assist
the individual with lip reading, a common compensatory mecha-
nism for older adults.
3. Have at least one pocket amplifier on the nursing unit to use with
hearing-impaired individuals.
4. Do not shout at people with hearing impairments; rather, use a
lower tone of your voice.
5. Provide written instructions (use a large black marker if the per-
son is also visually impaired).
6. Ensure appropriate care for hearing aids: remove batteries at
night; use the brush provided to gently clean the tubes to reduce
wax accumulation.
7. Before sending bed linens or clothing to the laundry, make sure
the hearing aid is in the patient’s ear or in the designated location
(e.g., bedside table or medication cart).
8. Notify the primary-care provider of any sudden change in hear-
ing.
9. Referral to an audiologist and/or ENT as indicated.
C. Taste and Smell
1. Take seriously all complaints of inability or decreased ability to
smell or taste. Do not pass them off to medications or poor denti-
tion.
2. Notify primary-care provider of an abrupt change in taste or
smell.
3. Schedule an ENT referral for evaluation for a sudden change in
smell or taste.
4. Patient teaching should focus on safety issues regarding odors of
gas and spoiled food.
5. Educate seniors about carbon-monoxide detectors in their home
and to evaluate food with methods other than the sense of smell
and taste.
D. Peripheral Sensation
1. Individuals should be taught to examine their feet daily as well
as look inside their shoes before putting them on each day.
2. Individuals should be instructed to inform their primary provider
of any lesions, calluses, or red areas.
3. Extremities should be clean and thoroughly dry before applying
lotion.
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4. Encourage individuals to bring in footwear for evaluation by the
advanced practice nurse if they have concerns about safety. Most
medical-supply companies carry diabetic healing shoes that have
wide toe boxes and Velcro straps, which can be purchased for less
than $50.
5. Refer diabetics to facilities with a CertifiedDiabetes Educator and
foot-care specialist.
6. Implement fall precautions and initiate referral to physical ther-
apy for all diabetics with peripheral neuropathy.
7. Refer all older adults with decreased sensation or circulation to a
podiatrist or foot-care specialist for ongoing foot care.
IV. EXPECTED OUTCOMES
A. Baseline visual acuity and hearing acuity for all older patients will be
performed prior to discharge from the hospital and upon admission
to home care or a nursing home.
B. Fall precautions should be in place for all older patients with sensory
impairments.
C. Older adults should avoid falls and injuries to extremities if they
have decreased sensation of the lower extremities.
D. Accidental exposure to toxins either in the air or food due to de-
creased sense of smell or taste should be avoided.
V. FOLLOW-UP MONITORING
A. Annual vision assessment: Medicaid in most states will pay for a new
pair of eyeglasses every 2 years.
B. When vision is worse than 20/125, individuals should be referred to a
low-vision specialist to provide training in the use of visual assistive
devices.
C. Given that hearing can change significantly over time, an audiological
evaluation for hearing-impaired older adults every 2 years is impor-
tant. Some states pay through Medicaid for one hearing aid under
limited conditions. Hearing aids have been shown to be better ac-
cepted if older adults receive them when they start having difficulty
with word finding with background noise. Encouragement is needed
to improve the consistent use of a hearing aid. Audiologists can help
train older adults and their families in the use of hearing aids if nec-
essary.
D. When abrupt changes in smell or taste are reported, a referral to a
dentist or ENT is indicated.
E. Long-term adjustments must be made in the home when smell and
taste are affected. First, food should be dated and discarded after 48
hours to avoid accidentally eating spoiled food.
F. When xerostomia (i.e., severe dry mouth) is found, a referral to a
dentist is indicated.
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G. Older adults with decreased peripheral sensation should be followed
regularly by a podiatrist or foot-care specialist.
VI. INTERPROFESSIONAL CARE OF SENSORY CHANGES
Care of the aging senses is an interdisciplinary endeavor. Nurses, who fre-
quently have the most contact with patients, can take the lead in assess-
ing and screening older adults for decreased sensory function. Once these
deficits are identified, it is important to take the appropriate steps and iden-
tify the resources available to older adults. Occupational therapists, low-
vision specialists, audiologists, nutritionists, otolaryngologists, and neurol-
ogists are just some of the professionals whomay be part of the team caring
for sensory-impaired older adults. Good communication amongdisciplines
is essential to help older adults benefit from each specialist.
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Introduction
The Centers for Medicare and Medicaid Services (CMS; formerly Health Care
Finance Administration [HCFA]) defines physical restraint as “any (emphasis
added) manual method, physical or mechanical device, material, or equipment
that immobilizes or reduces the ability of the patient to move his or her arms,
legs, body or head freely” (Federal Register, 2006). Examples of these are wrist
or leg restraints, hand mitts, Geri-chairs, and, in certain situations, full side
rails and reclining chairs. Despite the federal regulations placed on hospitals
since 1999, the use of physical restraints for the management of patients in
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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acute nonpsychiatric settings remains a controversial and challenging practice.
Typically, health care professionals utilize physical restraints and/or side rails to
protect the patient or others. However, the use of physical restraints or side rails
for the involuntary immobilization of a patient may not only be an infringement
of the patient’s rights but can also result in patient harm, including soft-tissue
injury, fractures, delirium, and even death (Bower, McCullough, & Timmons,
2003; Evans, Wood, & Lambert, 2003; Miles, 1993 [both Level V]).
The standards from the Joint Commission on Accreditation of Healthcare
Organizations (JCAHO) and regulations from CMS have raised concerns among
hospital professionals about the feasibility and safety of reducing or eliminating
use of physical restraints and side rails in hospitals. The almost nonexistent use
of physical restraint in theUnitedKingdom in comparable settings provides evi-
dence that this can be achieved (O’Keeffe, Jack, & Lye, 1996 [Level IV]; Williams
& Finch, 1997 [Level VI]). This chapter focuses on the issues of physical re-
straint in acute, nonpsychiatric hospital settings with particular attention to the
frail elderly, decisions to use physical restraint, legal and ethical issues, admin-
istrative responsibilities, and approaches to eliminating or minimizing physical
restraints on acute- and critical care units.
Legal Issues
Regulations and Accrediting Standards
In 1992, the U.S. Food and Drug Administration (FDA) issued a Medical Alert
on the potential hazards of restraint devices (FDA, 1992). Any harm that arises
from the use of a restraining device, which now includes bedside rails, must
be reported to the FDA. The hospital standards promulgated by the JCAHO
in the early 1990s began to address the use of physical restraints. Over the
ensuing years, the standards have become increasingly prescriptive as well as
more difficult for acute care settings to meet.
In 1999, HCFA established an interim rule for hospitals, Conditions of Par-
ticipation, regulating the use of physical restraints in all settings that accepted
Medicare or Medicaid participants (HCFA, 1999). In December 2006, a final
rule finalized the Patients’ Rights Condition of Participation (Federal Register,
2006). These conditions establish the minimum protections of patients’ rights
and safety and may be superseded by state regulations or accrediting agencies.
In brief, use of physical restraint should be used as a last resort; only used when
less restrictive mechanisms have been determined to be ineffective; the use of
restraint must be in accordance with a written modification to the patient’s plan
of care; used in accordance with the order of a physician or licensed indepen-
dent practitioner; must never be written as a PRN order; each order must be
renewed every 24 hours for reasons of violent or self-destructive behavior; each
order for restraint use for nonviolent reasons must be renewed according to
hospital policy; and restraint must be discontinued at the earliest possible time.
Risks of Liability
A major obstacle in reducing clinicians’ use of physical restraint or side rails is
the fear of liability if restraints are not used. Case law has been mixed on use
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of physical restraints in hospitals. Hospitals have been found liable both for the
use of physical restraints and for not using physical restraints (Kapp, 1994, 1999
[both Level VI]). However, the changing standards of care will lead to a different
legal standard of care than that of the 1980s or 1990s. Although hospitals have
a clear duty to protect patients from harm, they do not have a duty to restrain
patients. Indeed, as the practice in hospitals becomes one of reduced restraints
due to changing legal and accrediting standards, it will become easier for hos-
pitals to justify non-use of restraints in instances of patient injury where use of
nonrestraint interventions were clearly demonstrated (Kapp, 1999 [Level VI]).
However, it will also become harder for a hospital to justify its use of restraints
in instances of patient harm (Kapp, 1999 [Level VI]).
Professional Standards of Care
Several organizations have established guidelines for the use of physical re-
straints, including the American Geriatrics Society and The American Psychi-
atric Association. As early as 1994, a set of voluntary standards on physical
restraints was developed for hospital nurses by the Nurses Improving Care of
theHospitalized Elderly Project, sponsored by The JohnA.Hartford Foundation
(Mion&Strumpf, 1994 [Level V]). Subsequently, theNational Quality Forumhas
designated physical restraint use in hospitals and nursing facilities as a patient-
centered outcome for nursing-sensitive care. Last, as part of the condition for
participation as a Magnet facility, hospitals must examine use of physical re-
straint in relation to nursing-skill mix and hours.
These guidelines have become the standard for customary practice and are
used as an appropriate legal standard that defines the parameters of liability.
Furthermore, these guidelines in combination with JCAHO and CMS require-
ments are used to establish hospital-based policies and procedures, quality of
performance activity, and utilization of these criteria.
Prevalence and Rationale of Staff
Extent of Use
These standards and guidelines have led to an overall decrease in physical-
restraint use in acute care and a change in practice patterns (Minnick, Mion,
Johnson, Catrambone, & Leipzig, 2007; Minnick, Mion, Leipzig, Lamb, & Palmer,
1998; Whitman, Davidson, Sereika, & Rudy, 2001 [all Level IV]). In the 1980s, a
number of single-site studies examined the prevalence of physical restraint on
general adult units. The overall prevalence of physical restraint use on general
floors ranged from 6% to 13% with higher rates (18% to 22%) among elderly
patients (Mion, Minnick, Palmer, Kapp, & Lamb, 1996 [Level V]).
In the late 1990s, overall hospital restraint prevalence decreased but varied
as much as threefold with rates ranging from 39 restraint-days/1,000 patient-
days to 82 restraint-days/1,000 patient-days (Minnick et al., 1998 [Level IV];
Whitman et al., 2001 [Level IV]). For the first time, restraint use was examined
in critical care units and was noted to be as high as 500 restraint-days/1,000
patient-days. Intensive care unit (ICU) rates varied markedly, between units in
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the same hospital setting as well as matched units between hospitals (Minnick
et al., 1998 [Level IV]; Whitman et al., 2001 [Level IV]). During 1998–1999, a
longitudinal study was conducted at two acute care settings involving six ICUs
and seven non-ICUs (Mion et al., 2001 [Level III]). ICU rates were much higher
than non-ICU rates (i.e., up to 482 restraint-days/1,000 patient-days versus 0.1
restraint days/1,000 patient-days). The variation in ICUs within the same hos-
pital and by type of ICU again was present. For example, neurological ICUs had
rates greater than surgical ICUs.
A national prevalence study involving 434 units in 40 acute care hospitals
selected at random from five geographic areas was completed in 2005 (Minnick
et al., 2007 [Level IV]). Findings from this study revealed overall hospital preva-
lence of 50 restraint-days/1,000 patient-days but with a 10-fold variation among
hospitals from a rate of 9 to 94 restraint-days/1,000 patient-days. The majority
of use was accounted for in ICUs. The pattern of differences by type of unit
was again present (e.g., medical versus surgical and adult versus pediatric).
However, even when controlling by type of unit, a more than 10-fold varia-
tion existed among similar settings. For example, overall prevalence among the
41 general ICUs was 202.6 restraint-days/1,000 patient-days, with a range of 9
to 351/1,000 patient-days. An examination of staffing ratios and nursing-skill
mix failed to demonstrate an association with physical-restraint rates. Further
analyses revealed that variation in practice persisted even when controlling for
size of hospital, academic/nonacademic status, geographic region, and type of
hospital (i.e., nonprofit, profit, and government). Clearly, there are patient pop-
ulations associated with clinicians’ decisions to use physical restraint but, more
important, there are major practice differences even when controlling for patient
population.
Rationale for Use
In the 1980s, hospital nurses cited fall prevention as the primary reason for re-
straint use (56% to 77%) (Mion, Frengley, Jakovcic, & Marino, 1989 [Level III];
Robbins, Boyko, Lane, Cooper, & Jahnigen, 1987 [Level IV]; Strumpf & Evans,
1988 [Level IV]). Although fall risk is still a concern, today’s hospital nurses cite
prevention of patient initiated therapy disruption as the primary reason for re-
straint use (reported for 75% of restraint-days) (Minnick et al., 2007 [Level IV]).
It is somewhat disconcerting that nurses still tend to use the term confusion as
a reason for use of physical restraints. In this study, it was cited in 25.4% of the
restraint-days, and in 8.25% of the restraint-days it was the sole reason for use.
Prevention of falls was identified in only 17.6% of the restraint-days. Other less
commonly voiced reasons includedmanagement of agitation or violent behavior,
wandering, and positioning. Most nurses cite patient-care issues for the ratio-
nale to use physical restraint. However, a small proportion of nurses have cited
insufficient staffing for restrained patients (Evans & Fitzgerald, 2002 [Level IV];
Matthiesen, Lamb, McCann, Hollinger-Smith, & Walton, 1996 [Level IV]; Min-
nick et al., 1998 [Level IV]; Minnick et al., 2007 [Level IV]; Scherer, Janelli, Wu,
& Kuhn, 1993 [Level V]; Schott-Baer, Lusis, & Beauregard, 1995 [Level V]).
There have been many studies of the perceptions of caregiving staff about
their attitudes and beliefs regarding physical restraint. In the 1980s, clinicians
rarely questioned the use of physical restraints, instead assuming that this
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widespread practice was necessary as well as appropriate (Frengley, 1996 [Level
VI]; Strumpf & Evans, 1988 [Level IV]). Early studies on attitudes toward re-
straints, mostly conducted at single sites with small sample sizes, found that 75%
to 82% of nursing staff were “comfortable” using restraints and up to 78% be-
lieved that restraints prevented injury (Houston & Lach, 1990 [Level V]; Neary,
Kanski, Janelli, Scherer, & North, 1991 [Level IV]; Scherer, 1991 [Level VI]). In
the late 1990s, well after JCAHO had begun more restrictive standards, a study
of 799 nurses and physicians at three teaching hospitals found that only 46% felt
a patient suffered loss of dignity when placed in restraints, 17% felt guilty using
restraints, and 16% felt embarrassment when family entered the room of a re-
strained patient (Lamb,Minnick,Mion, Palmer, &Leipzig, 1999 [Level IV]).Most
of the respondents believed that the benefits of restraints outweighed the risks.
Withmore than 5 years of federal regulations restricting their use, one won-
ders to what extent any of the attitudes or knowledge has changed among acute
care personnel. Given the variation in actual use of restraint, it appears that the
decision to use physical restraint continues to be one based on individual judg-
ment and beliefs rather than on scientifically validated guidelines or protocols.
Ethical Issues in the Use of Physical Restraint
The use of physical restraints has been examined from an ethical perspective
(Moss&LaPuma, 1991 [LevelVI]; Robinson, 1995; Schafer, 1985; Slomka,Agich,
Stagno, & Smith, 1998 [all Level VI]). The primary ethical dilemma resulting
fromphysical restraint is the clinician’s value or emphasis of beneficence versus
the patient’s autonomy. The presence of a physical restraint, by its very nature,
is applied against a patient’s wishes and inevitably compromises the individual’s
dignity and diminishes respect for the person. Beneficence requires that at least
no harm should arise from the use of physical restraint and that, optimally, a
good outcome would result from use. The lack of beneficial results from the use
of physical restraints has been well documented in many health care settings.
Little is known, however, of the risk-to-benefit ratio of use or non-use of physical
restraint in patients who are critically ill (Maccioli et al., 2003 [Level VI]).
The discussion of physical restraints from an ethical viewpoint must also
incorporate the socioculture and political contexts. For example, clinicians have
reported on low to nonexistent use of physical restraint in the United Kingdom,
stemming perhaps from a legal mandate existing since the 1800s prohibiting
their use. It has been suggested that in the United States, the domination of risk
in geriatric assessment (e.g., prevent harm, prevent falls) shapes much of clin-
icians’ understanding of old age (Kaufmann, 1994 [Level VI]). If one’s primary
focus is on the likelihood of patient risk resulting in harm, one is less likely to
see self-esteem or dignity as themore important value ormodel to guide clinical
decisions (Slomka, et al. 1998 [Level VI]). Interestingly, Slomka and associates
(1998 [Level VI]) point out the contradictory nature of the frequent use of phys-
ical restraint in the United States—that is, a society that places a high value on
autonomy yet is so willing to violate that autonomy in the interest of perceived
patient benefit. This contradiction may stem from the youth-oriented culture
that places low value on aging.
The discussion of ethics in clinical practice must also acknowledge the re-
alities of reduced resources and escalating costs (Slomka et al., 1998 [Level VI];
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Minnick et al., 2007 [Level IV]). Decisions and protocols about use of phys-
ical restraints and methods to reduce and/or eliminate restraints will be im-
pacted by cost-containment efforts. There is a shortage of registered nurses
and a need to change our models of care delivery to account for this change, at
a time of sicker patients (Johnson, Billingsley, & Costa, 2006 [Level VI]). Given
this scenario, clinicians and administrators alike may be reluctant to minimize
or eliminate restraints. If alternatives to physical restraints in acute care set-
tings can be shown to contribute to quality outcomes (e.g., patient safety, patient
dignity/satisfaction) and within existing cost-containment efforts, then there is
an increased likelihood of successfully implementing and maintaining practice
guidelines. There is a chance, however, that if restraint-reduction efforts are
seen as too expensive (e.g., use of “sitters”), then the emphasis on cost-constraint
may trump other considerations (Slomka, et al., 1998 [Level VI]).
Administrative Responsibilities
Changing established practices and philosophies of care can be a daunting task.
Although education and training are important, the singlemost important factor
in affecting a major shift in the present paradigm of care to one that is restraint-
free care is the commitment by administrators and key clinical leaders (Mion
et al., 2001 [Level III];Williams & Finch, 1997 [Level VI]). Indeed, the huge vari-
ation seen in the rates among 40 hospitals that cannot be explained by size of
hospital, type of hospital, or geographic location lends support to this observa-
tion. The administrators, including nursemanagers, set the tone for the practice
on the unit. Clinical staff, especially the frontline care providers, must feel sup-
ported during the transition period. Reducing health care providers’ reliance on
physical restraint in managing confused or agitated patients, especially in the
critical care units, is a major shift that leaves many staff uneasy. The goal set
and supported by administration of a restraint-free (or restraint-minimal) en-
vironment would establish the presence of a physical restraint as an outlier that
requires a full analysis as for any sentinel event. The outcome of such analyses
maywell lead to the recognition of systemproblems and organizational arrange-
ments that can be improved, which, in turn, lead to even fewer restraints in use.
Settings of Care
The studies of the prevalence of the use of physical restraints for nonpsychiatric
purposes in hospitals have shown that there is great discrepancy between gen-
eral medical and surgical units and intensive-care units in terms of the extent
and rationale. Therefore, the use of physical restraints and approaches to pos-
sible alternatives can be considered separately for general hospital units and
critical care units.
General Medical–Surgical Units
Rates of physical restraint use on general medical and surgical units have de-
clined in the past 20 years (Frengley & Mion, 1986 [Level IV]; Minnick et al.,
2007 [Level IV]). Although the rate of use has declined, the evidence of wide
variation among these units exists; the range was 3 to 123 restraint-days/1,000
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patient-days on 70 medical units and 0 to 65 restraint-days/1,000 patient-days
on 50 surgical units (Minnick et al., 2007 [Level IV]). It is apparent that there are
units that demonstrate best practices but also that further efforts are needed to
diminish this practice as a national standard. Otherwise, significant numbers of
patients will continue to be restrained.
Many hospitals provide care for acutely ill, frail elderly in settings that are
not designed environmentally for the care of such older people (Mion, 1992
[Level VI]; Palmer, Landefeld, Kresevic, &Kowal, 1994 [Level VI]). Environmen-
tal structure can either facilitate or inhibit monitoring and surveillance, noise
control, appropriate lighting, socialization, cognition, and function (Inouye &
Charpentier, 1996 [Level IV]; Palmer et al., 1994 [Level VI]). Studies in long
term care settings have demonstrated that the use of environmental strategies
can enhance function among those suffering from dementia; similar strategies
need to be considered in acute care settings.
In addition to environmental strategies, organizational factors, such as sys-
tems to determine staffing numbers andmix, models of care delivery, and trans-
mission or communication of the plan of care among multiple disciplines and
departments, are gaining increased recognition in the patient-safety movement
(Leape & Berwick, 2005 [Level VI]). Many health care providers lack the knowl-
edge, skills, and sensitivity in providing appropriate care to older adults. The
JCAHO standard to ensure age-specific education and training is a step in the
right direction, but further efforts are required.
No single approach to eliminating physical restraints on general medical–
surgical units can be successful. Studies in a variety of settings have shown
that the use of advanced practice nurses, comprehensive interdisciplinary ap-
proaches to enhance cognitive and physical function, staff education, organi-
zational strategies, and environmental interventions can eliminate or reduce
physical restraints in a cost-effective manner while promoting other patient
outcomes, such as reduced fall rates (Amato, Salter, & Mion, 2006 [Level V];
Landefeld et al., 1995 [Level II]; Mion et al., 2001 [Level III]).
Critical Care Units
Thepractice of physical restraints is nowpredominantlywithin ICUs tomaintain
needed life-sustaining therapies or life-maintaining therapies (Minnick et al.,
2007 [Level IV]). Strategies that have been used with success in long term care
settings, rehabilitation settings, and general hospital units are not as successful
in critical care environments (Mion et al., 2001 [Level III]). The severity of ill-
ness of patients; the intensity and delivery of care; the pace of activity; and the
consequences of interruptions, delays, or disruptions of therapeutic devices dif-
fer significantly among non-ICUs and ICUs. The thought of delirious patients
dislodging external ventricular drains with subsequent brain damage, pulling
out central lines with threat of hemorrhage, or self-extubation from mechani-
cal ventilation with subsequent respiratory arrest is one that heavily influences
critical care nurses’ decisions to use physical restraints (Frengley & Mion, 1998
[Level V]; Happ, 2000 [Level V]).
Efforts to limit physical-restraint use in the ICU are hampered by lack
of information regarding the extent of therapy disruption in these units or
the resulting immediate and subsequent harm to patients (Maccioli et al.,
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2003 [Level VI]). A number of studies, mostly single-site, have examined self-
extubation frommechanical ventilation (Betbese, Perez, Bak, Rialp, &Mancebo,
1998 [Level IV]; Boulain, 1998 [Level IV]; Carrion et al., 2000 [Level IV]; Chevron
et al., 1998 [Level IV]; Chiang, Lee, Lee, &Wei, 1996 [Level V]; Christie, Dethelf-
sen, & Cane, 1996 [Level IV]; Fraser, Riker, Prato, & Wilkins, 2001 [Level IV];
Frezza, Carleton, & Valenziano, 2000 [Level III]; Kapadia, Bajan, & Raje, 2000
[Level IV]; Moons, Sels, De Becker, De Geest, & Ferdinande, 2004 [Level IV]).
Rates have ranged from 0.3% to 14.3%, with higher rates in medical ICUs. Re-
intubation after self-extubation ranged from 11% to 76%. Importantly, 33% to
91% of those who self-extubated did so while physically restrained. As part
of the national prevalence study described earlier, the authors also examined the
prevalence of patient-initiated device removal, patient contexts, patient risk-
adjusted factors, and consequences (Mion, Minnick, Leipzig, Catrambone, &
Johnson, n.d. [Level V]). In 49 ICUs in 39 hospitals, data was collected on 49,470
patient-days. Patients removed 1,623 devices on 1,097 occasions, for an overall
rate of 22.1 episodes/1,000 patient-days. Similar to results on physical-restraint
prevalence, wide variation in rates were noted: from 0 to 102.1 episodes/1,000
patient-days. Approximately one-half the episodes occurred on the day shift,
and 44% were in physical restraint at the time of the episode. Patient harm
occurred in 250 (23%), mostly minor in nature. In 10 (0.9%) episodes, patients
incurred major harm. No deaths occurred. The authors examined rates of rein-
sertion and found that these varied by type of device. Devices that are easily
applied, such as monitor leads or oxygen masks, had much higher reinsertion
rates than devices that are more complex and difficult to insert (e.g., endotra-
cheal tubes or surgical drains). It may be that devices are utilized too long,
which could contribute to prolonged use of physical restraint. In turn, physical
restraint may contribute to agitation and delirium (Inouye & Charpentier, 1996
[Level IV]). Additional hospital resources (e.g., x-rays, laboratory tests) were
utilized in slightly more than half the episodes; Fraser and associates (2001
[Level IV]) commented on the potential costliness of this problem.
Information gathered on staffing levels and mix showed little variation
among these ICUs; hence, there was no association between staffing ratios and
therapy disruptions. Of the three studies on self-extubation that examined rela-
tionship to staffing levels, two also showed no association (Boulain, 1998 [Level
IV]; Chevron et al., 1998 [Level IV]; Marcin et al., 2005 [Level IV]). The propor-
tion of unit days were collected involving use of physical restraint and found
no association between a unit’s restraint rate and rate of therapy disruption,
a finding similar to some other studies (Kapadia, Bajan, & Raje, 2000 [Level
IV]; Mion et al., 2001 [Level III]) but not others (Carrion et al., 2000 [Level IV];
Frezza, Carleton, & Valenziano, 2000 [Level III]; Tominaga, Rudzwick, Scannell,
& Waxman, 1995 [Level III]).
Finally, the pattern of sedation and analgesia in these units was unclear
and 30% of the patients had received no analgesia or sedation in the 24 hours
prior to the episode. Others have reported on inconsistent sedation and anal-
gesia practices in ICUs (Bair, Bobek, Hoffman-Hogg, Mion, & Arroliga, 2000
[Level IV]; Egerod, Christensen, & Johansen, 2006 [Level IV]; Mehta et al., 2006
[Level IV]; Siegel, 2003 [Level VI]; Weinhart, Chlan, & Gross, 2001 [Level IV]).
In an earlier cohort study, the authors examined ICU patient outcomes after
implementing sedation and analgesia guidelines and found that those cared for
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with the guidelines had less self-extubations and use of physical restraints (Bair
et al., 2000 [Level IV]). Examining appropriate strategies for sedation and anal-
gesia in critically ill patientsmaywell result in improved clinical outcomeswhile
providing care in a more humane fashion.
Attention to the environment of the ICU is as important as any other set-
ting. Indeed, the environment can affect more strongly persons whose personal
competence is low and who are unable to exert control over the environment.
Inouye and Charpentier (1996 [Level IV]) exquisitely demonstrated the inverse
relationship of the individual’s level of vulnerability with that of environmental
or process insults on subsequent development of delirium among hospitalized
older adults. Environmental features such as noise, light, and unit design have
been shown to be associated with agitation, anxiety, and disorientation of ICU
patients (Williams, 1988 [Level VI]).
Lack of communication with ICU patients by care providers has been docu-
mented and results in distress, anxiety, and confusion (Fontaine, 1994 [Level V]).
Attention to the physical environment; use of communication techniques with
seemingly noncommunicative patients; encouragement of collaborative prac-
tice among ICU disciplines; and nonpharmacologic approaches to relieve pa-
tient distress, anxiety, and agitation have been suggested but largely untested
(Maccioli et al., 2003 [Level VI). Nevertheless, a multi-prong approach to opti-
mize physical and cognitive function, address onset as well as management of
delirium, and appropriate and adequate pain control are likely to affect nurses’
and physicians’ reliance on physical restraint.
Alternatives to Physical Restraints
This book has provided the reader with a number of protocols addressing care
issues such as falls, delirium, sleep, nutrition, medications, and function. The
reader is encouraged to review these protocols closely. Implementing best prac-
tices aimed at these areas will in itself reduce the use of physical restraints. A
brief overview of an approach the authors have found to be successful is pre-
sented herein.
The two major reasons for using physical restraints—to prevent therapy
disruption and falls—require comprehensive yet targeted approaches. The act
of self-terminating therapy among hospitalized, acutely ill older adults is most
likely a manifestation of delirium and less likely a desire to enact a clinical
decision, as with advanced directives. Both falls and delirium are well-known
syndromes with significant morbidity and mortality among older adults. Both
are complex syndromes with multiple underlying etiologies that require a com-
bination of individual-, environmental-, and organizational-specific strategies
(Tinetti, Inouye, Gill, & Doucette, 1995 [Level VI]).
Inouye and colleagues (1999 [Level II]) demonstrated an approach to pre-
venting delirium in a randomized controlled trial. However, most strategies are
based on nonrandomized trials and/or clinical experience. Given the complexity
of falls and delirium, it is unlikely that any single intervention would suffice as
an alternative to physical restraint. Rather, attention to the environment and or-
ganization of the unit, as described in the two previous sections, combined with
patient-specific approaches provides the most successful approach to this issue
(Mion et al., 2001 [Level III]; Amato et al., 2006 [Level V]). Tables 22.1 and 22.2
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22.1 Interventions to Reduce Fall Risk
Patient-Centered
Interventions
Organizational
Interventions
Environmental
Interventions
Supervised, progressive ambulation Examine pattern of falls on
unit (e.g., time of day, day of
week)
Keep bed in low, locked
position
PT/OT consultation: weakened or
unsteady gait, trunk weakness,
upper arm weakness
Examine unit factors that can
contribute to falls that can be
ameliorated (e.g., report in
back room versus walking
rounds to improve
surveillance)
Safety features such as grab
bars, call bells, and bed
alarms are in good working
order
Provide physical aids, hearing,
vision, walking
Restructure staff routines to
increase number of available
staff throughout day
Ensure that bedside tables
and dressers are in easy
reach
Modify clothing: skid-proof slippers,
slipper-socks; robes no longer than
ankle length
Set and maintain toilet
schedules
Clear pathways of hazards
Bedside commode if impaired or
weakened gait
Install electronic alarms for
wanderers
Bolster cushions to assist
with posture, maintain seat in
chair
Postural hypotension: behavioral
recommendations such as ankle
pumps, hand clenching, reviewing
medications, elevating head of bed
Provide bed/chair alarms* Adequate lighting, especially
bathroom at night
Moving patient closer to
nurse station
Furniture to facilitate seating:
reclining chairs†, extended
arm rests, high back
Increased checks on high risk
patients
*Note that alarms do not necessarily prevent a patient from attempting to arise from bed or chair or leave a unit. They are
primarily to be used to ensure more timely notification to staff that patients are attempting unsupervised transfers or
ambulation.
† For those with poor trunk balance and who slide out of chairs; in other instances, could be viewed as a restraint.
Although there is no strong evidence to support each of these interventions, they have been used in multicomponent
interventions studies that have demonstrated reduced fall risk (Oliver et al., 2007 [Level I]).
22.2 Interventions to Minimize or ReducePatient-Initiated Device Removal
Determining Underlying Cause for
Agitation/Cognitive Impairment Device Removal
Immediate Assessment Disruption of Any Device
If abrupt change in perception, attention, or
level of consciousness:
– Assess for life-threatening physiologic
impairments: respiratory, neurologic,
fever/sepsis, hypo/hyperglycemia,
alcohol/substance withdrawal, fluid and
electrolyte imbalance.
– Notify physician of change in mental status
& compromised physiologic status
– Determine if medically possible to discontinue device;
try alternative mode of therapy
– For mild-to-moderate cognitive impairment, explain
device and allow patient to feel under nurse’s
guidance
Differential assessment (Interdisciplinary) Attempted or actual disruption: ventilator
– Obtain baseline or pre-morbid cognitive
function from family caregivers
– Establish whether the patient has history
of dementia or depression
– Review medications to identify drug–drug
interactions, adverse effects
– Review current laboratory values
– Determine underlying cause of behavior for
appropriate medical and/or pharmacologic approach
– More secure anchoring
Start with less restrictive means: mitts, elbow
extenders
Treatment (Interdisciplinary) Attempted or actual disruption: Nasogastric tube
– Treat underlying disorder(s)
– Judicious, low dose use of medication if
warranted for agitation
– Communication techniques: low voice,
simple commands, reorientation
– Frequent reassurance and orientation
– Surveillance/observation: Determine
whether family member(s) willing to stay
with patient; move patient closer to nurses’
station; perform safety checks more
frequently; redeploy staff to provide
one-on-one observation if other measures
ineffective.
– If for feeding purposes, consult with nutritionist,
speech or occupational therapist for swallow
evaluation
– Consider gastrotomy tube for feeding as appropriate
if other measures ineffective
– Anchoring of tube, either by taping techniques or
commercial tube holder
– If restraints needed, start with least restrictive
restraints: mitts, elbow extenders
Attempted or actual disruption: IV lines
– Commercial tube holder for anchoring
– Long-sleeved robes, commercial sleeves for arms
– Consider Hep-Lock and cover with gauze
– Taping, securement of IV line under gown, sleeves
– Keep IV bag out of visual field
– Consider alternative therapy: oral fluids, drugs
Attempted or actual disruption: Bladder catheter
– Proper securement, anchoring to leg; commercial
tube holders available
Although there is no strong evidence to support each interventions, they have been used in a multicomponent quality
improvement study that demonstrated reduced rates of therapy disruption (Mion, Fogel, Sandhu, et al., 2001 [Level III]).
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display selected interventions aimed at reducing the likelihood of falls and the
attenuation of delirium and subsequent disruption of therapy.
Falls are well-known, serious events in hospitalized older patients. The goal
is to minimize the risk or probability of falling without compromising an older
individual’s mobility and functional independence. Using a systematic or stan-
dardized approach, the nurse and physician assess the patient for intrinsic (per-
sonal), extrinsic (environment), and situational (activity) factors. The evaluation
need not be complex or time-consuming, and several fall risk assessment guide-
lines are available. For instance, a nurse can do a simple evaluation of gait and
balance by simply observing a person’s ability to transfer in and out of bed or
chair and the ability to walk to and from the bathroom. A nurse can quickly
note any difficulty with steadiness, ability to stand up independently without
using a rocking motion or use of upper extremities, ability to sit down without
“plopping” onto the surface of the chair, and the ability to walk steadily to the
bathroom without holding onto objects or the wall. At this time, notation can be
made of lightheadedness or dizziness, presence of orthostatic hypotension, and
use of sedating medications.
Extrinsic factors include clothing and footwear. Shoes or slippers should be
nonskid, but rubber-soled footwear is not recommended. Furniture design, such
as beds at a proper height and chairs with extended armrests for easier leverage,
can facilitate mobility. Reclining chairs are helpful for those with poor trunk
control and who slide out of chairs with a 90-degree seating angle. On the other
hand, reclining chairs couldbe a typeof restraint if used for patientswith general
deconditioning or weakened states who subsequently struggle to rise out of the
chair. Although beds low to the floor assist with preventing fall injury, they may
actually contribute to a fall in a person with weak quadriceps muscle strength;
hence, the nurse must use clinical judgment of whether the intervention is to
prevent a fall or prevent a fall injury; these goals do not necessarily result in
similar interventions. Hospital equipment can also contribute to falls, such as
legs collapsing on bedside commodes, wheelchairs tipping when a patient leans
forward, or tubing from lower extremity intermittent compression devices that
are left on when a patient gets up from bed.
Thefindings of either intrinsic or extrinsic factors should lead to targeted in-
terventions. There are some fall-prevention strategies that one could consider
as “universal”—that is, be implemented for all patients regardless of the risk
level. For instance, all patients should have beds at appropriate heights for ease
of exiting and entering, have call bells within reach, and have clear pathways.
Depending on the type of unit, some units may elect to incorporate universal
interventions that other floors would consider a targeted intervention. For ex-
ample, an acute-stroke unit may elect to automatically place all patients on a
toileting schedule at time of admission and reevaluate continually whether this
intervention is required, whereas other units in the hospital would elect to use
this as a targeted intervention only for those patients with cognitive impair-
ment and incontinence. Table 22.1 provides a number of suggestions reported
in the literature and based on clinical experience to reduce the risk of falls (see
chapter 9, Preventing Falls in Acute Care, for greater detail).
Disruption of therapy or self-termination of devices can be dealt with by
first identifying the underlying reason for a patient’s attempts to terminate ther-
apies. In many cases, a nurse will identify confusion as the underlying cause. As
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discussed in earlier chapters, nurses need to differentiate dementia, delirium,
and delirium with dementia. A systematic approach to determine the cause of
the behavior is necessary for treatment. For example, if an older adult is suffer-
ing from alcohol withdrawal, it is unlikely that interventions such as increased
surveillance or pain relief will have much impact on the person’s agitation and
delirium. Refer to chapter 4, Assessing Cognitive Function, and chapter 7, Delir-
ium, for further protocols to identify cognitive impairments and to prevent and
manage delirium.
As the health care team works to address a patient’s behavior, nonphar-
macological approaches to protecting the device from self-termination can be
made. First, determine whether the device is absolutely necessary. Even in the
critical care environment, major therapy devices may not be reinserted once a
patient pulls it out. Thus, always question whether the device is absolutely nec-
essary or a less noxious device or approach may be used instead. For example,
if a nasogastric tube is used for nutrition, request the assessment of other dis-
ciplines, such as speech or occupational therapists, to determine whether oral
feeding could be introduced. If long-term enteral feeding is required, an inter-
disciplinary team planwith the patient and family is warranted given the known
deleterious effects of tube feedings with certain conditions. A second approach
is to use anchoring or camouflaging techniques to secure the device against
the patient’s attempts to dislodge the device and to “hide” the device from the
patient. For instance, one cannot disguise or hide a nasogastric tube from the
person. The tube, however, can be placed so as to not interfere with or interrupt
the person’s visual field. Seeing the tube dangling in front of one’s eyes or pulling
on one’s nares is an obvious irritant. If a gastrostomy tube is determined to be
appropriate in a person’s plan of care, abdominal binders can aid in reducing
the person’s ability to pull it out. There are several commercial products avail-
able to secure various tubes, including nasogastric tubes, endotracheal tubes,
intravenous lines, and indwelling bladder catheters. Although none of these de-
vices is likely to prevent a determined person from pulling out a device, they
do provide anchoring and stability of the device that are probably more secure
than taping methods (Tasota, Hoffman, Zullo, & Jamison, 1987 [Level II]).
Side Rails
A discussion on physical restraints in hospitals would not be complete without
mentioning side rails. Side rails, in and of themselves, are not considered a
restraining device by either the JCAHO or CMS. It is a nurse’s intent of their
use that determines whether side rails are a restraining device or a protective
device. This has led to some confusion by nurses. Full side rails to transfer
patients in carts, during procedures (e.g., conscious sedation), or to protect a
sedated or lethargic patient from rolling out of the bed can be considered as
protective devices. A number of specialty beds, such as ICU pulmonary beds
or bariatric beds, require full side rails in use. Many bed manufacturers have
bed controls and call systems embedded in the side rail frames, resulting in
patients requesting that the side rails be kept raised for ease of control. Hospital
patients have also been observed to request partial to full side rails to be raised
because of the narrowness of the beds or to facilitate movement (e.g., transfers,
repositioning).
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Full side rails to keep patients in bed who desire to leave bed are restraints.
It does not matter the cognitive level of the person. If a severely demented
patient wishes to leave the bed, full side rails are considered a restraint, even
if a nurse believes the side rails are for “patient safety.” Side rails have been
shown to increase fall injuries because patients either try to squeeze through
rails or climb over the foot of the bed; they are never a recommended strategy
for fall prevention. Moreover, the FDA has received reports of more than 400
deaths as a direct result of side-rail entrapment from a variety of health care
settings, including hospitals (FDA, 2006). The reader is referred to Capezuti and
Braun (2001 [Level V]) for an excellent review of the legal and medical aspects
of side rail use.
Conclusion
The pattern and rationale for physical-restraint use has changed over the past 2
decades. Focusing on assessment and prevention of delirium and falls will likely
minimize their use. Furtherwork is needed in the ICU settings for best strategies
to identify delirium, prevent delirium, and manage delirium that would include
nonpharmacological as well as pharmacological approaches. To avoid the use
of physical restraints, practical and cost-effective strategies need to be devised
and tested. This would best be done in an interdisciplinary patient-centered
fashion.
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Health Care
Decision
Making
Ethel L. Mitty
Linda Farber Post
Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. define informed consent and the supporting
bioethical and legal principles
2. understand the role of culture in treatment decision
making
3. differentiate between competence and capacity
4. understand the process of assessment of
decisional capacity
5. describe a nurse’s role and responsibility as an
advocate for a patient’s voice in treatment decision
making
Overview
Until the latter half of the 20th century, patients were told which health care
interventions would benefit them and they rarely questioned the doctor’s in-
structions. The rise of the rights movement in most areas of society promoted
the idea that patients would benefit from robust participation in health care de-
cision making affecting their health outcomes. Building on the well-established
doctrine of informed consent, statutory law, and case law, all states came to
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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require that patient wishes and values be central to treatment decisions. The
result was a greater degree of clinician–patient collaboration in planning and
implementing care decisions affecting them.
Health care is about decisions. How and whether health care and treat-
ment are provided, limited, or modified depends on who makes the decisions
and according to what standards. In this chapter, treatment is considered a
therapeutic intervention, either a single act or a coordinated plan of care, in-
tended to affect cure or improve the disease or injury-caused process. Simi-
larly, diagnostic interventions are specific tests intended to assist the identifi-
cation and assessment of clinical conditions that may benefit from treatment.
Care or caring is considered a series of acts (including treatments, diagnostic
tests, activities of daily living [ADLs], planning for discharge or future ther-
apy, and provision of comfort measures) that defines the clinical interaction.
Care is seen as a philosophy or attitude of nurturing that encompasses all as-
pects of the therapeutic dynamic, including both cure-oriented and palliative
ministrations.
Although all health care activities require principled and thoughtful deci-
sion making, treatment and diagnostic interventions—because of their benefit-
burden-risk calculus—typically require specific informed consent by or on
behalf of the patient. For this reason, the determination of decision-making
capacity, authority, and standards becomes a most pressing clinical issue when
deciding about treatment or diagnostic interventions.
Background
Ethical Principles and Professional Obligations
Core ethical principles that underlie the health care decision process and give
rise to clinician obligations include the following:
■ Respect for autonomy: supporting and facilitating a capable patient’s ex-
ercise of self-determination
■ Beneficence: promoting a patient’s best interest and well-being and pro-
tecting the patient from harm
■ Nonmaleficence: avoiding actions likely to cause a patient harm
■ Distributive justice: allocating fairly the benefits and burdens related to
health care delivery (Beauchamp & Childress, 2001)
These principles and the professional obligations they create often give rise
to conflict and tension for clinicians. For example, care providers are expected
to respect patients’ autonomy by honoring their decisions and protecting them
from the harm of risky choices. Care providers are also expected to provide
care to patients who need it and be responsible stewards of limited resources.
Clinical, legal, and ethically valid decisions by or for patients invoke a careful
balancing of information, principles, rights, and responsibilities in the light of
medical realities, cultural factors, and, increasingly, concerns about resource
allocation.
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Autonomy, Capacity, and Consent
The well-settled right to determine what shall be done with one’s own body
has two equally important components: the right to consent to treatment and
the right to refuse treatment. Grounded in the ethical principle of respect for
persons, this right to bodily integrity is considered so fundamental that it is
protected by the U.S. Constitution, state constitutions, and decisions of the U.S.
Supreme Court (Cruzan, 1990; Rivers, 1986). All persons are considered to have
the potential for autonomy, expressed in the clinical setting through informed
decision making. The threshold question is whether they have the capacity to
act autonomously.
Autonomy is widely considered to be the ethical principle most central
to health care decision making because of its emphasis on self-governance
and choices that reflect personal values. The heightened emphasis on self-
determination is largely a Western phenomenon and not universally shared.
Capable patients who are elderly, those who are easily confused or with dimin-
ished or fluctuating capacity, or from cultures that do not consider autonomy a
central value may not be capable of or comfortable with pure autonomous de-
cision making. Instead, they may involve trusted others in planning their care,
thus exhibiting assisted, supported, or delegated autonomy as their preferred
method of decision making. For these patients, autonomy may not be reflected
in self-determined decision making about treatment but rather in expressions
of values and goals of care. Thus, diminished or fluctuating capacity should be
seen not as the reason to ignore the patient’s voice but rather as an indicator
to attend more carefully to what is being communicated. The “what” and “how”
of the treatment may be a decision of others to make; the “why” in the patient’s
voice must be heard.
Consent and Refusal
In the clinical setting, the principle of respect for autonomy is most clearly ex-
pressed in the doctrine of informed consent and refusal (Beauchamp & Chil-
dress, 2001). Because therapeutic and diagnostic interventions typically involve
a range of benefits, burdens, and risks, express consent is almost always re-
quired before they are implemented. Consent should be a process over time
rather than a single event or a signed document. As an expression of autonomy,
the process can be solitary or, more likely, a collaborative process that includes
consultation with clinicians, family, and trusted others.
Capable patients or surrogates acting on behalf of patients without capac-
ity are engaged in a process, which is considered to include the following ele-
ments:
■ decisional capacity
■ disclosure of sufficient information relevant to the decision in question
■ understanding of the information provided
■ voluntariness (a patient’s right to make health care choices free of any
undue influence) in choosing among the options, and, on the basis of
these
■ consent to or refusal of the intervention (Lo, 2000)
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Research shows that patients may lack sufficient information to make an
informed, autonomous choice (Agard, Hermeren, & Herlitz, 2001 [Level II]).
Education can improve decisional capacity to give safe, informed consent, even
for clinically depressed older adults (Lapid, Rumman, Pankratz, & Applebaum,
2004 [Level II]). In addition, a physician’s emphasis on the distinctions about
the efficacy of a treatment, as to whether it would be curative or palliative,
can influence a patient’s decision even more than information given about the
disease or treatment options; “framing” can be persuasive (van Kleffens, van
Baarsen, & van Leeuwen, 2004 [Level IV]).
Decision-Making Authority
Decisions about treatment are typically made by capable patients based on their
goals and values in response to information they receive about their diagnosis,
prognosis, and therapeutic options. These decisions are thus an expression of
autonomy, reflecting the view that health care is not something that is done to
patients; rather, it is a collaborative endeavor in which patients and clinicians
contribute to the shared goal of recovery, rehabilitation, or palliation. Only when
patients are not capable of making decisions about their treatment are others
asked to choose for them, basing their decisions as much as possible on what is
known of the patients’ preferences orwhat is considered to be in their best inter-
est. Autonomous decision making is not the same as isolated decision making,
and drawing on the assistance or support of trusted others does not diminish the
integrity of the process. As noted previously, even capable patients may choose
to include others in the process. Voluntarily delegating decision-making author-
ity to others is also an autonomous choice, but it is one that must be explicitly
confirmed, not inferred.
The determination of decision-making authority is among the most critical
tasks in the clinical setting. Capable persons have a well-settled right, grounded
in law and ethics, to determine what is done to their bodies, an exercise of au-
tonomy expressed most fully in the doctrine of informed consent and refusal.
When patients lack the ability to make treatment decisions, authority to act on
their behalf must be vested in others—appointed agents, family, or other surro-
gates. The threshold determination, then, is of the patient’s decisional capacity:
an assessment of an individual’s ability to make decisions about health care and
treatment.
Assessment
Decision-Making Capacity
Although the terms capacity and competence are often used interchangeably, in
the health care setting their distinctions go beyond semantics. Competence is a
legal presumption that an adult has the mental ability to negotiate various le-
gal tasks, such as entering into a contract, making a will, and standing for trial
(Beauchamp & Childress, 2001). Incompetence is a judicial determination that
because a person lacks this ability, he or she should be prevented fromdoing cer-
tain things (Beauchamp & Childress, 2001). Capacity is a clinical determination
that a person has the ability to understand, make, and take responsibility for
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the consequences of health care decisions (Beauchamp & Childress, 2001). Be-
cause the legal system is and should be rarely involved inmedical decisions, it is
customary to determine a patient’s capacity for decision making, an assessment
made by clinicians.
The importance of capacity determination can be appreciated in the pre-
sumption that adults have decisional capacity and, absent contrary evidence,
treatment decisions defer to patient wishes. Moreover, this deference usually
extends to all decisions made by individuals with capacity, including those deci-
sions that appear risky or ill advised. Capacity assessment is important because
patients who lack the ability to appreciate the implications of and accept re-
sponsibility for their choices are vulnerable to the risks of deficient decision
making. Whereas honoring the decisions of a capacitated patient demonstrates
respect for the person, honoring the decisions of a patient without capacity is an
act of abandonment. Thus, clinicians have an obligation to ensure that capable
patients have the opportunity to make treatment decisions that will be imple-
mented and that incapacitated patients will be protected by having decisions
made for them by others who act in their best interest.
Fulfilling this obligation requires that clinicians appreciate the character-
istics of decision-making capacity. The elements of decisional capacity include
the ability to:
■ understand and process information about diagnosis, prognosis, and
treatment options
■ weigh the relative benefits, burdens, and risks of the care options
■ apply a set of values to the analysis
■ arrive at a decision that is consistent over time
■ communicate the decision (Roth, Meisel, & Lidz, 1997)
Capacity assessment depends on interaction with the patient over time
rather than on specific tests. There is no “gold standard” instrument or
“capacimeter” that assesses decisional capacity (Kapp & Mossman, 1996). The
Mini-Mental Status Examination (MMSE) estimates orientation, long- and
short-term memory, and mathematical and language dexterity. It is not a test
of executive function (an assessment more likely to broach reasoning and re-
call) and is, therefore, less helpful in gauging a patient’s ability to understand the
implications of a decision (Allen et al., 2003 [Level IV]). It has been suggested,
however, that an MMSE score below 19 or above 23 might be able to differ-
entiate those with capacity from those who lack capacity for decision making
(Karlawish, Casarett, James, Xie, & Kim, 2005 [Level IV]). Persons with mild to
moderate dementia (n = 88) can make or at least participate in treatment deci-
sion making, but impaired memory recall might be a barrier to demonstrating
their understanding of treatment options (Moye, Karel, Azar, & Gurrera, 2004
[Level IV]). Standard assessment of appreciation of diagnostic and treatment
information should focus on the patient’s ability to state the importance or im-
plications of the choice on his or her future health state. Specific neuropsycho-
logical tests (e.g., MacArthur Competence Assessment Tool, Hopemount Ca-
pacity Assessment Interview) can predict decisional capacity for those with
mild-to-moderate dementia, although reasoning and appreciation might differ
among those with mental illness (Gurrera, Moye, Karel, Azar, & Armesto, 2006
[Level IV]).
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Among a group of respondents including geriatricians, psychologists, and
ethics committees members, most agreed about the elements that have to be
present to determine decisional capacity for health care decision making (Vo-
licer & Ganzini, 2003 [Level IV]). The standard of decision making most highly
valued is the ability to appreciate the consequences of a decision followed by
the ability to respond “yes” or “no” to a question; the standard least supported
is that the decision has to seem reasonable.
A review of the research on decision-making capacity of cognitively im-
paired older adults (Kim & Karlawish, 2003 [Level V]) reports that of 32 rele-
vant studies, there is no consistent standardized definition of decisional capacity.
Among the studies examined, there is sufficient evidence that safe and appro-
priate decision making is retained in early-stage dementia. Cognitive changes
associated with the stages of Alzheimer’s disease (AD) were examined in rela-
tionship to different legal thresholds of competency: capacity to make a choice
(minimal legal standard [LS 1]), capacity to appreciate the consequences of a
decision (moderate standard [LS 3]), and capacity to understand the medical
situation and options (stringent standard [LS 5]). Receptive aphasia and severe
dysnomia associated with advanced AD precluded making a simple treatment
choice (LS 1). Patients with mild to moderate AD, evidenced by impaired ex-
ecutive function, lack the capacity to identify treatment consequences (LS 3).
Multiple deficits in ability to conceptualize, verbal recall, and word memory
preclude AD patients’ understanding of diagnoses and treatment options (LS 5)
(Marson, Chatterjee, Ingram, & Harrell, 1996 [Level IV]).
Decisional capacity is a clinical judgment that should be made by care pro-
fessionals most familiar with the patient. Nursing staff are ideally situated to
contribute important and necessary information. Because capacity may fluctu-
ate, decision-making ability should be assessed over time rather than at a given
moment (Mezey, Mitty, & Ramsey, 1997 [Level V]).
Clinical Importance of Decisional Capacity
Accurate and useful capacity assessment depends on the recognition that ca-
pacity is decision-specific rather than global. For example, a person with di-
minished capacity may be able to decide what to have for lunch or when to
shower. Evidence also suggests that adults with mild-to-moderate mental re-
tardation are able to make and provide a rationale for their treatment decisions
and evaluate the risks and benefits of treatment options (Cea & Fisher, 2003
[Level IV]). Because most people have the ability to make some decisions and
not others, respect for autonomy requires clinicians to identify the widest range
of decisions each patient is capable of making. A note in the chart saying, “Pa-
tient lacks decision-making capacity” arbitrarily precludes the individual from
making any decisions about anything when, in fact, the patient may only lack
the ability to make complex treatment decisions. Far more helpful would be an
entry that says, “Patient lacks the capacity to make decisions about participation
in a drug study.”
Likewise, decisional capacity may not be constant but may fluctuate, de-
pending on the clinical condition, medication, and/or the time of day. It is im-
perative for the protection of those with mild-to-moderate dementia that their
understanding and reasoning with regard to treatments and interventions is
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periodically assessed (Moye,Karel,Gurrera,&Azar, 2006 [Level IV]). Approach-
ing patients for discussions and decisions when they are at their most capable
(e.g., during the patient’s “window of lucidity”) enhances their opportunities to
participate in determining their treatment and health care.
Whereas disagreement with a proposed care plan or refusal of recom-
mended treatment does not by itself demonstrate incapacity, risky or poten-
tially harmful decisions should be carefully scrutinized to protect vulnerable
patients from the consequences of deficient decision making. Because appoint-
ing a health care proxy agent requires a lower level of capacity than that needed
to make the often complex decisions the agent will make, even patients with
diminished capacity may be able to select the persons they want to speak for
them (Mezey, Teresi, Ramsey, Mitty, & Bobrowitz, 2002 [Level IV]).
Decision Making in the Absence of Capacity
The more difficult clinical scenario is decision making on behalf of patients
who have lost or never had the capacity to make decisions for themselves. Two
approaches have been developed in response to the needs of incapacitated pa-
tients: advance directives and surrogate decision making. Advance directives
(see chapter 24, Advance Directives) include the living will (i.e., a list of inter-
ventions the patient does or does not want in specified circumstances) and the
preferred directive, the health care proxy (i.e., the appointment of a health care
agent with the same decision-making authority as the patient).
Because only 15% to 25% of the adult population in the United States has ad-
vance directives, the majority of health care decisions for incapacitated patients
are made by surrogates. Absent explicit instructions from the patient, decisions
by others are based on either substituted judgment (when the patient’s wishes
are known or can be inferred) or the best-interest standard (when the patient
didnot have or articulate treatment preferences). Substituted judgment assesses
what the patient would choose, based on prior statements and patterns of de-
cision making. The best-interest standard is the surrogate’s evaluation of the
proposed intervention’s benefits and burdens to the patient.
A health care surrogate may be any competent adult older than 18 who, al-
though not specifically chosen or legally appointed by a patient, assumes the re-
sponsibility for making health care decisions on behalf of a person who does not
have the ability to do so. In some states, statutory or case law provides authority
for surrogates to make substitute decisions. Informal surrogates are individu-
als, usually family or others close to the patient, who are asked by the care team
to participate in making treatment decisions. Most states accord considerable
latitude to surrogates, especially next of kin, in consenting to treatment. Deci-
sions about limiting treatment are more problematic and may be significantly
restricted, depending on the state in which the patient is receiving care (See
Resources, American Bar Association Commission on Law & Aging, for state
guidelines).
Context of Health Care Decision Making
Studies indicate that individual treatment preferences can change as a patient’s
health and functional status changes (Fried et al., 2006 [Level IV]) and that
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patients may have different treatment and comfort goals than their family care-
givers and professional providers (Steinhauser et al., 2000 [Level IV]). Previ-
ously unacceptable treatment states can become more acceptable. For example,
patients already experiencing pain are less likely to refuse a treatment outcome
that includes being in pain than patients who are not currently experiencing
moderate to severe pain (Fried et al., 2006 [Level IV]). Steinhauser and col-
leagues found that being able to maintain a sense of humor and knowing what
to expect were more important to patients than to their family members or
physician (Steinhauser et al., 2000 [Level IV]).
Illness is not only a condition but a social role (Segall, 1976). Culture de-
fines and sanctions adoption of the sick role. Being in the sick role means being
exempt from social obligations (e.g., spouse, breadwinner, parent, caregiver),
seeking advice, and doing as advised. The role trajectory includes recognition
that being sick is an undesirable state and should be ended as soon as pos-
sible. Culture influences member attitudes toward truth-telling or disclosure,
life-sustaining treatment, and decision-making processes (Kagawa-Singer &
Blackhall, 2001 [Level V]). For the patient whose decision-making ability is
questionable or deteriorating, the nature of communication, amount of infor-
mation provided, and boundaries of acceptable decision making may impel the
surrogate to protect the individual from an inappropriate and/or risky decision.
Moving away from the divisive notion that decision making is either family-
or patient-centered, the challenge in situations in which the individual’s deci-
sional capacity may be wavering is to determine how much support the family
(and others) can give to the patient’s decision making and how much decision
making must be done by others.
Just as there is the right to know one’s medical information, there is also a
right not to be burdened with unwanted information. Some persons—for exam-
ple, some older adults and those from cultures that traditionally shield patients
from knowing about their illness—may prefer to have information given to and
decision making assumed by a particular family member, the family as a group,
or trusted others.Although it is important to respect patient preferences and cul-
tural traditions, a patient’s waiver of the disclosure obligation must be explicitly
confirmed, not presumed. Since the implementation of HIPAA, many hospitals
have a form for the patient to sign designating who this decision maker will be.
One approach is to ask, “When we have information about your condition and
decisions will need to be made, who would you like us to talk to? Would you like
to be part of those discussions? What would make you comfortable?”
Trust in professional health care providers is a critical element in health
care and no less so in decision-making situations in which information is given
and questions have to be answered. A national sample reported that African
American patients were significantly more likely than White patients to report
low trust, unrelated to age or socioeconomic status (Halbert, Armstrong, Gandy,
& Shaker, 2006 [Level IV]).
Using focus-group methodology, 73 male and female adults (age range 50
to 3) provided ample evidence of diversity within and across ethnic groups
with regard to end-of-life treatment preferences (Duffy, Jackson, Schim, Ronis,
& Fowler, 2006 [Level IV]). Among Arab Muslims, Arab Christians, Hispanic,
Black, andWhite participants, somewere against assisted suicide, telling the pa-
tient “bad news,” and artificial feeding. Between groups, some participants were
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opposed to nursing homes and favored extending life. Within specific groups,
the men and women were sometimes on opposite sides of an issue. Treatment
decision making for care at the end of life clearly needs to be adapted to an
individual’s culturally specific preferences.
Quality-of-Life Considerations in Decision Making
Even in the presence of diminishing or questionable capacity, a patient’s notion
of quality of life, as death approaches, may differ from those of their physicians
or families (Kim & Karlawish, 2002 [Level V]; Rosenfeld, Wenger, & Kagawa-
Singer, 2000 [Level IV]; Steinhauser et al., 2000 [Level IV]). Whereas there is
almost universal acknowledgment of the desire to be comfortable (i.e., relief
from pain and suffering) and to achieve a sense of completion, attitudes about
the importance of clergy, of being physically touched, of using all available tech-
nology can vary (Steinhauser et al., 2000). In one study, 21 older adults (average
age 83), with varying degrees of functional impairment and past experiences
with treatment decision making, were more interested in the outcome of a seri-
ous medical event than with the interventions that might be used to cure them
(Rosenfeld et al., 2000 [Level IV]). Participantswere interested in a treatment in-
sofar as it could restore or maintain their ability to participate in activities they
valued. “Acceptable health states” in the face of advanced age were relevant
discussion points rather than specific interventions. Among physicians, nurses,
and family members in two nursing homes in The Netherlands, decisions about
withholding artificial nutrition and hydration were more influenced by a pa-
tient’s medical condition, likely trajectory of illness, and inferred quality of life
than by a duly executed advance directive (The, Pasman, Onwuteaka-Philipsen,
Ribbe, & van der Wal, 2002 [Level IV]).
Interventions
Assessing a patient’s orientation and understanding can provide critical infor-
mation about decision-making behavior in different circumstances and ability
to articulate wishes about care. Reporting that a patient is “disoriented to time
and place” is helpful only in establishing the context in which more specific and
useful assessment of decisional capacity should take place.
Documentation needs to be specific and descriptive. The entry should de-
scribe the circumstances or interaction that led to the conclusion about a pa-
tient’s ability to make decisions. Because capacity is decision-specific, it is not
helpful to read, “Patient lacks capacity to make decisions.” The implication is
that the patient lacks the ability to make any and all decisions. More accurate
anduseful statements are “Patient appears to lack the capacity tomake decisions
about discharge. She is unable to describe how she will cook or get to the bath-
room at home” or “Patient lacks the capacity tomake decisions about surgery; he
was unable to name the type of surgery, what the surgery is supposed to correct,
or what is involved or to be expected in recovery after surgery.”
Communicating needed information includes determining what the deci-
sion maker(s)—including the patient or other surrogate(s)—want to know, who
should participate, determining what the patient and family understand, having
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the relevant medical facts available, and avoiding jargon. It can be useful to con-
sider the participants in the decision making: Who should be present? What is
their actual relationship and their decision-making relationship to the patient?
Why is the informationnecessary andhowwill it beused?Atwhat level of detail?
When is the information to be provided; over what period of time? Where will
the discussion take place (i.e., patient’s room or other private place)? Popejoy
(2005 [Level V]) commented on the importance of understanding how patients
and their families make decisions, the processes and steps they go through, the
congruence between their expectations, and the likely goals of treatment.
Interpreters might be the only health care staff who recognize that substi-
tute decision makers and the physician/health care professionals have differing
interpretations of illness, treatment and health; disparate views about death
and dying; and use language and a decision-making framework differently. An
interpreter may realize that truth-telling might not only be disrespectful and
dangerous but could shorten the patient’s life span, as believed in certain cul-
tures. As such, ideally, an interpreter is more than a word-for-word translator
but rather a mediator, culture broker, patient advocate, witness, educator, and
participator who is interpreting fact and nuance.
Case Study and Discussion
Mr. Peters is an 85-year-old man with advanced Alzheimer’s disease who
has been living in a nursing home for the past 6 months. His condition has
been deteriorating and, when he stopped eating several weeks ago, he was
hospitalized for the insertion of a PEG tube to provide artificial nutrition
and hydration. He returned to the nursing home briefly but developed un-
controlled diarrhea and apparent abdominal discomfort. Two days ago, his
PEG tube fell out and he has been readmitted to the hospital for treatment
of the diarrhea and possible replacement of the PEG.
Mr. Peters opens his eyes and responds to painful stimuli but does not
interact and appears not to recognize family members. He is clearly in-
capable of participating in discussions or decisions about care and has no
advance directives to provide guidance about his wishes. He does have close
family, however, including his son and granddaughter, who are visiting from
California, and his grandson, Jason, who has been very involved for several
years in providing and making decisions about care.
A clinical ethics consultation has been convened, including Mr. Peters’s
family, his two attending physicians, and the house and nursing staff who
have cared for him most consistently. Discussion focuses on clarifying his
condition and probable clinical course, the goals of care, and his likely care
preferences.
Jason describes his grandfather as very active and fiercely independent
until age 78, when his dementia began. With his wife, he had raised Jason
and, when she died, he continued to raise the boy alone until he left for col-
lege. When the dementia worsened several years ago, Jason arranged for his
grandfather anda teamof 24-hour caregivers tomove into anapartmentnext
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to his. That arrangement continued until Mr. Peters required care that could
best be provided in a skilled-nursing facility. All three familymembers agree
that, given Mr. Peters’s personality, values, and lifetime behavior pattern, he
would not have wanted to be maintained in his current condition, especially
dependent on artificial nutrition and hydration. Nevertheless, they express
concern about the ethics, legality, and clinical effect of not replacing the
PEG tube, and they are especially uncomfortable about whether it would be
considered “starving” him to death.
According to the care team, Mr. Peters’s advanced dementia is not re-
versible and he will continue to deteriorate mentally and physically un-
til death. The doctors referred to the considerable literature demonstrat-
ing that, in patients with advanced dementia, artificial nutrition and hy-
dration can cause GI distress, including nausea, bloating, gas, and diar-
rhea, which appears to have happened to Mr. Peters. In the opinion of
the care team, continued artificial nutrition and hydration would only con-
tribute to the patient’s suffering and prolong the dying process. The doc-
tors also explain that, far from suffering, Mr. Peters appears more com-
fortable since the PEG fell out and the diarrhea has stopped. They assure
the family that the patient could be admitted to the nursing home’s hospice
unit, where he will receive comfort care, including pain and other symptom
management.
The ethics analysis of this case focuses on decision making for an inca-
pacitated patient, promoting the patient’s best interest, and protecting him
from harm, and forgoing life-sustaining treatment, specifically artificial nu-
trition and hydration, at the end of life.
Surrogate decision making on behalf of patients lacking capacity uses
the following standards:
■ the patient’s wishes as expressed directly through discussions with
others or in advance directives (i.e., health care proxy appointments
or living wills)
■ substituted judgment (when the patient’s wishes are known or can be
inferred)
■ the best-interest standard (when the patient’s wishes are not known
or inferable) (Beauchamp & Childress, 2001)
Mr. Peters has not left any explicit instructions, but his family, knowing
him very well, is able to predict with confidence what he would and would
not have wanted based on his characteristic patterns of behavior and de-
cision making. In this case, the family’s substituted judgment is consistent
with what was considered by the family and the care team to be in the pa-
tient’s best interest, protecting him from continued artificial nutrition and
hydration that would have increased his suffering without providing benefit
and prolonged his dying.
One of the most difficult surrogate decisions is forgoing life-sustaining
treatment and, because providing nourishment is so intimately associ-
ated with love and nurturing, forgoing artificial nutrition and hydration is
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especially wrenching for families and caregivers. Clinicians, ethicists, and
courts have consistently agreed that artificial nutrition and hydration is a
medical treatment, the benefits, burdens, and risks of which should be as-
sessed like those of any other intervention.
How these decisions are made for Mr. Peters will depend as much on
state law as on his clinical condition and his family’s concern for his well-
being. Capable patients and the appointed health care agents of incapaci-
tated patients have a well-settled right to refuse any treatment, including
those that are life-sustaining. Absent capacity or advance directives, the
family’s authority to make end-of-life decisions, including forgoing artifi-
cial nutrition and hydration, depends on the laws of the state in which the
patient is treated. Many states permit family and surrogates authorized by
case or statutory law tomake these decisions based on substituted judgment
or their assessment of the patient’s best interest. Other states, such as New
York and Missouri, require surrogates, even next of kin, to provide explicit
evidence that the patient would have refused life-sustaining treatment, par-
ticularly artificial nutrition and hydration, in order to authorize withholding
or withdrawing the interventions.
Summary
Health care decisionmaking should be, in and of itself, a therapeutic interaction
between and among the key players. Paterson and colleagues (2001) suggest
a paradigm for those living with and managing their chronic illness; a model
that reflects the individual’s pursuit of their preferences and lifestyle, and a
perspective that behaviors contrary to the prescribed medical regimen should
not be construed as noncompliant (Paterson, Russell, & Thorne, 2001 [Level V]).
Their view of the rational decision making exercised on a daily basis by those
living with chronic illness facilitates understanding that health care decision
making is grounded in personal values and context. The notion of “ownership”
of one’s body should apply to health care decisionmaking even at times of crisis.
Paterson and colleagues advise viewing the decision-making process as one that
in all likelihood contains conflicting goals and expectations among the various
parties, framing issues, social and cultural factors, and complex processes in
meaning making.
In summary, every capable patient who is temporarily confused or has fluc-
tuating decisional capacity should not be denied the opportunity to make the
specific health care decisions they are capable of making. A vulnerable patient
who lacks capacity, despite some social or conversational skills, needs to be pro-
tected from the potentially harmful effects of uninformed, poorly reasoned, and
potentially risky health care decisions. The ethical obligations that must be as-
sumed by health care professionals are skillfully assessing the clinical situation;
the benefits, burdens, and risks of the therapeutic options; the patient’s capacity
to make and take responsibility for the relevant decisions; and the proxy’s need
for guidance and information.
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Resources
American Bar Association (ABA)
321 North Clark Street
Chicago, IL 60610
312.988.5000
and/or
American Bar Association (ABA)
740 15th Street, N.W.
Washington, DC 20005-1019
202.662.1000
www.abanet.org
American Bar Association Commission on Law & Aging, Legislative Updates
See link for chart that summarizes the wide variation in how states allocate
decisional authority in the absence of patient capacity to make health care
decisions.
http://www.abanet.org/aging/legislativeupdates/home.shtml
American Society of Bioethics and Humanities
4700 W. Lake
Glenview, IL 60025-1485
Telephone: 847.375.4745
Fax: 877.734.9385
Email: info@asbh.org
www.asbh.org
The Hastings Center
21 Malcolm Gordon Road
Garrison, NY 10524-4125
Telephone: 845.424.4040
Fax: 845.424.4545
Email: mail@thehastingscenter.org
www.thehastingscenter.org
Box 23.1
Nursing Standard of Practice Protocol: Health Care
Decision Making
I. GOALS
To ensure nurses in acute care:
A. Understand the supporting bioethical and legal principles of in-
formed consent.
B. Are able to differentiate between competence and capacity.
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C. Understand the issues and process of assessing decisional capacity.
D. Can describe the nurse’s role and responsibility as an advocate for
the patient’s voice in health care decision making.
II. OVERVIEW
A. Capable persons (i.e., those with decisional capacity) have a well-
established right, grounded in law and Western bioethics, to deter-
mine what is done to their bodies.
B. In any health care setting, the exercise of autonomy (self-
determination) is seen in the process of informed consent to and
refusal of treatment and/or care planning.
C. Determination of decision-making capacity is a compelling clinical
issue because treatment and diagnostic interventions have the po-
tential for significant benefit, burden, and/or risk.
D. Honoring the decisions of a capable patient demonstrates respect
for the person; honoring the decisions of a patient without capacity
is an act of abandonment.
III. BACKGROUND AND STATEMENT OF PROBLEM
A. Introduction
1. Core ethical principles that are the foundation of clinician obli-
gation are:
a. Respect for autonomy, beneficence, nonmaleficence, and dis-
tributive justice.
b. Clinically, legally, and ethically valid decisions by or for pa-
tients requires a careful balancing of information, principles,
rights, and responsibilities in light ofmedical realities, cultural
factors, and, increasingly, concerns about resource allocation.
c. Even capable patients, including those who are elderly, eas-
ily confused, or from cultures that do not consider autonomy
a central value, as well as patients with diminished or fluc-
tuating capacity, may not be capable of or comfortable with
exercising purely autonomous decision making.
d. Care professionals have an obligation to be alert to question-
able or fluctuating capacity both in patients who refuse and
those who consent to recommended treatment. Capable indi-
viduals may choose to make their own care decisions or they
may voluntarily delegate decision-making authority to trusted
others. Delegation of decisional authority must be explicitly
confirmed, not inferred.
e. The context of decision making can include cultural impera-
tives and taboos, perceptions of pain, suffering and quality of
life and death, education and socioeconomic status, language
barriers, and advance health care planning.
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B. Definitions
1. Consent: the informed-consent process requires evidence of de-
cisional capacity, disclosure of sufficient information, under-
standing of the information provided, voluntariness in choosing
among the options, and, on those bases, consent to or refusal of
the intervention.
2. Competence: a legal presumption that an adult has the mental
ability to negotiate various legal tasks (e.g., entering into a con-
tract, making a will).
3. Incompetence: a judicial determination that a person lacks the
ability to negotiate legal tasks and should be prevented from do-
ing so.
4. Decisional capacity: a clinical determination that an individual
has the ability to understand and to make and take responsibility
for the consequences of health decisions. Because capacity is not
global but decision-specific, patientsmayhave the ability tomake
some decisions but not others. Capacity may fluctuate according
to factors, including clinical condition, time of day, medications,
and psychological and comfort status.
C. Essential Elements
1. Decisional capacity reflects the ability to understand the facts,
appreciate the implications, and assume responsibility for the
consequences of a decision.
2. The elements of decisional capacity: the ability to understand
and process information; weigh the relative benefits, burdens,
and risks of each option; apply personal values to the analysis;
arrive at a consistent decision; and communicate the decision.
3. Standards of decision making:
a. Prior explicit articulation: decision based on the previous ex-
pression of a capable person’s wishes through oral or written
comments or instructions.
b. Substituted judgment: decision by others based on the for-
merly capable person’s wishes that are known or can be in-
ferred from prior behaviors or decisions.
c. Best-interest standard: decision based onwhat others judge to
be in the best interest of an individual who never had or made
known health care wishes and whose preferences cannot be
inferred.
IV. ASSESSMENT OF DECISIONAL CAPACITY
A. There is no “gold standard” instrument to assess capacity.
B. Assessment should occur over a period of time, at different times of
day, and with attention to the patient’s comfort level.
C. The MMSE or Mini-Cog is not a test of capacity. Tests of executive
function might better approximate the reasoning and recall needed
to understand the implications of a decision.
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D. Clinicians agree that the ability to understand the consequences of
a decision is an important indicator of decisional capacity.
E. Safe and appropriate decision-making is retained in early-stage de-
mentia (Kim & Karlawish, 2002 [Level V]) and by adults with mild
to moderate mental retardation (Cea & Fisher, 2003 [Level IV]).
V. NURSING CARE STRATEGIES
A. Communicate with patient and family or other/surrogate decision
makers to enhance their understanding of treatment options.
B. Be sensitive to racial, ethnic, religious, and cultural mores and tradi-
tions regarding end-of-life care planning, disclosure of information,
and care decisions.
C. Be aware of conflict resolution support and systems available in the
care-providing organization.
D. Observe, document, and report the patient’s ability to:
1. articulate his or her needs and preferences
2. follow directions
3. make simple choices and decisions (e.g., “Do you prefer the TV
on or off?” “Do you prefer orange juice or water?”)
4. communicate consistent care wishes
E. Observe period(s) of confusion and lucidity; document the specific
time(s) when the patient seemsmore or less “clear.” Observation and
documentation of the patient’s mental state should occur during the
day, evening, and at night.
F. Understanding is assessed relative to the particular decision at is-
sue. The following probes and statements are useful in assessing the
degree to which the patient has the skills necessary to make a health
care decision:
■ “Tell me in your own words what the physician explained to you.”
■ “Tell me which parts, if any, were confusing.”
■ “What do you feel you have to gain by agreeing to (the proposed
intervention)?”
■ “Tell me what you feel you have to lose by agreeing to (the pro-
posed intervention)?”
■ “Tell me what you feel you have to gain/lose by refusing (the pro-
posed intervention)?”
■ “Tell me why this decision is important (difficult, frightening, etc.)
to you.”
G. Select (or construct) appropriate decision aids.
H. Help the patient express what he or she understands about the clin-
ical situation, the goals of care, the expectation of the outcomes of
the diagnostic or treatment interventions.
I. Help the patient identify who should participate in diagnostic and
treatment discussions and decisions.
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VI. EVALUATION AND EXPECTED OUTCOME(S)
A. The number of referrals to the ethics committee or ethics consul-
tant in situations of decision-making conflict between any of the
involved parties.
B. The use of interpreters in communication of, or decision-making
about, diagnostic and/or treatment interventions.
C. Plan of Care: instructions regarding frequency of observation to as-
certain the patient’s lucid periods, if any.
D. Documentation
1. Is the process of the capacity assessment described?
2. Is the assessment specific to the decision at issue?
3. Is the informed consent and refusal interaction described?
4. Are the specifics of the patient’s degree or spheres of orientation
described?
5. Is the patient’s language used to describe the diagnostic or treat-
ment intervention under consideration recorded? Is the patient’s
demeanor during this discussion recorded?
6. Are the patient’s questions and the clinician(s) answers rec-
orded?
7. Are appropriate mental-status descriptors used consistently?
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Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. explain and differentiate between a Durable Power
of Attorney for Health Care and a Living Will
2. describe assessment parameters to ensure that
older adults receive advance directive information
3. identify strategies to ensure good communication
about advance directives among patients, families,
and health care professionals
4. guide a discussion of the benefits and burdens of
various treatment options to assist proxy treatment
decision-making
5. describe measurable outcomes to be expected
from implementation of this practice protocol
Overview
One of the most difficult situations health care professionals face is how to as-
sist with treatment decision making for those who can no longer communicate
their treatment preferences. Decision-making capacity of older adults may be
diminished, fluctuating, or lapsed. Substitute decision makers rely on direc-
tions or instructions left by the patient when they had capacity to express and
communicate their treatment preferences and goals of care. The justification
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
Adapted from a chapter in the second edition by Gloria Ramsey and Ethel L. Mitty. (2003). Advance
directives: Protecting patient’s rights. In M. Mezey, T. Fulmer, & I. Abraham (Eds.), Geriatric nursing protocols
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for advance care planning is that a person with capacity can state their wishes,
values, and treatment preferences in advance, prospectively, so that their au-
thentic voice will be heard when their capacity has lapsed. Decision making can
be especially difficult when care providers barely know the patient, have little
knowledge of what treatments a patient would or would not want, or there is
no one available to speak for the patient. Approximately 30% of older adults do
not have a relative, friend, or guardian who can make health care decisions for
them. The right to not complete an advance directive must also be respected.
It is very important that patients are informed (and, in some cases, reassured)
that neither providers nor the facility will abandon them or provide substandard
care if the patient elects not to formulate an advance directive.
Background
ThePatient Self DeterminationAct (PSDA), enacted in 1991, is the federal statu-
tory codification of an advance planning and decision-making approach for
thosewho are no longer able tomake their own health care decisions. The PSDA
requires all agencies and institutions that receive Medicare or Medicaid reim-
bursement to inform their clients and patients of their right to make health care
decisions, including their option to complete an advance directive (AD). Pred-
icated on the Western philosophic tradition of individual freedom and choice,
self-determination as amoral right, the U.S. Supreme Court decision in themat-
ter of Nancy Cruzan (1990) articulated the need for “clear and convincing evi-
dence” that an incompetent patientwouldnotwant a specific treatment. Because
few oral statements could meet this standard, written ADs were promulgated as
constituting clear and convincing evidence.
An AD (i.e., health care proxy appointment and/or living will) is created
by a capable/capacitated person to prospectively state his or her wishes and
treatment preferences regarding medical care that are to be communicated and
implemented in the event that the individual is unable to communicate and/or
capacity has lapsed. ADs are value-neutral and can be used to request as well
as refuse treatments; they provide guidance for health care professionals and
families. Importantly, ADs provide immunity for health care professionals and
families from civil and criminal liability when health care professionals follow
the AD in good faith. State statutes generally outline the conditions under which
an AD is legally valid and when it should be followed (see state statutes link in
the Resources section).
Nurses need to be sensitive to the reasons why people do and do not create
an AD. Approximately 25% of the general public and only slightly more than
51% of nursing home residents have an AD (Mezey, Mitty, Rappaport, & Ramsey,
1997b [Level IV]); advance planning is still not the norm formost adults (Tilden,
Nelson, Dunn, Donius, & Tolle, 2000 [Level IV]). Older adults who create an AD
feel that their physicians know their wishes and do not feel that the AD would
be a constraint on their care. Those who do not create an AD want their fam-
ilies to make decisions for them and apparently fail to see the flexibility that
having an AD provides (Beck, Brown, Boles, & Barrett, 2002 [Level II]). Many
patients with chronic illness want pain and symptommanagement and support-
ive care rather than aggressive life-sustaining interventions (Zerzan, Stearns,
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& Hanson, 2000 [Level IV]). Hospice patients who talk with their surrogates
about their treatment wishes for their last week of life have a higher rate of
agreement with their surrogate’s understanding of their treatment wishes than
patients who do not have these discussions (Engelberg, Patrick, & Curtis, 2005
[Level III]). Treatment preferences of capacitated nursing home residents are
relatively stable over time and, in fact, indicate a preference for less invasive
interventions as dependency increases (Berger & Majerovitz, 1998 [Level V];
Danis, Garret, Harris, & Patrick, 1994 [Level V]).
Although family surrogate decision-making is more accurate than primary
physicians regarding older patients’ preferences for life-sustaining treatments
in hypothetical scenarios, having an AD does not improve congruence be-
tween patients’ wishes and decisions made by others (Coppola, Ditto, Danks, &
Smucker, 2001 [Level II]). Substitute decision makers are not necessarily mak-
ing treatment choices or decisions that represent the patient’s preferences (Ditto
et al., 2001 [Level II]; Hines et al., 2001 [Level IV]; Mitchell, Berkowitz, Lawson,
& Lipsitz, 2000 [Level IV]). The lack of concordance between a patient’s stated
wishes and physician orders, as found in 65% of cases in one study (Hardin
& Yusufaly, 2004 [Level II]), cannot simply be viewed as a denial of a patient’s
rights; physiciansmight be relying on additional information to guide their treat-
ment decisions. Using interview and qualitativemethods with 30 pairs of patient
and primary caregiver at an outpatient clinic, Rodriquez and Young (2006 [Level
IV]) report that participants talk about life-sustaining treatments in terms of
four goals of end-of-life care: extending life, improving quality of life, improv-
ing or maintaining a specific function, and temporary assistance. Patients feel
that their professional health care providers are more interested in extending
their life than with the quality of that life. In the patients’ view, life-sustaining
treatments were acceptable in the short term but not for an extended period.
Caregivers are torn between quality of life and simply extending life. Given this
body of evidence of discordance among patient wishes, surrogates’ decisions,
and physician orders, it can be argued that nurses have a responsibility to hear
the patient’s voice, to ascertain the patient’s treatment wishes and goals of care,
and to represent the patient when treatment decisions are made—even in the
seeming absence of conflict between parties.
Types of Advance Directives
Durable Power of Attorney for Health Care
There are two types of ADs: the Durable Power of Attorney for Health Care
(DPAHC) and the Living Will (LW). The DPAHC allows an individual to appoint
a relative, friend, or trusted other—called a health care proxy, agent, attorney-
in-fact, or surrogate—to make health care decisions if the individual loses the
ability to make decisions or communicate his or her wishes. (An alternate agent
should also be appointed.) A key presumption of health care proxy appointment
is that the patient andproxy have discussed the patient’s treatmentwishes; some
states require that the proxy sign theADas an attempt to ensure that the proxy is
aware of their appointment and has accepted decision-making responsibilities
as the patient’s voice in care planning and decisionmaking. A proxy has the legal
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authority to interpret the patient’s wishes on the basis of the medical circum-
stances of the situation and is not restricted to only deciding if life-sustaining
treatment can be withdrawn or withheld. Thus, the proxy can make decisions
as the need arises, and such decisions can respond directly to the situation at
hand rather than being restricted only to circumstances that were thought of
previously.
Thirty-one states have “family consent laws” that designate the order in
which family members can make decisions for an incapacitated patient who did
not appoint a proxy; a spouse is usually first, then adult children, parents, and
distant relatives. The decisions of family members acting in this capacity are
restricted in various ways by 41 states. This includes the requirement that the
patient must be terminal or in a persistent vegetative state, comatose, and so
forth. Disputes between family members who bear the same relationship to the
patient (e.g., two sons) are not uncommon and often very difficult to resolve
(see the section on conflict mediation). A proxy’s decision legally supercedes a
decision made by a family member or nonproxy concerned party. This is not to
say, however, that a proxy’s decision is always easy and conflict-free or that the
burden is light. Whereas a living will is in effect at the end of life, the DPAHC
springs into effect at any time that the patient has a temporary (or permanent)
absence of decisional capacity, as might be associated with trauma, illness, or
mental impairment (e.g., dementia, stroke, delirium).
Living Will
For adults who have no one to appoint as their proxy, completing a LW that
outlines their wishes is preferable to not providing any information at all about
care preferences. A LW is also helpful for those with a DPAHC who want to
provide their proxy with some guidance about their treatment preferences and
end-of-life care wishes, including artificial nutrition and hydration, ventilator
support, and pain management.
A LW provides specific instructions to health care providers about partic-
ular kinds of health care treatments or interventions that an individual would
or would not want in specific clinical circumstances, usually at the end of life
(e.g., comfort care, all life-sustaining treatments). A LW is a prospective decla-
ration. All but three states (i.e., New York, Massachusetts, and Michigan) have
detailed statutes recognizing LWs. The usefulness of a LW is limited, however,
to those clinical circumstances that were thought of before the person became
incapable of making decisions. If a situation occurs that the LW does not ad-
dress, providers and families may not know how to proceed and still respect
the patient’s wishes. Hence, it is recommended that individuals also appoint a
proxy—that is, a trusted other who knows their values and wishes. When an in-
dividual completes both the LW and DPAHC, the proxy/agent might not be obli-
gated (in some states) to follow the wishes outlined in the LW; the LW serves as a
guide.
Some states have a combined directive that includes elements of the LWand
the DPAHC. A section on organ donation (i.e., “anatomical gift”) has been added
to the AD document of some states that allows individuals to indicate if they
wish to donate an organ(s). However, in New York State, for example, the proxy
cannot affect this wish unless the proxy is also the identified decision maker
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for organ donation, a distinct statutory authority separate from a health care
proxy’s rights and responsibilities. Once again, this speaks to nurses knowing
the relevant law regarding ADs as well as after-death decision making.
“Instructional directives” have been suggested to compensate for the de-
ficiencies of LWs; they address specific clinical situations and interventions
that are acceptable to the patient. Also known as a “Medical Directive,” indi-
viduals must decide prospectively which interventions they would want in the
face of four scenarios: coma with virtually no chance of recovery; coma with
a small chance of recovery but restored to an impaired physical and mental
state; advanced dementia and a terminal illness; advanced dementia (Emanuel
& Emanuel, 1989 [Level IV]). Among the interventions are CPR, artificial hy-
dration and nutrition, dialysis, invasive diagnostic tests, antibiotics, and blood
transfusion. Nursing homes using this directive demonstrate improved patient
and family satisfaction, reduced health care costs, and lower hospitalization
rates (Molloy et al., 2000 [Level II]). The Medical Directive does not address a
patient’s desired goals of care, willingness to allow a short-term intervention, or
treatment choices associated with stage of chronic illness or exacerbation.
The notion of a “research” AD has been suggested (National Bioethics Ad-
visory Commission, 1998). The conduct of research with participants suffering
from a dementing illness is daunting with regard to obtaining informed con-
sent. A Research AD must be executed while the individual still retains deci-
sional capacity and must contain a fairly detailed description of the person’s
understanding of the research intention, possible risks, benefits, and burdens.
The proxy decision maker must make a determination of whether or not the
person’s intention to participate in research is congruent with the proposed
research. A study involving patients with moderate dementia and their family
proxies sought to learn whether the patients wanted to retain decision making
about their participation in research in the future or allow their proxy to make
the decision. Although the majority of patients granted future decision mak-
ing to their proxies, it was also clear that proxies did not always want to make
research participation decisions (Stocking et al., 2006 [Level IV]).
Two other AD documents that further the goals of advance care planning
and that are accepted in many states are the Physician Order for Life Sustain-
ing Treatment (POLST) and the Five Wishes document. POLST originated in
Oregon in 1995 and is a state-endorsed protocol to honor an individual’s wish
to die in a setting of their choice without unwanted life-supporting interven-
tions. It contains four separate categories of physician’s orders that are based
on patient–physician discussion about comfort measures, antibiotics, parenteral
feeding, and cardiopulmonary resuscitation. Studies indicate that Oregon nurs-
ing home residents with POLST documents received more intense comfort care
and fewer aggressive life-sustaining interventions, were less likely to be trans-
ferred to a hospital to die, and had more orders for narcotic analgesia at the
time of death than did nursing home residents without POLSTs (Tolle, Tilden,
Nelson, & Dunn, 1998 [Level IV]). The Five Wishes document combines the
health care proxy, LW, values, instructional directions, and proxy designation.
Open-ended statements guide individuals to express their thoughts and wishes
about how they want to be physically and emotionally supported, the medical
treatments they want and do not want, and the funeral arrangements and eu-
logy they would like. It is legally valid in all but 12 states. Values “statements”
544 Chapter 24
generally do not explore or express a patient’s understanding of the benefits and
burdens of various treatments, thereby making it difficult to act on a patient’s
wishes and preferences (Lo & Steinbrook, 2006 [Level V]).
Oral Advance Directive
Although the courts prefer written ADs, oral ADs are respected, especially in
emergency situations, and can be persuasive in a judicial decision to withhold
a life-sustaining treatment. Ten states permit a patient to orally designate a
proxy in discussion with their physician rather than execute a written AD (Lo &
Steinbrook, 2006 [Level V]). However, there are limitations to their applicability
and they might need to be witnessed. In determining the validity of an oral AD,
the court seeks information about whether the statement was made on serious
or solemn occasions, consistently repeated, made by a mature person who un-
derstood the underlying issues, was consistent with the values demonstrated in
other aspects of the patient’s life (including the patient’s religion), made before
the need for the treatment decision, and specifically addressed the actual con-
dition of the patient (Lo & Steinbrook, 2006 [Level V]). What might seem like
an occasional comment made by a patient (whether in a practitioner’s office or
at the bedside) should be recorded for just such an occasion when “clear and
convincing evidence” is required. It has been argued that oral instructions ex-
plicated during conversation with one’s physician can be taken to signify the
patient’s genuine intent on having his or her instructions followed. This has
been contrasted with statements made to family and friends that are likely to be
emotion-laden and not a true reflection of the patient’s wishes (Lo& Steinbrook,
2006 [Level V]).
Legal statutes stipulate that health care providers, including physicians,
must heed the wishes stated in an AD; by law, a person cannot be treated with-
out explicit permission—that is considered “battery.” In most states, unless the
patient has severely limited the proxy’s scope, the proxy’s decision has the same
weight and power as the patient speaking on his or her own behalf. A proxy’s
power is no greater or less than the capable patient. Vague or ambiguous lan-
guage in an AD (e.g., refusal of “heroic measures”) deprives the proxy as well
as providers of the guidance needed to honor the patient’s wishes. This speaks
to assisting patients and proxies in a dialogue that elicits the patient’s wishes,
sometimes by hypothesizing or imagining diverse illness and treatment sce-
narios. In such cases when, based on conscience or religion, a facility and/or
physician objects to a request in an AD or a proxy’s decision, the patient must
be assisted with transfer to another facility and/or provider who will honor the
decision/directive.
Do-Not-Resuscitate Orders
Consent to cardiopulmonary resuscitation (CPR) is presumed unless a physi-
cian writes a Do-Not-Resuscitate (DNR) order. Respecting (or not) a patient’s
resuscitation wishes is a frequent cause of moral distress for nurses. The SUP-
PORT Study (i.e., Study to Understand Prognoses and Preference for Outcomes
and Risks of Treatment), a multi-hospital study involving almost 2,000 seriously
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ill patients, found that less than one-fourth of patients had discussed their
resuscitation wishes with their physician. Among patients who had not dis-
cussed their preferences, slightly more than half were not interested in having
the discussion (Hofmann et al., 1997 [Level III]). Nurses, specially trained for the
study, reported that patient requests for DNR were frequently ignored; physi-
cians were not always aware of their patient’s end-of-life care wishes.
It has been suggested that CPR should not be instituted when it will not
offer a medical benefit or when death is inevitable and expected (Tresch et al.,
1994 [Level V]). All states have a Natural Death Act that recognizes the right of
competent patients, in their written AD, to refuse life-sustaining treatments. Pa-
tients have a right to refuse CPR after they have been informed of the risks and
benefits involved and may, in fact, request a DNR order. If the physician is un-
willing to write a DNR order to comply with the patient’s request, the physician
has a duty to notify the patient or family and assist the patient to obtain another
physician (Sabatino, nd). Nurses need to be aware of such situations and, as
well, need to know their institution’s policy and law in their state governing a
DNR directive. It is important, however, that otherwise healthy elderly hospital-
ized patients who may benefit from CPR should not be denied this life-saving
intervention.
Community-dwelling adults with a hospital-originated DNR order are likely
to be resuscitated by emergency medical services (EMS), which are required to
do so until the patient is at the hospital. Some states have created an acceptable
community-based or certified DNR order and require the individual to have a
special identifier, such as a wrist band.
Artificial Nutrition and Hydration
As health care professionals and families grapplewith issues around treatments
and care at the end of life, artificial nutrition and hydration continues to pose
challenging ethical, legal, and cultural questions. How can you not feed or hy-
drate a dying person? The U.S. Supreme Court, in 1990 (before the PSDA), es-
tablished that competent patients have a “constitutionally protected liberty” to
refuse unwanted medical treatment. The court further established that artifi-
cial nutrition and hydration is no different than other forms of medical treat-
ment. Many physicians and nurses are unaware that a capable patient has a
legal and ethical right to discontinue artificial nutrition and hydration, and they
erroneously believe that there is a legal difference between forgoing versus dis-
continuing artificial nutrition and hydration. The legal evidence and procedures
required to forgo or discontinue artificial nutrition and hydration vary by state.
Several states’ statutes hold that proxies cannotmake decisions about withhold-
ing unless the patient specifically directs, in the AD, that the proxy can make
this decision on his or her behalf. In 20 states, the DPAHC document contains a
statement and box to check, if the patient wishes, that states: “My proxy knows
my wishes.” Nothing has to be written regarding precisely what those wishes
are. Because the LW directive in some states regards artificial nutrition and hy-
dration as a medical treatment, whereas other states regard this intervention
as a comfort measure (Gillick, 2006 [Level V]), it is important that nurses are
aware of their specific state’s statutes and definitions in this regard in order
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to accurately and appropriately inform patients, families, and proxies. Given
the extensive variation between states in regulation and administration of tube
feeding (Aronheim, Mulvihill, Sieger, Park, & Fries, 2001 [Level IV]), nurses
need to be aware of their state law in this regard and the extent to which pa-
tients (and proxies) are correctly informed about the consequences of artificial
nutrition and hydration at the end of life and the caring and comfort treatment
alternatives.
Whether to institute artificial feeding and hydration or to withdraw it once
started has themoral equivalence, formany people, of “killing” the patient. Deci-
sions to withhold artificial nutrition and hydration from nursing home residents
with advanced dementia are more influenced by the patient’s presumed quality
of life, stage of illness, and co-morbidities than byAD instructions (The, Pasman,
Onwuteaka-Philipsen, Ribbe, & van der Wal, 2002 [Level IV]).
Pain Management
There is a moral as well as a professional imperative to relieve pain even in
the absence of an AD. Compassionate pain relief does not require consent be-
cause it is grounded in respect for and dignity of the person (i.e., principles of
autonomy and beneficence). An individual’s constitutionally protected interest
in pain relief was made clear in the U.S. Supreme Court ruling in Quill versus
Vacco (1996). Rejecting the argument that there is a constitutionally protected
right to assisted suicide, the Court reaffirmed, however, the doctrine of “double
effect.” This principle holds that a single act having two foreseen effects, one
good and one bad, is not legally or morally wrong or prohibited if the harmful
effect is not intended. For a terminally ill, incapacitated patient who lacks a di-
rective or proxy to advocate on behalf of his or her comfort needs, it is ethically
and legally appropriate to provide as much medication as necessary to relieve
pain, even if the effect hastens death. For the patient with capacity, refusal of
pain relief might be a value-based choice between intellectual and emotional
awareness versus relief from pain.
Assessment
A primary consideration in approaching a patient about AD creation is the per-
son’s capacity to make decisions about his or her health care. “Competence” and
“capacity” are not the same, yet they are frequently used synonymously and in-
terchangeably (see chapter 23,Health Care DecisionMaking). The law presumes
competency unless shown otherwise; only the court can rule that an individual
is incompetent. Capacity is a clinical determination and is not determined solely
by a medical or psychiatric diagnosis or test. Inability to make financial deci-
sions or communicate verbally does not preclude the ability to communicate
important information about one’s treatment preferences. The determination
that a patient lacks capacity is often made on the basis of a mental-status as-
sessment test—an inappropriate measure of decisional capacity. Thus, there is
a grave risk that individuals with communication disorders or those with mild
dementia might not have the opportunity to appoint a health care proxy or to
execute a LW.
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Decisional Capacity to Create an Advance Directive
The steps in determining if a patient has sufficient decisional capacity to create
an AD are similar to the basic elements of a valid consent and are based on
observation of a specific set of abilities. These steps include (1) the patient ap-
preciates and understands that he or she has the right to make a choice;(2) the
patient understands themedical situation, prognosis, risks, benefits, and conse-
quences of treatment consent (or refusal); (3) the patient can communicate the
decision; and (4) the patient’s decision is stable and consistent over a period of
time (Roth, Meisel, & Lidz, 1977).
Not all health decisions require the same level of decision-making capac-
ity to make a decision. Decision-making capacity is not an all-or-none, “on-off”
switch. Rather, capacity should be viewed as “task-specific.” An individual may
be able to perform some tasks adequately, may have the ability to make some
decisions, but is unable to perform all tasks or make all decisions. The notion
of “decision-specific capacity” assumes that an individual has or lacks capac-
ity for a particular decision at a particular time and under a particular set of
circumstances (Meisel, 2002 [Level VI]; Mezey, Mitty, & Ramsey, 1997a [Level
VI]). Most older adults have sufficient cognitive capability to make some but not
all decisions. An individual might have the requisite capacity or understanding
that they can choose someone to make health care decisions for them when
they no longer have the capacity to make treatment choices in advance as would
be required for a LW. The determination of decisional capacity becomes more
exacting in relationship to the complexity and risk associated with the health
care decision (Midwest Bioethics Center, 1996 [Level VI]).
The Mini-Mental Status Examination (MMSE) is a cognitive screen; it was
not designed for nor is it applicable to capacity determination (Mezey, Teresi,
Ramsey, Mitty, & Bobrowitz, 2002 [Level IV]). Appreciation of the consequences
of an option or decision is a key component of capacity determination. Although
more than three-quarters of nursing home residents (n = 68) could make a
treatment choice, few understood their treatment options or the consequences
of each treatment. The MMSE score explained only 6% of variance in apprecia-
tion of consequences (Allen et al., 2003 [Level IV]). There is no “gold standard”
or “capacimeter” to assess capacity (Kapp & Mossman, 1996 [Level V]). It is
generally agreed among bioethicists, legal scholars, and clinicians that a low
level of capacity is needed to create a DPAHC and there is evidence to support
this (Mezey et al., 2002 [Level IV]). As such, the informed consent necessary to
ensure that the individual understands the issues relating to a proxy appoint-
ment can be simpler and less rigorous than the process required for decisions
of greater risk, such as creating a LW.
Nurses can make a valuable contribution in determining decision-making
capacity sufficient to create an AD. Relevant documentation about the patient
includes patients’ ability to express their needs, follow directions, state a pref-
erence, and exhibit stability of their choices. Objective assessment of capacity
can avoid two types of mistakes: (1) mistakenly preventing persons who ought
to be considered capacitated from directing the course of their treatment; and
(2) failing to protect incapacitated persons from the harmful effects of their
decisions.
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Advance care planning is not without legal, ethical, language, communica-
tion, and cultural conundrums. Persuasive argument can be brought to set lim-
its on the treatment preferences expressed by a formerly competent but now
demented individual. It has been argued that the person with Alzheimer’s dis-
ease is a different person than the one who existed prior to the profoundmental
changes andwho stated his or her treatment preferences. The opposing position
is that the now incapacitated person is the same person who expressed those
treatment preferences and that any decision to disregard the wishes should be
based on a judgment about the person’s quality of life (as he or she is living it!)
and on the benefits and burdens associatedwith a particular treatment decision.
Benefit-Burden Assessment
Proxyor surrogate decisionmakers areunlikely to knowwhat andhowabenefit–
burden analysis can assist them in their decision-making responsibilities. As
such, nurses can be invaluable to families and proxies simply by taking them
through the steps of the analysis. A benefit–burden analysis considers the in-
tended and unintended consequences of a particular treatment, estimates the
likelihood that the intended benefit will occur, and weighs the importance of the
benefit and burden to the patient. As each treatment or intervention is consid-
ered, the benefit (advantage) and burden (disadvantage, risk potential) to the
patient is evaluated. The proxy can be helped to infer how the patient would
evaluate the benefits and burdens based on knowledge of the patient’s values,
preferences, and past behavior. The nurse can ask the proxy, “If [the patient]
could join this discussion, what would he say?” “Faced with similar situations
in the past, how did he decide?” A survey of almost 3,429 hospitalized seriously
ill older adults found that almost 75% preferred to have their family and physi-
cian make a resuscitation decision for them—not follow their previously stated
wishes–should they lose decisional capacity (Puchalski et al., 2000 [Level V]).
Advance care planning discussions with patients and their proxies can eluci-
date patients’ perceptions of benefits and barriers. Higher congruence between
patient and proxy regarding the patient’s end-of-life care preferences was as-
sociated with a nurse-led discussion intervention compared to a patient–proxy
control group. Intervention-group patients were more knowledgeable about
life-sustaining treatments (LSTs), less willing to receive LSTs for a new se-
rious medical event, and less willing to live in a state of poor health (Schwartz
et al., 2002 [Level II]).
The rationale for withholding or withdrawing a treatment is to eliminate
a burdensome intervention/treatment that is not producing the desired result.
The motivation is not to hasten death. In those situations where the proxy has
scant knowledge about the patient for whom he or she must make health care
decisions (or there is no AD, proxy appointment, or person who speaks for the
patient), a decision is made on what would be in the patient’s best interest.
Known as the “reasonable person” or “best interest” standard, the decision re-
lies on the notion of what an average person in the patient’s particular situation
would consider beneficial or burdensome. Questions that could move the pro-
cess along would ask, “What does [this patient] have to gain or lose as a result
of this treatment?” and “In what ways will [this patient] be better or worse off
as a result of this treatment—or not having this treatment?”
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Cultural Perspectives on Advance Care Planning
The notion of advance care planning and written directives is not universally
acceptable. In some cultures, for a closeknit family anAD is intrusive, irrelevant,
and a refusal if not a legitimized denial of care. They do not view the DPAHC as
the voice of the patient and a means for someone to advocate for the patient’s
desired care. Disinterest in creating an AD because of a present-day rather
than a future orientation and an unwillingness to write, speak, or plan for one’s
death are pervasive cultural influences on a decision not to create an AD. As
well, deference to physician decision making, the family’s role in protecting
the patient from the burdens of life and death decision making, and spiritual
obligations or beliefs can exert a powerful influence on the decision.
Studies indicate different life-sustaining treatment preferences and
decision-making contexts between racial and ethnic groups (Cox et al., 2006
[Level I]). Among four ethnic groups, Asian and Hispanic patients preferred
family-centered decision-making in contrast to White and African American
patients’ preference for patient-directed decision-making (Kwak & Haley, 2005
[LevelV]).Asmanyhave shown,White patients aremore interested in and likely
to discuss treatment preferences, execute a LW, refuse certain life-sustaining
treatments, and appoint a health care proxy decision maker than Black or His-
panic patients (Hopp & Duffy, 2000 [Level IV]). AD completion is more con-
centrated among White patients with higher education and income levels than
among Black and Hispanic patients at low income levels and less than a high
school education (Mezey, Leitman, Mitty, Bottrell, & Ramsey, 2000b [Level IV]).
In contrast, African American patients are more likely to want life-sustaining
treatments to prolong life. Some Black patients believe that having anAD is a le-
gal way to deny access to treatment and care, and they tend to distrust the health
care system more than MexicanAmericans and Euro-Americans (Perkins, Gep-
pert, Gonzales, Cortez, & Hazuda, 2002 [Level IV]). An intervention study using
same-race peer mentors to discuss advance care planning with dialysis patients
demonstrated a significant positive effect on Black patients but not on White
patients. Positive outcomes included increased comfort in discussion and com-
pletion of ADs and improved feelings of well-being (Perry et al., 2005 [Level II]).
Cultural assimilation, as well as cultural diversity, makes even a simplis-
tic assumption about why people do and do not create an AD extremely haz-
ardous. When patients and health care professionals are from different ethnic
backgrounds, the value systems that form the basis for AD decision making
may conflict, often leading to distinct ethical and interpersonal tensions. Pre-
dictors of AD completion for multi-ethnic urban seniors include what inves-
tigators called “modifiable factors,” such as an established relationship with a
primary-care physician and their doctor’s willingness to start the discussion, be-
ing knowledgeable about advance care planning, recognition of the family role
in decision making, and prior experience with decision making about mechan-
ical ventilation (Morrison & Meier, 2004 [Level IV]). A nurse’s role in the midst
of diverse cultural and religious belief systems is to approach the patient and/or
the proxy with awareness, sensitivity, and competency that respect their values.
These conversations occur over time; they are not interviews per se. Discussion
is always patient-centered, not proxy or provider centered.
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Nurses’ Roles in Advance Directives
All adult patients, regardless of their gender, religion, socioeconomic status,
diagnosis, or prognosis, should be approached with information about and en-
couraged to discuss ADs. Time and workload permitting, nurses can have a
major role in checking their patients’ knowledge about end-of-life treatment
options and the benefits, burdens, and consequences of each option. Yet, nurses
lack confidence in their knowledge and ability to assist patients to create an AD
(Jezewski et al., 2005 [Level IV]). Failure to consider language barriers and hear-
ing and visual deficits can result in the erroneous conclusion that a person lacks
the capacity to execute an AD. Although surveys of the general public report
positive attitudes toward ADs, few patients actually have completed one (Lynn,
Schuster, & Kabcenell, 2000 [Level V]). Even patients at higher risk of becoming
incapable of making decisions and who, therefore, might be more likely to need
an AD are not necessarily more likely to complete a directive. Patients’ under-
standing of their clinical and legal options about care at the end of life is limited
and often mistaken. A study involving 1,000 English-speaking adult outpatients
revealed that almost two-thirds did not know the difference between euthana-
sia and assisted suicide and did not understand treatment refusal; less than half
understood treatment withdrawal (Silviera, DiPiero, Gerrity, & Feudtner, 2000
[Level IV]). Correct information/knowledge was associated with being college
educated, White, and prior experience as a proxy for another.
Educating and talking with patients about ADs can make a difference in
completion rates (Gutheil & Heyman, 2005 [Level II]; Patel, Sinuff, & Cook,
2004 [Level I]). Patients say that they complete ADs to ease their family’s finan-
cial and emotional burden and to ease decision making. They want to discuss
end-of-life care and LWs, but they expect providers to initiate these discus-
sions. Community-dwelling older patients attending a general medical clinic
were more likely to create an AD when they received AD information by mail in
advance of their appointment and their physician received a reminder to discuss
ADs in comparison to patients whose physicians only received a reminder to
document ADs (Heiman, Bates, Fairchild, Shaykevich, & Lehmann, 2004 [Level
II]). Interestingly, discussions of end-of-life care and ADs were a statistically
significant predictor of satisfaction with primary-care physicians among almost
700 outpatients 50 to75 years old (Tierney et al., 2001 [Level II]). Attitude, skills,
and knowledge regarding advance care planning among medical residents car-
ing for hospitalized older adults influenced theirwillingness to discuss it; aswell,
they had incomplete and often erroneous understanding of patients’ decision-
making process (Gorman, Ahern, Wiseman, & Skrobik, 2005 [Level V]).
Educating health care professionals about the virtues and methods of ad-
vance care planning can be instrumental in creating and communicating a clear
and sufficiently detailedAD.Nursing home residents cared for by social workers
(SWs) who were educated about ADs and given a structure for follow-up, docu-
mentation, and communication of residents’ ADwishesweremore likely to have
their life-sustaining treatment and hospitalization preferences documented
than were residents of control-group SWs who only received information about
ADs (Morrison et al., 2005 [Level II]). Subsequently, control-group residents
were significantly more likely than intervention-group residents to receive a
treatment that was not in accordance with their stated wishes and preferences.
Advance Directives 551
Nurses have a responsibility in dispelling myths and misperceptions about
ADs. A pervasivemyth among patients, and one influenced by a history of abuse
anddenial of health care, is that anADmeans “Donot treat” (Sabatino, nd).Many
people believe that an AD, particularly a LW, is necessary to protect one from
being kept alive against their wishes, with all manner of tubes and technology.
Some patients believe, erroneously, that a lawyer is needed to execute an AD
and that each state has its own specific AD document that must be used. It is
partially correct that absent an AD, a “surrogate decision maker,” most often a
family member, is the designated decision maker. This reflects custom as well
as recognition of the pivotal role of the family in important decisions as well as
the fact that a family member is most likely to be aware of the patient’s values,
wishes, and preferences. The reality in many cases is that families disagree
or might be ignorant of a patient’s wishes. Nurses are in a position to identify
pending family conflict and act to mitigate the drastic effects of poor or delayed
treatment decisions. It can also be helpful, in some circumstances, to help the
patient and family/proxy think about alternative treatments and goals of care.
Perhaps an intervention that is less burdensome or one that has a rapid positive
result if only for the short term—for example, to satisfy a patient’s wish to be
present at a major personal event would be acceptable.
One way for a nurse to begin the discussion about advance care planning
is by helping the patient and/or proxy explore and express what quality of life
means for the patient, the importance of preservation of life, and how the pa-
tient’s illness (and death) will affect others (e.g., emotionally, financially). Some
patients might want to focus on the quality of their living, whereas others, the
quality of their dying. Some patients might want to talk about from whom and
where they will receive care at the end of life. Some may abhor their coming
dependence on others; others may not like or want it but will accept it. Still oth-
ers might opt for hospice care out of the home to distance their dependency on
family caregivers. Patients (and proxies) might need or want to talk about what
they each fear most and what will be important when dying.
Copies of the completed AD(s) should be given to the primary health care
provider (physician, nurse practitioner), agency or institution, and the proxy.
Wallet-size cards indicating that the person has an AD and with the name and
contact information for the proxy should be carried. Nurses in virtually every
kind of health care delivery setting can take the initiative to review the docu-
mentwith patients annually and in the event of a significant change of condition.
While doing so, the nurse or other appropriate person should checkwhether the
proxy is still alive and willing to continue to act in that capacity. If the proxy has
died or is no longer willing, the nurse should discuss with the patient which per-
son they would like to become their surrogate decision maker, follow-through
that someone has been selected, and check that the new proxy is aware of the
patient’s wishes and preferences.
Interventions and Care Strategies
Conflict Mediation
As seen in the literature, as well as by anecdotal report, many nurses experi-
ence moral distress when patients’ proxy decision makers do not appear to be
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honoring the patients’ treatment and care wishes (Bookvar & Lachs, 1998 [Level
IV]; Van Niekerk & Martin, 2002 [Level IV]). Although couched in clinical lan-
guage and scenarios, there is no escaping the fact that these situations speak to
patient rights and the ethical principle of respect for persons.
Differences of opinion about a patient’s quality of life, goals of care, and
treatment preferences should not be characterized as a “conflict” when it is not
seen that way by the proxy, the patient’s family, or the health care providers. A
nurse’s role in this kind of situation is to try to level the playing field so that all
parties can voice their concerns while avoiding power struggles.
Conflict mediation can solve problems by identification of the concerned
parties and determination of their needs and interests. Sometimes, the prob-
lem is not one of irrevocable conflict but rather lack of sufficient and accu-
rate information—a communication problem (Dubler & Marcus, 1994 [Level
VI]). Sensitivity to the values of all the involved parties facilitates explo-
ration of alternatives and agreement about the best decisions for the patient.
Steps in mediation and their general sequence are collection of information
about the patient’s medical conditions and nursing needs; discussion of the
goals of care and the medical uncertainties; review of the process by which
health care decisions were made in the past; and identification of any le-
gal, ethical, cultural, or spiritual issues that exert pressure on the decision. A
“principled solution” is one that reflects the fairness of the process and one
that was not predetermined by the power status of any one of the parties.
If this type of informal but focused deliberation is unable to arrive at reso-
lution that reflects the patient’s wishes and with which all are in accord, an
ethics consultation or meeting of the institution’s ethics committee may be the
next step. An ethics committee should look like members of the health care
team—interdisciplinary. If the institution’s lawyer or risk manager is a commit-
tee member, it is essential that the potential legal risk to the institution does
not dominate discussion and trump the ethical discussion relevant to the key
figures.
Communication About Advance Care Planning
Under state law and JCAHO standards, patients have the right to have a quali-
fied interpreter translate and transmit discussion between themselves and the
health care professional. The interpreter may be the only person who recog-
nizes that patients and their families have a totally different “take” than the
health care team on words like “health” and “illness,” on what a treatment is
supposed to do, and on what dying is and what it is not. If “telling bad news” is
prohibited (e.g., Navajo, Greece, Korea, Horn of Africa nations), then it will be
difficult to discuss end-of-life planning. It should not be assumed that facility,
family, or other interpreters are neutral and will simply “translate” words. An
interpreter is communicating fact and nuance, explanation and rationale, and
might influence a treatment decision by virtue of attempting a 1:1 word trans-
lation or a clumsy approximation of two distinct languages. In the presence of
conflict about treatment decisions, or an unexpected decision, it may be in the
patient’s best interest to bring in another interpreter and repeat the exchange
of information and questions.
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Case Study and Discussion
Mrs. R. is an 88-year-old female, widowed for 22 years and with no next
of kin, who lived alone prior to her admission to the nursing home 2
years ago, at which time she consented to a DNR order. She has severe
COPD; chronic renal failure (BUN 58); dementia mild/mod (MMSE 20/30);
is mildly depressed (by GDS score); and is below her IBW (-22 pounds).
Mrs. R. now requires one person for all personal care; she bruises eas-
ily. Her prognosis is poor; goals of care are symptom management with
comfort/palliative care. She has had multiple hospitalizations for “pneu-
monia”; the latest was 10 weeks ago, after which she had further weight
loss and developed a grade II pressure ulcer on her right hip. She is re-
ceiving the standard meds for COPD, an anti-anxiety med, a short-acting
sleeping med, and appetite stimulants. Recent discussion about her qual-
ity of life by the interdisciplinary team noted that she no longer attends
parties, Sabbath candle lighting, or discussions, all of which she used to en-
joy. Mrs. R. seemed unable to make health care decisions as of 6 months
ago; her decisional capacity appears to fluctuate in relation to her O2
saturation.
Five years ago, Mrs. R. created a LW that stipulated “aggressive comfort
care, including ventilator support.” There are no verbal statements docu-
mented that might indicate Mrs. R.’s feelings about being hospitalized if she
has another COPDexacerbation, which is to be expected given the trajectory
of this disease.
Two days ago, Mrs. R. began to have stertorous breathing, a nonpro-
ductive cough, and episodes of diaphoresis. She appears exhausted; her
solid food intake is minimal and she gets very dyspneic when taking small
sips of fluid. A chest x-ray was equivocal and is to be repeated today. At
present, her vital signs are T: 100.8, Pulse Ox: 82%; P and BP WNL. The
nursing home has the resources to provide oxygen and IV fluids including
antibiotics.
The difficulty of this case is a LW instruction, written before the disease
trajectory had reached a terminal state, and that now might not be in Mrs.
R.’s best interest; aggressive intervention might be more burdensome than
beneficial. Whose voice will articulate the benefits and burdens of hospital-
ization or remaining in the nursing home for palliative/terminal care? The
nurse assistants feel she should be hospitalized; their advocacy is based on 2
years of knowing her and feelings of great affection for her. The clinical pro-
fessional staff argue from prognostications about the likely aggressive inter-
ventions (e.g., intubation and ventilator support) and probablemultiple skin
breakdowns if she is hospitalized. The standard of “substituted judgment”
that a proxy uses when deciding on behalf of a patient whose wishes and
preferences are known is not available to us. One could ask, “What would
Mrs. R. choose if she could join the discussion?” The “best interest” standard
of decision making asks what we think would promote Mrs. R.’s well-being.
Can we bring her back to baseline (i.e., the status at which staff knew and
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loved her)? At this point, the benefit–burden assessment becomes a critical
part of the discussion.
Conflict among the professional and paraprofessional staff has to be
addressed. For the nurses, administering morphine to provide respiratory
comfort might well hasten Mrs. R.’s death. Are we prolonging life or pro-
longing death? Are we treating resident or institutional anxiety? What are
our learning needs? COPD is a disease with no cure; it progresses inex-
orably to death. What is meant by quality of life? It is a complex personal
phenomenon and judgment, not a medical determination. To what extent
can the facility provide a reasonable quality of life, a degree of comfort and
safety that might meet Mrs. R.’s interests at this time? Life and engagement
for Mrs. R. at this time will be different from the one the staff previously
enjoyed with her. What are the contingencies, the “what-ifs” for the nursing
home? What are the legal and ethical implications of departing from Mrs.
R.’s AD?What are the risks to the nursing home in administering morphine,
of the principle of double (i.e., unintended) effect?
After discussion with an ethics consultant at an interdisciplinary
meeting that included the nurse assistants involved in her care, a consensus
decision was made not to hospitalize Mrs. R. The decision was guided by
the clinical facts, Mrs. R.’s prior wishes (for “aggressive comfort care”), edu-
cation about COPD, fact-gathering, values discussion, and reflection about
Mrs. R.’s condition after each hospitalization. Mechanical ventilation was
likely to bemore of a burden than a benefit at this point in her illness;Mrs. R.
could be made comfortable with judicious use of medication and intensive
nursing care. This case teaches us that advance care planning is not a static
one-time event. Whether a person’s wishes and preferences are stated
through an AD document or verbally, they must be periodically reviewed
upon a person’s change of condition, lifestyle, proxy, heart, and mind. The
ability to reach consensus through mediation that addressed each person’s
concerns but kept the discussion resident-centered was key to arriving at
a medically and ethically appropriate decision that focused on the goals of
care.
Conclusion
Discussions about care at the end of life should occur over time. Having such
discussions shortly after hospitalization for an acute event can blur the pri-
orities of advance care planning, focusing more on resuscitation preferences
than on the long-range goals of care and treatment (Happ et al., 2002 [Level
IV]). Notions of quality of life, confusion about what it looks and feels like, and
how to measure this complex phenomenon influence patient, proxy, and fam-
ily decisions regarding end-of-life care and interventions (O’Brien et al., 1995
[Level IV]; Suri, Egleston, Brody, & Rudberg, 1999 [Level IV]). Rather than dis-
cussing the technology of life-sustaining treatment and end-of-life care, nurses
can help reorient and center the discussion on the patient’s wishes and prefer-
ences. It may be wiser and more humane to discuss with patients, families, and
proxies the acceptable state of health, desired functionality, and the “valued life
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activities” that patients want. Construing quality of life in this manner might be
more meaningful and helpful.
Although hardly a justification, having an AD can be cost effective—if not
for the patient, then for the health care system—and with no decrease in sat-
isfaction with care. Patients suffering from advanced illness and approaching
the end of their life were randomly assigned to a coordinated care program for
advanced illness or usual care. Intervention-group patients were more satisfied
with care and communication, and their surrogates reported fewer difficulties
in accessing providers, in comparison to patients receiving usual care (Engel-
hardt et al., 2006 [Level II]). There was no difference in mortality rate; 6-month
costs were lower in the intervention group. Another study demonstrated that
after systematic implementation of an AD program in several nursing homes,
a significant number of competent residents and families of incompetent res-
idents created ADs in the intervention homes; satisfaction with care was no
different between intervention and control homes (Molloy et al., 2000 [Level
II]). There were fewer hospitalizations per resident and less resource use in the
intervention homes and no difference in percentage of deaths for intervention
and control homes.
An environment conducive to meaningful discussions about ADs and end-
of-life care requires an appropriate time and location. An emergency admission
is not an appropriate time. Distribution without discussion, commonly done in
hospital admissions offices at the time of an elective admission, is not an ap-
propriate time either. (Nursing homes tend to wait 2 weeks before discussing
ADs with a new admission.) Patients may be more receptive to read about ADs
if the information is part of a preadmission package or discussed as part of
the discharge process when the impact of hospitalization is still fresh but the
acute symptoms (and probable anxiety) are no longer present. It is unlikely that
education and information about ADs will completely counteract the natural
discomfort associated with discussing death and dying; this is generally as true
for patients and families as it is for care providers. Awareness of the patient and
family’s spiritual and cultural “surround,” as well as the provider’s moral biases
about life-sustaining treatment, gives rise to sensitive and realistic discussion.
Nurses can improve care at the end of life for elderly patients by encouraging
advance care planning and creation of ADs.
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Resuscitate, Comfort and Relief, Patient Self-Determination Act
■ Selected Bibliographies on Ethical Issues Such as End-of-Life Decisions,
Forgoing Artificial Nutrition and Hydration, Nursing Ethics Committees,
and Assisted Suicide and Euthanasia
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The American Society of Bioethics and Humanities
4700 West Lake Avenue
Glenview, IL 60025
Telephone: (847) 375-4745
www.asbh.org
■ International Journal of Nursing Ethics
Choice in Dying/Partnership for Caring, Inc.
National Office
1620 I Street NW, Suite 202
Washington, DC 20006
Telephone: (202) 296-8071
http://www.choices.org
■ Questions and Answers: Advance Directives and End-of-Life Decisions;
Medical Treatments andYourAdvanceDirectives; Artificial Nutrition and
Hydration andEnd-Of-Life DecisionMaking; Do-Not-Resuscitate Orders
and End-of-Life Decisions
■ Video: Who’s Death Is It, Anyway? (PBS special)
Hospice and Palliative Nurses Association
Medical Center East, Suite 375
211 North Whitfield Street
Pittsburgh, PA 15206-3031
Telephone: (412) 361-2470
■ Standards of Hospice Nursing
■ Symptom Management
■ Algorithms for Palliative Care
The Kennedy Institute of Ethics
P.O. Box 571212
Georgetown University
Washington, DC 20057-1212
www.georgetown.edu/research/kie/
■ Scope Note series
■ Ethics Journal (available electronically)
Last Acts
1620 I Street, NW, Suite 202
Washington, DC 20006
Telephone: (202) 296-8352
www.lastacts.org
■ Journal article summaries
■ State initiatives on EOL Care—Focus: Pain Management
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■ Helping employees deal with EOL issues
■ Statement on diversity in EOL care
Aging With Dignity (Five Wishes AD)
P.O. Box 1661
Tallahassee, FL 32302-1661
Telephone: (888) 5WISHES (594-7437)
www.agingwithdignity.org
Physician’s Orders for Life-Sustaining Treatment (POLST)
Washington State Medical Association
2033 6th Avenue, Suite 1100
Seattle, WA 98121
Telephone: (800) 552-0612
www.wsma.org/patients/polst.html
End-of-Life Nursing Education Consortium (ELNEC)
American Association of Colleges of Nursing
One Dupont Circle, NW, Suite 530.
Washington, DC 20036
Telephone: (202) 785-8320
www.aacn.nche.edu/elnec
End-of-Life Physician Education Research Center (EPERC)
Medical College of Wisconsin, MEB, Room 3235
8701 Watertown Plank Road
Milwaukee, WI 53226
Telephone: (414) 456-4353
www.eperc.mcw.edu
Box 24.1
Nursing Standard of Practice Protocol:
Advance Directives Protocol
GUIDING PRINCIPALS
A. All people have the right to decide what will be done with their bod-
ies.
B. All individuals are presumed to have decision-making capacity until
deemed otherwise.
C. All patients who can participate in a conversation, either verbally
or through an alternate means of communication, should be ap-
proached to discuss and record their treatment preferences and
wishes.
D. Health care professionals can improve end-of-life care for elderly
patients by encouraging the use of ADs.
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I. BACKGROUND
A. Education about Advance Directives
1. Patients uniformly state that they want more information about
ADs.
2. Patients want nurses (and doctors) to approach them about ADs.
3. Fewer than 20% of Americans have completed an AD.
B. Advance Directives
1. Allow individuals to provide directions about the kind of medical
care they do or do not want if they become unable to make deci-
sions or communicate their wishes.
2. Provide guidance for health care professionals, families, and sub-
stitute decision makers about health care decision making that
reflect the person’s wishes.
3. Provide immunity for health care professionals, families, and ap-
pointed proxies from civil and criminal liability when health care
professionals follow the AD in good faith.
C. Two types of Advance Directives: durable power of attorney for
health care (DPAHC) (also called a health care proxy) and living will
(LW)
1. A durable power of attorney allows individuals to appoint someone,
called a health care proxy, agent, or surrogate, to make health care
decisions for them should they lose the ability to make decisions
or communicate their wishes.
2. A living will provides specific instructions to health care providers
about particular kinds of health care treatment an individualwould
or would not want to prolong life. Living wills are often used to de-
clare a wish to refuse, limit, or withhold life-sustaining treatment.
D. Instructional or Medical Directive: Intended to compensate for the
weaknesses of LWs, this kind of directive identifies specific interven-
tions that are acceptable to a patient in specific clinical situations.
E. Oral AdvanceDirectives (verbal directives) are allowed in some states
if there is clear and convincing evidence of the patient’s wishes. Clear
and convincing evidence can include evidence that the patient made
the statement consistently and seriously, over time; specifically ad-
dressed the actual condition of the patient; and was consistent with
the values seen in other areas of the patient’s life. Legal rules sur-
rounding oral ADs vary by state.
II. ASSESSMENT PARAMETERS
A. All adult patients regardless of age (with the exception of patients
with persistent vegetative state, severe dementia, or coma) should
be asked if they have a LW or if they have designated a proxy.
B. All patients, regardless of age, gender, religion, socioeconomic status,
diagnosis, or prognosis, should be approached to discuss ADs and
advance care planning.
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C. Discussions about ADs should be conducted in the patient’s pre-
ferred language to enable information transfer and questions and
answers.
D. Patients who have been determined to lack capacity to make other
decisions may still have the capacity to designate a proxy or make
some health care decisions. Decision-making capacity should be de-
termined for each individual based on whether the patient has the
ability to make the specific decision in question.
E. If a LW has been completed or proxy has been designated:
1. The document should be readily available on the patient’s current
chart.
2. The attending physician should know that the directive exists and
has a copy.
3. The designated health care proxy should have a copy of the doc-
ument.
4. The AD should be reviewed periodically by the patient, attend-
ing physician/nurse, and the proxy to determine if it reflects the
patient’s current wishes and preferences.
III. CARE STRATEGIES
A. Nurses should assist patients and families trying to deal with end-
of-life care issues.
B. Patients may be willing to discuss their health situation and mor-
tality with a nurse or clergyman rather than with a family member
and should be supported in doing so.
C. Patients should be assisted in talking with their family/proxy about
their treatment and care wishes.
D. Patients should be assessed for their ability to cope with the infor-
mation provided.
E. Nurses must be mindful of and sensitive to the fact that race, cul-
ture, ethnicity, and religion can influence the health care decision-
making process. The fact that patients from non-Western cultures
may not subscribe to Western notions of autonomy does not mean
that these patients do not want to talk about their treatment wishes
or that they would not have conversations with their families about
their treatment preferences.
F. Patients must be respected for their decision to not complete an AD
and reassured that they will not be abandoned or receive substan-
dard care if they do not elect to formulate an AD.
G. Nurses should be aware of the institution’smechanism for resolving
conflicts between family members and the patient or proxy or be-
tween the patient/family and care providers and assist the parties
in using this resource.
H. Nurses should be aware of which professional in their agency/
institution is responsible for checkingwith the patient that copies of
the AD have been given to their primary-care provider(s), to their
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proxy, and that the patient is carrying a wallet-size card with AD
and contact information.
IV. EVALUATION OF EXPECTED OUTCOMES
To determine whether implementation of this protocol influenced the
type as well as the number of ADs created, changes should be mea-
surable and contribute to the facility’s ongoing quality improvement
program. Look at:
A. As documented in the record:
1. whether patients are asked about advance care planning and
directives
2. whether patients do or do not have an AD
B. Of those patients with an AD, the percentage of ADs included in
patient charts
C. The use of interpreters to assist staff discussion of ADs with pa-
tients for whom English is not their primary language
D. The number of ADs completed in association with admission to or
receipt of services from the agency/institution
E. The number of nurse referrals to the Ethics Committee of patient
or staff situations regarding ADs
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Comprehensive
Assessment and
Management of
the Critically Ill
Michele C. Balas
Colleen M. Casey
Mary Beth Happ
Educational
Objectives
On completion of this chapter, the reader will be
able to:
1. identify factors that influence an older adult’s ability
to survive and rehabilitate from a catastrophic
illness
2. list examples of an atypical presentation of illness
in critically ill older adults
3. describe geriatric-specific assessment and
physical examination of critically ill older adults
4. identify nursing interventions that decrease
critically ill older adults’ risk for adverse medical
outcomes
Overview
More than half (55.8%) of all intensive care unit (ICU) days are incurred by
patients older than 65 and this number is expected to increase to unprecedented
levels in the next 10 years as the population ages (Angus et al., 2000 [Level IV]).
Although older adults are an extremely heterogeneous group, they share some
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
Adapted from the American Association of Colleges of Nursing, “Preparing nursing students to care for older
adults: Enhancing gerontology in senior-level undergraduate courses” curriculum module. Assessment and
Management of Older Adults with Complex Illness in the Critical Care Unit, prepared by Michele C. Balas,
Colleen M. Casey, and Mary Beth Happ.
565
566 Chapter 25
age-related characteristics and are susceptible to various geriatric syndromes
and diseases that may influence ICU treatments and outcomes.
Ideally, the goals of providing nursing care to a critically ill older adult
include restoring physiologic stability, preventing complications, maintaining
comfort and safety, and preserving or preventing decline in pre-illness func-
tional ability and quality of life (QOL). There is evidence, however, suggesting
that many critically ill older adults are at risk for poor outcomes. A critical re-
view of the literature found that, once hospitalized for a life-threatening illness,
older adults suffer from high ICU, hospital, and long-term crude mortality rates
and are at risk for deterioration in functional ability and post-discharge insti-
tutional care (Chelluri, Grenvik, & Silverman, 1995 [Level V]). Older age is also
one of the factors that may lead to physician bias in refusing ICU admission
(Joynt et al., 2001 [Level IV]; Mick & Ackerman, 2004 [Level VI]); the decision
towithholdmechanical ventilation, surgery, or dialysis (Hamel et al., 1999 [Level
III]); and an increased frequency of Do-Not-Resuscitate (DNR) orders (Hakim
et al., 1996 [Level III]). Despite these findings, most critically ill older adults
demonstrate resiliency, report being satisfied with their QOL post-discharge,
and, if needed, would reaccept ICU care and mechanical ventilation (Chelluri
et al., 1995 [Level V]; Guentner et al., 2006 [Level IV]; Kleinpell & Ferrans, 2002
[Level IV]).
Background
Chronologic age alone is not an acceptable or accurate predictor of poor out-
comes after critical illness (Chelluri et al., 1995 [Level V]; Esteban et al., 2004
[Level IV]; Kleinpell, 2003 [Level IV]). Factors influencing an older adult’s abil-
ity to survive a critical illness include severity of illness, nature and extent of
co-morbidities, diagnosis, reason for/duration of mechanical ventilation, com-
plications, length of ICU/hospital stay, preadmission nursing home residence,
pulmonary artery catheterization, prehospitalization functional ability, gender,
and ethnicity (Adnet et al., 2001 [Level IV]; Chelluri et al., 1995 [Level V]; Chel-
luri, Pinsky, Donahoe, & Grenvik, 1993 [Level IV]; Djaiani & Ridley, 1997 [Level
IV]; Esteban et al., 2004 [Level IV];Hamel et al., 1999 [Level III]; Kass, Castriotta,
& Malakoff, 1992 [Level IV]; Knaus et al., 1991 [Level IV]; Mayer-Oakes, Oye,
& Leake, 1991 [Level IV]; Nicolas, Le Gall, Alperovitch, Loirat, & Villers, 1987
[Level IV]; Nierman, Schechter, Cannon, & Meier, 2001 [Level IV]; Richmond,
Kauder, Strumpf, & Meredith, 2002 [Level IV]; Shapira et al., 1997 [Level IV];
Wu, Rubin, & Rosen, 1990 [Level IV]). Other less well investigated variables in-
clude senescence, cognitive impairment, ageism, decreased social support, and
the critical care environment (Mick & Ackerman, 2004 [Level VI]; Tullmann &
Dracup, 2000 [Level VI]).
The onset of new geriatric syndromes for an older hospitalized adult, such
as urinary incontinence, infection, delirium, or falls, can often be prevented
with appropriate and timely ICU nursing interventions (for more information,
visit www.ConsultGeriRN.org). This chapter presents strategies and rationales
for comprehensive assessment of critically ill older adults to guide optimal care
management.
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Assessment of Problem and Nursing Care Strategies
Assessment of Baseline Health Status
Comprehensive assessment of a critically ill older adult’s preadmission health
status, functional and cognitive ability, and social support systems helps nurses
identify risk factors that make older adults susceptible to cascade iatrogenesis
(Creditor, 1993 [Level VI]), the development of life-threatening conditions, and
frequently encountered geriatric syndromes.
Pre-existing Cognitive Impairment
Several anatomic and physiologic changes occur in the aged central nervous
system (Table 25.1) and are not necessarily synonymous with cognitive impair-
ment (Urden, Stacy, & Lough, 2002 [Level VI]). The additive effect of chronic
illness (e.g., diabetes, hypertension, or coronary artery disease [CAD]) coupled
with common aging changes and acute pathology may, however, partially ex-
plain the high rates of pre-existing cognitive impairment (31% to 42%) found in
older adults admitted tomedical ICUs (Pisani, Inouye,McNicoll, & Redlich, 2003
[Level IV]). Relatives or other caregivers should be asked for baseline informa-
tion about memory, executive function (problem solving, planning, organization
of information), and overall functional ability in daily living prior to the criti-
cal care admission (Kane, Ouslander, & Abrass, 2004 [Level VI]) (see chapter 4,
Assessing Cognitive Function).
Developmental and Psychosocial Factors
Various living and family arrangements are evidenced in this heterogeneous age
group. Although many older adults live independently or are cared for by adult
children or other relatives, many elders are also caregivers themselves, caring
for their aging spouses, relatives, grandchildren, and friends (Administration
on Aging, 2005 [Level IV]). The lack of presence of family or a significant other
threatens a nurse’s ability to obtain accurate data about the person, which is
often needed to make urgent, important care management decisions. The very
nature of the critical illness often renders older adults physically unable to ef-
fectively communicate with the health care team.
The inability to communicate may stem from multiple factors including
physiologic instability, tracheal intubation, and/or sedative and narcotic use
(Happ, 2000 [Level IV]; Happ, 2001 [Level IV]). Family members are therefore
a crucial source for obtaining important preadmission information such as past
medical and surgical history, drug and alcohol use, nutritional status, sensory
impairments, home environment, and medication use, as well as information
about advance directives and decisional choices (see chapter 23, Health Care
Decision Making, and chapter 24, Advance Directives).
Functional Ability
Although the majority of older adults report having at least one chronic con-
dition, they remain relatively independent (Administration on Aging, 2005
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25.1 Age-Associated Changes by Body System in theOlder ICU Patient∗
System Age-Associated Changes
Respiratory Decrease in chest-wall compliance, rib mobility, lung elasticity, ventilatory
response to hypoxia and hypercapnia, strength of respiratory muscles, PaO2
level, mucociliary clearance, total lung capacity (minimal), vital capacity, forced
expiratory volume (FEV1), peak and maximal expiratory flow rate, and maximal
inspiratory and expiratory pressure
Increases in: functional residual capacity, closing volume, A/A gradient,
ventilation/perfusion (VQ) imbalance
Gastrointestinal Delayed gastric emptying and thinning of smooth muscle in gastric mucosa
Decrease in the number of mucus-secreting cells, mucosal prostaglandin
concentrations, bicarbonate secretion, transit time of feces, pepsin and acid
secretion, ability to swallow (secondary to poor mastication and decrease in the
number and velocity of peristaltic contractions in esophagus), enteric nervous
system neurons, and the capacity to repair gastric mucosa
Increase in body fat, changes to interstitial tissue (predisposing to soft-tissue
injury and increasing the time and course for mobilization of extracellular water)
Decreases in calcium absorption, lean muscle mass and strength, daily energy
expenditure, and intracellular water
Hepatobiliary Decrease in the number of hepatocytes and overall weight and size of liver
(compensatory increase in cell size and proliferation of bile ducts), hepatic blood
flow, metabolism of and sensitivity to drugs
Genitourinary Nephrons/glomeruli become sclerotic, functional units hypertrophy, afferent and
efferent arterioles atrophy
Decline in GFR, renal tubular cell function and number, renal blood flow, and
creatinine clearance
Ability to conserve sodium and excrete hydrogen ions falls as does ability to
excrete salt and water loads, ammonia, and certain drugs
Decline in the activity of the renin-angiotensin system and end organ
responsiveness to antidiuretic hormone
Bladder: Increase in collagen
In women, alterations in estrogen cause changes in urethral sphincter
In males, benign prostatic hypertrophy
Skin Decreased subcutaneous and connective tissue, number of eccrine and sebaceous
glands, vascular supply to dermis, and skin turgor
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25.1 (continued)
System Age-Associated Changes
Neurologic Decrease in size of brain, number of neurons and dendrites, length of dendrite
spines, and cerebral blood flow
Increase in liposuscins, neuritic plaques, neurofibrillary bodies, and ventricle size
Changes in hypothalamus and neurotransmitter turnover and function
Decline in visual acuity and depth perception (secondary to anatomic and functional
changes to the auditory and vestibular apparatus) and proprioception, balance
and postural control, and tactile and vibratory sensation
Cardiovascular Decrease in number of myocytes, ventricular compliance, rate of relaxation,
baroreceptor sensitivity, compliance of arteries, response of myocardium to
catecholamine stimulation, resting heart rate, and heart rate with stress
Increase in myocardial collagen content, stiffening of the outflow tract and great
vessels (causing resistance to vascular emptying), ventricular hypertrophy,
pulse wave velocity
Autonomic tissue is replaced by connective tissue and fat, whereas fibrosis causes
conduction abnormalities through the intranodal tracts and the Bundle of His
Immune/
Hematopoi-
etic
Change in T-cell populations, products and response to stimuli; defects in B-cell
function; mix of immunoglobulins change (i.e., IgM decreases, IGG and IGA
increase), and decline in neutrophil function
Source: Adapted from:
Nagappan, R., & Parkin, G., 2003 [Level VI]. Geriatric critical care. Critical Care Clinics, 19, 253–270.
Rosenthal, R. A., & Kavic, S. M., 2004 [Level VI]. Assessment and management of the geriatric patient. Critical Care
Medicine, 32(4 Suppl.), S92–S105.
Urden et al., 2002 [Level VI]. Gerontological Alterations and Management. In Thelan’s critical care nursing: diagnosis and
management (4th ed., pp. 199–220). St. Louis, MO: Mosby.
[Level IV]);Waldrop & Stern, 2003 [Level IV]). Ascertaining preadmission func-
tional status is a major determinant in the recovery of critically ill older adults
(Mick&Ackerman, 2004 [LevelVI]; Roche,Kramer,Hester, &Welsh, 1999 [Level
IV]; Tullmann & Dracup, 2000 [Level VI]). Both the Katz Index of Activities of
Daily Living (Katz, Ford, Moskowitz, Jackson, & Jaffe, 1963) and the Functional
Independence Measure (FIM) (Kidd et al., 1995 [Level III]) have been recom-
mended for use with an older population (Kresevic & Mezey, 2003 [Level VI])
(see chapter 3, Assessment of Function).
Assessment and Interventions During ICU Stay
Although a full discussion of the physiologic changes that accompany common
aging is beyond the scope of this chapter, in the following sections we provide
readers with (1) an overview of themajor age-related changes to organ systems;
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(2) a discussion of how these changes often manifest on physical exam; (3) a
discussion of atypical presentations of some common ICU diagnoses; and (4) a
description of interventions that may decrease risk for untowardmedical events
for critically ill older adults (also see the Box 25.1). Common nursing interven-
tions that benefitmultiple organ systems are discussed only in the first section in
which the intervention is introduced. These interventions include encouraging
early, frequent mobilization/ambulation; obtaining timely and appropriate con-
sults (e.g., physical, occupational, speech, respiratory, and nutritional therapy);
providing proper oral hygiene and adequate pain control; securing and ensur-
ing the proper functioning of tubes/catheters; maintaining normothermia; and
reviewing and assessing medication appropriateness. The importance of these
interventions and vigilance to these elements of nursing care cannot be over-
stated.
Respiratory System
An older ICU patient’s respiratory status can become the most tenuous com-
ponent of his or her recovery. Common pulmonary changes in aging include
progressive decreases in the strength of respiratory muscles, lung elasticity,
chest-wall compliance, PaO2 level, ventilatory responses to hypoxia and hyper-
capnia, and number and efficiency of airway cilia (see Table 25.1) (Nagappan &
Parkin, 2003 [Level VI]; Rosenthal & Kavic, 2004 [Level VI]; Urden et al., 2002
[Level VI]). Nurses may observe some of the skeletal changes common in aging,
including possible kyphosis and an increased anteroposterior diameter of the
chest (Bates, 1995 [Level VI]) and on auscultation, hear a few bibasilar crackles
that clear with deep breathing and coughing (Urden et al., 2002 [Level VI]).
Commonpulmonary changes in aging elevate anolder adult’s risk for aspira-
tion, atelectasis, and pneumonia (Nagappan & Parkin, 2003 [Level VI]; Rosen-
thal & Kavic, 2004 [Level VI]; Urden et al., 2002 [Level VI]). These risks are
further heightened in older adults who undergo thoracic or abdominal surgery;
sustain rib fractures or chest injury; receive narcotics or sedatives; have tubes
that bypass the oropharyngeal airway; or who are weak, deconditioned, de-
hydrated, and have poor oral hygiene (Nagappan & Parkin, 2003 [Level VI];
Rosenthal & Kavic, 2004 [Level VI]; Urden et al., 2002 [Level VI]). Pre-existing
pulmonary disease and manipulations of the abdominal and thoracic cavities
may lead to the unreliability of traditional values associated with central venous
(CVP) and pulmonary artery occlusion (PAOP) pressures (Rosenthal & Kavic,
2004 [Level VI]). Consequently, it is important to discuss with the ICU team any
unusual preexisting or acute influences on these hemodynamic parameters so
that adequate trends can be monitored.
Older patients with pre-existing obstructive or restrictive lung disease
who are mechanically ventilated are also at increased risk for ventilator as-
sisted pneumonia (VAP) and delayed extubation. To minimize this complica-
tion, nurses should aggressively exercise standard VAP precautions, including
keeping the head of the bed elevated to more than 30 degrees, providing fre-
quent oral care, maintaining adequate cuff pressures, assessing the need for
stress ulcer prophylaxis, turning the patient as tolerated, maintaining general
hygiene practices, and advocating for weaning trials as early as possible (Kunis
& Puntillo, 2003 [Level VI]).
Comprehensive Assessment and Management of the Critically Ill 571
Caring for an older adult who requiresmechanical ventilation is particularly
challenging. Althoughdebate exists as towhether age influences outcome in this
population, evidence suggests that chronic ventilatory dependency dispropor-
tionately affects older patients, whether as a complication of a critical illness or
as a result of a chronic respiratory system limitation (Esteban et al., 2004 [Level
IV]; Kleinhenz & Lewis, 2000 [Level VI]). Patients who require 4 or more days
of mechanical ventilation are more likely to die in the hospital or, if they sur-
vive, to spend a considerable amount of time in an extended-care facility upon
discharge, experience an increased risk for hospital readmission, suffer from
continued morbidity, and experience a decreased quality of life (Chelluri et al.,
2004 [Level IV]; Daly, Douglas, Kelley, O’Toole, & Montenegro, 2005 [Level II];
Douglas, Daly, Brennan, Gordon, & Uthis, 2001 [Level IV]; Douglas et al., 1997
[Level IV]; Douglas, Daly, Gordon, & Brennan, 2002 [Level IV]). In addition to
advocating for weaning trials and extubation as early as possible, the health care
team, including the ICU nurse, must include these potential consequences as
part of a discussion of treatment options with patients and their families.
Cardiovascular System
Because so many older adults live with hypertension, peripheral vascular dis-
ease, or CAD, individual responses to treatment can dramatically differ depend-
ing on the severity of their illness and any preexisting co-morbidities. Even
“disease-free” older adults may experience a decrease in their ability to respond
to stressful situations due to the many changes that accompany cardiovascular
aging (see Table 25.1). Upon auscultation, many healthy older adults display a
fourth heart sound (S4), an aortic systolic murmur, higher systolic blood pres-
sure with a widening pulse pressure, and a slower resting heart rate (Bates, 1995
[Level VI]).
Cardiovascular-associated aging changes ultimately render themyocardium
less compliant and responsive to catecholamine stimulation, can cause ventric-
ular hypertrophy, and predispose the older adult to the development of arrhyth-
mias (Nagappan & Parkin, 2003 [Level VI]; Rosenthal & Kavic, 2004 [Level VI];
Urden et al., 2002 [Level VI]). During times of stress, an older adult achieves
an increase in cardiac output by increasing diastolic filling rather than increas-
ing heart rate (Nagappan & Parkin, 2003 [Level VI]; Rosenthal & Kavic, 2004
[Level VI]; Urden et al., 2002 [Level VI]). The practical implication of this find-
ing is that older adults often require higher filling pressures (i.e., CVPs in the
8 to 10 range, PAOPs in the 14 to 18 range) to maintain adequate stroke vol-
ume and may be especially sensitive to hypovolemia (Rosenthal & Kavic, 2004
[Level VI]). However, over-hydration of the older adult should also be avoided
because it can lead to systolic failure, poor organ perfusion, and hypoxemia with
subsequent diastolic dysfunction (Rosenthal & Kavic, 2004 [Level VI]). Careful
monitoring of hemodynamic and fluid status is therefore essential to optimize
an older patient’s cardiac status.
Many conduction abnormalities (i.e., atrial arrhythmias, sick sinus syn-
drome, and bundle branch blocks) are common in aging. Although many of
the randomized controlled trials of beta-blocker therapy are small, the weight
of evidence, in aggregate, suggests that the use of preoperative beta-adrenergic
blockade decreases the incidence of postoperative cardiac complications and
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death in patients considered high risk (Fleisher et al., 2006 [Level I]; Mangano,
Layug,Wallace, & Tateo, 1996 [Level II]; Poldermans et al., 1999 [Level II]). High
cardiovascular risk includes older adults with unstable coronary syndromes, de-
compensated heart failure, significant arrhythmias, previous myocardial infarc-
tion, and even patients with diabetes mellitus and renal insufficiency (Fleisher
et al., 2006 [Level I]).
Certain drugs commonly used in the ICU setting may prove to be either not
as effective (e.g., isoproterenol and dobutamine) or more effective (e.g., after-
load reducers) in the older adult population (Rosenthal & Kavic, 2004 [Level
VI]). Symptoms of a myocardial infarction may be blunted in older adults, re-
quiring the need to monitor for nonspecific and atypical presentations in this
patient population, including shortness of breath, acute confusion, or syncope.
Finally, because older adults may have difficulty with thermoregulation, espe-
cially during a critical illness, nurses should take active measures to maintain
normothermia (Rosenthal & Kavic, 2004 [Level VI]).
Neurologic System
The central and peripheral nervous system changes that accompany the aging
process include decreases in both the overall size of the brain and the number
of neurons, hypothalamic alterations, neurotransmitter turnover, and anatomic
changes to the auditory, visual, and vestibular apparatus (see Table 25.1) (Na-
gappan & Parkin, 2003 [Level VI]; Rosenthal & Kavic, 2004 [Level VI]; Urden
et al., 2002 [Level VI]). On physical exam, these changes are often manifested
by a decreased papillary response to penlight, as well as a decrease in near
and peripheral vision and loss of visual acuity to dim light (Urden et al., 2002
[Level VI]). Other alterations on physical exam findings may include evidence
of muscle wasting and atrophy, presentation of a benign essential tumor, slower
and less agile movement as compared to younger adults, diminished peripheral
reflexes, and a decreased vibratory sense in the feet and ankles (Bates, 1995
[Level VI]).
Older adults oftenpresent to emergencydepartments or ICUwith acuteneu-
rologic symptoms. These acute neurological changes may represent an atypical
presentation of an acute illness and can be reversible (e.g., delirium), including
alterations caused by infection, an imbalance of electrolytes, or drug toxicity. A
thorough physical examination, with follow-up testing, must be conducted to
accurately diagnose the etiology of an older adult’s neurologic changes, as well
as to review medications that are likely to cause delirium.
Age-related changes to the neurologic system, when coupled with acute
pathology and the ICUenvironment,may increase a critically ill older adult’s risk
for cognitive dysfunction, falls, restraint use, over-sedation, alterations in body
temperature, and anorexia. Most important, these changes also elevate the risk
for delirium that occurs in up to 70% of older adults admitted to a medical ICU
(McNicoll et al., 2003 [Level IV]; Petersonet al., 2006 [Level IV]) and is associated
with increased morbidity, mortality, length of hospital stay, and poor functional
outcomes (Ely et al., 2001 [Level II]). Pain, sleep deprivation, visual impairment,
illness severity, prior cognitive impairment, dehydration, co-morbidities, lab-
oratory abnormalities, multiple medications, chemical withdrawal syndromes,
infections, fever, windowless units, and ICU length of stay may place a critically
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ill older adult at risk for delirium (Aldemir, Ozen, Kara, Sir, & Bac, 2001 [Level
IV]; Dubois, Bergeron, Dumont, Dial, & Skrobik, 2001 [Level IV]; Inouye et al.,
1999 [Level II]; Sveinsson, 1975; Tullmann & Dracup, 2000 [Level VI]; Wilson,
1972 [Level III]).
Achieving adequate pain control for critically ill older adults is of utmost im-
portance, both related to and independent of its relationship to delirium; how-
ever, nurses also need to avoid over-sedation and under-treatment of pain in
this population because both are associated with multiple negative outcomes,
including distress, delirium, sleep disturbances, and impaired mobility (Graf
& Puntillo, 2003 [Level VI]; Rosenthal & Kavic, 2004 [Level VI]). A number of
tools exist to assess a critically ill patient’s level of sedation and delirium sta-
tus. The Richmond Agitation and Sedation Scale (RASS) (Sessler et al., 2002
[Level IV]) and the Confusion Assessment Method-ICU (CAM-ICU) (Ely et al.,
2001 [Level IV]; Miller & Ely, 2006 [Level VI]) are two of the most common in
the critical care setting (see the Resources section for additional information on
these tools and the Protocol for interventions to reduce delirium (Box 25.1).
Gastrointestinal (GI) System
Common age-related changes to the GI system can predispose older ICU pa-
tients to complications during their ICU stay, ranging from altered presentation
of illness to issues of medication effectiveness. Physiologic changes include de-
layed gastric emptying, alterations in the secretion of gastric enzymes and acid,
loss of enteric nervous system neurons, and a decrease in the number of hep-
atocytes and overall weight and size of liver, all of which influence the phar-
macodynamics and pharmacokinetics associated with drug dosing, metabolism,
and sensitivity (see Table 25.1) (Nagappan & Parkin, 2003 [Level VI]; Rosenthal
& Kavic, 2004 [Level VI]; Urden et al., 2002 [Level VI]). Older adults also ex-
perience changes in their body composition (i.e., decrease in lean body mass)
and energy use that can potentiate the effect of medications on these GI system
changes.
Ironically, whereas many conditions affecting the GI system are more com-
mon in older adults (e.g., constipation, under-nutrition and malnutrition, gas-
tritis), their presence is not fully explained by the aging processes (Rosenthal &
Kavic, 2004 [Level VI]). When assessing the GI function of a critically ill older
adult, it is important for the nurse to realize that age may blunt the manifesta-
tions of acute abdominal disease. For example, pain may be less severe; fever
less pronounced or absent; and signs of peritoneal inflammation, such as mus-
cle guarding and rebound tenderness, may be diminished or even absent (Bates,
1995 [Level VI]). Because of changes in the secretion of gastric enzymes, the
stomach wall of older adults can be more susceptible to acid injury, especially in
the face of critical illness. ICU nurses must be alert for signs of gastrointestinal
bleeding and be proactive in advocating for gastric ulcer prophylaxis, especially
in those elders requiring mechanical ventilation.
Delayed gastric emptying may predispose older adults to abdominal dis-
tension, nausea, vomiting, aspiration, and constipation. This delayed motility is
especially true in the postoperative period when many older adults are immo-
bile and receiving narcotics.Many older adults takemultiplemedications, which
along with age-related changes such as altered thresholds for taste and smell,
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a hypersensitive hypothalamic satiety center, and oropharyngeal atrophy, can
inhibit their intake of solids and liquids (Rosenthal & Kavic, 2004 [Level VI]).
This baseline GI functionality, in combination with their critical illness, must be
proactively addressed.Nursesneed tobe alert for ill-fittingdentures, swallowing
difficulties, silent aspiration, and the possibility of decreased saliva production
(due to either salivary dysfunction or the use of drugs, such as sympathomimet-
ics). These alterations can lead to insufficient mastication and can combine with
other risk factors that put the older ICU patient at risk for aspiration. Aspiration
should be considered a life-threatening situation, requiring immediate nursing
intervention.
Older adults facing stress from illness, injury, or infection are also at high
risk for protein-calorie malnutrition, as evidenced by low serum albumin and
prealbumin levels, a decline in hepatic function, decreased muscle mass and
strength, and dysfunction in those tissues with high cell turnover (Nagappan
& Parkin, 2003 [Level VI]; Rosenthal & Kavic, 2004 [Level VI]). These changes
lead to a breakdown in barrier function, increased susceptibility to infection,
delayed wound healing, fluid shifts, deconditioning, and further impairment
in absorption of essential nutrients (Rosenthal & Kavic, 2004 [Level VI]).
Thus, early enteral or parental nutritional support is crucial when considering
advance directives.
Reductions with age in the activity of the drugmetabolizing enzyme system
and blood flow through the liver influences the liver’s capacity tometabolize var-
ious drugs (Kane et al., 2004 [LevelVI]; Urden et al., 2002 [LevelVI]). Splanchnic
blood flow is further compromised in states of shock or even mild hypotension.
These changes may predispose older adults to adverse drug reactions (Urden
et al., 2002 [Level VI]). For example, drugs like warfarin, which work directly
on hepatocytes, may reach their therapeutic effect at lower doses (Rosenthal &
Kavic, 2004 [Level VI]). Common pharmacologic agents used in the critical care
setting and their common side effects often experienced by the gerontologic
patient are listed in Table 25.2 (see chapter 12, Preveating Adverse Drug Events).
Finally, many older adults have diabetes and even those older adults with-
out pre-existing diabetes may experience elevated blood glucose levels as a re-
sult of medications and a stress response to critical illness. Studies have shown
that strict control of blood glucose using insulin drips leads to better outcomes,
across ages, in terms of mortality, bloodstream infections, acute renal failure,
blood transfusions needed, and polyneuropathy (van den Berghe et al., 2001
[Level II]). However, glycemic control in the older ICU patient may be more
difficult because of a declining glucose tolerance associated with aging. In light
of an older adult’s susceptibility to iatrogenesis, strict control of the exaggerated
glucose response in this population may prove especially important (Rosenthal,
2004 [Level VI]).
Genitourinary (GU) System
Preservation of the older adult’s preadmission renal status is one of the goals
of ICU care. Age-related renal changes to this system include declines in re-
nal blood flow, glomerular filtration rate (GFR), and creatinine clearance, and
a decreased ability to conserve sodium and excrete hydrogen ions (see Table
25.1) (Nagappan & Parkin, 2003 [Level VI]; Rosenthal & Kavic, 2004 [Level VI];
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25.2 High Risk Medications Commonly Used in OlderICU Patients
Drug
Severity
Rating+ Potential Adverse Effects
*Amiodarone (Cordarone) High May provoke torsades de pointes and QT interval
problems. Lack of efficacy in older adults.
*Clonidine (Catapres) Low Orthostatic hypotension, CNS adverse effects
*Diazepam (Valium) High Increased sensitivity to benzodiazepines; long half-life
in older patients (can be several days); prolonged
sedation; increasing risk of falls/fractures; short- and
intermediate-acting benzodiazepines preferred
Digoxin (Lanoxin) Low Decreased renal clearance may lead to increased risk
of toxic effects; dose should not exceed >0.125 mg/d
except when treating atrial arrhythmias
*Diphenhydramine
(Benadryl)
High Strong anticholinergic effects, confusion, over-sedation;
also can cause dry mouth, urinary retention;
aggravates benign prostatic hypertrophy and
glaucoma; use smallest possible dose
*Ketorolac (Toradol) High Peptic ulceration, GI bleeding, perforation; GI effects can
be asymptomatic
*Meperidine (Demerol) High Active metabolite accumulation may cause CNS toxicity,
tremor, confusion, irritability; other narcotics
preferred
*Promethazine
(Phenergan)
High Highly anticholinergic; confusion, over-sedation; also
can cause dry mouth, urinary retention; aggravates
benign prostatic hypertrophy and glaucoma
Propofol (Diprivan) Unrated Lipophilic drug; decreased clearance in older adults
related to increased total body fat
Cimetidine (Tagamet) and
Ranitidine (Zantac)
Low CNS effects, confusion
*Source: Adapted from Bonk et al., 2006 [Level IV]. Potentially inappropriate medications in hospitalized senior patients.
American Journal of Health System Pharmacists, 63(12), 1161–1165.
Fick et al., 2003. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a U.S.
consensus panel of experts. Archives of Internal Medicine, 163 (22), 2716–2724 [Level VI].
+Severity Rating—Adverse effects of medications rated as high or low severity based on the probability of event occurring
and significance of the outcome (Beers, 1997; Bonk et al., 2006 [Level IV]).
*Identified in Bonk et al., 2006 [Level IV] as seven most commonly prescribed Beers medications used in older hospitalized
patients.
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Urden et al., 2002 [Level VI]). Common age-related changes in the GU system
decrease older adults’ ability to excrete ammonia and drugs, diminish their ca-
pacity to regulate fluid and acid base balance, and often impair their ability to
properly empty their bladder (Nagappan & Parkin, 2003 [Level VI]; Rosenthal
& Kavic, 2004 [Level VI]; Urden et al., 2002 [Level VI]). The coupling of these
common age-related changes with conditions commonly seen in the ICU envi-
ronment such as hypovolemia, shock, sepsis, and polypharmacy render older
adults at increased risk for acute renal failure, metabolic acidosis, and adverse
drug events. The increased prevalence in the older population of asymptomatic
bacteriuria also exacerbates an older ICU patient’s infection risk related to Foley
catheter use (Richards, 2003 [Level VI]).
Nurses must consider older patients’ baseline cardiovascular status relative
to their renal function. If an older patient was typically hypertensive prior to
hospitalization, for example, this patient’s renal vasculaturemay be accustomed
to a higher than normal pressure to perfuse the kidneys. Furthermore, common
indicators of dehydration, such as skin turgor, should be considered an unre-
liable sign in older adults, related to their loss of subcutaneous tissue (Sheehy,
Perry, & Cromwell, 1999 [Level VI]). Although the Cockroft and Gault formula
(see chapter 12, Reducing Adverse Drug Events) has been derived to estimate
creatinine clearance in the healthy aged, care must be taken when applying
this formula to critically ill older patients or to those patients on medications
that directly affect renal function (Rosenthal & Kavic, 2004 [Level VI]). Finally,
nurses should be especially cognizant of medications known to contribute to re-
nal failure including aminoglycosides, certain antibiotics, and contrast dyes, and
closely monitor laboratory results as warranted (Urden et al., 2002 [Level VI]).
Immune/Hematopoietic System
The changes that occur in the aged immune and hematological system mainly
involve altered T and B cell functioning and a decrease in hematopoietic reserve
(see Table 25.1) (Nagappan & Parkin, 2003 [Level VI]; Rosenthal & Kavic, 2004
[Level VI]; Urden et al., 2002 [Level VI]). The consequences of these changes
include an increased susceptibility to infection, increases in auto antibodies
and monoclonal immunoglobulins, and tumorigenesis (Rosenthal & Kavic, 2004
[Level VI]). These common aging changes coupled with the stress, malnutrition,
and number of invasive procedures seen in the critical care environment may
heighten an older adult’s risk for a nosocomial infection. Furthermore, because
an older adult’s ability to mount a febrile response to infection diminishes with
age (related to a decline in hypothalamic function), an older patient may even
be septic without the warning of a fever (Urden et al., 2002 [Level VI]) and
instead may exhibit only a decline in mental status. Close assessment of other
nonfebrile signs of infection (i.e., restlessness, agitation, delirium, hypotension,
and tachycardia) is essential and warranted.
Although recent research suggests that giving blood more liberally to pa-
tients may be associated with worse patient outcomes, these findings may not
necessarily apply to the older adult population for several reasons: (1) the
chronic anemia often seen in aging, (2) the exclusion of many older adults from
previous clinical trials, (3) research findings that suggest higher transfusion
triggers in older patients with acute myocardial infarction actually decreases
mortality, and (4) the association of low hemoglobin levels with increased
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incidence of delirium, functional decline, and decreased mobility (Rosenthal
& Kavic, 2004 [Level VI]).
Skin and Wounds
Older adults are at high risk for skin breakdown in the ICU setting due to loss of
elastic, subcutaneous, and connective tissues; a decrease in sweat gland activity;
and a decrease in capillary arterioles supplying the skin with age (Urden et al.,
2002 [Level VI]) (see Table 25.1). On physical exam, a nurse may observe that
an older adult’s skin has become thin, fragile, wrinkled, loose, or transparent
and is dry, flaky, rough, and often itchy. Older adults’ nails lose their luster, with
hair color and loss also occurring as part of aging (Bates, 1995 [Level VI]).
Because the skin changes that occur in older adults can cause difficulty with
thermoregulation, can heighten the risk for skin breakdown and IV infiltrations,
may delay wound healing, and can make hydration assessment difficult, nurses
shouldmake every effort to prevent heat loss, carefullymonitor hydration status,
and conduct thorough skin assessments (Bates, 1995; Urden et al., 2002 [both
Level VI]) (see chapter 18, Preventing Pressure Ulcers and Skin Tears).
Case Study and Discussion
Ned Saunders is a 71-year-old man who fell off of a ladder while stringing
holiday lights and suffered serious complications, including Adult Respirat-
ory Distress Syndrome (ARDS), after laminectomy. He required a second
back surgery (revision of the laminectomy) during the same hospital stay,
and developed a clostridium difficile (c. difficile) infection and nutritional
problems secondary to the severe diarrhea. Infection with antibiotic-resist-
ant organisms necessitated the use of isolation protocol. Tracheostomy
placement occurred on the 17th ICU day and progressive weaning trials
began.
Preadmission
Mr. Saunders was a former smoker and his past medical history included
mild COPD and hypertension. His medications prior to admission were Al-
buterol inhaler 2 puffs every 6 hours and hydrochlorothiazide 50mgs for
blood pressure. He smoked a half pack per day for 30 years. A retired school
teacher, Mr. Saunders was slightly overweight but active around the house
and enjoyed an active social life, especially dancing with his wife at local
dance halls. He was a “social drinker,” as reported by his wife, having three
to four glasses of wine per week. Mr. Saunders was completely independent
in all activities of daily living before this hospitalization. MMSE score on
admission before surgery was 29. CAM-ICU (for delirium) on admission to
the ICU was positive for delirium.
Psychosocial
Mr. Saunders was unable to focus attention formore than 5 seconds at a time
and was intermittently agitated during the early stages of ICU stay. Delirium
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was treated with around-the-clock dosages of intravenous haldoperidol. He
also received fentanyl patch (dose) for pain and lorazepam (dose and fre-
quency taken) as needed for anxiety/sedation. Efforts were made to mini-
mize and taper the use of the benzodiazepine (lorazepam) in an attempt to
clear the delirium.
Anxiety and communication difficulties were identified by nurses as
problems possibly influencing his “mental state” during ventilator wean-
ing. Communication was inhibited by respiratory tract intubation, cognition
problems, and lack of dentures. Because his thinking was unclear, nurses
used visual cues in the form of written words, gestures, and pictures to
augment their messages to Mr. Saunders. They cued him to use a simple
communication board and asked yes/no questions by categories (e.g., fam-
ily, your body, comfort needs) whenever possible. After the tracheostomy
procedure was completed, his wife was advised to bring in his dentures to
improve lip reading. He began using a tracheostomy speaking valve after
5-1/2 weeks of hospitalization.
The patient’s wife was his sole support. They had no children or close
relatives. A reserved woman, she remained positive when at the patient’s
bedside. Nurses coached her to use touch and encouragement at the bed-
side. Mrs. Saunders asked the therapists to teach her range of motion
exercises and she performed these during afternoon visits. She provided
calm and distracting talk during weaning trials, reading getwell cards from
friends.
Cardiac
Mr. Saunders remained in a sinus tachycardia through most of the hospi-
talization with occasional PVCs. His hemoglobin and hematocrit dropped
to 10/36 after the second back surgery. He received one unit of packed red
blood cells and diuretics before weaning trials were resumed.
Respiratory
Mr. Saunders progressed from dependence on mechanical ventilation in
assist control mode (FiO2 = 40%, CPAP=5, PS=10) to tracheostomy mask
oxygen at 50% FiO2 over a 10-day period. Did he have pain that interfered
with weaning?
GI
Nutritional balance was particularly challenging with Mr. Saunders due to
the impaired absorption of nutrients during C. difficile infection. Nutri-
tion/dietician consult should be obtained. The infection was treated with
intravenous vancomycin.A jejunostomy tubewasplaced for continuous tube
feeding and caloric requirements adjusted frequently with careful attention
to blood albumin levels. Vancomycin drug levels must also be monitored.
Skin
Meticulous attention was given to wound healing at the back surgery site
and fit of “turtle shell” to prevent friction or skin tears.
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Rehabilitation
Mr. Saunders received early physical therapy, beginning as passive range
during the most critical phase of his illness and progressing to active range
of motion and chair sitting. His mobility was limited by the protective turtle-
shell appliance required for healing of his spine during any out of bed activ-
ity. Adaily chair sitting periodwas arranged, requiring coordinationbetween
physical therapy and nursing. The team initiated speech and swallowing re-
habilitation (i.e., speechand swallowing evaluation) beginningwith lollipops
to reestablish swallowing.
Discharge Planning
Mr. Saunders’s progress was slow and respiratory status still tenuous at the
end of his ICU stay. He required significant physical rehabilitation following
his critical illness. A long term acute care hospital (LTACH) was the best
choice for continued care and rehabilitation. As Mr. Saunders’s respiratory
status and speaking ability improved, his anxiety diminished. Because Mr.
Saunders had multiple risk factors for delirium, the exact cause of the delir-
ium was unknown at discharge. Attention to normalizing the fluid and elec-
trolyte balance, re-establishing and maintaining normal sleep–wake cycles,
and gradually withdrawing the use of benzodiazepines continued as care
was transferred to the LTACH. His mental status improved as evidenced
by less frequent periods of inattention and confusion. Short term memory
problems persisted and required frequent cueing and reminders from staff
and his wife.
Conclusion
Nurses in the acute care settingmust recognize and respond to themany factors
that influence a critically ill older adult’s ability to survive and rehabilitate from
a catastrophic illness. To identify some of these risk factors, it is essential that
nurses perform a comprehensive assessment of each older adult’s preadmission
health status, functional and cognitive ability, and social support systems. It is
equally important that nurses understand the implications of common aging
changes, co-morbidities, and acute pathology that interacts with and heightens
the risk for adverse and often preventable medical outcomes. The application of
evidence-based nursing interventions aimed at restoring physiologic stability,
preventing complications, maintaining comfort and safety, and preserving pre-
illness functional ability and quality of life are crucial components of caring for
this extremely vulnerable population.
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Box 25.1
Nursing Standard of Practice Protocol:
Comprehensive Assessment and Management of the
Critically Ill
I. GOAL: To restore physiologic stability, prevent complications, maintain
comfort and safety, and preserve pre-illness functional ability and quality
of life (QOL) in older adults admitted to critical care units.
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II. OVERVIEW: Caring for an older adult who is experiencing a serious
or life-threatening illness often poses significant challenges for critical
care nurses. Although older adults are an extremely heterogeneous group,
they share some age-related characteristics that leave them susceptible
to various geriatric syndromes and diseases. This vulnerability may
influence both their intensive care unit (ICU) utilization rates and out-
comes. Critical care nurses caring for this population must not only rec-
ognize the importance of performing ongoing, comprehensive physical,
functional, and psychosocial assessments tailored to older ICU patients
but also must be able to identify and implement evidence-based interven-
tions designed to improve the care of this extremely vulnerable population.
III. BACKGROUND
A. Definition
Critically ill older adult: a person, age 65 or older, who is currently
experiencing or at risk for some form of physiologic instability or al-
teration warranting urgent or emergent, advanced nursing/medical
interventions and monitoring.
B. Etiology/Epidemiology
1. More than half (55.8%) of all ICU days are incurred by patients
older than 65 (Angus et al., 2000 [Level IV]).
2. Older adults are living longer, are more racially and ethnically
diverse, often have multiple chronic conditions, and more than
one-quarter report difficulty performing one ormore activities of
daily living (ADLs) (Administration on Aging, 2005 [Level IV]).
These factors may affect both the course and outcome of critical
illness.
3. Once hospitalized for a life-threatening illness, older adults of-
ten:
a. Experience high ICU, hospital, and long-term crude mortality
rates.
b. Are at risk for deterioration in functional ability and post-
discharge institutional care (Chelluri et al., 1995 [Level V]).
c. Older age is also a factor that may lead to:
i. Physicianbias in refusing ICUadmission (Joynt et al., 2001;
Mick & Ackerman, 2004 [both Level VI]).
ii. The decision to withhold mechanical ventilation, surgery,
or dialysis (Hamel et al., 1999 [Level III]).
iii. An increased likelihood of an established resuscitation di-
rective (Hakim et al., 1996 [Level III]).
d. Most critically ill older adults:
i. Demonstrate resiliency.
ii. Report being satisfied with their QOL post-discharge.
iii. Would reaccept ICU care and mechanical ventilation if
needed. (Chelluri et al., 1995 [Level V]; Guentner et al.,
2006 [Level IV]; Kleinpell & Ferrans, 2002 [Level IV]).
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e. Chronologic age alone is not an acceptable or accurate pre-
dictor of poor outcomes after critical illness (Chelluri et al.,
1995 [Level V]; Esteban et al., 2004 [Level IV]; Kleinpell, 2003
[Level IV]).
f. Factors that may influence an older adult’s ability to survive a
catastrophic illness include:
i. Severity of illness
ii. Nature and extent of co-morbidities
iii. Diagnosis, reason for/duration of mechanical ventilation
iv. Complications length of ICU/hospital stay
■ Preadmission nursing home residence
■ Pulmonary artery catheterization
■ Prehospitalization functional ability
■ Gender
■ Pre-existing cognitive impairment
■ Delirium
■ Ethnicity
■ Senescence
■ Ageism
■ Decreased social support
■ The critical care environment
Adnet et al., 2001 [Level IV]; Chelluri et al., 1993 [Level IV]; Chelluri et
al., 1995 [Level V]; Djaiani & Ridley, 1997 [Level IV]; Esteban et al., 2004
[Level IV]; Hamel et al., 1999 [Level III]; Kass et al., 1992 [Level IV]; Knaus
et al., 1991 [Level IV]; Mayer-Oakes et al., 1991 [Level IV]; Mick & Acker-
man, 2004 [Level VI]; Nicolas et al., 1987 [Level IV]; Nierman et al., 2001
[Level IV]; Richmond et al., 2002 [Level IV]; Shapira et al., 1997 [Level IV];
Tullmann & Dracup, 2000 [Level VI]; Wu et al., 1990 [Level IV].
IV. PARAMETERS OF ASSESSMENT
A. Preadmission: Comprehensive assessment of a critically ill older
adult’s preadmission health status, cognitive and functional ability,
and social support systems helps identify risk factors for cascade ia-
trogenesis, the development of life-threatening conditions, and fre-
quently encountered geriatric syndromes. Factors that nurses need
to consider when performing the admission assessment include the
following:
1. Pre-existing cognitive impairment: Many older adults admitted
to ICUs suffer from high rates of unrecognized, pre-existing cog-
nitive impairment (Pisani, Inouye et al., 2003 [Level IV]; Pisani,
Redlich, McNicoll, Ely, & Inouye, 2003 [Level IV]).
a. Knowledge of preadmission cognitive ability could aid practi-
tioners in:
i. Assessing decision making capacity, informed consent is-
sues, and evaluation of mental status changes throughout
hospitalization (Pisani, Redlich et al., 2003 [Level IV])
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ii. Making anesthetic and analgesic choices
iii. Considering one-to-one care options
iv. Weaning from mechanical ventilation
v. Assessing fall risk
vi. Planning for discharge from the ICU
b. Upon admission of an older adult to the ICU, nurses should ask
relatives or other caregivers for baseline information about the
older adult’s:
i. memory, executive function (e.g., fine motor coordination,
planning, organization of information), and overall cogni-
tive ability (Kane et al., 2004 [Level VI])
ii. behavior on a typical day, how the patient interacts with
others, their responsiveness to stimuli, how able they are
to communicate (reading level, writing, and speech), and
their memory, orientation, and perceptual patterns prior to
their illness (Milisen, DeGeest, Abraham, & Delooz, 2001
[Level VI])
iii. medication history to assess for potential withdrawal syn-
dromes (Broyles, Happ, Tate, Swigart, & Hoffman, 2005
[Level IV])
c. Developmental and Psychosocial Factors: Critical illness can
render older adults unable to effectively communicate with
the health care team, often related to physiologic instability,
technology that leaves them voiceless, and sedative and nar-
cotic use. Family members are therefore often a crucial source
for obtaining important preadmission information. Upon ICU
admission, nurses need to determine:
i. What is the elder’s past medical, surgical, and psychiatric
history? What medications was the older adult taking be-
fore coming to the ICU? Does the elder regularly use illicit
drugs, tobacco, or alcohol? Do they have a history of falls,
physical abuse, or confusion?
ii. What is the older adult’smarital status?Who is the patient’s
significant other? Will this person be the one responsible
to make decisions for the elder if they are unable to do so?
Does the elder have an advanced directive for health care?
Is the elder a primary caregiver to an aging spouse, child,
grandchild, or other person?
iii. How would the elder describe his/her ethnicity? Do they
practice a particular religion or have spiritual needs that
should be addressed? What was their quality of life like
before becoming ill?
d. Preadmission functional ability/nutritional status: Limited
preadmission functional ability and poor nutritional status are
associated with many negative outcomes for critically ill older
adults (Mick & Ackerman, 2004 [Level VI]; Roche et al., 1999
[Level IV]; Rosenthal & Kavic, 2004 [Level VI]; Tullmann &
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Dracup, 2000 [Level VI]). Therefore, nurses should assess the
following:
i. Did the elder suffer any limitations in the ability to perform
their ADLs preadmission? If so, what were these limita-
tions?
ii. Does the elder use any assistive devices to perform their
ADLs? If so, what type?
iii. Where did the patient live prior to admission? Did they
live alone or with others? What was the elder’s physical
environment like (e.g., house, apartment, stairs, multiple
levels)?
iv. What was the older adult’s nutritional status like pread-
mission? Do they have enough money to buy food? Do
they need assistance with making meals/obtaining food?
Do they have any particular food restrictions/preferences?
Were they using supplements/vitamins on a regular
basis? Do they have any signs ofmalnutrition, including re-
centweight loss/gain,musclewasting, hair loss, skin break-
down?
B. During ICU stay: There aremany anatomic/physiologic changes that
occur with aging (see Table 25.1). The interaction of these changes
with the acute pathology of a critical illness, co-morbidities, and the
ICU environment leads not only to atypical presentation of some of
the most commonly encountered ICU diagnoses but may also ele-
vate the older adult’s risk for complications. The older adult must be
systematically assessed for the following:
1. Co-morbidities/common ICU diagnoses
a. Respiratory: chronic obstructive pulmonary disease, pneumo-
nia, acute respiratory failure, adult respiratory distress syn-
drome, rib fractures/flail chest
b. Cardiovascular: acute myocardial infarction, coronary artery
disease, peripheral vascular disease, hypertension, coronary
artery bypass grafting, valve replacements, abdominal aortic
aneurysm, dysrhythmias
c. Neurologic: cerebral vascular accident, dementia, aneurysms,
Alzheimer’s disease, Parkinson’s disease, closed head injury,
transient ischemic attacks
d. Gastrointestinal: biliary tract disease, peptic ulcer disease,
gastrointestinal cancers, liver failure, inflammatory bowel dis-
ease, pancreatitis, diarrhea, constipation, and aspiration
e. Genitourinary: renal cell cancer, chronic renal failure, acute
renal failure, urosepsis, and incontinence
f. Immune/Hematopoietic: sepsis, anemia, neutropenia, and
thrombocytopenia
g. Skin: necrotizing fasciitis, pressure ulcers
2. Acute Pathology: Thoracic or abdominal surgery, hypovolemia,
hypervolemia, hypo/hyperthermia, electrolyte abnormalities,
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hypoxia, arrhythmias, infection, hypo/hypertension, delirium,
ischemia, bowel obstruction, ileus, blood loss, sepsis, disrupted
skin integrity, multisystem organ failure.
3. ICU/Environmental Factors: Deconditioning, poor oral hygiene,
sleep deprivation, pain, immobility, nutritional status, mechan-
ical ventilation, hemodynamic monitoring devices, polyphar-
macy, high risk medications (e.g., narcotics, sedatives, hyp-
notics, nephrotoxins, vasopressors), lack of assistive devices (e.g.,
glasses, hearing aids, dentures), noise, tubes that bypass the
oropharyngeal airway, poorly regulated glucose control, Foley
catheter use, stress, invasive procedures, shear/friction, intra-
venous catheters
4. Atypical Presentation: Commonly seen in older adults experi-
encing the following: myocardial infarction, acute abdomen, in-
fection, and hypoxia
V. NURSING CARE STRATEGIES
A. Preadmission: Based on their preadmission assessment findings,
nurses should consider:
1. Obtaining appropriate consults (i.e., nutrition, physical/ occupa-
tional/speech therapist)
2. Implementing safety precautions
3. Using pressure-relieving devices
4. Organizing family meetings
5. Providing older adults with a consistent primary nurse
B. During ICU: Nursing interventions that may benefit:
1. Multiple organ systems:
a. Encouraging early, frequent mobilization/ambulation
b. Providing proper oral hygiene.
c. Ensuring adequate pain control.
d. Reviewing/assessing medication appropriateness.
e. Avoiding polypharmacy/high riskmedications (see Table 25.2).
f. Securing and ensuring the proper functioning of tubes/
catheters.
g. Actively taking measures to maintain normothermia.
h. Closely monitoring fluid-volume status.
2. Respiratory
a. Encourage and assist with coughing, deep breathing, incentive
spirometer use; use alternative device when appropriate (e.g.,
PEP).
b. Assess for signs of swallowing dysfunction and aspiration.
c. Closely monitor pulse oximetry and arterial blood gas results.
d. Consider the use of specialty beds.
e. Advocate for early weaning trials and extubation as soon as
possible.
f. Exercise standard VAP precautions (Kunis & Puntillo, 2003
[Level VI]):
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1. Keep the head of the bed elevated to more than 30 degrees.
2. Provide frequent oral care.
3. Maintain adequate cuff pressures.
4. Assess the need for stress ulcer prophylaxis.
5. Turn the patient as tolerated.
6. Maintain general hygiene practices.
3. Cardiovascular
a. Carefully monitor the older adult’s hemodynamic and elec-
trolyte status.
b. Closely monitor the older adult’s EKG with an awareness of
many conduction abnormalities seen in aging. Consult with
physician regarding prophylaxis when appropriate.
c. Advocate for the removal of invasive devices as soon as the
patient’s condition warrants. The least restrictive device may
include long-term access.
d. Recognize that both pre-existing pulmonary disease and ma-
nipulations of the abdominal and thoracic cavities may lead to
unreliability of traditional values associated with central ve-
nous and pulmonary artery occlusion pressures (Rosenthal &
Kavic, 2004 [Level VI]).
e. Because of age-related changes to the CV system, the nurse
should acknowledge (Rosenthal & Kavic, 2004 [Level VI]):
i. Older adults often require higher filling pressures (i.e.,
CVPs in the 8 to 10 range, PAOPs in the 14 to18 range)
to maintain adequate stroke volume and may be especially
sensitive to hypovolemia.
ii. Over-hydration of the older adult should also be avoided
because it can lead to systolic failure, poor organ perfusion,
and hypoxemia with subsequent diastolic dysfunction.
iii. Certain drugs commonly used in the ICU setting may prove
to be either not as effective (e.g., isoproterenol and dobu-
tamine or more effective (e.g., afterload reducers).
4. Neurologic/Pain
a. Closely monitor the older adult’s neurologic/mental status.
b. Screen for delirium and sedation level at least once per
shift.
c. Implement interventions to reduce delirium (Inouye et al., 1999
[Level II]; Jacobi et al., 2002 [Level V]; Milbrandt et al., 2005
[Level IV]; Tullmann&Dracup, 2000 [Level VI]; Yeh et al., 2004
[Level III]; Zeleznik, 2001 [Level VI]):
i. Promote sleep, mobilize as early as possible, review med-
ications that can lead to delirium, treat dehydration, re-
duce noise or provide “white noise,” close doors/drapes to
allow privacy, provide comfortable room temperature, en-
courage family and friends to visit, allow the older adult to
assume the preferred sleeping positions, discontinue any
unnecessary lines or tubes, and avoid the use of physical
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restraints using least restraint for minimum time only when
absolutely necessary.
ii. Maximize older adults’ ability to communicate their needs
effectively and interpret their environment.
■ Promote theolder adultwearing glasses, hearing aids, and
other appropriate assistive devices.
■ Face patients when speaking to them, get their atten-
tion before talking, speak clearly and loud enough for
them to understand, allow themenough time (pause time)
to respond to questions, provide them with a consistent
provider (i.e., a primary nurse), use visual clues to re-
mind them of the date and time, and provide written or
visual input for a message (Garrett & Beukelman, 1995
[Level III]; Lasker, Hux, Garrett, Moncrief, & Eischeid,
1997 [Level III]).
■ Provide older adults with alternate means of communi-
cation (e.g., providing a pen/paper; using nonverbal ges-
tures; and/or using specially designed boards with alpha-
bet letters, words, or pictures) (Connolly, 1995 [Level IV];
Patak, Gawlinski, Fung, & Berg, 2004 [Level IV]; Stovsky,
Rudy, & Dragonette, 1988 [Level III]).
■ Provide translators/interpreters as needed.
d. Provide adequate pain control while avoiding over- or under-
sedation. For a full discussion, see chapter 10, Pain Manage-
ment.
5. Gastrointestinal
a. Monitor for signs of GI bleeding and delayed gastric empty-
ing/motility.
i. Encourage adequate hydration, assess for signs of fecal im-
paction, and implement a bowel regimen.
ii. Avoid use of rectal tubes.
b. Advocate for stress ulcer prophylaxis.
c. Provide dentures as soon as possible.
d. Implement aspiration precautions.
i. Keep the head of the bed elevated to a high Fowler’s position,
frequently suction copious oral secretions, bedside evaluate
swallowing ability by a speech therapist, assess phonation
and gag reflex, monitor for tachypnea.
e. Advocate for early enteral/parental nutrition if consistent with
advace directive.
f. Ensure tight glucose control.
6. Genitourinary (GU)
a. Assess any GU tubes to ensure patency and adequate urinary
output. If an older adult should experience an acute decrease
in urinary output, consider using bladder scanner (if available)
rather than automatic straight catheterization to check for dis-
tension.
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b. Advocate for early removal of Foley catheters. Use other less
invasive devices/methods to facilitate urine collection (i.e., ex-
ternal or condom catheters, offering the bedpan on a scheduled
basis, and keeping the nurse’s call bell/signal within the older
adult’s reach).
c. Monitor blood levels of nephrotoxic medications as ordered.
7. Immune/Hematopoietic
a. Ensure the older adult is ordered appropriate DVT prophylaxis
(i.e., heparin, sequential compression devices)
b. Monitor laboratory results, assess for signs of anemia relative
to patient’s baseline
c. Recognize early signs of infection: restlessness, agitation, delir-
ium, hypotension, tachycardia, because older adults are less
likely to develop fever as a first response to infection.
d. Meticulously maintain infection control/prevention protocols.
8. Skin
a. Conduct thorough skin assessment.
b. Vigilantlymonitor room temperature, make every effort to pre-
vent heat loss, and carefully use and monitor rewarming de-
vices.
c. Use methods known to reduce the friction and shear that often
occurs with repositioning in bed.
d. In severely compromised patients, the use of specialty beds
may be appropriate.
e. Techniques such as frequent turning, pressure-relieving de-
vices, early nutritional support, as well as frequent ambulation
may not only protect an older adult’s skin but also promote the
health of their cardiovascular, respiratory, and gastrointestinal
systems.
f. Closely monitor IV sites, frequently check for infiltrations and
use of nonrestrictive dressings and paper tape.
VI. EVALUATION AND EXPECTED OUTCOMES
A. Patient
1. Hemodynamic stability will be restored.
2. Complications will be avoided/minimized.
3. Preadmission functional ability will be maintained/optimized.
4. Pain/anxiety will be minimized.
5. Communication with the health care team will be improved.
B. Provider
1. Employ consistent and accurate documentation of assessment
relevant to older ICU patients.
2. Provide consistent, accurate, and timely care in response to de-
viations identified through ongoing monitoring and assessment
of older ICU patients.
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3. Provide patient/caregiver with information and teaching related
to their illness and regarding transfer of care and/or discharge.
C. Institution: include QA/QI
1. Evaluate staff competence in the assessment of older critically ill
patients.
2. Utilize unit-specific, hospital-specific, and national standards of
care to evaluate existing practice.
3. Identify areas for improvement and work collaboratively across
disciplines to develop strategies for improving critical care to
older adults.
VII. Relevant Practice Guidelines
Jacobi et al. (2002). Clinical Practice Guidelines for the sustained use
of sedatives and analgesics in the critically ill adult (Jacobi et al.,
2002).Task Force of the American College of Critical Care Medicine
(ACCM) of the Society of Critical Care Medicine (SCCM), American
Society of Health-System Pharmacists (ASHP), and American College
of Chest Physicians
ACC/AHA (2006). Guideline Update on perioperative cardiovascular
evaluation for noncardiac surgery: Focused update on perioperative
beta-blocker therapy. A report of the American College of Cardiol-
ogy/American Heart Association Task Force on Practice Guidelines.
Developed in collaboration with the American Society of Echocardiog-
raphy, American Society of Nuclear Cardiology, Heart Rhythm Society,
Society of Cardiovascular Anesthesiologists, Society for Cardiovascu-
lar Angiography and Interventions, and Society for Vascular Medicine
and Biology.
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Fluid Overload:
Identifying and
Managing Heart
Failure Patients at
Risk for Hospital
Readmission
Jessica Coviello
Deborah A. ChyunEducational Objectives
At the conclusion of this chapter, the reader will be
able to:
1. describe the older adult with heart failure who is at
risk for hospital readmission
2. conduct a comprehensive cardiac history
3. identify three physical findings that may be
associated with fluid overload in an older adult
patient with heart failure
4. name three key symptoms associated with fluid
overload in the older adult patient with heart failure
5. define cardiovascular stability in relation to the five
key indicators
6. plan monitoring strategies to reduce fluid overload
in the older adult with heart failure
Overview
The most common cause of hospital admission in older adults is heart failure
(Funk & Krumholtz, 1996 [Level IV]) and the most common cause for hospital
readmission for the patient with heart failure is fluid overload. The evidence-
based literature indicates that heart failure patients delay seeking medical
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
Adapted from the American Association of Colleges of Nursing, “Preparing nursing students to care for older
adults: Enhancing gerontology in senior-level undergraduate courses” curriculum module, Assessment and
Management of Hypertension and Heart Failure, prepared by Deborah A. Chyun and Jessica Coviello.
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advice despite progressive symptoms; the delay is, on average, anywhere from
12 hours to 14 days (Rich & Kitzman, 2005 [Level VI]). An important focus of
research for the past several years has been to identify patients, particularly
older patients, at risk for readmission. This chapter presents the complex nature
of heart failure and fluid imbalance that places older adults at risk for hospi-
tal readmission due to fluid overload and nursing strategies to reduce hospital
readmission rates. A detailed protocol for practice is presented highlighting the
nursing assessment and management of heart failure.
Background
Cardiovascular disease (CVD), which includes hypertension (HTN) and heart
failure (HF), along with stroke, arrhythmias, valvular heart disease, peripheral
vascular disease (PVD), and coronary heart disease (CHD), are major contrib-
utors to mortality and co-morbidity in older adults, accounting for 40% of all
deaths in those aged 75 to 85 and 48% of all deaths in those 85 and older (Thom
et al., 2006 [Level VI]). Chronic heart failure is the leading cause of hospital ad-
mission in patients older than 65, and readmission rates to acute care facilities
have averaged 17.2% nationally (Funk & Krumholtz, 1996 [Level IV]).
HF is a public health problem affecting more than 5 million Americans
yearly (Thom et al., 2006 [Level VI]). The prevalence of HF increases with age,
and more than 75% of those affected are older than 65. Development of HF
is higher with male sex, lower level of education, low levels of physical activ-
ity, cigarette smoking, overweight, diabetes mellitus (DM), HTN, valvular heart
disease, left ventricular hypertrophy (LVH) and CHD (Ho, Pinsky, Kannel, &
Levy, 1993 [Level II]). The presence of HTN, as an antecedent, occurs in 75%
of individuals with HF (Thom et al., 2006 [Level VI]). Both the incidence and
prevalence of HF continues to increase as the population ages.
Hypertension is the most common cause of HF in patients without CHD,
accounting for 24% of the cases of HF (Ho et al., 1993 [Level II]). HTN is also
extremely common in Type II DM, occurring in 40% to 60% of older adults with
Type II DM (Hypertension in Diabetes Study Group, 1993 [Level II]). Women
with DM are at extremely high risk of developing HF (Levy, Larson, Vasan,
Kannel, & Ho, 1996 [Level VI). Individuals with HTN and DM often develop
diastolic rather than systolic dysfunction (Piccini, Klein, Gheorghiade, & Bonow,
2004 [Level V]).
Risk Factors for Developing HF in Older Adults
Diabetes in particular is an important contributor to HF, with women and those
individuals treated with insulin at the greatest risk. In a sample of older Medi-
care patients with Type II DM, 22% had a diagnosis of HF, and this prevalence
increased with advancing age (Bertoni et al., 2004 [Level VI]). In addition, the
presence of Type II DM is associated with higher HF-related morbidity and
mortality. After myocardial infarction (MI) or coronary revascularization proce-
dures, individuals with Type II DM also have a highmorbidity andmortality due
to a large extent to the development of HF. In a separate analysis of older adult
patients receiving Medicare, the year following an MI, 11% of patients without
DM, 17% of patients with DM on oral agents, and 25% of those treated with
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insulin were admitted for HF (Chyun, Vaccarino, Murillo, Young, & Krumholz,
2002 [Level VI]). Patients at risk for readmission after initial diagnosis for HF
include the following (Chyun et al., 2002; Lewis et al., 2003; Rich & Kitzman,
2005 [all Level VI]):
■ age >70 years
■ newly diagnosed HF
■ hospitalizations for any reason in the last 5 years
■ social isolation
■ HF related to acute MI or uncontrolled HTN
■ history of alcohol abuse
■ HF with acute infection
■ HF with an exacerbation of a co-morbidity
■ history of depression or anxiety
■ noncompliance to diet, fluid intake, or medications
Pathophysiology of Heart Failure
Understanding the pathophysiology of HF provides insight into the rationale
for treatment. Left ventricular (LV) remodeling is dependent on changes in
the myocyte structure and function. These changes occur during compensated
(asymptomatic) as well as decompensated (symptomatic) failure. The change in
structure is dependent on several factors: over expression of neurohormones,
peptides (norepinephrine, angiotensin II, cytokines, vasopressin, aldosterone)
found in HF, which in turn produce increased hemodynamic stress on the left
ventricle, sodium retention, and peripheral vasoconstriction, which then exert
toxic effects on the myocyte leading to fibrosis. These factors are cyclical unless
treated. Untreated, there is further disruption of LV architecture and perfor-
mance. However, timing of treatment is important. Patients who have hadHF for
years prior to the aggressive treatment that is currently available will have high
levels of neurohormone. Although treatment reduces these neurohormone lev-
els, the danger is that without delicate titration ofmedications such as carvedilol
(Coreg), a sudden disruption of long-standing compensatory mechanisms and
a rebound episode of fluid overload can occur.
The standard American College of Cardiology/American Heart Association
Task Force (ACC/AHA) guidelines classifies HF in four stages (Hunt et al., 2005
[Level VI]), as follows:
Stage A is considered a pre heart failure stage or an “at risk” stage. It includes
patients with HTN, atherosclerotic disease, DM, obesity, metabolic syn-
drome, those using cardiotoxic substances (i.e., anthracyclines), or those
with a family history of cardiomyopathy.
Stage B includes individuals with previous MI, LVH and low ejection frac-
tion, and symptomatic valvular disease.
Stage C includes individuals with known heart disease and symptoms—
shortness of breath and fatigue and reduced exercise tolerance—or those
who are now asymptomatic due to treatment.
Stage D includes individuals with refractory HF requiring the use of spe-
cialized interventions and includes patientswithmarked symptoms at rest
despite maximal medical therapy.
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The symptoms of HF are related to impairment to fill the left ventricle (dias-
tolic failure) or due to impairment of the left ventricle to empty (systolic failure).
Atherosclerotic CHD is themost commonetiology ofHF in theUnited States, fol-
lowed closely by HTN alone and valvular disease, although thyroid dysfunction
and excessive alcohol intakemay also lead to HF. In the absence of CVD, systolic
function of the heart remains relatively unchanged in older adults, as does exer-
cise tolerance. However, diastolic function is often impaired even in the absence
of HTN or hypertrophic cardiomyopathy, which are known to contribute to dias-
tolic failure. Diastolic dysfunction is characterized by an exaggerated heart rate
(HR) with activity, which, clinically, is often one of the first signs.
Hypertension, CHD, andhypertrophic cardiomyopathy are all abnormalities
that are exacerbated by tachycardia underscoring the importance of avoiding a
high heart rate in all older individuals. Diastolic abnormalities caused by HTN,
aortic stenosis (AS), or CHD may precipitate HF. Patients with either systolic
or diastolic heart failure are at risk for fluid overload. Although discussed as
two separate entities, many older adults have components of both systolic and
diastolic dysfunction.
Assessment of Heart Failure
For older adults diagnosed with HF, the health history and physical assessment
is directed at monitoring symptoms and assessing cardiovascular function. For
nurses assessing and managing the patient with HF, the recognition of fluid
overload is not always straightforward. Unlike the classic picture ofHF observed
in younger adults, the symptoms of fluid overload can be subtle and elusive
in older adults. Once symptoms become pronounced in an older adult, nurses
have a challenging task to resolve the HF, especially if it is of a long-standing
duration. Monitoring parameters must be established in which the patient and
nurse actively identify subtle changes and seek intervention as early as possible
(Coviello, 2004 [Level VI]).
The Health History
HF has both a symptomatic and a nonsymptomatic phase. When symptoms
occur, they are related to intravascular and interstitial fluid overload and/or
inadequate tissue perfusion during exertion. HF in older adults is often inade-
quately recognized and treated. Both patients and providers frequently attribute
symptoms of fluid overload to aging. Older adult responses to HF medications
and treatment are variable. In addition, other drugs commonly used in this age
group, such as nonsteroidal anti-inflammatory agents, can actually exacerbate
fluid overload by increasing sodium retention.
HF is a pathophysiologic process in which left ventricular dysfunction oc-
curs independently from symptom development. Symptom expression is de-
pendent on compensatory mechanisms and the length of time HF has been
present. Patients with acute HF, as seen with MI, may be more symptomatic
because their compensatory mechanisms have not fully developed. In compar-
ison, patients with long-standing HF may have severe dysfunction but may not
become symptomatic at all until they eat a high sodium meal and develop fluid
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overload rapidly, oftentimes overnight. In this case, compensatory mechanisms
are now exhausted and, as a result, fail. The window of opportunity to success-
fully intervene is narrow as is the margin of error. Treatment for fluid over-
load in this case must be swift and brisk but gentle enough to maintain blood
pressure (Coviello, 2004 [Level VI]). Nurses need to be aware of the impor-
tance of both early recognition and early intervention in the patient with fluid
overload. A few hour delay in providing treatment can mean the difference be-
tween successful management at home and hospital admission with variable
outcomes.
Knowledge of the past medical history will help to anticipate problems re-
lated to other conditions, because their presence may complicate assessment
andmanagement of HF. Cardiac risk factors; levels of physical activity; and con-
trol of lipids, HTN, obesity, DM, and smoking need to be determined. Nurses
should routinely ask questions related to activity-limiting dyspnea. A key indi-
cator in establishing a baseline for functional capacity is to ask patients what
their maximal asymptomatic activity is now, what it was 6 months ago, and what
it was 1 year ago. Other important questions include “How far can you walk
without getting short of breath?,” “What is the activity that commonly produces
shortness of breath?,” and, “Do you experience shortness of breath at rest?”
Repeating these questions in subsequent interviews will help monitor changes
in activity associated with treatment or with suspected fluid gain. Is the pa-
tient physically capable of performing activities of daily living (ADLs)? Previ-
ous questions related to cardiovascular functional capacity may have already
provided some information, but additional information on musculoskeletal and
neurologic function is important.
Assessment of additional symptoms is also important. Orthopnea is themost
sensitive and specific symptom of elevated filling pressures, and it tends to re-
liably parallel filling pressures in patients with this symptom (Grady et al., 2000
[Level VI]; Stevenson & Perloff, 1989 [Level II]). Nocturnal or exertional cough
is often a dyspnea equivalent and should not be confused with the cough from
an angiotensin converting enzyme (ACE) inhibitor, which is not associated with
activity or position. Individual patients generally exhibit reproducible patterns
of fluid overload. These should be documented, made available to all on the
care team, and used in patient education and subsequent monitoring. Questions
related to symptoms and function should be part of not only the initial assess-
ment but also of subsequent visits as a means of surveillance (Grady et al., 2000
[Level VI]).
The clinical presentation of HF may include various symptoms reflective
of pulmonary congestion and decreased cardiac output, which are important
health history questions to include and/or observe during the health encounter.
Although thepresence of any one symptom is sufficient towarrant consideration
of HF when they occur with other physical findings, orthopnea, paroxysmal
nocturnal dyspnea, and progressive dyspnea on exertion are virtually diagnostic
of fluid overload.
The presence of other co-morbidities among older adults, such as DM, renal
dysfunction, and liver disease, along with systemic physiologic changes associ-
ated with aging, further complicate the assessment and management of HF in
older adults. Co-morbidities should also be carefully assessed by reviewing lab-
oratory data. DM may necessitate monitoring of blood glucose because wide
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variations in glucose can affect ischemic threshold. Renal and liver disease may
affect pharmacodynamics of drugs used to treat HF. Anemia, a commonmedical
condition in older adults, affects oxygenation, activity tolerance, and subsequent
fluid balance. The presence of the co-morbidity chronic obstructive pulmonary
disease (COPD) may necessitate special precautions when assessing and man-
aging oxygen therapy and use of beta-blockers.
Because overuse of salt in the diet may precipitate fluid overload, a compre-
hensive dietary history is absolutely essential. Nurses should include specific
questions concerning the additional use of salt or salt substitutes and review
with older adult patients those foods high in sodium. For instance, important
dietary questions related to use of canned products or deli meats that contain
higher amounts of sodium should be included. A list of the sodium and potas-
sium content of a variety of foods, including fruits and vegetables, can be helpful
in providing the information necessary for a patient to make appropriate daily
choices. Because assessment of nutritional status is critical to elicit accurate
fluid and sodium intake, it is prudent in the acute care setting for older adults
to have a dietary consultation. Additionally, because cachexia is a harbinger of
a downward spiral in patients with HF, questions need to be included on the
health history related to appetite and weight loss.
Current prescription and over-the-counter (OTC)medications should be as-
sessed, along with any alternative therapies. Many older adults who are eligible
for aspirin, beta-blockers, and ACE inhibitors do not receive these medications,
despite the important role that these agents have in reducing CHD-relatedmor-
bidity and mortality.
Included in the health history should be questions related to medication
adherence and the patient’s decision to either take or not take medications.
Understanding a patient’s rationale to selectively not take certain medications
at certain times will help reveal ways for the nurse to intervene. Patients may
wish to adjust their diuretic dose so that they can function socially during the day.
This is not a compliance issue but rather a sound decision based on a patient’s
rationale as to how to fit the medication regimen into his or her lifestyle. The
interview can reveal if “nonadherence” has a rationale or not. If a cause is not
found, other issues need to be explored, such as cost, number of medications,
and/or frequency of the doses. Ways to simplify the drug regimen should be
explored.
Psychosocial factors, personal beliefs and behaviors, and environmental
along with cultural influences all contribute to management of chronic disease.
The importance of depression and social support has been well documented
in older adults; therefore, all of these factors need to be assessed. The nurs-
ing assessment in individuals with HF should identify the individual’s response
to treatment, which can then be used to assist the individual in subsequent
management of symptoms and the underlying condition, health-promotion and
disease-prevention activities, and chronic disease management. Awareness of
patients’ own perception of why they sought medical care and a detailed anal-
ysis of the symptoms will assist in assessing individuals’ or caregivers’ ability
to identify symptoms; their knowledge regarding their condition, its prognosis,
general health beliefs; and their prior ability to manage this or other medical
conditions.
Fluid Overload: Identifying and Managing Heart Failure Patients 601
The Physical Assessment of an Older Adult
with Fluid Overload
Physical assessment of the patient with suspected fluid overload includes in-
spection, palpation, and auscultation of the peripheral vasculature, heart, lungs,
and abdomen. Orientation, functional limitations, and mental status are exam-
ined as well as vital signs, including height and weight.
A patient’s height and baseline weight are important indicators of both nu-
tritional and fluid status. Weights should subsequently be taken daily by the
patient, typically the first thing in the morning upon arising, before breakfast,
and with no clothes or wearing light clothing to avoid false fluctuations. This
provides the best baseline for the day. A 2-pound weight gain overnight or a
3-pound weight gain in a week is an indication that medical management must
change. Measurement of an older adult’s waist circumference is also important
to determine at baseline because many times this is the location for fluid ac-
cumulation (Coviello, 2004 Level VI]). Once height and weight are measured, a
body mass index (BMI) should be calculated. Research has shown that higher
BMIs (25 to 30 kg/m2) are associated with longer survival (Anker et al., 2003;
Davos et al., 2003; Horwich et al., 2001; Lavie, Osman, Milani, &Mehra, 2003 [all
Level VI]).
A thorough evaluation of the blood pressure (BP) should be performed. Var-
ious environmental factors can influence BP determination; therefore, the room
should be of a comfortable temperature, the patient as relaxed as possible, and a
5-minute rest provided before taking the first reading. Clothing that covers the
area where the cuff will be placed should be removed and the individual should
be seated comfortably, with legs uncrossed and the back and arm supported.
The middle of the cuff on the upper arm should be at a level of the right atrium
(Pickering et al., 2005 [Level VI]). The initial BP reading should be taken in
both arms. Proper cuff size is critical to obtaining an accurate measurement be-
cause many individuals are obese with large arm circumference; bladder length
should be 80% of the arm circumference and width at least 40%. The midline of
the bladder should be placed above the brachial artery, 2 to 3 cm above the ante-
cubital fossa, where the artery should have first been palpated. When using the
auscultatory method, which remains the “gold standard” for BP measurement,
palpating the radial pulse first while inflating the cuff will identify the point at
which the pulse disappears. For the subsequent auscultatory measurement, the
cuff should then be inflated to at least 30 mm Hg above this point. The rate of
deflation is also extremely important with a rate of 2 to 3 mm Hg per second
recommended. The first and last audible sounds are the systolic BP (SBP) and
diastolic BP (DBP), respectively. Two readings, taken 5minutes apart, should be
averaged and if there is a >5 mm Hg difference, additional readings should be
obtained.
Pseudohypertension is a phenomenon resulting from noncompressibility of
thickened arteries and, if not recognized, will result in the recording of falsely
high BP when indirect methods are used. This tendency for peripheral arteries
to become rigid with aging may result in a need to increase cuff pressure in
order to compress the artery. This is common in older adults, particularly in
men or those with HTN or stroke. If suspected, an intra-arterial reading must
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be obtained to avoid over-medication with antihypertensives. Older adults are
also more likely to exhibit “white-coat” HTN, in which the BP may be elevated
over 140/90mmHg in the presence of a health careworker and an actual reading
at home is usually 135/85mmHg. Isolated systolic hypertension is also common
in older adults and is defined by a SBP > 140 and DBP < 90 mm Hg. Therefore,
assessment of the BP not only requires careful attention to technique but also
consideration of the physiologic abnormalities associated with aging.
In addition, the standing BP should be assessed because older adults have a
tendency for postural hypotension. Orthostatic hypotension is diagnosed when
the SBP falls by at least 20 mm Hg or the DBP by 10 mm Hg within 3 minutes.
The presence of orthostatic hypotension may also reveal early dehydration in
a patient who is usually otherwise stable (Sansevero, 1997 [Level VI]). Because
dehydration is the second most common admission for an older adult with HF,
standing BPs should be part of the routine assessment. In addition, patients
should be assessed for dehydration whenever a condition exists in which fluid
loss could occur. This includes not only with vomiting or diarrhea but also with
diaphoresis due to extremes in temperature and humidity.
Inspection is the first step of the physical assessment. General inspection
of the periphery includes the following:
■ Observing color of the skin and mucous membranes.
■ Inspecting the patient’s nails, including nail beds, and the angle between
the base of the nail and the skin of the cuticle (normally <160 degrees).
An angle of 180 degrees is called “clubbing”: the distal phalanx appears
rounded. Clubbing is associated with chronic hemoglobin desaturation.
■ If cachetic, check dependent areas for decubiti.
Palpation of the extremities occurs following inspection of the skin, color,
and turgor as well as the color of the nail beds. Capillary refill of the nail should
be assessed by compressing the nail for 2 to 3 seconds and then releasing. Note
the time elapsed until the original color returns. Normally, the nail bed is pink
and capillary refill occurs within 2 to 3 seconds. A pale or cyanotic nail with
delayed capillary refill may indicate decreased peripheral perfusion. The pe-
ripheral pulses should be palpated bilaterally, including radial, femoral, pedal,
and posterior tibial pulse. Note pulse rate, rhythm, and symmetry.
The presence of peripheral edema, a symptom that can be related to fluid
overload from cardiac, renal, or peripheral vasculature disease, should be evalu-
ated. Edema can also occur in response to calcium channel blockers. Dependent
parts of the body such as the feet, the ankles, and the sacrum are the most likely
locations to find edema. The presence and location of edema and whether it
is pitting or nonpitting should be assessed. Depress an edematous area over a
bony prominence for 5 to 15 seconds, then release. The grading scale for edema
is as follows:
0 = no pitting
1+ = trace
2+ = moderate, disappears in 10 to 45 seconds
3+ = deep, disappears in 1 to 2 minutes
4+ = very deep, disappears in 3 to 5 minutes
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Respiratory rate and effort should be assessed prior to auscultation of the
lungs. If possible, oxygen saturation during rest and activity should be recorded.
Patients whose oxygen levels desaturate during activity may require oxygen
support at home. In addition, surveillance of oxygen saturation during sleep
may be required if the patient or family reports difficulty with sleep at night. It
is not uncommon to see sleep apnea in patients with HF (Arzt & Bradley, 2006
[Level III]; Cormican & Williams, 2005 [Level V]; Kaneko et al., 2003 [Level
II]; Lanfranchi et al., 2003 [Level VI]; Mansfield et al., 2003 [Level III]). Use
the diaphragm of the stethoscope to assess the lungs. Listen in all the lobes for
diminished sounds, crackles,wheezes, or rhonchi. Lung sounds are an important
part of the assessment, particularly in patients with a history of HF.
The cardiovascular assessment begins with checking the apical pulse loca-
tion, pulse rate regularity, fullness, and amplitude noted. Heart sounds should
be ascertained with both the diaphragm and the bell of the stethoscope. Note
the presence of S1 and S2 and of extra sounds, S3, S4, murmurs, clicks, or rubs.
If extra heart sounds are present, also examine the carotid arteries by listening
on both sides of the neck with the bell. Bruits sound like murmurs so it is impor-
tant to differentiate between the two. Some aortic murmurs will radiate into the
neck. Always listen to the heart before listening for extra sounds in the neck. In
addition, the carotids should not be palpated bilaterally because this can lead
to dysrhythmias and decreased blood flow to the brain.
Jugular veins are assessed with the patient in supine, semi-Fowler’s, and
Fowler’s position. With the patient’s head in straight alignment, observe the
jugular neck veins for the presence of distention. In the absence of pathology,
the vein distention is not present. Jugular venous distention provides the most
sensitive sign of elevated filling pressures and is present with fluid overload,
cor pulmonale, or high venous pressure (Grady et al., 2000 [Level VI]).
The abdomen should then be examined. First, determine if the abdomen
is soft and nontender. A protuberant abdomen with bulging flanks suggests the
possibility of ascitic fluid. Because ascitic fluid characteristically sinkswith grav-
ity while gas-filled loops of bowel float to the top, percussion gives a dull note in
dependent areas of the abdomen. Look for such a pattern by percussing outward
in several directions from the central area of tympany. Map the area between
tympany and dullness. To palpate the liver, place your hand behind the patient,
parallel to and supporting the right 11th and 12th ribs and adjacent soft tissues
below. Remind the patient to relax. By pressing your left hand forward, the pa-
tient’s liver may be felt more easily by the other hand. Patients who are sensitive
to palpation can rest their hand on your palpating hand. Note any tenderness. If
at all palpable, the edge of the liver is soft, sharp, and regular. The liver can be
enlarged with HF. To assess, place the patient in a semi-Fowler’s position at the
highest level at which the jugular neck pulsations remain visible. Firmly apply
pressure with the palmar surface of the hand over the right upper quadrant of
the patient’s abdomen for 1minute. A 1-cm rise in the jugular pressure confirms
the presence of fluid overload. A hepatojugular reflux may be associated with
or without tenderness. Patients may also complain of a feeling of fullness.
The neurological assessment is often overlooked; however, changes in heart
rate and rhythm, a decrease in cardiac output, and side effects of cardiac medi-
cations may cause significant changes in mental status. Questions about the pa-
tient’s mental status help assess orientation, mentation, and function. Because
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depression is common among both older adults and the chronically ill, signs
of depression should be assessed. Examples include feelings of hopelessness
and sadness (also see chapter 5, Depression). Nurses can observe and assess a
patient’s mood, thought processes, thought content, abnormal perceptions, in-
sight, judgment, memory, and retention. The time, the day, and the year, as well
as orientation to place, should be included. Memory of hospitalization, teaching
that occurred while hospitalized, and subsequent events post-discharge can be
addressed depending on whether a patient is hospitalized or being seen as an
outpatient (Bennett & Sauve, 2003 [Level VI]; Coviello, 2004 [Level VI]).
To summarize, the physical examinationfindings consistentwithHF include
the following:
■ Hepatomegaly/splenomegaly
■ Jugular venous distention (JVD)
■ Hepatojugular reflux
■ Basilar crackles, bronchospasm, and wheezing
■ Presence of S3 or S4; heart murmur
■ Displaced apical impulse
■ Elevated heart rate and BP
■ Cool extremities
Laboratory and Diagnostic Studies
The initial laboratory evaluation of patients presenting with symptoms of HF
should include complete blood count, urinalysis, serum electrolytes including
calcium and magnesium, blood urea nitrogen, serum creatinine, fasting blood
glucose, glycosylated hemoglobin A1c (HbA1c), lipid profile, liver function tests,
and thyroid stimulating hormone. B-type natriuretic peptide (BNP) can be use-
ful in the evaluation of symptomatic patients presenting in the urgent care set-
ting in whom the clinical diagnosis of HF is uncertain. A baseline BNP in the
patient with a confirmed diagnosis of HF can provide a yardstick to measure
both the presence of fluid overload and response to therapy (Wang, Fitzger-
ald, Shulzer, Mak, & Nyas, 2005). Review of diagnostic tests results is important.
Electrolyte abnormalities are common in older adults, particularly in individuals
on chronic diuretic therapy. Renal function as well as electrolyte levels should
remain current and repeated whenever a patient has to increase diuretic ther-
apy for longer than 3 days due to fluid overload. Anemia is frequently observed
and may contribute to hypoxia, myocardial ischemia, and fluid overload. Car-
diac enzymes assist in determining the presence of acuteMIwhen an acute fluid
overload event occurs. This is not an uncommon occurrence in older adults who
may have a MI in the total absence of symptoms or with atypical symptoms.
A 12-lead electrocardiogram (ECG) and chest x-ray (PA and lateral) should
be performed initially in all patients presentingwith symptoms ofHF. A baseline
ECG is vital so that ST and T waves, axis changes, prolongation in PR, and QRS
and QT intervals can be assessed in response to medications and ongoing is-
chemia. A new-onset arrhythmia heralded by an episode of fluid overload is not
uncommon. HF can cause a stretch of the atrium, which in turn can lead to atrial
fibrillation, which is common in patients with CHF. Two-dimensional echocar-
diography with Doppler should be performed during the initial evaluation to
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assess left ventricular ejection fraction (LVEF), LV size, wall thickness, and valve
function. Radionuclide ventriculography can be performed to assess ventricu-
lar volumes, LVEF, and myocardial perfusion abnormalities. Cardiac catheteri-
zation should be performed on patients presenting with symptoms of HF who
have angina or significant ischemia or who have known, suspected, or are at
high risk for CHD, unless the patient is not eligible for revascularization of any
kind.
Holter monitoring may be considered in patients presenting with HF who
have a history of MI and/or syncope and are being considered for an electro-
physiology study to document inducibility of ventricular tachycardia. In ad-
dition, other candidates for electrophysiology include those with an LVEF of
30% or less with a QRS complex duration that exceeds 0.12 ms. Patients who
meet the criteria may receive a dual chamber pacemaker in combination with
an automatic implantable defibrillator in order to prevent sudden death from
arrhythmia, as well as improve left ventricular function (Hunt et al., 2005
[Level VI]).
Interventions and Care Strategies
Initial goals in the acute management of HF are to alleviate symptoms and im-
prove oxygenation, improve circulation, and correct the underlying causes of the
HF. Longer term goals are to improve exercise tolerance and functional capac-
ity, reduce readmission rates, and decrease mortality. The management of HF
follows standard ACC/AHA Task Force expert consensus recommendations, in-
cluding intensive treatment of coexistent hypertension, CHD, and renal disease
(Hunt et al., 2005 [Level VI]). Importantly, optimal treatment of HTN is critical
to both the prevention and treatment of HF. Although the level at which medi-
cation should be started is still debated (Chobanian et al., 2003 [Level VI]), the
BP should be reduced to below 130/80 mm Hg.
There are key prognostic indicators of 4-year mortality for older adults di-
agnosed with HF. Patients with renal dysfunction, pulmonary disease, a BMI of
<25 kg/m2, diabetes, hypertension, and cancer, as well as those who continue to
smoke, have a greater risk of mortality. Those with a functional deficit in ADLs
and IADLs (e.g., difficulty bathing, managing finances, walking several blocks,
or pushing or pulling heavy objects) combined with one or more of these factors
are at greater risk for mortality. A chart review and history during hospitaliza-
tion should then include not only the standard accepted cardiac risk factors but
also the key indicators as listed herein. Detecting these additional prognostic
indicators can aid in developing interventions that can affect quality of life and
survival (Lee, Lindquist, Segal, & Covinsky, 2006 [Level III]). Goals for therapy
should include reaching goals for fasting blood sugar and HbA1c, BP, choles-
terol, and HF therapy through the use of evidenced-based standards of care.
In Stage A HF, hypertension and lipid disorders are treated appropriately,
and smoking cessation is encouraged, as is regular exercise.Metabolic syndrome
is controlled and use of alcohol intake and illicit drug use is discouraged. ACE
inhibitors or angiotensin receptor blockers (ARBs) are used to treat patients
with vascular disease or in those with DM. In Stage B, these same measures are
used, with ACE inhibitors, ARBs, and beta-blockers used in certain patients. In
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Stage C, dietary sodium restriction is added to this regimen and diuret-
ics are added to treat fluid retention, along with ACE inhibitors and beta-
blockers. In certain patients, aldosterone antagonists, ARBs, digitalis, and hy-
dralazines/nitrates are added. These patients my also require a pacemaker
or implantable defibrillators to treat arrhythmias. In Stage D, end-of-life
care/hospice care is initiated, and the use of extraordinary measures such as
heart transplantation, chronic inotrope therapy, permanentmechanical support,
and experimental drugs or surgery is considered. Nurses have an important role
in assisting individuals and their caregivers in understanding the disease pro-
cess and treatment options, including end of life care.
Open and honest discussion regarding the chronic, progressive nature of
HF must begin early in the disease process because the natural history of HF
involves declining physical as well as psychological functioning. Although de-
pression is commonly seen in older adults, aswell as individualswith CVD, there
are few studies that have addressed this important problem in an older adult
with HF (Lane, Chong & Lip, 2006 [Level I]). Because pharmacotherapy and
behavioral interventions have demonstrated effectiveness, all older individuals
should be screened for depression and treated appropriately. Early discussions
related to the goals of care and advanced directives with frequent revisiting of
patient understanding of the disease course and patient preferences as the ill-
ness progresses ensures patient participation in decision making. This is best
done utilizing a multidisciplinary team approach where not only the caregivers
and the patient/family unit are involved but there is also a spiritual and/or a
psychological representative.
The benefits of the multidisciplinary team to provide care to HF patients
have been discussed for the last several years. In most cases, they have been
related to the use of the team approach to help keep patients stable in order
to prevent hospital readmissions (Barrella & Monica, 1998 [Level V]; Naylor et
al., 1994 [Level II]; Rich et al., 1995 [Level V]; Rich & Neese, 1999 [Level II];
Simon, Vandenbroek, Pearson, & Horowitz, 1999 [Level VI]). Comprehensive
transitional care interventions have been shown not only to reduce costs and
cardiac outcomes but also to have a beneficial effect on hospitalization for co-
morbid conditions (Naylor et al., 2004 [Level II]). In the case of the patient
in end-stage HF, a multidisciplinary team either for in-patient or outpatient
management can provide cost effective service providing patients with their last
wishes in the environment that they choose (Coviello, 2004; Coviello, Borges, &
Masulli, 2002 [both Level VI]).
Once the initial history and physical assessment have been completed, an
individualized care plan to monitor and treat fluid overload should be imple-
mented. A 2-poundweight gain overnight or a 3-poundweight gain in the course
of a week is reason to alter diuretic dosage for up to 3 days. If patients return
to baseline weight before the 3-day period, they may reduce their dose back
to the standard daily dose (Coviello, 2004 [Level VI]). Patients can be taught
how to regulate their diuretic doses based on their symptoms and weight. The
nurse and patient can construct a self-care algorithm that gives them a sound
“recipe” to follow if fluid overload occurs. The important factor is early recog-
nition and swift, brief action. Clear guidelines as to when to contact caregivers
should also be provided. Consideration should be given to the patient’s baseline
functional capacity, as well as renal function. Diuretics are used in both systolic
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and diastolic HF to relieve congestive symptoms by promoting the excretion of
sodium and water and by decreasing cardiac filling pressures, thereby decreas-
ing preload. They should be used cautiously with diastolic dysfunction, where
maintaining an adequate cardiac output is heavily preload dependent, to avoid
syncope, falls, or confusion.
A double dose of oral diuretics for up to 3 days is usually well tolerated in
both systolic and diastolic HF.When diuretics are used, serum-potassium levels
should be monitored due to an increased risk of hyperkalemia with potassium-
sparing agents and of hypokalemia with loop diuretics. Patients should be fore-
warned about signs of hypokalemia, such as profound weakness. Loop diuretics
may be useful for patients who are volume sensitive or who have a tendency
to retain fluid because of renal impairment. Aldosterone antagonists prevent
hypokalemia resulting from loop diuretics; however, serum-potassium levels
should be monitored due to an increased risk of hyperkalemia, as well as when
ACE inhibitors are used. However, recent evidence suggests that many individ-
uals, particularly African Americans, may still require potassium supplemen-
tation (Cavallari et al., 2004 [Level IV]). In addition, dehydration is a signifi-
cant problem in older adults taking diuretics and appears to be an even greater
concern in African Americans (Lancaster, Smiciklas-Wright, Heller, Ahern, &
Jensen, 2003 [Level IV]), making assessment of hydration status an important
nursing concern (Sansevero, 1997 [Level VI]).
Use of diuretic agents increases the risk for sudden loss of urinary control
(i.e., urinary incontinence) in older adults, a very common, potentially reversible
geriatric syndrome (formore information, visit www.ConsultGeriRN.org and se-
lect Try This: Urinary Incontinence Assessment). Practice with an older-adult
population requires frequent monitoring and detection of symptoms related to
the onset of urinary incontinence, which is often signaled by symptoms of uri-
nary frequency, urgency, or nocturia. These symptoms may actually be present
in an older adult fromother coexisting problems.Nocturia is particularly evident
in patients with heart disease, as when supine an increase in vascular return
can precipitate a need to get up frequently at night to urinate. With nocturia
comes the possibility of an older adult incurring a nighttime fall. Preexisting
co-morbidities such as visual impairment or osteoarthritis of the hip and knees
make timing to the bathroom facilities a factor in the prevention of such events.
Overall, management considerations for older adults with heart disease and the
new development of urinary incontinence or falls include reevaluation of med-
ication regimen, activity considerations, and the use of additional adaptive aids
to help ensure the avoidance of such preventable events. Use of a nighttime
bedpan or urinal, frequent toileting rounds, and reduction of nighttime fluids
all are possible worthwhile solutions.
Because of their negative chronotropic effect, beta-blockers are useful in
the management of diastolic HF, thereby decreasing heart rate and increasing
time for diastolic filling. More recently, beta-blockers have been shown to be
beneficial in the treatment of systolic HF, where they are usually begun af-
ter symptoms have resolved; however, these agents should be initiated at low
doses. Use of beta-blockers in combination with ACE inhibitors has demon-
strated both an improvement in LVEF and functional capacity once titrated to
tolerance. Although beta-blockers may potentially worsen insulin resistance,
mask hypoglycemia, or aggravate orthostatic hypotension in older individuals
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with DM, these agents have been shown to contribute to improved outcomes.
Therefore, careful monitoring and treatment for these effects are required.
Digoxin increases contractility and decreases heart rate. It is not used rou-
tinely with diastolic failure; however, it may be useful in those patients with
persistent symptoms despite diuretic and ACE inhibitor therapy and in those
who also have atrial fibrillation. Assessment should bemade for digoxin toxicity
as well as for interactions with quinidine, amiodarone, verapamil, and vasodila-
tors; hypokalemia should be avoided. Other medications that have a positive
inotropic effect are dopamine and dobutamine. Both of these drugs can im-
prove contractility and subsequent cardiac output; however, they also increase
myocardial oxygen demand. Amiodarone and milrinone are phosphodiesterase
inhibitors that have been shown to be beneficial in the management of hospi-
talized patients with HF, providing a positive inotropic effect, as well as a va-
sodilation (see chapter 12, Reducing Adverse Drug Events, for potential sequelae
to several CV medications).
Vasodilators are also useful in the treatment of systolic and diastolic failure
through reduction in preload. As with diuretics, they should be used cautiously
in those with diastolic HF. Hydralazine and isosorbide reduce both preload and
afterload, relieving symptoms and improving exercise tolerance. This combi-
nation is commonly used when patients do not tolerate ACE therapy. In addi-
tion, recent studies have shown the combination is more effective in reducing
morbidity and mortality in African Americans (Taylor et al., 2004 [Level II]).
Morphine sulfate, often used in an emergent situation, also has a peripheral va-
sodilating effect and is useful with pulmonary edema or in patients with breath-
lessness at end of life.
With appropriate titration of these medications, an improvement in both
left ventricular function and functional capacity can be achieved. Medications
to treat HTN and lipid abnormalities may not be well tolerated and the potential
for side effects and drug interactions is increased in the setting of polypharmacy.
Both antihypertensive agents and lipid-lowering agents should be used in the
lowest doses possible to bring about the desired goal for treatment.
Patients and caregivers need to understand the warning signs of HF and
recurrentMI such as chest pain, pressure, shortness of breath, indigestion, nau-
sea, dizziness, palpitations, confusion, weakness, and weight gain. A clear plan
for obtaining immediate medical attention should be developed. This is espe-
cially important if an older person lives alone; some type of “medical alert”
system may be needed. Understanding and the ability to follow the medica-
tion regimen is paramount; therefore, a thorough assessment of the patient and
their caregivers is vital. The older individual may be on multiple medications
and the schedule may be confusing. The need to maintain cardiac medications
must be stressed and the risk of the patient abruptly discontinuing beta-blocker,
nitrates, and antiarrhythmics must be assessed. All medications should be re-
viewedwithpatients and their caregivers, stressing desired effects, commonside
effects, and possible interactions with OTC medications (for more information,
visit www.ConsultGeriRN.org and select Geriatric Topics “Medication”). Nurses
should also review what to do if medications are accidentally omitted or become
too costly to maintain. Long-term management of HF requires a multidisci-
plinary team approach (Phillips et al., 2004) and diseasemanagement programs
have been effective in reducing readmission rates (Gonseth, Guallar-Castillon,
Banegas, & Rodriguez-Artajo, 2004 [Level I]). Furthermore, even though many
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of these individuals are debilitated, exercise training has been shown to im-
prove functional ability (McKelvie et al., 2002 [Level II]; Piepoli, Davos, Francis,
Coats, & Collaborative, 2004 [Level I]; Rees, Taylor, Singh, Coats, & Ebrahim,
2006 [Level I]).
Medication titration for HF, coupled with activity progression, can enhance
a patient’s activity capacity. An active patient may notice early signs of fluid
overload; therefore, questions related to activity tolerance can provide insight
for nurseswhomonitor a patient. Patients with gradual fluid gainwill first notice
a change in their level of fatigue, which will translate into a change in their
daily routine. Previous experience with fluid overload will also reveal to the
nurse the patient’s own unique signs and symptoms because not every patient
has the same indicators. It is important to not only assess these factors directly
with patients during the interview but also to reinforce that these symptoms are
important for patients to monitor as well (Coviello, 2004 [Level VI]). In addition
to changes in weight, deviation from the baseline functional ability may be an
early clue, even before peripheral edema or lung congestion appears.
The prevention and treatment of HF in patients with DM requires optimal
management of coexistent HTN, CHD, and left ventricular dysfunction. Addi-
tionally, control of hyperglycemia is an important issue because the presence of
HF affects the choice of medications used to treat Type II DM. Although insulin
and insulin secretagogues are considered safe for use in individuals with HF,
metformin and thiazolidinediones (TZDs) are not recommended in individuals
with moderate-to-severe HF, even though recent data suggest that they may
lower the risk of death (Masoudi et al., 2005 [Level IV]). Decreased clearance of
metformin in individuals with HF due to hypoperfusion or renal insufficiency
can lead to potentially dangerous lactic acidosis. TZDs are sometimes associ-
ated with fluid retention, pedal edema, and weight gain, particularly when used
in conjunction with insulin, and occasionally contribute to HF. However, this is
relatively infrequent, usually occurring with higher doses, concomitant insulin
treatment, or active HF (Nesto et al., 2004 [Level VI]); Tang, Francis, Hoogwerf,
& Young, 2003 [Level IV]). Therefore, the use of these agents requires close
monitoring for stages C and D heart failure. Careful clinical assessment prior to
initiation of TZDs, lower doses with slow dose escalation, and careful ongoing
monitoring should be implemented when these drugs are used in the presence
of known structural heart disease or a prior history of HF.
Adequate control of BP is also essential in the management of HF. Treat-
ment of older persons with HTN has been shown to reduce CVD morbidity and
mortality (Mulrow, Lau, & Brand, 2006 [Level I]). An important nursing con-
sideration is to monitor for adverse effects of medications used to manage HF,
as well as HTN, along with patient and caregiver education. ACE inhibitors are
important in the management of systolic HF and may also be helpful in dias-
tolic failure. In the Heart Outcomes Prevention Evaluation (HOPE) Study, ACE
inhibitors prevented cardiac events in high risk patients without HF or known
low ejection fractions (HOPE Investigators, 2000 [Level II]).
In addition, ACE inhibitors have a renal protective benefit that is extremely
important in preventing the development or worsening of HF, especially in pa-
tientswithDM.Recent evidence suggests that use ofACE inhibitors is associated
with a larger lower extremity muscle mass, which may have benefit in wasting
syndromes and prevention of disability (Di Bari et al., 2004 [Level IV]) and that
they are particularly efficacious in older adults (Wing et al., 2003 [Level II]).
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ARBs are also used widely for the prevention and treatment of HF, particularly
when patients are unable to use ACE inhibitors due to the development of cough
(Brenner et al., 2001 [Level II]; Lindholm et al., 2002 [Level II]). Renal function
and hyperkalemia should be assessed when using both classes of agents, espe-
cially in the presence of underlying renal dysfunction.
Case Study and Discussion
CTG is a 72-year-old woman with a history of diet-controlled glucose in-
tolerance and HF with normal renal function who is seen in the geriatric
clinic with a 3-day history of poor appetite, nausea, and occasional vomit-
ing. She complains of a constant feeling of fullness. Shewas last hospitalized
3 months ago due to fluid overload related to newly diagnosed HF. Her di-
uretic was increased 6 weeks ago for mild ankle swelling. She denies recent
lower extremity swelling, orthopnea, or paroxysmal nocturnal dyspnea. Her
blood sugars have been well controlled in the 90 to 130 range without hy-
poglycemic episodes. She denies fever, chills, cough, or urinary symptoms.
She says she never misses her medications. Until 5 days ago, she was able
to walk 30 minutes a day without difficulty. She had noticed a gradual in-
crease in fatigue during the last 10 days and found herself too tired to attend
several social and church events in the evening. When asked what her daily
weights have been, she confessed that because she had been feeling so good
she had abandoned this as a daily practice. Concerned, however, about her
recent symptoms, she weighed herself this morning and found that she had
gained 6 pounds since she last weighed herself 2 weeks ago. However, she
has been compliant to her medications for HF, which include:
Coreg 6.25 mg twice a day
Altace 5 mg daily
Aldactone 12.5 mg daily
Lasix 20 mg daily
Imdur 15 mg daily
She has not taken a double dose of lasix with the additional weight
gain as shown in her self-care action plan. She had been unaware of that
weight gain because she had not been weighing herself. In addition, she
had attended two social events 2 weekends ago that included eating out.
Her self-care action plan had shown that she should increase her diuretic
for 1 day following eating out the day before.
On physical examination, her blood pressure is 132/86 with a heart rate
of 88 bpm. She is afebrile. She has fine crackles in the lower bases bilaterally.
There is +1 edema. Heart sounds demonstrate S1, S2, and S3. Her apical
impulse is displaced to the left. There is jugular neck vein distention. Her
abdominal girth has increased 2 inches since her last visit.
Lasix was increased to 40 mg for a maximum of 3 days. If at any point
during the 3 days her weight returned to baseline, she was instructed to
return to her usual dose of lasix. She was advised of the importance of daily
weighing to maintain her baseline weight. She was referred back to her
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self-care action plan for changes in diuretic depending on her daily weight
and the maintenance of her low-sodium diet in light of her social schedule.
She will return to the clinic in 1 week.
This patient exemplifies the need for educational reinforcement in a
newly diagnosed HF patient who is just learning how to incorporate a self-
care action plan. Like many patients who have had to take antibiotics in
the past, compliance can wane when the patient feels well. It is important
to make contact with a newly diagnosed HF patient fairly frequently to be
available for questions that might influence the self-care decision making
of the patient.
Summary
Hospital admissions can be reduced in older adults with HF:
■ whencare is spent in identifying thepatient’s ownunique signs and symp-
toms of fluid overload.
■ by creatingmonitoring parameters for the nurse in the form of the history
and the physical assessment.
■ by creating monitoring parameters for the patient in the form of a self-
care algorithm with clear guidelines for self-care action.
■ by achieving goals for clinical stability.
Resources
Relevant Practice Guidelines
ADA guidelines: Summary of Revisions for the 2007 Clinical Practice Recom-
mendations Diabetes Care 2007, 30, S3.
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo,
J. L., et al. (2003). The seventh report of the Joint National Committee on
Prevention, Detection, Evaluation and Treatment of High Blood Pressure.
Journal of the American Medical Association, 289, 1560–1572.
Grady, K., Dracup, K., Kennedy, G., Moser, D., Piano, M., Stevenson, L., et
al. (2000). Team anagement of patients with heart failure: A statement of
healthcare professionals from the Cardiovascular Nursing Council of the
American Health Association. Circulation, 102, 2443–2456.
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Gani-
ats, T. G., et al. (2005). ACC/AHA 2005 guideline update for the diagnosis
and management of chronic heart failure in the adult [Electronic Version].
Circulation, e154–e235.
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and Intervention
Strategies
Janine Overcash
Educational
Objectives
At the conclusion of this chapter, the reader will be
able to:
1. recognize the incidence and prevalence of U.S.
statistics on malignancy in older adults
2. identify three common malignancies in older adults
3. recognize three common co-morbidities in older
adults with cancer
4. identify three common cancer-related
emergencies in older adults
5. identify three instruments useful in the
assessment of older adults
6. identify three important elements of a health
history specific to an older cancer patient
7. identify three important elements of a physical
examination specific to an older cancer patient
8. define clinical parameters of frailty of an older
adult with cancer
OVERVIEW
The probability of developing a malignancy increases with age. In the years be-
tween 1998 and 2002, the National Cancer Institute Surveillance, Epidemiology,
and End Results Program (SEER) found that 56% of all cancers were diagnosed
in adults 65 years and older (Ries et al., 2007). Cancer is often one of many
diagnoses (or co-morbidities) found in the medical history of an adult 65 or
older (Extermann, Overcash, Lyman, Parr, & Balducci, 1998 [Level IV]). Acute
care nurses must appreciate that cancer is common in older adult patients and
be aware of potential health limitations and emergencies associated with the
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4.
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diagnosis and treatment of malignancy. This chapter presents the incidence and
prevalence of cancers more common in adults aged 65 and older. Assessment
strategies and instruments are identified and potential medical emergencies
associated with the cancer-disease process and treatment are discussed.
Incidence and Prevalence of Malignancies Common
in Older Patients
The National Cancer Institute suggests that in 2002, there were approximately
10.1 million cancer survivors in the United States, and most (61%) were older
than 65 (National Center for Health Statistics, 2002). The median age at the
time of diagnosis is 67 years and the median age at death due to malignancy
is 73 years (Ries et al., 2007). The leading cancer diagnosis in women living
in the United States is breast cancer; for men, it is prostate cancer (American
Cancer Society, 2007). According to the SEER data, the median age at diagnosis
of colorectal cancer is 71; of lung cancer, the median age at diagnosis is 69; of
breast cancer, the median age is 61; of prostate cancer, the median age is 68; and
of bladder cancer, the median age is 73 (Ries et al., 2007). The leading cause of
cancer-related death in the United States is from lung and bronchusmalignancy
(American Cancer Society, 2007).
Assessment of the Older Cancer Patient
A person aged 70 and older has, on average, 5.6 diagnoses (Fried et al., 2001
[Level II]). Common nonmalignant co-morbidities in the United States are
hypertension, osteoarthritis, and coronary heart disease (National Center for
Health Statistics, 2002 [Level I]). A diagnosis of cancer may be only one of sev-
eral co-morbidities and it is important to understand how the malignant and
nonmalignant conditions affect an older adult’s health. An acute health crisis
may be the result of the culmination of several co-morbidities interacting with
the cancer diagnosis and treatment (Reiner & Lacasse, 2006 [Level II]). Older
adults with cancer, those with multiple co-morbidities, and those who are hos-
pitalized more than 120 days are more likely to die in the hospital (Kozyrskyi,
Black, Chateau, & Steinbach, 2005[Level II]). It is therefore vital to conduct an
assessment that considers multiple diagnoses as well as the emotional and so-
cial components of daily living in the acute care setting. Nurses are in a primary
role to gather the panorama of health care information with the intention of
providing a basis of quality care (Overcash, 2004a [Level IV]; Overcash, 2004b
[Level III]; Sinding, Wiernikowski, & Aronson, 2005 [Level II]).
Caring for an older adult is complicated due in part to factors such as health
care access and insurance concerns that may impede adequate medical and
nursing attention. Further, an older adult who lives alone is less likely to re-
ceive adequate health care (Goodwin, Hunt, Key, & Samet, 1987 [Level IV]).
Conversely, older men who are married tend to have better cancer survival out-
comes (Goodwin et al., 1987 [Level IV]; Vercelli et al., 2006 [Level II]. Under-
standing access to regular health care and caregivers will help the construction
of realistic discharge plans (Bindman, Chattopadhyay, Osmond, Huen, & Bac-
chetti, 2005 [Level III]).
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Caregiver coping strategies are important to understand in order to pro-
vide the necessary support in an effort to enhance the quality of life of the
patient/family/caregiver triad (McMillan et al., 2006 [Level II]). Caregivers re-
port the most stress with managing medications, recognizing significant signs
and symptoms, and maintaining a level of pain control for the patient (Ha-
ley, 2003 [Level III]). Receiving adequate information in the management of
an older person with cancer has been found to be considered very important
to caregivers (Hudson, 2006 [Level III]); however, despite the evidence, many
caregivers report a lack of sufficient support and education (Akechi et al., 2006
[Level III]). Integrating the caregiver, support person, and/or spouse into the
patient assessment may reveal limitations that occur in the home and impact
health care. Understanding such limitations that occur outside the hospital is
critical in developing a reasonable discharge plan and reducing the incidence
of return emergency room visits after discharge home (Guttman et al., 2004
[Level III]).
Geriatric syndromes are health problems that are multifaceted and can be
caused by several synergistic factors (Flood et al., 2006 [Level III]). Examples
of geriatric syndromes are incontinence, pain, dementia falls, and weight loss.
Acute care nursesmust consider the presence of geriatric syndromes on assess-
ment to reduce the opportunity of harmful complications caused by cancer and
cancer treatment (Naeim & Reuben, 2001 [Level V]).
Due to the complexity of care in an older cancer patient, it is essential to
conduct a complete assessment. The comprehensive geriatric assessment (CGA)
can be helpful in identifying many of the actual and potential health concerns
that may affect the health of an older person (Balducci & Yates, 2000 [Level
IV]). The premise for conducting a CGA in an older cancer patient is to cast a
wide assessment net around issues that contribute to the spectrum of health in
order to determine actual and potential limitations and to develop reasonable
intervention strategies.
Comprehensive Geriatric Assessment (CGA)
A CGA is an assessment designed to consider physical, emotional, functional,
and social elements that comprise health and quality of life of older patients
(Pfeiffer, 1991 [Level IV]; Rubenstein, Siu, & Wieland, 1989 [Level IV]). A
CGA for an older person with cancer is particularly important in the detec-
tion of limitations that can potentially go unnoticed until signs and symp-
toms become magnified and cause alteration in independence or interfere
with daily living (Burns, Nichols, Martindale-Adams, & Graney, 2000 [Level II];
Extermann et al., 1998 [Level IV]). Be careful and do not assume that an
older adult who appears independent is without limitations (Extermann et al.,
1998 [Level IV]). A 76-year-old woman may look healthy and active; how-
ever, upon screening with a CGA, signs of dementia, potential for falls, and/or
other limitations may be found. A CGA early in the hospital admission and
after discharge home has been found to be important in the care, and of-
ten survival, of an older person (Sinoff, Clarfield, Bergman, & Beaudet, 1998
[Level III]).
No one definition of a CGA exists. A CGA can be developed to in-
clude screening instruments necessary to meet the needs of a particular
older-patient population. The instruments that commonly comprise the CGA
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and that guide screening practices in many health care domains are all found
onwww.ConsultGeriRN.org and other chapters in this text.Whereas a CGAmay
be more relevant to primary-care settings, understanding such issues as medi-
cation history and polypharmancy, caregiver situation, and emotional condition
is also important to an acute assessment.
Prescreening older cancer patients to target those who would be most likely
to benefit from the entire CGA may be helpful to acute care nurses (Applebaum
& Wilson, 1987 [Level IV]). The CGA often requires a reasonable length of
time to administer and acute care nurses are often limited by time constraints.
The abbreviated comprehensive geriatric assessment (aCGA) can be used to
target older cancer patients in need of further screening with the more time-
consuming CGA (Extermann et al., 1998 [Level IV]). The aCGA is not used in
lieu of the full CGA but rather is intended to save clinician time by identify-
ing patients who need more in-depth screening (Overcash, Beckstead, Moody,
Extermann, & Cobb, 2006 [Level II]).
The following instruments can identify functional, physical, emotional, and
medication history as well as cognitive impairment in acute care patients and
are generally included in a CGA (see related chapters):
A. Assess for emotional distress.
1. The Geriatric Depression Scale (Yesavage et al., 1982 [Level II]).
2. The SF-12 Tool (Ware, Kosinski, & Keller, 1996 [Level II]). The SF-12 is a
general health-related quality-of-life instrument widely used in research
and clinical assessment. Two summary scores are the culmination of the
measures from the mental health aspect and the physical health domain.
The SF-12 is simple to administer and provides the clinician with a mea-
sure of emotional and physical health.
B. Assessment for cognitive limitations.
1. Mini-Mental State Exam (MMSE) (Folstein, Folstein, & McHugh, 1983
[Level II]).
C. Assess thenumber and indications ofmedications. Look formedicationswith
the same indications and potential harmful interactions, and consider any
difficulty with cancer-treatment agents. For more information on polyphar-
macy screening, visit www.ConsultGeriRN.org and select “Try This: The
Beers Medication Screen, Criteria for Potentially Inappropriate Medication
Use in the Elderly”).
D. Assess for geriatric syndromes such as urinary incontinence, falls, or depres-
sion (for more information, visit www.HarfordIGN.org and select “Try This:
“Urinary Incontinence Assessment, Fall Risk Assessment, or The Geriatric
Depression Scale”).
E. Assess prior fall history (American Geriatrics Society, 2001 [Level VI]).
1. If a patient has fallen in the last year, then further screening is recom-
mended.
a. The Physical Performance Test Battery (Simmonds, 2002 [Level II])
has age-related norms and is a valid and reliable tool used with cancer
patients.
b. The 6-Minute Walk assesses the speed and ability to ambulate for the
entire time (Enright et al., 2003 [Level II]).
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c. The timed Get Up & Go Test includes rising from a chair, walking 3
meters, and returning to the chair in a sitting position (Podsiadlo &
Richardson, 1991 [Level II]).
d. Assessment of physical status can take place on observation of gait
(Tinetti, 1986 [Level II]) using the Gait Assessment Scale (Tinetti,
Mendes de Leon, Doucette, & Baker, 1994 [Level II]).
F. Assess the ability to perform self-care activities.
1. Activities of Daily Living Scale (Katz, Downs, Cash, & Grotz, 1970
[Level II])
2. Instrumental Activities of Daily Living Scale (Lawton & Brody, 1969
[Level II])
Health History
The subjective information obtained from an older adult is a critical factor in the
development of the plan of care. Respect and confidence are not only prudent
but also standard practice for acute care nurses and can set the stage for a
productive health centered dialogue. Nurses should assess the reason(s) for
seeking care (i.e., chief complaint) and include the family and support person(s).
The following issues should be considered when conducting a health history of
an older adult with cancer:
A. Assess history of present illness in regard to cancer diagnosis, cancer stage
at diagnosis, cancer stage currently, and cancer treatment (i.e., surgical,
chemotherapy, radiation therapy, hormonal therapy).
B. Assess past medical history as related to a diagnosis of cancer (include dates
of diagnosis and treatments and regular oncological assessment continue).
C. Assess familymedical history ofmalignancy and ages on diagnosis (i.e., some
families have strong familial histories of malignancy and younger genera-
tions should consider genetic counseling).
D. Assess regular cancer-screening examinations.
E. Assess for common geriatric syndromes (i.e., issues such as incontinence or
falls).
Physical Examination
Conducting a physical examination of an older adult must orchestrate an un-
derstanding of normative aging changes and knowledge of likely pathology. The
physical examination is also an opportunity to teach about the importance of
self examination (i.e., breast and skin exams) and provides relevant health in-
formation. When older adults perceive the physical examination as informative
and understandable, they are more likely to be more satisfied with their health
care encounter (Foxall, Barron, & Houfek, 2003 [Level II]).
Physical examination provides objective information to nurses that is syn-
ergistic to self report measures. Self report measures are instruments such as
the InstrumentalActivities ofDaily Living (IADLs) assessment (Lawton&Brody,
1969 [Level II]) andActivities ofDaily Living (ADLs) (Katz et al., 1970 [Level II]),
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which focus on tasks vital to independent living. It has been shown that self-
report instruments tend to over-estimate abilities (Kuriansky, Gurland, & Fleiss,
1976 [Level IV]; Naeim & Reuben, 2001 [Level V]) and objective assessments
(e.g., observing gait or balance) may produce more realistic data.
Functional status, and not chronological age, is an important indicator of
cancer treatment tolerance (Balducci & Yates, 2000 [Level IV]; Garman & Co-
hen, 2002 [Level III]). Changes in functional status may help determine cancer-
treatment tolerance or disease progression (Chen et al., 2003 [Level II]; Given,
Given, Azzouz, & Stommel, 2001 [Level II]; Reiner & Lacasse, 2006 [Level II]).
Assessment of physical function and recognition of patients with physical de-
ficiency can also identify those patients who have an increased risk of hospi-
talization (Wyrwich & Wolinsky, 2000 [Level III]). It is important to conduct a
functional assessment at regular intervals while the patient is receiving acute
care to look at trends throughout the cancer-treatment process. Patients may
show functional compromise during periods following cancer therapy and be-
come more functionally apt when not receiving treatment.
Physical examination and functional-status assessment can help reveal a
clinical presentation of frailty. Fried et al. (2001 [Level II]) suggest that frail in
part can be defined as follows:
■ older than age 85
■ dependent in one or more ADLs
■ the presence of one or more geriatric syndromes
Older adults who are considered frail are more likely to receive palliative
cancer treatment as compared to those not considered frail and who receive
curative therapy (Balducci & Yates, 2000 [Level IV]).
A complete head-to-toe assessment including the general elements of a
subjective and objective physical exam, accompanied with the CGA assessment
instruments and performance evaluations, provides the infrastructure to de-
velop a reasonable treatment plan. Assessment of an older adult with cancer is
a vital, dynamic component of care for the interdisciplinary health care team.
Medical Emergencies Associated With Cancer
and Cancer Treatment
Adiagnosis of cancer can lead tomedical emergencies such as electrolyte imbal-
ances, unstable fractures, and neutropenia (i.e., lowwhite cell counts) leading to
infection. It is important to obtain cancer-related history and physical informa-
tion concerning the type of treatment and the exact diagnosis with metastasis
(i.e., spread of the malignancy from the original site). It is also important for
acute care nurses to know the cycle of chemotherapy administration for a par-
ticular patient. Chemotherapy such as doxorubicin and cyclophamide often are
given 4 times, 3 weeks apart. As the chemotherapy proceeds, various issues such
asnausea and vomiting, neutropenia, andmouth soresmay occur andbepresent
upon acute evaluation. The following are considered oncological emergencies
and require acute care.
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Hypercalcemia
Hypercalcemia is a reasonably common complication associated with multiple
myeloma, breast, and lung cancers. The most common cause of hypercalcemia
is malignancy (Fisken, Heath, Somers, & Bold, 1981 [Level IV]) and generally
found in 3% to 5% of emergency admission patients (Lee et al., 2006 [Level
II]). Nonmalignant causes are hyperparathyroidism and renal failure. When
hyperthyroidism is associated with hyperparathyroidism and malignancy, sur-
vival is much greater as compared to hypercalcemia due to malignancy alone
(Hutchesson, Bundred, & Ratcliffe, 1995 [Level III]). It is important to measure
parathyroid hormones in patients with hypercalcemia in order to predict time
of survival (Hutchesson et al., 1995 [Level III]).
Hypercalcemia is defined as calcium concentration of greater than
10.2mg/dL (Lee et al., 2006 [Level II]). Signs and symptomsof hypercalcemia are
often not evident in patients with mild or moderate hypercalcemia (i.e., calcium
levels of 10.3 to 14.0 mg/dL). Gastrointestinal discomfort, changes in level of
consciousness, and general nonspecific discomfort can be experienced in cases
of moderate hypercalcemia. Other signs and symptoms are lethargy, confusion,
anorexia, nausea, constipation, polyuria, and polydipsia (Halfdanarson, Hogan,
& Moynihan, 2006 [Level II]).
Treatment of hypercalcemia depends on the severity. Thiazide diuretics
should be discontinued. Hydration must be maintained to diminish risk of ex-
acerbation of hypercalcemia (Bushinsky & Monk, 1998 [Level V]). Severe hy-
percalcemia should be considered a medical emergency. Intravenous normal
saline and loop diuretics should be implemented but will only last as long as
the treatments are infusing. Bisphosphonates can help reduce bone reabsorp-
tion resulting in reduced serum calcium levels (Budayr, Nissenson, & Klien,
1989 [Level I]). Calcitonin also can be administered subcutaneously or in-
tramuscularly and can also reduce calcium levels (Halfdanarson et al., 2006
[Level II]).
Tumor Lysis Syndrome
Tumor Lysis Syndrome (TLS) is caused when a tumor breaks down and “in-
tercellular ions, nucleic acids, proteins and their metabolites” release into the
extracellular space (Del Toro, Morris, & Cairo, 2005, p. 3 [Level IV]). The syn-
drome develops when chemotherapy or radiation therapy causes hyperkalemia,
hyperuricemia, and hyperphosphatemia, which can increase the risk for renal
failure and reduced cardiac function (Cantril & Haylock, 2004 [Level V]). As
chemotherapy agents becomemore effective, the risks increase for TLS. Agents
including “cisplatin, etoposide, flurarabine, intrathecalmethotrexate, paclitaxel,
rituximab, radiation therapy, interferon alpha, corticosteroids and tamoxifen”
can cause TLS (Davidson et al., 2004, p. 546 [Level IV]; Lin, Lucas, & Byrd, 2003
[Level II]).
Hyperphosphatemia and hypocalcemia can occur about 24 to 48 hours fol-
lowing thefirst chemotherapy administration. Signs and symptoms suchasmus-
cle cramps, anxiety, depression, confusion, hallucinations, cardiac arrhythmia,
and seizures can result (Cantril & Haylock, 2004 [Level V]). Untreated TLS can
lead to renal failure (Davidson et al., 2004 [Level IV]).
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Hyperkalaemia is created by a release of potassium from the debilitation of
the tumor cells. High serum potassium levels can cause severe arrhythmias and
sudden death (Cairo & Bishop, 2004 [Level IV]).
Hyperuricemia (i.e., uric acid >10 mg/dl) can result in acute obstruction
uropathy and cause hematuria, flank pain, hypertension, edema, lethargy, and
restlessness (Cairo & Bishop, 2004 [Level IV]; Cantril & Haylock, 2004 [Level
V]). Hydration, administration of allupurinol, and diuresis generally comprise
the first-line treatment (Cantril & Haylock, 2004 [Level V]). Treatment with
rasburicase has been found to be effective in the treatment and prevention of
hyperuricemia and TLS (Annemans et al., 2003 [Level I]).
The signs and symptoms associated with TLS include decreased urine out-
put, seizures, and arrhythmias. Electrolytes must be assessed to determine the
presence of hyperkalemia, hyperuricemia, and hyperphosphatemia. Electrocar-
diograms should be obtained to assess arrhythmia.
Spinal Cord Compression
Spinal cord compression is not uncommon and can occur when metastasis
spreads to the vertebral bodies and invades the spinal cord. The spinal column
in the thoracic area is the most common location andmust be recognized imme-
diately to prevent critical, irreversible damage (Halfdanarson et al., 2006 [Level
II]). Spinal cord compression can lead to paraplegia and long-term neurological
deficits (Hirschfeld, Beutler, Seigle, & Manz, 1988 [Level IV]).
Signs and symptoms arenumbness and tingling in the extremities andupper
thorax and back pain (Lowey, 2006 [Level IV]). Pain can radiate or localize and
may seem chronic, which may disguise the emergent spinal cord compression
and delay critical treatment. Bowel and bladder dysfunction can also result.
Diagnosis is oftenmade with magnetic resonance imaging (MRI), computed
tomography (CT), and sometimes plain radiographic films of the affected area.
Treatment is often initiated with glucocortocoids followed by radiation therapy
and/or surgery. Surgery has been debated, but many agree it is reasonable in
conjunction with radiation therapy and sometimes chemotherapy (McLain &
Bell, 1998 [Level IV]; Schmidt, Klimo, & Vrionis, 2005 [Level IV]). Nurses have
the ability to recognize the signs and symptoms of this debilitating and often
lethal oncological emergency (Bucholtz, 1999 [Level II]).
Neutropenic Fever
Neutropenic fever is an oncological medical emergency caused by the diminish-
ment of neutrophils by various chemotherapeutic agents. Neutropenia is con-
sidered present when the neutrophil count is less than 1.0 x 109/L; severe neu-
tropenia is neutrophil counts less than 0.5 x 109/L (Halfdanarson et al., 2006
[Level II]).
Generally fever is the presenting sign; however, skin rashes and mucositis
may also be present. For some patients, neutropenic fever can occur after the
first cycle of chemotherapy; patients who have undergone aggressive surgery
with bowel resections are at increased risk (Sharma, Rezai, Driscoll, Odunsi, &
Lele, 2006 [Level II]).
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An instrument has been developed to help screen for the likelihood of neu-
tropenia and the identification of patients who are likely to benefit fromprophy-
laxis granulocyte-colony–stimulating factors (G-CSFs) (Donohue, 2006[Level
III]). G-CSF works to elevate white blood cell counts necessary in fighting in-
fection. A great amount of nursing literature exists on the definition, preven-
tion, andmanagement of neutropenic fever. Prevention of neutropenia and neu-
tropenic fever should be proactive in the administration of G-CSFs in patients
who are considered at high risk for neutropenia (Krol et al., 2006 [Level IV]).
An older cancer patient receiving myelotoxic chemotherapy (i.e., cyclophos-
phamide, doxorubicin, vincristine, and prednisolone) is considered high risk
and should receive prophylactic G-CSF administration (Repetto et al., 2003
[Level I]).
Case Study and Discussion
A 76-year-old White woman presents to the emergency department with
delirium and trauma to her left hip. The patient’s daughter reports that the
patient fell in the bathroom several hours earlier. She has a diagnosis of
breast cancer and is currently undergoing chemotherapy and has received
four cycles of Adriamycian and Cyclophospimide. She also has a history of
osteoarthritis, hypertension, and gastric reflux disease. Presenting signs and
symptoms are delirium, cracked mucus membranes, low B/P at 88/42, and
tachycardia.
Situations such as dehydration are not uncommon in an older person un-
dergoing chemotherapy. Patients may have vomiting or diarrhea and become
dehydrated as a result. Seniors have less functional reserve and are therefore
more likely to suffer from complications of cancer treatment (Balducci, 2006
[Level V]). Older adults require careful examination and intervention in order
to maintain and enhance health and independence.
1. In this clinical scenario, which geriatric syndromes are present?
Answer: Falls, delirium, pain associated with trauma, functional-status limi-
tations, and ambulatory difficulty.
Rationale: This patient has multiple geriatric syndromes and is at risk for
further deconditioning. It is important to recognize the geriatric syndromes
present and anticipate any additional injuries. Ensure caregiver support and
help facilitate a plan for care while at home.
2. In this clinical scenario, which oncological emergency is this patient at great-
est risk to develop?
Rationale: Based on the signs and symptoms of dehydration, hypercalcemia
is of concern. Hydrate to prevent hypercalcemia and to reduce signs and
symptoms of dementia. Falls are also of concern because the risk of fu-
ture falls is associated with prior falls. Dehydration in an older adult can-
cer patient can be associated with many problematic health and functional
limitations.
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Conclusion
Acute care of an older patient requires nurses’ health assessment skills to be
proactive in detecting and addressing limitations that can result from a cancer
diagnosis and treatment. Nonmalignant co-morbidities and geriatric syndromes
play a role in the diagnosis and treatment of cancer and should be assimilated
into the critical thinking involved in developing the nursing plan of care. Care-
ful health assessment and evaluation are critical to acute care nurses in under-
standing the disease progress, treatment tolerance, and presence of oncological
emergencies. Nurses working in acute settings must be acquainted with princi-
ples of geriatric care that should be applied to patientswith any type of diagnosis
and not limited to malignancy. Understanding normative aging changes versus
pathology can help facilitate a specialized plan of care with enhanced health
and independence as the intended patient outcomes.
Resources
The National Comprehensive Cancer Network offers Clinical Practice Guide-
lines, including Senior Adult Oncology. http://www.nccn.org/professionals/
physician˙gls/default.asp
The American Geriatrics Society offers clinical guidelines in using the CGA in
the older person. http://www.americangeriatrics.org
The Oncology Nursing Society offers recommendations for practice of the on-
cology patient. www.ons.org
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Issues
Regarding
Sexuality
Jacqueline M. Arena
Meredith Wallace
Educational
Objectives
On completion of this chapter, the reader should be
able to:
1. describe an older adult’s interest in sexuality
2. identify barriers and challenges to sexual health
among older adults
3. discuss normal and pathological changes of aging
and their influence on sexual health
4. identify interventions that may help older adults
achieve sexual health
Overview
Sexuality is an innate quality present in all human beings and is extremely im-
portant to an individual’s self-identity and general well-being (Wallace, 2003
[Level V]). Sexuality is defined as “a central aspect of being human throughout
life and encompasses sex, gender identities and roles, sexual orientation, eroti-
cism, pleasure, intimacy and reproduction” (World Health Organization, 2004
[Level VI]). Sexual health as a manifestation of sexuality is “a state of physi-
cal, emotional, mental and social well-being related to sexuality” (World Health
Organization, 2004 [Level VI]). Sexual health contributes to the satisfaction of
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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physical needs; however, it is often not as apparent that sexual contact ful-
fills many social, emotional, and psychological components of life as well. This
is evidenced by the fact that human touch and a healthy sex life may evoke
sentiments of joy, romance, affection, passion, and intimacy, whereas despon-
dency and depression often result from an inability to express one’s sexuality
(Kamel &Hajjar, 2003 [Level V]). When this occurs, sexual dysfunction, defined
as impairment in normal sexual functioning, may result (American Psychiatric
Association, 1994 [Level VI]).
It is frequently assumed that sexual desires and the frequency of sexual
encounters begin to diminish later in life. Moreover, the notion of older adults
engaging in sexual activities has become taboo in today’s youth-loving society
(Kamel&Hajjar, 2003 [Level V]). Despite this stereotype, sexual identity and the
need for intimacy do not disappear with increasing age, and older adults do not
morph into celibate, asexual beings. Current research conducted by the AARP
(1999 [Level IV]) found that in a study of 1,709 older adults, 38.4% had inter-
course once aweek ormore. A study of 179 residents of subsidized independent-
living facilities revealed that the majority had physical and sexual experiences
in the past year (Ginsberg, Pomerantz, & Kramer-Feeley, 2005 [Level IV]).
Background and Statement of the Problem
Despite the persistence of sexual patterns throughout the lifespan, there is lim-
ited research and information to assist nurses to assess and intervene to promote
sexual health among older adults. Lack of research literature and insufficient
clinical resources are a product of the lack of societal recognition of sexuality
as a continuing human need and a factor that perpetuates lack of sexual as-
sessment and intervention among the older population. In addition to the lack
of literature, there are several factors that further impact the sexual health of
older adults. Zeiss andKasl-Godley (2001 [LevelV]) stress that although sexual-
ity remains rather central and complex throughout the lifespan, many physical,
psychosocial, and environmental changes contribute to decreased sexuality in
older adults. Evidence suggests that despite older adults’ continued sexual in-
terest and desires, many barriers may prevent them from engaging in fulfilling
sexual health. These barriers include the presence of normal and pathological
aging changes, environmental barriers to sexual health, and special problems of
the elderly that interfere with sexual fulfillment, such as cognitive impairment.
Health Providers’ Views Toward Sexuality and Aging
Nurses’ hesitancy to discuss sexuality with older adults has a significant im-
pact on the sexual health of this population. Gott, Hincliff, and Galena (2004
[Level IV]) report that general practitioners do not discuss sexual health fre-
quently in providing primary care to older adults. Their study of 55 older men
and women resulted in the finding that a major factor affecting sexual discus-
sion between patients and their physicians included the hesitancy of discussing
sexuality with a health care provider who was not the patient’s age or sex. In
this qualitative study, clients stated that sexuality discussions would be more
comfortable and forthcoming with health care providers who matched their sex
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and age. Moreover, attitudes toward sexuality later in life, making jokes about
sexuality, shame/embarrassment and fear, perception of sexual problems as not
serious, and lack of knowledge regarding available interventions were also seen
as barriers to sexual discussion between older clients and health care providers
(Gott & Hinchliff, 2003 [Level IV]).
General discomfort with discussing sexuality among nurses and lack of ex-
perience in assessment and management of sexual dysfunction among older
adults often prevent nurses from addressing the sexual needs of this popula-
tion. Moreover, the sexuality of older adults is generally excluded from sparse
gerontological curricula. Without education and experience in managing sen-
sitive issues around sexuality, health professionals are often not comfortable
discussing sexual issues with older adults. Peck (2001 [Level V]) reports that
creating a trusting and comfortable environment and increasing familiarity with
diverse sexual issuesmay enhance the assessment of sexual health among older
adults.
Nurses’ understanding of sexuality should be broadened beyond that of a
relationship between just men and women. Many clients within various health
care systems are gay or lesbian, bisexual, and transgender (GLBT) adults, and
these alternative sexual preferences require respect and consideration. In a
focus-group study, older gay and lesbians reported extensive discrimination in
accessing health care services by excluding them from program planning (Brot-
man, Ryan, & Cormier, 2003 [Level IV]). Discrimination among GLBT older
adults is especially seen in the development of residential services to meet the
needs of older adults. In a qualitative analysis of geriatric health care providers
to gay and lesbian older adults, providers demonstrated open attitudes but
lacked commitment in planning services to meet the needs of older lesbians
(Chamberland, 2003 [Level IV]). In a larger study of 400,000 GLBT adults, dis-
crimination was seen among administrators, care providers, and other residents
of a retirement-care community (Johnson, Jackson, Arnette, & Koffman, 2005
[Level IV]).
Normal and Pathological Aging Changes
The “sexual response cycle,” or the organized pattern of physical response to
sexual stimulation, changeswith age in bothwomen andmen. Aftermenopause,
a loss of estrogen inwomen results in significant sexual changes. This deficiency
frequently results in the thinning of the vaginal walls and decreased or delayed
vaginal lubrication, whichmay lead to pain during intercourse (HarvardMedical
School, 2003 [Level VI]). Additionally, the labia atrophy, the vagina shortens, and
the cervixmay descend downward into the vagina, causing further pain and dis-
comfort. Moreover, vaginal contractions are fewer and weaker during orgasm,
and after sexual intercourse is completed, women return to the prearoused stage
faster than they would at an earlier age (Harvard Medical School, 2003 [Level
VI]). The result of these physiological age-related changes in women is the
potential for significant alterations in sexual health that have traditionally re-
ceived little attention from research or individual health care providers. The
pain resulting from anatomical changes and vaginal dryness may result in the
avoidance of sexual relationships in order to prevent painful intercourse.
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Men also experience decreased hormone levels, mainly testosterone, yet
this seems to have a limited impact on sexual functioning due to the fact that
only a minimal amount of testosterone is needed for the purposes of sex. This
reduction in testosterone, which has been controversially labeled viropause or
andropause and male menopause, generally begins between the ages of 46 and
52 and is characterized by a gradual decrease in the amount of testosterone
(Kessenich & Cichon, 2001 [Level V]). The loss of testosterone is not patholog-
ical and does not result in sexual dysfunction. However, men may experience
fatigue, loss of muscle mass, depression, and a decline in libido (Kessenich &
Cichon, 2001 [Level V]). As a result of normal aging changes, older men require
more direct stimulation of the penis to experience a somewhat weaker erection
(Araujo, Mohr, & McKinlay, 2004 [Level IV]). As with postmenopausal women,
orgasms are fewer andweaker in oldermen, the force and amount of ejaculation
is reduced, and the refractory period after ejaculation is significantly increased
from that of younger men (Araujo et al., 2004 [Level IV]). The Massachusetts
male aging study of 1,085 older men indicated that age was identified as an in-
dependent risk factor for decreased sexual function in older men (Araujo et al.,
2004 [Level IV]).
Bodily changes, such as wrinkles and sagging skin, may cause both older
women and men to feel insecure about initiating a sexual encounter and main-
taining emotionally secure relationships. In addition, lack of knowledge and
understanding among older adults about sexuality is common because sexual
education was rarely provided in formal educational systems as the older adults
developed and was rarely discussed informally. Strict beliefs and values are
likely to impact sexual action, freedom, and desires and may result in sexual
frustration and conflict. Physical changes in the sexual response cycle that oc-
cur with increasing age do not completely explain the extensive changes in sex-
uality that occur among older adults. Many individual psychosocial and cultural
factors play a role in how older adults perceive themselves as sexual beings.
Zeiss and Kasl-Godley (2001 [Level V]) emphasize that liberal and positive at-
titudes toward sexuality, greater sexual knowledge, satisfaction with intimate
relationships, good social lives, general psychological health, and a sense of
self-worth and self-efficacy are associated with greater sexual interest, activity,
and satisfaction.
Although sexual disorders have not been well addressed among the older
population, they have been defined and fall into four categories: hypoactive sex-
ual desire disorder, sexual arousal disorder, orgasmic disorder, and sexual pain
disorders (Walsh &Berman, 2004 [Level V]).With improved assessment and di-
agnosis of these sexual disorders, older adultsmay benefit from limited research
supporting the efficacy of sildenafil citrate for the treatment of some sexual dis-
orders amongwomen, including female sexual arousal disorder (FSAD), and for
men with erectile dysfunctions (see nursing care strategies, Box 28.1).
In addition to normal aging changes and pathological sexual disorders, there
are a number of medical conditions that have been associated with poor sexual
health and functioning in the older population (Morley & Tariq, 2003 [Level V]).
Rosen (2006 [Level V]) reports that the main predictors of sexual dysfunction
are age, cardiovascular diseases, and diabetes. One of themost frequently occur-
ring medical conditions among older adults is cardiovascular disease. In a study
of 2,763 postmenopausal women, the presence of coronary heart disease was
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associated with lack of interest, inability to relax, arousal and orgasmic disor-
ders, and general discomfort with sex (Addis, Ireland, Vittinghoff, Lin, Stuenkel,
& Hulley, 2005 [Level II]). Diabetes is a large problem among older adults, ef-
fecting approximately 14.7 million individuals in the United States each year.
Approximately 40% of those with diabetes are 65 or older (CDC, 2007 [Level
IV]. In a study of eight women aged 24 to 83, older women with diabetes re-
ported lower sexual function, desire, and enjoyment than their younger coun-
terparts (Rockcliffe-Fidler & Kiemle, 2003 [Level IV]). The presence of depres-
sion among older adults impacts sexual health, in that depression often causes
a decline in desire and ability to perform with this disease and treatment. The
presence of loss and depression should be assessed among older adults and con-
sidered for the impact of these emotional and psychological factors on sexual
health (see chapter 5, Depression).
Other medical conditions occurring among older adults also have the po-
tential to impact sexual health. Older adults who have experienced strokes and
subsequent aphasias reported alterations in sexual health (Lemieux, Cohen-
Schneider, & Holzapfel, 2001 [Level IV]). In this study, difficulties in commu-
nication were major contributors to the sexual dysfunction. Parkinson’s disease
(PD) is predominantly an older-adult disease with the potential for impact on
sexual health. In a study of 444 older adults with PD, sexual limitations were
reported in 73.5% of the sample as a product of difficulty in movement (Mott,
Kenrick, Dixon, & Bird, 2005 [Level IV]). Benign prostatic hypertrophy (BPH) in
older men may result in altered circulation to the penis affecting erectile func-
tion and sexual arousal. Rosen (2006 [Level V]) reports that in conjunction with
other predictors of poor sexual health, BPH further impacts erectile function
and may contribute to ejaculatory dysfunction.
Medications used to treat commonly occurring medical illnesses among
older adults also impact sexuality. Two of the major groups of medications are
antidepressants and antihypertensives. Causative antidepressants include the
commonly used selective serotonin reuptake inhibitors (SSRI). Montejo, Llorca,
Izquierdo, and Rico-Villademoros (2001 [Level IV]) report in a study of 610
women and 412 men that 59.1% of the individuals taking SSRI antidepressant
medications reported sexual dysfunction. Although the use of MAO inhibitors
and tricylic antidepressants has decreased in favor of the SSRIs with lower side-
effect profiles, thesemedications also impact sexual function by reducing sexual
drive and causing impotence and erectile and orgasmic disorders. Antihyperten-
sives, ACE inhibitors, and alpha and beta cell blockers also result in impotence
and ejaculatory disturbances among older adults (Girerd et al., 2003 [Level IV]).
Antipsychotics, commonly used statin medications, and H2 blockers also impact
the sexual health of older adults.
Special Issues Related to Older Adults and Sexuality
Cognitively impaired older adults continue to have sexual needs and desires
(Alagiakrishnan et al., 2005 [Level IV]) that present a challenge to nurses. These
continuing sexual needs often manifest in inappropriate sexual behavior. Sex-
ual behaviors common to cognitively impaired older adults may include cud-
dling, touching of the genitals, sexual remarks, propositioning, grabbing and
groping, use of obscene language, masturbating without shame, aggression, and
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irritability (Nagaratnam & Gayagay, 2002 [Level IV]). In a study by Alagiakrish-
nan and colleagues (2005 [Level IV]), of 41 cognitively impaired older adults,
1.8% had sexually inappropriate behavior manifesting in verbal and physical
problems. In a study that used computed tomography (CT) of the head to scan
10 patients with these problematic sexual behaviors, cerebral infarction was
seen in 6 of them, and severe disease in 2 others, supporting the organic basis
for these symptoms (Nagaratnam & Gayagay, 2002 [Level IV]).
Masturbation is a method in which cognitively impaired men and women
may become sexually fulfilled. Nurses in long term care facilities may assist
older adults to improve sexual health by providing an environment in which an
older adult may masturbate in private. Alkhalil and colleagues (2004 [Level V])
report that the use of Gabapentin to decrease sexual behavior problems (e.g.,
inappropriate sexual overtures and public masturbation) has demonstrated ef-
fectiveness anecdotally. Accurate assessment and documentation of the ability
of cognitively impaired older adults tomake competent decisions regarding sex-
ual relationships with others while in long term care is essential. If it has been
determined that a resident is incapable of decision making, then the health care
staff must prevent the cognitively impaired resident from unsolicited sexual
advances by a spouse, partner, or other residents.
Environmental settings may also influence sexuality among older adults.
Normally, engaging in sexual intercourse occurs within the privacy of one’s bed-
room; however, for some older adults, extended-care facilities are the substitute
for what one called home. Kamel & Hajjar (2003 [Level V]) are of the opinion
that a large proportion of long term care residents are sexually inactive, yet say
they would like to be sexually active. These residents state that many of the
obstacles they face regarding their sexuality include lack of opportunity, lack of
available partner, poor health, feeling sexually undesirable, and guilt for having
sexual feelings. Furthermore, negative staff attitudes and beliefs regarding res-
idents’ sexual activity bar the expression of sexuality in long term care settings
(Hajjar & Kamel, 2004 [Level V]).
Of all AIDS cases, 11% are developed in adults older than 50, underscoring
the significant risk of HIV transmission in the older age group. Older adults
with HIV are more likely to be diagnosed late in the disease, progress more
quickly, and have a shorter survival (Goodroad, 2003 [Level V]). Falvo and Nor-
man (2004 [Level IV]) conducted a sex education workshop for older adults that
supported the acquisition and retention of HIV prevention knowledge 3 months
after workshop completion. Goodroad (2003 [Level V]) states that nurses are
in a unique position to assess and manage HIV among the older population,
but greater education regarding the risk for HIV in the older population is
needed.
Assessment
A model to guide sexual assessment and intervention is available and has been
well used among younger populations since the 1970s. The PLISSITmodel (An-
non, 1976 [Level VI]) begins by first seeking permission (P) to discuss sex-
uality with the older adult. Because many sexual disorders originate in feel-
ings of anxiety or guilt, asking permission may put the client in control of the
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discussion and facilitate communication with the health care provider. This per-
missionmaybe gainedby asking general questions, such as “Iwould like to begin
to discuss your sexual health; what concerns would you like to share with me
about this area of function?” Questions to guide the sexual assessment of older
adults are available on many health care assessment forms. The next step of
the model affords an opportunity for the health care provider to share limited
information (LI) with the older adult. In the case of older adults, this part of
the model gives health care providers the opportunity to dispel myths of ag-
ing and sexuality and to discuss the impact of normal and pathological aging
changes, as well as medications for sexual health. The next part of the model
guides the health care provider to provide specific suggestions (SS) to improve
sexual health. In so doing, nurses may implement several of the interventions
recommended for improved sexual health, such as safe sex practices, more
effective management of acute and chronic diseases, removal or substitution
of causative medications, environmental adaptations, and need for discussions
with partners and families. The final part of the model calls for intensive ther-
apy (IT) when needed for clients whose sexual dysfunction goes beyond the
scope of nursing management. In these cases, referral to a sexual therapist is
appropriate.
Sexual assessmentswill bemost effective using open-ended questions, such
as, “Can you tellmehowyou express your sexuality?,” “What concerns you about
your sexuality?,” “How has your sexuality changed as you have aged?,” “What
changes have you noticed in your sexuality since you have been diagnosed or
treated for disease?,” and “What thoughts have you had about ways in which
you would like to enhance your sexual health?” The loss of relationships with
significant, intimate partners is unfortunately common among older adults and
often ends communication about the importance of self to the person experi-
encing the loss. This greatly impacts an older adult’s sexual health. Asking an
older adult about past and present relationships in his or her life will help to aid
this assessment.
Barriers to sexual health should be assessed, including normal and patho-
logical changes of aging, medications, and psychological problems, such as de-
pression. Moreover, lack of knowledge and understanding about sexuality, loss
of partners, and family influence on sexual practice often present substantial
barriers to sexual health among older adults. Nurses should assess for the pres-
ence of physiological changes through a health history, review of systems, and
physical examination for the presence of normal and aging changes that impact
sexual health. Older adults may view the normal changes of aging and their
subsequent impact on appearance as embarrassing or indicative of illness. This
may result in a negative body image and a reluctance to pursue sexual health.
It is important for nurses to consider the impact of normal and pathological
changes of aging on body image and assess their impact frequently.
As discussed previously, there are a number of medical conditions that
have been associated with poor sexual health and functioning (Morley & Tariq,
2003 [Level V]), including depression, cardiac disease (Addis et al., 2005 [Level
II]), diabetes (Rockliffe-Fidler & Kiemle, 2003 [Level IV]), stroke and aphasia
(Lemieux et al., 2001 [Level IV]), Parkinson’s disease (Mott, Kenrick, Dixon, &
Bird, 2005 [Level IV]), and BPH (Rosen, 2006 [Level V]). Effective assessment
of these illnesses using open-ended health history questions, review of systems,
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physical examination, and appropriate lab testing will provide necessary infor-
mation for appropriate disease management and improved sexual function.
Assess the impact of medications among older adults, especially those com-
monly used to treat medical illnesses among older adults such as antidepres-
sants (Montejo et al., 2001 [Level IV]) and antihypertensives (Girerd et al., 2003
[Level IV]). Potential medications should be identified by reviewing a client’s
medication bottles and the client should be questioned about the potential im-
pact of these medications on sexual health. If the medication is found to im-
pact sexual health, alternative medications should be considered. Older adults
should also be questioned regarding the use of alcohol because this substance
also has a potential impact on sexual response.
Intervention and Care Strategies
Following a thorough assessment of normal and pathological aging changes, as
well as environmental factors, a number of interventions may be implemented
to promote the sexual health of older adults. These interventions fall into sev-
eral broad categories, including (1) education regarding age-associated change
in sexual function; (2) compensation for normal aging changes; (3) effective
management of acute and chronic illness effecting sexual function; (4) removal
of barriers associated with difficulty in fulfilling sexual needs; and (5) special
interventions to promote sexual health in cognitively impaired older adults.
Client Education
The most important intervention to improving sexuality among the older pop-
ulation is education. It is important to remember that sexuality was likely not
addressed in formal educational systems as the older adults developed and was
rarely discussed informally. Older adults may possess dated values that impact
sexual action, freedom, and desires, leading to both sexual frustration and con-
flict. Masters reported in his seminal work on the sexuality of older adults (1986
[Level VI]) that older women were raised to believe that when menstruation
ceased, they would cease to be feminine. Knowledge is essential to the success-
ful fulfillment of sexuality for all people.
The incidence of HIV and AIDS infection is rising among older adults, with
11% of all AIDS cases resulting in adults older than 50. This underscores the
significant risk of HIV transmission in the older age group and the need for
effective teaching regarding safe sex practices. Teaching about the use of con-
doms to prevent the transmission of sexually transmitted diseases is essential.
In response to this rise in HIV cases and the presence of other sexually trans-
mitted diseases, it is essential to provide older adults with safe sex information
provided by the Centers for Disease Control.
Compensating for Normal Aging Changes
Assisting older adults to compensate for normal aging changes related to sexual
dysfunction will greatly lessen the impact of these changes on sexual health.
Among women, the discussion of anatomical changes in sexual anatomy will
help them to anticipate these changes. For example, the decreases in the size of
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the vagina and increased vaginal dryness among women may require the use of
artificial water-based lubricants (Araujo et al., 2004 [Level IV]). Inmen, delayed
response and the increased length of time needed for erections and ejaculation
are among normal changes of aging, of which older adults may not be aware.
When older adults understand the impact of normal aging changes, they then
understand the need to plan for more time and direct stimulation to become
aroused.
One of themost important preventive measures older adults may undertake
to reduce the impact of normal aging changes on sexual health is to continue
to engage in sexual activity. Planning for more time during sexual activities;
being sensitive to changes in one another’s bodies; the use of aids to increase
stimulation and lubrication; the exploration of foreplay, masturbation, sensual
touch, and different sexual positions; along with education about these common
changes associatedwith sex andagingmayhelp immensely. Bydoing so, changes
in sexual response patterns are less likely to occur. Eating healthy foods, getting
adequate amounts of sleep, exercising, stress-management techniques, and not
smoking are also important to sexual health.
Effective Management of Acute and Chronic Illness
Effective management of both acute and chronic illnesses that impair sex-
ual health is also important. Interventions that improve sexual health are
frameworked within the current interventions to treat disease. In other words,
effective disease management using primary, secondary, and tertiary interven-
tions will not only effectively treat the disease but also result in improved sexual
health. Consequently, better glucose control among diabetics enhances circula-
tion and may increase arousal and sexual response, whereas appropriate treat-
ment of depression with medication and psychotherapy will enhance desire
and sexual response (Beutel et al., 2005; Girerd et al., 2003 [Level IV]); Morley
& Tariq, 2003 [Level V]; Rockliffe-Fidler & Kiemle, 2003 [Level IV]; Walsh &
Berman, 2004 [Level V]).
Sparse research is available to guide the treatment of sexual disorders
amongolder adults.New researchhas demonstrated the efficacy of sildenafil cit-
rate for the treatment of some sexual disorders among women, including FSAD.
In a double-blind randomized controlled trial of this medication in a study of
202 postmenopausal women with FSAD, significant improvements were noted
in the control group who received the medication compared with the placebo
group (Berman et al., 2003 [Level II]). Walsh and Berman (2004 [Level V]) re-
port that centrally acting serotonin agonists and vasodilating creams are also
undergoing investigation and may result in more effective treatment for age-
related FSAD. The emergence of sildenafil for erectile dysfunction in men has
also been demonstrated inmultiple clinical trials to be a generallywell-tolerated
treatment for erectile dysfunction in older men (Fink, MacDonald, Rutks, Nel-
son, & Wilt, 2002 [Level I]).
Medications used to treat diseases may result in sexual dysfunc-
tion among older adults (see http://www.netdoctor.co.uk/menshealth/feature/
medicinessex.htm for a list of these medications). There are many medications
that may result in decreased sexual drive and impotence as well as orgasmic
and ejaculatory disorders. These medications are widely prescribed for many
chronic illnesses among older adults, including psychological disorders such as
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depression, hypertension, elevated cholesterol, sleep disorders, and peptic ul-
cer diseases. Moreover, because of the hesitancy among older adults and nurses
to discuss sexual problems, the effect of these medications on sexual function
is often not discussed in clinical settings. This may result in either prolonged
sexual dysfunction among older adults or a noncompliance with the medica-
tion. Recognition of the continuing sexual needs of older adults among nurses
is essential to beginning a dialogue about sexual problems. Effective assessment
will uncover medications affecting an older adult’s sexual function and lead to
the consideration of stopping the medication in favor of alternative disease-
management strategies or substituting the medication causing the dysfunction
with another one with fewer sexual side effects.
Removal of Barriers to Sexual Health
One of the greatest barriers to sexual health among older adults lies within
nurses’ persistent beliefs that older adults are not sexual beings. Nurses should
be encouraged to open lines of communication in order to effectively assess and
manage the sexual health needs of aging individuals with the same consistency
as other bodily systems and treat alterations in sexual health with available
evidence-based strategies.
An essential intervention to promoting sexual health in this population is
to attempt to educate nurses regarding the continuing sexual needs and desires
persisting throughout the lifespan. Education regarding older adult sexuality
as a continuing human need should be included in multidisciplinary education
and staff-development programs. Educational sessionsmay begin by discussing
prevalent societal myths around older adult sexuality. Nurses should be encour-
aged to discuss their own feelings about sexuality and its role in the life of older
adults. Moreover, the development of policies and procedures to manage sexual
issues of older adults is important throughout environments of care.
Environmental adaptations to ensure privacy and safety among long term
care and community-dwelling residents are essential. Arrangements for privacy
must bemade so thedignity of older adults is protectedduring sexual activity. For
example, nursesmayassist infinding other activities for the resident’s roommate
so that privacymay be obtained or in securing a common room that may be used
by older adults for private visits. Call lights or telephones should be kept within
reach during sexual activity and adaptive equipment such as hospital beds, side
rails, and trapezes may need to be obtained. Interventions such as providing
rooms for privacy and offering consultations for residents regarding evaluation
and treatment of their sexual problems are a few of the many ways this may be
accomplished (Wallace, 2003 [Level V]). Roach (2004 [Level IV]) suggests that
nursing home staff and administration work to develop environments that are
supportive and respectful of older residents’ continuing sexual rights and that
promote sexual health.
Families are an integral part of the interdisciplinary team.However, for older
couples, especially those in relationships with new partners, it is often difficult
for families to understand that their older relativemayhave a sexual relationship
with anyone other than the person they are accustomed to them being with. A
family meeting, with a counselor if needed, is appropriate to help the family
understand and accept the older adult’s decisions about the relationship.
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Special Interventions to Promote the Sexual Health
of Cognitively Impaired Older Adults
Cognitively impaired older adults continue to have sexual needs and desires but
may lack the capacity to make appropriate decisions regarding sexual relation-
ships. Accurate assessment anddocumentation of ability tomake informeddeci-
sions regarding sexual relationships must be conducted by an interdisciplinary
team. If an older adult is not capable of making competent decisions, participa-
tion in sexual relationships may be considered abusive and must be prevented.
On the other end of the spectrum, nurses should not attempt to prevent sex-
ual relationships and may play an important role in promoting sexual health
among older adults who are cognitively competent to make decisions regard-
ing sexual relationships. In these cases, nurses should implement all necessary
interventions to promote the sexual health of older adults.
Inappropriate sexual behavior such as public masturbation, disrobing, or
making sexually explicit remarks to other patients or health care professionals
may be a warning sign of unmet sexual needs among older adults. A full sexual
assessment should be conducted using clear communication and limit-setting in
these situations. Following this, a plan should be developed to manage this be-
havior while providing the utmost respect for and preserving the dignity of the
older adult. Providing an environment in which older adults may pursue their
sexuality in private may be a simple solution to a difficult problem. Medication
management for hypersexual behavior may be considered. Pathological hyper-
sexuality is usually related to the presence of cognitive disorders in older adults
(Levitsky and Owens, 1999 [Level V]). Antipsychotic medications have tradi-
tionally been used to treat hypersexuality. However, Levitsky and Owens (1999
[Level V]) report that antiandrogens, estrogens, Gonadotropin-releasing hor-
mone analogues, and serotonergic medications may be successful when other
methods are ineffective.
Case Study and Discussion
Mrs. Jones is a highly functioning 79-year-old widow, recently admitted to
a nursing home with mild cognitive impairment (MCI). Mrs. Jones began a
friendship with Mr. Carl, who is cognitively intact and wheelchair bound.
Mr. Carl is married to a woman who resides outside the facility. The nursing
staff has noticed more and more intimate touches among the two residents
and is concerned aboutMrs. Jones’s competency tomake the decision to par-
ticipate in this increasingly intimate relationship.Moreover, general concern
about the sexual relationship within a long term care setting prevails among
the nursing staff.
Thefirst step in this situation is to conduct a full assessment to determine
Mrs. Jones’s capacity to participate in this intimate relationship. The right to
Mrs. Jones’s autonomy is complicated by the presence of MCI and must be
explored further. The question remains, does Mrs. Jones have the decisional
capacity to participate in an intimate relationship?
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The actual and projected outcomes of the intimate relationship would
require assessment to determine what nursing actions are required regard-
ing this relationship. If an assessment of Mrs. Jones finds that she is inca-
pable of understanding the consequences of her relationship with Mr. Carl,
then she must be protected from unsolicited sexual advances by a spouse,
partner, or other residents. However, if the assessment leads nurses to be-
lieve that Mrs. Jones and Mr. Carl understand the risks and consequences
of their relationship, then the right to autonomy prevails.
If clinicians determine that older adults have the decisional capacity to
consent to a sexual relationship, then a comprehensivehealthhistory, review
of systems, and physical examination to determine normal and pathologi-
cal changes of aging that may play a role in this sexual relationship must
be conducted. Appropriate lab work for the potential presence of sexually
transmitted diseases should be included. A care plan focusing the need to
promote sexual health for this couple should be developed. Teaching about
normal and pathological aging changes and the impact of these changes,
as well as medications on sexual function, should be conducted. Normal
changes of aging must be compensated for and diseases affecting sexual
response should be treated with medications that will not impact sexual
health. Safety regarding sexually transmitted diseases and privacy should
be provided for the residents, ensuring that their dignity is respected at all
times.
Summary and Conclusions
One of themost prevalent myths of aging is that older adults are no longer inter-
ested in sex. It is commonly believed that older adults no longer have any inter-
est or desire to participate in sexual relationships. Because sexuality is mainly
considered a young person’s activity, often associated with reproduction, society
does not usually associate older adults with sex. Furthermore, most of the cur-
rent information society has regarding sexuality in older adults is from young,
Caucasian, healthy, and educated individuals (Zeiss & Kasl-Godley, 2001 [Level
V]). In the youth-oriented society of today,many consider sexuality among older
adults to be distasteful and prefer to assume it does not exist. However, despite
popular belief, sexuality continues to be important, even in the lives of older
adults.
Whereas the sexual health of older adults has been largely ignored in past
decades, evolving images of older adults as healthy and vibrant members of so-
ciety may result in a decrease in the prevalence of myths of this population as
nonsexual beings. Changes in the societal image of older adults as asexual celi-
bate beings will greatly enhance removal of barriers to sexual health in the older
population. Improved assessment and management of normal and pathological
changes of aging and appropriate environmental adaptations and management
of special issues of sexuality and aging will also result in improved sexual health
in the older population.Moreover, the development of new interventions includ-
ing oral erectile agents may also play a role in enhanced sexual health among
older adults.
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The fulfillment of sexual needs may be just as satisfying for older adults
as it is for younger people. However, several normal and pathological changes
of aging complicate sexuality among older adults. Environmental changes may
create further barriers to sexual expression among older adults. Despite the
many barriers to achieving sexual health among an aging population, nurses
are in a critical position to understand sexual needs and capabilities in later life
and to assist older adults in developing compensatory strategies for improving
sexual health in order to have the best possible sexual life. If these strategies and
interventions are undertaken, increased awareness and acceptance of elderly
sexuality will ultimately take place, and the concept of sex in old age will no
longer be such a shocking topic.
Resources
World Health Organization (2004). Sexual Health: A New Focus for
WHO. Progress. Reproductive Health Research, 67,1–8. http://www.who.int/
reproductive-health/gender/sexual health.html
MedlinePlus http://www.nlm.nih.gov/medlineplus/sexualhealthissues.html
National Institutes on Aging http://www.niapublications.org/engagepages/
sexuality.asp
American Foundation for Urological Disease, Inc. http://www.impotence.org
Prentiss Care Networks Project (Care Networks for Formal and Informal Care-
givers of Older Adults) http://caregiving.case.edu
Geriatric Video Productions http://www.geriatricvideo.com/
Nursing Spectrum Education/CE: Self-Study Modules http://www.
nursingspectrum.com/ContinuingEducation/NSSelfStudy/index.cfm
Hartford Institute for Geriatric Nursing (2003). Partners for dissemina-
tion of best nursing practices in care of older adults. http://www.
ConsultGeriRN.org/resources/education/bsnPartners.html
Videos
A Rose by Any Other Name (1976). Post Perfect Productions, Backseat Bingo
Films
Freedom of Sexual Expression: Dementia and Resident Rights in Long Term Care
Facilities. Terra Nova Films
The Heart Has No Wrinkles. Terra Nova Films
Box 28.1
Nursing Standard of Practice Protocol: Sexuality in
Older Adults
I. GOAL: To enhance the sexual health of older adults.
II. OVERVIEW:Although it is generally believed that sexual desires decrease
with age, several researchers have identified that sexual desires, thoughts,
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and actions continue throughout all decades of life. Human touch and a
healthy sex lives evoke sentiments of joy, romance, affection, passion, and
intimacy, whereas despondency and depression often result from an in-
ability to express one’s sexuality. Health care providers play an important
role in assessing and managing normal and pathological aging changes in
order to improve the sexual health of older adults.
III. BACKGROUND AND STATEMENT OF PROBLEM
A. Definitions
1. Sexuality: a central aspect of being human throughout life and
encompasses sex, gender identities and roles, sexual orientation,
eroticism, pleasure, intimacy, and reproduction (WorldHealthOr-
ganization, 2004)
2. Sexual health: a state of physical, emotional, mental, and social
well-being related to sexuality (WorldHealth Organization, 2004)
3. Sexual dysfunction: impairment in normal sexual functioning
(American Psychiatric Association, 1994)
B. Etiology and/or Epidemiology
1. Despite the continuing sexual needs of older adults, many bar-
riers prevent sexual health among older adults (Zeiss and Kasl-
Godley, 2001 [Level V])
2. Health care providers often lack knowledge and comfort in dis-
cussing sexual issues with older adults (Gott, Hincliff, & Galena,
2004 [Level IV])
3. The older population is more susceptible to many disabling med-
ical conditions; a number of medical conditions are associated
with poor sexual health and functioning (Morley & Tariq, 2003
[Level V]) including cardiac disease (Addis et al., 2005 [Level
II]); stroke andaphasia (Lemieux,Cohen-Schneider,&Holzapfel,
2001[Level IV]); Parkinson’s disease (Mott, Kenrick, Dixon, &
Bird, 2005 [Level IV]); diabetes (Rockliffe-Fidler & Kiemle, 2003
[Level IV]); BPHy (Rosen, 2006 [Level V]); and dental problems
(Heydecke, Thomason, Lund, & Feine, 2005) that make sexuality
difficult.
4. Medications among older adults, especially those commonly used
to treat medical illnesses, also impact sexuality, such as an-
tidepressants (Montejo, Llorca, Izquierdo, & Rico-Villademoros,
2001[Level IV]) and antihypertensives (Girerd et al., 2003 [Level
IV]).
5. Normal aging changes, such as a higher frequency of vaginal
dryness in women and erectile dysfunction in men, make sexual
health difficult to achieve (HarvardMedical School, 2003; Araujo,
Mohr, & McKinlay, 2004 [Level IV]).
6. Environmental barriers also present barriers to sexual health
among older adults (Hajjar & Kamel; 2003 [Level V]).
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IV. ASSESSMENT
A. The PLISSITmodel (Annon, 1976 [Level VI]) begins by first seeking
permission (P) to discuss sexualitywith an older adult. The next step
of the model affords an opportunity for the health care provider to
share limited information (LI) with the older adult. The next step
guides the health care provider to provide specific suggestions (SS)
to improve sexual health. The Final part calls for intensive therapy
(IT) when needed for clients whose sexual dysfunction goes beyond
the scape of nursing management.
B. Ask open-ended questions such as “Can you tell me how you ex-
press your sexuality,” “What concerns you about your sexuality?,”
and “How has your sexuality changed as you have aged?”
C. Assess for presence of physiological changes through a health his-
tory, review of systems, and physical examination for the presence
of normal and aging changes that impact sexual health.
D. Reviewmedications among older adults, especially those commonly
used to treat medical illnesses that also impact sexuality, such as
antidepressants (Montejo, Llorca, Izquierdo, & Rico-Villademoros,
2001[Level IV]) and antihypertensives (Girerd et al., 2003
[Level IV]).
E. Assess medical conditions that have been associated with poor sex-
ual health and functioning (Morley & Tariq, 2003 [Level V]) in-
cluding cardiac disease (Addis et al., 2005 [Level II]); stroke and
aphasia (Lemieux et al., 2001 [Level IV]); Parkinson’s disease (Mott
et al., 2005 [Level IV]); diabetes (Rockliffe-Fidler & Kiemle, 2003
[Level IV]); BPH (Rosen, 2006); and dental problems (Heydecke
et al., 2005).
V. NURSING CARE STRATEGIES
A. Communication and Education
1. Discuss normal age-related physiological changes.
2. Address how the effects of medications/medical conditions may
affect one’s sexual function.
3. Facilitate communication with older adults and their families re-
garding sexual health as desired, including:
a. Encourage family meetings with open discussion of issues if
desired.
b. Teach about safe sex practices.
c. Discuss use of condoms to prevent transmission of STDs and
HIV.
B. Health Management
1. Perform a thorough patient assessment.
2. Conduct a health history, review of systems, and physical exami-
nation.
3. Effectively manage chronic illness.
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4. Improve glucose monitoring and control among diabetics.
5. Ensure appropriate treatment of depression and screening for de-
pression (see chapter 5, Depression).
6. Discontinue/substitute medications that may result in sexual dys-
function (e.g., hypertension or depression medications).
7. Accurately assess and document older adults’ ability to make in-
formed decisions (see chapter 23, Health Care Decision Making).
8. Participation in sexual relationships may be considered abusive
if an older adult is not capable of making decisions.
C. Sexual Enhancement
1. Compensate for normal changes of aging
a. Females:
i. Use of artificial water-based lubricants
ii. Treatment of FSAD with sildenafil citrate (Viagra) (Berman
et al., 2003)
iii. Use of centrally acting serotonin agonists and vasodilating
creams (Walsh & Berman, 2004)
b. Males:
i. Recognizing the possibility for more time and direct stimu-
lation for arousal due to aging changes
ii. Use of sildenafil citrate (Viagra) for erectile dysfunction
(Fink et al., 2002)
2. Environmental Adaptations
a. Ensure privacy and safety among long term care and
community-dwelling residents (Wallace, 2003)
VI. EXPECTED OUTCOMES
A. Patients will:
1. Report high quality of life as measured by a standardized quality
of life assessment.
2. Be provided with privacy, dignity, and respect surrounding their
sexuality.
3. Receive communication and education regarding sexual health
as desired.
4. Be able to pursue sexual health free of pathological and prob-
lematic sexual behaviors.
B. Health care providers will:
1. Include sexual health questions in their routine history and phys-
ical.
2. Frequently reassess patients for changes in sexual health.
C. Institutions will:
1. Include sexual healthquestions on intake and reassessmentmea-
sures.
2. Provide education on the ongoing sexual needs of older adults
and appropriate interventions to manage these needs with dig-
nity and respect.
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3. Provide needed privacy for individuals to maintain intimacy and
sexual health (e.g., in long term care).
VII. FOLLOW-UP MONITORING OF CONDITION
Sexual outcomes are difficult to directly assess and measure. How-
ever, with the illustrated link between sexual health and quality of
life, quality of life measures such as the SF-36 Health Survey may be
used to determine the effectiveness of interventions to promote sex-
ual health. Retrieved March 7, 2007, at http://www.rand.org/health/
surveys/sf36item/question.html.
Content for this protocol was adapted from geronurseonline.org (pro-
tocol now available at www.ConsultGeriRN.org).
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Substance
Misuse and
Alcohol Use
Disorders
Madeline Naegle
Educational
Objectives
On completion of this chapter, the reader will be able
to:
1. describe common substance-related disorders
diagnosed in people older than 55
2. outline screening steps for substance-use
disorders in people 55 and older
3. discuss the rationale and steps of assessment of
an identified substance-use disorder
4. describe intervention strategies for
substance-related disorders in people 55 and older
5. list potential referral resources for older adults
(and their families) experiencing substance-related
disorders
Overview
Alcohol dependence and drug use among people 55 and older is changing as a
function of an aging population anticipated to live longer and more active lives.
The projected increase from 33 million to approximately 80 million older adults
by 2050 predicts that the frequency of substance-related problems among elders
will increase, and nurses must be prepared to identify and intervene with them
(U.S. Bureau of Census, 1996). In addition, because the area of drug use among
ethnic minorities is grossly understudied, suggestions for nursing interventions
For a description of Evidence Levels cited in this chapter, see chapter 1,
Developing and Evaluating Clinical Practice Guidelines, page 4
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must be interpreted in a culturally competent way and individualized to the
primary membership group for an older adult (Grant et al., 2004).
Background and Significance
Substance-use problems are costly to society with direct and indirect economic
costs of alcohol abuse and dependence, including costs of illness and crime, es-
timated at $184 billion in 1998 (NIAAA, 2000). Another $143.4 billion in costs
is attributed to illicit and prescription drugs (NIAAA, 2000). In older adults, the
misuse of medications in people older than 60 costs the United States $60 bil-
lion annually. Nearly 22% of community-dwelling older adults use potentially
addictive prescription medications; risks of psychological and/or physical de-
pendence associated with this phenomenon are considerable (Simoni-Wastila,
Zuckerman, Singhai, Briesacher, & Hsu, 2005 [Level III]). Although the rate of
alcohol dependence in the general population remains somewhat stable at 6%
for men and 2% for women, the rates of heavy alcohol use among older peo-
ple are emerging as a new area of study. Among people older than 60 seen in
primary care, 15% ofmen and 12% of women regularly drank in excess of the NI-
AAA recommended levels (i.e., one drink per day and nomore than three drinks
on any one occasion) (Fink, Elliott, Tsai, & Beck, 2005 [Level III]; NIAAA, 1995).
The burden of disease associated with smoking continues to be heaviest among
older individuals, who have smoked the longest and manifest the most health
problems. In 2004, 18.5 million Americans older than 45 smoked (about 42% of
all adult smokers) and 9% of older Americans were smokers in 2000 (National
Center for Health Statistics, 2007), for whom health risks are greater than for
younger smokers (Rimer, Orleans, Reintz, Critinzia, & Fleisher, 1990 [Level III]).
As baby-boomers age, their lifetime illicit drug use is anticipated to continue at
the levels of their younger years, contributing to the number of people older
than 55 using illicit drugs (i.e., marijuana and cocaine) (SAMHSA, 2000). Using
survey research and modeling methods to project trends, the number of people
50 and olderwhousemarijuana is projected to increase from1.0% in 1999 to 2.9%
(3.3 million users) by 2020. Use of many illicit drugs is expected to increase from
2.2% (1.6million) to 3.1% (3.5million), and nonmedical use of psychotherapeutic
drugs is projected to increase from 1.2% to 2.4% (Colliver, Compton, Gfroerer,
& Condon, 2006 [Level III]). If borne out, these projections represent signifi-
cant changes in drug use by older individuals and emphasize the need for both
education and improved proactive treatment planning.
Growing numbers of older people, coupled with their reluctance to seek as-
sistance for mental health problems (i.e., fewer than 3% of older people visit a
mental health professional), suggest that nurses and health professionals caring
for older adults in all settings need to be knowledgeable about substance use,
abuse, and dependence (Bartels et al., 2004 [Level III]). Psychiatric disorders
often co-occurwith alcohol abuse in older adults with a prevalence ranging from
12% to 30% (Koenig&Blazer, 1996;Oslin, 2005 [Level III]), anddepression is both
a cause and a consequence of excessive drinking. ThePrism study, a randomized
trial of 23,828 participants, found that 14% of older adults had positive assess-
ments for depressive or anxiety disorders and 6%were consuming alcohol at lev-
els that placed them at risk for health problems (Levkoff et al., 2004 [Level IV]).
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Health problems related to drug and alcohol use are influenced bymetabolic
changes that increase morbidity in advancing age. Older people respond differ-
ently to alcohol because of decreased total body water, decreased rates of alco-
hol metabolism in the gastrointestinal tract, and increased sensitivity to alcohol
combinedwith decreased tolerance (USDHHS, 2004b [Level VI]). Consequently,
more dramatic behavioral changes occur at lower doses in older adults, and so-
cial and legal problems aremore frequent andmorepronounced than in younger
people (USDHHS, 2004b [Level VI]).
Assessment of Substance Use Disorders
Substance use and related disorders in older adults are classified in the cat-
egories of use, abuse, and dependence. In reference to older adults, however,
the category of misuse is most often applicable. Older people tend to use alco-
hol and other drugs in response to physical and psychological symptoms they
experience as they age. Classification categories are linked to the particular sub-
stance used; the length of time of use, misuse, abuse, or dependence; and the
social, legal, and health consequences for the individual. For example, people
who drink four or fewer drinks per year are considered abstinent and low-risk
drinkers, which for an older adult is nomore than one drink daily and is not con-
sidered problematic (USDHHS, 2005). Most individuals who are users of and/or
dependent on alcohol, nicotine, and illicit drugs have developed these disorders
before the age of 60, and one-half to two-thirds of elderly alcoholics are believed
to have developed the disease early in life. “Late-onset alcoholism” or patterns
of prescription drug abuse, marked by increased use of alcohol or over-reliance
on prescription drugs, appears to be more closely associated with the losses,
chronic illness, psychological traumas, and other stresses of advancing age. A
common example of this is the change from social use to risky drinking or drug
misuse by people who have lost a spouse, partner, or job; are estranged from
family or are facing serious illness; or any combination of situations mentioned
(USDHHS, 2004b [Level VI]).
Alcohol Use Disorders
The most common substance-abuse problems among older adults stem from
alcohol consumption, including interactions of alcoholwithprescribed andover-
the-counter (OTC) drugs (USDHHS, 2004b [Level VI]).
At-Risk or Problem Drinking
At-risk drinking is a pattern, which, while not appearing to cause usual alcohol-
related problems, may bring about harmful consequences to the user or others,
including accidents, health and/or mental health problems, or social and legal
problems. For people older than 60, consumption of amounts of alcohol that
caused no problems earlier in life may result in social, legal, or medical prob-
lems. This is linked to sensitivity, the frequency of use of prescribed drugs (i.e.,
alcohol interacts with at least 50% of prescription drugs), and the frequent co-
occurrence of other chronic illnesses. Similarly, a decline in visual, hearing, or
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other perceptual capacitiesmake alcohol consumption hazardous. Heavy drink-
ing is associated with ulcers, respiratory disease, stroke, and myocardial infarc-
tion. Most adults decrease alcohol consumption with age but significant num-
bers (5% to 16%) continue heavy consumption at age 60 and older (Blow et al.,
2000 [Level III]).
A recent New York City study found that 7% of individuals 65+ in all eth-
nic groups are drinking excessively (NYC DH&MH, 2005). Approximately 11%
of men and 9% of women 75 years and older report heavy use, placing them
at risk for a range of problems (Lyness, Canine, King, Cox, & Yoedino, 1997
[Level III]).
Abuse
Abuse of a substance is characterized by a maladaptive pattern of use, leading
to impairment or distress (legal, interpersonal, emotional/mental) such as fail-
ing to fulfill role obligations, use in physically hazardous situations, occurring
in a 12-month period (modified from American Psychiatric Association, 2000).
Even when an individual does not meet the DSM-TR-IV criteria for abuse or
dependence, alcohol consumption at levels of more than seven drinks per week
for people older than 65 is linked to health consequences. Excessive alcohol
consumption may place an older individual at risk for falls(Kursthaler, et al.
2005 [Level III]), self-neglect, diminished cognitive capacity, and long-term al-
cohol use is related to the development of common medical problems such as
sleep complaints, restlessness and agitation, liver-function abnormalities, pneu-
monia, pancreatitis, gastrointestinal bleeding, and trauma, as well as chronic
diseases, particularly neuropsychiatric and digestive disorders, diabetes, car-
diovascular disease, and pancreatic or head and neck cancer (Blow, 1998; US-
DHHS, 2004b [Level IV]). Because of the high co-morbid occurrence of alcohol
and nicotine dependence, chronic obstructive pulmonary disease (COPD) and
cancer of the mouth often co-occur, as do esophageal and laryngeal cancer (US-
DHHS, 2004b). Excess alcohol use also impacts health by interfering with the
absorption and utilization of prescribed drugs and nutrients.
Drug Dependence (Addiction)
Drug dependence is amaladaptive pattern of substance use that leads to impair-
ment or distress (i.e., legal, interpersonal, emotional/mental occurring in a 12-
month period (American Psychiatric Association, 2000). Addiction is a chronic
illness characterized by brief “slips” from sobriety and “relapse,” a return to
regular use of the substance. It has two components: (1) physiological depen-
dence, which occurs with alcohol, tobacco, benzodiazepines, barbiturates, am-
phetamines, and opioids; involves “tolerance,” the need for increasing amounts
of a substance to achieve the desired effect; and “withdrawal,” manifested in a
characteristic pattern of symptoms when the substance is suddenly terminated,
including craving; and (2) psychological dependence, which is the perceived
need to use the drug. Psychological dependence occurs with abuse, and is the
more difficult dependence to resolve.
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Illicit Drug Use
Illicit drug use in late adulthood is less prevalent than alcohol abuse or
prescription-drug misuse. Recent trends associated with the baby-boomer gen-
eration, however, suggest that thismay be changing.Marijuana use, for example,
is nowmore prevalent among persons 55+ than among adolescents and, in 2000,
more than one-half million persons 55+ reported illicit drug use (CSAT, 2000).
Two recent studies indicate, however, that among people older than 50 report-
ing illicit drug use, toxicology screens on small samples as seen in urban emer-
gencydepartmentswerepositive for cocaine (63%), opiates (16%), andmarijuana
(14%) (Rivers et al., 2004 [Level III]; Schlaerth, Splawn, Ong, & Smith, 2004
[Level III]).
Many older persons are in recovery from the use of alcohol, cocaine, heroin,
or other drugs. Changes associated with aging, such as the number of losses that
increase with age, and the onset of chronic illness may be perceived as stressors
and become “triggers,” placing the individual at risk for relapse. Nurses should
be aware of situations and stressors thatmaypredispose an individual to relapse.
In this discussion, the term drug encompasses OTC medications, prescription
medications, nicotine, alcohol, and illicit drugs. Herbs and food supplements
are also being used frequently, especially by older adults. Whereas the chemi-
cal composition of drugs of abuse is essential to understanding their effects of
mind and body, this chapter focuses primarily on drug misuse and the effects
and consequences of excessive use for health, as well as appropriate nursing
assessment and intervention strategies. Please reference www.nih.nida.gov for
a full listing of drugs of abuse and their chemical attributes.
Drug Misuse
Drugmisuse, defined as use of a drug for reasons other than forwhich it was pre-
scribed, occurs with increasing frequency with advancing age because (1) pre-
scriptions formultiplemedications and cognitive changes, ranging from “benign
senile forgetting” to early signs of dementia, can lead to medication misuse; (2)
failure to discard expired medications; (3) trading medications with friends and
companions; and (4) combinations of medication and alcohol. The most com-
mon resulting problems are related to overdose, additive effects, and adverse
reactions to drugs used or drug interactions, especially with alcohol. Although
people older than 65 comprise only 13% of the population, they are prescribed
more than 33% of all prescription drugs, and the nonmedical use of prescription
drugs is increasing in persons older than 60 (NIDA, 2007 [Level V]). Among
older women who misuse medications and alcohol, as high as 30% developed
such habits after age 60 (CASA, 1998 [Level IV]).
Taking numerous drugs formultiplemedical conditions (i.e., polypharmacy)
maybe complicatedby anolder person’s use of alcohol or illicit drugs (Lang, 2001
[Level VI]). Prescription drug use/misuse contributes to falls, the second most
common cause of death and cognitive impairment in American adults (NIDA,
2007 [Level V]). In people age 18 to 70 treated for falls, 40% of men and 8% of
women tested positive for alcohol, benzodiazepines (9% vs 3%), or both (3% vs
0.3%) (Kursthaler et al., 2005 [Level IV]).
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Smoking and Nicotine Dependence
Today’s older Americans have smoked at rates among the highest of any U.S.
generation (American Lung Association, 2006 [Level IV]), resulting in many
health problems and contributing to the estimated 438,000 American deaths an-
nually caused by smoking (CDC, 2005 [Level V]). An older adult’s vulnerability to
the effects of smoking varies by gender withmen beingmore than twice as likely
as women to die of stroke secondary to smoking (American Lung Association,
2003 [Level IV]). The risk of dying of a heart attack for men 65 and older is twice
that for women smokers and 60% higher than for nonsmoking men of the same
age. Smokers also have higher risk than nonsmokers for Alzheimer’s disease or
other types of dementia, as well as visual problems (CDC, 2005 [Level V]).
Polysubstance Abuse
Polysubstance abuse, the misuse, abuse, or dependence of three or more drugs,
is not uncommon in older adults. In older people, prescription analgesics are
frequently used for chronic pain and can induce dependence, depending on the
class of drug being used. Pain is a common complaint in older people; older
problem drinkers report more severe pain, greater disruption of activities due
to pain, and the frequent use of alcohol to manage pain (Brennan, Schutte, &
Moos, 2005 [Level III]). These findings underscore the importance ofmonitoring
the drinking behavior of patients who present with pain complaints, especially
those with a history of alcohol abuse or dependence. Examples of substances
that older adults often self-administer are alcohol, tobacco, benzodiazepines,
marijuana, and analgesic opioids.
Assessment of Substance-Use Problems
History
Nurses should review data obtained on the most recent nursing and medical
histories and findings of the most recent physical examination. When patients
are using excess alcohol, there will be deviations in standard liver-function
tests (LFTs) and elevations in gamma glutamyltransferase (GGT) and carbo-
hydrate deficient transferrin (CDT) levels (Godsell, Whitfield, Conigrave, Han-
ratty, & Saunders, 1995 [Level III]). Patients who report use of marijuana and/or
other drugs should have toxicology tests to establish baseline use level. Findings
should be the basis for brief interventions and counseling.
Nurses in clinical practice need to note frequent changes in habits of drug
use and note these in substance-use histories, dating from first use to the cur-
rent situation. Nurses should ask if an individual ever experienced problems
related to drug or alcohol use, spontaneously stopped using a drug or alcohol,
or is in recovery and participating in self-help programs, such as Alcoholics
Anonymous or Narcotics Anonymous.
In taking the patient history, it is important that the nurse ask the pa-
tient about a history of smoking, alcohol use, OTC medications, prescrip-
tion and recreational drugs, and herbal and food/drink supplement use. The
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Quantity-Frequency Index (described herein) should be used to record such in-
formation. Another helpful technique in assessing drug use is the Brown Bag
technique (see chapter 12, Reducing Adverse Drug Events). Ask patients to bring
in a brown bag containing all of the prescribed, OTC, food supplements, and
other legal/illicit drugs that they consume weekly. Use this material to develop
the history and to discuss the implications of the drug use with patients. Be sure
to talk with patients about what the use of any drug means to them—that is, if
the drug is used to relieve pain, feelings of loneliness, or anxiety (Brennan et al.,
2005 [Level III]).
Screening
Screening for alcohol and/or other drug-related problems by nurses, physi-
cians, and other care providers is infrequent in primary and secondary care
settings as well as on admission to hospitals or long-term-care facilities (McG-
lynn et al., 2003 [Level III]). Health providers, family members, and friends
may overlook substance-related problems in older persons because they do
not disrupt their lives or are not clearly linked to physical disorders. Be-
cause health professionals are often pessimistic that older persons can change
long-standing behaviors, they do not raise questions about drug and alcohol
use; therefore, drug-using patterns are not clearly linked to health problems
such as COPD, stroke, or depression. Evidence suggests that many health pro-
fessionals doubt the effectiveness of alcohol or drug treatment (Vastag, 2002
[Level V]).
Now, however, alcohol and other drug disorders are more often recognized
as chronic conditions, characterized by slips and relapses, which respond to
treatment (McLellan, Lewis, O’Brien, & Kleber, 2000 [Level VI]). Interventions
and treatment must be matched to exacerbations of the disease and stages of
recovery. Screening identifies risky drug use or heavy drinking and abuse and
dependence (i.e., addiction).
Screening Tools for Alcohol and Drug Use
A Quantity-Frequency Index such as the Khavari Alcohol Test (described next)
asks respondents to report their usual frequency of drinking, the usual amount
consumed per occasion, the maximum amount consumed on any one occasion,
and the frequency of the maximum amount (NIAAA, 2003 [Level VI]).
The Khavari Alcohol Test (KAT)
The KAT (Khavari & Farmer, 1978 [Level VI]) consists of the four questions
noted previously that are asked for each type of beverage (beer, wine, spirits,
liqueurs) and can be administered in 6 to 8 minutes. The amounts can then be
comparedwithNIAAAnorms for persons older than 65, which are one drink per
day for men and women and nomore than three drinks per occasion (USDHHS,
2005 [Level VI]).
Additional questions, such as (1) “Did you ever feel you had a problem re-
lated to alcohol or other drug use?,” and (2) “Have you ever been treated for an
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alcohol or drug problem?,” can also reveal personal information about problems
and treatment related to drug use.
The Michigan Alcohol Screening Test-Geriatric Version (MAST-G)
TheMAST-G is an effective tool for screening elders in all settings. The complete
drug-use history should be used in comprehensive assessment. The original in-
strument fromwhich this was derived has a sensitivity of 93.9% and a specificity
of 78.1% (Blow et al., 1992 [Level III]).
Alcohol Use Disorders Identification Test (AUDIT)
This 10-item questionnaire has good validity in ethnically mixed groups and
scores classify alcohol use as hazardous, harmful, or dependent. Administration:
2 minutes (Saunders, Aasland, Babor, de la Fuente, & Grant, 1993 [Level III]).
The AUDIT has been found to have high specificity in adults older than 65
(Babor, Biddle, Saunders, & Monteiro, 2001 [Level IV]).
Fagerstrom Test for Nicotine Dependence (FTND) (revised)
This six-question scale provides an indicator of the severity of nicotine depen-
dence (Scores of 0–2, Very Low, to 8–10, Very High). The questions inquire as to
first use early in the day, amount and frequency, inability to refrain, and smok-
ing despite illness. This instrument has good internal consistency and reliability
in culturally diverse, mixed-gender samples (Pomerleau, Carton, Lutzke, Fless-
land, & Pomerleau, 1994 [Level V]).
Intervention and Care Strategies
Because drug and alcohol use affects physical, mental, spiritual, and emotional
health, interdisciplinary collaboration is essential to the success of all treatment
modalities used for substance-use disorders and related problems. Primary-
care providers, psychologists, dentists, nurses, and social workers should all be
equipped to detect and refer a problem, and all dimensions of health should
be addressed during treatment and aftercare. This is especially true for older
persons who are disinclined to seek or continue care with mental health or
addictions specialists. Interventions with older adults need to be flexible, indi-
vidualized, and implemented over time. Brief interventions, such as Frames, and
motivational interviewing have been found to be equally effective in producing
short-term reduction in alcohol consumption for older as well as younger per-
sons and for both men and women (Ballesteros, Gonzalez-Pinto, Querejeta, &
Arino, 2004; Wutzke, Conigrave, Saunders, & Hall, 2002 [Level I]).
Researchfindings suggest that once enrolled in treatment for alcohol depen-
dence, however, older people treated in chemical-dependency programs with
Naltrexone and individualized, supportive, medically based psychosocial inter-
ventions have better outcomes than younger patients (Oslin, Pettinati, & Volpo-
licelli, 2002; Satre, Arean, & Weisner, 2004 [both Level III]).
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Inpatient Hospitalization
An older adult who suddenly stops consuming more than 10 ounces of alcohol a
day for a week experiences symptoms of withdrawal and has a greater duration
of symptoms than younger people. Onset of withdrawal may be as early as 4 to
8 hours after the last drink and can persist up to 72 hours. A key determination
is whether the patient requires detoxification. This clinical judgment is made
following a history, including history of drug and alcohol use, and physical and
mental-status assessments.
A 10- to 28-day period of acute-care hospitalization in a mental health unit
or alcohol and drug treatment center is indicated for an older person addicted
to alcohol, benzodiazepines, heroin, amphetamines, or cocaine when (1) the
living situation and access to the drug makes abstinence unlikely, (2) a like-
lihood of severe withdrawal symptoms, (3) co-morbid physical or psychiatric
diagnoses such as depression and accompanying suicidal ideation are present,
(4) daily ingestion of alcohol or a sedative hypnotic has been above the rec-
ommended doses for 4 weeks or more, and (5) mixed addiction, as in alcohol
and benzodiazepines or cocaine and alcohol. It is helpful if programs specifi-
cally designed tomeet the needs of older persons are available (USDHHS, 2004a
[Level VI]).
Ambulatory Care
People dependent onalcohol, tobacco, andheroin canbe successfullywithdrawn
in community-based care through the collaboration of amedical doctor or nurse
practitioner and family members and friends. Specialists in addiction should
be sought as supervisors/collaborators in the process. Older persons drinking
at risky levels or abusing alcohol or other drugs are generally treated in the
community. Tobacco cessation protocols are now available directly to consumers
as well as to primary-care providers and mental health professionals.
Residential Treatment
Residential treatment is available in specialty care centers, therapeutic com-
munities, and some long term care facilities. Programs designed specifically
for the older person, although not numerous, are beneficial in their focus on
the specific challenges to abstinence that an older person faces, such as the
long-standing nature of the habits of use, a diminished social network, and chal-
lenges to financial and health resources.
Therapeutic Communities
Therapeutic communities provide long-term (up to 18 months) treatment and
are abstinence-oriented programs. They use 12-Step Models of individual and
group counseling, as well as participation in a social community, to address
drug-related problems. For the isolated, older drug user with a history of fre-
quent relapse, these are good treatment options.
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Pharmacological Treatment
Agents for pharmacological treatment of substance abuse and dependence are
more numerous than previously but not all are appropriate for use with elders.
The best outcomes of pharmacological interventions occur when they are used
with individual and/or group counseling. Attendance at 12-step programs also
enhances adherence to treatment regimens.
Alcohol Abuse/Dependence Pharmacological Treatment
Alcohol Dependence: Naltrexone, in the form of Revia, is used to decrease crav-
ings in heavy drinkers and is now available in injectable form, Vivitrex. Viv-
itrex is an extended-release formulation of naltrexone that acts up to 28 days
to decrease the euphoric effects of and craving for alcohol (Bartus et al., 2003).
Evidence suggests that it is well tolerated by older people who do not have renal
problems. Study findings stress the importance of psychosocial interventions to
improve adherence to pharmacologic interventions for alcohol dependence, a
finding similar to those regarding smoking cessation (Reid, Teeson, Sannibale,
Matsuda, & Haber, 2005 [Level III]). Acamprosate (Campral), a recent addition
to prescription drug choices, has appeared promising but outcomes in reducing
the craving and consumption of alcohol are variable. Antabuse or Disulfiram
to deter alcohol consumption produce an elevation in vital signs and severe
gastrointestinal symptoms if alcohol is ingested and is poorly tolerated by an al-
coholic older than 55. In addition, it must be taken every day if aversive effects
on consumption are to occur.
Opioid Dependence: The use of methadone, an opioid agonist, assists the
opioid-dependent person to focus on psychological and life problems. The drug
Buprenorphine, both an opioid antagonist and agonist, is longer acting and now
available. Involvement in psychosocial treatment may assist in patient adher-
ence to pharmacologic treatment (Mayer, Farrell, Ferri, Amato, & Davoli, 2005
[Level I]).
Smoking: Buproprion in doses of 75 mg with administration begun 2 weeks
before the smoker intends to quit has proved a helpful adjunct to smoking cessa-
tion (NYC DH&MH, 2002 [Level III]). Nicorette transdermal patches and nico-
tine gum are now available OTC and there is research support for their pharma-
cological contribution to smoking cessation. The best outcomes with smoking
cessation are a combination of individual or group psychosocial support and the
medications described herein (NYC DH&MH, 2002 [Level III]).
Individualized Plan of Care
Individualized care plans should be developed for elders at risk for substance
abuse or dependence in accord with the classes of drugs used and the severity of
the disorders. Guidelines for all interventions should include the following:
■ A nonjudgmental, health-oriented approach to substance-related prob-
lems. Drug/alcohol use and abuse are highly stigmatized in American
society, particularly in minority communities, leading to denial and/or re-
jection by family members. When nurses and other health professionals
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understand addiction as a disease, approaches similar to care for other
chronic illness can be planned.
■ A supportive, encouraging approach to the possibilities of changing use
habits. Using the Stages of Change Model helps the patient/client under-
stand that change occurs in stages and that support and assistance are
available at each stage (Prochaska & Di Clemente, 1992 [Level II]).
■ Education of patient and family on the risks associated with drug mis-
use in older people. Because older persons use so many medications, the
potential health consequences may be minimized in the eyes of others.
■ Assessment of substance use in relation to lifestyle, existing chronic ill-
nesses, nutritional patterns, sleep, exercise, sexual patterns, and recre-
ation. Counsel the patient and/or family about the effects of substances
used in these areas of the patient’s life.
■ Set the goal of “Harm Reduction” in the forms of decreased use and su-
pervised use if abstinence is not imperative or achievable.
■ Monitor substance-use patterns at each encounter or visit, documenting
changes and providing reinforcement of positive changes and/or move-
ment toward treatment.
■ Enhance the involvement of members of the patient’s support system,
including family and friends identified by the patient, community-based
groups, support groups, appropriate clergy, or organizational groups such
as senior centers.
■ Support the development of coping mechanisms, including modifications
in social, housing, and recreational environments, to minimize associ-
ations with settings and groups in which substance use and abuse are
common (USDHHS, 2004a [Level VI]).
Counseling and Psychotherapy
Older people tend to seek care from their primary care, medical specialist,
or nurse/nurse practitioner provider even in regard to assistance with mental
health and substance-related problems. This practice relates to old beliefs about
depression or anxiety being manifestations of weakness or lack of character.
Excess use of alcohol or use of an illicit drug or misuse of prescriptions
drugs remain socially stigmatized, especially among older persons. Counseling
done by the nurse using a brief intervention model or supportive counseling
is more readily acceptable to older patients than referral to mental health or
substance-abuse clinics.
Optimally, short-term psychotherapy by a practitioner knowledgeable in
substances and their problematic use is extremely helpful. The model of cog-
nitive behavioral therapy, in particular, has demonstrated good outcomes with
excessive drinking and marijuana use (Project Match, 1997 [Level III]). These
approaches assist an older person to modify behavior and to deal with negative
feelings and/or chronic pain that often motivate use.
Treatment Outcomes
Health care providers and older persons may feel pessimistic about the pos-
sibilities of changing their substance-use behavior. Health providers often do
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not intervene because they believe that older people cannot change. Treatment
outcomes for older persons with substance-use problems, however, have been
shown to be as good as or better than those for younger people (Atkinson &
Ganzini, 1994 [Level VI]; Oslin, Liberto, O’Brien, Krois, & Norbeck, 1997 [Level
III]). A compromising factor to good treatment outcomes is the inconsistency
with which aftercare is available to older adults by community and specific to
the needs of older adults.
Case Study and Discussion
Joseph and Mary P., both 71, reside in a small rural community where Mr.
P. owned the only pharmacy. Retired 5 years, Mr. P. suffers from arthritis
and Mrs. P. has mitral valve insufficiency, which frequently results in car-
diac symptoms that are frightening but readily managed. She has also been
treated for generalized anxiety disorder for which she has been prescribed
Paxil. The couple enjoys a nightly cocktail hour at which Mr. P. consumes
two scotch whiskies and Mrs. P. has “wine.” Recently, the visiting nurse who
has been monitoring Mrs. P.’s recovery from a recent episode of congestive
heart failure, received a phone call from their daughter who stated that on
her last three evening phone calls to her parents, Mrs. P. sounded somewhat
confused and her speech was slurred. When the daughter questioned Mr. P.
about their drinking, he became irritable and defensive.
The visiting nurse made it a point to visit the P.’s in the early evening
on her way home. She found them enjoying their cocktails and took the
opportunity to conduct a drug and alcohol assessment, including making a
list of all of their medications. The nurse diagnosed “drug misuse” because
it appears that neither of them considered how their continued alcohol use
was affecting their bodies in older age. She conducted a brief intervention,
giving them feedback about their respective illnesses, pointed out the pros
and cons of modifying their drinking, such as decreasing the gastric distress
Mr. P. experiences, and the benefits of limitedwine intakewhile taking Paxil.
The nurse educated them (building on autonomy and responsibility) about
the relationship between bodily changes and the increased effects of alcohol
on their sleep patterns, mood, and balance. She also pointed out that both
were consuming alcohol above one daily drink and recommended that they
cut down to one standard drink per day. At first, they seemed unhappy about
the recommendation but both committed to attempting to do so. When she
visited 2 weeks later, they had begun to journal their drinking and both were
recording consistent declines in the amount of alcohol consumed.
Summary and Conclusions
Two current trends are predicted to result in an increase in the already sig-
nificant number of men and women older than 55 who experience various
substance-use–related disorders: the growing numbers of older persons in
America, and the continuation of drug and alcohol use patterns established
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earlier in life. Althoughmost people decrease the amount of alcohol and kinds of
drugs they use with age, anywhere from 10% to 24% of older persons do not (US-
DHHS, 2004b [Level VI]). The most common type of substance-use disorders is
heavy drinking, especially by Caucasianmen older than 65 and living alone (US-
DHHS, 2004b [LevelVI]). Thehighnumbers of prescription drugs usedby elders
also pose serious problems related to misuse and drug interactions. Health pro-
fessionals are disinclined to query elders about substance use, with the result
that problems become known in the context of the care of other medical dis-
orders. Nurses in daily contact with institutionalized and community-dwelling
elders must be skilled in screening for and counseling about the use of nicotine,
alcohol, and prescription, illicit, and OTC drugs. Educating patient and family
about health risks and referring patients to specialists and community resources
are essential “best practices.”
Resources
Web sites
AHCPRGuidelines: AHCPR Clinical Practice Guidelines are available to down-
load.
http://www.ahcpr.gov
American Nurses’ Association
http://www.ana.org
American Psychiatric Association
http://www.apa.org
American Psychiatric Nursing Association
http://www.apna.org
Center for Disease Control and Prevention
www.cdc.gov/tobacco/how2quit.htm
National Institute of Mental Health: Download patient teaching materials
for Panic Disorders, Obsessive Compulsive Disorder, Posttraumatic Stress,
Acute Stress, and General Anxiety Disorders
http://www.nih.nimh.gov
National Institute of Alcohol and Alcohol Abuse (NIAAA)
http://www.nih.niaaa.gov
National Institute of Drug Abuse (NIDA)
http://www.nih.nida.gov
Centers for Disease Control and Prevention (CDC)
http://www.cdc.gov/tobacco/how2quit.html
NYC Department of Health
http://www.nyc.gov/htm/doh/html
International Nurses’ Society on Addictions
http://www.intnsa.org/
American Lung Association
http://www.ffsonline.org
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Assessment Tools
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid
Dependence. Download fromhttp://www.guideline.gov/summary/summary.
aspx?ss=15&doc-id=5887&nbr=3873
See GeroNurseOnline, topic Substance Abuse, for assessment tools and other
important resources at http://www.ConsultGeriRN.org
Alcohol Use Disorders Identification Test (AUDIT Tool) AUDIT: Saunders, J.
B., Asland, O. G., Babor, T. F., et al. 1993 [Level III]). WHO collaborative
project on early detection of persons with harmful alcohol consumption II.
Development of the screening instrument AUDIT. Addiction, 88, 79–804.
Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-
AR). (Sullivan, Sykora, Schneiderman, Naranjo, & Sellers, 1989 [Level III]).
Downloaded from http://209.85.165.104/search?q=cache:ypb-pA96p3EJ:
images2.clinical tools.com/images/pd.
Quantity-Frequency Index: The Khavari Alcohol Test (KAT) (Khavari & Farmer,
1978)
FagerstromTest for Nicotine Dependence (FTND) (revised 1991). Access online
at American Psychiatric Association PsychNET 2002 at http://www.apa.org/
videos/fagerstrom.html
FRAMES: Dyehouse, J., Howe, S., & Ball, S. (1996 [Level VI]). FRAMES model
in the Training Manual for Nursing Using Brief Intervention for Alcohol
Problems. U.S. Department of Health and Human Services: Rockville, MD.
Access online at SAMHA (Substance Abuse and Mental Health Associa-
tion) Pathways Courses: SilenceHurts. http://pathwayscourses.samhsa.gov/
vawp/vawp supps pg20.htm
SMAST: Naegle, M.A. (2003).Try This: Best practices in nursing care of older
adults: Alcohol use screening and assessment, Issue # 17. A series provided
byTheHartford Institute forGeriatricNursing.NewYorkUniversityCollege
ofNursing. http://www.ConsultGeriRN.org/publications/trythis/issue17.pdf
Guidelines
TheNational Quality Forum is completing review for “Evidence-based practices
to treat substance use disorders.” These guidelines are inclusive of primary
care, the settings in which most elders seek treatment. Accessed March
29, 2007, from http://www.qualityforum.org/projects/completed/substance
abuse.asp
The following guidelines were accessed March 29, 2007, from AHRQ/NGC Web
site at www.guideline.gov:
■ Elder abuse prevention. University of Iowa Gerontological Nursing In-
terventions Research Center, Research Translation and Dissemination
Core– Academic Institution. 2004 Dec. 68 pages. NGC:004196 or access
hardcopy from Gerontological Nursing Interventions Research Center
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(GNRIC) at University of Iowa. Accessed March 29, 2007, from http://
www.nursing.uiowa.edu/centers/gnirc/rtdcore.htm
■ Screening and ongoing assessment for substance use. New York State
Department of Health—State/Local Government Agency (U.S.). 2005Mar.
11 pages. NGC:004202. Accessed May 3, 2007, from http://www.guideline.
gov/summary/summary.aspx?doc id=6848&nbr=004202&string=
alcohol+AND+abuse
■ Management of alcohol withdrawal delirium. An evidence-based practice
guideline. American Society of Addiction Medicine—Medical Specialty
Society. 2004 Jul 12. 8 pages. NGC:004109. Accessed May 3, 2007, from
http://www.guideline.gov/summary/summary.aspx?doc id=6543&nbr=
004109&string=alcohol+AND+abuse
■ Detoxification and substance abuse treatment: An overview of the psy-
chosocial and biomedical issues during detoxification. Substance Abuse
and Mental Health Services Administration (U.S.)—Federal Government
Agency (U.S.). 2006. 23 pages. NGC:004931. Accessed May 3, 2007, from
http://www.guideline.gov/summary/summary.aspx?doc id=9117&nbr=
004931&string=alcohol+AND+abuse
■ Screening andmanagement of substance use disorders. Michigan Quality
Improvement Consortium. 2003 Aug. (revised 2005 Aug.). 1 page. NGC:
004548. Accessed May 3, 2007, from http://www.guideline.gov/summary/
summary.aspx?doc id=8161&nbr=004548&string=alcohol+AND+abuse
■ Medication-assisted treatment for opioid addiction in opioid treatment
programs: Clinical pharmacotherapy. Substance Abuse andMental Heal-
th Services Administration (U.S.)—Federal Government Agency (U.S.).
2005. 23 pages. NGC:004672. Accessed May 3, 2007, from http://www.
guideline.gov/summary/summary.aspx?doc id=8349&nbr=004672
&string=alcohol+AND+abuse
■ Medication-assisted treatment for opioid addiction in opioid treatment
programs: Phases of treatment. Substance Abuse andMental Health Ser-
vices Administration (U.S.)—Federal Government Agency (U.S.). 2005.
20 pages. NGC:004674. Accessed May 3, 2007, from http://www.guideline.
gov/summary/summary.aspx?doc id=8351&nbr=004674&string=alcohol+
AND+abuse
■ Medication-assisted treatment for opioid addiction in opioid treatment
programs: Drug testing as a tool. Substance Abuse and Mental Health
ServicesAdministration (U.S.)—Federal GovernmentAgency (U.S.). 2005.
17 pages. NGC:004676. Accessed May 3, 2007, from http://www.guideline.
gov/summary/summary.aspx?doc id=8353&nbr=004676&string=alcohol+
AND+abuse
■ Detoxification and substance abuse treatment: Settings, levels of care,
and patient placement. Substance Abuse andMental Health Services Ad-
ministration (U.S.)—Federal Government Agency (U.S.). 2006. 10 pages.
NGC:004930. Accessed May 3, 2007, from http://www.guideline.gov/
summary/summary.aspx?doc id=9116&nbr=004930&string=alcohol+
AND+abuse
■ Medication-assisted treatment for opioid addiction in opioid treatment
programs: Approaches to providing comprehensive care and maximizing
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patient retention. Substance Abuse and Mental Health Services Ad-
ministration (U.S.)—Federal Government Agency (U.S.). 2005. 22 pages.
NGC:004675. Accessed May 3, 2007, from http://www.guideline.gov/
summary/summary.aspx?doc id=8352&nbr=004675&string=alcohol+
AND+abuse
■ Substance abuse treatment and family therapy. Substance Abuse and
Mental Health Services Administration (U.S.)—Federal Government
Agency (U.S.). 2004. 232 pages. NGC:003872. Accessed May 3, 2007, from
http://www.guideline.gov/summary/summary.aspx?doc id=5886&nbr=
003872&string=alcohol+AND+abuse
Older Americans Substance Abuse and Mental Health Technical
Assistance Center
Evidence-Based Practices for Preventing Substance Abuse and Mental Health
Problems in Older Adults
http://www.samhsa.gov/OlderAdultsTAC/EBPLiteratureReviewFINAL.pdf
Box 29.1
Nursing Standard of Practice Protocol: Substance
Abuse in Older Adults
I. GOAL: Implement best nursing practices to care for older persons with
drug, alcohol, tobacco, or other drug abuse or dependencies.
II. OVERVIEW
A. Several factors increase the risks associated with alcohol and drug
use for an older individual, making any drug use in circumstances
that, earlier in life were commonplace, potentially harmful. Consti-
tutional risk factors include changes in body composition like de-
creased muscle mass, decreased organ efficiency (especially kidney
and liver), and increased vulnerability of the central nervous system
(Lang, 2001 [Level VI]; Kennedy, 2000 [Level IV]).
B. The consequences of alcohol use in combination with other drugs
and excessive use include falls, impaired cognition, malnourish-
ment, and decreased resistance to disease, interpersonal, and legal
problems (Kennedy, 2000 [Level IV]).
C. At-risk drinking for older adults increases the likelihood of nega-
tive health consequences and is defined as more than one drink per
day, 7 days a week, or more than three drinks on any one occasion
(USDHHS, 2004 [Level V]).
D. Any amount of smoking places older persons at risk for negative
health consequences, and advancing age increases the likelihood of
the emergence of respiratory and cardiovascular illnesses.
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III. BACKGROUND/STATEMENT OF PROBLEM
A. Definitions
1. Substance Use Disorders: A broad category of disorders that in-
clude a continuum of use or misuse of alcohol, tobacco, prescrip-
tion or illicit drugs, and the abuse or dependence on these drugs
(modified from APA, 2000).
2. Substance Abuse: A maladaptive pattern of substance use evi-
denced in recurrent and significant adverse consequences re-
lated to the repeated use of substances. It is associated with re-
peated failure to fulfill role obligations, use in situations where
use is physically hazardous, and/orwhen it results in legal and/or
interpersonal problems (modified from APA, 2000).
3. Substance Dependence: A pattern of self-administration of a drug
that is maladaptive and results in the development of tolerance,
withdrawal, and compulsive drug-taking behavior. Dependence
is both physiologic and psychological (modified fromAPA, 2000).
4. DrugMisuse: Use of a drug for purposes other than that for which
it was intended.
5. Polysubstance-Related Disorder: Misuse, abuse, or dependence
on three or more drugs (modified from APA, 2000).
6. Tolerance: (1) A need for markedly increased amounts of a sub-
stance to achieve intoxication or the desired effects, or (2) a
markedly diminished effects with the continued use of the same
amount of a substance (APA, 2000).
7. Withdrawal: A characteristic group of signs and symptoms that
has its onset following the sudden cessation of consumption of
a drug (including alcohol and nicotine) that induces physiologic
dependence (APA, 2000).
8. At-Risk Drinking: Defined as more than one drink per day, 7
days a week, or more than three drinks on any one occasion.
For elders, at-risk drinking increases the likelihood of negative
health consequences (Fleming, Manwell, Barry, & Johnson, 1998
[Level III]).
B. Etiology and/or Epidemiology
1. In 1998, the prevalence of alcoholism, alcohol abuse, or prob-
lem drinking in persons aged 60+ was estimated at 5% to 10% in
community studies. Approximately 11% of men and 9% of women
75 years and older report heavy use, placing them “at risk” for a
range of problems (Fleming et al., 1998 [Level III]).
2. Excessive drinking among individuals of all ethnic groups 65+
years is approximately 7%, down from 12% in persons ages 55 to
64 (NYC DH&MH, 2005).
3. 500,000 persons ages 55 and older reported monthly use of illicit
drugs in the National Household Survey of Drug Use National
Institute of Drug Abuse (NIDA, 2001).
4. Approximately 11% of women older than 59 misuse psychoactive
drugs (Fingeld-Connett, 2004 [Level IV]).
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C. Risk Factors (USDHHS, 2004b [Level VI])
1. Family history of dependence on alcohol, tobacco, prescription
or illicit drugs
2. Co-occurrence of addictionwith dependency or abuse of another
substance dependence (i.e., alcohol and tobacco)
3. Lifelong pattern of substance use, including heavy drinking
4. Male gender
5. Social isolation
6. Recent and multiple losses
7. Chronic pain
8. Co-occurrence with depression
9. Unmarried and/or living alone
IV. PARAMETERS OF ASSESSMENT
A. Screening for alcohol, tobacco, and other drug use is recommended
for all community-dwelling and hospitalized older adults. It is es-
sential that the nurse:
1. state the purpose of questions about substances used and link
them to health and safety
2. be empathic and nonjudgmental
3. ask the questions when the patient is alcohol- and drug-free
4. inquire re: patient’s understanding of the question (Aalto, Pekuri,
& Seppa, 2003 [Level III])
B. Assessment/Screening Tools
1. The Quantity-Frequency Index (Khavari & Farber, 1978 [Level
VI]): Review all classes of drugs: alcohol, nicotine, illicit drugs,
prescriptiondrugs,OTCdrugs and vitamin supplements, for each
drug used. Record the Types of drugs, including types of bever-
ages; Frequency: the number of occasions on which the drug is
consumed (daily, weekly, monthly); Amount of drug consumed on
each occasion during the last 30 days. The psychological function
that the substance serves for the individual is also important to
identify. TheQuantity-Frequency Index tool should be part of the
intake nursing history. The Brown Bag approach is useful. The
patient is asked to bring all drugs and supplements listed herein
to the interview with the provider (Armor, Polish, & Stambul,
1978 [Level VI]).
2. Short Michigan Alcohol Screening Test-Geriatric Version
(SMAST-G):
Highly valid and reliable, this is a 10-item tool that can be used in
all settings. Threeminutes for administration. This instrument is
derived from theMAST-Gwith a sensitivity of 93.6% and positive
predictive values of 87.2% (Blow et al., 1992 [Level III]).
3. Alcohol Use Disorders Identification Test (AUDIT):
This 10-item questionnaire has good validity in ethnically mixed
groups and scores classify alcohol use as hazardous, harmful, or
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dependent. Administration: 2 minutes. Sensitivity scores range
from 0.74% to 0.84% and specificity around 0.90% in mixed age
and ethnic groups (Allen, Fertig, Litten, & Babor, 1997 [Level
III]). This instrument is highly effective for use with elders as
well (Roberts, Marshall, & MacDonald, 2005 [Level III]).
4. Fagerstrom Test for Nicotine Dependence (Pomerleau, et al.,
1994 [Level V]):
This six-question scale provides an indicator of the severity of
nicotine dependence (Scores of 0–2, Very low, to 8–10, VeryHigh).
The questions inquire as to first use early in the day, amount
and frequency, inability to refrain, and smoking despite illness.
This instrument has good internal consistency and reliability in
culturally diverse, mixed-gender samples (Pomerleau et al., 1994
[Level V]).
C. Atypical Presentation:
Men and women older than 65 may have substance-use and de-
pendence problems even though the signs and symptoms may not
correspond to those listed in the DSM-IV TR.
D. Signs of CNS Intoxication (i.e., slurred speech, drowsiness, un-
steady gait, decreased reaction time, impaired judgment, disinhi-
bition, ataxia):
1. Assess in individual or collateral (speakingwith familymembers)
data collection, consumption of amount and type of depressant
medications including alcohol, sedatives, hypnotics, and opioid
or synthetic opioid analgesics.
2. Assess vital signs and determine respiratory, cardiac, or neuro-
logical depression.
3. Assess for treatable existing medical conditions, including de-
pression.
4. Arrange for emergency room/hospitalization treatment as nec-
essary.
5. Obtain urine for toxicology, if possible.
E. At-risk Drinking Consumption of alcohol in excess of one drink per
day for seven days a week or more than three drinks on any one
occasion (USDHHS, 2005 [Level VI]).
1. Assess for readiness to change behavior using Stages of Change
Model (Prochaska & Di Clemente, 1992 [Level II]).
2. Is drinker concerned about amount or consequences of the
drinking? Has she/he contemplated cutting down?
3. Does she/he have a plan for cutting down/stopping consump-
tion?
4. Has he/she previously stopped but then resumed risky
drinking?
5. Personalized feedback and education and education on at-risk
drinking results in a reduction in at-risk drinking among older
primary-care patients (Fink et al., 2005 [Level III]).
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F. Signs of Withdrawal of CNS Depressant Drugs (including alcohol
such as tremors, disorientation, tachycardia, irritability, anxiety, in-
somnia, moderate diaphoresis):
1. May develop extreme CNS stimulation and progress to seizures,
hallucinosis, withdrawal delirium, extreme hypertension, pro-
fuse diarrhea, from 4 to 8 hours and for up to 72 hours following
cessation of alcohol intake (Delirium Tremens/DTs).
2. Assess for risk factors: (a) previous episodes of detoxification,
(b) recent heavy drinking, (c) medical co-morbidities including
liver disease, pneumonia, anemia, (d) previoushistory of seizures
or delirium (Wetterling, Weber, Depfenhart, Schneider, & Jung-
hanns, 2006 [Level III]).
3. Assess neurological signs using the CIWA-AR. This Clinical In-
stitute Withdrawal Assessment of Alcohol Scale, revised (CIWA-
Ar), is a 10-item rating scale that delineates symptoms of
gastric distress, perceptual distortions, cognitive impairment,
anxiety, agitation, and headache (Sullivan, Sykora, Schneider-
man, Naranjo, & Sellers, 1989 [Level III]).
4. Medicate with a short-acting benzodiazepine (Lorazepam or Ox-
azepam) in doses titrated to patient’s score on theCIWA, patient’s
age and weight (Sullivan et al., 1989 [Level III]).
G. Reported Sleep Disturbance, Anxiety, Depression, Problems with
Attention and Concentration (Acute Care):
1. Assess for neuropsychiatric conditions using the Mental Status
exam, Geriatric Depression Scale, or Hamilton Anxiety Scale.
2. Obtain sleep history because drugs disrupt already altered sleep
patterns in older persons.
3. Assess intake of all drugs, including alcohol, OTC, prescription,
herbal and food supplements, and nicotine. Use BrownBag strat-
egy.
4. If positive for alcohol use, assess for last time of use and amount
used.
5. Assess for alcohol or sedative drug withdrawal as indicated.
H. Smoking Cigarettes or Using Smokeless Tobacco:
1. Assess for level of dependence using the Fagerstrom Test (See
tool above).
V. NURSING-CARE STRATEGIES
A. At-risk Drinking (consumption of alcohol in excess of one drink
per day for seven days a week or more than three drinks on any one
occasion.):
1. Hydratewith clear fluid p.o. as indicated. Limit use of intravenous
fluid except as necessary. Hospitalize if:
a. Blood alcohol level (BAL) >100 mg/dL
b. Severe withdrawal symptoms
c. Suicidal ideation or attempts
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d. Co-morbid conditions that compromise treatment
e. Polysubstance dependence
2. Conduct Brief Intervention (FRAMES) (Dyehouse, Howe, & Ball,
1996 [Level VI]):
a. Feedback information to patients about current health prob-
lems or potential problems associated with their level of con-
sumption.
b. Responsible choice about how to respond to the information
provided to the patients is their choice.
c. Advice must be clear about drinking their amounts and rec-
ommended moderate levels of drinking.
d. Menu of choices is provided by the nurse to the patient/client
regarding future drinking behaviors.
e. Empathy is essential to the exchange. Offer information based
on scientific evidence, acknowledge the difficulty of change,
avoid confrontation.
f. Self-efficacy of the individual is supported and thenursehelps
patient explore options for change.
B. Smoking cigarettes or using smokeless tobacco.
1. Apply the Five A’s Intervention (AHCPR Guidelines):
a. Ask: Identify and document tobacco use.
b. Advise: Urge the user to quit in a strong personalized manner.
c. Assess: Is the tobacco user willing to make a quit attempt at
this time?
d. Assist: If user iswilling to attempt, refer for individual or group
counseling and pharmacotherapy.
e. Arrange: Referrals to providers, agencies, and self-help
groups. Monitor pharmacotherapy once quit date is estab-
lished. FDA-approved pharmacotherapies for smoking ces-
sation are:
■Bupropion SR (Zyban) and nicotine replacement products
such as nicotine gum, nicotine inhalers, nicotine nasal spray,
and nicotine patch. Psychoeducation about these medica-
tions is essential.
■Zyban, for example, should not be combined with alco-
hol. Nurses working with in-patients in a case-management
model were found to produce outcomes in smoking cessa-
tion (Smith, Reilly, Houston-Miller, DeBusk, & Taylor, 2002;
Daniel, Cropley, Usher, & West, 2004 [both Level II]).
2. Communicate Caring and Concern:
a. Encouragemoderate intensity exercise as ameans of reducing
cravings for nicotine because 5 minutes of such exercises is
associated with short-term reduction in the desire to smoke
and tobacco withdrawal symptoms (Daniel et al., 2004 [Level
II]).
b. Arrange: Schedule follow-up contact in person or by tele-
phone within 1 week after planned quit date. Continue
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telephone counseling for thoseusingnicotinepatches (Cooper
et al., 2004; Boyle et al., 2005 [Level III]).
C. SmokingMarijuana: Little research regarding effective intervention
for psychological dependence onmarijuana is available. Some guid-
ance can be found in smoking cessation and self-help approaches.
1. Refer to Steps for Smoking Cessation.
2. Refer patient to addiction specialist for counseling for psycho-
logical dependence and/or cognitive-behavioral therapy.
3. Refer to community-based self-help groups such as Narcotics
Anonymous, Alcoholics Anonymous, and Al-Anon.
4. Encourage development or expansion of patient’s social support
system.
D. Heroin or Opioid Dependence
1. Older long-term opioid usersmay relapse and require treatment.
MethadoneorBuprenorphine are current pharmacological treat-
ment options, effective in conjunction with self-help programs
and/or psychosocial interventions (Clinical Guidelines for the
use of Buprenorphine in the treatment of opioid addiction, 2006
[Level IV]).
2. Treatment with methadone, a synthetic narcotic agonist, sup-
presses withdrawal symptoms and drug cravings associated with
opioid dependence but requires daily dosing of 60mg, minimum.
It is dispensed only in specially licensed clinics.
3. Buprenorphine (Subutex or Suboxone), recently approved for
use in office practice by trained physicians, is an opioid par-
tial agonist-antagonist. Alone and in combination with Nalox-
one (Suboxone), it can preventwithdrawalwhen someone ceases
use of an opioid drug and can be used for long-term treatment.
Naloxone is an opioid antagonist used to reverse depressant
symptoms in opiate overdose and at different dosages to treat
dependence.
■ Close collaboration with the prescriber is required because
these drugs should not be abruptly terminated, used with
antidepressants, and interact negatively with many prescrip-
tion medications.
4. Naltrexone, a long-acting opioid antagonist, blocks opioid ef-
fects and is most effective with those who are no longer opioid-
dependent but are at high risk for relapse (Srisurapanont &
Jarusuraisin, 2005 [Level III]).
5. Treatment of an older patient who has become addicted to oxy-
contin or other opioids should be done in consultation with an
addictions specialist nurse or physician.
a. It is recommended that the prescriber avoid opioids and the
synthetic opioids Demerol, Dilaudid, and Oxycontin. The opi-
oids have high potential for addiction and Demerol has been
associated with delirium in elders (Collins & Kleber, 2004
[Level VI].
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b. Barbiturates should be avoided for use as hypnotics and the
use of benzodiazepines for anxiety should be limited to 4
months (USDHHS, 2004b [Level VI]).
E. Relapse Prevention
1. Monitor pharmacologic treatment such as Naltrexone as short-
term treatment for alcohol dependence. Thebenefits of this treat-
ment are dependent on adherence, and psychosocial treatment
should accompany its use (WHO, 2000 [Level I]). Methadone or
Buprenorphine should be used for long-term treatment of opioid
dependence.
2. Refer to community-based Alcoholics Anonymous, Narcotics
Anonymous, Al-Anon groups, and encourage attendance.
3. Educate family and patient regarding signs of risky use or relapse
to heavy or alcohol-dependent behavior.
4. Counsel patient to reduce drug use (Harm Reduction) and en-
gage in relationship healing/building, community or intellectu-
ally rewarding activities, spiritual growth, which increase valued
nondrinking rewards.
5. Counsel in the development of coping skills:
a. Anticipate and avoid temptation.
b. Learn cognitive strategies to avoid negative moods.
c. Make lifestyle changes to reduce stress, improve the quality
of life, and increase pleasure.
d. Learn cognitive and behavioral activities to copewith cravings
and urges to use.
e. Encourage development or expansion of patient’s social sup-
port system.
VI. EVALUATION/EXPECTED OUTCOMES
A. Patient will have:
1. Improved physical health and function.
2. Improved quality of life, sense of well-being and mental health.
3. More satisfying interpersonal relationships.
4. Enhanced productivity and mental alertness.
5. Decreased likelihood of falls and other accidents.
B. Nurses will have:
1. Increased accuracy in detecting patient problems related to
use/misuse of substances.
2. Interventions will be more evidence-based resulting in better
outcomes.
C. Institution will have:
1. Increased number of referrals to ambulatory substance-abuse/
mental health treatment programs.
2. Improved links with community-based organizations engaged in
prevention, education, and treatment of elders with substance-
related disorders.
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VII. FOLLOW-UP MONITORING OF CONDITION
A. Evaluate for increase in substance use/misuse associated with
growing numbers of aging adults.
B. Increase outreach to targeted vulnerable populations.
C. Document chronic care needs of elders diagnosed with substance-
related disorders.
D. Monitor alcohol use among older adults with chronic pain (Bren-
nan, Schutte, & Moos, 2005 [Level III]).
E. Communicate findings to all members of the involved caregiver
team.
VIII. GUIDELINES
The National Quality Forum is completing review for “Evidence-based
practices to treat substance use disorders.” These guidelines are inclusive
of primary care, the settings in which most elders seek treatment.
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Appendix
National Geriatric Websites Links
Aging Institutions and Associations
Administration on Aging http://www.aoa.gov
Alzheimer’s Association http://www.alz.org
American Association of
Homes and Services for the
Aging
http://www.aahsa.org
American Association of Retired
Persons
http://www.aarp.org
American Geriatrics Society http://www.americangeriatrics.org
Geriatrics at Your Fingertips
Online Edition
http://www.geriatricsatyourfingertips.org
American Healthcare
Association
http://www.ahca.org
American Medical Directors
Association Resources in
Long-term Care
http://www.amda.com/resources
American Nurses Association http://www.nursingworld.org
The American Society of
Consultant Pharmacists
http://www.ascp.com/resources
American Society on Aging http://www.asaging.org
Building Academic Geriatric
Nursing Capacity
http://www.geriatricnursing.org
Centers for Medicare & Medicaid
Services
http://www.cms.hhs.gov
Gerontological Society of America http://www.geron.org
Hartford Geriatric Nursing
Initiative
http://www.HGNI.org
Hospice and Palliative Nurses
Association
http://www.hpna.org
Institute for Healthcare
Improvement
http://www.ihi.org/ihi
The John A. Hartford Foundation http://www.jhartfound.org
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The John A. Hartford Foundation
Centers of Geriatric Nursing
Excellence:
Oregon Health Sciences
University School of Nursing
http://www.ohsu.edu/hartfordcgne
University of Arkansas for
Medical Sciences College of
Nursing
http://hartfordcenter.uams.edu/
University of California San http://nurseweb.ucsf.edu/www/resrch4
Francisco .htm
University of Iowa College of
Nursing
http://www.nursing.uiowa.edu/hartford
University of Pennsylvania http://www.nursing.upenn.edu/centers/
School of Nursing hcgne
Nursing Gero TIPS http://www.nursing.upen.edu/center/
hcgne/ gero tips
National Chronic Care Consortium http://www.nccconline.org
National Citizen’s Coalition for
Nursing Home Reform
http://www.nccnhr.org
National Conference of
Gerontological Nurse
Practitioners
http://www.ncgnp.org
National Council on Aging http://www.ncoa.org
National Gerontological Nursing
Assciation
http://www.ngna.org
National Institute on Aging http://www.nia.nih.gov
On-line Resources for Geriatric
Healthcare Providers
https://www.geriatricvideo.com
Journals/Magazines/Educational/Resources/Statistics
Hartford Institute for Geriatric
Nursing:
http://www.hartfordIGN.org
research, resources and links
GeroNurseOnline: http://www.hartfordIGN.org
geriatric nursing protocols,
continuing education,resources,
advocacy information, and
affiliated National Nursing
Organizations
American Association of Colleges http://www.aacn.nche.edu/Education/
of Nursing Hartford
American Journal of Nursing: http://www.NursingCenter.com/
New Look at the Old series,
cutting- Edge research/best
practices, in print/video
AJNolderadults
How to Try This series, geriatric
nursing assessment tools,
articles, demonstrations, videos.
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Careplans http://www.careplans.com
Centers for Disease Control and
Prevention Department of
Health and Human Services
http://www.cdc.gov
Clinical Geriatrics http://www.clinicalgeriatrics.com
ElderWeb http://www.elderweb.com/home
Geriatric Nursing http://journals.elsevierhealth.com/
periodicals/ymgn
The Gerontlogist http://gerontologist.gerontologyjournals
.org
Journal of the American Geriatrics http://www.blackwellpublishing.com/
Society journal.asp?ref=0002-8614&site=1
The Joint Commission (JCAHO):
sentinel events, patient safety,
performance measures
http://www.jointcommission.org
Journal of Gerontological Nursing http://www.jognonline.com
The Merck Manual Online http://www.merck.com
Geriatric Merck Manual http://www.merck.com/mmpe/sec22/
ch337
National Guideline Clearinghouse/
Agency for Healthcare Research
and Quality (AHRQ): evidence
based guidelines
http://www.guideline.gov
Registered Nurses Association of
Ontario Nursing Best Practice
Guidelines Project
www.rnao.org/bestpractices
Terra Nova Films: videos on
aging
http://www.terranova.org
US Department of Health and
Human Services
http://www.hhs.gov
U.S. Food and Drug Administration http://www.fda.gov
Curriculum Guides
Hartford Institute for Geriatric http://www.hartfordign.org/resources/
Nursing education/bsnPartners.html
Long-Term Care Nursing http://www.nursing.umn.edu/CGN/
Leadership and Management LTCNurseLeader
Teaching Gerontology Newsletter http://www.brookdale.org
Gerontology Centers/Education Centers
Andrus Gerontology Center http:/www.usc.edu/dept/gero
Brookdale Center on Aging http://brookdale.org
Gerontological Nursing http://www.nursing.uiowa.edu/centers/
Interventions Research Center gnirc
National Association of Geriatric
Education Centers
http://www.nagec.org
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Practicing Physicians Education in
Geriatrics: geriatric toolkits
http://www.gericareonline.net
Stanford Geriatric Education
Center Ethnogeriatric Education
http://sgec.stanford.edu
UAMS Reynolds Center on Aging http://centeronaging.uams.edu
University of Iowa Geriatric http://www.medicine.uiowa.edu/igec/
Education lecture series,
assessment tools, E-Learning
index.html
University of Iowa Geriatric Mental http://www.nursing.uiowa.edu/hartford/
Health Training Series nurse/training.htm
Wayne State University Institute of http://www.iog.wayne.edu/
Gerontology agingandhealthresources
Websites Retrieved July 19, 2007
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Abandonment, 59, 135, 525
Abbreviated comprehensive geriatric
assessment (aCGA), 618
Abdominal pain, 213
Absorption, of drugs, 205, 262, 450
Acamprosate (Campral), 666
ACE. See Acute-Care of the Elderly
ACEI. See Angiotensin-converting
enzyme inhibitors
Acetaminophen, 32, 206–207, 208, 265,
276, 286
Acetyl cholinesterase inhibitors, 90–92
aCGA. See Abbreviated comprehensive
geriatric assessment
Acid-base disorders, 64
Acidosis, 437
ACOVE. See Assessing Care of
Vulnerable Elders
Activities of daily living (ADL), 18, 24,
26, 619
ACDS-ADL inventory for dementia,
86
dementia and, 85
environment and, 92–93
feeding as, 338
in functional assessment, 25, 27,
86
impairment with, 84
Acute pain, 201
Acute sensory loss, 491–492
Acute-Care of the Elderly (ACE), 163
AD. See Advance directives; Alzheimer’s
disease
Adalat. See Nifedipine
ADCS-ADL. See Modified Alzheimer’s
Disease Cooperative
Study-Activities of Daily Living
Inventory
Addiction, 652
ADEs. See Adverse drug events
ADL. See Activities of daily living
ADR. See adverse drug reactions
Admissions, 47, 52
Adrenergics, 465
Advance directives (AD), 527, 539–560
assessment for, 558–559
benefit-burden, 548
communication about, 552
conflict mediation with, 551–552
cultural perspectives on, 549
decisional capacity, 524–527, 547
health care decision making for,
547–548
nursing care and, 550–551, 559–560
oral, 544
pain management and, 546
types of, 541–547, 558
Adverse drug events (ADEs), 224, 227,
258, 575. See also
and adherence, 260, 279
assessment to reduce, 261, 275–286,
296–298
changes in pharmacokinetics and,
275–277
changes in pharmacodynamicsa and,
262–264
epidemiology of, 295–296
high risk medications, 280–286
iatrogenic causes of, 259–261
reducing, 257–29
inappropriatie medications, 259,
265–270, 271–274, 276–277
interventions to reduce, 286–288,
298–300
medication history form, 279–280
and errors, 260
and reconciliation, 278
Adverse drug reactions (ADRs), 259
assessment for, 264, 276–277
drug-drug interactions, 275, 276–277
drug-disease interactions, 259,
271–274
over-the-counter interactions, 275
herbal remedies and interactions,
258, 261, 275–277
iatrogenic causes, 258, 259–260
interventions for prevention of, 278,
299–300 681
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African Americans, 528
depression in, 63
as family caregivers, 131
LSTs and, 549
potassium and, 607
pressure ulcers with, 408–411
Age-related changes See also in
critically ill; aging
cardiovascular system, 432–434
critical in ICU, 568–569
implications for. 447–453
in sleep, 461
pulmonary system, 434–436
renal and GU systems, 436–439
oropharyngeal and GI systems,
439–441
musculoskeletal system, 441–443
nervous system and cognition,
443–444
pharmacokinetics,
pharmacodynamics, 262–264
sensory 478–480
sexuality, 631–634
nursing assessment and strategies
for, 447–453
AGREE instrument
Aggression, 59, 88, 94, 207, 633
Aging
body system changes with, 568–569
dehydration and, 373
delirium and, 115
falls and, 170
health changes with, 431–453
hearing and, 488
sensory changes with, 477–499
skin and, 568, 577
sleep and, 461
Agitation
with dementia, 94
restraints for, 506, 511, 513
AGREE (Appraisal of Guidelines for
Research & Evaluation)
instrument, 2–4
AIDS, 634, 640
Alcohol, 440, 649–672
COPD and, 651
diabetes and, 651
falls and, 651
MI and, 651
OTC drugs and, 651
use disorders, 651–652
stroke and, 651
Alcohol Use Disorders Identification
Test (AUDIT), 656
Aldomet. See Methyldopa
Aldosterone antagonists, 607
Aleve. See Naproxen
Alpha-adrenergic blockers, 321
Alpha-blockers, 281
Alprazolam (Xanax), 266
Alzheimer’s disease (AD), 84
capacity and, 526
caregivers and, 131
depression with, 58
pain with, 203
REACH and, 145–147
tobacco and, 654
Ambulation, 24, 29, 312, 435, 512,
570
American Indians, 63
Amiodarone (Cordarone), 269, 276, 575
Amitriptyline (Elavil), 266
Amphetamines, 268, 271, 652
Analgesics, 210–218
Anaphylaxis, 235
Android. See Methyltestosterone
Andropause, 632
Anemia, 463
delirium and, 115
Anesthesia, 116, 224, 236, 374
Angioedema, 235
Angiotensin-converting enzyme
inhibitors (ACEI), 285, 599, 606,
607, 609
Angiotensin-receptor blockers (ARBs),
605, 610
Anhedonia, 59
Anorexia. See Malnutrition
Anosmia, 490
Antabuse, 658
Anti-arrhythmics, 167, 275
falls and, 170
Antibiotics, 95, 227, 267, 262, 436,
543
Anticholinergics, 284, 321
Anticoagulants, 181, 180, 268, 278
Anticonvulsants, 213, 465
Antidepressants. See also Tricyclic
antidepressants
falls and, 170
sexuality and, 633, 636
Antiemetics, 210
Antihistamines, 210
Antihypertensives, 281
sexuality and, 633, 636
Anti-inflammatory drugs, 92
Antipsychotics, 91
Anxiety, 621
of caregivers, 129
with depression, 58
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Aortic stenosis (AS), 598
Aphasia, 526
Apolipoprotein E, 62
Appraisal of Guidelines for Research &
Evaluation. See AGREE
instrument
ARBs. See Angiotensin-receptor
blockers
Aricept. See Donepezil hydrobromide
Aripiprazole, 91
Arrhythmias, 433, 571, 606
drugs and, 269
Arthritis, 200
falls and, 168
juvenile chronic, 204
osteoarthritis, 211, 213
rheumatoid, 204
Artificial hydration and nutrition, 543,
545–546
AS. See Aortic stenosis
Asian Americans
as caregivers, 131
LSTs and, 549
Asphyxiation, 168
Aspiration, 229, 235, 357, 570, 573, 574
Assessing Care of Vulnerable Elders
(ACOVE), 45
Assisted suicide, 528
Atarax. See Hydroxyzine
Atelectasis, 570
Ativan. See Lorazepam
AUDIT. See Alcohol Use Disorders
Identification Test
Auscultation, 571
Autonomy, 523
Avaprox. See Naproxen
Barbiturates, 265, 652
Barthel Index of Instrumental Activities
of Daily Living (IADLs), 27
Bed rails. See Side rails
Beers criteria, 259–260, 277–278
Behavioral assessment in demenia, 88
Belladonna alkaloids (Donnatal), 264
Benadryl. See Diphenhydramine
Benefit-burden analysis, 548
Benefits Improvement and Protection
Act (BIPA), 13
Benign prostatic hypertrophy (BPH),
284, 438
sexuality and, 633
Bentyl. See Dicyclomine
Benzodiazepines (BZDs), 92, 266, 280,
282, 465, 652, 654
falls and, 170
Beta blockers, 281, 571, 600, 605, 607
BIA. See Bioelectrical impedance
analysis
Biaxin, 276
Bioelectrical impedance analysis (BIA),
376
Biofeedback, 211
BIPA. See Benefits Improvement and
Protection Act
Bisacodyl (Dulcolax), 269
Bladder obstruction, 268
Blood pressure (BP), 145, 178, 190, 236,
601
Blood transfusions, 543
BMI. See Body mass index
Body mass index (BMI), 353, 433, 440
HF and, 605
BP. See Blood pressure
BPH. See Benign prostatic
hypertrophy
Braden Scale, 407, 419
Breast cancer, 616
Brown Bag Method, 261
Bundle branch blocks, 571
Buprenorphine, 658
Bupropion, 658
Burning mouth syndrome, 490
BZDs. See Benzodiazepines
CABSIs. See Catheter-associated blood
stream infections
CAD. See Coronary artery disease
Calcium, 439, 443. See also
Hypercalcemia
Calcium carbonate, 276
Calcium channel blockers, 317
CAM-ICU. See Confusion Assessment
Method-ICU
Campral. See Acamprosate
Cancer, 33
assessment of, 615–620
breast, 616
HF and, 605
Incidence and prevalence, 616
intervention for, 615–624
lung, 616
medical emergencies with,
620–623
pain and, 200
prostate, 616
screening for, 618
Canes, 185
Capacity. See Cognitive capacity
Carbohydrate deficient transferrin
(CDT), 654
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Cardiopulmonary resuscitation (CPR),
543, 545
Cardiotonics, 284
Cardiovascular disease (CVD), 596
Cardiovascular system, 432–434. See
also Heart
aging and, 569, 571–572
assessment of, 447–448
hydration and, 571
stress and, 571
Cardura. See Doxazosin
Caregiver Strain Index (CSI), 136
Caregivers, 617
anxiety of, 129
assessment of, 89–90, 133–137,
152–153
for dementia, 93
depression of, 65, 129
education of, 94
family as, 127–154, 567
health of, 129, 133, 136
imact on, 129
informal, 129, 150
interventions for, 137–145
negative outcomes with, 130–133
nursing care strategies, 147–148
preparedness of, 135, 147
psychotherapy for, 137–138
quality of care from, 135
rewards to, 136
self-care activities for, 136–137
Caregiving, 127–160
Risk factors for negative outcomes of,
130
Carisoprodol (Soma), 265
Cascade iatrogenesis, 226, 567
Catapres. See Clonidine
Cataracts, 170, 482, 483–484
Catheter-associated blood stream
infections (CABSIs), 228–229
Catheter-associated UTI (CAUTI), 117,
228–229, 232
CAUTI. See Catheter-associated UTI
CDT. See Carbohydrate deficient
transferrin; Clock Drawing Test
Celebrex, 208
Cellulitis, 404
Center for Epidemiological
Studies-Depression Scale
(CES-D), 136
Centers for Medicare and Medicaid
Services (CMS), 11, 165, 503
Central auditory processing disorder,
488
Central venous pressure (CVP), 570, 571
CES-D. See Center for Epidemiological
Studies-Depression Scale
CGA. See Comprehensive geriatric
assessment
CHD. See Coronary heart disease
Checklist for Nonverbal Pain Behaviors,
203
Chemosensation, 489
Chemotherapy, 620, 621
CHF. See Congestive heart failure
Chlordiazepoxide (Librium), 263
Chlordiazepoxide-amitriptyline
(Limbitrol), 265, 266
Chlorhexidine, 394
Chlorpheniramine (Chlor-Trimeton),
267
Chlorpropamide (Diabinese), 267
Chlor-Trimeton. See Chlorpheniramine
Chlorzoxazone (Paraflex), 265
Chronic obstructive pulmonary disease
(COPD), 600
alcohol and, 651
drugs and, 272
Chronic pain, 201
Cimetidine (Tagamet), 270, 277, 575
CINAHL. See Cumulative Index to
Nursing and Allied Health
Literature
Cipro, 276
Cisplatin, 621
Clarithromycin, 275, 276
Clidinium-chlordiazepoxide (Librax),
266
Clinical practice guidelines (CPGs), 1–7
Clock Drawing Test (CDT), 88, 99
Clonidine (Catapres), 270, 575
Clorazepate (Tranxene), 266
CMS. See Center for Medicare Services;
Centers for Medicare and
Medicaid Services
Cocaine, 653
Cochlear implants, 489
Cochrane Database of Systematic
Reviews, Cumulative Index to
Nursing and Allied Health
Literature (CINAHL), 144
Cockroft-Gault Formula, 261, 273, 436
Codeine, 209
Cognitive behavioral therapy, 145, 211
Cognitive functioning/capacity, 41–54,
523, 524–525, 535–536, 546
absence of, 527
Alzheimer’s disease and, 526
assessment of, 30, 41–54,87
clinical importance of, 526–527
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in dementia, 87–88
evaluation of, 87
functional decline in, 42
interventions with, 529–530
monitoring of, 45–46
screening for, 45–46, 54
Cognitive impairment, 567. See also
Delirium and Dementia
sexuality and, 633–634, 642–643
Colonic perforation, 236
Comiogenic illness. See Iatrogenesis
Competence, 524–525
assessment of, 546
Comprehensive geriatric assessment
(CGA), 617–620
Computed tomography (CT), 89
Computerized physician order entry
(CPOE), 231, 243
Concentration, 59
Confusion, 506
Confusion Assessment Method-ICU
(CAM-ICU), 573
Congestive heart failure (CHF), 226,
235, 236, 239, 284; See also Fluid
Overload, 596–611
assessment of HF, 598–601
fluid overload, assessment, 601
diagnosis of, 604–605
risk factors for HF, 596
pathophysiology of HF, 597
interventions, 605–610
Consent, 523–524
Constipation, 236, 370, 441, 573
drugs and, 274
Continuous positive airway pressure
(CPAP), 462
Contrast sensitivity, 482–483
COPD. See Chronic obstructive
pulmonary disease
Cordarone. See Amiodarone
Coronary artery disease (CAD), 567, 571
Coronary heart disease (CHD), 596, 598
sexuality and, 632–633
Corticosteroids, 621
Cotrimoxazole, 275
Coumadin. See Warfarin
COX-2 inhibitors. See Cyclooxygenase-2
inhibitors
CPAP. See Continuous positive airway
pressure
CPGs. See Clinical practice guidelines
CPOE. See Computerized physician
order entry
CPR. See Cardiopulmonary
resuscitation
CrCl. See Creatinine clearance
Creatinine clearance (CrCl), 261, 263,
371, 436, 449, 574
Creutzfeldt-Jacob disease, 84
Critically ill, 565–589
assessment of, 567–577, 582–585
cardiovascular system, 432, 569,
571–572
GI system and, 437–441, 568, 573–574
GU system, 436–439,68, 574–576
hematological system in, 576–577
immune system in, 576–577
interventions for, 567–577
nervous system and, 569, 572–573
nursing care for, 585–588
pain management for, 573, 201–219
pulmonary system in, 434–436, 568,
570–571
Cruzan, Nancy, 540
CSI. See Caregiver Strain Index
CT. See Computed tomography
Cumulative Index to Nursing and Allied
Health Literature (CINAHL),
6–7
CVD. See Cardiovascular disease
CVP. See Central venous pressure
Cyclandelate (Cyclospasmol), 268, 269
Cyclobenzaprine (Flexeril), 265
Cyclooxygenase-2 (COX-2) inhibitors,
208
Cyclophamide, 620
Cyclospasmol. See Cyclandelate
Cyproheptadine (Periactin), 267
DAFA. See Direct Assessment of
Functional Abilities
Dalmane. See Flurazepam
Darvocet, 210
Darvon. See Propoxyphene
Daypro. See Oxaprozin
Daytime sleepiness, 459
Decision-making authority, 524
Decision-making See also advance
directives, Cognitive capacity,
capacity
absence of capacity for, 527, 541
assessment of capacity, 524–527
capacity, 524–526, 547
durable poser of attorney for, 541–542
ethical principals and obligations for,
52
interventions regarding, 529–530
quality of life in, 529
surrogate, 541
Degenerative joint disease, 33
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Dehydration, 372, 376–377, 438, 576
dehydration risk appraisal checklist
(DRAC), 378
delirium and, 115
at EOL, 374, 375
risk factors for, 372–375
Dehydration Risk Appraisal Checklist
(DRAC), 377–378
Delegated autonomy, 523
Delirium, 43–44, 52
age and, 115
anemia and, 115
assessment of, 113–114, 120–121
causes of reversible cognitive
impairment, 86
comparison with dementia and
depression, 43
defined 112, 119
dehydration and, 115
features of, 44
drugs for, 114
hearing and, 115
with hip surgery, 112
during hospitalization, 227
infections and, 117
interventions and care strategies,
114, 121–122
pain and, 116
prevention of, 111–122, 566
reality orientation for, 117
restraints with, 117, 509, 511
risk factors for, 112, 120
treatment for, 111–122
vision and, 115
Dementia, 33, 43–44, 52, 83–103, 617.
See also Alzheimer’s disease,
Cognitive Impairment
ADL and, 85
advanced planning for, 95
aggression with, 94
agitation with, 94
assessment of, 85–90
cognitive, 87–88, 99
functional, 86, 100
behavioral assessment for, 88–89
behavior management, 91–92, 100
care strategies 101–102
caregiver assessment, 89, 100
caregivers 93, 94,144–145
clock-drawing test, 99
choking and, 95
comparison with delirium and
depression, 43
with Creutzfeldt-Jacob disease,
84
decision making and, 85
with depression, 58
drugs for, 90–92
environment and, 92–93
fatigue and, 95
feeding and, 340
with HIV, 84
infections and, 95
memory and, 85
Mini-Cog for, 88, 99
MMSE for, 87, 99
nutrition and, 95
pain and, 95, 205
pharmacological interventions,
90
physical exam with, 89
psychosis with, 91–92
reversible causes of, 86
shortness of breath and, 95
skin breakdown and, 95
TCAs and, 92
thyroid and, 89
UI and, 95
vehicular safety and, 92–93
wandering with, 94
Dementia with Lewy bodies (DLB), 84,
85
Demerol. See Meperidine
Dentures, 392–393
Depression, 43–44, 52, 57–77, 238, 604
with Alzheimer’s disease, 58
anxiety with, 58
appetite and, 59
assessment of, 66–68, 73, 78–80
care strategies, 80–81
of caregivers, 65, 129, 133
causes, 67, 69
comparison with delirium and
dementia
concentration and, 59
course of, 60
criteria for, 59
defined, 58
dementia with, 58
disability and, 60
drugs and, 69, 270
drugs for, 66–68
electroconvulsive therapy for, 67
falls and, 168
fatigue and, 59
genetics and, 62
guilt and, 59
with hip fractures, 63
hospitalization and, 60, 227
illnesses associated with, 64–65
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individualized interventions for,
70–71
major, 59
memory and, 58
minor, 59–60
in minorities, 63–66
pain and, 60
sexuality and, 633
sleep and, 59
suicidal ideation and, 58, 59
suicide and, 60–61
supportive social network and,
63
treatment for, 62, 69
unmarried status and, 62
weight and, 59
Desipramine, 209
Device removal prevention, 509–511,
513
Dexchlorpheniramine (Polaramine),
267
Diabetes, 463, 567, 572, 596–597
alcohol and, 651
HF and, 605
oral health and, 391
sexuality and, 633
Diabetic neuropathy, 491
Diabetic retinopathy, 484
Diabinese. See Chlorpropamide
Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV-TR),
58
Dialysis, 543, 566
Diazepam (Valium), 114, 266, 282,
575
Dicyclomine (Bentyl), 267
Digitalis, 606
Digoxin (Lanoxin), 267, 276, 275,
284–285, 575, 608
falls and, 170
Dilantin. See Phenytoin
Diltiazem, 276
Diphenhydramine (Benadryl), 267, 268,
284, 575
Diprivan. See Propofol
Dipyridamole (Persantine), 267
Direct Assessment of Functional
Abilities (DAFA), 27
Discharge, cognitive assessment during,
47, 53
Discomfort Scale, 203
Disopyramide (Norpace), 267
Distance vision, 482
Disulfiram, 666
Ditropan. See Oxybutynin
Diuretics, 276, 280, 284, 437, 606–607
falls and, 170
UI and, 607
DLB. See Dementia with Lewy bodies
DNR. See Do-Not-Resuscitate orders
Dobutamine, 572
Donepezil hydrobromide (Aricept),
90–92
Donnatal. See Belladonna alkaloids
Do-Not-Resuscitate (DNR) orders,
544–545, 566
Doral. See Quazepam
Dorsal kyphosis, 442
Doxazosin (Cardura), 269
Doxorubicin, 620
DPAHC. See Durable Power of Attorney
for Health Care
DRAC. See Dehydration Risk Appraisal
Checklist
Drug dependence, See also substance
misuse
Drug-disease interactions, 226, 258,
271–274
Drug-drug interactions, 226, 258, 275,
276
with OTC, 275
DRUGS tool. See Drugs Regimen
Unassisted Grading Scale
Drugs. See also ACE inhibitors;
Anti-arrhythmics; Antibiotics;
Anticholinergics; Anticoagulants;
Antidepressants; Antihistamines;
Antihypertensives;
Antipsychotics; Cardiotonics,
Nonsteroidal anti-inflammatory
drugs; Over-the-counter drugs;
Substance misuse
absorption of, 205, 262, 450
addiction to, 208
antipsychotics
benzodiazepines (BZDs)
cognitive assessment and, 47, 52
constipation and, 274
COPD and, 274
dehydration and, 370
for delirium, 114
for dementia, 90–92
dependency on, 208
for depression, 66–67
depression and, 273
distribution of, 262
elimination of, 263
errors with, 12
falls and, 168
HF and, 271
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Drugs (cont.)
herbal remedies, 275–277
with high risks, 280–286
history of, 279–280
HTN and, 271
metabolism of, 262–263, 574
obesity and, 273
for pain, 204–212
pharmacodynamics, 205, 262
pharmacokinetics, 262
psychoactive, 282–282
seizures and, 271
self-administration of, 260–261,
277–278
SSRI (selective serotonin reuptake
inhibitors), 69–70, 283
stress and, 269
tolerance for, 208
training about, 30
Drugs Regimen Unassisted Grading
Scale (DRUGS), 261
DSM-IV-TR. See Diagnostic and
Statistical Manual of Mental
Disorders
Dulcolax. See Bisacodyl
Durable Power of Attorney for Health
Care (DPAHC), 541–542
Dysnomia, 526
Dysphagia, 440
Dysthymic depression, 60
EAI. See Elder Assessment Instrument
EBP. See Evidence-based practice
Edecrin. See Ethacrynic acid
Edema, 602
EdFED-Q test, 338
Elavil. See Amitriptyline
Elder Assessment Instrument (EAI),
135
Electrical stimulation (ES), 211
Electroconvulsive therapy, 67
Electronic medical record (EMR), 243
Emergency medical services (EMS), 545
EMR. See Electronic medical record
EMS. See Emergency medical services
End-of-life (EOL), 374, 375
treatment at, 528–529
End-of-Life Care Toolkit, 136
End-stage renal disease (ESRD), 18
EOL. See End-of-life
Epilepsy, 271
Epworth sleepiness scale, 464, 465
Equanil. See Meprobamate
Equianalgesia, 209
Erectile dysfunction, 632
Ergot mesylids (Hydergine), 268
Erythromycin, 276
ES. See Electrical stimulation
Esophagus, 439
ESRD. See End-stage renal disease
Estrogen, 92, 270
sexuality and, 631
Ethacrynic acid (Edecrin), 270
Ethnicity. See Minorities
Etoposide, 621
Evidence-based practice (EBP), 2
implementation of, 9
Evidence, levels of, 4, 5
search strategies for, 6
Excessive sleepiness, 459–474
assessment of, 465–466, 472–473
causes, 462–465
consequences of, 461
definition, 472
interventions for, 466–468
nursing care for, 473
physiological changes in sleep, 461
severity of, 467
tools for assessment, 464, 466, 467
Exelon. See Rivastigmine tartrate
Exercise, 92
for caregivers, 145
fall prevention and, 187
HF and, 596
for pain management, 210
Faces scale, 202
Fagerstrom Test for Nicotine
Dependence (FTND), 656
Falls, 193–194, 442, 514, 617
in acute care, 165–168
alcohol and, 651
assessment of, 173–180, 190–191
causes of, 173
contributors to, 170–171
definition of, 164–165, 189
dehydration and, 370
drugs and, 273
early mobility after, 182–183
during hospitalization, 227
insomnia and, 463
interventions for prevention, 180–184
nursing care strategies, 184–185,
191–193
prevention of, 161–194, 514, 566
exercise and, 181
interventions for, 180–187, 512
programs for, 162–164, 183
post fall assessment, 176–189
reducing risk of, 512
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restraints and, 168, 512–514
risk factors for, 164, 166–167, 190
substance misuse and, 653
tools for assessment of, 174–175
wheelchairs and, 168
Family caregivers, 127–154, 567
African Americans as, 131
Hispanic Americans as, 131
Family caregiving activities, 129,
150
Family consent laws, 542
FAQ. See Functional Activities
Questionnaire
Fecal incontinence, 440
Feeding. See Nutrition
Feldene. See Piroxicam
Female sexual arousal disorder (FSAD),
632, 641
Ferrous sulfate, 268
FIM. See Functional Independence
Measure
Finger-rubbing test, 487
Five Wishes document, 543
Flexeril. See Cyclobenzaprine
Fluconazole, 276
Fludarabine, 621
Fluid overload, 595–611, See also
congestive heart failure
assessment of patient with, 601–604
BP and, 601
diagnosis of, 604–605
interventions 605–610
Fluoxetine (Prozac), 269, 283
Flurazepam (Dalmane), 265
Folic acid, 439
Fowler’s position, 603
Frontotemporal dementia, 84
FSAD. See Female sexual arousal
disorder
FTND. See Fagerstrom Test for Nicotine
Dependence
Functional Activities Questionnaire
(FAQ), 86
Functional assessment, 23–38
in acute care, 33–38
of ambulation, 29
of cognitive capacity, 30, 41–50
for dementia, 86
direct assessment, 28–31
of functional decline, 30–31
instruments for, 26–28
parameters for, 33–34
from patient, 28
QOL and, 24
of sensory capacity, 29–30
Functional decline, prevention of, 31
interventions for 31
care strategies for 35–37
strategis for coping with, 36
Functional Independence Measure
(FIM), 27
Functional Outcomes of Sleep
Questionnaire, 465
Gabapentin, 209
Galantamine hydrobromide (Reminyl),
90–92
Gallstones, 440
Gamma glutamyltransferase (GGT),
654
Gastritis, 573
Gastroesophageal reflux disease
(GERD), 439
Gastrointestinal (GI) system, 439–441
aging and, 568, 573–574
assessment of, 450–451
nursing care for, 451
Gastrostomy tubes, 395
Gay or lesbian, bisexual, and
transgender (GLBT), 631
G-CSFs. See Granulocyte-colony-
stimulating factors
GDS. See Geriatric Depression Scale
GDS-SF. See Geriatric Depression
Scale—Short Form
Genitourinary (GU) system, 436–439.
See also Urinary
aging and, 568, 574–576
assessment of, 449
nursing care for, 449–450
GERD. See Gastroesophageal reflux
disease
Geriatric Depression Scale (GDS), 17,
89, 618
falls and, 179
Geriatric Depression Scale—Short Form
(GDS-SF), 66–67
Get Up and Go test, 29, 619
falls and, 174
GFR. See Glomerular filtration rate
GGT. See Gamma glutamyltransferase
GI. See Gastrointestinal system
Glaucoma, 483, 484
GLBT. See Gay or lesbian, bisexual, and
transgender
Glomerular filtration rate (GFR), 436,
574
Glucose intolerance, 574
Glyburide, 275, 276
Gout, 200
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Granulocyte-colony-stimulating factors
(G-CSFs), 623
GU. See Genitourinary system
Guanadrel (Hylorel), 269
Guanethidine (Ismelin), 269
Guilt, 59
Gums, 393
HAI. See Health care-acquired injuries
HAIs. See Hospital-acquired infections
Halazepam (Paxipam), 263
Halcion. See Triazolam
Haldol, 91
Hallucinations, 44, 75, 85, 88, 113, 621
auditory, 155
Haloperidol, 114
Hand washing, 231
HAP. See Hospital-acquired pneumonia
HBBS. See Healthy bladder behavior
skills
Health care decision making, 521–537
for advance directives, 547–548
assessment of, 524–529
authority for, 524
dementia and, 85
ethics of, 522
QOL and, 529
Health care-acquired injuries (HAI),
227–233
Health-related quality of life (HRQOL),
310
Healthy bladder behavior skills (HBBS),
320–322
Hearing, 30, 478, 486–489
aging and, 488
delirium and, 116
nursing care for, 478
Hearing aids, 117, 489
Hearing Handicap for the
Elderly-Screen (HHIE-S), 486
Heart failure (HF), 33, 437, 595–611,
605–610 See also fluid overload
andcongestive hart failure
assessment of, 598–605
BMI and, 605
cancer and, 605
diabetes and, 605
DM and, 596–597
drugs and, 271
hypertension and, 605
interventions for, 605–610
laboratory studies for, 604–605
pathophysiology of, 597–598
risk factors for, 596–597
warning signs of, 608
Hematological system, 576–577
Heroin, 653
HF. See Heart failure
HHIE-S. See Hearing Handicap for the
Elderly-Screen
High-Risk Diagnoses for the Elderly
Scale, 235
Hip fractures
depression with, 63
from falls, 166
osteoporosis and, 170–171
pressure ulcers with, 404
Hip protectors, 184–185
Hip surgery, delirium with, 112
Hispanic Americans
as family caregivers, 131
LSTs and, 549
HIV, 84, 634, 640
Holter monitoring, 605
Hopemount Capacity Assessment
Interview, 525
Hospital-acquired infections (HAIs),
224, 227–233
Hospital-acquired pneumonia (HAP),
229
HRQOL. See Health-related quality of
life
HTN. See Hypertension
Humphrey Visual Field Test, 483
Hydergine. See Ergot mesylids
Hydralazine, 608
Hydration, Oral 92, 433, 435. See also
Dehydration
artificial, 543, 545–546
assessment of, 375–377, 384–385
at end of life, 375
cardiovascular system and, 571
dehydration risk factors, 372,
384
dehydration risk appraisal checklist
(DRAC), 378
evaluation of, 381, 384
in institutionalized, 373
lab tests, 377, 381
management of, 379–386
nursing care for, 385–386
in specialized populations, 374
Hydroxyzine (Vistaril, Atarax),
267
Hylorel. See Guanadrel
Hyoscyamine (Levsin), 266
Hypercalcemia in cancer, 621
Hyperkalemia, 607, 621–622
Hypernatremia, 437
Hyperphosphatemia, 621
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Hypertension (HTN), 281, 567, 596, 598
drugs and, 271
HF and, 605
Hypertensive retinopathy, 484
Hypertrophic cardiomyopathy, 598
Hyperuricemia, 621–622
Hypoactive sexual desire disorder,
632
Hypoglycemia, 279, 607
Hypokalemia, 236, 607
Hyponatremia, 437
Hyposmia, 490
Hypotension, 433, 607
Hypovolemia, 571
Hypoxemia, 117
IADL. See Instrumental activities of
daily living
Iatrogenesis, 223–244
ADEs and, 227–228
assessment for, 227–233
attitudes and beliefs causing, 238
cascade, 226, 567
geriatric syndromes and, 234–236
hospital-acquired infections, 227–233
medical error and, 239
national and organizational priorities
for, 240–244
from procedures, 235–237
Immediate post-fall assessment (PFA),
178–179
Immune system, 569
aging and, 576–577
Implantable defibrillator, 605, 606
Individualized Sensory Enhancement of
the Elderly (I-SEE), 493
Indocin. See Indomethacin
Indomethacin (Indocin), 265
Infections. See also Urinary tract
infections
CABSIs, 228–229
dehydration and, 370
delirium and, 117
dementia and, 95
hospital-acquired (HAIs), 224,
227–233
of mouth, 393
prevention of, 566
risk for, 226
Informant Questionnaire on Cognitive
Decline in the Elderly (IQCDE),
47, 52
Informed consent. See Consent
Insomnia, 272, 462–463
Institute of Medicine (IOM), 11, 260
Instrumental activities of daily living
(IADL), 18, 27, 619
See Barthel Index of IADLs, 27
functional assessment in, 24
Instrumental directives, 543
Insulin, 574
Intensive care units (ICU), 112, 225, 231,
233, 510–511, 565. See also
Critically ill
Interferon alpha, 621
Intrathecal methotrexate, 621
IOM. See Institute of Medicine
IQCDE. See Informant Questionnaire on
Cognitive Decline in the Elderly
Iron supplements, 465
I-SEE. See Individualized Sensory
Enhancement of the Elderly
Ismelin. See Guanethidine
Isoproterenol, 572
Isosorbide, 608
isoxsupine (Vasodilan), 266
JCAHO. See Joint Commission on
Accreditation of Healthcare
Organizations
Joint Commission on Accreditation of
Healthcare Organizations
(JCAHO), standards
JCAHO Standards and falls, 161–162
JCAHO Standards and medications,
263, 287, 552
JCAHO Standards and pain, 200
JCAHO Standards for reducing
restraint and side rail use, 504
Juvenile chronic arthritis, pain with, 204
KAT. See Khavari Alcohol Test
Katz Index of Independence in
Activities of Living, 26–27
“Keeping Patients Safe: Transforming
the Work Environment of
Nurses,” 241
Ketorolac (Toradol), 216, 268, 575
Khavari Alcohol Test (KAT), 655–656
Kussmaul’s respirations, 437
Lanoxin. See Digoxin
Large intestine, 439
Laxatives, 209, 269, 275, 291, 440
Left ventricular ejection fraction
(LVEF), 605
Left ventricular hypertrophy (LVH),
571, 596
Levothyroxine, 276
Levsin. See Hyoscyamine
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LFTs. See Liver-function tests
Librax. See Clidinium-chlordiazepoxide
Librium. See Chlordiazepoxide
Life-sustaining treatments (LSTs), 548
ethnicity and, 549
Limbitrol. See Chlordiazepoxide-
amitriptyline
Lithium, 282, 463
Liver-function tests (LFTs), 654
Living will (LW), 540, 542–544
LLLT. See Low-level laser therapy
Lorazepam (Ativan), 92, 266, 282
Low-level laser therapy (LLLT), 216–217
LSTs. See Life-sustaining treatments
Lung cancer, 616
LVEF. See Left ventricular ejection
fraction
LVH. See Left ventricular hypertrophy
LW. See Living will
MacArthur Competence Assessment
Tool, 525
Macrodantin. See Nitrofurantoin
Macular degeneration, 484
Magnetic resonance imaging (MRI), 89
Male Urinary Distress Inventory
(MUDI), 318
Malnutrition, 227, 573
drugs and, 270
oral health and, 391
Marijuana, 653, 654
MAST-G. See Michigan Alcohol
Screening Test-Geriatric Version
Masturbation, 634, 639
Mealtime difficulties, 337–348 See also
Nutrition
assessment for, 338, 346
causes of, 345
and cognitive impairment, 340
EdFed-Q, 339
Environement and, 341
feeding assistance, 341
interventions for 346–347
MNA see mini-nutritional
assessment
Mechanical ventilation, 566, 570–571
restraints and, 509–510
Medical errors. See Iatrogenesis
Medicare Modernization Act (MMA), 13
Medication(s). See Drugs
Adherence, 260, 279
anticholinergics, 284
antihypertensives, 281
assessment and management,
286–289, 297–300
assessment tools, 261, 296–297
complete history, 279
errors, 260
and delirium, 112, 114
and falls, 166, 170
high risk, 280–286, (ADE pg)
high risk in ICU, 575
history collection, 279
inappropriate use in older adults, 259
over-the-counter, 275, 285
psychoactive drugs, 282
reconcillation, 278
warfarin, 280
Meditation, 145
Medication errors, 14, 16, 258–260
Medline, 6
Mellaril. See Thioridazine
Memantine (Namenda), 90
Memory, 41, 58, 85
Meniere’s disease, 488
Menopause, 631
Mental status. See Cognitive capacity,
MMSE, MiniCog
Exam/Evaluation, 87
Meperidine (Demerol), 210, 268, 575
Meprobamate (Miltown, Equanil), 266
Mesoridazine (Serentil), 270
Metaxalone (Skelaxin), 266
Metformin, 609
Methicillin-resistant streptococcal
aureus (MRSA), 230
Methocarbamol (Robaxin), 266
Methyldopa (Aldomet), 267
Methyltestosterone (Android, Virilon,
Testrad), 270
Metronidazole, 276
MI. See Myocardial infarction
Michigan Alcohol Screening
Test-Geriatric Version (MAST-G),
656
MID. See Multi-infarct dementia
Miltown. See Meprobamate
Mini-Cog, 46, 52, 88
Mini-Mental State Examination
(MMSE), 45–46, 52, 87, 618
cognitive capacity and, 525, 547
for dementia, 87–88
Mini-Nutritional Assessment (MNA),
338, 355–356
Minor depressive disorder, 66
Minorities. See also African Americans;
American Indians; Asian
Americans; Hispanic Americans
depression in, 63–66
MMA. See Medicare Modernization Act
Index 693
MMSE. See Mini-Mental State
Examination
MNA. See Mini-Nutritional Assessment
Modified Alzheimer’s Disease
Cooperative Study-Activities of
Daily Living Inventory
(ADCS-ADL), 86
Morphine, 209, 608
MRI. See Magnetic resonance imaging
MRSA. See Methicillin-resistant
streptococcal aureus
MUDI. See Male Urinary Distress
Inventory
Multi-infarct dementia (MID), 84
Multivariable Apnea Prediction Index,
465
Muscle relaxants, 265
Musculoskeletal system, 441–443
nursing care for, 451–452
Mutuality, 135
Myocardial infarction (MI), 572, 596
alcohol and, 651
warning signs of, 608
Naltrexone (Revia, Vivitrex), 658,
670
Namenda. See Memantine
Naprosyn. See Naproxen
Naproxen (Naprosyn, Avaprox, Aleve),
269
National Cancer Institute Surveillance,
Epidemiology and End Results
Program (SEER), 615
National Database of Nursing Quality
Indicators (NDNQI), 16, 165
National Nosocomial Infections
Surveillance (NNIS), 232
National Patient Safety Goals (NPSG),
161
Natural Death Act, 545
NDNQI. See National Database of
Nursing Quality Indicators
Nervous system, 443–445
aging and, 569, 572–573
assessment of, 442
nursing care for, 452–453
Neuropathic pain, 201
Neuropsychiatric Inventory (NPI),
88–89
Neutropenic fever in cancer, 622–623
NICHE. See Nurses Improving Care for
Healthsystem Elders
Nicorette, 658
Nicotine. See Tobacco
Nifedipine (Procardia, Adalat), 270
Nitrofurantoin (Macrodantin), 269
NNIS. See National Nosocomial
Infections Surveillance
NOC WATCH, 184
Nociceptive pain, 201
Nocturnal myoclonus, 463
Nonsteroidal anti-inflammatory drugs
(NSAIDs), 206, 269, 276, 280
NOPPAIN scale, 203
Norflex. See Orphenadrine
Norpace. See Disopyramide
Nortriptyline, 209
NPI. See Neuropsychiatric Inventory
NPSG. See National Patient Safety Goals
NSAIDs. See Nonsteroidal
anti-inflammatory drugs
Nurses Improving Care for
Healthsystem Elders (NICHE),
10
for fall prevention, 163
Nursing: Scope and Standards of Practice
(ANA), 2
Nutrition, 92, 353–366. See also
Malnutrition, Mealtime
Difficulties, 337
appetite and, 59
artificial, 543, 545–546
assessment of, 355–356, 361–362
assistance with, 341
dementia and, 95
etiology, 360
follow-up monitoring, 365
interventions for, 356
mealtime difficulties with, 337–348
nursing care strategies/interventions,
357, 362–364
pressure ulcers and, 412–413
OARS. See Older Americans Resource
and Services-IADL
Obesity, 340–341
depression and, 59
drugs and, 276
HF and, 596
Obstructive sleep apnea (OSA), 460,
462
OHAT. See Oral Health Assessment Tool
Olanzapine, 91, 114, 283
Older Americans Resource and
Services-IADL scale (OARS), 27
Opiod dependence, 662
Opioids, 208, 209, 465, 652, 654, 658
Oral advance directives, 544
Oral Health Assessment Tool (OHAT),
393
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Oral health care, 391–400
assessment of, 392–393, 399
interventions and care strategies,
393–395, 399–400
Oral nutritional supplementation, 357
Organ donation, 542
Orgasmic disorder, 632
Oropharyngeal system, 439–441
assessment of, 450–451
nursing care for, 451
Orphenadrine (Norflex), 269
Orthopnea, 599
OSA. See Obstructive sleep apnea
Osteoarthritis, 204, 211
Osteomyelitis, 404
Osteoporosis, 439, 442, 443
hip fractures and, 170–171
OTC. See Over-the-counter drugs
Over-the-counter (OTC) drugs, 258,
285–286, 600
alcohol and, 651
interactions with, 275
Oxaprozin (Daypro), 269
Oxazepam (Serax), 92, 266
Oxybutynin (Ditropan), 265, 284
Oxycontin, 671
Oxygen, 600
Paclitaxel, 621
Pain, 617
abdominal, 213
acute, 201
with AD, 203
assessment of, 201–204, 215–216
cancer and, 200
chronic, 201
definitions of, 200, 205
delirium and, 116
dementia and, 95, 211
depression and, 62
drugs for, 204–212
inappropriate medications for, 265,
271, 276
management of, 199–219
advance directives and, 546
for critically ill, 573
nonpharmacological, 216–218
outcomes with, 216–217
pharmacological, 210–218
neuropathic, 201
nociceptive, 201
observed indicators for, 203–204
persistent, 201
phantom-limb, 491
QOL and, 200
with rheumatoid arthritis, 204
self-reported, 202–203
sexual pain disorder, 632
treatment for, 217–218
types of, 201
Pancreas, 439–440
Paraflex. See Chlorzoxazone
Parkinson’s disease (PD), 33, 463
caregivers for, 144–145
dementia with, 84
drugs and, 272
falls and, 168
sexuality and, 633
Parosmia, 490
PATIENT SAFE, 243
Patient safety indicators (PSI), 166
Patient Self Determination Act (PSDA),
540
Paxipam. See Halazepam
PCGS. See Preparedness for Caregiving
Scale
PD. See Parkinson’s disease
PDSA. See Plan-Do-Study-Act
Pelli-Robson Contrast Sensitivity Chart,
483
Pelvic-floor muscle exercises (PFMEs),
320–322
Pemphigus vulgaris, 393
Pentazocine (Talwin), 210, 265
Performance measurement, 9–20
of clinical outcomes, 13
indicators for, 15–19
performance improvement, 19
publicly reported quality measures,
13
quality assessment in, 19–20
quality of care and, 11–12
risk-adjusted, 18
selection of quality indicators, 15–19
Periactin. See Cyproheptadine
Peripheral neuropathy, 491
Peripheral sensation, 480, 491–493, 497
Peripheral vascular disease (PVD), 596
Perphenazine-amitriptyline (Triavil),
265
Persantine. See Dipyridamole
Persistent vegetative state, 542
Personal alarms, 190
PFA. See Post-fall assessment
PFMEs. See Pelvic-floor muscle
exercises
Phantom-limb pain, 491
Phantosmia, 490
Pharmacotherapy. See Drugs
Pharmokinetics, 262–263
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Phenergan. See Promethazine
Phenobarbital, 268
Phenytoin (Dilantin), 277
Physical Performance Test Battery, 618
Physical restraints. See Restraints
Physician Order for Life Sustaining
Treatment (POLST), 543
PICO. See Population, intervention,
comparison, and outcome
Piroxicam (Feldene), 269
Plan-Do-Study-Act (PDSA), 10
Plaque, 392
PLISSIT model, 634–635
PLST. See Progressively Lowered Stress
Threshold
Pneumonia, 570
HAP, 229
oral health and, 391
VAP, 231, 570
Polaramine. See Dexchlorpheniramine
POLST. See Physician Order for Life
Sustaining Treatment
Population, intervention, comparison,
and outcome (PICO), 4
Post-fall assessment (PFA), 174–180
immediate, 178–179
Potassium, 437, 600, 607
African Americans and, 607
Power of attorney. See Durable Power of
Attorney for Health Care
PPI. See Proton pump inhibitor
Preparedness for Caregiving Scale
(PCGS), 135
Presbycusis, 478–480
Presbyopia, 478
Pressure ulcers, 236
assessment for, 405–408, 419
definition of, 409–410
with hip fractures, 404
during hospitalization, 227
interventions for prevention,
411–413, 419–421
NPUAP nursing competencies for
prevention, 406
nutrition and, 412–413
prevention of, 403–424
race and, 408
risk assessment for, 405–408
tools for risk assessment of, 407
Prevention of Falls Network Europe
(ProFaNE), 165
Pro-Banthine. See Propantheline
Procardia. See Nifedipine
ProFaNE. See Prevention of Falls
Network Europe
Progressively Lowered Stress Threshold
(PLST), 94
Promethazine (Phenergan), 267, 575
Propantheline (Pro-Banthine), 266
Propofol (Diprivan), 575
Propoxyphene (Darvon), 210, 266
Proprioception, 492
Prostate cancer, 616
Proton pump inhibitor (PPI), 209
Proxy appointments, 540
Prozac. See Fluoxetine
PSDA. See Patient Self Determination
Act
Pseudohypertension, 601
PSI. See Patient safety indicators
Psychoactive drugs, 282–284
Psychosis
with dementia, 91–92
with depression, 58, 67
PsycINFO, 6
PubMed, 6
Pulmonary artery occlusion pressure
(PAOP), 570, 571
Pulmonary system, 434–436
aging and, 568, 570–571
assessment of, 448
nursing care for, 448–449
Pure tone audiometry, 487
PVD. See Peripheral vascular disease
QOL. See Quality-of-life
Quality of care
challenges with, 14–15
defined, 11–12
for individuals, 11
performance measures of, 14
for populations, 11
quality indicators, 13
Quality-of-life (QOL), 566
functional assessment and, 24
health care decision making and,
529
HRQOL, 310
pain and, 200
Quazepam (Doral), 263
Quetiapine, 91
Radiation therapy, 621
Ranitidine (Zantac), 575
RASS. See Richmond Agitation and
Sedation Scale
REACH. See Resources for Enhancing
Alzheimer’s Caregiver Health
Reality orientation, 93
for delirium, 117
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Reconciliation, of medication, 286
Recreational therapy, 93
Reliability and validity, 17
Refusal of care/treatment, 523–524
Reminyl. See Galantamine
hydrobromide
Renal system, 436–439
assessment of, 449
nursing care for, 449–450
Repetitive verbalization, 59
Reserpine, 266
Resources for Enhancing Alzheimer’s
Caregiver Health (REACH),
145–147
Respiratory system. See Pulmonary
system
Respite care, 137
Restless legs syndrome, 463–465
Restoril. See Temazepam
Restraints, 503–516
alternatives to, 512–515
for agitation, 506, 511, 513
asphyxiation from, 168
with delirium, 117, 509, 511
ethics of, 507–508
falls and, 4–5, 168, 190, 506
legal issues of, 504–505
mechanical ventilation and, 509–510
reducing fall risk, 512
sedatives and, 510–511
setting specific use of, 508–511
standards of care, 505–507
for wandering, 506
Revia. See Naltrexone
Rheumatoid arthritis, 463
pain with, 204
Richmond Agitation and Sedation Scale
(RASS), 573
Risperidone, 91, 114, 284
Rituximab, 621
Rivastigmine tartrate (Exelon), 90
Robaxin. See Methocarbamol
Sarcopenia, 441
Sedatives, 210, 321
falls and, 170
restraints and, 510–511
SEER. See National Cancer Institute
Surveillance, Epidemiology and
End Results Program
Seizures, 437, 621
drugs and, 271
Selective serotonin reuptake inhibitors
(SSRI), 69, 282, 463, 633
SELFCARE(D), 66
Self-reported pain, 202–203
Semmes-Weinstein monofilament test,
492
Senile miosis, 170
Sensorineural hearing loss, 488
Sensory capacity, 29–30
Sensory changes, 495
assessment and management of,
481–492
common in aging, 477–499
epidemiology of impairment, 480
implications of impairment in, 485,
488, 491, 492
Sensitivity and Specificity, 17
Sepsis, 404
Serax. See Oxazepam
Serentil. See Mesoridazine
Serotonin syndrome, 282
Serotonin-norepinephrine reuptake
inhibitors (SNRIs), 70
Serum folate, 69
Sexual arousal disorder, 632
Sexual pain disorder, 632
Sexual response cycle, 631
Sexuality, 629–645
aging changes, 631
antidepressants and, 633, 636
antihypertensives and, 633, 636
assessment for, 634–636, 643
BPH and, 633
CHD and, 632–633
cognitive impairment and, 633–634,
639
depression and, 633
diabetes and, 633
estrogen and, 631
nursing care for, 638, 636–639
PD and, 633
PLISSIT model for, 634–635
stroke and, 633
views about, 630
Sexually transmitted diseases, 636
Sheepskin mattresses, 412
Shoes, falls and, 168, 514
Shortness of breath, 177, 379, 572, 599
dementia and, 95
Sick sinus syndrome, 571
Side rails, 515–516
falls and, 168
Sildenafil citrate (Viagra), 644
6-Minute Walk, 618
Skelaxin. See Metaxalone
Skin
aging and, 568, 577
breakdown of
Index 697
dementia and, 95
from UI, 323
Skin tears
assessment of, 413–414, 422
interventions for, 414, 423–424
nursing care for, 423–424
prevention of, 423–424
Sleep, 92. See also Excessive sleepiness;
Obstructive sleep apnea
aging and, 461
depression and, 59
Smell, 480, 489–492, 573
nursing care for, 497
SMIs. See Sustained maximal
inspiration devices
Smoking. See Tobacco
SNRIs. See Serotonin-norepinephrine
reuptake inhibitors
Social workers (SWs), 550
Sodium, 437, 574, 600, 606
Soma. See Carisoprodol
Spinal cord compression, 622
Spondylosis, 442
SSIs. See Surgical-site infections
SSRI. See Selective serotonin reuptake
inhibitors
St. John’s Wort, 283
Stenosis, 442
Stool softeners, 209
Stress
cardiovascular system and,
571
with caregivers, 133
drugs and, 269
UI and, 312
Stroke
alcohol and, 651
caregivers for, 144–145
dehydration and, 374
pseudohypertension and, 601
sexuality and, 633
Subclinical depression, 61
Substance misuse, 649–672
assessment of, 651–654, 666–668
definitions, 657
falls and, 653
nursing care for, 668–671
relapse prevention, 671
risk factors, 666
screening for, 655–656
withdrawal, 660
Subsyndromal depression, 60
Suicidal ideation
with depression, 58
depression and, 59
Suicide, 60–61
assisted, 528
Supported autonomy, 523
Supportive social network, 64
Surgical-site infections (SSIs), 229–230
Sustained maximal inspiration devices
(SMIs), 435–436
SWs. See Social workers
Syncope, 164, 188, 235, 273, 607
Tachycardia, 598
Tacrine. See Tacrine hydrochloride
Tacrine hydrochloride (Tacrine), 90–92
Tagamet. See Cimetidine
Talwin. See Pentazocine
Tamoxifen, 621
Taste, 480, 489–492, 573
nursing care for, 498
TBI. See Traumatic brain injury
TBW. See Total body water
TCAB. See Transforming Care at the
Bedside
TCAs. See Tricyclic antidepressants
Teeth. See Oral health care
Temazepam (Restoril), 263
Temporal arteritis, 484
TENS. See Transcutaneous electrical
nerve stimulation
Testosterone, 632
Testrad. See Methyltestosterone
Theophylline, 277
Thiazolidinediones (TZDs), 609
Thioridazine (Mellaril), 272
Thyroid, 67, 89
Ticlid. See Ticlopidine
Ticlopidine (Ticlid), 268
Tigan. See Trimethobenzamide
Tinnitus, 488
TLS. See Tumor Lysis Syndrome
To Err Is Human, 240
Tobacco, 440, 652, 654
Alzheimer’s disease and, 654
HF and, 596
Toileting, 2, 24, 28, 33, 169, 184,
319
rounds for, 189–190
for UI, 320
Toothbrush, 393–394
Toradol. See Ketorolac
Total body water (TBW), 376
Tramadol (Ultram, Ultracet), 209
Transcutaneous electrical nerve
stimulation (TENS), 210–211
Transforming Care at the Bedside
(TCAB), 239
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Transient urinary incontinence, 312,
319–320
Tranxene. See Clorazepate
Traumatic brain injury (TBI), 171
Triavil. See Perphenazine-amitriptyline
Triazolam (Halcion), 263
Tricyclic antidepressants (TCAs), 69,
209, 282, 317, 463
dementia and, 92
Trimethobenzamide (Tigan), 262
Tumor Lysis Syndrome (TLS), 621–622
Tuning fork tests, 487
TZDs. See Thiazolidinediones
UDI-6. See Urinary Distress Inventory-6
UI. See Urinary incontinence
Ultracet. See Tramadol
Ultram. See Tramadol
Unmarried status, 666
Uremia, 463
Urge UI, 312–313
Urinary Distress Inventory-6 (UDI-6),
314
Urinary incontinence (UI), 309–326, 313,
438, 617
assessment of, 313, 317–319, 328
dementia and, 95
diuretics and, 607
etiologies of, 311–313
during hospitalization, 227
history-taking for, 314
nursing care strategies and
interventions 319, 328–330
prevention of, 566
risk factors for, 319–320
types of, 313, 327
Urinary tract infections (UTI), 117, 226,
228–229, 232, 310, 318–319,
438
Urticaria, 235
UTI. See Urinary tract infections
Vaccinations, 92
VaD. See Vascular dementia
Validation therapy, 93
Validity and reliability, 17
Valium. See Diazepam
Valsalva maneuver, 317–318
Vancomycin, 230, 233
VAP. See Ventilator-associated
pneumonia
VAS. See Visual analog scale
Vascular dementia (VaD), 84
Vasodilan. See isoxsupine
Vasodilators, 608
Vehicular safety, dementia and, 92–93
Venous thrombotic embolism (VTE),
236
Ventilator-associated pneumonia (VAP),
231, 570
Verapamil, 272
Verbal descriptor scale, 202
Viagra. See Sildenafil citrate
Vibratory sense, 492
Virilon. See Methyltestosterone
Viropause, 632
Vision, 30, 478, 480–485
delirium and, 115
falls and, 168, 170
nursing care for, 484–485, 496
Vistaril. See Hydroxyzine
Visual analog scale (VAS), 202
Vitamin B12, 67, 89, 92, 439
Vitamin D, 439
Vitamin E, 92
Vivitrex. See Naltrexone
Volume depletion, 372
VTE. See Venous thrombotic embolism
Walkers, 188
Wandering
with dementia, 94
restraints for, 506
Warfarin (Coumadin), 272, 281
metabolism of, 574
Water intoxication, 437
Weight. See Obesity
Wheelchairs, 168
Whisper test, 486–487
White-coat hypertension, 602
Xanax. See Alprazolam
Xanthines, 463
Xerostomia, 490–491
Yoga, 145
Zantac. See Ranitidine
